PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Enquist-Newman, M; Faust, AME; Bravo, DD; Santos, CNS; Raisner, RM; Hanel, A; Sarvabhowman, P; Le, C; Regitsky, DD; Cooper, SR; Peereboom, L; Clark, A; Martinez, Y; Goldsmith, J; Cho, MY; Donohoue, PD; Luo, L; Lamberson, B; Tamrakar, P; Kim, EJ; Villari, JL; Gill, A; Tripathi, SA; Karamchedu, P; Paredes, CJ; Rajgarhia, V; Kotlar, HK; Bailey, RB; Miller, DJ; Ohler, NL; Swimmer, C; Yoshikuni, Y				Enquist-Newman, Maria; Faust, Ann Marie E.; Bravo, Daniel D.; Santos, Christine Nicole S.; Raisner, Ryan M.; Hanel, Arthur; Sarvabhowman, Preethi; Le, Chi; Regitsky, Drew D.; Cooper, Susan R.; Peereboom, Lars; Clark, Alana; Martinez, Yessica; Goldsmith, Joshua; Cho, Min Y.; Donohoue, Paul D.; Luo, Lily; Lamberson, Brigit; Tamrakar, Pramila; Kim, Edward J.; Villari, Jeffrey L.; Gill, Avinash; Tripathi, Shital A.; Karamchedu, Padma; Paredes, Carlos J.; Rajgarhia, Vineet; Kotlar, Hans Kristian; Bailey, Richard B.; Miller, Dennis J.; Ohler, Nicholas L.; Swimmer, Candace; Yoshikuni, Yasuo			Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform	NATURE			English	Article							URONIC-ACID; METABOLISM; MANNITOL; SYSTEMS	The increasing demands placed on natural resources for fuel and food production require that we explore the use of efficient, sustainable feedstocks such as brown macroalgae. The full potential of brown macroalgae as feedstocks for commercial-scale fuel ethanol production, however, requires extensive re-engineering of the alginate and mannitol catabolic pathways(1-3) in the standard industrial microbe Saccharomyces cerevisiae. Here we present the discovery of an alginate monomer (4-deoxy-L-erythro-5-hexoseulose uronate, or DEHU) transporter from the alginolytic eukaryote Asteromyces cruciatus(4). The genomic integration and overexpression of the gene encoding this transporter, together with the necessary bacterial alginate and deregulated native mannitol catabolism genes, conferred the ability of an S. cerevisiae strain to efficiently metabolize DEHU and mannitol. When this platform was further adapted to grow on mannitol and DEHU under anaerobic conditions, it was capable of ethanol fermentation from mannitol and DEHU, achieving titres of 4.6%(v/v) (36.2 g l(-1)) and yields up to 83% of the maximum theoretical yield from consumed sugars. These results show that all major sugars in brown macroalgae can be used as feedstocks for biofuels and value-added renewable chemicals in a manner that is comparable to traditional arable-land-based feedstocks.	[Enquist-Newman, Maria; Faust, Ann Marie E.; Bravo, Daniel D.; Santos, Christine Nicole S.; Raisner, Ryan M.; Hanel, Arthur; Sarvabhowman, Preethi; Le, Chi; Regitsky, Drew D.; Cooper, Susan R.; Clark, Alana; Martinez, Yessica; Goldsmith, Joshua; Cho, Min Y.; Donohoue, Paul D.; Luo, Lily; Lamberson, Brigit; Tamrakar, Pramila; Kim, Edward J.; Villari, Jeffrey L.; Gill, Avinash; Tripathi, Shital A.; Karamchedu, Padma; Paredes, Carlos J.; Rajgarhia, Vineet; Bailey, Richard B.; Ohler, Nicholas L.; Swimmer, Candace; Yoshikuni, Yasuo] Bio Architecture Lab Inc, Berkeley, CA 94710 USA; [Peereboom, Lars; Miller, Dennis J.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Kotlar, Hans Kristian] Statoil ASA, Statoil Res Ctr, N-7005 Trondheim, Norway; [Yoshikuni, Yasuo] BALChile SA, Santiago 7550000, Chile; [Yoshikuni, Yasuo] BAL Biofuels SA, Santiago 7550000, Chile	Michigan State University; Equinor	Yoshikuni, Y (corresponding author), Bio Architecture Lab Inc, 604 Bancroft Way,Suite A, Berkeley, CA 94710 USA.	candacesw@yahoo.com; yoshikuni@ba-lab.com	Yoshikuni, Yasuo/K-7741-2019; Yoshikuni, Yasuo/A-8804-2019	Yoshikuni, Yasuo/0000-0002-8372-640X; Cooper, Susan/0000-0002-1608-6713; Donohoue, Paul/0000-0003-0426-3927; bravo, daniel/0000-0003-1872-6929	DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award [DE-AR0000006]; CORFO INNOVA CHILE [09CTEI-6866]; Statoil ASA; agency of the US government	DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award; CORFO INNOVA CHILE; Statoil ASA; agency of the US government	We thank R. Schekman, J. H. D. Cate and P. A. Silver for critical discussion and suggestions. This work is supported by the DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award (DE-AR0000006), by CORFO INNOVA CHILE (codigo 09CTEI-6866), and by Statoil ASA. This report was prepared as an account of work sponsored by an agency of the US government. Neither the US government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favouring by the US government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US government or any agency thereof.	Chapman VJ, 1970, SEAWEEDS THEIR USES; Food and Agriculture Organization of the United Nations, 2009, EXP M FEED WORLD 205; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hilditch S, 2010, THESIS U HELSINKI; Horn SJ, 2000, J IND MICROBIOL BIOT, V25, P249, DOI 10.1038/sj.jim.7000065; Interagency Agricultural Projections Committee, 2012, USDA AGR PROJ 2021; International Energy Agency, 2012, WORLD EN OUTL 2012; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/nchembio.970, 10.1038/NCHEMBIO.970]; Mairta P. K., 1971, J BIOL CHEM, V246, P425; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Patel MK., 2006, MEDIUM LONG TERM OPP; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; PREISS J, 1962, J BIOL CHEM, V237, P317; QUAIN DE, 1987, J GEN MICROBIOL, V133, P1675; Roesijadi G., 2010, PNNL19944; Santos CNS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3503; SCHAUMANN K, 1995, HELGOLANDER MEERESUN, V49, P159, DOI 10.1007/BF02368346; Stewart WM, 2005, AGRON J, V97, P1, DOI 10.2134/agronj2005.0001; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; United Nations Educational Scientific and Cultural Organization., 2012, 4 UN ED SCI CULT ORG; Valdes C., 2011, Amber Waves, V9, P38; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wheeler KA, 1996, BIOCHEM J, V315, P195, DOI 10.1042/bj3150195; World Population Prospects, 2013, 2012 REV, V1; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	235	246	10	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					239	+		10.1038/nature12771	http://dx.doi.org/10.1038/nature12771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24291791				2022-12-28	WOS:000329441500043
J	Gao, LB; Ni, GX; Liu, YP; Liu, B; Neto, AHC; Loh, KP				Gao, Libo; Ni, Guang-Xin; Liu, Yanpeng; Liu, Bo; Castro Neto, Antonio H.; Loh, Kian Ping			Face-to-face transfer of wafer-scale graphene films	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; LARGE-AREA; RAMAN-SCATTERING; GROWTH; ENERGY; COPPER	Graphene has attracted worldwide interest since its experimental discovery(1,2), but the preparation of large-area, continuous graphene film on SiO2/Si wafers, free from growth-related morphological defects or transfer-induced cracks and folds, remains a formidable challenge(3). Growth of graphene by chemical vapour deposition on Cu foils(4-7) has emerged as a powerful technique owing to its compatibility with industrial-scale roll-to-roll technology(6). However, the polycrystalline nature and microscopic roughness of Cu foils means that such roll-to-roll transferred films are not devoid of cracks and folds(6,7). High-fidelity transfer or direct growth of high-quality graphene films on arbitrary substrates is needed to enable wide-ranging applications in photonics or electronics, which include devices such as optoelectronic modulators, transistors, on-chip biosensors and tunnelling barriers(3,8,9). The direct growth of graphene film on an insulating substrate, such as a SiO2/Si wafer, would be useful for this purpose, but current research efforts remain grounded at the proof-of-concept stage, where only discontinuous, nanometre-sized islands can be obtained(10). Here we develop a face-to-face transfer method for wafer-scale graphene films that is so far the only known way to accomplish both the growth and transfer steps on one wafer. This spontaneous transfer method relies on nascent gas bubbles and capillary bridges between the graphene film and the underlying substrate during etching of the metal catalyst, which is analogous to the method used by tree frogs to remain attached to submerged leaves(11,12). In contrast to the previous wet(4,5,13-15) or dry(6,7) transfer results, the face-to-face transfer does not have to be done by hand and is compatible with any size and shape of substrate; this approach also enjoys the benefit of a much reduced density of transfer defects compared with the conventional transfer method. Most importantly, the direct growth and spontaneous attachment of graphene on the underlying substrate is amenable to batch processing in a semiconductor production line, and thus will speed up the technological application of graphene.	[Gao, Libo; Ni, Guang-Xin; Liu, Bo; Castro Neto, Antonio H.; Loh, Kian Ping] Natl Univ Singapore, Graphene Res Ctr, Singapore 117546, Singapore; [Gao, Libo; Liu, Yanpeng; Liu, Bo; Loh, Kian Ping] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Ni, Guang-Xin; Castro Neto, Antonio H.] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Loh, KP (corresponding author), Natl Univ Singapore, Graphene Res Ctr, 6 Sci Dr 2, Singapore 117546, Singapore.	chmlohkp@nus.edu.sg	Castro Neto, Antonio/C-8363-2014; Loh, Kian Ping/M-3122-2016; Ni, Guangxin/A-1341-2016; Ni, Guangxin/AAE-6412-2019; Gao, Libo/G-5928-2015	Castro Neto, Antonio/0000-0003-0613-4010; Loh, Kian Ping/0000-0002-1491-743X; Ni, Guangxin/0000-0002-2394-8924; Gao, Libo/0000-0002-7822-9812; Liu, Bo/0000-0003-1407-8434	MOE Tier 2 grant 'Interface engineering of graphene hybrids for energy conversion' [R-143-000-488-112]; NRF-CRP grant 'Novel 2D materials with tailored properties: beyond graphene' [R-144-000-295-281]	MOE Tier 2 grant 'Interface engineering of graphene hybrids for energy conversion'; NRF-CRP grant 'Novel 2D materials with tailored properties: beyond graphene'	We thank C. T. Nai for help with X-ray photoelectron spectroscopy and B. K. Chong (Agilent Technologies) for the liquid AFM. This work was supported by MOE Tier 2 grant 'Interface engineering of graphene hybrids for energy conversion' (R-143-000-488-112) and by NRF-CRP grant 'Novel 2D materials with tailored properties: beyond graphene' (R-144-000-295-281).	Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Chen JY, 2011, J AM CHEM SOC, V133, P17548, DOI 10.1021/ja2063633; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Gao LB, 2008, ACS NANO, V2, P1625, DOI 10.1021/nn800307s; Gao LB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1702; Gao LB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3512865; Gao LB, 2009, ACS NANO, V3, P933, DOI 10.1021/nn8008799; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; JANOS S, 2007, COLORIMETRY UNDERSTA, P25; Kang J, 2012, ACS NANO, V6, P5360, DOI 10.1021/nn301207d; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kobayashi H, 1997, APPL PHYS LETT, V71, P1978, DOI 10.1063/1.119760; Levendorf MP, 2012, NATURE, V488, P627, DOI 10.1038/nature11408; Li XS, 2011, J AM CHEM SOC, V133, P2816, DOI 10.1021/ja109793s; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu M, 2011, NATURE, V474, P64, DOI 10.1038/nature10067; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Persson BNJ, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/37/376110; Persson BNJ, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/31/315007; Rafiee J, 2012, NAT MATER, V11, P217, DOI [10.1038/NMAT3228, 10.1038/nmat3228]; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527; Yoon T, 2012, NANO LETT, V12, P1448, DOI 10.1021/nl204123h	30	333	338	22	999	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					190	194		10.1038/nature12763	http://dx.doi.org/10.1038/nature12763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24336218				2022-12-28	WOS:000329441500033
J	Gandhi, S; Fleet, JL; Bailey, DG; McArthur, E; Wald, R; Rehman, F; Garg, AX				Gandhi, Sonja; Fleet, Jamie L.; Bailey, David G.; McArthur, Eric; Wald, Ron; Rehman, Faisal; Garg, Amit X.			Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FELODIPINE; MORTALITY; VERAPAMIL; TOXICITY; OUTCOMES	IMPORTANCE Calcium-channel blockers are metabolized by the cytochrome P450 3A4 (CYP3A4; EC 1.14.13.97) enzyme. Blood concentrations of these drugs may rise to harmful levels when CYP3A4 activity is inhibited. Clarithromycin is an inhibitor of CYP3A4 and azithromycin is not, which makes comparisons between these 2 macrolide antibiotics useful in assessing clinically important drug interactions. OBJECTIVE To characterize the risk of acute adverse events following coprescription of clarithromycin compared with azithromycin in older adults taking a calcium-channel blocker. DESIGN, SETTING, AND PARTICIPANTS Population-based retrospective cohort study in Ontario, Canada, from 2003 through 2012 of older adults (mean age, 76 years) who were newly coprescribed clarithromycin (n = 96 226) or azithromycin (n = 94 083) while taking a calcium-channel blocker (amlodipine, felodipine, nifedipine, diltiazem, or verapamil). MAIN OUTCOMES AND MEASURES Hospitalization with acute kidney injury (primary outcome) and hospitalization with hypotension and all-cause mortality (secondary outcomes examined separately). Outcomes were assessed within 30 days of a new coprescription. RESULTS There were no differences in measured baseline characteristics between the clarithromycin and azithromycin groups. Amlodipine was the most commonly prescribed calcium-channel blocker (more than 50% of patients). Coprescribing clarithromycin vs azithromycin with a calcium-channel blocker was associated with a higher risk of hospitalization with acute kidney injury (420 patients of 96 226 taking clarithromycin [0.44%] vs 208 patients of 94 083 taking azithromycin [0.22%]; absolute risk increase, 0.22%[95% CI, 0.16%-0.27%]; odds ratio [OR], 1.98 [95% CI, 1.68-2.34]). In a subgroup analysis, the risk was highest with dihydropyridines, particularly nifedipine (OR, 5.33 [95% CI, 3.39-8.38]; absolute risk increase, 0.63%[95% CI, 0.49%-0.78%]). Coprescription with clarithromycin was also associated with a higher risk of hospitalization with hypotension (111 patients of 96 226 taking clarithromycin [0.12%] vs 68 patients of 94 083 taking azithromycin [0.07%]; absolute risk increase, 0.04%[95% CI, 0.02%-0.07%]; OR, 1.60 [95% CI, 1.18-2.16]) and all-cause mortality (984 patients of 96 226 taking clarithromycin [1.02%] vs 555 patients of 94 083 taking azithromycin [0.59%]; absolute risk increase, 0.43%[95% CI, 0.35%-0.51%]; OR, 1.74 [95% CI, 1.57-1.93]). CONCLUSIONS AND RELEVANCE Among older adults taking a calcium-channel blocker, concurrent use of clarithromycin compared with azithromycin was associated with a small but statistically significant greater 30-day risk of hospitalization with acute kidney injury. These findings support current safety warnings regarding concurrent use of CYP3A4 inhibitors and calcium-channel blockers.	[Gandhi, Sonja; Fleet, Jamie L.; McArthur, Eric; Rehman, Faisal; Garg, Amit X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Gandhi, Sonja; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Bailey, David G.; Garg, Amit X.] London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; [McArthur, Eric; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wald, Ron] St Michaels Hosp, Dept Med, Div Nephrol, Toronto, ON M5B 1W8, Canada; [Wald, Ron] Univ Toronto, Toronto, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL 101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Fleet, Jamie L/GYJ-7373-2022; Garg, Amit X/G-3295-2011; Rehman, Faisal/GYA-3738-2022	Fleet, Jamie/0000-0002-9468-0697	Ontario Ministry of Health and Long-term Care; Academic Medical Organization of Southwestern Ontario; Canadian Institutes of Health Research	Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. The ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. ICES Western is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. This project was conducted with members of the provincial ICES Kidney, Dialysis, and Transplantation Research Program, which receives programmatic grant funding from the Canadian Institutes of Health Research.	[Anonymous], 2012, CPS 2012 COMP PHARM; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bailey DG, 1996, CLIN PHARMACOL THER, V60, P25, DOI 10.1016/S0009-9236(96)90163-0; BAILEY DG, 1991, LANCET, V337, P268, DOI 10.1016/0140-6736(91)90872-M; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Fleet JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002857; Fleet JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-81; Food and Drug Administration, 2011, DRUG DEV DRUG INT TA; Gandhi S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001921; Geronimo-Pardo M, 2005, ANN PHARMACOTHER, V39, P538, DOI 10.1345/aph.1E432; Glesby MJ, 2005, CLIN PHARMACOL THER, V78, P143, DOI 10.1016/j.clpt.2005.04.005; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Jalava KM, 1997, CLIN PHARMACOL THER, V61, P410, DOI 10.1016/S0009-9236(97)90191-0; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Josefsson M, 1996, EUR J CLIN PHARMACOL, V51, P189, DOI 10.1007/s002280050183; Kaeser YA, 1998, AM J HEALTH-SYST PH, V55, P2417, DOI 10.1093/ajhp/55.22.2417; Kidney Disease; Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, KDIG CLIN PRACT GUID; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LIEDHOLM H, 1991, DICP ANN PHARMAC, V25, P1007, DOI 10.1177/106002809102500918; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Pai MP, 2000, ANN PHARMACOTHER, V34, P495, DOI 10.1345/aph.19138; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reed M, 2005, ANN PHARMACOTHER, V39, P357, DOI 10.1345/aph.1E496; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Sica Domenic A, 2005, J Clin Hypertens (Greenwich), V7, P21, DOI 10.1111/j.1524-6175.2006.04482.x; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Statistics Canada, 2011, POP SEX AG GROUP PRO; US Food and Drug Administration, BIX FILMT CLAR TABL; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Westphal JF, 2000, BRIT J CLIN PHARMACO, V50, P285, DOI 10.1046/j.1365-2125.2000.00261.x; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]	37	79	82	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2544	2553		10.1001/jama.2013.282426	http://dx.doi.org/10.1001/jama.2013.282426			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346990	Bronze			2022-12-28	WOS:000328503600024
J	Brennan, PM; Jubb, A; Baillie, JK; Partridge, RW				Brennan, P. M.; Jubb, A.; Baillie, J. K.; Partridge, R. W.			CHRISTMAS 2013: AGGRAVATIONS Deciding authorship order	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brennan, P. M.] Univ Edinburgh, Western Gen Hosp, Dept Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Jubb, A.; Baillie, J. K.] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Royal Infirm Edinburgh, Edinburgh EH16 4SA, Midlothian, Scotland; [Partridge, R. W.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Baillie, JK (corresponding author), Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Royal Infirm Edinburgh, Edinburgh EH16 4SA, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, Kenneth/AEK-6650-2022; Baillie, John Kenneth/F-3124-2011	Baillie, Kenneth/0000-0001-5258-793X; Baillie, John Kenneth/0000-0001-5258-793X				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2009, OXFORD ENGLISH DICT, VThird; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; BAILLIE JK, 2004, J R COLL PHYS EDINB, V34, P130; Chatrchyan S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.111804; McCain RS, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6968; Molla M, 2007, ROLL CREDITS SOMETIM; Research Excellence Framework, 2012, PAN CRIT WORK METH; Rund S., 2010, LORE PLAYGROUND 100; Subramanian P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7506; Zhao DZ, 2011, J AM SOC INF SCI TEC, V62, P654, DOI 10.1002/asi.21495	11	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2013	347								f7182	10.1136/bmj.f7182	http://dx.doi.org/10.1136/bmj.f7182			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277LV	24342630				2022-12-28	WOS:000328821800003
J	Mertelj, A; Lisjak, D; Drofenik, M; Copic, M				Mertelj, Alenka; Lisjak, Darja; Drofenik, Miha; Copic, Martin			Ferromagnetism in suspensions of magnetic platelets in liquid crystal	NATURE			English	Article							COLLOIDAL INTERACTIONS; TOPOLOGICAL DEFECTS; NANOPARTICLES; FERRONEMATICS; OPTICS; FLUIDS	More than four decades ago, Brochard and de Gennes proposed that colloidal suspensions of ferromagnetic particles in nematic (directionally ordered) liquid crystals could form macroscopic ferromagnetic phases at room temperature. The experimental realization of these predicted phases has hitherto proved elusive, with such systems showing enhanced paramagnetism but no spontaneous magnetization in the absence of an external magnetic field. Here we show that nanometre-sized ferromagnetic platelets suspended in a nematic liquid crystal can order ferromagnetically on quenching from the isotropic phase. Cooling in the absence of a magnetic field produces a polydomain sample exhibiting the two opposing states of magnetization, oriented parallel to the direction of nematic ordering. Cooling in the presence of a magnetic field yields a monodomain sample; magnetization can be switched by domain wall movement on reversal of the applied magnetic field. The ferromagnetic properties of this dipolar fluid are due to the interplay of the nematic elastic interaction (which depends critically on the shape of the particles) and the magnetic dipolar interaction. This ferromagnetic phase responds to very small magnetic fields and may find use in magneto-optic devices.	[Mertelj, Alenka; Lisjak, Darja; Drofenik, Miha; Copic, Martin] J Stefan Inst, SI-1000 Ljubljana, Slovenia; [Drofenik, Miha] Univ Maribor, Fac Chem & Chem Engn, SI-2000 Maribor, Slovenia; [Copic, Martin] Univ Ljubljana, Fac Math & Phys, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Maribor; University of Ljubljana	Mertelj, A (corresponding author), J Stefan Inst, SI-1000 Ljubljana, Slovenia.	alenka.mertelj@ijs.si	Lisjak, Darja/Q-7474-2016; Mertelj, Alenka/C-6209-2011	Lisjak, Darja/0000-0003-4154-4592; Mertelj, Alenka/0000-0002-2766-9121	Slovenian Research Agency [P1-0192, P2-0089-4]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (A. M. and M. C.., grant no. P1-0192; D. L. and M. D., grant no. P2-0089-4). We thank the CENN Nanocenter for use of the LakeShore 7400 Series vibrating-sample magnetometer.	Albrecht T, 1997, APPL PHYS A-MATER, V65, P215, DOI 10.1007/s003390050569; Born M., 1916, SITZBER K PREUSS AKA, V30, P614; BROCHARD F, 1970, J PHYS-PARIS, V31, P691, DOI 10.1051/jphys:01970003107069100; Buluy O, 2011, SOFT MATTER, V7, P644, DOI 10.1039/c0sm00131g; CHEN SH, 1983, PHYS REV LETT, V51, P2298, DOI 10.1103/PhysRevLett.51.2298; Dalton LR, 1997, P NATL ACAD SCI USA, V94, P4842, DOI 10.1073/pnas.94.10.4842; de  Gennes P. G., 1995, PHYS LIQUID CRYSTALS, P41; Eskandari Z, 2012, SOFT MATTER, V8, P10100, DOI 10.1039/c2sm26022k; Evans JS, 2011, J APPL PHYS, V110, DOI 10.1063/1.3620550; Ilg P, 2009, LECT NOTES PHYS, V763, P249, DOI 10.1007/978-3-540-85387-9_4; Jarkova E, 2003, J CHEM PHYS, V118, P2422, DOI 10.1063/1.1533788; Lapointe CP, 2009, SCIENCE, V326, P1083, DOI 10.1126/science.1176587; Lavrentovich OD, 2011, P NATL ACAD SCI USA, V108, P5143, DOI 10.1073/pnas.1102130108; Lev BI, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021709; LIECHTENSTEIN AI, 1984, J PHYS F MET PHYS, V14, pL125, DOI 10.1088/0305-4608/14/7/007; Lisjak D, 2012, CRYST GROWTH DES, V12, P5174, DOI 10.1021/cg301227r; Lopez-Lopez MT, 2010, SOFT MATTER, V6, P4346, DOI 10.1039/c0sm00261e; Mahle S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016305; Moreno-Razo JA, 2011, SOFT MATTER, V7, P6828, DOI 10.1039/c0sm01506g; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Ovtar S, 2009, J COLLOID INTERF SCI, V337, P456, DOI 10.1016/j.jcis.2009.05.041; PAULSON DN, 1978, PHYS REV LETT, V40, P557, DOI 10.1103/PhysRevLett.40.557; Pleiner H., 2001, MAGNETOHYDRODYNAMICS, V37, P254, DOI [10.22364/mhd, DOI 10.22364/MHD]; Podoliak N, 2012, J COLLOID INTERF SCI, V386, P158, DOI 10.1016/j.jcis.2012.07.082; Podoliak N, 2011, SOFT MATTER, V7, P4742, DOI 10.1039/c1sm05051f; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; RAULT J, 1970, PHYS LETT A, VA 32, P199, DOI 10.1016/0375-9601(70)90274-4; Rosensweig R. E., 1997, FERROHYDRODYNAMICS, P237; Senyuk B, 2012, SOFT MATTER, V8, P8729, DOI 10.1039/c2sm25821h; Senyuk B, 2012, NANO LETT, V12, P955, DOI 10.1021/nl204030t	31	218	219	10	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					237	+		10.1038/nature12863	http://dx.doi.org/10.1038/nature12863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336284				2022-12-28	WOS:000328121500028
J	Tan, CL; Plotkin, JL; Veno, MT; von Schimmelmann, M; Feinberg, P; Mann, S; Handler, A; Kjems, J; Surmeier, DJ; O'Carroll, D; Greengard, P; Schaefer, A				Tan, Chan Lek; Plotkin, Joshua L.; Veno, Morten T.; von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Handler, Annie; Kjems, Jorgen; Surmeier, D. James; O'Carroll, Donal; Greengard, Paul; Schaefer, Anne			MicroRNA-128 Governs Neuronal Excitability and Motor Behavior in Mice	SCIENCE			English	Article							SYNAPTIC PLASTICITY; RECEPTOR; BRAIN; SPECIFICITY; ACTIVATION; EXPRESSION; STRIATUM; EPILEPSY; KINASE	The control of motor behavior in animals and humans requires constant adaptation of neuronal networks to signals of various types and strengths. We found that microRNA-128 (miR-128), which is expressed in adult neurons, regulates motor behavior by modulating neuronal signaling networks and excitability. miR-128 governs motor activity by suppressing the expression of various ion channels and signaling components of the extracellular signal-regulated kinase ERK2 network that regulate neuronal excitability. In mice, a reduction of miR-128 expression in postnatal neurons causes increased motor activity and fatal epilepsy. Overexpression of miR-128 attenuates neuronal responsiveness, suppresses motor activity, and alleviates motor abnormalities associated with Parkinson's-like disease and seizures in mice. These data suggest a therapeutic potential for miR-128 in the treatment of epilepsy and movement disorders.	[Tan, Chan Lek; von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Handler, Annie; Greengard, Paul; Schaefer, Anne] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Plotkin, Joshua L.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Fac Sci, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Fac Sci, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Schaefer, Anne] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, Fishberg Dept Neurosci, New York, NY 10029 USA; [O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [O'Carroll, Donal] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10065 USA	Rockefeller University; Northwestern University; Feinberg School of Medicine; Aarhus University; Aarhus University; Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL); Rockefeller University	Schaefer, A (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	anne.schaefer@mssm.edu	Plotkin, Joshua/AAJ-5043-2021; Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317; Veno, Morten/0000-0002-4754-5193; Greengard, Paul/0000-0002-4437-0893; Handler, Annie/0000-0001-6414-8627; Tan, Chan Lek/0000-0001-5032-5119; Plotkin, Joshua/0000-0001-6232-7613; O'Carroll, Donal/0000-0002-8626-2217	NIH [1DP2MH100012-01, DA025962, P50MH090963, DA10044, NS34696]; Seaver Autism Foundation; USAMRAA [W81XWH-090100402]; JPB Foundation; Lundbeck Foundation; Center for Integrative Sequencing at Aarhus University; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100012, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R03DA025962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Autism Foundation; USAMRAA; JPB Foundation; Lundbeck Foundation(Lundbeckfonden); Center for Integrative Sequencing at Aarhus University; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Rajewsky, G. Schuetz, and N. Heintz for mice and reagents. We thank C. Bargman and A. Tarakhovsky for valuable comments and P. Zamore for advice and critical reading of the manuscript. This work was supported by the NIH 1DP2MH100012-01 and DA025962 (A. S.), P50MH090963 (P. G., A. S., and D.J.S.), DA10044 (P. G.), NS34696 (D.J.S.), the Seaver Autism Foundation (A. S.), the USAMRAA W81XWH-090100402 and JPB Foundation (P. G.), the Lundbeck Foundation and Center for Integrative Sequencing at Aarhus University (M. T. V. and J.K), and the CHDI Foundation (D.J.S.). The authors declare no competing financial interests. The microarray data reported in this paper are archived at the Gene Expression Omnibus (GEO) Repository (www.ncbi.nlm.nih.gov/geo, accession no. GSE48813). Correspondence and requests for materials should be addressed to A. S. via anne.schaefer@mssm.edu. Mount Sinai and The Rockefeller University filed a United State provisional patent application (61/896,463 and 61/898,952) that covers the treatment of epilepsy using miR-128.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blair MA, 2011, EPILEPSIA, V52, P993, DOI 10.1111/j.1528-1167.2011.03059.x; Brodie MJ, 2010, SEIZURE-EUR J EPILEP, V19, P650, DOI 10.1016/j.seizure.2010.10.027; Cenci MA, 2010, PROG BRAIN RES, V183, P209, DOI 10.1016/S0079-6123(10)83011-0; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chioza BA, 2009, EPILEPSY RES, V87, P247, DOI 10.1016/j.eplepsyres.2009.09.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feyder M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00071; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Megraw M, 2010, THEOR CHEM ACC, V125, P593, DOI 10.1007/s00214-009-0647-4; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Valjent E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-20; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267	30	195	200	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1254	1258		10.1126/science.1244193	http://dx.doi.org/10.1126/science.1244193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311694	Green Accepted			2022-12-28	WOS:000327857900053
J	Dhaliwal, G; Hauer, KE				Dhaliwal, Gurpreet; Hauer, Karen E.			The Oral Patient Presentation in the Era of Night Float Admissions Credit and Critique	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dhaliwal, Gurpreet; Hauer, Karen E.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Dhaliwal, G (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 111, San Francisco, CA 94121 USA.	gurpreet.dhaliwal@ucsf.edu						Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Green EH, 2009, J GEN INTERN MED, V24, P370, DOI 10.1007/s11606-008-0900-x; Harber RJ, 2001, J GEN INTERN MED, V16, P308, DOI 10.1046/j.1525-1497.2001.00233.x; Stephens MB, 2011, ACAD MED, V86, P11, DOI 10.1097/ACM.0b013e3181ff7271; Wiese J, 2002, AM J MED, V112, P212, DOI 10.1016/S0002-9343(01)01085-3	5	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2247	2248		10.1001/jama.2013.282322	http://dx.doi.org/10.1001/jama.2013.282322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302082				2022-12-28	WOS:000327746300004
J	Mitchell, KR; Mercer, CH; Ploubidis, GB; Jones, KG; Datta, J; Field, N; Copas, AJ; Tanton, C; Erens, B; Sonnenberg, P; Clifton, S; Macdowall, W; Phelps, A; Johnson, AM; Wellings, K				Mitchell, Kirstin R.; Mercer, Catherine H.; Ploubidis, George B.; Jones, Kyle G.; Datta, Jessica; Field, Nigel; Copas, Andrew J.; Tanton, Clare; Erens, Bob; Sonnenberg, Pam; Clifton, Soazig; Macdowall, Wendy; Phelps, Andrew; Johnson, Anne M.; Wellings, Kaye			Sexual function in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	LANCET			English	Article							PRIMARY-CARE; HEALTH; DYSFUNCTION; DEPRESSION; PREVALENCE; SAMPLE; WOMEN	Background Despite its importance to sexual health and wellbeing, sexual function is given little attention in sexual health policy. Population-based studies are needed to understand sexual function across the life course. Methods We undertook a probability sample survey (the third National Survey of Sexual Attitudes and Lifestyles [Natsal-3]) of 15 162 individuals aged 16-74 years who lived in Britain (England, Scotland, and Wales). Interviews were done between Sept 6, 2010, and Aug 31, 2012. We assessed the distribution of sexual function by use of a novel validated measure (the Natsal-SF), which assessed problems with individual sexual response, sexual function in a relationship context, and self-appraisal of sex life (17 items; 16 items per gender). We assess factors associated with low sexual function (defined as the lowest quintile of distribution of Natsal-SF scores) and the distribution of components of the measure. Participants reporting one or more sexual partner in the past year were given a score on the Natsal-SF (11 690 participants). 4122 of these participants were not in a relationship for all of the past year and we employed the full information maximum likelihood method to handle missing data on four relationship items. Findings We obtained data for 4913 men and 6777 women for the Natsal-SF. For men and women, low sexual function was associated with increased age, and, after age-adjustment, with depression (adjusted odds ratio 3.70 [95% CI 2.90-4.72] for men and 4.11 [3.36-5.04] for women) and self-reported poor health status (2.63 [1.73-3.98] and 2.41 [1.72-3.39]). Low sexual function was also associated with experiencing the end of a relationship (1.52 [1.18-1.95] and 1.77 [1.44-2.17]), inability to talk easily about sex with a partner (2.36 [1.94-2.88] and 2.82 [2.28-3.48]), and not being happy in the relationship (2.89 [2.32-3.61] and 4.10 [3.39-4.97]). Associations were also noted with engaging in fewer than four sex acts in the past 4 weeks (3.13 [2.58-3.79] and 3.38 [2.80-4.09]), having had same sex partners (2.28 [1.56-3.35] and 1.60 [1.16-2.20]), paying for sex (in men only; 2.62 [1.46-4.71]), and higher numbers of lifetime sexual partners (in women only; 2.12 [1.68-2.67] for ten or more partners). Low sexual function was also associated with negative sexual health outcomes such as experience of non-volitional sex (1.98 [1.14-3.43] and 2.18 [1.79-2.66]) and STI diagnosis (1.50 [1.06-2.11] and 1.83 [1.35-2.47]). Among individuals reporting sex in the past year, problems with sexual response were common (41.6% of men and 51.2% of women reported one or more problem) but self-reported distress about sex lives was much less common (9.9% and 10.9%). For individuals in a sexual relationship for the past year, 23.4% of men and 27.4% of women reported an imbalance in level of interest in sex between partners, and 18.0% of men and 17.1% of women said that their partner had had sexual difficulties. Most participants who did not have sex in the past year were not dissatisfied, distressed, or avoiding sex because of sexual difficulties. Interpretation Wide variability exists in the distribution of sexual function scores. Low sexual function is associated with negative sexual health outcomes, supporting calls for a greater emphasis on sexual function in sexual health policy and interventions.	[Mitchell, Kirstin R.; Datta, Jessica; Macdowall, Wendy; Wellings, Kaye] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England; [Ploubidis, George B.] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1H 9SH, England; [Erens, Bob] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Mercer, Catherine H.; Jones, Kyle G.; Field, Nigel; Copas, Andrew J.; Tanton, Clare; Erens, Bob; Sonnenberg, Pam; Clifton, Soazig; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Mitchell, KR (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Ctr Sexual & Reprod Hlth Res, 15-17 Tavistock Pl, London WC1H 9SH, England.	kirstin.mitchell@lshtm.ac.uk	Ploubidis, George B/G-9531-2011; Field, Nigel/ABG-3948-2020; Weatherburn, Peter/AAC-2701-2019	Ploubidis, George B/0000-0002-8198-5790; Mercer, Catherine/0000-0002-4220-5034; Macdowall, Wendy/0000-0001-5868-8336; Tanton, Clare/0000-0002-4612-1858; Mitchell, Kirstin/0000-0002-4409-6601; Johnson, Anne/0000-0003-1330-7100; Jones, Kyle/0000-0002-7127-1612; Sonnenberg, Pam/0000-0002-1067-1583; Erens, Bob/0000-0002-4430-954X; Field, Nigel/0000-0002-2825-6652; Copas, Andrew/0000-0001-8968-5963; Clifton, Soazig/0000-0002-4171-0805; Erens, Robert/0000-0002-3054-504X	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [MET-11-19-101, NF-SI-0508-10244, CL-2010-18-010] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	Aggleton P., 2000, SEX RELATSH THER, V15, P283, DOI DOI 10.1080/14681990050109863; ALTMAN DG, 1994, BRIT MED J, V309, P996, DOI 10.1136/bmj.309.6960.996; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Boul L., 2007, SEX RELATSH THER, V22, P209; DeRogatis LR, 2008, INT J IMPOT RES, V20, P35, DOI 10.1038/sj.ijir.3901591; Dunn KM, 2002, J SEX MARITAL THER, V28, P399, DOI 10.1080/00926230290001529; Erens B, 3 NATL SURVEY SEXUAL; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Graham C. A., 2005, WOMENS SEXUAL FUNCTI, P52; Green P, 2008, INT J STD AIDS, V19, P30, DOI 10.1258/ijsa.2007.007153; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; Ingham R., 2005, SEX ED, V5, P375, DOI [DOI 10.1080/14681810500278451, 10.1080/14681810500278451]; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; Levin R.J., 2007, SEX RELATSH THER, V22, P135, DOI [10.1080/14681990601149197, DOI 10.1080/14681990601149197]; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Little R.J.A., 2002, STAT ANAL MISSING DA; Lutfey KE, 2009, ARCH SEX BEHAV, V38, P514, DOI 10.1007/s10508-007-9290-0; Macdowall W, 2013, LANCET; MAY JL, 1988, J SEX MARITAL THER, V14, P253; McCabe M, 2010, J SEX MED, V7, P327, DOI 10.1111/j.1743-6109.2009.01618.x; Mercer CH, 2005, SEX TRANSM INFECT, V81, P394, DOI 10.1136/sti.2005.015149; Mercer CH, 2003, BRIT MED J, V327, P426, DOI 10.1136/bmj.327.7412.426; Mercer CH, 2013, LANCET; Mitchell KR, 2013, J SEX RES, V50, P17, DOI 10.1080/00224499.2011.621038; Mitchell KR, 2012, EUR J EPIDEMIOL, V27, P409, DOI 10.1007/s10654-012-9697-3; Mitchell KR, 2011, SOCIOL HEALTH ILL, V33, P540, DOI 10.1111/j.1467-9566.2011.01318.x; Mitchell KR, 2008, THESIS U LONDON; MOROKOFF PJ, 1987, HEALTH PSYCHOL, V6, P545, DOI 10.1037/0278-6133.6.6.545; Moynihan R., 2010, BMJ-BRIT MED J, V341, P698; Payne R. A., 2012, Health Statistics Quarterly, P22; Riley A, 2007, J SEX MARITAL THER, V33, P461, DOI 10.1080/00926230701480422; Rizvi SJ, 2011, J PSYCHOSOM RES, V70, P99, DOI 10.1016/j.jpsychores.2010.05.009; Rowland DL, 2007, J SEX MARITAL THER, V33, P385, DOI 10.1080/00926230701477022; Sandfort TGM, 2002, ANN REV SEX RES, V12, P93; Sonnenberg P, 2013, LANCET; Tiefer L, 2001, J SEX RES, V38, P89, DOI 10.1080/00224490109552075; Tiefer L., 1996, ANN REV SEX RES, V7, P252; Trompeter SE, 2012, AM J MED, V125, P37, DOI 10.1016/j.amjmed.2011.07.036; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; World Health Organization, 2006, DEF SEX HLTH REP TEC	46	299	300	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1817	1829		10.1016/S0140-6736(13)62366-1	http://dx.doi.org/10.1016/S0140-6736(13)62366-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286787	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000327540700026
J	Zhai, SY; Ark, ED; Parra-Bueno, P; Yasuda, R				Zhai, Shenyu; Ark, Eugene D.; Parra-Bueno, Paula; Yasuda, Ryohei			Long-Distance Integration of Nuclear ERK Signaling Triggered by Activation of a Few Dendritic Spines	SCIENCE			English	Article							LATE-PHASE; TRANSCRIPTION FACTORS; SYNAPTIC ACTIVATION; TERM POTENTIATION; PLASTICITY; CA2+; RAS; RECEPTORS; CELL	The late phase of long-term potentiation (LTP) at glutamatergic synapses, which is thought to underlie long-lasting memory, requires gene transcription in the nucleus. However, the mechanism by which signaling initiated at synapses is transmitted into the nucleus to induce transcription has remained elusive. Here, we found that induction of LTP in only three to seven dendritic spines in rat CA1 pyramidal neurons was sufficient to activate extracellular signal-regulated kinase (ERK) in the nucleus and regulate downstream transcription factors. Signaling from individual spines was integrated over a wide range of time (>30 minutes) and space (>80 micrometers). Spatially dispersed inputs over multiple branches activated nuclear ERK much more efficiently than clustered inputs over one branch. Thus, biochemical signals from individual dendritic spines exert profound effects on nuclear signaling.	[Zhai, Shenyu; Ark, Eugene D.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Parra-Bueno, Paula; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Max Planck Society; Duke University; Howard Hughes Medical Institute	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ryohei.yasuda@mpfi.org		Yasuda, Ryohei/0000-0001-6263-9297; Zhai, Shenyu/0000-0002-7097-9387	Howard Hughes Medical Institute; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. West, S. Dudek, S. Soderling, K. Tanaka, and G. Augustine for discussion; N. Hedrick and L. Colgan for comments on the manuscript; A. Wan for preparing cultured slices; and D. Kloetzer for laboratory management. This study was funded by Howard Hughes Medical Institute, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The authors made the following contributions: S.Z. and R.Y. designed experiments, S.Z. collected the majority of the data, E.D.A. performed the GCaMP imaging with pharmacological inhibitors, P.P.-B. performed the patch clamp experiments, S.Z. and R.Y. analyzed the data and wrote the paper, and all authors discussed the results and commented on the manuscript.	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	35	76	79	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1107	1111		10.1126/science.1245622	http://dx.doi.org/10.1126/science.1245622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288335	Green Accepted			2022-12-28	WOS:000327518600061
J	Bockle, BC; Sepp, NT				Boeckle, Barbara C.; Sepp, Norbert T.			Systemic AL-amyloidosis	LANCET			English	Editorial Material									[Boeckle, Barbara C.; Sepp, Norbert T.] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Sepp, Norbert T.] Barbara Bommer Fdn Clin Immunodermatol, Innsbruck, Austria	Medical University of Innsbruck	Bockle, BC (corresponding author), Med Univ Innsbruck, Dept Dermatol & Venereol, Anichstr 35, A-6020 Innsbruck, Austria.	barbara.boeckle@i-med.ac.at							0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					257	257		10.1016/S0140-6736(13)60859-4	http://dx.doi.org/10.1016/S0140-6736(13)60859-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	24315519				2022-12-28	WOS:000339384100027
J	Langrish, JP; Mills, NL				Langrish, Jeremy P.; Mills, Nicholas L.			Air pollution and mortality in Europe	LANCET			English	Editorial Material							COMPARATIVE RISK-ASSESSMENT; LONG-TERM EXPOSURE; LUNG-CANCER; ASSOCIATION; DISEASE		[Langrish, Jeremy P.; Mills, Nicholas L.] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk		Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [FS/10/024/28266, PG/11/27/28842] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Committee on the Medical Effects of Air Pollutants (COMEAP), 2009, LONG TERM EXP AIR PO; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Langrish JP, 2012, J INTERN MED, V272, P224, DOI 10.1111/j.1365-2796.2012.02566.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Yang G, 2013, LANCET; Zhang LW, 2014, ENVIRON INT, V62, P41, DOI 10.1016/j.envint.2013.09.012	14	13	14	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					758	760		10.1016/S0140-6736(13)62570-2	http://dx.doi.org/10.1016/S0140-6736(13)62570-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3EV	24332275				2022-12-28	WOS:000332398700005
J	Ioannidis, JPA				Ioannidis, John P. A.			More Than a Billion People Taking Statins? Potential Implications of the New Cardiovascular Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Ajay VS, 2010, INDIAN J MED RES, V132, P561; Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5535; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	9	157	160	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					463	464		10.1001/jama.2013.284657	http://dx.doi.org/10.1001/jama.2013.284657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24296612				2022-12-28	WOS:000330589800013
J	Yang, Z; Jiang, LX				Yang, Zhe; Jiang, Lixin			Building clinical research capacity in China: the National Clinical Research Centres	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL		[Yang, Zhe] Minist Sci & Technol Peoples Republ China, Beijing, Peoples R China; [Jiang, Lixin] Natl Clin Res Ctr Cardiovasc Dis, Fuwai Hosp, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Jiang, LX (corresponding author), Natl Clin Res Ctr Cardiovasc Dis, Fuwai Hosp, Beijing 100037, Peoples R China.	lixin.jiang@fwoxford.org						[Anonymous], 2011, OUTL 15 5 YEAR PLAN; Chen ZM, 2005, LANCET, V366, P1622; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Ministry of Science and Technology of the People's Republic of China, 2013, OFF LAUNCH NAT CLIN; Ministry of Science and Technology of the People's Republic of China, 2013, NAM NAT CLIN RES CTR; Ministry of Science and Technology of the People's Republic of China, 2012, NOT APPL NAT CLIN RE; Ministry of Science and Technology of the Peoples Republic of China, 2012, ANN REP STAT PROGR S; National Bureau of Statistics of China, 2012, NAT EC SOC DEV STAT; National Natural Science Foundation of China, 2011, APPL FUND REP NAT NA; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	10	6	10	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					200	201		10.1016/S0140-6736(13)62387-9	http://dx.doi.org/10.1016/S0140-6736(13)62387-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24290403				2022-12-28	WOS:000330027500011
J	Kirmani, A; Venkatraman, D; Shin, D; Colaco, A; Wong, FNC; Shapiro, JH; Goyal, VK				Kirmani, Ahmed; Venkatraman, Dheera; Shin, Dongeek; Colaco, Andrea; Wong, Franco N. C.; Shapiro, Jeffrey H.; Goyal, Vivek K.			First-Photon Imaging	SCIENCE			English	Article							SINGLE-PHOTON DETECTION; KILOMETER-RANGE; LASER-RADAR; DETECTOR; IMAGES	Imagers that use their own illumination can capture three-dimensional (3D) structure and reflectivity information. With photon-counting detectors, images can be acquired at extremely low photon fluxes. To suppress the Poisson noise inherent in low-flux operation, such imagers typically require hundreds of detected photons per pixel for accurate range and reflectivity determination. We introduce a low-flux imaging technique, called first-photon imaging, which is a computational imager that exploits spatial correlations found in real-world scenes and the physics of low-flux measurements. Our technique recovers 3D structure and reflectivity from the first detected photon at each pixel. We demonstrate simultaneous acquisition of sub-pulse duration range and 4-bit reflectivity information in the presence of high background noise. First-photon imaging may be of considerable value to both microscopy and remote sensing.	[Kirmani, Ahmed; Venkatraman, Dheera; Shin, Dongeek; Colaco, Andrea; Wong, Franco N. C.; Shapiro, Jeffrey H.; Goyal, Vivek K.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Goyal, Vivek K.] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Boston University	Kirmani, A (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	akirmani@mit.edu; v.goyal@ieee.org	Goyal, Vivek K/B-7955-2008	Goyal, Vivek K/0000-0001-8471-7049	Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office [W911NF-10-1-0404]; U.S. NSF [1161413]; Qualcomm Innovation Fellowship; Samsung Scholarship; Microsoft Ph.D. Fellowship; Direct For Computer & Info Scie & Enginr [1161413] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office; U.S. NSF(National Science Foundation (NSF)); Qualcomm Innovation Fellowship; Samsung Scholarship(Samsung); Microsoft Ph.D. Fellowship; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office award W911NF-10-1-0404, the U.S. NSF under grant number 1161413, a Qualcomm Innovation Fellowship, a Samsung Scholarship, and a Microsoft Ph.D. Fellowship. The authors thank H. S. Yang for assistance with figure preparation and the Research Laboratory of Electronics for hosting external database S1 (www.rle.mit.edu/first-photon-imaging), which contains the experiment's data and computer codes for Figs. 2 to 4, movie S2, and the parts of movie S1 that contain the mannequin data set.	Albota MA, 2002, APPL OPTICS, V41, P7671, DOI 10.1364/AO.41.007671; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Boyd S., 2004, COVEX OPTIMIZATION; Buller GS, 2007, IEEE J SEL TOP QUANT, V13, P1006, DOI 10.1109/JSTQE.2007.902850; Busck J, 2004, APPL OPTICS, V43, P4705, DOI 10.1364/AO.43.004705; Chang CW, 2010, PROC SPIE, V7570, DOI 10.1117/12.845787; Chen SJ, 2013, APPL OPTICS, V52, P3241, DOI 10.1364/AO.52.003241; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gol'tsman GN, 2001, APPL PHYS LETT, V79, P705, DOI 10.1063/1.1388868; Harmany ZT, 2012, IEEE T IMAGE PROCESS, V21, P1084, DOI 10.1109/TIP.2011.2168410; Hernandez-Marin S, 2007, IEEE T PATTERN ANAL, V29, P2170, DOI 10.1109/TPAMI.2007.1122; Jack M, 2011, PROC SPIE, V8033, DOI 10.1117/12.888134; Jiang W, 2003, J STRUCT BIOL, V144, P114, DOI 10.1016/j.jsb.2003.09.028; McCarthy A, 2013, OPT EXPRESS, V21, P22098, DOI 10.1364/OE.21.022098; McCarthy A, 2013, OPT EXPRESS, V21, P8904, DOI 10.1364/OE.21.008904; NICOLAS JC, 1994, J BIOLUM CHEMILUM, V9, P139, DOI 10.1002/bio.1170090307; O'Brien M. E., 2005, Lincoln Laboratory Journal, V15, P37; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Pellegrini S, 2000, MEAS SCI TECHNOL, V11, P712, DOI 10.1088/0957-0233/11/6/314; Savage N, 2009, NAT PHOTONICS, V3, P738, DOI 10.1038/nphoton.2009.232; Schwarz B., 2010, NATURE PHOTON, V4, P429, DOI 10.1038/nphoton.2010.14; Snyder D, 1975, RANDOM POINT PROCESS; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; Wallace AM, 2001, COMPUT CONTROL ENG J, V12, P157, DOI 10.1049/cce:20010403	27	256	268	28	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					58	61		10.1126/science.1246775	http://dx.doi.org/10.1126/science.1246775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24292628				2022-12-28	WOS:000329162000046
J	Schatz, H; Gupta, S; Moller, P; Beard, M; Brown, EF; Deibel, AT; Gasques, LR; Hix, WR; Keek, L; Lau, R; Steiner, AW; Wiescher, M				Schatz, H.; Gupta, S.; Moeller, P.; Beard, M.; Brown, E. F.; Deibel, A. T.; Gasques, L. R.; Hix, W. R.; Keek, L.; Lau, R.; Steiner, A. W.; Wiescher, M.			Strong neutrino cooling by cycles of electron capture and beta(-) decay in neutron star crusts	NATURE			English	Article							X-RAY-BURSTS; INNER CRUST; MODELS; IGNITION; OCEAN	The temperature in the crust of an accreting neutron star, which comprises its outermost kilometre, is set by heating from nuclear reactions at large densities(1-4), neutrino cooling(5,6) and heat transport from the interior(7-11). The heated crust has been thought to affect observable phenomena at shallower depths, such as thermonuclear bursts in the accreted envelope(10,11). Here we report that cycles of electron capture and its inverse, beta(-) decay, involving neutron-rich nuclei at a typical depth of about 150 metres, cool the outer neutron star crust by emitting neutrinos while also thermally decoupling the surface layers from the deeper crust. This 'Urca' mechanism(12) has been studied in the context of white dwarfs(13) and type Ia supernovae(14,15), but hitherto was not considered in neutron stars, because previous models(1,2) computed the crust reactions using a zero-temperature approximation and assumed that only a single nuclear species was present at any given depth. The thermal decoupling means that X-ray bursts and other surface phenomena are largely independent of the strength of deep crustal heating. The unexpectedly short recurrence times, of the order of years, observed for very energetic thermonuclear superbursts(16) are therefore not an indicator of a hot crust, but may point instead to an unknown local heating mechanism near the neutron star surface.	[Schatz, H.; Brown, E. F.; Keek, L.; Lau, R.] Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA; [Schatz, H.; Moeller, P.; Beard, M.; Brown, E. F.; Deibel, A. T.; Keek, L.; Lau, R.; Steiner, A. W.; Wiescher, M.] Univ Notre Dame, Joint Inst Nucl Astrophys, Notre Dame, IN 46556 USA; [Schatz, H.; Brown, E. F.; Deibel, A. T.; Keek, L.; Lau, R.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Gupta, S.] Indian Inst Technol Ropar, Rupnagar Ropar 140001, Punjab, India; [Moeller, P.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Beard, M.; Wiescher, M.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Gasques, L. R.] Univ Sao Paulo, Inst Fis, Dept Fis Nucl, BR-05315970 Sao Paulo, Brazil; [Hix, W. R.] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA; [Hix, W. R.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Steiner, A. W.] Univ Washington, Inst Nucl Theory, Seattle, WA 98195 USA	Michigan State University; University of Notre Dame; Michigan State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Ropar; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Notre Dame; Universidade de Sao Paulo; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Washington; University of Washington Seattle	Schatz, H (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, 640 South Shaw Lane, E Lansing, MI 48824 USA.	schatz@nscl.msu.edu	Gasques, Leandro Romero/E-2530-2012; Hix, William/E-7896-2011	Gasques, Leandro Romero/0000-0002-0963-1816; Hix, William/0000-0002-9481-9126; Moller, Peter/0000-0002-5848-3565; Steiner, Andrew/0000-0003-2478-4017	NSF [PHY 08-22648, PHY 06-06007, AST 11-09176]; INT DOE [DE-FG02-00ER41132]; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; Division Of Astronomical Sciences [1109176] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); INT DOE; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory(National Nuclear Security Administration); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This project was funded by NSF grants PHY 08-22648 (Joint Institute for Nuclear Astrophysics) and PHY 06-06007. A. W. S. was supported by INT DOE grant DE-FG02-00ER41132. E. F. B. was supported by NSF grant AST 11-09176. P.M. was supported by the National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory under contract no. DE-AC52-06NA25396. We thank D. M. Yakovlev, P. Shternin and S. Reddy for discussions and comments on the manuscript.	Brown EF, 2009, ASTROPHYS J, V698, P1020, DOI 10.1088/0004-637X/698/2/1020; Brown EF, 2000, ASTROPHYS J, V531, P988, DOI 10.1086/308487; Brown EF, 2004, ASTROPHYS J, V614, pL57, DOI 10.1086/425562; Cumming A, 2001, ASTROPHYS J, V559, pL127, DOI 10.1086/323937; Cumming A, 2006, ASTROPHYS J, V646, P429, DOI 10.1086/504698; Galloway DK, 2008, ASTROPHYS J SUPPL S, V179, P360, DOI 10.1086/592044; Goriely S, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.035804; Gupta S, 2007, ASTROPHYS J, V662, P1188, DOI 10.1086/517869; Haensel P, 2008, ASTRON ASTROPHYS, V480, P459, DOI 10.1051/0004-6361:20078578; HAENSEL P, 1990, ASTRON ASTROPHYS, V227, P431; Horowitz CJ, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.065803; Jones S, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/150; Keek L, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/150; Keek L, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/189; KRUMLINDE J, 1984, NUCL PHYS A, V417, P419, DOI 10.1016/0375-9474(84)90406-8; Lund N., 2008, PROC 7TH INTEGRAL WO; MAYER MG, 1950, PHYS REV, V78, P22, DOI 10.1103/PhysRev.78.22; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Nilsson SG., 1955, MAT FYS MEDD DAN VID, V29, P1; PACZYNSKI B, 1972, ASTROPHYS LETT COMM, V11, P53; Page D., 2013, PREPRINT; SATO K, 1979, PROG THEOR PHYS, V62, P957, DOI 10.1143/PTP.62.957; Steiner AW, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.015802; Strohmayer TE, 2002, ASTROPHYS J, V566, P1045, DOI 10.1086/338337; TSURUTA S, 1970, ASTROPHYS SPACE SCI, V7, P374, DOI 10.1007/BF00653278; Woosley SE, 2004, ASTROPHYS J SUPPL S, V151, P75, DOI 10.1086/381533; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225; Yakovlev DG, 2001, PHYS REP, V354, P1, DOI 10.1016/S0370-1573(00)00131-9	29	77	79	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					62	+		10.1038/nature12757	http://dx.doi.org/10.1038/nature12757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24291788	Green Submitted			2022-12-28	WOS:000329163300023
J	Rice, DW; Alverson, AJ; Richardson, AO; Young, GJ; Sanchez-Puerta, MV; Munzinger, J; Barry, K; Boore, JL; Zhang, Y; dePamphilis, CW; Knox, EB; Palmer, JD				Rice, Danny W.; Alverson, Andrew J.; Richardson, Aaron O.; Young, Gregory J.; Virginia Sanchez-Puerta, M.; Munzinger, Jerome; Barry, Kerrie; Boore, Jeffrey L.; Zhang, Yan; dePamphilis, Claude W.; Knox, Eric B.; Palmer, Jeffrey D.			Horizontal Transfer of Entire Genomes via Mitochondrial Fusion in the Angiosperm Amborella	SCIENCE			English	Article							GENE-TRANSFER; PLANT-MITOCHONDRIA; FLOWERING PLANTS; EVOLUTION; SUGGESTS; FISSION; ORIGINS	We report the complete mitochondrial genome sequence of the flowering plant Amborella trichopoda. This enormous, 3.9-megabase genome contains six genome equivalents of foreign mitochondrial DNA, acquired from green algae, mosses, and other angiosperms. Many of these horizontal transfers were large, including acquisition of entire mitochondrial genomes from three green algae and one moss. We propose a fusion-compatibility model to explain these findings, with Amborella capturing whole mitochondria from diverse eukaryotes, followed by mitochondrial fusion (limited mechanistically to green plant mitochondria) and then genome recombination. Amborella's epiphyte load, propensity to produce suckers from wounds, and low rate of mitochondrial DNA loss probably all contribute to the high level of foreign DNA in its mitochondrial genome.	[Rice, Danny W.; Alverson, Andrew J.; Richardson, Aaron O.; Young, Gregory J.; Virginia Sanchez-Puerta, M.; Knox, Eric B.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Munzinger, Jerome] IRD, Lab Bot & Ecol Vegetale Appl, UMR Bot & Bioinformat Architecture Plantes AMAP, Noumea, New Caledonia; [Barry, Kerrie; Boore, Jeffrey L.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Zhang, Yan; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Indiana University System; Indiana University Bloomington; Institut de Recherche pour le Developpement (IRD); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Palmer, JD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpalmer@indiana.edu	Barry, Kerrie Whitelaw/AAA-5500-2020; dePamphilis, Claude W/P-6652-2016; Palmer, Jeffrey/P-6747-2014	Barry, Kerrie Whitelaw/0000-0002-8999-6785; Palmer, Jeffrey/0000-0002-4626-2220; Alverson, Andrew/0000-0003-1241-2654; Rice, Danny/0000-0002-1123-4617; Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093	U.S. Department of Energy-Joint Genome Institute Community Sequencing Program [DE-AC02-05CH11231, NSF-GRF-112955, NSF-DBI-0638595]; METACyt Initiative of Indiana University; Lilly Endowment;  [NIH-RO1-GM-76012]	U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; METACyt Initiative of Indiana University; Lilly Endowment; 	We thank E. Dalin, J. Gummow, and P. Lowry for assistance; R. Wing and the Arizona Genomics Institute for Amborella bacterial artificial chromosome sequences; the North and South Environmental Services of New Caledonia for collecting permits; M. Moore, P. Soltis, and D. Soltis for two unpublished plastid-genome sequences; and those individuals (see table S11) who supplied the photographs for figures. This work was supported by NIH-RO1-GM-76012 (J.D.P. and E. B. K), the U.S. Department of Energy-Joint Genome Institute Community Sequencing Program under contract DE-AC02-05CH11231 (J.D.P, E. B. K, and J.L.B), NSF-GRF-112955 (A.O.R.), NSF-DBI-0638595 (C. W. D), and the METACyt Initiative of Indiana University, funded by the Lilly Endowment. The data reported in this paper are deposited in GenBank under accessions KF754799-KF754803 and KF798319-KF798355.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Archibald JM, 2011, SYMBIOSIS, V54, P69, DOI 10.1007/s13199-011-0129-z; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bergthorsson U, 2004, P NATL ACAD SCI USA, V101, P17747, DOI 10.1073/pnas.0408336102; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Christin PA, 2012, CURR BIOL, V22, P445, DOI 10.1016/j.cub.2012.01.054; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Gao H, 2006, P NATL ACAD SCI USA, V103, P6759, DOI 10.1073/pnas.0507287103; Kitazaki K, 2011, PLANT J, V68, P262, DOI 10.1111/j.1365-313X.2011.04684.x; Kuroiwa T, 2006, BBA-MOL CELL RES, V1763, P510, DOI 10.1016/j.bbamcr.2006.03.007; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; MARECHALDROUARD L, 1990, NUCLEIC ACIDS RES, V18, P3689, DOI 10.1093/nar/18.13.3689; Mileshina D, 2011, NUCLEIC ACIDS RES, V39, pE115, DOI 10.1093/nar/gkr517; Morat P, 2012, ADANSONIA, V34, P179, DOI 10.5252/a2012n2a1; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2012, ADV BOT RES, V63, P41, DOI 10.1016/B978-0-12-394279-1.00003-X; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Nickrent DL, 2010, TAXON, V59, P538, DOI 10.1002/tax.592019; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Wakamatsu K, 2010, PLANT CELL REP, V29, P1139, DOI 10.1007/s00299-010-0897-6; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Won H, 2003, P NATL ACAD SCI USA, V100, P10824, DOI 10.1073/pnas.1833775100; Xi ZX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003265	31	211	220	8	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1468	1473		10.1126/science.1246275	http://dx.doi.org/10.1126/science.1246275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357311	Green Published			2022-12-28	WOS:000328644300048
J	Abbott, NL				Abbott, Nicholas L.			Colloid Science Collides with Liquid Crystals	SCIENCE			English	Editorial Material							ANOMALOUS DIFFUSION; MOTION		Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	abbott@engr.wisc.edu						Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Lin IH, 2011, SCIENCE, V332, P1297, DOI 10.1126/science.1195639; Loudet JC, 2004, SCIENCE, V306, P1525, DOI 10.1126/science.1102864; Mondiot F, 2013, J AM CHEM SOC, V135, P9972, DOI 10.1021/ja4022182; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; OTT A, 1990, PHYS REV LETT, V65, P2201, DOI 10.1103/PhysRevLett.65.2201; Paxton WF, 2006, ANGEW CHEM INT EDIT, V45, P5420, DOI 10.1002/anie.200600060; Planer J., 1861, ANN CHEM PHARM, V118, P25, DOI DOI 10.1002/JLAC.18611180104; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Stark H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031711; Turiv T, 2013, SCIENCE, V342, P1351, DOI 10.1126/science.1240591; von Smoluchowski M, 1906, ANN PHYS-BERLIN, V21, P756	15	5	5	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1326	1327		10.1126/science.1244987	http://dx.doi.org/10.1126/science.1244987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337282	Green Submitted			2022-12-28	WOS:000328196000033
J	Webb, J; Ward, DE				Webb, Jessica; Ward, David E.			Phoning the patient's general practitioner	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Webb, Jessica; Ward, David E.] St George Hosp, London SW17 0QT, England	St Georges University London	Webb, J (corresponding author), St George Hosp, London SW17 0QT, England.	jesswebb@inbox.com						[Anonymous], GP PAT SURV; Benson T, 2002, BRIT MED J, V325, P1086, DOI 10.1136/bmj.325.7372.1086; General Medical Council, 2013, GOOD MED PRACTICE	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2013	347								f7048	10.1136/bmj.f7048	http://dx.doi.org/10.1136/bmj.f7048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZU	24336452	Bronze			2022-12-28	WOS:000328575600002
J	Donato, F; Rompani, SB; Caroni, P				Donato, Flavio; Rompani, Santiago Belluco; Caroni, Pico			Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning	NATURE			English	Article							CRITICAL-PERIOD; VISUAL-CORTEX; INTERNEURONS; INHIBITION; CIRCUITS; MOUSE; CONNECTIVITY; INNERVATION; ACTIVATION; SYNAPSES	Learning and memory processes can be influenced by recent experience, but the mechanisms involved are poorly understood. Enhanced plasticity during critical periods of early life is linked to differentiating parvalbumin (PV)-interneuron networks(1-7), suggesting that recent experience may modulate learning by targeting the differentiation state of PV neurons(8-11) in the adult. Here we show that environmental enrichment and Pavlovian contextual fear conditioning induce opposite, sustained and reversible hippocampal PV-network configurations in adult mice. Specifically, enrichment promotes the emergence of large fractions of low-differentiation (low PV and GAD67 expression) basket cells with low excitatory-to-inhibitory synaptic-density ratios, whereas fear conditioning leads to large fractions of high-differentiation (high PV and GAD67 expression) basket cells with high excitatory-to-inhibitory synaptic-density ratios. Pharmacogenetic inhibition or activation of PV neurons was sufficient to induce such opposite low-PV-network or high-PV-network configurations, respectively. The low-PV-network configuration enhanced structural synaptic plasticity(12,13), and memory consolidation and retrieval, whereas these were reduced by the high-PV-network configuration. We then show that maze navigation learning(14) induces a hippocampal low-PV-network configuration paralleled by enhanced memory and structural synaptic plasticity throughout training, followed by a shift to a high-PV-network configuration after learning completion. The shift to a low-PV-network configuration specifically involved increased vasoactive intestinal polypeptide (VIP)-positive GABAergic boutons and synaptic transmission onto PV neurons(15,16). Closely comparable low-and high-PV-network configurations involving VIP boutons were specifically induced in primary motor cortex upon rotarod motor learning(17,18). These results uncover a network plasticity mechanism induced after learning through VIP-PV microcircuit modulation(19), and involving large, sustained and reversible shifts in the configuration of PV basket-cell networks in the adult. This novel form of experience-related plasticity in the adult modulates memory consolidation, retrieval and learning, and might be harnessed for therapeutic strategies to promote cognitive enhancement and neuroprotection.	[Donato, Flavio; Rompani, Santiago Belluco; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch		Donato, Flavio/0000-0002-0732-1654; Rompani, Santiago/0000-0002-3994-3052	Novartis Research Foundation; NCCR Synapsy	Novartis Research Foundation; NCCR Synapsy	We thank S. Arber for valuable comments on the manuscript and S. Sternson (Janelia), S. Arber and A. Dayer for reagents. F. D. was supported by the NCCR Synapsy. The Friedrich Miescher Institut is part of and supported by the Novartis Research Foundation.	Acsady L, 1996, NEUROSCIENCE, V73, P299, DOI 10.1016/0306-4522(95)00610-9; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Ruediger S, 2012, NAT NEUROSCI, V15, P1563, DOI 10.1038/nn.3224; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Volman V, 2011, J NEUROSCI, V31, P18137, DOI 10.1523/JNEUROSCI.3041-11.2011; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	31	410	416	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					272	+		10.1038/nature12866	http://dx.doi.org/10.1038/nature12866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336286				2022-12-28	WOS:000328121500035
J	Nowotny, H				Nowotny, Helga			Preserve the European Research Council's legacy	NATURE			English	Editorial Material												helga.nowotny@wwtf.at							0	5	5	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					189	189		10.1038/504189a	http://dx.doi.org/10.1038/504189a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	267TQ	24336250	Bronze			2022-12-28	WOS:000328121500004
J	Engstrom, H; Khin, PT; Coll-Seck, A; Petersen, RH; Asamoa-Baah, A; Machel, G; Sezibera, R; Phumaphi, J; Pablos-Mendes, A; Muller, U; Grijns, L; Whitbread, J; Dare, L; Laxminarayan, R; Lange, JE; Nordstrom, A				Engstrom, Hillevi; Khin, Pe Thet; Coll-Seck, Awa; Petersen, Rasmus Helveg; Asamoa-Baah, Anarfi; Machel, Graca; Sezibera, Richard; Phumaphi, Joy; Pablos-Mendes, Ariel; Mueller, Ursula; Grijns, Lambert; Whitbread, Jasmine; Dare, Lola; Laxminarayan, Ramanan; Lange, John E.; Nordstrom, Anders			Reinvesting in health post-2015	LANCET			English	Editorial Material									[Engstrom, Hillevi; Nordstrom, Anders] Minist Foreign Affairs, Dept Multilateral Dev Cooperat, S-10339 Stockholm, Sweden; [Khin, Pe Thet] Minist Hlth, Nay Pyi Taw, Myanmar; [Coll-Seck, Awa] Minist Hlth, Dakar, Senegal; [Petersen, Rasmus Helveg] Minist Foreign Affairs, Copenhagen, Denmark; [Asamoa-Baah, Anarfi] WHO, CH-1211 Geneva, Switzerland; [Machel, Graca] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Sezibera, Richard] East African Community, Off Secretary Gen, Arusha, Tanzania; [Phumaphi, Joy] African Leaders Malaria Alliance, New York, NY USA; [Pablos-Mendes, Ariel] US Agcy Int Dev, Washington, DC 20523 USA; [Mueller, Ursula] Fed Minist Econ Cooperat & Dev, Berlin, Germany; [Grijns, Lambert] Minist Foreign Affairs, The Hague, Netherlands; [Whitbread, Jasmine] Save Children Int, London, England; [Dare, Lola] CHESTRAD, Lagos, Nigeria; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Lange, John E.] United Nations Fdn, Washington, DC USA	World Health Organization; United States Agency for International Development (USAID); Save the Children; Public Health Foundation of India	Nordstrom, A (corresponding author), Minist Foreign Affairs, Dept Multilateral Dev Cooperat, S-10339 Stockholm, Sweden.	anders.nordstrom@gov.se	Laxminarayan, Ramanan/ABD-5050-2021					Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Jamison DT, 2013, LANCET; Stenberg K, 2013, LANCET; *WORLD BANK, 1993, WORLD DEV REP 1993 I	4	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1861	1864		10.1016/S0140-6736(13)62560-X	http://dx.doi.org/10.1016/S0140-6736(13)62560-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24315164				2022-12-28	WOS:000328222400010
J	Coin, I; Katritch, V; Sun, TT; Xiang, Z; Siu, FY; Beyermann, M; Stevens, RC; Wang, L				Coin, Irene; Katritch, Vsevolod; Sun, Tingting; Xiang, Zheng; Siu, Fai Yiu; Beyermann, Michael; Stevens, Raymond C.; Wang, Lei			Genetically Encoded Chemical Probes in Cells Reveal the Binding Path of Urocortin-I to CRF Class B GPCR	CELL			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTOR; FACTOR TYPE-1 RECEPTOR; SAUVAGINE CROSS-LINKS; COMPETITIVE ANTAGONISTS; PHOTOLABILE PROBES; MAMMALIAN-CELLS; AMINO-ACID; MID-REGION; HORMONE	Molecular determinants regulating the activation of class B G-protein-coupled receptors (GPCRs) by native peptide agonists are largely unknown. We have investigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) and its native 40-mer peptide ligand Urocortin-I directly in mammalian cells. By incorporating unnatural amino acid photochemical and new click-chemical probes into the intact receptor expressed in the native membrane of live cells, 44 intermolecular spatial constraints have been derived for the ligand-receptor interaction. The data were analyzed in the context of the recently resolved crystal structure of CRF1R transmembrane domain and existing extracellular domain structures, yielding a complete conformational model for the peptide-receptor complex. Structural features of the receptor-ligand complex yield molecular insights on the mechanism of receptor activation and the basis for discrimination between agonist and antagonist function.	[Coin, Irene; Sun, Tingting; Xiang, Zheng; Wang, Lei] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Katritch, Vsevolod; Siu, Fai Yiu; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Beyermann, Michael] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Salk Institute; Scripps Research Institute; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	lwang@salk.edu	Xiang, Zheng/D-9625-2011; Katritch, Vsevolod/Y-2721-2019; Katritch, Vsevolod/Q-8357-2016; Wang, Lei/E-7912-2011; Stevens, Raymond/K-7272-2015	Katritch, Vsevolod/0000-0003-3883-4505; Wang, Lei/0000-0002-5859-2526; Stevens, Raymond/0000-0002-4522-8725; Xiang, Zheng/0000-0003-2925-842X	European Commission; NIH [U54 GM094618, F32 DK088392, 1DP2OD004744-01, P30CA014195]; CIRM [RN1-00577-1]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004744] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Peptide Biology Laboratory at Salk for sharing the alpha Ucn1 antibody prepared by Joan Vaughan. I.C. was supported by a Marie Curie fellowship from the European Commission (FP7). V.K. and R.C.S. acknowledge support from NIH (U54 GM094618). F.Y.S. was supported by an NIH fellowship (F32 DK088392). L.W. acknowledges support from CIRM (RN1-00577-1) and NIH (1DP2OD004744-01 and P30CA014195). R.C.S. is a founder of Receptors, a GPCR SBDD company, which does not work on CRF1R.	Abagyan RA, 2012, ICM MANUAL; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Assil-Kishawi I, 2008, J BIOL CHEM, V283, P35644, DOI 10.1074/jbc.M806351200; Beyermann M, 2007, BRIT J PHARMACOL, V151, P851, DOI 10.1038/sj.bjp.0707293; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Hoare SRJ, 2006, BIOCHEM PHARMACOL, V72, P244, DOI 10.1016/j.bcp.2006.04.007; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; RIVIER J, 1983, P NATL ACAD SCI-BIOL, V80, P4851, DOI 10.1073/pnas.80.15.4851; Rivier J, 1998, J MED CHEM, V41, P2614, DOI 10.1021/jm980164e; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; ROMIER C, 1993, PROTEIN ENG, V6, P149, DOI 10.1093/protein/6.2.149; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiang Z, 2013, NAT METHODS, V10, P885, DOI [10.1038/NMETH.2595, 10.1038/nmeth.2595]	39	125	125	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1258	1269		10.1016/j.cell.2013.11.008	http://dx.doi.org/10.1016/j.cell.2013.11.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24290358	Green Accepted, Bronze			2022-12-28	WOS:000328271100011
J	Guo, JY; Xia, B; White, E				Guo, Jessie Yanxiang; Xia, Bing; White, Eileen			Autophagy-Mediated Tumor Promotion	CELL			English	Review							SUPPRESSES TUMORIGENESIS; NRF2; INSTABILITY; PROGRESSION; INTERACTS; CANCERS; KEAP1; P53; P62	Mouse models for cancer are revealing novel cancer-promoting roles for autophagy. Autophagy promotes tumor growth by suppressing the p53 response, maintaining mitochondrial function, sustaining metabolic homeostasis and survival in stress, and preventing diversion of tumor progression to benign oncocytomas.	[Guo, Jessie Yanxiang; Xia, Bing; White, Eileen] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Guo, Jessie Yanxiang; White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Xia, Bing] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08904 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	White, E (corresponding author), Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA.	epwhite@cinj.rutgers.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	NIH [R37CA53370, RC1CA147961, R01CA163591, R01CA130893]; Department of Defense [W81XWH-09-01-0394]; Val Skinner Foundation; New Jersey Commission for Cancer Research; Rutgers Cancer Institute of New Jersey; American Cancer Society [RSG TBG-119822]; NATIONAL CANCER INSTITUTE [RC1CA147961, R01CA163591, R01CA138804, R01CA130893, R37CA053370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Val Skinner Foundation; New Jersey Commission for Cancer Research; Rutgers Cancer Institute of New Jersey; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The White laboratory acknowledges support from NIH grants R37CA53370, RC1CA147961, R01CA163591, and R01CA130893, the Department of Defense (W81XWH-09-01-0394), the Val Skinner Foundation, the New Jersey Commission for Cancer Research, and the Rutgers Cancer Institute of New Jersey. The Xia laboratory is supported by the NIH (RC1CA147961), the American Cancer Society (RSG TBG-119822), and the Rutgers Cancer Institute of New Jersey. The authors apologize for the limited number of citations due to space limitation. Eileen White is a member of the scientific advisory board of Forma Therapeutics.	Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhu Y, 2009, MOL CELL, V36, P351, DOI 10.1016/j.molcel.2009.10.026	21	334	359	2	128	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1216	1219		10.1016/j.cell.2013.11.019	http://dx.doi.org/10.1016/j.cell.2013.11.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315093	Green Accepted, Bronze			2022-12-28	WOS:000328271100007
J	Al-Shukri, I; Davidson, E; Tan, A; Smith, DB; Wellington, L; Johannessen, I; Ramalingam, S				Al-Shukri, Intisar; Davidson, Emma; Tan, Adrian; Smith, Donald B.; Wellington, Louise; Johannessen, Ingolfur; Ramalingam, Sandeep			Rash and arthralgia caused by hepatitis E	LANCET			English	Editorial Material									[Al-Shukri, Intisar; Johannessen, Ingolfur; Ramalingam, Sandeep] Royal Infirm Edinburgh NHS Trust, Dept Lab Med, Edinburgh EH16 4SA, Midlothian, Scotland; [Davidson, Emma] Bonnyrigg Hlth Ctr, Bonnyrigg, Midlothian, Scotland; [Tan, Adrian] Western Gen Hosp, Dept Rheumatol, Edinburgh EH4 2XU, Midlothian, Scotland; [Smith, Donald B.] Univ Edinburgh, Virus Evolut Grp, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Wellington, Louise] NHS Lothian, Hlth Protect Team, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Ramalingam, S (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Lab Med, 51 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.	sandeep.ramalingam@nhslothian.scot.nhs.uk						Crossan C, 2012, EMERG INFECT DIS, V18, P2085, DOI 10.3201/eid1812.120924; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Serratrice J, 2007, CLIN RHEUMATOL, V26, P1973, DOI 10.1007/s10067-007-0595-0; Smith DB, 2013, EMERG INFECT DIS, V19, P468, DOI 10.3201/eid1903.121510; Smith DB, 2012, J GEN VIROL, V93, P2408, DOI 10.1099/vir.0.045351-0	5	19	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1856	1856		10.1016/S0140-6736(13)62074-7	http://dx.doi.org/10.1016/S0140-6736(13)62074-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24290589				2022-12-28	WOS:000327540700029
J	Mayer, K				Mayer, Klaus			Expand nuclear forensics	NATURE			English	Editorial Material									Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany	European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU)	Mayer, K (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany.	klaus.mayer@ec.europa.eu							0	28	28	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					461	462		10.1038/503461a	http://dx.doi.org/10.1038/503461a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24298568	Bronze			2022-12-28	WOS:000327464200014
J	Park, K; Antoine, DJ; Pirmohamed, M				Park, Kevin; Antoine, Daniel J.; Pirmohamed, Munir			Treatment of paracetamol overdose: room for improvement?	LANCET			English	Editorial Material							N-ACETYLCYSTEINE; MULTICENTER; BIOMARKERS		[Park, Kevin; Antoine, Daniel J.; Pirmohamed, Munir] Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Park, K (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	bkpark@liverpool.ac.uk	Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266	MRC [MR/L006758/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish; Medical Research Council [MR/L006758/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Bateman DN, 2014, LANCET, V383, P697, DOI 10.1016/S0140-6736(13)62062-0; Commission on Human Medicines Paracetamol Expert Group, 2013, BEN RISK PROF AC MAN; Ferner RE, 2001, BRIT J CLIN PHARMACO, V52, P573, DOI 10.1046/j.0306-5251.2001.01490.x; Ferner RE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2218; Matheis K, 2011, DRUG DISCOV TODAY, V16, P600, DOI 10.1016/j.drudis.2011.04.011; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; PRESCOTT LF, 1977, LANCET, V2, P432; Sandilands EA, 2009, CLIN TOXICOL, V47, P81, DOI 10.1080/15563650802665587; Schmidt LE, 2002, LANCET, V360, P1151, DOI 10.1016/S0140-6736(02)11194-9; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401	12	8	8	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					672	674		10.1016/S0140-6736(13)62303-X	http://dx.doi.org/10.1016/S0140-6736(13)62303-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24290402				2022-12-28	WOS:000331653300005
J	Vaniman, DT; Bish, DL; Ming, DW; Bristow, TF; Morris, RV; Blake, DF; Chipera, SJ; Morrison, SM; Treiman, AH; Rampe, EB; Rice, M; Achilles, CN; Grotzinger, JP; McLennan, SM; Williams, J; Bell, JF; Newsom, HE; Downs, RT; Maurice, S; Sarrazin, P; Yen, AS; Morookian, JM; Farmer, JD; Stack, K; Milliken, RE; Ehlmann, BL; Sumner, DY; Berger, G; Crisp, JA; Hurowitz, JA; Anderson, R; Des Marais, DJ; Stolper, EM; Edgett, KS; Gupta, S; Spanovich, N				Vaniman, D. T.; Bish, D. L.; Ming, D. W.; Bristow, T. F.; Morris, R. V.; Blake, D. F.; Chipera, S. J.; Morrison, S. M.; Treiman, A. H.; Rampe, E. B.; Rice, M.; Achilles, C. N.; Grotzinger, J. P.; McLennan, S. M.; Williams, J.; Bell, J. F., III; Newsom, H. E.; Downs, R. T.; Maurice, S.; Sarrazin, P.; Yen, A. S.; Morookian, J. M.; Farmer, J. D.; Stack, K.; Milliken, R. E.; Ehlmann, B. L.; Sumner, D. Y.; Berger, G.; Crisp, J. A.; Hurowitz, J. A.; Anderson, R.; Des Marais, D. J.; Stolper, E. M.; Edgett, K. S.; Gupta, S.; Spanovich, N.		MSL Sci Team	Mineralogy of a Mudstone at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							CHEMCAM INSTRUMENT SUITE; OMEGA/MARS EXPRESS; MERIDIANI-PLANUM; CLAY-MINERALS; BASSANITE; WATER; SURFACE; SYSTEM; TRANSFORMATIONS; CONSTRAINTS	Sedimentary rocks at Yellowknife Bay (Gale crater) on Mars include mudstone sampled by the Curiosity rover. The samples, John Klein and Cumberland, contain detrital basaltic minerals, calcium sulfates, iron oxide or hydroxides, iron sulfides, amorphous material, and trioctahedral smectites. The John Klein smectite has basal spacing of similar to 10 angstroms, indicating little interlayer hydration. The Cumberland smectite has basal spacing at both similar to 13.2 and similar to 10 angstroms. The larger spacing suggests a partially chloritized interlayer or interlayer magnesium or calcium facilitating H2O retention. Basaltic minerals in the mudstone are similar to those in nearby eolian deposits. However, the mudstone has far less Fe-forsterite, possibly lost with formation of smectite plus magnetite. Late Noachian/Early Hesperian or younger age indicates that clay mineral formation on Mars extended beyond Noachian time.	[Vaniman, D. T.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bish, D. L.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Ming, D. W.; Morris, R. V.; Rampe, E. B.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Bristow, T. F.; Blake, D. F.; Des Marais, D. J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Chipera, S. J.] Chesapeake Energy, Oklahoma City, OK 73154 USA; [Morrison, S. M.; Downs, R. T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Rice, M.; Grotzinger, J. P.; Stack, K.; Ehlmann, B. L.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Achilles, C. N.] ESCG UTC Aerosp Syst, Houston, TX 77058 USA; [McLennan, S. M.; Hurowitz, J. A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Williams, J.; Newsom, H. E.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Bell, J. F., III; Farmer, J. D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Maurice, S.; Berger, G.] Univ Toulouse, CNRS, IRAP, F-31400 Toulouse, France; [Sarrazin, P.] SETI Inst, Mountain View, CA 94043 USA; [Yen, A. S.; Morookian, J. M.; Ehlmann, B. L.; Crisp, J. A.; Anderson, R.; Spanovich, N.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Milliken, R. E.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Edgett, K. S.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England	Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; California Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; Arizona State University; Arizona State University-Tempe; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; University of California System; University of California Davis; Imperial College London	Vaniman, DT (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	dvaniman@psi.edu	Stipp, Susan L.S./B-8494-2019; De Pablo, Miguel Ángel/J-6442-2014; Franz, Heather B/F-3508-2012; Hayes, Alexander G/P-2024-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Lemmon, Mark T/E-9983-2010; FABRE, Cécile/B-5827-2012; Crisp, Joy/H-8287-2016; BERGER, Gilles/F-7118-2016; Balic-Zunic, Tonci/A-6362-2013; Blanco, Juan Jose/E-3627-2014; Harri, Ari-Matti/C-7142-2012; Muller, Jan-Peter/Q-8886-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Prats, Benito/F-9467-2019; Rodriguez-Manfredi, Jose/L-8001-2014; Farmer, Jack D/B-9343-2019; GEFFROY, Claude/AAB-9152-2019; Glavin, Daniel P/D-6194-2012; Martin-Torres, Javier/G-6329-2015; Avalos, Juan Jose Blanco/AAB-9447-2021; Bish, David/AAY-7618-2020; Floyd, Melissa/D-4626-2012; Gómez, Felipe/L-7315-2014; Stack Morgan, Kathryn/AGY-7985-2022; Teinturier, Samuel/AAS-8663-2020; Navarro-González, Rafael/D-1748-2009; Gomez-Elvira, Javier/K-5829-2014; szopa, cyril/C-6865-2015; Benna, Mehdi/F-3489-2012; Romeral Planelló, Julio J./T-1788-2017; Dworkin, Jason P./C-9417-2012; Sumner, Dawn Y/E-8744-2011; Steele, Andrew/A-3573-2013; Ramos, Miguel/K-2230-2014; Zorzano, María-Paz/F-2184-2015; Gasnault, Olivier/F-4327-2010; Vicenzi, Edward/T-9430-2017	Stipp, Susan L.S./0000-0001-7009-643X; De Pablo, Miguel Ángel/0000-0002-4496-2741; Hayes, Alexander G/0000-0001-6397-2630; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Lemmon, Mark T/0000-0002-4504-5136; FABRE, Cécile/0000-0001-8627-4050; Crisp, Joy/0000-0002-3202-4416; Balic-Zunic, Tonci/0000-0003-1687-1233; Blanco, Juan Jose/0000-0002-8666-0696; Harri, Ari-Matti/0000-0001-8541-2802; Muller, Jan-Peter/0000-0002-5077-3736; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; GEFFROY, Claude/0000-0002-2731-9658; Glavin, Daniel P/0000-0001-7779-7765; Martin-Torres, Javier/0000-0001-6479-2236; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Gómez, Felipe/0000-0001-9977-7060; Teinturier, Samuel/0000-0003-1755-9524; Navarro-González, Rafael/0000-0002-6078-7621; Gomez-Elvira, Javier/0000-0002-9068-9846; szopa, cyril/0000-0002-0090-4056; Romeral Planelló, Julio J./0000-0002-2205-067X; Dworkin, Jason P./0000-0002-3961-8997; Sumner, Dawn Y/0000-0002-7343-2061; Steele, Andrew/0000-0001-9643-2841; Ramos, Miguel/0000-0003-3648-6818; Zorzano, María-Paz/0000-0002-4492-9650; Gupta, Sanjeev/0000-0001-6415-1332; Johnson, Jeffrey/0000-0002-5586-4901; Edgett, Kenneth/0000-0001-7197-5751; Gasnault, Olivier/0000-0002-6979-9012; Vicenzi, Edward/0000-0003-2085-6546; Rice, Melissa/0000-0002-8370-4139; BERGER, Gilles/0000-0003-4806-5594; McLennan, Scott/0000-0003-4259-7178; Morrison, Shaunna/0000-0002-1712-8057	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/I003118/1, ST/J005169/1] Funding Source: researchfish	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	This paper was significantly improved by comments and recommendations from two anonymous reviewers. Support from the NASA Mars Science Laboratory Mission is gratefully acknowledged. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; Bell III J. F., 2013, LUNAR PLANET SCI C, V44; Bell III J. F., 2012, LUNAR PLANET SCI C, V43; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Bish DL, 2003, ICARUS, V164, P96, DOI 10.1016/S0019-1035(03)00140-4; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Bristow TF, 2011, CLAY CLAY MINER, V59, P339, DOI 10.1346/CCMN.2011.0590401; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; Campbell JL, 2012, SPACE SCI REV, V170, P319, DOI 10.1007/s11214-012-9873-5; CHANG HK, 1986, CLAY CLAY MINER, V34, P407, DOI 10.1346/CCMN.1986.0340408; Chipera SJ, 2002, J APPL CRYSTALLOGR, V35, P744, DOI 10.1107/S0021889802017405; Douglas S, 2002, GEOLOGY, V30, P1075, DOI 10.1130/0091-7613(2002)030<1075:MBIEPO>2.0.CO;2; Edgett K. S., 2013, LUNAR PLANET SCI C, V44; Glamoclija M., 2010, ASTR SCI C 2010 EV L; Glotch T, 2008, PHYS CHEM MINER, V35, P569, DOI 10.1007/s00269-008-0249-z; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Grotzinger J, 2009, NAT GEOSCI, V2, P231, DOI 10.1038/ngeo480; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; GUNATILAKA A, 1985, J U KUWAIT-SCI, V12, P157; Hahn B. C., 2011, LUNAR PLANET SCI C, V42; HARDIE LA, 1967, AM MINERAL, V52, P171; Janchen J, 2006, ICARUS, V180, P353, DOI 10.1016/j.icarus.2005.10.010; JONES BF, 1983, CLAY CLAY MINER, V31, P161, DOI 10.1346/CCMN.1983.0310301; KELLER LP, 1994, GEOCHIM COSMOCHIM AC, V58, P5589, DOI 10.1016/0016-7037(94)90252-6; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Malin M. C., 2010, LUNAR PLANET SCI C, V41; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; McAdam A.C., 2004, 2 C EARL MARS GEOL H; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; McQuivey R. S., 1969, US GEOL SURV PROF D, V650-D, pD244; Mees F, 2005, SEDIMENT GEOL, V181, P225, DOI 10.1016/j.sedgeo.2005.09.002; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; Milliken R. E., 2010, LUNAR PLANET SCI C, V41; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Mirwald PW, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2826321; Morris R. V., 2013, LUNAR PLANET SCI C, V44; Morrison S. M., 2013, LUNAR PLANET SCI C, V44; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Nambu, 1968, J JPN ASS MINERAL, V59, P143, DOI [10.2465/ganko1941.59.143, DOI 10.2465/GANKO1941.59.143]; Oetzel M, 2000, ZKG INT, V53, P354; PEVEAR DR, 1982, CLAY CLAY MINER, V30, P241, DOI 10.1346/CCMN.1982.0300401; Rice MS, 2010, ICARUS, V205, P375, DOI 10.1016/j.icarus.2009.03.035; Rice M. S., 2011, AM GEOPH UN FALL M; RICH CI, 1968, CLAY CLAY MINER, V16, P15, DOI 10.1346/CCMN.1968.0160104; Robertson K, 2013, ICARUS, V223, P407, DOI 10.1016/j.icarus.2012.10.028; SKIPPER NT, 1991, J CHEM PHYS, V94, P7434, DOI 10.1063/1.460175; SLINGERLAND R, 1986, ANNU REV EARTH PL SC, V14, P113, DOI 10.1146/annurev.ea.14.050186.000553; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Sutley SJ., 2007, USGS DIGITAL SPECTRA; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Vaniman D. T., 2009, LUNAR PLANET SCI C, V40; Vaniman D. T., 2006, WORKSH SULF REC ATM; Vaniman DT, 2006, AM MINERAL, V91, P1628, DOI 10.2138/am.2006.2092; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; WORKU T, 1992, MINERAL MAG, V56, P258, DOI 10.1180/minmag.1992.056.383.15; Wray JJ, 2010, ICARUS, V209, P416, DOI 10.1016/j.icarus.2010.06.001; Zolotov MY, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002882	64	430	435	8	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1243480	10.1126/science.1243480	http://dx.doi.org/10.1126/science.1243480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324271	Green Accepted			2022-12-28	WOS:000330039300003
J	Cambier, CJ; Takaki, KK; Larson, RP; Hernandez, RE; Tobin, DM; Urdahl, KB; Cosma, CL; Ramakrishnan, L				Cambier, C. J.; Takaki, Kevin K.; Larson, Ryan P.; Hernandez, Rafael E.; Tobin, David M.; Urdahl, Kevin B.; Cosma, Christine L.; Ramakrishnan, Lalita			Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids	NATURE			English	Article							MARINUM INFECTION; IMMUNE-RESPONSE; NITRIC-OXIDE; TUBERCULOSIS; ZEBRAFISH; SUSCEPTIBILITY; GRANULOMA; VIRULENCE; HUMANS; MICE	The evolutionary survival of Mycobacterium tuberculosis, the cause of human tuberculosis, depends on its ability to invade the host, replicate, and transmit infection. At its initial peripheral infection site in the distal lung airways, M. tuberculosis infects macrophages, which transport it to deeper tissues(1). How mycobacteria survive in these broadly microbicidal cells is an important question. Here we show in mice and zebrafish that M. tuberculosis, and its close pathogenic relative Mycobacterium marinum, preferentially recruit and infect permissive macrophages while evading microbicidal ones. This immune evasion is accomplished by using cell-surface-associated phthiocerol dimycoceroserate (PDIM) lipids(2) to mask underlying pathogen-associated molecular patterns (PAMPs). In the absence of PDIM, these PAMPs signal a Toll-like receptor (TLR)-dependent recruitment of macrophages that produce microbicidal reactive nitrogen species. Concordantly, the related phenolic glycolipids (PGLs)(2) promote the recruitment of permissive macrophages through a host chemokine receptor 2 (CCR2)-mediated pathway. Thus, we have identified coordinated roles for PDIM, known to be essential for mycobacterial virulence(3), and PGL, which (along with CCR2) is known to be associated with human tuberculosis(4,5). Our findings also suggest an explanation for the longstanding observation that M. tuberculosis initiates infection in the relatively sterile environment of the lower respiratory tract, rather than in the upper respiratory tract, where resident microflora and inhaled environmental microbes may continually recruit microbicidal macrophages through TLR-dependent signalling.	[Cambier, C. J.; Larson, Ryan P.; Urdahl, Kevin B.; Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Takaki, Kevin K.; Tobin, David M.; Cosma, Christine L.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Larson, Ryan P.; Urdahl, Kevin B.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Hernandez, Rafael E.; Urdahl, Kevin B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	lalitar@uw.edu		Urdahl, Kevin/0000-0003-0088-1066; Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533; Tobin, David/0000-0003-3465-5518	National Science Foundation; American Lung Association; National Institutes of Health (NIH); NIH; American Cancer Society Postdoctoral Fellowship; NIH Bacterial Pathogenesis Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076327, R01AI036396, R37AI054503, R01AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006782] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Lung Association; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH Bacterial Pathogenesis Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Falkow and P. Edelstein for sharing their knowledge and insights, P. Donald for discussions about human infectivity in tuberculosis, B. Cormack for manuscript review and editing, J. Bubeck-Wardenberg for the fluorescent S. aureus strain, K. Hicks for initial MyD88 experiments, T.-Y. Chen, B. Moody, P. Manzanillo and J. Cox for help with lipid analyses, and J. Cameron for fish facility management. Supported by a National Science Foundation predoctoral fellowship to C. J. C., a Senior Research Training Fellowship from the American Lung Association and the National Institutes of Health (NIH) Training Grant "Training Clinical and Basic Immunologists" to R. P. L., a NIH "Academic Pediatric Infectious Disease" Training Grant award to R. E. H., an American Cancer Society Postdoctoral Fellowship and NIH Bacterial Pathogenesis Training Grant Award to D. M. T., and NIH grants to K. B. U. and L. R. D. M. T. is a recipient of the NIH Director's New Innovator Award and L. R. is a recipient of the NIH Director's Pioneer Award.	Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Mendonca-Lima L, 2003, CELL MICROBIOL, V5, P65, DOI 10.1046/j.1462-5822.2003.00237.x; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Feng WX, 2012, INT J TUBERC LUNG D, V16, P150, DOI 10.5588/ijtld.11.0205; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murry JP, 2009, J INFECT DIS, V200, P774, DOI 10.1086/605128; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; ROSENTHAL S, 1975, ANN INTERN MED, V83, P355, DOI 10.7326/0003-4819-83-3-355; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yu J, 2012, INFECT IMMUN, V80, P1381, DOI 10.1128/IAI.06370-11	39	296	305	7	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					218	+		10.1038/nature12799	http://dx.doi.org/10.1038/nature12799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24336213	Green Accepted			2022-12-28	WOS:000329441500039
J	Cuker, A				Cuker, Adam			Risk-stratified vs routine antithrombotics for TKA: fewer wound complications without increasing DVT	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							KNEE ARTHROPLASTY		Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Cuker, A (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Mont MA, 2011, J AM ACAD ORTHOP SUR, V19, P768, DOI 10.5435/00124635-201112000-00007; Vince K, 2007, J ARTHROPLASTY, V22, P39, DOI 10.1016/j.arth.2007.03.014	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC5	10.7326/0003-4819-159-12-201312170-02005	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343410				2022-12-28	WOS:000329735300004
J	Turiv, T; Lazo, I; Brodin, A; Lev, BI; Reiffenrath, V; Nazarenko, VG; Lavrentovich, OD				Turiv, T.; Lazo, I.; Brodin, A.; Lev, B. I.; Reiffenrath, V.; Nazarenko, V. G.; Lavrentovich, O. D.			Effect of Collective Molecular Reorientations on Brownian Motion of Colloids in Nematic Liquid Crystal	SCIENCE			English	Article							ANOMALOUS DIFFUSION; PARTICLE TRACKING; STOKES DRAG; FLUIDS; NANOPARTICLES	In the simplest realization of Brownian motion, a colloidal sphere moves randomly in an isotropic fluid; its mean squared displacement (MSD) grows linearly with time tau. Brownian motion in an orientationally ordered fluid-a nematic-is anisotropic, with the MSD being larger along the axis of molecular orientation, called the director. We found that at short time scales, the anisotropic diffusion in a nematic becomes anomalous, with the MSD growing slower or faster than t; these states are respectively termed subdiffusion and superdiffusion. The anomalous diffusion occurs at time scales that correspond to the relaxation times of director deformations around the sphere. Once the nematic melts, the diffusion becomes normal and isotropic. Our experiment shows that the deformations and fluctuations of long-range orientational order profoundly influence diffusive regimes.	[Turiv, T.; Brodin, A.; Nazarenko, V. G.] Inst Phys NASU, UA-03039 Kiev, Ukraine; [Turiv, T.; Lazo, I.; Lavrentovich, O. D.] Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA; [Brodin, A.] Natl Tech Univ Ukraine KPI, UA-03056 Kiev, Ukraine; [Lev, B. I.] Bogolyubov Inst Theoret Phys NASU, UA-03680 Kiev, Ukraine; [Reiffenrath, V.] Merck KGaA, Liquid Crystals Div, D-64271 Darmstadt, Germany	National Academy of Sciences Ukraine; Institute of Physics of the National Academy of Sciences of Ukraine; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Ministry of Education & Science of Ukraine; Igor Sikorsky Kyiv Polytechnic Institute; National Academy of Sciences Ukraine; Bogolyubov Institute for Theoretical Physics; Merck KGaA	Lavrentovich, OD (corresponding author), Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA.	olavrent@kent.edu	Brodin, Alexander/AAK-4374-2020; nazarenko, vassili/AAE-2445-2020; Turiv, Taras/AAV-9107-2021; Lavrentovich, Oleg D./AAP-2151-2020; Lavrentovich, Oleg D/B-4996-2011	Lavrentovich, Oleg D./0000-0002-0128-0708; 	NSF [DMR 1104850, 1121288]; Science & Technology Center in Ukraine [5258]; DFFD [F35/534-2011]; NASU [1.4.1B/10]	NSF(National Science Foundation (NSF)); Science & Technology Center in Ukraine; DFFD(State Fund for Fundamental Research (SFFR)); NASU	We thank R. Kamien, E. I. Kats, T. C. Lubensky, and E. Weeks for fruitful discussions, and O. Boiko, U. Ognysta, and A. Nych for help in the experiments. Supported by NSF grants DMR 1104850 and 1121288, Science & Technology Center in Ukraine project no. 5258, DFFD F35/534-2011, and NASU 1.4.1B/10. See supplementary materials for further details on data.	Abras D, 2012, SOFT MATTER, V8, P2026, DOI 10.1039/c1sm06794j; Alam MM, 2011, LANGMUIR, V27, P6171, DOI 10.1021/la200116e; Angelico R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031403; Coffey W. T., 1996, LANGEVIN EQUATION AP; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Gambin Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110602; Ganapathy R, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/18007; KENKRE VM, 1981, Z PHYS B CON MAT, V41, P177, DOI 10.1007/BF01293416; Koenig GM, 2009, NANO LETT, V9, P2794, DOI 10.1021/nl901498d; Kumar N, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021101; Loudet JC, 2004, SCIENCE, V306, P1525, DOI 10.1126/science.1102864; Lubensky TC, 1998, PHYS REV E, V57, P610, DOI 10.1103/PhysRevE.57.610; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mondiot F, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.010401; Moreno-Razo JA, 2011, SOFT MATTER, V7, P6828, DOI 10.1039/c0sm01506g; OTT A, 1990, PHYS REV LETT, V65, P2201, DOI 10.1103/PhysRevLett.65.2201; Pishnyak OP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127802; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Pumpa M, 2012, J PHYS CHEM B, V116, P14487, DOI 10.1021/jp307403w; REIFFENRATH V, 2001, ANISOTROPIC ORGANIC, P195; Ruhwandl RW, 1996, PHYS REV E, V54, P5204, DOI 10.1103/PhysRevE.54.5204; SCHER H, 1973, PHYS REV B, V7, P4491, DOI 10.1103/PhysRevB.7.4491; Skarabot M, 2010, SOFT MATTER, V6, P5476, DOI 10.1039/c0sm00437e; Sprakel J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061502; Stark H, 2003, J PHYS-CONDENS MAT, V15, pS191, DOI 10.1088/0953-8984/15/1/324; Voloschenko D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.060701; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; Wu XL, 2001, PHYS REV LETT, V86, P557, DOI 10.1103/PhysRevLett.86.557	30	84	85	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1351	1354		10.1126/science.1240591	http://dx.doi.org/10.1126/science.1240591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337292	Green Submitted			2022-12-28	WOS:000328196000045
J	Wang, P; Dong, SW; Shieh, JH; Peguero, E; Hendrickson, R; Moore, MAS; Danishefsky, SJ				Wang, Ping; Dong, Suwei; Shieh, Jae-Hung; Peguero, Elizabeth; Hendrickson, Ronald; Moore, Malcolm A. S.; Danishefsky, Samuel J.			Erythropoietin Derived by Chemical Synthesis	SCIENCE			English	Article							PHASE PEPTIDE-SYNTHESIS; PROTEINS; CYSTEINE; GLYCOPEPTIDES; GLYCOSYLATION; ADVANCE; DESIGN	Erythropoietin is a signaling glycoprotein that controls the fundamental process of erythropoiesis, orchestrating the production and maintenance of red blood cells. As administrated clinically, erythropoietin has a polypeptide backbone with complex dishomogeneity in its carbohydrate domains. Here we describe the total synthesis of homogeneous erythropoietin with consensus carbohydrate domains incorporated at all of the native glycosylation sites. The oligosaccharide sectors were built by total synthesis and attached stereospecifically to peptidyl fragments of the wild-type primary sequence, themselves obtained by solid-phase peptide synthesis. The glycopeptidyl constructs were joined by chemical ligation, followed by metal-free dethiylation, and subsequently folded. This homogeneous erythropoietin glycosylated at the three wild-type aspartates with N-linked high-mannose sialic acid-containing oligosaccharides and O-linked glycophorin exhibits Procrit-level in vivo activity in mice.	[Wang, Ping; Dong, Suwei; Danishefsky, Samuel J.] Sloan Kettering Inst Canc Res, Bioorgan Chem Lab, New York, NY 10065 USA; [Shieh, Jae-Hung; Peguero, Elizabeth; Moore, Malcolm A. S.] Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY 10065 USA; [Hendrickson, Ronald] Sloan Kettering Inst Canc Res, Dept Pharmacol & Chem, New York, NY 10065 USA; [Danishefsky, Samuel J.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Danishefsky, SJ (corresponding author), Sloan Kettering Inst Canc Res, Bioorgan Chem Lab, 1275 York Ave, New York, NY 10065 USA.	s-danishefsky@ski.mskcc.org		Peguero, Elizabeth/0000-0003-2387-3595; Wang, Ping/0000-0002-8640-1483	National Institutes of Health [HL025848]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for support from the National Institutes of Health (grant HL025848), for spectroscopic assistance from G. Sukenick and H. Fang of the Sloan-Kettering Institute's nuclear magnetic resonance core facility, and to L. Wilson and L. Ambrosini Vadola for preparation of the manuscript. We also thank M. Luo and H. Guo for their assistance on gel electrophoresis and Y. Xia for helpful discussions regarding mass spectroscopy.	Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; Chen G, 2006, J AM CHEM SOC, V128, P7460, DOI 10.1021/ja061588y; Danishefsky SJ, 2000, ANGEW CHEM INT EDIT, V39, P836, DOI 10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I; Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dong SW, 2011, ISR J CHEM, V51, P968, DOI 10.1002/ijch.201100077; Elliott Steven G., 2009, P115, DOI 10.1007/978-3-7643-8698-6_8; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hirano K, 2009, ANGEW CHEM INT EDIT, V48, P9557, DOI 10.1002/anie.200904376; Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085; Liu SH, 2012, ANGEW CHEM INT EDIT, V51, P993, DOI 10.1002/anie.201106060; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Murakami M, 2012, ANGEW CHEM INT EDIT, V51, P3567, DOI 10.1002/anie.201109034; Narhi LO, 2001, PROTEIN ENG, V14, P135, DOI 10.1093/protein/14.2.135; Nett JH, 2012, J BIOTECHNOL, V157, P198, DOI 10.1016/j.jbiotec.2011.11.002; RECNY MA, 1987, J BIOL CHEM, V262, P17156; RUSH RS, 1995, ANAL CHEM, V67, P1442, DOI 10.1021/ac00104a022; SAKAKIBARA S, 1995, BIOPOLYMERS, V37, P17, DOI 10.1002/bip.360370105; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Schwarz JB, 1999, J AM CHEM SOC, V121, P2662, DOI 10.1021/ja9833265; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; SYTKOWSKI AJ, 2004, ERYTHROPOIETIN; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; Ullmann V, 2012, ANGEW CHEM INT EDIT, V51, P11566, DOI 10.1002/anie.201204272; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Wang P, 2012, ANGEW CHEM INT EDIT, V51, P11576, DOI 10.1002/anie.201206090; Wang P, 2012, ANGEW CHEM INT EDIT, V51, P11571, DOI 10.1002/anie.201205038; Wang T, 2013, P NATL ACAD SCI USA, V110, P11708, DOI 10.1073/pnas.1310431110; Warren JD, 2004, J AM CHEM SOC, V126, P6576, DOI 10.1021/ja0491836; Wilson RM, 2013, ANGEW CHEM INT EDIT, V52, P7646, DOI 10.1002/anie.201301666; Wu B, 2006, TETRAHEDRON LETT, V47, P8009, DOI 10.1016/j.tetlet.2006.09.050; Wu B, 2006, TETRAHEDRON LETT, V47, P5577, DOI 10.1016/j.tetlet.2006.05.086; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m	35	166	168	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1357	1360		10.1126/science.1245095	http://dx.doi.org/10.1126/science.1245095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337294	Green Accepted			2022-12-28	WOS:000328196000047
J	Delling, M; DeCaen, PG; Doerner, JF; Febvay, S; Clapham, DE				Delling, Markus; DeCaen, Paul G.; Doerner, Julia F.; Febvay, Sebastien; Clapham, David E.			Primary cilia are specialized calcium signalling organelles	NATURE			English	Article							HEDGEHOG; LINKS	Primary cilia are solitary, non-motile extensions of the centriole found on nearly all nucleated eukaryotic cells between cell divisions. Only similar to 200-300 nm in diameter and a few micrometres long, they are separated from the cytoplasm by the ciliary neck and basal body. Often called sensory cilia, they are thought to receive chemical and mechanical stimuli and initiate specific cellular signal transduction pathways. When activated by a ligand, hedgehog pathway proteins, such as GLI2 and smoothened (SMO), translocate from the cell into the cilium(1,2). Mutations in primary ciliary proteins are associated with severe developmental defects(3). The ionic conditions, permeability of the primary cilia membrane, and effectiveness of the diffusion barriers between the cilia and cell body are unknown. Here we show that cilia are a unique calcium compartment regulated by a heteromeric TRP channel, PKD1L1-PKD2L1, in mice and humans. In contrast to the hypothesis that polycystin (PKD) channels initiate changes in ciliary calcium that are conducted into the cytoplasm(4), we show that changes in ciliary calcium concentration occur without substantially altering global cytoplasmic calcium. PKD1L1-PKD2L1 acts as a ciliary calcium channel controlling ciliary calcium concentration and thereby modifying SMO-activated GLI2 translocation and GLI1 expression.	[Delling, Markus; DeCaen, Paul G.; Doerner, Julia F.; Febvay, Sebastien; Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, 320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	NIH [T32-HL007572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC; NIHP30-HD 18655). We thank the Image and Data Analysis Core (IDAC) at Harvard Medical School for help with three-dimensional reconstruction. We also thank A. Salic for anti-SMO and anti-GLI2 antibodies. P. G. D. was supported by NIH T32-HL007572. We thank M. Desai for graphical assistance and A. von Gise and H. Tukachinsky (Harvard Medical School) and the members of the Clapham laboratory for advice and discussion.	Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Gibbs D, 2003, ADV EXP MED BIOL, V533, P347; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Martin V, 2010, PEDIATR SURG INT, V26, P769, DOI 10.1007/s00383-010-2622-5; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Yasuda Ryohei, 2004, Sci STKE, V2004, ppl5, DOI 10.1126/stke.2192004pl5; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	24	307	311	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					311	+		10.1038/nature12833	http://dx.doi.org/10.1038/nature12833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336288	Green Accepted, Green Submitted			2022-12-28	WOS:000328121500043
J	Klass, P				Klass, Perri			Getting Through the Night	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10016 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10016 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2279	2281		10.1056/NEJMp1312946	http://dx.doi.org/10.1056/NEJMp1312946			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328465				2022-12-28	WOS:000328156300005
J	Ferner, R				Ferner, Robin			A fat chance of slimming	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				[Anonymous], 1946, BMJ-BRIT MED J, V2, P949; [Anonymous], 1937, BMJ-BRIT MED J, V1937, P1076; [Anonymous], 1973, BMJ-BRIT MED J, V4, P692; [Anonymous], 2008, ANN ICRP, V38, P1; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; BHASIN S, 1981, AM J MED, V71, P887, DOI 10.1016/0002-9343(81)90392-2; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Fishman AP, 1999, CIRCULATION, V99, P156, DOI 10.1161/01.CIR.99.1.156; Gokmen MR, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4000; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; HEDBERG CW, 1987, NEW ENGL J MED, V316, P993, DOI 10.1056/NEJM198704163161605; Horner W D, 1941, Trans Am Ophthalmol Soc, V39, P405; NHS Choices, 2013, WARN ISS DEADL DNP D; Patterson S W, 1935, Br Med J, V2, P442; REES SG, 1985, BMJ-BRIT MED J, V291, P1764, DOI 10.1136/bmj.291.6511.1764	15	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7389	10.1136/bmj.f7389	http://dx.doi.org/10.1136/bmj.f7389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24326891				2022-12-28	WOS:000328574700011
J	Christiansen, EH; Jensen, LO				Christiansen, Evald Hoj; Jensen, Lisette Okkels			Sex and percutaneous coronary intervention	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; WOMEN; REGISTRY; TRIAL; STENT; SORT; MEN		[Christiansen, Evald Hoj] Skejby Hosp, Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark; [Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital	Christiansen, EH (corresponding author), Skejby Hosp, Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark.	evald.christiansen@dadlnet.dk		Christiansen, Evald/0000-0002-8740-4862; Jensen, Lisette Okkels/0000-0002-4838-2429				Ahmed B, 2013, CIRCULATION, V127, P641, DOI 10.1161/CIRCULATIONAHA.112.108290; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Doyle F, 2005, EUR J CARDIOV PREV R, V12, P376, DOI 10.1097/01.hjr.0000160725.82293.63; Hvelplund A, 2010, EUR HEART J, V31, P684, DOI 10.1093/eurheartj/ehp493; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Mortensen KH, 2009, CATHETER CARDIO INTE, V74, P710, DOI 10.1002/ccd.22115; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Ndrepepa G, 2013, AM HEART J, V166, P534, DOI 10.1016/j.ahj.2013.07.006; Reynolds HR, 2012, CURR OPIN CARDIOL, V27, P655, DOI 10.1097/HCO.0b013e3283583247; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Wijnbergen I, 2013, CATHETER CARDIO INTE, V82, P379, DOI 10.1002/ccd.24800	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1864	1865		10.1016/S0140-6736(13)62030-9	http://dx.doi.org/10.1016/S0140-6736(13)62030-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24315165				2022-12-28	WOS:000328222400011
J	Levine, JH; Lin, YH; Elowitz, MB				Levine, Joe H.; Lin, Yihan; Elowitz, Michael B.			Functional Roles of Pulsing in Genetic Circuits	SCIENCE			English	Review							NUCLEAR-LOCALIZATION; DEPENDENT DYNAMICS; NOISE; OSCILLATIONS; ACTIVATION; P53; INFORMATION; PERSISTENCE; EXPRESSION; DIVERSITY	A fundamental problem in biology is to understand how genetic circuits implement core cellular functions. Time-lapse microscopy techniques are beginning to provide a direct view of circuit dynamics in individual living cells. Unexpectedly, we are discovering that key transcription and regulatory factors pulse on and off repeatedly, and often stochastically, even when cells are maintained in constant conditions. This type of spontaneous dynamic behavior is pervasive, appearing in diverse cell types from microbes to mammalian cells. Here, we review recent work showing how pulsing is generated and controlled by underlying regulatory circuits and how it provides critical capabilities to cells in stress response, signaling, and development. A major theme is the ability of pulsing to enable time-based regulation analogous to strategies used in engineered systems. Thus, pulsatile dynamics is emerging as a central, and still largely unexplored, layer of temporal organization in the cell.	[Levine, Joe H.; Lin, Yihan; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	melowitz@caltech.edu			NIH [R01 GM079771-06, R01 GM086793A, P50GM068763]; Defense Advanced Research Projects Agency Biochronicity program [D12AP00025]; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM079771, R01GM086793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency Biochronicity program; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Dunlop, J. Dworkin, N. Friedman, J. Garcia-Ojalvo, R. Kishony, G. Lahav, J. McKinney, R. Murray, R. Phillips, G. Suel, S. Tay, N. Wingreen, and members of the Elowitz lab including M. Budde, F. Ding, P. Li, J. Markson, and A. Rosenthal for critical comments and feedback. This work was supported by NIH grants R01 GM079771-06, R01 GM086793A, and P50GM068763; Defense Advanced Research Projects Agency Biochronicity program grant D12AP00025; and the Packard Foundation.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Garcia-Bernardo J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003229; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Levine JH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001252; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rue P, 2013, ANNU REV BIOPHYS, V42, P605, DOI 10.1146/annurev-biophys-083012-130335; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Vishnoi M, 2013, MOL MICROBIOL, V90, P181, DOI 10.1111/mmi.12357; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yissachar N, 2013, MOL CELL, V49, P322, DOI 10.1016/j.molcel.2012.11.003; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	47	258	259	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1193	1200		10.1126/science.1239999	http://dx.doi.org/10.1126/science.1239999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311681	Green Accepted			2022-12-28	WOS:000327857900036
J	Lim, XH; Tan, SH; Koh, WLC; Chau, RMW; Yan, KS; Kuo, CJ; van Amerongen, R; Klein, AM; Nusse, R				Lim, Xinhong; Tan, Si Hui; Koh, Winston Lian Chye; Chau, Rosanna Man Wah; Yan, Kelley S.; Kuo, Calvin J.; van Amerongen, Renee; Klein, Allon Moshe; Nusse, Roel			Interfollicular Epidermal Stem Cells Self-Renew via Autocrine Wnt Signaling	SCIENCE			English	Article							HAIR FOLLICLE; PROGENITOR CELLS; EXPRESSION; REVEALS; LABEL; SKIN	The skin is a classical example of a tissue maintained by stem cells. However, the identity of the stem cells that maintain the interfollicular epidermis and the source of the signals that control their activity remain unclear. Using mouse lineage tracing and quantitative clonal analyses, we showed that the Wnt target gene Axin2 marks interfollicular epidermal stem cells. These Axin2-expressing cells constitute the majority of the basal epidermal layer, compete neutrally, and require Wnt/beta-catenin signaling to proliferate. The same cells contribute robustly to wound healing, with no requirement for a quiescent stem cell subpopulation. By means of double-labeling RNA in situ hybridization in mice, we showed that the Axin2-expressing cells themselves produce Wnt signals as well as long-range secreted Wnt inhibitors, suggesting an autocrine mechanism of stem cell self-renewal.	[Lim, Xinhong; van Amerongen, Renee; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA; [Tan, Si Hui] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Koh, Winston Lian Chye; Chau, Rosanna Man Wah] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Klein, Allon Moshe] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School	Klein, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	allon_klein@hms.harvard.edu; rnusse@stanford.edu	van Amerongen, Renee/G-2945-2017; Koh, Lian Chye Winston/GYD-5873-2022; van Amerongen, Renee/N-6645-2019	van Amerongen, Renee/0000-0002-8808-2092; Koh, Lian Chye Winston/0000-0003-4611-6490; van Amerongen, Renee/0000-0002-8808-2092; Kuo, Calvin/0000-0002-7427-5985; Tan, Si Hui/0000-0002-0809-0085	HHMI; California Institute of Regenerative Medicine [TR1-01249]; NIH [NIH 1U01DK085527, 1R01DK085720, 5K08DK096048]; A*STAR, Singapore; Scientific Interface from the Burroughs Wellcome Fund; Burroughs Wellcome Fund; European Molecular Biology Organization [ALTF 122-2007]; Dutch Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, K08DK096048, R01DK085720, U01DK085527] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Burroughs Wellcome Fund(Burroughs Wellcome Fund); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the HHMI, California Institute of Regenerative Medicine grant TR1-01249, and NIH grants NIH 1U01DK085527, 1R01DK085720, and 5K08DK096048. We thank L. De Simone, A. E. Marcy, and P. H. Chia for cell quantification assistance; C. Logan, S. J. Habib, and A. Oro for manuscript comments; and J. Akech and L.-C. Wang at Advanced Cell Diagnostics for assistance with RNA in situ hybridization. X. L., S. H. T., W. L. C. K., and R. M. W. C. are supported by National Science Scholarships from A*STAR, Singapore. A. M. K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. K.S.Y. has a Burroughs Wellcome Fund Career Award for Medical Scientists. R. v. A. was supported by a European Molecular Biology Organization long-term fellowship (ALTF 122-2007) and a Dutch Cancer Society fellowship.	Barrantes ID, 2006, MOL CELL BIOL, V26, P2317, DOI 10.1128/MCB.26.6.2317-2326.2006; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; BICKENBACH JR, 1986, CELL TISSUE KINET, V19, P325, DOI 10.1111/j.1365-2184.1986.tb00684.x; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Choi Y. S., 2013, CELL STEM CELL, DOI [10.1016/j.stem.2013.10.00, DOI 10.1016/J.STEM.2013.10.00]; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Du G, 2011, EXP DERMATOL, V20, P273, DOI 10.1111/j.1600-0625.2010.01244.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jorizzo J. L., 2012, DERMATOLOGY, P869; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032331; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Schluter H, 2013, J INVEST DERMATOL, V133, P1669, DOI 10.1038/jid.2013.42; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122	25	241	247	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1226	1230		10.1126/science.1239730	http://dx.doi.org/10.1126/science.1239730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311688	Green Accepted			2022-12-28	WOS:000327857900046
J	Wicherts, JM; Scholten, AZ				Wicherts, Jelte M.; Scholten, Annemarie Zand			Comment on "Poverty Impedes Cognitive Function"	SCIENCE			English	Editorial Material								Mani et al. (Research Articles, 30 August, p. 976) presented laboratory experiments that aimed to show that poverty-related worries impede cognitive functioning. A reanalysis without dichotomization of income fails to corroborate their findings and highlights spurious interactions between income and experimental manipulation due to ceiling effects caused by short and easy tests. This suggests that effects of financial worries are not limited to the poor.	[Wicherts, Jelte M.] Tilburg Univ, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands; [Scholten, Annemarie Zand] Univ Amsterdam, Dept Child Dev & Educ Sci, Amsterdam, Netherlands	Tilburg University; University of Amsterdam	Wicherts, JM (corresponding author), Tilburg Univ, Dept Methodol & Stat, POB 90153, NL-5000 LE Tilburg, Netherlands.	j.m.wicherts@uvt.nl	Wicherts, Jelte M./A-2664-2008	Wicherts, Jelte M./0000-0003-2415-2933				Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Embretson SE, 1996, APPL PSYCH MEAS, V20, P201, DOI 10.1177/014662169602000302; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Kang SM, 2005, APPL PSYCH MEAS, V29, P87, DOI 10.1177/0146621604272737; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Wicherts JM, 2010, LEARN INDIVID DIFFER, V20, P135, DOI 10.1016/j.lindif.2009.12.001; Wicherts JM, 2010, INTELLIGENCE, V38, P169, DOI 10.1016/j.intell.2009.09.008; Wicherts JM, 2009, P R SOC B, V276, P2675, DOI 10.1098/rspb.2009.0238; Wicherts JM, 2005, J PERS SOC PSYCHOL, V89, P696, DOI 10.1037/0022-3514.89.5.696	11	22	24	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163								10.1126/science.1246680	http://dx.doi.org/10.1126/science.1246680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264DT	24311665				2022-12-28	WOS:000327857900020
J	Smith, JM				Smith, Jeanette M.			The Tiff	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2228	2229		10.1001/jama.2013.5444	http://dx.doi.org/10.1001/jama.2013.5444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302079				2022-12-28	WOS:000327746300001
J	Teherani, A; Papadakis, MA				Teherani, Arianne; Papadakis, Maxine A.			Clinical Performance of Medical Students With Protected Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Teherani, Arianne; Papadakis, Maxine A.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Teherani, A (corresponding author), Univ Calif San Francisco, 1855 Folsom St, San Francisco, CA 94143 USA.	teherani@medsch.ucsf.edu						GRIMM LG, 2000, READING UNDERSTANDIN; Hegazi I, 2013, MED EDUC, V47, P1022, DOI 10.1111/medu.12252; World Health Organization, WORLD REP DIS	3	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2309	2311		10.1001/jama.2013.283198	http://dx.doi.org/10.1001/jama.2013.283198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302095	Bronze			2022-12-28	WOS:000327746300017
J	Liu, CH; Huang, CF; Liu, CJ; Dai, CY; Liang, CC; Huang, JF; Hung, PH; Tsai, HB; Tsai, MK; Chen, SI; Lin, JW; Yang, SS; Su, TH; Yang, HC; Chen, PJ; Chen, DS; Chuang, WL; Yu, ML; Kao, JH				Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng			Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							28B GENETIC POLYMORPHISMS; DIALYSIS PATIENTS; PLUS RIBAVIRIN; TREATMENT DURATION; KIDNEY-TRANSPLANTATION; ANTIVIRAL THERAPY; VIRAL KINETICS; HCV PATIENTS; INFECTION; ALPHA-2A	Background: Data are limited on the efficacy and safety of pegylated interferon plus ribavirin for patients with hepatitis C virus genotype 1 (HCV-1) receiving hemodialysis. Objective: To compare the efficacy and safety of combination therapy with pegylated interferon plus low-dose ribavirin and pegylated interferon monotherapy for treatment-naive patients with HCV-1 receiving hemodialysis. Design: Open-label, randomized, controlled trial. (ClinicalTrials.gov: NCT00491244) Setting: 8 centers in Taiwan. Patients: 205 treatment-naive patients with HCV-1 receiving hemodialysis. Intervention: 48 weeks of pegylated interferon-alpha 2a, 135 mu g weekly, plus ribavirin, 200 mg daily (n = 103), or pegylated interferon-alpha 2a, 135 mu g weekly (n = 102). Measurements: Sustained virologic response rate and adverse event-related withdrawal rate. Results: Compared with monotherapy, combination therapy had a greater sustained virologic response rate (64% vs. 33%; relative risk, 1.92 [95% CI, 1.41 to 2.62]; P < 0.001). More patients receiving combination therapy had hemoglobin levels less than 8.5 g/dL than those receiving monotherapy (72% vs. 6%; risk difference, 66% [CI, 56% to 76%]; P < 0.001). Patients receiving combination therapy required a higher dosage (mean, 13 946 IU per week [SD, 6449] vs. 5833 IU per week [SD, 1169]; P = 0.006) and longer duration (mean, 29 weeks [SD, 9] vs. 18 weeks [SD, 7]; P = 0.004) of epoetin-beta than patients receiving monotherapy. The adverse event-related withdrawal rates were 7% in the combination therapy group and 4% in the monotherapy group (risk difference, 3% [CI, -3% to 9%]). Limitation: Open-label trial; results may not be generalizable to patients on peritoneal dialysis. Conclusion: In treatment-naive patients with HCV-1 receiving hemodialysis, combination therapy with pegylated interferon plus low-dose ribavirin achieved a greater sustained virologic response rate than pegylated interferon monotherapy.	[Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei 10002, Taiwan; Coll Med, Taipei, Taiwan; Far Easter Mem Hosp, Taipei, Taiwan; Kaohsiung Med Univ, Kaohsiung, Taiwan; Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; Ditmanson Med Fdn, Chiayi Christian Hosp, Chiayi, Taiwan; Buddhist Tzu Chi Gen Hosp, Tzu, Chiayi County, Taiwan; Taichung Vet Gen Hosp, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Chia-Yi Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Veterans General Hospital	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, 7 Chung Shan South Rd, Taipei 10002, Taiwan.	kaojh@ntu.edu.tw	Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020; Liu, Chen-Hua/F-6608-2018; Kao, Jia-Horng/AAB-8947-2019; Yu, Ming-Lung/AAZ-4306-2020; Tsai, Hung-Bin/G-3761-2011	Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051; Liu, Chen-Hua/0000-0003-3622-9707; Kao, Jia-Horng/0000-0002-2442-7952; Yu, Ming-Lung/0000-0001-8145-1900; Tsai, Hung-Bin/0000-0002-0689-8339; CHEN, DING-SHINN/0000-0001-7791-6154; SU, TUNG-HUNG/0000-0002-6747-7941; LIU, CHUN-JEN/0000-0002-6202-0993; TSAI, MENG-KUN/0000-0002-2962-8913; Chen, Pei-Jer/0000-0001-8316-3785; Yang, Sheng-Shun/0000-0001-5800-1901; YANG, HUNG-CHIH/0000-0003-3864-9895	National Center of Excellence for Clinical Trial and Research	National Center of Excellence for Clinical Trial and Research	National Center of Excellence for Clinical Trial and Research.	[Anonymous], 2011, PEG PACK INS; [Anonymous], 2013, INC PACK INS; [Anonymous], 2011, VECTR BOC CAPS; [Anonymous], 2011, COP PACK INS; Berenguer M, 2008, HEPATOLOGY, V48, P1690, DOI 10.1002/hep.22545; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; Bruchfeld A, 2006, J VIRAL HEPATITIS, V13, P316, DOI 10.1111/j.1365-2893.2005.00680.x; Bruchfeld A, 2001, J VIRAL HEPATITIS, V8, P287, DOI 10.1046/j.1365-2893.2001.00300.x; Carriero D, 2008, INT J ARTIF ORGANS, V31, P295, DOI 10.1177/039139880803100404; Deltenre P, 2011, ALIMENT PHARM THER, V34, P454, DOI 10.1111/j.1365-2036.2011.04741.x; Di Martino V, 2011, HEPATOLOGY, V54, P789, DOI 10.1002/hep.24480; Dumortier J, 2013, J CLIN VIROL, V56, P146, DOI 10.1016/j.jcv.2012.10.009; Fabrizi F, 2008, J VIRAL HEPATITIS, V15, P79, DOI [10.1111/j.1365-2893.2007.00907.x, 10.1111/j.1365-2893.2008.01039.x]; Fabrizi F, 2007, J VIRAL HEPATITIS, V14, P697, DOI 10.1111/1365-2893.2007.00868.x; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2011, J VIRAL HEPATITIS, V18, pE263, DOI 10.1111/j.1365-2893.2010.01405.x; Fabrizi F, 2008, INT J ARTIF ORGANS, V31, P1004, DOI 10.1177/039139880803101204; Pereira PDF, 2013, INT J INFECT DIS, V17, pE50, DOI 10.1016/j.ijid.2012.09.001; Gordon CE, 2008, AM J KIDNEY DIS, V51, P263, DOI 10.1053/j.ajkd.2007.11.003; Gordon CE, 2011, CLIN J AM SOC NEPHRO, V6, P2226, DOI 10.2215/CJN.00410111; Gupta SK, 2012, EUR J CLIN PHARMACOL, V68, P415, DOI 10.1007/s00228-011-1137-x; Hakim W, 2009, J CLIN GASTROENTEROL, V43, P477, DOI 10.1097/MCG.0b013e318180803a; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huraib S, 2001, AM J NEPHROL, V21, P435, DOI 10.1159/000046646; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Liu CH, 2008, GUT, V57, P525, DOI 10.1136/gut.2007.133884; Liu CH, 2009, GUT, V58, P314, DOI 10.1136/gut.2008.165076; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu CH, 2012, ANTIVIR THER, V17, P1059, DOI 10.3851/IMP2322; Liu CH, 2012, ANTIVIR THER, V17, P477, DOI 10.3851/IMP2026; Liu CH, 2011, J GASTROEN HEPATOL, V26, P228, DOI 10.1111/j.1440-1746.2010.06488.x; Liu CH, 2010, CLIN INFECT DIS, V51, P541, DOI 10.1086/655682; Liu CH, 2010, KIDNEY INT, V78, P103, DOI 10.1038/ki.2010.74; Martin P, 2008, J HEPATOL, V49, P613, DOI 10.1016/j.jhep.2008.06.003; Mathurin P, 1999, HEPATOLOGY, V29, P257, DOI 10.1002/hep.510290123; Mousa DH, 2004, TRANSPLANT P, V36, P1831, DOI 10.1016/j.transproceed.2004.07.025; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rendina M, 2007, J HEPATOL, V46, P768, DOI 10.1016/j.jhep.2006.12.016; Roth D, 2011, J AM SOC NEPHROL, V22, P1152, DOI 10.1681/ASN.2010060668; Russo MW, 2003, AM J GASTROENTEROL, V98, P1610, DOI 10.1111/j.1572-0241.2003.07526.x; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Tan ACITL, 2001, NEPHROL DIAL TRANSPL, V16, P193, DOI 10.1093/ndt/16.1.193; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; van Leusen R, 2008, NEPHROL DIAL TRANSPL, V23, P721, DOI 10.1093/ndt/gfm724; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319	47	74	80	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					729	+		10.7326/0003-4819-159-11-201312030-00005	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297189				2022-12-28	WOS:000328731000002
J	Deris, JB; Kim, M; Zhang, ZG; Okano, H; Hermsen, R; Groisman, A; Hwa, T				Deris, J. Barrett; Kim, Minsu; Zhang, Zhongge; Okano, Hiroyuki; Hermsen, Rutger; Groisman, Alexander; Hwa, Terence			The Innate Growth Bistability and Fitness Landscapes of Antibiotic-Resistant Bacteria	SCIENCE			English	Editorial Material												hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Hermsen, Rutger/A-4739-2012; Groisman, Alexander/AAU-7843-2021; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; Hermsen, Rutger/0000-0003-4633-4877; 	NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA143803, 1 U54 CA143803] Funding Source: Medline; NIGMS NIH HHS [R01 GM095903, R01-GM095903] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	119	122	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1068	1068		10.1126/science.1237435	http://dx.doi.org/10.1126/science.1237435			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288338	Green Accepted			2022-12-28	WOS:000327518600049
J	HAMMER, M				HAMMER, M			AN IDENTIFIED NEURON MEDIATES THE UNCONDITIONED STIMULUS IN ASSOCIATIVE OLFACTORY LEARNING IN HONEYBEES	NATURE			English	Article							APIS-MELLIFERA; MUSHROOM BODIES; TERM-MEMORY; BEE; MUTANTS; BRAIN; GENE	DURING classical conditioning, animals learn to associate a neutral stimulus with a meaningful, or unconditioned, stimulus. The unconditioned stimulus is essential for forming associations, and modifications in the processing of the unconditioned stimulus are thought to underlie more complex learning forms1-4. Information on the neuronal representation of the unconditioned stimulus is therefore required for understanding both basic and higher-order features of conditioning. In honeybees, conditioning of the proboscis extension reflex occurs after a single pairing of an odour (conditioned stimulus) with food (unconditioned stimulus)5,6 and shows several higher-order features of conditioning6-8. I report here the identification of an interneuron that mediates the unconditioned stimulus in this associative learning. Its physiology is also compatible with a function in complex forms of associative learning. This neuron provides the first direct access to the cellular mechanisms underlying the reinforcing properties of the unconditioned stimulus pathway.			HAMMER, M (corresponding author), FREE UNIV BERLIN,INST NEUROBIOL,KONIGIN LUISE STR 28-30,D-14195 BERLIN,GERMANY.							ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BUONOMANO DV, 1990, NEURAL NETWORKS, V3, P507, DOI 10.1016/0893-6080(90)90002-3; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; FARLEY J, 1987, BEHAV NEUROSCI, V101, P28, DOI 10.1037/0735-7044.101.1.28; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; HAWKINS RD, 1989, COMPUTATIONAL MODELS, P65; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; MACKEY SL, 1989, J NEUROSCI, V9, P4227; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MENZEL R, 1988, NEUROETHOLOGY BEHAVI, P206; Menzel Randolf, 1993, P79; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; REHDER V, 1987, J INSECT PHYSL, V33, P303; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; SMITH BH, 1991, J EXP BIOL, V161, P367; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Wagner A.R., 1981, P5	25	479	486	0	58	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 4	1993	366	6450					59	63		10.1038/366059a0	http://dx.doi.org/10.1038/366059a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MF007	24308080				2022-12-28	WOS:A1993MF00700053
J	Fisher, DB; Bolatto, AD; Herrera-Camus, R; Draine, BT; Donaldson, J; Walter, F; Sandstrom, KM; Leroy, AK; Cannon, J; Gordon, K				Fisher, David B.; Bolatto, Alberto D.; Herrera-Camus, Rodrigo; Draine, Bruce T.; Donaldson, Jessica; Walter, Fabian; Sandstrom, Karin M.; Leroy, Adam K.; Cannon, John; Gordon, Karl			The rarity of dust in metal-poor galaxies	NATURE			English	Article							INFRARED-EMISSION; MOLECULAR GAS; METALLICITY; REDSHIFT; I-ZW-18	Galaxies observed at redshift z>6, when the Universe was less than a billion years old, thus far very rarely show evidence(1-3) of the cold dust that accompanies star formation in the local Universe, where the dust-to-gas mass ratio is around one per cent. A prototypical example is the galaxy Himiko (z = 6.6), which-a mere 840 million years after the Big Bang-is forming stars at a rate of 30-100 solar masses per year, yielding a mass assembly time of about 150 x 10(6) years. Himiko is thought to have a low fraction (2-3 per cent of the Sun's) of elements heavier than helium (low metallicity), and although its gas mass cannot yet be determined its dust-to-stellar mass ratio is constrained(3) to be less than 0.05 per cent. The local dwarf galaxy I Zwicky 18, which has a metallicity about 4 per cent that of the Sun's(4) and is forming stars less rapidly (assembly time about 1.6 x 10(9) years) than Himiko but still vigorously for its mass(5), is also very dust deficient and is perhaps one of the best analogues of primitive galaxies accessible to detailed study. Here we report observations of dust emission from I Zw 18, from which we determine its dust mass to be 450-1,800 solar masses, yielding a dust-to-stellar mass ratio of about 10(-6) to 10(-5) and a dust-to-gas mass ratio of 3.2-13 x 10(-6). If I Zw 18 is a reasonable analogue of Himiko, then Himiko's dust mass must be around 50,000 solar masses, a factor of 100 below the current upper limit. These numbers are quite uncertain, but if most high-z galaxies are more like Himiko than like the very-high-dust-mass galaxy SDSS J114816.64 + 525150.3 at z approximate to 6, which hosts a quasar(6), then our prospects for detecting the gas and dust inside such galaxies are much poorer than hitherto anticipated.	[Fisher, David B.; Bolatto, Alberto D.; Herrera-Camus, Rodrigo; Donaldson, Jessica] Univ Maryland, Dept Astron, Lab Millimeter Wave Astron, College Pk, MD 20742 USA; [Fisher, David B.; Bolatto, Alberto D.; Herrera-Camus, Rodrigo; Donaldson, Jessica] Univ Maryland, Joint Space Inst, College Pk, MD 20742 USA; [Fisher, David B.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Draine, Bruce T.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Walter, Fabian; Sandstrom, Karin M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Leroy, Adam K.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Cannon, John] Macalester Coll, Dept Phys & Astron, St Paul, MN 55105 USA; [Gordon, Karl] Space Telescope Sci Inst, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Swinburne University of Technology; Princeton University; Max Planck Society; National Radio Astronomy Observatory (NRAO); Macalester College; Space Telescope Science Institute	Fisher, DB (corresponding author), Univ Maryland, Dept Astron, Lab Millimeter Wave Astron, College Pk, MD 20742 USA.	dfisher@swin.edu.au; bolatto@astro.umd.edu	Sandstrom, Karin M/J-7544-2016; Herrera-Camus, Rodrigo/AAH-9612-2020	Sandstrom, Karin M/0000-0002-4378-8534; Herrera-Camus, Rodrigo/0000-0002-2775-0595; Gordon, Karl/0000-0001-5340-6774; Bolatto, Alberto/0000-0002-5480-5686; Leroy, Adam/0000-0002-2545-1700; Walter, Fabian/0000-0003-4793-7880; Fisher, Deanne/0000-0003-0645-5260	University of Maryland; Laboratory for Millimeter Astronomy; NSF [AST0838178, AST1008570, AST1211683]; CAREER NSF [AST0955836, AST1139998]; Research Corporation for Science Advancement Cottrell Scholar award; Marie Curie International Incoming fellowship; BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France); DLR (Germany); ASI/INAF (Italy); CICYT/MCYT (Spain); Direct For Mathematical & Physical Scien [1008570] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1211683] Funding Source: National Science Foundation	University of Maryland; Laboratory for Millimeter Astronomy; NSF(National Science Foundation (NSF)); CAREER NSF; Research Corporation for Science Advancement Cottrell Scholar award; Marie Curie International Incoming fellowship(European Commission); BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France)(French Atomic Energy CommissionCentre National D'etudes Spatiales); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); ASI/INAF (Italy)(Istituto Nazionale Astrofisica (INAF)Agenzia Spaziale Italiana (ASI)); CICYT/MCYT (Spain)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	D.B.F., A. D. B. and R. H.-C. acknowledge support from the University of Maryland and the Laboratory for Millimeter Astronomy and NSF grant number AST0838178. A. D. B. acknowledges partial support from CAREER NSF grant numbers AST0955836 and AST1139998 and from a Research Corporation for Science Advancement Cottrell Scholar award. B. T. D. acknowledges partial support from NSF grant number AST1008570. J.M.C. is supported by NSF grant number AST1211683. K. M. S. acknowledges support from a Marie Curie International Incoming fellowship. PACS has been developed by a consortium of institutes led by MPE (Germany) and including UVIE (Austria); KU Leuven, CSL, IMEC (Belgium); CEA, LAM (France); MPIA (Germany); INAF-IFSI/OAA/OAP/OAT, LENS, SISSA (Italy) and IAC (Spain). This development has been supported by the funding agencies BMVIT (Austria), ESA-PRODEX (Belgium), CEA/CNES (France), DLR (Germany), ASI/INAF (Italy) and CICYT/MCYT (Spain).	Aloisi A, 2007, ASTROPHYS J, V667, pL151, DOI 10.1086/522368; Bouwens R. J., 2013, PREPRINT; Cannon JM, 2002, ASTROPHYS J, V565, P931, DOI 10.1086/324691; Draine BT, 2007, ASTROPHYS J, V663, P866, DOI 10.1086/518306; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Elmegreen BG, 2013, NATURE, V495, P487, DOI 10.1038/nature11933; Engelbracht CW, 2008, ASTROPHYS J, V678, P804, DOI 10.1086/529513; Fisher DB, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/174; Galametz M, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201014904; Gnedin NY, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/88; Herrera-Camus R, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/112; Kanekar N, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L20; Kennicutt RC, 2009, ASTROPHYS J, V703, P1672, DOI 10.1088/0004-637X/703/2/1672; Lelli F, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117867; Leroy A, 2007, ASTROPHYS J, V658, P1027, DOI 10.1086/511150; Magnelli B, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118312; Ouchi M., 2013, PREPRINT; Remy-Ruyer A, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321602; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Skibba RA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/89; SKILLMAN ED, 1993, ASTROPHYS J, V411, P655, DOI 10.1086/172868; Van Zee L, 1998, ASTRON J, V115, P1000, DOI 10.1086/300251; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Walter F, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/93; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Wu YL, 2007, ASTROPHYS J, V662, P952, DOI 10.1086/517988	26	70	70	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					186	189		10.1038/nature12765	http://dx.doi.org/10.1038/nature12765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317694				2022-12-28	WOS:000329441500032
J	DeWeerdt, S				DeWeerdt, Sarah			BACTERIOLOGY A caring culture	NATURE			English	Editorial Material																			0	17	19	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S4	S5		10.1038/504S4a	http://dx.doi.org/10.1038/504S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352362	Bronze			2022-12-28	WOS:000328575300003
J	Trehan, A; Dunn, TJ				Trehan, Abhishek; Dunn, Tristan J.			The robotic surgery monopoly is a poor deal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Trehan, Abhishek] John Radcliffe Hosp, Nuffield Dept Surg, Hugh Cairns Surg Soc, Oxford OX3 9DU, England; [Dunn, Tristan J.] Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England	University of Oxford; University of Cambridge	Trehan, A (corresponding author), John Radcliffe Hosp, Nuffield Dept Surg, Hugh Cairns Surg Soc, Oxford OX3 9DU, England.	abhishek.trehan@lincoln.ox.ac.uk						Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Bennett K., 2012, ANN ROY COLL SURG, V94, P8; Bolenz C, 2010, EUR UROL, V57, P453, DOI 10.1016/j.eururo.2009.11.008; Kmietowicz Z, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3520; Liu HQ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008978.pub2; Lowrance WT, 2012, J UROLOGY, V187, P2087, DOI 10.1016/j.juro.2012.01.061; Novara G, 2012, EUR UROL, V62, P431, DOI 10.1016/j.eururo.2012.05.044; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186	8	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7470	10.1136/bmj.f7470	http://dx.doi.org/10.1136/bmj.f7470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355387				2022-12-28	WOS:000328824300008
J	Zavattero, E; Fasolis, M				Zavattero, Emanuele; Fasolis, Massimo			Lingual Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An otherwise healthy 58-year-old man was referred for the management of painful swelling on the left side of his tongue. A lesion had been growing insidiously for the preceding 8 months, with no sign of bleeding. An otherwise healthy 58-year-old man was referred for the management of painful swelling on the left side of his tongue. A lesion had been growing insidiously for the preceding 8 months, with no sign of bleeding. The patient had been smoking more than 20 cigarettes a day for 26 years. Examination of the oral cavity revealed a vegetative circular mass on the left side of the tongue (measuring 2 cm in diameter) and associated leukoplakia. A biopsy was performed, and histopathological examination revealed squamous-cell carcinoma. The tumor was surgically removed, and the tongue was reconstructed with the use of a ...	[Zavattero, Emanuele; Fasolis, Massimo] Univ Turin, Turin, Italy	University of Turin	Zavattero, E (corresponding author), Univ Turin, Turin, Italy.			Fasolis, Massimo/0000-0001-6993-5793					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2437	2437		10.1056/NEJMicm1307062	http://dx.doi.org/10.1056/NEJMicm1307062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24350952				2022-12-28	WOS:000328586000011
J	Smith, JM				Smith, Jeanette M.			Rooftops Under Snow Gustave Caillebotte	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2486	2487		10.1001/jama.2013.5470	http://dx.doi.org/10.1001/jama.2013.5470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346970				2022-12-28	WOS:000328503600001
J	Gutmann, A				Gutmann, Amy			The Bioethics Commission on Incidental Findings	SCIENCE			English	Editorial Material									[Gutmann, Amy] Presidential Commiss Study Bioeth Issues, Washington, DC 20005 USA; [Gutmann, Amy] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Gutmann, A (corresponding author), Presidential Commiss Study Bioeth Issues, Washington, DC 20005 USA.	info@bioethics.gov						Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hilgenberg S., 2013, INC FIND RES PRES CO; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; US Preventive Services Task Force, 2013, AHRQ PUBLICATION; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82	6	12	12	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1321	1323		10.1126/science.1248764	http://dx.doi.org/10.1126/science.1248764			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	268UL	24337279				2022-12-28	WOS:000328196000030
J	Roll-Mecak, A				Roll-Mecak, Antonina			Shining Light at Microtubule Crossroads	SCIENCE			English	Editorial Material							KATANIN; ARRAYS; ORGANIZATION; SITES		NIH, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Roll-Mecak, A (corresponding author), NIH, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, 35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	antonina@mail.nih.gov		Roll-Mecak, Antonina/0000-0003-2621-7307	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS003165] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Wasteneys GO, 2002, J CELL SCI, V115, P1345; Wightman R, 2007, PLANT J, V52, P742, DOI 10.1111/j.1365-313X.2007.03271.x; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Zhang Q, 2013, CURR BIOL, V23, P2191, DOI 10.1016/j.cub.2013.09.018	13	2	3	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1180	1181		10.1126/science.1248235	http://dx.doi.org/10.1126/science.1248235			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311672	Green Accepted			2022-12-28	WOS:000327857900027
J	Pfeffer, SR				Pfeffer, Suzanne R.			A Prize for Membrane Magic	CELL			English	Editorial Material							PROTEIN; FUSION; TRANSPORT; YEAST; RECONSTITUTION; PATHWAY		Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@stanford.edu			NIDDK NIH HHS [R01 DK037332] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0	15	19	19	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1203	1206		10.1016/j.cell.2013.11.014	http://dx.doi.org/10.1016/j.cell.2013.11.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315088	Green Accepted, Bronze			2022-12-28	WOS:000328271100002
J	Guevara, JP; Adanga, E; Avakame, E; Carthon, MB				Guevara, James P.; Adanga, Emem; Avakame, Elorm; Carthon, Margo Brooks			Minority Faculty Development Programs and Underrepresented Minority Faculty Representation at US Medical Schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIVERSITY; EXPERIENCE; WOMEN	IMPORTANCE Diversity initiatives have increased at US medical schools to address underrepresentation of minority faculty. OBJECTIVE To assess associations between minority faculty development programs at US medical schools and underrepresented minority faculty representation, recruitment, and promotion. DESIGN Secondary analysis of the Association of American Medical Colleges Faculty Roster, a database of US medical school faculty. PARTICIPANTS Full-time faculty at schools located in the 50 US states or District of Columbia and reporting data from 2000-2010. EXPOSURE Availability of school-wide programs targeted to underrepresented minority faculty in 2010. MAIN OUTCOMES AND MEASURES Percentage of underrepresented minority faculty, defined as self-reported black, Hispanic, Native American, Alaskan Native, Native Hawaiian, or Pacific Islander faculty. Percentage of underrepresented minority faculty was computed by school and year for all faculty, newly appointed faculty, and newly promoted faculty. Panel-level analyses that accounted for faculty clustering within schools were conducted and adjusted for faculty- and school-level variables. RESULTS Across all schools, the percentage of underrepresented minority faculty increased from 6.8%(95% CI, 6.7%-7.0%) in 2000 to 8.0% (95% CI, 7.8%-8.2%) in 2010. Of 124 eligible schools, 36 (29%) were identified with a minority faculty development program in 2010. Minority faculty development programs were heterogeneous in composition, number of components, and duration. Schools with minority faculty development programs had a similar increase in percentage of underrepresented minority faculty as schools without minority faculty development programs (6.5%-7.4% vs 7.0%-8.3%; odds ratio [OR], 0.91 [95% CI, 0.72-1.13]). After adjustment for faculty and school characteristics, minority faculty development programs were not associated with greater representation of minority faculty (adjusted OR, 0.99 [95% CI, 0.81-1.22]), recruitment (adjusted OR, 0.97 [95% CI, 0.83-1.15]), or promotion (adjusted OR, 1.08 [95% CI, 0.91-1.30]). In subgroup analyses, schools with programs of greater intensity (present for >= 5 years and with more components) were associated with greater increases in underrepresented minority representation than schools with minority faculty development programs of less intensity. CONCLUSIONS AND RELEVANCE The percentage of underrepresented minority faculty increased modestly from 2000 to 2010 at US medical schools. The presence of a minority faculty development program targeted to underrepresented minority faculty was not associated with greater underrepresented minority faculty representation, recruitment, or promotion. Minority faculty development programs that were of greater intensity were associated with greater increases in underrepresented minority faculty representation.	[Guevara, James P.; Adanga, Emem] Childrens Hosp Philadelphia, PolicyLab, Ctr Bridge Res Practice & Policy, Philadelphia, PA 19104 USA; [Guevara, James P.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Guevara, James P.] Univ Penn, Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Avakame, Elorm] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Carthon, Margo Brooks] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Rutgers State University New Brunswick; University of Pennsylvania	Guevara, JP (corresponding author), Childrens Hosp Philadelphia, PolicyLab, Ctr Bridge Res Practice & Policy, 34th & Civ Ctr Blvd,CHOP North,Room 1531, Philadelphia, PA 19104 USA.	guevara@email.chop.edu		Guevara, James/0000-0003-1665-4503	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by a New Connections grant from the Robert Wood Johnson Foundation.	Adanga E, 2012, ACAD MED, V87, P1540, DOI 10.1097/ACM.0b013e31826cf4fb; Anderson H, 2008, THE LONG TERM RETENT; Association of American Medical Colleges, 2010, FACULTY ROSTER 2010; Association of American Medical Colleges, 2009, STRIVING TOWARD EXCE; Association of American Medical Colleges, 2008, DIVERSITY RESEARCH F; Bastedo MN, 2010, AM J EDUC, V116, P163, DOI 10.1086/649437; BICKEL J, 1991, ACAD MED, V66, P249, DOI 10.1097/00001888-199105000-00002; Castillo-Page L., 2010, DIVERSITY IN THE PHY; Cropsey KL, 2008, J WOMENS HEALTH, V17, P1111, DOI 10.1089/jwh.2007.0582; Daley SP, 2008, MT SINAI J MED, V75, P533, DOI 10.1002/msj.20084; Diggle P, 2002, THE ANALYSIS OF LONG; Flanigan S, METHODOLOGY BEST MED; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Kosoko-Lasaki O, 2006, J NATL MED ASSOC, V98, P1449; Lewellen-Williams C, 2006, ACAD MED, V81, P275, DOI 10.1097/00001888-200603000-00020; Liu CQ, 2010, PROMOTION RATES FOR; Mahoney MR, 2008, ACAD MED, V83, P781, DOI 10.1097/ACM.0b013e31817ec002; Nivet MA, 2008, MT SINAI J MED, V75, P491, DOI 10.1002/msj.20079; Palermo AGS, 2008, MT SINAI J MED, V75, P523, DOI 10.1002/msj.20083; Peterson NB, 2004, J GEN INTERN MED, V19, P259, DOI 10.1111/j.1525-1497.2004.20409.x; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ries A, 2012, ACAD MED, V87, P1046, DOI 10.1097/ACM.0b013e31825d0d31; Smedley B, 2004, IN THE NATIONS COMPE; Smith LH, 1995, 1995 EVALUATION OF M; Stata Corp, 2011, STATA STATISTICAL SO	25	85	85	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2297	2304		10.1001/jama.2013.282116	http://dx.doi.org/10.1001/jama.2013.282116			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302093	Bronze			2022-12-28	WOS:000327746300015
J	Moyer, VA; LeFevre, ML; Siu, AL; Peters, JJ; Baumann, LC; Bibbins-Domingo, K; Curry, SJ; Ebell, M; Flores, G; Garcia, FAR; Cantu, AG; Grossman, DC; Herzstein, J; Nicholson, WK; Owens, DK; Phillips, WR; Pignone, MP; Leipzig, R; Petitti, D; Wilt, T				Moyer, Virginia A.; LeFevre, Michael L.; Siu, Albert L.; Peters, James J.; Baumann, Linda Ciofu; Bibbins-Domingo, Kirsten; Curry, Susan J.; Ebell, Mark; Flores, Glenn; Garcia, Francisco A. R.; Cantu, Adelita Gonzales; Grossman, David C.; Herzstein, Jessica; Nicholson, Wanda K.; Owens, Douglas K.; Phillips, William R.; Pignone, Michael P.; Leipzig, Rosanne; Petitti, Diana; Wilt, Timothy		US Preventive Serv Task Force	Screening for Glaucoma: U.S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; UNITED-STATES; TRIAL	Description: Update of the 2004 U. S. Preventive Services Task Force (USPSTF) recommendation on screening for glaucoma. Methods: The USPSTF reviewed evidence on the benefits and harms of screening for glaucoma and of medical and surgical treatment of early glaucoma. Beneficial outcomes of interest included improved vision-related quality of life and reduced progression of early asymptomatic glaucoma to vision-related impairment. The USPSTF also considered evidence on the accuracy of glaucoma screening tests. Population: This recommendation applies to adults who do not have vision symptoms and are seen in a primary care setting. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement)	[Moyer, Virginia A.; US Preventive Serv Task Force] Amer Board Pediat Inc, Chapel Hill, NC 27514 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO 65211 USA; [Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Peters, James J.] Vet Affairs Med Ctr, Bronx, NY USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI 53706 USA; [Bibbins-Domingo, Kirsten] Univ California, San Francisco, CA 94143 USA; [Curry, Susan J.] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Flores, Glenn] Univ Texas Southwestern, Dallas, TX USA; [Garcia, Francisco A. R.] Pima County Dept Hlth, Tucson, AZ USA; [Cantu, Adelita Gonzales] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; [Grossman, David C.] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Herzstein, Jessica] Air Prod, Allentown, PA USA; [Nicholson, Wanda K.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Owens, Douglas K.] Veteran Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of Iowa; University System of Georgia; University of Georgia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Group Health Cooperative; Air Products & Chemicals; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Moyer, VA (corresponding author), Amer Board Pediat Inc, Chapel Hill, NC 27514 USA.		Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Pignone, Michael/0000-0002-6657-7342	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Optometric Association Consensus Panel on Comprehensive Adult Eye and Vision Examination, 2005, OPT CLIN PRACT GUID; [Anonymous], 2010, PREF PRACT PATT GUID; Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Boland MV, 2012, AHRQ PUBLICATION, V60; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Ervin AM, 2012, AHRQ PUBLICATION, V59; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Grosse S, 2011, PURCHASERS GUIDE CLI; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim E, 2010, CURR OPIN OPHTHALMOL, V21, P100, DOI 10.1097/ICU.0b013e3283360b1e; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; National Committee for Quality Assurance, 2010, STAT HLTH CAR QUAL R; Vass C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003167.pub3; Zhang XZ, 2012, AM J OPHTHALMOL, V154, pS53, DOI 10.1016/j.ajo.2011.08.045	15	68	68	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					484	489		10.7326/0003-4819-159-6-201309170-00686	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00686			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24325017				2022-12-28	WOS:000325628000006
J	Cameron, DA				Cameron, David A.			Breast cancer chemoprevention: little progress in practice?	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; PREVENTION; TAMOXIFEN; TRIAL		Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Cameron, DA (corresponding author), Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.	d.cameron@ed.ac.uk						Baum M, 2002, LANCET, V359, P2131; Cuzick J, 2013, LANCET; Fagerlin A, 2011, BREAST CANCER RES TR, V127, P681, DOI 10.1007/s10549-011-1450-1; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Kinsinger LS, 2002, LANCET, V360, P813, DOI 10.1016/S0140-6736(02)11009-9; National Cancer Intelligence Network, 2011, 2 ALL BREAST CANC RE; National Institute for Health and Care Excellence, 2019, FAM BREAST CANC CLAS; Port ER, 2001, ANN SURG ONCOL, V8, P580; Santen RJ, 2012, CANCER EPIDEM BIOMAR, V21, P1038, DOI 10.1158/1055-9965.EPI-12-0043; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	11	6	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1018	1020		10.1016/S0140-6736(13)62555-6	http://dx.doi.org/10.1016/S0140-6736(13)62555-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24333008	hybrid			2022-12-28	WOS:000333521200006
J	Tessarz, P; Santos-Rosa, H; Robson, S; Sylvestersen, KB; Nelson, CJ; Nielsen, ML; Kouzarides, T				Tessarz, Peter; Santos-Rosa, Helena; Robson, Samc.; Sylvestersen, Kathrine B.; Nelson, Christopher J.; Nielsen, Michael L.; Kouzarides, Tony			Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification	NATURE			English	Article							NUCLEOLAR PROTEIN; TRANSCRIPTION; FIBRILLARIN; ASSOCIATION; COMPLEXES; VERSATILE; DEFECTS; ROLES; SPT16; YFACT	Nucleosomes are decorated with numerous post-translational modifications capable of influencing many DNA processes(1). Here we describe a new class of histone modification, methylation of glutamine, occurring on yeast histone H2A at position 105 (Q105) and human H2A at Q104. We identify Nop1 as the methyltransferase in yeast and demonstrate that fibrillarin is the orthologue enzyme in human cells. Glutamine methylation of H2A is restricted to the nucleolus. Global analysis in yeast, using an H2AQ105me-specific antibody, shows that this modification is exclusively enriched over the 35S ribosomal DNA transcriptional unit. We show that the Q105 residue is part of the binding site for the histone chaperone FACT (facilitator of chromatin transcription) complex(2). Methylation of Q105 or its substitution to alanine disrupts binding to FACT in vitro. A yeast strain mutated at Q105 shows reduced histone incorporation and increased transcription at the ribosomal DNA locus. These features are phenocopied by mutations in FACT complex components. Together these data identify glutamine methylation of H2A as the first histone epigenetic mark dedicated to a specific RNA polymerase and define its function as a regulator of FACT interaction with nucleosomes.	[Tessarz, Peter; Santos-Rosa, Helena; Robson, Samc.; Nelson, Christopher J.; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Tessarz, Peter; Santos-Rosa, Helena; Robson, Samc.; Nelson, Christopher J.; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England; [Sylvestersen, Kathrine B.; Nielsen, Michael L.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Dept Prote, DK-2200 Copenhagen, Denmark	University of Cambridge; University of Cambridge; University of Copenhagen	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Tessarz, Peter/ABB-6551-2021; Tessarz, Peter/I-9035-2014	Tessarz, Peter/0000-0002-6953-9835; Tessarz, Peter/0000-0002-6953-9835; Nielsen, Michael/0000-0002-0067-9039; Kouzarides, Tony/0000-0002-8918-4162; Beck Sylvestersen, Kathrine/0000-0002-8201-4769	Cancer Research UK; Biotechnology and Biological Sciences Research Council [BB/K017438/1]; Cancer Research UK [10827, 17001] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0006477] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Michael Lund Nielsen] Funding Source: researchfish; BBSRC [BB/K017438/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Hurt, D. Stillman, T. Kobayashi, J. Smith and J. Boeke for providing strains; K. Lilley for mass spectrometry and M. Vermeulen for help with identifying H2AQ104me; S. Moss for running the Illumina MiSeq; members of the Kouzarides laboratory for discussions; and A. Bannister and R. Belotserkovskaya for reading the manuscript. This work has been financed by a programme grant from Cancer Research UK and a project grant from the Biotechnology and Biological Sciences Research Council (BB/K017438/1).	Albert B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/276948; Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; GORENSTEIN C, 1978, J BACTERIOL, V136, P142, DOI 10.1128/JB.136.1.142-147.1978; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JANSEN RP, 1991, J CELL BIOL, V113, P715, DOI 10.1083/jcb.113.4.715; Johnson JM, 2013, MOL CELL BIOL, V33, P2748, DOI 10.1128/MCB.00112-13; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lambert Jean-Philippe, 2009, Mol Cell Proteomics, V8, P870, DOI 10.1074/mcp.M800447-MCP200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; Wang B, 2008, ANAL CHEM, V80, P9526, DOI 10.1021/ac801708p; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittner M, 2011, CELL, V145, P543, DOI 10.1016/j.cell.2011.03.051	42	146	186	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					564	+		10.1038/nature12819	http://dx.doi.org/10.1038/nature12819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24352239	Green Accepted			2022-12-28	WOS:000329995000043
J	Mlynarski, SN; Schuster, CH; Morken, JP				Mlynarski, Scott N.; Schuster, Christopher H.; Morken, James P.			Asymmetric synthesis from terminal alkenes by cascades of diboration and cross-coupling	NATURE			English	Article							PALLADIUM; ALKYL; ESTERS; ALKYLBORANES; CATALYSTS; AMINATION; HALIDES	Terminal, monosubstituted alkenes are ideal prospective starting materials for organic synthesis because they are manufactured on very large scales and can be functionalized via a broad range of chemical transformations. Alkenes also have the attractive feature of being stable in the presence of many acids, bases, oxidants and reductants. In spite of these attributes, relatively few catalytic enantioselective transformations have been developed that transform aliphatic alpha-olefins into chiral products with an enantiomeric excess greater then 90 per cent. With the exception of site-controlled isotactic polymerization of alpha-olefins(1), none of these catalytic enantioselective processes results in chain-extending carbon-carbon bond formation to the terminal carbon(2-6). Here we describe a strategy that directly addresses this gap in synthetic methodology, and present a single-flask, catalytic enantioselective conversion of terminal alkenes into a number of chiral products. These reactions are facilitated by a neighbouring functional group that accelerates palladium-catalysed cross-coupling of 1,2-bis(boronates) relative to non-functionalized alkyl boronate analogues. In tandem with enantioselective diboration, this reactivity feature transforms alkene starting materials into a diverse array of chiral products. We note that the tandem diboration/cross-coupling reaction generally provides products in high yield and high selectivity (>95:5 enantiomer ratio), uses low loadings (1-2 mol per cent) of commercially available catalysts and reagents, offers an expansive substrate scope, and can address a broad range of alcohol and amine synthesis targets, many of which cannot be easily addressed with current technology.	[Mlynarski, Scott N.; Schuster, Christopher H.; Morken, James P.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Morken, JP (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	morken@bc.edu		Schuster, Christopher/0000-0003-4110-3551	US National Institutes of Health, Institute of General Medical Sciences [GM-59417]; John LaMattina graduate fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059417] Funding Source: NIH RePORTER	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); John LaMattina graduate fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-59417). S.N.M. and C.H.S. were supported by John LaMattina graduate fellowships. We thank Allychem for providing B<INF>2</INF>(pin)<INF>2</INF>.	Amatore C, 2011, CHEM-EUR J, V17, P2492, DOI 10.1002/chem.201001911; [Anonymous], 2001, US. Pat., US, Patent No. [6,197,819 B1, 6197819]; Becker H, 1996, ANGEW CHEM INT EDIT, V35, P448, DOI 10.1002/anie.199604481; Carrow BP, 2011, J AM CHEM SOC, V133, P2116, DOI 10.1021/ja1108326; Charles MD, 2005, ORG LETT, V7, P3965, DOI 10.1021/ol0514754; Christmann U, 2005, ANGEW CHEM INT EDIT, V44, P366, DOI 10.1002/anie.200461189; Coombs JR, 2013, J AM CHEM SOC, V135, P11222, DOI 10.1021/ja4041016; Endo K, 2010, J AM CHEM SOC, V132, P11033, DOI 10.1021/ja105176v; HIMMELE W, 1980, ANGEW CHEM INT EDIT, V19, P184, DOI 10.1002/anie.198001841; ITOH T, 1993, J ORG CHEM, V58, P5717, DOI 10.1021/jo00073a034; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Lee Y, 2009, J AM CHEM SOC, V131, P18234, DOI 10.1021/ja9089928; Lo MMC, 1998, J AM CHEM SOC, V120, P10270, DOI 10.1021/ja982488y; Matos K, 1998, J ORG CHEM, V63, P461, DOI 10.1021/jo971681s; Miller SP, 2004, ORG LETT, V6, P131, DOI 10.1021/ol036219a; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mlynarski SN, 2012, J AM CHEM SOC, V134, P16449, DOI 10.1021/ja305448w; Nogrady T., 2005, MED CHEM MOL BIOCH A, P193; Noonan GM, 2012, ANGEW CHEM INT EDIT, V51, P2477, DOI 10.1002/anie.201108203; Resconi L, 2000, CHEM REV, V100, P1253, DOI 10.1021/cr9804691; Ridgway BH, 1998, J ORG CHEM, V63, P458, DOI 10.1021/jo970803d; SADHU KM, 1985, ORGANOMETALLICS, V4, P1687, DOI 10.1021/om00128a038; Sandrock DL, 2010, J AM CHEM SOC, V132, P17108, DOI 10.1021/ja108949w; SATO M, 1989, CHEM LETT, P1405, DOI 10.1246/cl.1989.1405; Silverio DL, 2013, NATURE, V494, P216, DOI 10.1038/nature11844; Subbarayan V, 2009, CHEM COMMUN, P4266, DOI 10.1039/b905727g; UOZUMI Y, 1991, J AM CHEM SOC, V113, P9887, DOI 10.1021/ja00026a044; Yang CT, 2012, ANGEW CHEM INT EDIT, V51, P528, DOI 10.1002/anie.201106299; Yus M, 2011, CHEM REV, V111, P7774, DOI 10.1021/cr1004474; Zou G, 2001, TETRAHEDRON LETT, V42, P5817, DOI 10.1016/S0040-4039(01)01128-5	30	162	163	2	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					386	390		10.1038/nature12781	http://dx.doi.org/10.1038/nature12781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24352229	Green Accepted			2022-12-28	WOS:000329621800039
J	Oberlander, J; Perreira, K				Oberlander, Jonathan; Perreira, Krista			Implementing Obamacare in a Red State - Dispatch from North Carolina	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								How is health care reform faring in states that refuse to implement major provisions of the Affordable Care Act? North Carolina is one such state, and its experiences highlight the unexpectedly difficult path that Obamacare faces in much of the country. Serious problems have plagued the much-anticipated rollout of the health insurance exchanges created under the Affordable Care Act (ACA). Many Americans have been unable to sign up for insurance because of difficulties with the online marketplaces, and insurers are often receiving inaccurate information from the government about people who do manage to enroll. If such problems persist, they could deter relatively healthy persons from obtaining coverage and prevent the ACA from meeting its enrollment goals. Problems with the federal website will probably recede over time; indeed, its accessibility to consumers is already improving. The greatest long-term challenge to Obamacare remains ...	[Oberlander, Jonathan; Perreira, Krista] Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							Chou R, 2013, WRAL            0204; Frank J., 2013, RALEIGH NEWS OB 0204; Holohan J, 2013, COST NOT EXPANDING M; Jones DK, 2013, J HLTH POLIT POLICY; The Kaiser Commission on Medicaid and the Uninsured, 2013, COV GAP UN POOR AD S	5	6	6	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2469	2471		10.1056/NEJMp1314861	http://dx.doi.org/10.1056/NEJMp1314861			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	278BT	24328441				2022-12-28	WOS:000328863700002
J	Bourzac, K				Bourzac, Katherine			MEDICAL IMAGING Removing the blindfold	NATURE			English	Editorial Material																		Bousso P., 2008, J CLIN INVEST, V118, P1390; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Pageon SV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003947	3	2	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S10	S12		10.1038/504S10a	http://dx.doi.org/10.1038/504S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352358				2022-12-28	WOS:000328575300006
J	Davies, E				Davies, Edward			Volunteer doctors start a clinic for the marginalized of New York city	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Colangelo LL, 2013, N Y DAILY NEWS  1022; Feinmann J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7193; Hurley R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7374	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7586	10.1136/bmj.f7586	http://dx.doi.org/10.1136/bmj.f7586			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355388	Bronze			2022-12-28	WOS:000328824300010
J	Humphries, C				Humphries, Courtney			ADOPTIVE CELL THERAPY Honing that killer instinct	NATURE			English	Editorial Material																		Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116	5	39	48	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S13	S15		10.1038/504S13a	http://dx.doi.org/10.1038/504S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352359	Bronze			2022-12-28	WOS:000328575300007
J	Jiang, L; Liu, X; Xiong, GS; Liu, HH; Chen, FL; Wang, L; Meng, XB; Liu, GF; Yu, H; Yuan, YD; Yi, W; Zhao, LH; Ma, HL; He, YZ; Wu, ZS; Melcher, K; Qian, Q; Xu, HE; Wang, YH; Li, JY				Jiang, Liang; Liu, Xue; Xiong, Guosheng; Liu, Huihui; Chen, Fulu; Wang, Lei; Meng, Xiangbing; Liu, Guifu; Yu, Hong; Yuan, Yundong; Yi, Wei; Zhao, Lihua; Ma, Honglei; He, Yuanzheng; Wu, Zhongshan; Melcher, Karsten; Qian, Qian; Xu, H. Eric; Wang, Yonghong; Li, Jiayang			DWARF 53 acts as a repressor of strigolactone signalling in rice	NATURE			English	Article							ORYZA-SATIVA-L; CO-REPRESSOR; ARABIDOPSIS; TOPLESS; OUTGROWTH; KARRIKIN; ORTHOLOG; GENES; MAX1; LEAF	Strigolactones (SLs) are a group of newly identified plant hormones that control plant shoot branching. SL signalling requires the hormone-dependent interaction of DWARF14 (D14), a probable candidate SL receptor, with DWARF3 (D3), an F-box component of the Skp-Cullin-F-box (SCF) E3 ubiquitin ligase complex. Here we report the characterization of a dominant SL-insensitive rice (Oryza sativa) mutant dwarf 53 (d53) and the cloning of D53, which encodes a substrate of the SCFD3 ubiquitination complex and functions as a repressor of SL signalling. Treatments with GR24, a synthetic SL analogue, cause D53 degradation via the proteasome in a manner that requires D14 and the SCFD3 ubiquitin ligase, whereas the dominant form of D53 is resistant to SL-mediated degradation. Moreover, D53 can interact with transcriptional co-repressors known as TOPLESS-RELATED PROTEINS. Our results suggest a model of SL signalling that involves SL-dependent degradation of the D53 repressor mediated by the D14-D3 complex.	[Jiang, Liang; Liu, Xue; Xiong, Guosheng; Liu, Huihui; Chen, Fulu; Wang, Lei; Meng, Xiangbing; Liu, Guifu; Yu, Hong; Yuan, Yundong; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Jiang, Liang; Liu, Xue; Xiong, Guosheng; Liu, Huihui; Chen, Fulu; Wang, Lei; Meng, Xiangbing; Liu, Guifu; Yu, Hong; Yuan, Yundong; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [Yi, Wei; Zhao, Lihua; Ma, Honglei; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Ctr Struct & Funct Drug Targets,VARI SIMM Ctr, Shanghai 201203, Peoples R China; [He, Yuanzheng; Wu, Zhongshan; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.	Eric.Xu@vai.org; yhwang@genetics.ac.cn; jyli@genetics.ac.cn	qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Yu, Hong/H-2770-2012	Melcher, Karsten/0000-0002-9125-4027; Yu, Hong/0000-0002-1748-8693; He, Yuanzheng/0000-0001-9131-140X; Xu, H. Eric/0000-0002-6829-8144; Ma, Honglei/0000-0003-3571-8867; meng, xiangbing/0000-0001-7040-7138	Ministry of Science and Technology of the People's Republic of China [2012AA10A301]; National Natural Science Foundation of China [31025004, 90817108, 91217311]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank K. Yoneyama for assistance in SL analysis and C. Yan for SL measurement. This work was supported by grants from Ministry of Science and Technology of the People's Republic of China (2012AA10A301) and National Natural Science Foundation of China (31025004, 90817108 and 91217311).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; CHU CC, 1975, SCI SINICA, V18, P659; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Fukui K, 2013, MOL PLANT, V6, P88, DOI 10.1093/mp/sss138; Fukui K, 2011, BIOORG MED CHEM LETT, V21, P4905, DOI 10.1016/j.bmcl.2011.06.019; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gao XQ, 2012, PLANTA, V235, P713, DOI 10.1007/s00425-011-1532-7; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; IWATA N, 1984, JPN J GENET, V59, P199, DOI 10.1266/jjg.59.199; Iwata N., 1977, JPN J BREED S1, V27, P250; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; Kierzkowski D, 2009, PLANT J, V59, P813, DOI 10.1111/j.1365-313X.2009.03915.x; Kwon Y, 2012, PLANT BIOTECHNOL REP, V6, P213, DOI 10.1007/s11816-011-0214-z; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Simons JL, 2007, PLANT PHYSIOL, V143, P697, DOI 10.1104/pp.106.087957; Smith SM, 2012, CURR BIOL, V22, pR924, DOI 10.1016/j.cub.2012.09.016; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stanga JP, 2013, PLANT PHYSIOL, V163, P318, DOI 10.1104/pp.113.221259; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Wei LR, 2006, J INTEGR PLANT BIOL, V48, P447, DOI 10.1111/j.1744-7909.2006.00248.x; Yoshida A, 2012, PLANT J, V70, P327, DOI 10.1111/j.1365-313X.2011.04872.x; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	50	469	551	31	472	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					401	+		10.1038/nature12870	http://dx.doi.org/10.1038/nature12870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24336200	Green Accepted			2022-12-28	WOS:000328575300044
J	Kalso, E; Aldington, DJ; Moore, RA				Kalso, Eija; Aldington, D. J.; Moore, R. A.			Drugs for neuropathic pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		[Kalso, Eija] Univ Helsinki, Cent Hosp, Dept Anaesthesia & Intens Care Med, Inst Clin Med,Fac Med,Pain Clin, FIN-00029 Helsinki, Finland; [Aldington, D. J.] Royal Hampshire Cty Hosp, Winchester, Hants, England; [Moore, R. A.] Univ Oxford, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Oxford OX3 7LE, England	University of Helsinki; Helsinki University Central Hospital; University of Oxford	Moore, RA (corresponding author), Univ Oxford, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Oxford OX3 7LE, England.	andrew.moore@ndcn.ox.ac.uk		Aldington, Dominic/0000-0001-6253-1649; Kalso, Eija/0000-0002-4899-605X				[Anonymous], 2013, MARTINDALE COMPLETE; Chaparro LE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008943.pub2; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Cochrane Pain Palliative and Supportive Care Group, PAPAS DOC; Derry S, 2013, COCHRANE DB SYST REV, V1; Hearn L, 2012, COCHRANE DB SYST REV, V2; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Lunn MP, 2009, COCHRANE DB SYST REV, V4; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; MHRA, 2012, DRUG SAFETY UPDATE, V6, P5; Moore RA, 2014, EUR J PAIN, V18, P67, DOI 10.1002/j.1532-2149.2013.00341.x; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub2; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; Moore RA, 2012, PAIN, V153, P265, DOI 10.1016/j.pain.2011.10.004; Moore RA, 2010, PAIN, V150, P386, DOI 10.1016/j.pain.2010.05.011; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; Moore RA, PAIN PRACT IN PRESS; NICE. Neuropathic pain-pharmacological management, 2013, PHARM MAN NEUR PAIN, V173, P1; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Sultan A, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-29; Vo T, 2009, PAIN, V143, P169, DOI 10.1016/j.pain.2009.03.013; Watson CPN, 1998, NEUROLOGY, V51, P1166, DOI 10.1212/WNL.51.4.1166; Wiffen P. J., 2011, COCHRANE DB SYST REV, V2	24	66	67	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7339	10.1136/bmj.f7339	http://dx.doi.org/10.1136/bmj.f7339			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355386				2022-12-28	WOS:000328824300005
J	Rothman, SM; Brudney, KF; Adair, W; Rothman, DJ				Rothman, Sheila M.; Brudney, Karen F.; Adair, Whitney; Rothman, David J.			Medical Communication Companies and Industry Grants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Medical communication companies (MCCs) are among the most significant health care stakeholders, supported mainly by drug and device companies. How MCCs share or protect physicians' personal data requires greater transparency. OBJECTIVE To explore the financial relationships between MCCs and drug and device companies, to describe the characteristics of the large MCCs, and to explore whether they accurately represent themselves to physicians. DESIGN We combined data from the 2010 grant registries of 14 pharmaceutical and device companies; grouped recipients into categories such as MCCs, academic medical centers, disease-targeted advocacy organizations, and professional associations; and created a master list of 19 272 grants. MAIN OUTCOMES AND MEASURES Determine the distribution of funds from drug and device companies to various entities and assess the characteristics of large MCCs. RESULTS Of the 6493 recipients of more than $657 million grant awards from drug and device companies, 18 of 363 MCCs received 26%, academic medical centers received 21%, and disease-targeted organizations received 15%. For-profit MCCs received 77% of funds (208 of 363). Among the top 5% of MCCs, 14 of 18 were for-profit. All 18 offered continuing medical education: 14 offered live and 17 offered online CME courses. All required physicians to provide personal data. Ten stated that they shared information with unnamed third parties. Eight stated they did not share information, but almost all added exceptions. None required explicit physician consent to their sharing policies. CONCLUSIONS AND RELEVANCE Medical communication companies receive substantial support from drug and device companies. Physicians who interact with MCCs should be aware that all require personal data from the physician and some share these data with unnamed third parties.	[Rothman, Sheila M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Brudney, Karen F.; Adair, Whitney; Rothman, David J.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University	Rothman, SM (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Med Profess, Dept Sociomed Sci,Mailman Sch Publ Hlth, 630 W 168th St,PH15-25, New York, NY 10032 USA.	smr4@columbia.edu			Selz Foundation; May and Samuel Rudin Foundation	Selz Foundation; May and Samuel Rudin Foundation	This work was funded by the Selz Foundation and the May and Samuel Rudin Foundation.	[Anonymous], 2011, 50 LARG PHARM CO SAL; [Anonymous], PRIV POL; De Hert P, EUROPEAN DATA PROTEC, P53; Federal Trade Commission, CTR DIG DEM COMPL RE; Institute on Medicine as a Profession, LINKS MCC GRANT REG; Rothman SM, 2011, AM J PUBLIC HEALTH, V101, P602, DOI 10.2105/AJPH.2010.300027; Steinbrook R, 2008, JAMA-J AM MED ASSOC, V299, P1060, DOI 10.1001/jama.299.9.1060; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V307, P1029, DOI 10.1001/jama.2012.211	8	10	10	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2554	2558		10.1001/jama.2013.281638	http://dx.doi.org/10.1001/jama.2013.281638			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346991				2022-12-28	WOS:000328503600025
J	Rocha, PP; Chaumeil, J; Skok, JA				Rocha, Pedro P.; Chaumeil, Julie; Skok, Jane A.			Finding the Right Partner in a 3D Genome	SCIENCE			English	Editorial Material							RAG2 C-TERMINUS; TRANSLOCATIONS; PROXIMITY		[Rocha, Pedro P.; Chaumeil, Julie; Skok, Jane A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University	Rocha, PP (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave,MSB 599, New York, NY 10016 USA.	jane.skok@nyumc.org	Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; CHAUMEIL, Julie/0000-0002-8976-2890; Rocha, Pedro/0000-0003-4691-7773	NIAID NIH HHS [R56 AI099111] Funding Source: Medline; NIGMS NIH HHS [R01 GM086852] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Chaumeil J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00423; Chaumeil J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3231; Deriano L, 2011, NATURE, V471, P119, DOI 10.1038/nature09755; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Rocha PP, 2013, CURR OPIN CELL BIOL, V25, P365, DOI 10.1016/j.ceb.2013.02.007; Rocha PP, 2012, MOL CELL, V47, P873, DOI 10.1016/j.molcel.2012.06.036; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150	11	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1333	1334		10.1126/science.1246106	http://dx.doi.org/10.1126/science.1246106			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337287	Green Accepted			2022-12-28	WOS:000328196000038
J	Davies, E				Davies, Edward			DATA BRIEFING How big is the US healthcare lobby?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, New York, NY USA		Davies, E (corresponding author), BMJ, New York, NY USA.	edavies@bmj.com						American College of Surgeons, 2010, AM COLL SURG CEL GRA; Center for Responsive Politics, INFL LOBB	2	1	1	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f7366	10.1136/bmj.f7366	http://dx.doi.org/10.1136/bmj.f7366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336003				2022-12-28	WOS:000328575200009
J	Parks, BW; Lusis, AJ				Parks, Brian W.; Lusis, Aldons J.			Macrophage Accumulation in Atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parks, Brian W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Parks, BW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL028481] Funding Source: Medline; NICHD NIH HHS [T32 HD007228] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Randolph GJ, 2013, NAT MED, V19, P1094, DOI 10.1038/nm.3316; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264	5	23	24	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2352	2353		10.1056/NEJMcibr1312709	http://dx.doi.org/10.1056/NEJMcibr1312709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328470	Green Accepted			2022-12-28	WOS:000328156300015
J	Turnpenny, PD				Turnpenny, Peter D.			CHRISTMAS 2013: MEDICAL HISTORIES From the Ottomans to the present day: 150 years of Scottish medical charity in the Holy Land	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Turnpenny, Peter D.] Royal Devon & Exeter Hosp, Exeter EX1 2ED, Devon, England; [Turnpenny, Peter D.] Univ Exeter, Sch Med, Exeter, Devon, England	University of Exeter; University of Exeter	Turnpenny, PD (corresponding author), Royal Devon & Exeter Hosp, Exeter EX1 2ED, Devon, England.	peter.turnpenny@nhs.net						Billings M, 2012, VARTAN NAZARETH MISS; Wilkinson John, 1991, COOGATE DOCTORS HIST	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f6994	10.1136/bmj.f6994	http://dx.doi.org/10.1136/bmj.f6994			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336306				2022-12-28	WOS:000328575200005
J	Due, C; Fox, W; Medlock, JM; Pietzsch, M; Logan, JG				Due, Christina; Fox, Wendy; Medlock, Jolyon M.; Pietzsch, Maaike; Logan, James G.			Tick bite prevention and tick removal	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IXODES-RICINUS ACARI; AMBLYOMMA-HEBRAEUM ACARI; LYME-DISEASE; REPELLENT EFFICACY; INSECT REPELLENTS; RESIDUAL ACTIVITY; LEMON EUCALYPTUS; AEDES-AEGYPTI; DEET; IXODIDAE		[Due, Christina; Logan, James G.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Due, Christina; Fox, Wendy; Logan, James G.] Borreliosis & Associated Dis Awareness UK BADA UK, Rotherham, S Yorkshire, England; [Medlock, Jolyon M.; Pietzsch, Maaike] Publ Hlth England, Salisbury, Wilts, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	Logan, JG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.	James.Logan@lshtm.ac.uk						Bonnefoy X, 2008, PUBLIC HLTH SIGNIFIC; Bowles DE, 1992, J MED ENTOMOL, V30, P748; Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5; CDC, 2013, REP CAS LYM DIS YEAR; Centers for Disease Control and Prevention, 2011, TICK REM; Centers for Disease Control and Prevention (CDC), 2013, SIGNS SYMPT LYM DIS; CONNAT JL, 1991, PARASITOL RES, V77, P452, DOI 10.1007/BF00931644; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; Daltroy LH, 2007, HEALTH EDUC BEHAV, V34, P531, DOI 10.1177/1090198106294646; DEBOER R, 1993, J MED ENTOMOL, V30, P748, DOI 10.1093/jmedent/30.4.748; Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008; Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472; Faulde MK, 2003, J MED ENTOMOL, V40, P935, DOI 10.1603/0022-2585-40.6.935; Garboui SS, 2006, EXP APPL ACAROL, V40, P271, DOI 10.1007/s10493-006-9031-4; Gardulf A, 2004, J MED ENTOMOL, V41, P1064, DOI 10.1603/0022-2585-41.6.1064; Hillyard PD, 1996, FIELD STUDIES COUNCI; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Jaenson TGT, 2006, J MED ENTOMOL, V43, P731, DOI 10.1603/0022-2585(2006)43[731:ROOOLE]2.0.CO;2; Jensenius M, 2005, T ROY SOC TROP MED H, V99, P708, DOI 10.1016/j.trstmh.2005.01.006; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Koren G, 2003, CAN MED ASSOC J, V169, P209; Malouin R, 2003, AM J EPIDEMIOL, V157, P1039, DOI 10.1093/aje/kwg076; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; NEEDHAM GR, 1985, PEDIATRICS, V75, P997; NHS Choices, 2012, INS BIT STINGS; OCONNELL S, 1994, J MED MICROBIOL, V40, P77, DOI 10.1099/00222615-40-2-77; Oteo JA, 1996, REV CLIN ESP, V196, P584; Parola P, 2004, COMP IMMUNOL MICROB, V27, P297, DOI 10.1016/j.cimid.2004.03.006; Piesman J, 2002, J MED ENTOMOL, V39, P509, DOI 10.1603/0022-2585-39.3.509; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Pitches D.W., 2006, EURO SURVEILLANCE, V11; Pretorius AM, 2003, J MED ENTOMOL, V40, P245, DOI 10.1603/0022-2585-40.2.245; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V131, P877, DOI 10.1093/oxfordjournals.aje.a115578; Semmler M, 2011, PARASITOL RES, V108, P899, DOI 10.1007/s00436-010-2131-4; SOLBERG VB, 1995, J MED ENTOMOL, V32, P870, DOI 10.1093/jmedent/32.6.870; Stafford K. C, 2005, TICK BITE PREVENTION; Staub D, 2002, WILD ENVIRON MED, V13, P12, DOI 10.1580/1080-6032(2002)013[0012:EOARCD]2.0.CO;2; Stewart RL, 1998, WILD ENVIRON MED, V9, P137, DOI 10.1580/1080-6032(1998)009[0137:EOTCTR]2.3.CO;2; Tijsse-Klasen E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-212; Trigg JK, 1996, PHYTOTHER RES, V10, P313, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;313::AID-PTR854&gt;3.0.CO;2-O; US Environmental Protection Agency, 1998, RER EL DEC RED DEET; Vaughn MF, 2011, VECTOR-BORNE ZOONOT, V11, P869, DOI 10.1089/vbz.2010.0158; Zenner L, 2006, VET REC, V159, P526, DOI 10.1136/vr.159.16.526	47	27	28	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7123	10.1136/bmj.f7123	http://dx.doi.org/10.1136/bmj.f7123			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZI	24324215	Green Accepted			2022-12-28	WOS:000328574400005
J	de la Roche, M; Ritter, AT; Angus, KL; Dinsmore, C; Earnshaw, CH; Reiter, JF; Griffiths, GM				de la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Dinsmore, Colin; Earnshaw, Charles H.; Reiter, Jeremy F.; Griffiths, Gillian M.			Hedgehog Signaling Controls T Cell Killing at the Immunological Synapse	SCIENCE			English	Article							PRIMARY CILIUM; ACTIVATION; POLARIZATION; INHIBITION	The centrosome is essential for cytotoxic T lymphocyte (CTL) function, contacting the plasma membrane and directing cytotoxic granules for secretion at the immunological synapse. Centrosome docking at the plasma membrane also occurs during cilia formation. The primary cilium, formed in nonhematopoietic cells, is essential for vertebrate Hedgehog (Hh) signaling. Lymphocytes do not form primary cilia, but we found and describe here that Hh signaling played an important role in CTL killing. T cell receptor activation, which "prearms" CTLs with cytotoxic granules, also initiated Hh signaling. Hh pathway activation occurred intracellularly and triggered Rac1 synthesis. These events "prearmed" CTLs for action by promoting the actin remodeling required for centrosome polarization and granule release. Thus, Hh signaling plays a role in CTL function, and the immunological synapse may represent a modified cilium.	[de la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Earnshaw, Charles H.; Griffiths, Gillian M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Dinsmore, Colin; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ritter, Alex T.] NICHD, NIH, Bethesda, MD 20892 USA	University of Cambridge; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Griffiths, GM (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	gg305@cam.ac.uk	Earnshaw, Charles/AAN-6210-2021	Griffiths, Gillian/0000-0003-0434-5842; Earnshaw, Charles/0000-0002-7926-8506; de la Roche, Maike/0000-0002-0558-4119; Dinsmore, Colin/0000-0002-6404-1202; Angus-Cole, Karen/0000-0002-6262-4041	Wellcome Trust [075880]; Wellcome Trust Strategic Award for core facilities at the CIMR [100140]; NIH [R01AR05439, R01GM095941]; Burroughs Wellcome Fund; David and Lucile F. Packard Foundation; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095941] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award for core facilities at the CIMR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile F. Packard Foundation; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Rohatgi for the MSCV-Ptch1-EYFP construct and the Smo antibodies; S. Munro (Cambridge) for PACT (pericentrin)-RFP; M. Davidson (University of Florida) for Farnesyl-5-TagBFP2; R. Zamoyska for Lck-depleted spleens; D. Fearon, T. Crompton, J. Kaufman, M. A. de la Roche, and A. Schuldt for helpful discussions and critical reading of the manuscript; and R. Rohatgi and J. Stinchcombe for helpful discussions. We also thank the flow cytometry core facility at the Cambridge Institute for Medical Research (CIMR) for cell sorting and assistance with the calcium assay. This work was supported by a Wellcome Trust Principal Research Fellowship to G. M. G. (075880), a Wellcome Trust Strategic Award for core facilities at the CIMR (100140), NIH (R01AR05439 and R01GM095941), the Burroughs Wellcome Fund, the David and Lucile F. Packard Foundation, and the Sandler Family Supporting Foundation to J. R. The data presented in this paper are provided in the main paper and supplementary materials.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; El Abdaloussi E, 2006, NAT IMMUNOL, V7, P418, DOI 10.1038/ni1313; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Kornberg TB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002447; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nishimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041413; Outram SV, 2009, BLOOD, V113, P2217, DOI 10.1182/blood-2008-03-144840; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yi JS, 2013, J CELL BIOL, V202, P779, DOI 10.1083/jcb.201301004	30	91	91	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1247	1250		10.1126/science.1244689	http://dx.doi.org/10.1126/science.1244689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311692	Green Accepted			2022-12-28	WOS:000327857900051
J	Post, VEA; Groen, J; Kooi, H; Person, M; Ge, SM; Edmunds, WM				Post, Vincent E. A.; Groen, Jacobus; Kooi, Henk; Person, Mark; Ge, Shemin; Edmunds, W. Mike			Offshore fresh groundwater reserves as a global phenomenon	NATURE			English	Review							ATLANTIC CONTINENTAL-SHELF; PORE-WATER; SEAWATER INTRUSION; COASTAL AQUIFERS; RESIDENCE TIME; FLUID-FLOW; BASIN; DIAGENESIS; INTERFACE; SYSTEMS	The flow of terrestrial groundwater to the sea is an important natural component of the hydrological cycle. This process, however, does not explain the large volumes of low-salinity groundwater that are found below continental shelves. There is mounting evidence for the global occurrence of offshore fresh and brackish groundwater reserves. The potential use of these non-renewable reserves as a freshwater resource provides a clear incentive for future research. But the scope for continental shelf hydrogeology is broader and we envisage that it can contribute to the advancement of other scientific disciplines, in particular sedimentology and marine geochemistry.	[Post, Vincent E. A.] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia; [Post, Vincent E. A.] Nat Ctr Groundwater Res & Training, Adelaide, SA 5001, Australia; [Groen, Jacobus; Kooi, Henk] Vrije Univ Amsterdam, Fac Earth & Life Sci, Crit Zone Hydrol Grp, NL-1081 HV Amsterdam, Netherlands; [Groen, Jacobus] Acacia Water, NL-2805 RN Gouda, Netherlands; [Person, Mark] New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA; [Ge, Shemin] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Edmunds, W. Mike] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England	Flinders University South Australia; Vrije Universiteit Amsterdam; New Mexico Institute of Mining Technology; University of Colorado System; University of Colorado Boulder; University of Oxford	Post, VEA (corresponding author), Flinders Univ S Australia, Sch Environm, POB 2100, Adelaide, SA 5001, Australia.	vincent.post@flinders.edu.au	Post, Vincent E.A./E-6054-2011	Post, Vincent E.A./0000-0002-9463-3081	Office Of The Director [1301346] Funding Source: National Science Foundation	Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))		Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Aeschbach-Hertig W, 2012, NAT GEOSCI, V5, P853, DOI [10.1038/NGEO1617, 10.1038/ngeo1617]; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], 2011, P INTEGR OCEAN DRIL, V317, P103; Appleyard SJ, 2006, APPL GEOCHEM, V21, P83, DOI 10.1016/j.apgeochem.2005.09.008; Bailey GN, 2011, QUATERNARY SCI REV, V30, P1533, DOI 10.1016/j.quascirev.2010.06.019; Bakari SS, 2012, J HYDROL, V466, P127, DOI 10.1016/j.jhydrol.2012.08.016; Bakken TH, 2012, WATER RESOUR MANAG, V26, P1015, DOI 10.1007/s11269-011-9806-1; Bakker M, 2006, ADV WATER RESOUR, V29, P417, DOI 10.1016/j.advwatres.2005.05.009; Barlow PM, 2003, GROUND WATER FRESHWA, V1262, DOI [10.3133/cir1262, DOI 10.3133/CIR1262]; Bazin B, 1997, MAR PETROL GEOL, V14, P481, DOI 10.1016/S0264-8172(97)00004-4; Berndt C, 2005, PHILOS T R SOC A, V363, P2855, DOI 10.1098/rsta.2005.1666; Berner R, 1987, GLOBAL WATER CYCLE G, P397; Bradley DC, 2008, EARTH-SCI REV, V91, P1, DOI 10.1016/j.earscirev.2008.08.001; Bratton JF, 2010, J GEOL, V118, P565, DOI 10.1086/655114; CHAMBERS SR, 1991, P OCEAN DRILLING PRO, V0119; Church TM, 1996, NATURE, V380, P579, DOI 10.1038/380579a0; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cohen D, 2010, GROUND WATER, V48, P143, DOI 10.1111/j.1745-6584.2009.00627.x; Constable S, 2007, GEOPHYSICS, V72, pWA3, DOI 10.1190/1.2432483; Davies C. P. N., 1997, THESIS U STELLENBOSC; De Melo MTC, 2001, GEOL SOC SPEC PUBL, V189, P139; DECARLO EH, 1992, P OC DRILL PROGR SCI, V0122; DeFoor W, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010536; Dugan B, 2000, SCIENCE, V289, P288, DOI 10.1126/science.289.5477.288; Edmunds WM, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P341, DOI 10.1007/1-4020-3023-1_21; Edmunds WM, 2001, GEOL SOC SPEC PUBL, V189, P71, DOI 10.1144/GSL.SP.2001.189.01.06; Edmunds WM, 2001, GEOL SOC SPEC PUBL, V189, P289, DOI 10.1144/GSL.SP.2001.189.01.17; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; ESSAID HI, 1990, WATER RESOUR RES, V26, P1431, DOI 10.1029/WR026i007p01431; Exon N.F., 2001, P OCEAN DRILLING PRO, P1, DOI [DOI 10.2973/ODP.PROC.IR.2189.2107.2001, 10.2973/odp.proc.ir.189.107.2001.]; Faure H, 2002, GLOBAL PLANET CHANGE, V33, P47, DOI 10.1016/S0921-8181(02)00060-7; Ferguson G, 2012, NAT CLIM CHANGE, V2, P342, DOI [10.1038/NCLIMATE1413, 10.1038/nclimate1413]; Fisher AT, 2005, HYDROGEOL J, V13, P69, DOI 10.1007/s10040-004-0400-y; Galloway DL, 2011, HYDROGEOL J, V19, P1459, DOI 10.1007/s10040-011-0775-5; GEYH MA, 1989, RADIOCARBON, V31, P919; Gieskes J. M., 1975, DEEP SEA DRILL PROJ, V28, P805; Gieskes J. M., 1978, INIT REPTS DSDP S, V38-41, P121; Grasby SE, 2009, APPL GEOCHEM, V24, P536, DOI 10.1016/j.apgeochem.2008.12.008; Green TR, 2011, J HYDROL, V405, P532, DOI 10.1016/j.jhydrol.2011.05.002; Greenlee LF, 2009, WATER RES, V43, P2317, DOI 10.1016/j.watres.2009.03.010; Groen J, 2000, J HYDROL, V234, P1, DOI 10.1016/S0022-1694(00)00235-3; Groen J, 2000, IAHS-AISH P, P417; Harrar WG, 2001, GEOL SOC SPEC PUBL, V189, P213, DOI 10.1144/GSL.SP.2001.189.01.13; HATHAWAY JC, 1979, SCIENCE, V206, P515, DOI 10.1126/science.206.4418.515; Hennig A., 2005, HYDRODYNAMIC CHARACT; Hesse R, 2003, EARTH-SCI REV, V61, P149, DOI 10.1016/S0012-8252(02)00117-4; Hinsby K, 2001, GEOL SOC SPEC PUBL, V189, P29, DOI 10.1144/GSL.SP.2001.189.01.04; Hoefel FG, 2001, ESTUAR COAST SHELF S, V52, P179, DOI 10.1006/ecss.2000.0718; Hughes JD, 2009, HYDROGEOL J, V17, P793, DOI 10.1007/s10040-008-0412-0; JOHNSTON RH, 1983, J HYDROL, V61, P239, DOI 10.1016/0022-1694(83)90251-2; KASTNER M, 1990, P OC DRILL PROGR SCI, V0112; KASTNER M, 1991, PHILOS T ROY SOC A, V335, P243, DOI 10.1098/rsta.1991.0045; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Kooi H, 2001, J HYDROL, V246, P19, DOI 10.1016/S0022-1694(01)00354-7; Kooi H, 2000, WATER RESOUR RES, V36, P3581, DOI 10.1029/2000WR900243; Kooi H., 2000, P 16 SALT WAT INTR M; Krantz DE, 2004, GROUND WATER, V42, P1035, DOI 10.1111/j.1745-6584.2004.tb02642.x; Kriete C, 2004, ESTUAR COAST SHELF S, V59, P499, DOI 10.1016/j.ecss.2003.11.001; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lettenmaier DP, 2009, NAT GEOSCI, V2, P452, DOI 10.1038/ngeo567; Loosli HH, 2001, GEOL SOC SPEC PUBL, V189, P193, DOI 10.1144/GSL.SP.2001.189.01.12; LOVE AJ, 1994, J HYDROL, V153, P157, DOI 10.1016/0022-1694(94)90190-2; LUNDEGARD PD, 1990, APPL GEOCHEM, V5, P669, DOI 10.1016/0883-2927(90)90064-C; Maathuis H, 2000, GROUNDWATER: PAST ACHIEVEMENTS AND FUTURE CHALLENGES, P209; Malone MJ, 2002, MAR GEOL, V189, P175, DOI 10.1016/S0025-3227(02)00474-7; Mansurbeg H, 2012, MAR PETROL GEOL, V37, P7, DOI 10.1016/j.marpetgeo.2012.03.009; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; Meisler H., 1984, US GEOLOGICAL SURVEY, P28; MIDDELBURG JJ, 1989, NETH J SEA RES, V24, P615, DOI 10.1016/0077-7579(89)90138-5; Moore WS, 2010, ANNU REV MAR SCI, V2, P59, DOI 10.1146/annurev-marine-120308-081019; Mora G, 2005, MAR GEOL, V219, P71, DOI 10.1016/j.margeo.2005.06.020; Morad S, 2000, SEDIMENTOLOGY, V47, P95, DOI 10.1046/j.1365-3091.2000.00007.x; Morrissey SK, 2010, NAT GEOSCI, V3, P683, DOI 10.1038/NGEO956; Mountain G. S., 2009, P IODP, V313; Mulligan AE, 2007, J HYDROL, V335, P313, DOI 10.1016/j.jhydrol.2006.11.025; OTERI AU, 1988, HYDROLOG SCI J, V33, P19, DOI 10.1080/02626668809491219; Person M, 2003, GEOL SOC AM BULL, V115, P1324, DOI 10.1130/B25285.1; Person M, 2012, HYDROGEOL J, V20, P325, DOI 10.1007/s10040-011-0795-1; Post VEA, 2005, HYDROGEOL J, V13, P120, DOI 10.1007/s10040-004-0417-2; Post VEA, 2003, HYDROGEOL J, V11, P549, DOI 10.1007/s10040-003-0271-7; Post V, 2010, HYDROGEOL J, V18, P1, DOI 10.1007/s10040-009-0561-9; ROBB JM, 1984, GEOLOGY, V12, P278, DOI 10.1130/0091-7613(1984)12<278:SSOTLC>2.0.CO;2; Sanford W. E., 1996, HYDROGEOL J, V4, P26, DOI DOI 10.1007/S100400050083; Sanford WE, 2010, NAT GEOSCI, V3, P671, DOI 10.1038/ngeo958; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Screaton EJ, 2010, HYDROGEOL J, V18, P1547, DOI 10.1007/s10040-010-0636-7; Soulet G, 2010, EARTH PLANET SC LETT, V296, P57, DOI 10.1016/j.epsl.2010.04.045; Stuyfzand PJ, 2010, HYDROGEOL J, V18, P117, DOI 10.1007/s10040-009-0527-y; Taniguchi M, 2002, HYDROL PROCESS, V16, P2115, DOI 10.1002/hyp.1145; van der Gun Jac, 2010, Sustainability, V2, P3418, DOI 10.3390/su2113418; van Geldern R, 2013, GEOSPHERE, V9, P96, DOI 10.1130/GES00859.1; Varma S, 2012, HYDROGEOL J, V20, P119, DOI 10.1007/s10040-011-0800-8; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Werner AD, 2013, ADV WATER RESOUR, V51, P3, DOI 10.1016/j.advwatres.2012.03.004; Weyhenmeyer CE, 2000, SCIENCE, V287, P842, DOI 10.1126/science.287.5454.842; Wilson AM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018499; Xiao SH, 2013, NATURE, V493, P28, DOI 10.1038/nature11765; [张志忠 Zhang Zhizhong], 2011, [海洋通报, Marine Science Bulletin], V30, P47	99	182	187	5	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					71	78		10.1038/nature12858	http://dx.doi.org/10.1038/nature12858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305150				2022-12-28	WOS:000327851700027
J	Russell, DG				Russell, David G.			Trp'ing Tuberculosis	CELL			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; HUMAN-FIBROBLASTS; GAMMA-INTERFERON; TRYPTOPHAN		Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Russell, David G/N-5280-2019; Russell, David G/D-4533-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X				Blumenthal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037314; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; MURRAY HW, 1989, INFECT IMMUN, V57, P845, DOI 10.1128/IAI.57.3.845-849.1989; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Peng KT, 2010, INFECT IMMUN, V78, P2723, DOI 10.1128/IAI.00008-10; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; PFEFFERKORN ER, 1986, J INTERFERON RES, V6, P267, DOI 10.1089/jir.1986.6.267; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	9	5	5	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1209	1210		10.1016/j.cell.2013.11.015	http://dx.doi.org/10.1016/j.cell.2013.11.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315090	Bronze			2022-12-28	WOS:000328271100004
J	McAndrew, P; Scanlon, E				McAndrew, Patrick; Scanlon, Eileen			Open Learning at a Distance: Lessons for Struggling MOOCs	SCIENCE			English	Editorial Material									[McAndrew, Patrick; Scanlon, Eileen] Open Univ, Inst Educ Technol, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	McAndrew, P (corresponding author), Open Univ, Inst Educ Technol, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	pat-rick.mcandrew@open.ac.uk		McAndrew, Patrick/0000-0002-9016-154X				Anderson T., 2003, INT REV RES OPEN DIS, V2003, P4; Borgman C. L., 2008, FOSTERING LEARING NE; Brown J.S., 2007, CREATIVE COMMON MOUN, P1; Butin D. W., 2012, ELEARN, V6; Chamberlin L., 2011, ELEARN, V2011, P8; Cross S., 2012, OULDI JISC PROJECT E; Daniel J, 2012, J INTERACT MEDIA EDU, DOI 10.5334/2012-18; Daniel J, 2012, OPEN LEARN, V27, P89, DOI 10.1080/02680513.2012.640791; Ferguson R, 2010, J COMPUT ASSIST LEAR, V26, P574, DOI 10.1111/j.1365-2729.2010.00386.x; Holliman R., 2013, ENCY SCI ED; Knight E., 2012, GAME CHANGERS ED INF, P279; Koller D., 2013, RETENTION INTENTION; Mains E. A. A., 2011, J R COLL SURG EDINBU, V9, P322; McAndrew P., 2009, LEARNING OPENLEARN R; McAndrew P, 2012, RES LEARN TECHNOL, V20, DOI 10.3402/rlt.v2010.18699; McCallum C. M., 2013, ELEARNING PAPERS OPE; Open University, 2013, OU FACTS FIG; Pepicello W., 2012, GAME CHANGERS ED INF, P133; Rowntree D., 1997, MAKING MAT BASED LEA; Sharples M., 2013, INNOVATING PEDAGOGY; Thorpe M., 1993, EVALUATING OPEN DIST; Whitelock D., 2012, INT J E ASSESSMENT, V2, P9	22	36	37	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1450	1451		10.1126/science.1239686	http://dx.doi.org/10.1126/science.1239686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	274ZI	24357302	Green Accepted			2022-12-28	WOS:000328644300035
J	Hu, LL; Li, Z; Cheng, JD; Rao, QH; Gong, W; Liu, MJ; Shi, YJG; Zhu, JY; Wang, P; Xu, YH				Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui			Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; 5-METHYLCYTOSINE OXIDATION; DNA DEMETHYLATION; CXXC DOMAIN; FAMILY PROTEINS; NUCLEIC-ACIDS; MAMMALIAN DNA; GENOMIC DNA; 5-HYDROXYMETHYLCYTOSINE; ENZYMES	TET proteins oxidize 5-methylcytosine (5mC) on DNA and play important roles in various biological processes. Mutations of TET2 are frequently observed in myeloid malignance. Here, we present the crystal structure of human TET2 bound to methylated DNA at 2.02 angstrom resolution. The structure shows that two zinc fingers bring the Cys-rich and DSBH domains together to form a compact catalytic domain. The Cys-rich domain stabilizes the DNA above the DSBH core. TET2 specifically recognizes CpG dinucleotide and shows substrate preference for 5mC in a CpG context. 5mC is inserted into the catalytic cavity with the methyl group orientated to catalytic Fe(II) for reaction. The methyl group is not involved in TET2-DNA contacts so that the catalytic cavity allows TET2 to accommodate 5mC derivatives for further oxidation. Mutations of Fe(II)/NOG-chelating, DNA-interacting, and zinc-chelating residues are frequently observed in human cancers. Our studies provide a structural basis for understanding the mechanisms of TET-mediated 5mC oxidation.	[Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui] Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200032, Peoples R China; [Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Hu, Lulu; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Yujiang Geno] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Shi, Yujiang Geno] Brigham & Womens Hosp, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Fudan University; Fudan University; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Xu, YH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200032, Peoples R China.	xuyh@fudan.edu.cn	Liu, Mengjie/AAD-7684-2020; Xu, Yanhui/D-5119-2019; Liu, Mengjie/AAZ-6249-2020; Wang, Ping/GZB-2001-2022	Liu, Mengjie/0000-0002-2889-2210; Liu, Mengjie/0000-0002-2889-2210; Wang, Ping/0000-0002-2710-7188	National Basic Research Program of China [2011CB965300, 2009CB918600]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507-002, 2011ZX09506-001]; National Natural Science Foundation of China [31270779, 31030019, 11079016, 30870493]; Basic Research Project of Shanghai Science and Technology Commission [12JC1402700]; Fok Ying Tung Education Foundation [20090071220012]	National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	We thank Drs. Zhiyong Lou and Haifeng Hou for their help in structure determination. We thank staff members of beamline BL17U at SSRF for assistance in data collection and Mr. Lei Zhang and staff members of Biomedical Core Facility, Fudan University for their help on mass spectrometry analyses. We thank Drs. Yang Shi and Guoliang Xu for critical reading of the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB965300, 2009CB918600), the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China (2014ZX09507-002, 2011ZX09506-001), the National Natural Science Foundation of China (31270779, 31030019, 11079016, 30870493), Basic Research Project of Shanghai Science and Technology Commission (12JC1402700), and Fok Ying Tung Education Foundation (20090071220012).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Ono R, 2002, CANCER RES, V62, P4075; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	48	261	275	2	127	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1545	1555		10.1016/j.cell.2013.11.020	http://dx.doi.org/10.1016/j.cell.2013.11.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24315485	Bronze			2022-12-28	WOS:000328693300011
J	Paterson, T; Inglis, T				Paterson, Timothy; Inglis, Tim			Metastatic Gas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Paterson, Timothy] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Inglis, Tim] Queen Elizabeth II Med Ctr, Perth, WA, Australia	University of Western Australia; University of Western Australia	Paterson, T (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	paterson_tim@hotmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					E33	E33		10.1056/NEJMicm1213053	http://dx.doi.org/10.1056/NEJMicm1213053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328488				2022-12-28	WOS:000328156300001
J	Bonvillian, WB				Bonvillian, William B.			Advanced Manufacturing Policies and Paradigms for Innovation	SCIENCE			English	Editorial Material									MIT, Washington Off, Washington, DC 20002 USA	Massachusetts Institute of Technology (MIT)	Bonvillian, WB (corresponding author), MIT, Washington Off, Washington, DC 20002 USA.	bonvill@mit.edu						ARTHUR B, 1994, INCREASING RETURNS P; Berger S, 2013, MAKING IN AMERICA: FROM INNOVATION TO MARKET, P1; Berger S., 2005, WE COMPETE WHAT CO A, P251; Bonvillian W. B., 2012, INNOVATIONS, V7, P97, DOI DOI 10.1162/INOV_A_00142; Bonvillian WB, 2014, SCI PUBL POLICY, V41, P425, DOI 10.1093/scipol/sct059; Bonvillian WB, 2011, J TECHNOL TRANSFER, V36, P469, DOI 10.1007/s10961-011-9223-x; Breznitz D., 2011, RUN RED QUEEN; Breznitz D., 2012, AM 2 SYSTEMS INNOVAT, P16; Bureau of Labor Statistics, 2013, DAT TABL CALC MAN AL; Helper S., 2012, WHY DOES MANUFACTURI; Industry 4.0 Working Group National Academy of Science and Engineering, 2013, SEC FUT GERM MAN REC; Information Technology and Innovation Foundation, 2012, WORS GREAT DEPR; Jones D. T., 1990, MACHINE CHANGED WORL; MIT Taskforce on innovation and Production, 2013, PREV MIT PROD INN EC, P27; Morris Charles R., 2012, DAWN INNOVATION 1 AM; Nahm J, 2014, WORLD DEV, V54, P288, DOI 10.1016/j.worlddev.2013.09.003; OECD, 2013, SCI TECHN IND SCOR 2, P47; Organization for Economic Cooperation and Development, 2013, GOODS TRAD BAL TRAD; President's Council of Advisors on Science and Technology, 2012, ADV MAN PARTN REP PR; Rosen W, 2010, MOST POWERFUL IDEA W; Ruttan V. W., 2006, ISSUES SCI TECHN WIN; Ruttan V.W., 2006, IS WAR NECESSARY EC; Shipp S., 2012, P4603 I DEF AN, P68; Solow R., 2000, GROWTH THEORY EXPOSI; Tassey G, 2010, J TECHNOL TRANSFER, V35, P283, DOI 10.1007/s10961-009-9150-2; Technology Strategy Board, 2008, HIGH VAL MAN KEY TEC; U.S. Bureau of Economic Analysis, US INT TRAD GOODS SE	27	24	27	5	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1173	1175		10.1126/science.1242210	http://dx.doi.org/10.1126/science.1242210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264DT	24311668				2022-12-28	WOS:000327857900023
J	Chester, FM; Rowe, C; Ujiie, K; Kirkpatrick, J; Regalla, C; Remitti, F; Moore, JC; Toy, V; Wolfson-Schwehr, M; Bose, S; Kameda, J; Mori, JJ; Brodsky, EE; Eguchi, N; Toczko, S				Chester, Frederick M.; Rowe, Christie; Ujiie, Kohtaro; Kirkpatrick, James; Regalla, Christine; Remitti, Francesca; Moore, J. Casey; Toy, Virginia; Wolfson-Schwehr, Monica; Bose, Santanu; Kameda, Jun; Mori, James J.; Brodsky, Emily E.; Eguchi, Nobuhisa; Toczko, Sean		Expedition 343 Scientist; Expedition 343T Scientist	Structure and Composition of the Plate-Boundary Slip Zone for the 2011 Tohoku-Oki Earthquake	SCIENCE			English	Article							PACIFIC COAST; TRENCH AXIS; FAULT; STRESS; DECOLLEMENT; THICKNESS; FRICTION; RUPTURE; JAPAN; AREA	The mechanics of great subduction earthquakes are influenced by the frictional properties, structure, and composition of the plate-boundary fault. We present observations of the structure and composition of the shallow source fault of the 2011 Tohoku-Oki earthquake and tsunami from boreholes drilled by the Integrated Ocean Drilling Program Expedition 343 and 343T. Logging-while-drilling and core-sample observations show a single major plate-boundary fault accommodated the large slip of the Tohoku-Oki earthquake rupture, as well as nearly all the cumulative interplate motion at the drill site. The localization of deformation onto a limited thickness (less than 5 meters) of pelagic clay is the defining characteristic of the shallow earthquake fault, suggesting that the pelagic clay may be a regionally important control on tsunamigenic earthquakes.	[Chester, Frederick M.] Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX 77843 USA; [Rowe, Christie] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Ujiie, Kohtaro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ujiie, Kohtaro] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Kirkpatrick, James] Colorado State Univ, Dept Geosci, Ft Collins, CO 80523 USA; [Regalla, Christine] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Remitti, Francesca] Univ Modena & Reggio Emilia Largo, Dipartimento Sci Terra, Modena, Italy; [Moore, J. Casey; Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Toy, Virginia] Univ Otago, Dept Geol, Dunedin, New Zealand; [Wolfson-Schwehr, Monica] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Joint Hydrog Ctr, Durham, NH 03824 USA; [Bose, Santanu] Univ Calcutta, Dept Geol, Kolkata, India; [Kameda, Jun] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan; [Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Earthquake Hazards Div, Kyoto, Japan; [Eguchi, Nobuhisa; Toczko, Sean] Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Yokohama, Kanagawa, Japan	Texas A&M University System; Texas A&M University College Station; McGill University; University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universita di Modena e Reggio Emilia; University of California System; University of California Santa Cruz; University of Otago; University System Of New Hampshire; University of New Hampshire; University of Calcutta; University of Tokyo; Kyoto University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Chester, FM (corresponding author), Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX 77843 USA.	chesterf@tamu.edu	Brodsky, Emily/B-9139-2014; Sample, James/A-9622-2015; Kirkpatrick, Jamie/AAV-4400-2020; Chester, Frederick M/U-6789-2017; Chester, Frederick/X-4706-2019; remitti, francesca/E-7856-2012; Toy, Virginia/F-9912-2014	Chester, Frederick M/0000-0001-7665-3647; remitti, francesca/0000-0002-0720-1927; Toy, Virginia/0000-0002-7621-2064; Regalla, Christine/0000-0003-2975-8336; Schwehr, Monica/0000-0001-5885-8606; Fulton, Patrick/0000-0002-6259-2369; Kirkpatrick, James/0000-0001-7504-6968; Ishikawa, Tsuyoshi/0000-0003-2886-7282; Brodsky, Emily/0000-0002-6855-6860; Bose, Santanu/0000-0003-0137-4322; Rowe, Christie/0000-0002-9208-3960	U.S. Science Support Program of IODP; Gordon and Betty Moore Foundation	U.S. Science Support Program of IODP; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research used samples and data provided by the IODP (www.iodp.org/access-data-and-samples). We thank all drilling and logging operation staff on board the D/V Chikyu during expedition 343 and 343T. Part of this work was supported by the U.S. Science Support Program of IODP, and participation by E. B. was funded in part by the Gordon and Betty Moore Foundation. F. M. C., C. Rowe, K. U., C. Regalla, J. Kirkpatrick, F. R., J. C. M., and E. E. B. prepared figures and wrote the manuscript; C. Regalla, J. Kirkpatrick, F. R., V. T., M.W.-S., S. B., and J. Kameda provided structural and lithologic descriptions of core samples; J. J. M., E. E. B., S. Kodaira, F. M. C., P. Fulton, N.E., and S. T. organized and managed the expedition; all expedition scientists contributed to the paper by providing shipboard measurements and scientific discussions.	Ammon CJ, 2011, EARTH PLANETS SPACE, V63, P693, DOI 10.5047/eps.2011.05.015; Chester F.M., 2013, P IODP, V343; Chester FM, 1998, TECTONOPHYSICS, V295, P199, DOI 10.1016/S0040-1951(98)00121-8; Dean SM, 2010, SCIENCE, V329, P207, DOI 10.1126/science.1189373; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Horn David R., 1970, GEOL SOC AM MEM, V126, P1, DOI DOI 10.1130/MEM126-P1; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; Kato A, 2011, EARTH PLANETS SPACE, V63, P745, DOI 10.5047/eps.2011.06.014; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; Koper KD, 2011, EARTH PLANETS SPACE, V63, P599, DOI 10.5047/eps.2011.05.026; Lay T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009133; Lin AM, 2010, J STRUCT GEOL, V32, P781, DOI 10.1016/j.jsg.2010.05.004; Lin WR, 2013, SCIENCE, V339, P687, DOI 10.1126/science.1229379; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; Nakamura Y, 2013, GEOPHYS RES LETT, V40, P1713, DOI 10.1002/grl.50364; Rowe CD, 2013, GEOLOGY, V41, P991, DOI 10.1130/G34556.1; Savage HM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007665; Shipboard Scientific Party, 1980, IN REP DEEP SEA DRIL, V56, P399, DOI DOI 10.2973/DSDP.PR0C.5657.107; Shipboard Scientific Party, 1980, DSDP5657 SHIPB SCIEN, P399, DOI DOI 10.2973/DSDP.PR0C.5657.107; Sibson RH, 2003, B SEISMOL SOC AM, V93, P1169, DOI 10.1785/0120020061; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P1549, DOI 10.1029/96GL01479; Tsuru T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001664; Ujiie K, 2013, SCIENCE, V342, P1211, DOI 10.1126/science.1243485; Vannucchi P, 2003, J STRUCT GEOL, V25, P673, DOI 10.1016/S0191-8141(02)00066-4; Wallace G, 2003, GEOL SOC AM BULL, V115, P288, DOI 10.1130/0016-7606(2003)115<0288:COLADO>2.0.CO;2	29	175	177	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1208	1211		10.1126/science.1243719	http://dx.doi.org/10.1126/science.1243719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311682				2022-12-28	WOS:000327857900040
J	Friedfeld, MR; Shevlin, M; Hoyt, JM; Krska, SW; Tudge, MT; Chirik, PJ				Friedfeld, Max R.; Shevlin, Michael; Hoyt, Jordan M.; Krska, Shane W.; Tudge, Matthew T.; Chirik, Paul J.			Cobalt Precursors for High-Throughput Discovery of Base Metal Asymmetric Alkene Hydrogenation Catalysts	SCIENCE			English	Article							AMINO-ACID DERIVATIVES; COMPLEXES; REDUCTION; LIGANDS; MECHANISM; C=O	Asymmetric hydrogenation of alkenes is one of the most widely used methods for the preparation of single enantiomer compounds, especially in the pharmaceutical and agrochemical industries. For more than four decades, precious metal complexes containing rhodium, iridium, and ruthenium have been predominantly used as catalysts. Here, we report rapid evaluation of libraries of chiral phosphine ligands with a set of simple cobalt precursors. From these studies, base metal precatalysts have been discovered for the hydrogenation of functionalized and unfunctionalized olefins with high enantiomeric excesses, demonstrating the potential utility of more earth-abundant metals in asymmetric hydrogenation.	[Friedfeld, Max R.; Hoyt, Jordan M.; Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Shevlin, Michael; Krska, Shane W.; Tudge, Matthew T.] Merck Res Labs, Dept Proc Chem, Rahway, NJ 07065 USA	Princeton University; Merck & Company	Friedfeld, MR (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08540 USA.			Shevlin, Michael/0000-0003-2566-5095	Federal Ministry of Education and Research (BMBF); State of Mecklenburg-Vorpommern	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern	We gratefully acknowledge the support from the Federal Ministry of Education and Research (BMBF) and the State of Mecklenburg-Vorpommern. We thank the analytical department of the Leibniz-Institute for Catalysis, Rostock for the nuclear magnetic resonance measurements. The Leibniz Institute for Catalysis has filed a patent on the catalysts reported herein. Author contributions: M.B. and R.V.J. planned the project; R.V.J. developed and prepared the catalysts; R.V.J designed and performed all catalytic hydrogenation experiments; R.V.J., M.B., and A.B. wrote the paper; A.-E.S., H.J., and M.B were involved in the development of this class of catalysts; M.-M.P. performed TEM measurements and analysis; J. Radnik did the XPS measurements; J. Rabeah and A.B. conducted EPR measurements; and H.H. and V.S. performed Mossbauer measurements.	ASHBY MT, 1991, J AM CHEM SOC, V113, P589, DOI 10.1021/ja00002a029; Bell S, 2006, SCIENCE, V311, P642, DOI 10.1126/science.1121977; Blaser H.-U., 2010, ASYMMETRIC CATALYSIS, Vsecond; Blaser HU, 2007, ACCOUNTS CHEM RES, V40, P1240, DOI 10.1021/ar7001057; BURK MJ, 1993, J AM CHEM SOC, V115, P10125, DOI 10.1021/ja00075a031; Busacca CA, 2011, ADV SYNTH CATAL, V353, P1825, DOI 10.1002/adsc.201100488; Church TL, 2008, COORDIN CHEM REV, V252, P513, DOI 10.1016/j.ccr.2007.09.015; CORMA A, 1992, J ORGANOMET CHEM, V431, P233, DOI 10.1016/0022-328X(92)80121-D; Cozzi PG, 2001, ADV SYNTH CATAL, V343, P450, DOI 10.1002/1615-4169(200107)343:5<450::AID-ADSC450>3.0.CO;2-7; Cui XH, 2005, CHEM REV, V105, P3272, DOI 10.1021/cr0500131; DiMasi JA, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422002-00002; HALPERN J, 1982, SCIENCE, V217, P401, DOI 10.1126/science.217.4558.401; Hoge G, 2003, J AM CHEM SOC, V125, P10219, DOI 10.1021/ja034715o; HORNER L, 1968, ANGEW CHEM INT EDIT, V7, P942, DOI 10.1002/anie.196809422; Hsiao Y, 2004, J AM CHEM SOC, V126, P9918, DOI 10.1021/ja047901i; Johnson NB, 2007, ACCOUNTS CHEM RES, V40, P1291, DOI 10.1021/ar700114k; Knijnenburg Q, 2005, J MOL CATAL A-CHEM, V232, P151, DOI 10.1016/j.molcata.2004.12.039; Knowles WS, 2002, ANGEW CHEM INT EDIT, V41, P1999; KNOWLES WS, 1968, CHEM COMMUN, P1445, DOI 10.1039/c19680001445; LEUTENEGGER U, 1989, ANGEW CHEM INT EDIT, V28, P60, DOI 10.1002/anie.198900601; Mazuela J, 2011, J AM CHEM SOC, V133, P13634, DOI 10.1021/ja204948k; Monfette S, 2012, J AM CHEM SOC, V134, P4561, DOI 10.1021/ja300503k; Nindakova LO, 2007, RUSS J ORG CHEM+, V43, P1322, DOI 10.1134/S1070428007090102; Nindakova LO, 2005, RUSS CHEM B+, V54, P348, DOI 10.1007/s11172-005-0258-8; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Plietker B., 2008, IRON CATALYSIS ORGAN; Roseblade SJ, 2007, ACCOUNTS CHEM RES, V40, P1402, DOI 10.1021/ar700113g; Rouhi AM, 2004, CHEM ENG NEWS, V82, P47, DOI 10.1021/cen-v082n024.p047; SCHROCK RR, 1971, J AM CHEM SOC, V93, P2397; Shultz CS, 2007, ACCOUNTS CHEM RES, V40, P1320, DOI 10.1021/ar700141v; Takeuchi S., 1981, B CHEM SOC JPN, V54, P2124; Thayer AM, 2007, CHEM ENG NEWS, V85, P11, DOI 10.1021/cen-v085n032.p011; Vineyard B. D., 1972, CHEM COMMUN, V1972, P10; Zhang GQ, 2013, J AM CHEM SOC, V135, P8668, DOI 10.1021/ja402679a; Zhang GQ, 2012, ANGEW CHEM INT EDIT, V51, P12102, DOI 10.1002/anie.201206051; Zhu D, 2010, ORGANOMETALLICS, V29, P1897, DOI 10.1021/om901045s	36	255	259	6	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1076	1080		10.1126/science.1243550	http://dx.doi.org/10.1126/science.1243550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288328				2022-12-28	WOS:000327518600052
J	Liu, HJ; Zhang, H; Niedzwiedzki, DM; Prado, M; He, GN; Gross, ML; Blankenship, RE				Liu, Haijun; Zhang, Hao; Niedzwiedzki, Dariusz M.; Prado, Mindy; He, Guannan; Gross, Michael L.; Blankenship, Robert E.			Phycobilisomes Supply Excitations to Both Photosystems in a Megacomplex in Cyanobacteria	SCIENCE			English	Article							TIME-RESOLVED FLUORESCENCE; ENERGY-TRANSFER; MASS-SPECTROMETRY; MOLECULAR CHARACTERIZATION; CROSS-LINKING; PROTEIN; POLYPEPTIDE; PEPTIDES; DATABASE	In photosynthetic organisms, photons are captured by light-harvesting antenna complexes, and energy is transferred to reaction centers where photochemical reactions take place. We describe here the isolation and characterization of a fully functional megacomplex composed of a phycobilisome antenna complex and photosystems I and II from the cyanobacterium Synechocystis PCC 6803. A combination of in vivo protein cross-linking, mass spectrometry, and time-resolved spectroscopy indicates that the megacomplex is organized to facilitate energy transfer but not intercomplex electron transfer, which requires diffusible intermediates and the cytochrome b(6)f complex. The organization provides a basis for understanding how phycobilisomes transfer excitation energy to reaction centers and how the energy balance of two photosystems is achieved, allowing the organism to adapt to varying ecophysiological conditions.	[Liu, Haijun; Prado, Mindy; Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Liu, Haijun; Zhang, Hao; Niedzwiedzki, Dariusz M.; Prado, Mindy; He, Guannan; Blankenship, Robert E.] Washington Univ, Photosynthet Antenna Res Ctr, St Louis, MO 63130 USA; [Zhang, Hao; He, Guannan; Gross, Michael L.; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Blankenship, RE (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu	Niedzwiedzki, Dariusz/B-9035-2008; Zhang, Hao/A-7420-2012	Niedzwiedzki, Dariusz/0000-0002-1976-9296; Zhang, Hao/0000-0002-6129-6410; Liu, Haijun/0000-0003-0537-0302	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Basic Energy Science [DE-SC 0001035]; National Institute of General Medical Science [8 P41 GM103422-35]; DOE; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Basic Energy Science(United States Department of Energy (DOE)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Bricker and H. Pakrasi for the HT3 strain, G. Ajlani and D. Kirilovsky for the Lambda AB strain, all the other members of the Gross and Blankenship laboratories for collegial discussions, and H. Rohrs and M. Plasencia for help with LC-MS/MS instrumentation. The research was supported by the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Basic Energy Science (grant no. DE-SC 0001035 to R.E.B) and National Institute of General Medical Science (grant no. 8 P41 GM103422-35 to M.L.G). H.L., D.M.N, M.P., and G.H. were funded by the DOE grant, H.Z. was funded equally by the DOE and NIH grants, and instrumentation was made available from both DOE and NIH grants. Additional data are available in the supplementary materials. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE (Proteomics Identifications Database) partner repository (29) with the data set identifier PXD000545.	Ajlani G, 1998, EUR J BIOCHEM, V257, P154, DOI 10.1046/j.1432-1327.1998.2570154.x; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BRUCE D, 1985, BIOCHIM BIOPHYS ACTA, V810, P295, DOI 10.1016/0005-2728(85)90213-0; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; GANTT E, 1966, BROOKHAVEN SYM BIOL, P393; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1975, ARCH MICROBIOL, V104, P15, DOI 10.1007/BF00447294; Gobets B, 2001, BIOPHYS J, V81, P407, DOI 10.1016/S0006-3495(01)75709-8; HASTINGS G, 1994, BIOCHEMISTRY-US, V33, P3185, DOI 10.1021/bi00177a007; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; MULLINEAUX CW, 1992, BIOCHIM BIOPHYS ACTA, V1100, P285, DOI 10.1016/0167-4838(92)90483-T; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Soukoulis V, 1999, BIOPHYS J, V76, P2711, DOI 10.1016/S0006-3495(99)77423-0; TANDEAUDEMARSAC N, 1977, P NATL ACAD SCI USA, V74, P1635; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yokono M, 2011, BBA-BIOENERGETICS, V1807, P847, DOI 10.1016/j.bbabio.2011.03.014; Zhao J., 1992, RES PHOTOSYNTHESIS, V1, P25; Zheng CX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006841	28	219	225	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1104	1107		10.1126/science.1242321	http://dx.doi.org/10.1126/science.1242321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288334	Green Accepted			2022-12-28	WOS:000327518600060
J	Larsen, TB; Lip, GYH				Larsen, Torben Bjerregaard; Lip, Gregory Y. H.			Warfarin or novel oral anticoagulants for atrial fibrillation?	LANCET			English	Editorial Material							2012 FOCUSED UPDATE; NATIONWIDE COHORT; ESC GUIDELINES; DABIGATRAN; STROKE; RIVAROXABAN; PREVENTION; MORTALITY; EFFICACY; QUALITY		[Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Aalborg AF Study Grp, Dept Cardiol, DK-9000 Aalborg, Denmark; [Larsen, Torben Bjerregaard; Lip, Gregory Y. H.] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	Aalborg University; Aalborg University Hospital; Aalborg University; University of Birmingham	Larsen, TB (corresponding author), Aalborg Univ Hosp, Aalborg AF Study Grp, Dept Cardiol, DK-9000 Aalborg, Denmark.	tobl@rn.dk	Larsen, Torben Bjerregaard/I-5081-2012	Larsen, Torben Bjerregaard/0000-0002-8485-8674				Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Banerjee A, 2012, THROMB HAEMOSTASIS, V107, P584, DOI 10.1160/TH11-11-0784; Boriani G, 2013, CHEST, V144, P1437, DOI 10.1378/chest.13-1285; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; Kansal AR, 2012, THROMB HAEMOSTASIS, V108, P672, DOI 10.1160/TH12-06-0388; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Lip GYH, 2013, J THROMB HAEMOST, V11, P615, DOI 10.1111/jth.12140; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Skjoth F, 2012, THROMB HAEMOSTASIS, V108, P405, DOI 10.1160/TH12-06-0438	11	18	20	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					931	933		10.1016/S0140-6736(13)62376-4	http://dx.doi.org/10.1016/S0140-6736(13)62376-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24315725				2022-12-28	WOS:000333520700005
J	Tonelli, M; Wanner, C				Tonelli, Marcello; Wanner, Christoph		Kidney Dis Improving Global Outcom	Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; EDUCATION-PROGRAM RECOMMENDATIONS; TYPE-2 DIABETES-MELLITUS; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR RISK; STATIN THERAPY; ASSOCIATION; HEART; MORTALITY; EVENTS	Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients). Methods: The KDIGO Lipid Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through August 2011 and supplemented by targeted searches through June 2013. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders. Recommendations: The full guideline includes 13 recommendations; a key element was the recommendation for statin or statin with ezetimibe treatment of adults aged 50 years or older with estimated glomerular filtration rates less than 60 mL/min/1.73 m2 but not treated with long-term dialysis or kidney transplantation. This synopsis focuses on 8 recommendations pertinent to assessment of lipid status and treatment with a statin-based regimen in adults.	[Tonelli, Marcello] Univ Alberta, Edmonton, AB T6B 2G3, Canada; [Wanner, Christoph] Univ Hosp Wurzburg, Dept Med, Div Nephrol, D-97080 Wurzburg, Germany; [Wanner, Christoph] Comprehens Heart Failure Ctr, D-97080 Wurzburg, Germany	University of Alberta; University of Wurzburg; University of Wurzburg	Tonelli, M (corresponding author), Univ Alberta, 7-129 CSB,8440 112 St NW, Edmonton, AB T6B 2G3, Canada.	celloadm@ualberta.ca	Kronenberg, Florian/B-1736-2008; Garg, Amit X/G-3295-2011; Tonelli, Marcello/B-3028-2009	Kronenberg, Florian/0000-0003-2229-1120; Tonelli, Marcello/0000-0002-0846-3187; Jardine, Alan/0000-0001-5815-9370	AHFMR Population Health Scholar award; Government of Canada Research	AHFMR Population Health Scholar award; Government of Canada Research	Dr. Tonelli was supported by an AHFMR Population Health Scholar award and a Government of Canada Research Chair in the optimal care of persons with chronic kidney disease.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BACHORIK PS, 1995, CLIN CHEM, V41, P1414; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Chiang CK, 2005, BLOOD PURIFICAT, V23, P134, DOI 10.1159/000083529; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Coresh J, 1998, J AM SOC NEPHROL, V9, pS; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Ezekowitz J, 2004, J AM COLL CARDIOL, V44, P1587, DOI 10.1016/j.jacc.2004.06.072; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Grundy SM, 2006, DIABETES CARE, V29, P457, DOI 10.2337/diacare.29.02.06.dc05-1904; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Hou WY, 2013, EUR HEART J, V34, P1807, DOI 10.1093/eurheartj/eht065; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Krane V, 2009, AM J KIDNEY DIS, V54, P902, DOI 10.1053/j.ajkd.2009.06.029; Latif F, 2009, JACC-CARDIOVASC INTE, V2, P37, DOI 10.1016/j.jcin.2008.06.012; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Marz W, 2011, CLIN J AM SOC NEPHRO, V6, P1316, DOI 10.2215/CJN.09121010; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; STEIN EA, 1995, CLIN CHEM, V41, P1421; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Takahashi O, 2010, HEART, V96, P448, DOI 10.1136/hrt.2009.172619; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Tonelli M, 2013, J AM SOC NEPHROL, V24, P979, DOI 10.1681/ASN.2012080870; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	38	127	141	2	60	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					182	+		10.7326/M13-2453	http://dx.doi.org/10.7326/M13-2453			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA2VE	24323134				2022-12-28	WOS:000330951500005
J	Roederer, M; Keele, BF; Schmidt, SD; Mason, RD; Welles, HC; Fischer, W; Labranche, C; Foulds, KE; Louder, MK; Yang, ZY; Todd, JPM; Buzby, AP; Mach, LV; Shen, L; Seaton, KE; Ward, BM; Bailer, RT; Gottardo, R; Gu, WJ; Ferrari, G; Alam, SM; Denny, TN; Montefiori, DC; Tomaras, GD; Korber, BT; Nason, MC; Seder, RA; Koup, RA; Letvin, NL; Rao, SS; Nabel, GJ; Mascola, JR				Roederer, Mario; Keele, Brandon F.; Schmidt, Stephen D.; Mason, Rosemarie D.; Welles, Hugh C.; Fischer, Will; Labranche, Celia; Foulds, Kathryn E.; Louder, Mark K.; Yang, Zhi-Yong; Todd, John-Paul M.; Buzby, Adam P.; Mach, Linh V.; Shen, Ling; Seaton, Kelly E.; Ward, Brandy M.; Bailer, Robert T.; Gottardo, Raphael; Gu, Wenjuan; Ferrari, Guido; Alam, S. Munir; Denny, Thomas N.; Montefiori, David C.; Tomaras, Georgia D.; Korber, Bette T.; Nason, Martha C.; Seder, Robert A.; Koup, Richard A.; Letvin, Norman L.; Rao, Srinivas S.; Nabel, Gary J.; Mascola, John R.			Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; DOSE CHALLENGE EXPERIMENTS; NEUTRALIZING ANTIBODIES; RHESUS MACAQUES; CELL RESPONSES; EFFICACY TRIAL; INFECTION; BINDING; SIVSME660; PREVENTION	A major challenge for the development of a highly effective AIDS vaccine is the identification of mechanisms of protective immunity. To address this question, we used a nonhuman primate challenge model with simian immunodeficiency virus (SIV). We show that antibodies to the SIV envelope are necessary and sufficient to prevent infection. Moreover, sequencing of viruses from breakthrough infections revealed selective pressure against neutralization-sensitive viruses; we identified a two-amino-acid signature that alters antigenicity and confers neutralization resistance. A similar signature confers resistance of human immunodeficiency virus (HIV)-1 to neutralization by monoclonal antibodies against variable regions 1 and 2 (V1V2), suggesting that SIV and HIV share a fundamental mechanism of immune escape from vaccine-elicited or naturally elicited antibodies. These analyses provide insight into the limited efficacy seen in HIV vaccine trials.	[Roederer, Mario; Schmidt, Stephen D.; Mason, Rosemarie D.; Welles, Hugh C.; Foulds, Kathryn E.; Louder, Mark K.; Yang, Zhi-Yong; Todd, John-Paul M.; Bailer, Robert T.; Seder, Robert A.; Koup, Richard A.; Rao, Srinivas S.; Nabel, Gary J.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Keele, Brandon F.] NIH, SAIC Frederick, Frederick Natl Lab, Frederick, MD 21702 USA; [Welles, Hugh C.] George Washington Univ, Washington, DC 20052 USA; [Fischer, Will; Korber, Bette T.] Los Alamos Natl Labs, Los Alamos, NM 87545 USA; [Labranche, Celia; Ward, Brandy M.; Ferrari, Guido; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Buzby, Adam P.; Mach, Linh V.; Shen, Ling; Letvin, Norman L.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Seaton, Kelly E.; Alam, S. Munir; Denny, Thomas N.; Tomaras, Georgia D.] Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; [Gottardo, Raphael] Fred Hutchison Canc Res Ctr, Seattle, WA 98109 USA; [Gu, Wenjuan; Nason, Martha C.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; George Washington University; United States Department of Energy (DOE); Los Alamos National Laboratory; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Duke University; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Roederer@NIH.gov	Seaton, Kelly/AAL-4983-2020; Welles, Hugh C/K-5259-2016; Roederer, Mario/G-1887-2011; Ferrari, Guido/A-6088-2015; Mascola, John/AAI-7193-2021; Fischer, Will/AAD-2807-2019; Schmidt, Stephen/AAC-6967-2019; Ferrari, Guido/Z-2137-2019; Schmidt, Stephen/B-5398-2012; Tomaras, Georgia/J-5041-2016; Gottardo, Raphael/HCH-3169-2022; Alam, S. Munir/AAC-6711-2019	Seaton, Kelly/0000-0002-2009-3270; Welles, Hugh C/0000-0002-3336-1203; Ferrari, Guido/0000-0001-7747-3349; Fischer, Will/0000-0003-4579-4062; Korber, Bette/0000-0002-2026-5757; Denny, Thomas/0000-0002-7364-8276; Gottardo, Raphael/0000-0002-3867-0232	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; NIH [HHSN261200800001E, HHSN27201100016C, AI100645]; Bill and Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005019, UM1AI100645, ZIAAI005073] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the following individuals: W. Shi, L. Wu, S.-Y. Ko, L. Wang and W.-P. Kong for immunogen construction; M. M. Donaldson, S.-F. Kao, D. Quinn, J. Owuor, K. Denison, H. Balachandran, C. Luedemann, W. T. Williams, G. Overman, A. Deal, C. Brinkley and L. Racz for technical assistance with immunology assays; A. Ault for assistance managing NHP studies; S. O'Connor for deep-sequencing data; M. Seaman for providing plasmids encoding E660 envelopes; F. McCutchan, J. Overbaugh and J. Kim for HIV-1 strains; and P. Gilbert for advice with using the Aalen and Johansen model. This work was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH; by NIH contracts HHSN261200800001E (B. F. K., W. G.) and HHSN27201100016C (D. C. M.); by NIH grant AI100645 (B. T. K., W. F.); and by the Bill and Melinda Gates Foundation grant OPP1032317.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bolton DL, 2012, MUCOSAL IMMUNOL, V5, P41, DOI 10.1038/mi.2011.45; Del Prete GQ, 2009, J VIROL, V83, P9911, DOI 10.1128/JVI.00533-09; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Fenimore PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044769; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Flatz L, 2012, J VIROL, V86, P7760, DOI 10.1128/JVI.00599-12; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Imholte GC, 2013, J IMMUNOL METHODS, V395, P1, DOI 10.1016/j.jim.2013.06.001; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lai LL, 2012, VACCINE, V30, P1737, DOI 10.1016/j.vaccine.2011.12.026; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lim SY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000997; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Lopker M, 2013, J VIROL, V87, P5477, DOI 10.1128/JVI.03419-12; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Schell JB, 2011, J VIROL, V85, P5764, DOI 10.1128/JVI.00342-11; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Yusim K, 2010, J GEN VIROL, V91, P1194, DOI 10.1099/vir.0.017491-0; Zhao J, 2009, J VIROL, V83, P4102, DOI 10.1128/JVI.02173-08	39	116	118	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					502	+		10.1038/nature12893	http://dx.doi.org/10.1038/nature12893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24352234	Green Accepted, Green Submitted			2022-12-28	WOS:000329995000030
J	James, AE; Gellad, WF; Primack, BA				James, A. Everette, III; Gellad, Walid F.; Primack, Brian A.			Implications of New Insurance Coverage for Access to Care, Cost-Sharing, and Reimbursement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[James, A. Everette, III] Univ Pittsburgh, Sch Hlth Sci, Hlth Policy Inst, Pittsburgh, PA 15261 USA; [James, A. Everette, III] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Gellad, Walid F.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Gellad, Walid F.] RAND Corp, Pittsburgh, PA USA; [Primack, Brian A.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	James, AE (corresponding author), Univ Pittsburgh, Hlth Policy Inst, 3550 Terrace St,S306 Scaife Hall, Pittsburgh, PA 15261 USA.	aejames@pitt.edu		Primack, Brian/0000-0002-5962-0939				American Hospital Association, MEDICAID; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Centers for Medicare & Medicaid Services, PHYSICIAN QUALITY RE; Decker SL, 2013, HEALTH AFFAIR, V32, P1182; George A, 2003, FAM PRACT, V20, P178, DOI 10.1093/fampra/20.2.178; Health Affairs, HEALTH AFFAIRS; The Association of Credit and Collection Professionals International, HEALTH CARE COLLECTI; Zuckerman S, EXECUTIVE SUMMARY HO	8	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					241	242		10.1001/jama.2013.283150	http://dx.doi.org/10.1001/jama.2013.283150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287TZ	24337312				2022-12-28	WOS:000329566400012
J	Wang, T; Wei, JJ; Sabatini, DM; Lander, ES				Wang, Tim; Wei, Jenny J.; Sabatini, David M.; Lander, Eric S.			Genetic Screens in Human Cells Using the CRISPR-Cas9 System	SCIENCE			English	Article							DNA MISMATCH REPAIR; RNAI SCREENS; STEM-CELLS; GENOME; CAS9; SPECIFICITY; INTERFERENCE; EXPRESSION; GENERATION; RESISTANCE	The bacterial clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system for genome editing has greatly expanded the toolbox for mammalian genetics, enabling the rapid generation of isogenic cell lines and mice with modified alleles. Here, we describe a pooled, loss-of-function genetic screening approach suitable for both positive and negative selection that uses a genome-scale lentiviral single-guide RNA (sgRNA) library. sgRNA expression cassettes were stably integrated into the genome, which enabled a complex mutant pool to be tracked by massively parallel sequencing. We used a library containing 73,000 sgRNAs to generate knockout collections and performed screens in two human cell lines. A screen for resistance to the nucleotide analog 6-thioguanine identified all expected members of the DNA mismatch repair pathway, whereas another for the DNA topoisomerase II (TOP2A) poison etoposide identified TOP2A, as expected, and also cyclin-dependent kinase 6, CDK6. A negative selection screen for essential genes identified numerous gene sets corresponding to fundamental processes. Last, we show that sgRNA efficiency is associated with specific sequence motifs, enabling the prediction of more effective sgRNAs. Collectively, these results establish Cas9/sgRNA screens as a powerful tool for systematic genetic analysis in mammalian cells.	[Wang, Tim; Wei, Jenny J.; Sabatini, David M.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wang, Tim; Wei, Jenny J.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Wang, Tim; Sabatini, David M.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wang, Tim; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sabatini@wi.mit.edu; lander@broadinstitute.org		Wang, Timothy/0000-0001-5730-3019; /0000-0002-1446-7256	U.S. National Institutes of Health [CA103866]; National Human Genome Research Institute [2U54HG003067-10]; Broad Institute of MIT and Harvard; U.S. National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA103866] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; U.S. National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all members of the Sabatini and Lander labs, especially J. Engreitz, S. Schwartz, A. Shishkin, and Z. Tsun for protocols, reagents, and advice; T. Mikkelsen for assistance with oligonucleotide synthesis; and L. Gaffney for assistance with figures. This work was supported by the U.S. National Institutes of Health (CA103866) (D. M. S.), National Human Genome Research Institute (2U54HG003067-10) (E. S. L.), the Broad Institute of MIT and Harvard (E. S. L.), and an award from the U.S. National Science Foundation (T. W.). The composition of the sgRNA pools and screening data can be found in the supplementary materials. A patent application has been filed by the Broad Institute relating to aspects of the work described in this manuscript. Inducible Cas9 and sgRNA backbone lentiviral vectors and the genome-scale sgRNA plasmid pool are deposited in Addgene.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Booker M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-50; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yan T, 2003, CLIN CANCER RES, V9, P2327; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186	32	1778	1997	18	942	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					80	84		10.1126/science.1246981	http://dx.doi.org/10.1126/science.1246981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24336569	Green Accepted, Green Submitted			2022-12-28	WOS:000329162000052
J	Cheung, KJ; Gabrielson, E; Werb, Z; Ewald, AJ				Cheung, Kevin J.; Gabrielson, Edward; Werb, Zena; Ewald, Andrew J.			Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program	CELL			English	Article							CELL-MIGRATION; MAMMARY EPITHELIUM; METASTATIC-DISEASE; CARCINOMA; EXPRESSION; MOUSE; TUMORS; MORPHOGENESIS; CYTOKERATINS; MACROPHAGES	Carcinomas typically invade as a cohesive multicellular unit, a process termed collective invasion. It remains unclear how different subpopulations of cancer cells contribute to this process. We developed three-dimensional (3D) organoid assays to identify the most invasive cancer cells in primary breast tumors. Collective invasion was led by specialized cancer cells that were defined by their expression of basal epithelial genes, such as cytokeratin-14 (K14) and p63. Furthermore, K14+ cells led collective invasion in the major human breast cancer subtypes. Importantly, luminal cancer cells were observed to convert phenotypically to invasive leaders following induction of basal epithelial genes. Although only a minority of cells within luminal tumors expressed basal epithelial genes, knockdown of either K14 or p63 was sufficient to block collective invasion. Our data reveal that heterotypic interactions between epithelial subpopulations are critical to collective invasion. We suggest that targeting the basal invasive program could limit metastatic progression.	[Cheung, Kevin J.; Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Dept Cell Biol, Baltimore, MD 21205 USA; [Cheung, Kevin J.; Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Dept Oncol, Baltimore, MD 21205 USA; [Gabrielson, Edward] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Dept Cell Biol, Baltimore, MD 21205 USA.	aewald2@jhmi.edu			NCI [R01 CA057621, U01 CA155758, P50 CA103175, P50 CA88843]; NIEHS [U01 ES019458]; U.S. Department of Defense [W81XWH-12-1-0018]; Mary Kay Foundation [036-13]; Safeway Foundation Award for Breast Cancer Research; Avon Foundation for Women; Cindy Rosencrans Fund for Triple Negative Breast Cancer Research; American Cancer Society [RSG-12-141-01-CSM];  [S10RR024550]; NATIONAL CANCER INSTITUTE [P50CA103175, T32CA009071, U01CA155758, P50CA088843, R01CA057621, P30CA006973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Defense(United States Department of Defense); Mary Kay Foundation; Safeway Foundation Award for Breast Cancer Research; Avon Foundation for Women; Cindy Rosencrans Fund for Triple Negative Breast Cancer Research; American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Koen Schipper, Jen Beck, and Audrey Brenot for technical support. We thank Ellen Tully for performing K14 immunohistochemistry on archival tumors. Human tissue samples were provided by the Johns Hopkins Hospital and by the Cooperative Human Tissue Network, which is funded by the NCI. We also thank William C. Hines, Paul Yaswen, Pedram Argani, and Lisa Jacobs for assistance with acquisition of primary human tumor specimens. We thank Mikala Egeblad, William Matsui, Vered Stearns, Sara Sukumar, Tamara Lotan, and Charles Rudin for scientific discussions. This study was funded by grants from the NCI (R01 CA057621 to Z.W.; U01 CA155758, P50 CA103175, and P50 CA88843 to A.J.E.), the NIEHS (U01 ES019458 to Z.W.), the U.S. Department of Defense (W81XWH-12-1-0018 to K.J.C.), the Mary Kay Foundation (036-13 to A.J.E.), a Safeway Foundation Award for Breast Cancer Research (to A.J.E.), funds from the Avon Foundation for Women (to A.J.E.), funds from the Cindy Rosencrans Fund for Triple Negative Breast Cancer Research (to A.J.E.), and a Research Scholar Grant (RSG-12-141-01-CSM to A.J.E.) from the American Cancer Society. This study benefited from a Zeiss 710 NLO 2-photon microscope (JHUSOM Microscope Facility) purchased through funds from S10RR024550.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gordon LA, 2003, INT J CANCER, V106, P8, DOI 10.1002/ijc.11172; Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Laakso M, 2006, CLIN CANCER RES, V12, P4185, DOI 10.1158/1078-0432.CCR-06-0353; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Polyak Kornelia, 2010, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgq019; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Rudland SD, 2011, AM J PATHOL, V179, P1061, DOI 10.1016/j.ajpath.2011.04.022; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522	41	497	506	9	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1639	1651		10.1016/j.cell.2013.11.029	http://dx.doi.org/10.1016/j.cell.2013.11.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24332913	Green Accepted, Bronze			2022-12-28	WOS:000328693300018
J	Johnson, EF; Jacobs, MH; Smidt, AC				Johnson, Emma F.; Jacobs, Michaela H.; Smidt, Aimee C.			Annular Vesiculobullous Eruption in a Healthy Young Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IGA BULLOUS DERMATOSIS; CHILDHOOD; DISEASE		[Johnson, Emma F.; Jacobs, Michaela H.; Smidt, Aimee C.] Univ New Mexico, Sch Med, Dept Dermatol, Albuquerque, NM 87131 USA; [Smidt, Aimee C.] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Johnson, EF (corresponding author), Michele Barth, 1021 Med Arts Ave, Albuquerque, NM 87131 USA.	emjohnson@salud.unm.edu						Egan CA, 1999, INT J DERMATOL, V38, P818, DOI 10.1046/j.1365-4362.1999.00813.x; Gerull R, 2011, CRIT CARE MED, V39, P1521, DOI 10.1097/CCM.0b013e31821201ed; Guide SV, 2001, CLIN DERMATOL, V19, P719, DOI 10.1016/S0738-081X(00)00185-1; Han JH, 2011, ANN DERMATOL, V23, P209, DOI 10.5021/ad.2011.23.2.209; Piette EW, 2011, DERMATOL CLIN, V29, P561, DOI 10.1016/j.det.2011.06.018; Powell J, 2001, BRIT J DERMATOL, V144, P769, DOI 10.1046/j.1365-2133.2001.04131.x	7	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2559	2560		10.1001/jama.2013.283530	http://dx.doi.org/10.1001/jama.2013.283530			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346992				2022-12-28	WOS:000328503600026
J	Friedman, JH				Friedman, Joseph H.			At 10 years, 55% of patients with Parkinson disease died; 23% had a good outcome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COHORT		[Friedman, Joseph H.] Brown Univ, Butler Hosp, Providence, RI 02912 USA; [Friedman, Joseph H.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Brown University; Butler Hospital Rhode Island; Brown University	Friedman, JH (corresponding author), Brown Univ, Butler Hosp, Providence, RI 02912 USA.							Auyeung M, 2012, J NEUROL NEUROSUR PS, V83, P607, DOI 10.1136/jnnp-2011-301590; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lethbridge L, 2013, PROG PALLIAT CARE, V21, P140, DOI 10.1179/1743291X12Y.0000000037	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC10	10.7326/0003-4819-159-12-201312170-02010	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343403				2022-12-28	WOS:000329735300009
J	Pollock, AM; Price, D; Kondilis, E; Freitag, A; Harding-Edgar, L				Pollock, Allyson M.; Price, David; Kondilis, Elias; Freitag, Andreas; Harding-Edgar, Louisa			Planning for closure: the role of special administrators in reducing NHS hospital services in England	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		[Pollock, Allyson M.; Price, David; Kondilis, Elias; Freitag, Andreas; Harding-Edgar, Louisa] Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England	University of London	Pollock, AM (corresponding author), Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England.	a.pollock@qmul.ac.uk	Kondilis, Elias/A-1873-2013	Kondilis, Elias/0000-0001-9592-2830; pollock, allyson/0000-0002-7388-3110				[Anonymous], 2013, STAT GUID TRUST SPEC; Department of Health, 2011, HLTH GAT REV NHS REC; Department of Health, 2010, CM7881; Department of Health, 2012, STAT GUID TRUST SPEC; HM Treasury, 2013, 2012 13 CONV P UNPUB; Independent Reconfiguration Panel, 2010, LEARN REV; NHS, 2011, QUART, V2; NHS London, 2011, REC GUID VERS 3; NHS Trust Development Authority, 2013, PUBL BOARD M 23 MAY; NHS Yorkshire and the Humber, 2010, GUID SERV CHANG; Nicholson D, 2013, PLANNING SUSTAINABLE; Office of the Trust Special Administrator, 2013, SEC SUST NHS SERV TR, V1; Office of the Trust Special Administrator of Mid Staffordshire NHS Foundation Trust, 2013, TRUST SPEC IN PRESS, V1; Pollock AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2364; Pollock AM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1729	15	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2013	347								f7322	10.1136/bmj.f7322	http://dx.doi.org/10.1136/bmj.f7322			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZU	24336392				2022-12-28	WOS:000328575600004
J	Rohner, N; Jarosz, DF; Kowalko, JE; Yoshizawa, M; Jeffery, WR; Borowsky, RL; Lindquist, S; Tabin, CJ				Rohner, Nicolas; Jarosz, Dan F.; Kowalko, Johanna E.; Yoshizawa, Masato; Jeffery, William R.; Borowsky, Richard L.; Lindquist, Susan; Tabin, Clifford J.			Cryptic Variation in Morphological Evolution: HSP90 as a Capacitor for Loss of Eyes in Cavefish	SCIENCE			English	Article							REGRESSIVE EVOLUTION; PHENOTYPIC VARIATION; EXPRESSION; STRESS; STICKLEBACKS; PRINCIPLES; CHAPERONES; RNA	In the process of morphological evolution, the extent to which cryptic, preexisting variation provides a substrate for natural selection has been controversial. We provide evidence that heat shock protein 90 (HSP90) phenotypically masks standing eye-size variation in surface populations of the cavefish Astyanax mexicanus. This variation is exposed by HSP90 inhibition and can be selected for, ultimately yielding a reduced-eye phenotype even in the presence of full HSP90 activity. Raising surface fish under conditions found in caves taxes the HSP90 system, unmasking the same phenotypic variation as does direct inhibition of HSP90. These results suggest that cryptic variation played a role in the evolution of eye loss in cavefish and provide the first evidence for HSP90 as a capacitor for morphological evolution in a natural setting.	[Rohner, Nicolas; Kowalko, Johanna E.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jarosz, Dan F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Yoshizawa, Masato; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Jeffery, William R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Borowsky, Richard L.] NYU, Dept Biol, New York, NY 10003 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Maryland; University of Maryland College Park; Marine Biological Laboratory - Woods Hole; New York University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	Yoshizawa, Masato/AFD-8467-2022; Yoshizawa, Masato/AAE-9415-2022	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-8455-8252; Jarosz, Daniel/0000-0003-3497-5888; Rohner, Nicolas/0000-0003-3248-2772	Deutsche Forschungsgemeinschaft [RO 4097/1-1]; Damon Runyon Cancer Research Foundation; NIH [RO1 HD047360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Martineau for animal husbandry and T. Luong for assistance in data acquisition; M. Taipale for HSP90 inhibitor and discussions; H. Boldt and M. Harris for providing zebrafish; L. Espinasa for practical support during the caving expedition; L. Legendre for comparison of environmental parameters; and J. Bibliowicz and Y. Elipot for discussions. N.R. was supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (RO 4097/1-1). D. F. J. was supported by a postdoctoral fellowship from Damon Runyon Cancer Research Foundation and a Pathway to Independence Award from the NIH. C.J.T. acknowledges the support of a grant from NIH RO1 HD047360.	Antonopoulou E, 2013, COMP BIOCHEM PHYS A, V165, P79, DOI 10.1016/j.cbpa.2013.02.019; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Choi CY, 2008, COMP BIOCHEM PHYS B, V149, P91, DOI 10.1016/j.cbpb.2007.08.009; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043	23	205	211	2	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1372	1375		10.1126/science.1240276	http://dx.doi.org/10.1126/science.1240276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337296	Green Accepted, Green Submitted			2022-12-28	WOS:000328196000051
J	Takwoingi, Y; Hopewell, S; Tovey, D; Sutton, AJ				Takwoingi, Yemisi; Hopewell, Sally; Tovey, David; Sutton, Alex J.			A multicomponent decision tool for prioritising the updating of systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Takwoingi, Yemisi] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Hopewell, Sally] Univ Oxford, Ctr Stat Med, Oxford, England; [Hopewell, Sally] INSERM, U738, Paris, France; [Tovey, David] Cochrane Editorial Unit, London, England; [Sutton, Alex J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Birmingham; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Leicester	Takwoingi, Y (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	y.takwoingi@bham.ac.uk		Sutton, Alexander/0000-0002-8934-9940; Hopewell, Sally/0000-0002-6881-6984; Takwoingi, Yemisi/0000-0002-5828-9746	National Institute for Health Research (NIHR) Cochrane-NHS Engagement Award Scheme [10/4000/01]	National Institute for Health Research (NIHR) Cochrane-NHS Engagement Award Scheme(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research (NIHR) Cochrane-NHS Engagement Award Scheme (project no 10/4000/01). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health.	[Anonymous], 2013, NUTS BOLTS TINY LITT; [Anonymous], 2013, COCHRANE DATABASE SY; Barrowman Nicholas J, 2003, BMC Med Res Methodol, V3, P13, DOI 10.1186/1471-2288-3-13; Ferreira ML, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5913; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; Hopewell S, 2013, DECISION TOOL UPDATI; Loudon K, 2008, Z EVID FORTBILD QUAL, V102, P24; MacLehose H, 2012, COCHR COLL STRAT SES; Moher D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000023.pub3; Shojania KG, 2007, PUBLICATION AGENCY H, V16; Sutton AJ, 2009, J CLIN EPIDEMIOL, V62, P241, DOI 10.1016/j.jclinepi.2008.04.005; Sutton AJ, 2007, STAT MED, V26, P2479, DOI 10.1002/sim.2704; Takwoingi Y, 2008, Z EVID FORTBILD QUAL, V102, P93; Tovey D, 2011, FIT PURPOSE CENTRALI; Tsafnat G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f139; Tsertsvadze A, 2011, J CLIN EPIDEMIOL, V64, P1208, DOI 10.1016/j.jclinepi.2011.03.011	18	35	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2013	347								f7191	10.1136/bmj.f7191	http://dx.doi.org/10.1136/bmj.f7191			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZU	24336453	Bronze			2022-12-28	WOS:000328575600003
J	Montoro, J; Tormo, M				Montoro, Juan; Tormo, Mar			Myeloid Sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Montoro, Juan; Tormo, Mar] Hosp Clin Univ, Valencia, Spain	Hospital Clinic Universitari de Valencia	Montoro, J (corresponding author), Hosp Clin Univ, Valencia, Spain.	juanmontorogomez@hotmail.com		Montoro, Juan/0000-0003-0024-8068; Tormo Diaz, Maria del Mar/0000-0001-9622-1649					0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2332	2332		10.1056/NEJMicm1301736	http://dx.doi.org/10.1056/NEJMicm1301736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328467				2022-12-28	WOS:000328156300011
J	Belgrano, A; Fowler, CW				Belgrano, Andrea; Fowler, Charles W.			How Fisheries Affect Evolution	SCIENCE			English	Editorial Material							BODY-SIZE; CONSEQUENCES		[Belgrano, Andrea] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, SE-45330 Lysekil, Sweden; [Belgrano, Andrea] Swedish Inst Marine Environm SIME, SE-40530 Gothenburg, Sweden; [Fowler, Charles W.] Seattle Univ, Dept Biol, Seattle, WA 98122 USA	Swedish University of Agricultural Sciences; Seattle University	Belgrano, A (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Turistgatan 5, SE-45330 Lysekil, Sweden.	andrea.belgrano@slu.se; fowlerc@seattleu.edu						Andersen KH, 2009, P NATL ACAD SCI USA, V106, P11657, DOI 10.1073/pnas.0901690106; Branch TA, 2013, TRENDS ECOL EVOL, V28, P409, DOI 10.1016/j.tree.2013.03.003; Eikeset AM, 2013, P NATL ACAD SCI USA, V110, P12259, DOI 10.1073/pnas.1212593110; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; van Wijk SJ, 2013, FRONT ECOL ENVIRON, V11, P181, DOI 10.1890/120229; Yamamichi M, 2011, AM NAT, V178, P287, DOI 10.1086/661241; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	12	21	21	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1176	1177		10.1126/science.1245490	http://dx.doi.org/10.1126/science.1245490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264DT	24311669				2022-12-28	WOS:000327857900024
J	Fulton, PM; Brodsky, EE; Kano, Y; Mori, J; Chester, F; Ishikawa, T; Harris, RN; Lin, W; Eguchi, N; Toczko, S				Fulton, P. M.; Brodsky, E. E.; Kano, Y.; Mori, J.; Chester, F.; Ishikawa, T.; Harris, R. N.; Lin, W.; Eguchi, N.; Toczko, S.		Expedition 343 Scientist; Expedition 343T Scientist; Expedition KR13-08 Scientist	Low Coseismic Friction on the Tohoku-Oki Fault Determined from Temperature Measurements	SCIENCE			English	Article							STRESS; EARTHQUAKE; RUPTURE; TRENCH; SLIP	The frictional resistance on a fault during slip controls earthquake dynamics. Friction dissipates heat during an earthquake; therefore, the fault temperature after an earthquake provides insight into the level of friction. The Japan Trench Fast Drilling Project (Integrated Ocean Drilling Program Expedition 343 and 343T) installed a borehole temperature observatory 16 months after the March 2011 moment magnitude 9.0 Tohoku-Oki earthquake across the fault where slip was similar to 50 meters near the trench. After 9 months of operation, the complete sensor string was recovered. A 0.31 degrees C temperature anomaly at the plate boundary fault corresponds to 27 megajoules per square meter of dissipated energy during the earthquake. The resulting apparent friction coefficient of 0.08 is considerably smaller than static values for most rocks.	[Fulton, P. M.; Brodsky, E. E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kano, Y.; Mori, J.] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Chester, F.] Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX USA; [Ishikawa, T.; Lin, W.] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi, Japan; [Harris, R. N.] Oregon State Univ, Corvallis, OR 97331 USA; [Eguchi, N.; Toczko, S.] Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Yokohama, Kanagawa, Japan	University of California System; University of California Santa Cruz; Kyoto University; Texas A&M University System; Texas A&M University College Station; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Oregon State University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Fulton, PM (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	pfulton@ucsc.edu	Brodsky, Emily/B-9139-2014; Lin, Weiren/AAC-2088-2020; Sample, James/A-9622-2015; Chester, Frederick/X-4706-2019; Chester, Frederick M/U-6789-2017; Toy, Virginia/F-9912-2014	Lin, Weiren/0000-0003-3228-2789; Chester, Frederick M/0000-0001-7665-3647; Toy, Virginia/0000-0002-7621-2064; Kirkpatrick, James/0000-0001-7504-6968; Ishikawa, Tsuyoshi/0000-0003-2886-7282; Fulton, Patrick/0000-0002-6259-2369; Brodsky, Emily/0000-0002-6855-6860; Kano, Yasuyuki/0000-0002-3809-698X	Gordon and Betty Moore Foundation [GBMF3289]; Grants-in-Aid for Scientific Research [25287134] Funding Source: KAKEN	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all drilling and operations staff on board the deep-sea drilling vessel Chikyu during IODP Expedition 343 and 343T and R/V Kairei during KR12-16, KR13-04, and KR13-08, operated by Japan Agency for Marine-Earth Science and Technology. The data are provided by IODP via CDEX (www.iodp.org/access-data-and-samples). The data analysis is funded by the Gordon and Betty Moore Foundation through grant GBMF3289 to E.E.B.	Brodsky EE, 2009, SCI DRILL, V8, P66, DOI 10.2204/iodp.sd.8.11.2009; Bullard E.C., 1947, GEOPHYS J INT, V5, P127, DOI [DOI 10.1111/J.1365-246X.1947.TB00348.X, 10.1111/j.1365-246X.1947.tb00348.x]; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Chester F. M., 2013, IODP P; Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Elkhoury JE, 2006, NATURE, V441, P1135, DOI 10.1038/nature04798; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Fulton PM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007103; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Kano Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026733; Kimura G, 2012, EARTH PLANET SC LETT, V339, P32, DOI 10.1016/j.epsl.2012.04.002; Lay T, 2011, PHYS TODAY, V64, P33, DOI 10.1063/PT.3.1361; Lin WR, 2013, SCIENCE, V339, P687, DOI 10.1126/science.1229379; Tanaka H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026673; Ujiie K, 2013, SCIENCE, V342, P1211, DOI 10.1126/science.1243485; Wang C. Y., 2010, LECT NOTES EARTH SCI, V114; WANG KL, 1995, J GEOPHYS RES-SOL EA, V100, P12907, DOI 10.1029/95JB00516; Wang KL, 1999, GEOPHYS RES LETT, V26, P2307, DOI 10.1029/1999GL900528	19	206	210	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1214	1217		10.1126/science.1243641	http://dx.doi.org/10.1126/science.1243641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311684	Green Accepted			2022-12-28	WOS:000327857900042
J	Kauranen, M				Kauranen, Martti			Freeing Nonlinear Optics from Phase Matching	SCIENCE			English	Editorial Material							METAMATERIALS; GENERATION		Tampere Univ Technol, Dept Phys, FI-33101 Tampere, Finland	Tampere University	Kauranen, M (corresponding author), Tampere Univ Technol, Dept Phys, POB 692, FI-33101 Tampere, Finland.	martti.kauranen@tut.fi	Kauranen, Martti O/G-4221-2014	Kauranen, Martti/0000-0001-8784-4780				Canalias C, 2007, NAT PHOTONICS, V1, P459, DOI 10.1038/nphoton.2007.137; FEJER MM, 1992, IEEE J QUANTUM ELECT, V28, P2631, DOI 10.1109/3.161322; Husu H, 2012, NANO LETT, V12, P673, DOI 10.1021/nl203524k; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Kim E, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.113102; Klein MW, 2006, SCIENCE, V313, P502, DOI 10.1126/science.1129198; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Rockstuhl C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155102; Rose A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063902; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Zhang S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137404	14	25	25	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1182	1183		10.1126/science.1247622	http://dx.doi.org/10.1126/science.1247622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311673				2022-12-28	WOS:000327857900028
J	Temmerman, S; Meire, P; Bouma, TJ; Herman, PMJ; Ysebaert, T; De Vriend, HJ				Temmerman, Stijn; Meire, Patrick; Bouma, Tjeerd J.; Herman, Peter M. J.; Ysebaert, Tom; De Vriend, Huib J.			Ecosystem-based coastal defence in the face of global change	NATURE			English	Article							MARSH RESTORATION; SEA-LEVEL; MANAGEMENT; SEDIMENTATION; CARBON	The risk of flood disasters is increasing for many coastal societies owing to global and regional changes in climate conditions, sea-level rise, land subsidence and sediment supply. At the same time, in many locations, conventional coastal engineering solutions such as sea walls are increasingly challenged by these changes and their maintenance may become unsustainable. We argue that flood protection by ecosystem creation and restoration can provide a more sustainable, cost-effective and ecologically sound alternative to conventional coastal engineering and that, in suitable locations, it should be implemented globally and on a large scale.	[Temmerman, Stijn; Meire, Patrick] Univ Antwerp, Ecosyst Management Res Grp, B-2610 Antwerp, Belgium; [Bouma, Tjeerd J.; Herman, Peter M. J.; Ysebaert, Tom] Royal Netherlands Inst Sea Res, Spatial Ecol Res Grp, NL-4400 AC Yerseke, Netherlands; [Ysebaert, Tom] Inst Marine Resources & Ecosyst Studies IMARES, NL-4400 AB Yerseke, Netherlands; [De Vriend, Huib J.] Delft Univ Technol, NL-3311 JG Dordrecht, Netherlands; [De Vriend, Huib J.] EcoShape, NL-3311 JG Dordrecht, Netherlands	University of Antwerp; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Wageningen University & Research; Delft University of Technology	Temmerman, S (corresponding author), Univ Antwerp, Ecosyst Management Res Grp, B-2610 Antwerp, Belgium.	stijn.temmerman@uantwerpen.be	Temmerman, Stijn/C-5521-2009; Bouma, Tjeerd J/A-9841-2011; Herman, Peter M.J./A-9018-2011	Herman, Peter M.J./0000-0003-2188-6341; Bouma, Tjeerd/0000-0001-7824-7546; Temmerman, Stijn/0000-0003-3346-9115	Research Foundation - Flanders (FWO); Research Fund of the University of Antwerp (BOF); Waterwegen Zeekanaal NV; EU [FP7.2009-1, 244104]; STW [07324]; Singapore-Delft Water Alliance; innovation program Building	Research Foundation - Flanders (FWO)(FWO); Research Fund of the University of Antwerp (BOF); Waterwegen Zeekanaal NV; EU(European Commission); STW(Technologiestichting STW); Singapore-Delft Water Alliance; innovation program Building	We gratefully acknowledge financial support to our research that is related to this article by the Research Foundation - Flanders (FWO), the Research Fund of the University of Antwerp (BOF), Waterwegen & Zeekanaal NV, the EU-funded THESUES project (FP7.2009-1, Contract 244104), STW grant 07324, the Singapore-Delft Water Alliance, the innovation program Building with Nature and its contributors (including the Netherlands Ministry of Infrastructure and the Environment, the European Fund for Regional Development, the Municipality of Dordrecht and the partners of the EcoShape consortium).	Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Broekx S, 2011, NAT HAZARDS, V57, P245, DOI 10.1007/s11069-010-9610-x; Burden A, 2013, ESTUAR COAST SHELF S, V120, P12, DOI 10.1016/j.ecss.2013.01.014; Carniello L, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001157; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Ecoshape, 2012, OYST REEFS TID FLAT; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Kabat P, 2009, NAT GEOSCI, V2, P450, DOI 10.1038/ngeo572; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Maris T, 2007, HYDROBIOLOGIA, V588, P31, DOI 10.1007/s10750-007-0650-5; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Nicholls R., 2007, RANKING WORLDS CITIE, DOI [https://doi.org/10.1787/011766488208, DOI 10.1787/011766488208]; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; Schmitt K, 2013, J COAST CONSERV, V17, P545, DOI 10.1007/s11852-013-0253-4; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Struyf E, 2007, BIOGEOCHEMISTRY, V82, P41, DOI 10.1007/s10533-006-9051-5; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Temmerman S, 2004, MAR GEOL, V212, P1, DOI 10.1016/j.margeo.2004.10.021; Temmerman S, 2012, GLOBAL PLANET CHANGE, V92-93, P267, DOI 10.1016/j.gloplacha.2012.06.001; Teuchies J, 2012, SCI TOTAL ENVIRON, V419, P187, DOI 10.1016/j.scitotenv.2012.01.016; Turner RK, 2007, GLOBAL ENVIRON CHANG, V17, P397, DOI 10.1016/j.gloenvcha.2007.05.006; United States Environmental Protection agency, 2013, SAN FRANC BAY DELT W; van Slobbe E, 2013, NAT HAZARDS, V65, P947, DOI 10.1007/s11069-012-0342-y; Vandenbruwaene W, 2011, GEOMORPHOLOGY, V130, P115, DOI 10.1016/j.geomorph.2011.03.004; Verspagen JMH, 2006, ECOL APPL, V16, P313, DOI 10.1890/04-1953; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wolters M, 2005, BIOL CONSERV, V123, P249, DOI 10.1016/j.biocon.2004.11.013; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	35	842	871	34	630	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					79	83		10.1038/nature12859	http://dx.doi.org/10.1038/nature12859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305151				2022-12-28	WOS:000327851700028
J	Moore, W				Moore, Wendy			PAST CARING And finally ...	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Beatty W., 1807, AUTHENTIC NARRATIVE; Mackaill A, 2007, C DOYLE J BELL REAL; RAMSAY JHR, 1994, BRIT MED J, V308, P1445, DOI 10.1136/bmj.308.6941.1445; Royal College of Surgeons, PLARRS LIV FELL ONL	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f7180	10.1136/bmj.f7180	http://dx.doi.org/10.1136/bmj.f7180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297978				2022-12-28	WOS:000328146700009
J	Spence, D				Spence, Des			FROM THE FRONTLINE Indebted to international medical graduates	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MRCGP EXAM; DISCRIMINATION					destwo@yahoo.co.uk						[Anonymous], 2013, PULSE           1018; [Anonymous], 2011, GUARDIAN; Bhopal Raj S, 2013, BMJ, V347, pf6479, DOI 10.1136/bmj.f6479; BMA, NHS WATCH MAN DOCT W; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; Knight RA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6438; Office of National Stastics, 2012, 2011 CENS SHOWS NONU; Shaw Q, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6442	8	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f7176	10.1136/bmj.f7176	http://dx.doi.org/10.1136/bmj.f7176			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297976				2022-12-28	WOS:000328146700007
J	Heslop, P; Blair, PS; Fleming, P; Hoghton, M; Marriott, A; Russ, L				Heslop, Pauline; Blair, Peter S.; Fleming, Peter; Hoghton, Matthew; Marriott, Anna; Russ, Lesley			The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study	LANCET			English	Article							LIFE EXPECTANCY; MORTALITY; DISPARITIES; SURVIVAL; CHILDREN; ADULTS; HEALTH	Background The Confidential Inquiry into premature deaths of people with intellectual disabilities in England was commissioned to provide evidence about contributory factors to avoidable and premature deaths in this population. Methods The population-based Confidential Inquiry reviewed the deaths of people with intellectual disabilities aged 4 years and older who had been registered with a general practitioner in one of five Primary Care Trust areas of southwest England, who died between June 1, 2010, and May 31, 2012. A network of health, social-care, and voluntary-sector services; community contacts; and statutory agencies notified the Confidential Inquiry of all deaths of people with intellectual disabilities and provided core data. The Office for National Statistics provided data about the coding of individual cause of death certificates. Deaths were described as avoidable (preventable or amenable), according to Office for National Statistics definitions. Contributory factors to deaths were identified and quantified by the case investigator, verified by a local review panel meeting, and agreed by the Confidential Inquiry overview panel. Contributory factors were grouped into four domains: intrinsic to the individual, within the family and environment, care provision, and service provision. The deaths of a comparator group of people without intellectual disabilities but much the same in age, sex, and cause of death and registered at the same general practices as those with intellectual disabilities were also investigated. Findings The Confidential Inquiry reviewed the deaths of 247 people with intellectual disabilities. Nearly a quarter (22%, 54) of people with intellectual disabilities were younger than 50 years when they died, and the median age at death was 64 years (IQR 52-75). The median age at death of male individuals with intellectual disabilities was 65 years (IQR 54-76), 13 years younger than the median age at death of male individuals in the general population of England and Wales (78 years). The median age at death of female individuals with intellectual disabilities was 63 years (IQR 54-75), 20 years younger than the median age at death for female individuals in the general population (83 years). Avoidable deaths from causes amenable to change by good quality health care were more common in people with intellectual disabilities (37%, 90 of 244) than in the general population of England and Wales (13%). Contributory factors to premature deaths in a subset of people with intellectual disabilities compared with a comparator group of people without intellectual disabilities included problems in advanced care planning (p=0.0003), adherence to the Mental Capacity Act (p=0.0008), living in inappropriate accommodation (p<0.0001), adjusting care as needs changed (p=0.009), and carers not feeling listened to (p=0.006). Interpretation The Confidential Inquiry provides evidence of the substantial contribution of factors relating to the provision of care and health services to the health disparities between people with and without intellectual disabilities. It is imperative to examine care and service provision for this population as potentially contributory factors to their deaths-factors that can largely be ameliorated.	[Heslop, Pauline; Blair, Peter S.; Fleming, Peter; Marriott, Anna] Univ Bristol, Bristol BS8 1TZ, Avon, England; [Hoghton, Matthew] Clevedon Med Ctr, Clevedon Riverside Grp, Clevedon, Somerset, England; [Russ, Lesley] Bristol City Publ Hlth Team, Bristol, Avon, England	University of Bristol	Heslop, P (corresponding author), Univ Bristol, Sch Policy Studies, Norah Fry Res Ctr, Bristol BS8 1TZ, Avon, England.	pauline.heslop@bristol.ac.uk	Blair, Peter S/C-1213-2009; Fleming, Peter/O-3231-2019; Heslop, Pauline/AAW-9538-2021	Fleming, Peter/0000-0003-2521-5764; Blair, Peter/0000-0002-7832-8087	Department of Health for England	Department of Health for England	Department of Health for England.	Cohen A, 2008, J CHILD NEUROL, V23, P536, DOI 10.1177/0883073807309795; Department of Health, 6 LIV PROGR REP HEAL; Emerson E, WORKING DEFINITION L; Emerson E., 2011, ESTIMATING FUTURE NE; Emerson E., 2012, HLTH INEQUALITIES PE; EYMAN RK, 1990, NEW ENGL J MED, V323, P584, DOI 10.1056/NEJM199008303230906; Forsgren L, 1996, EPILEPSIA, V37, P956, DOI 10.1111/j.1528-1157.1996.tb00533.x; FORSSMAN H, 1970, J MENT DEFIC RES, V14, P276; Glover G, PEOPLE LEARNING DIAS; Heslop P., 2013, CONFIDENTIAL INQUIRY; Hollins S, 1998, DEV MED CHILD NEUROL, V40, P50; Kiani R, 2013, J INTELL DISABIL RES, DOI [10.1111/jidr10247, DOI 10.1111/JIDR10247]; Krahn GL, 2006, MENT RETARD DEV D R, V12, P70, DOI 10.1002/mrdd.20098; Lavin KE, 2006, J INTELLECT DISABILI, V10, P155, DOI 10.1177/1744629506064011; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; Mencap, 2007, DEATH IND; Michael J., 2008, HEALTHCARE ALL; National Patient Safety Agency, ROOT CAUS AN TOOLK; Office for National Statistics, SEARCH KS201EW ENGL; Office for National Statistics, 2012, AV MORT ENGL WAL 201; Office for National Statistics, 2010, MOR UK; Ouellette-Kuntz H, 2005, J APPL RES INTELLECT, V18, P113, DOI 10.1111/j.1468-3148.2005.00240.x; Patja K, 2000, J INTELL DISABIL RES, V44, P591, DOI 10.1046/j.1365-2788.2000.00280.x; Patja K, 2001, J INTELL DISABIL RES, V45, P30, DOI 10.1046/j.1365-2788.2001.00290.x; Strauss D, 1997, J PEDIATR-US, V131, P712, DOI 10.1016/S0022-3476(97)70098-2; Tyrer F, 2007, J INTELL DISABIL RES, V51, P520, DOI 10.1111/j.1365-2788.2006.00918.x; Tyrer F, 2009, J INTELL DISABIL RES, V53, P898, DOI 10.1111/j.1365-2788.2009.01201.x; Tyrer F, 2007, J APPL RES INTELLECT, V20, P360, DOI 10.1111/j.1468-3148.2006.00343.x; World Health Assembly, 2013, RES DIS	29	267	268	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					889	895		10.1016/S0140-6736(13)62026-7	http://dx.doi.org/10.1016/S0140-6736(13)62026-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	24332307	Green Published, hybrid			2022-12-28	WOS:000332399500029
J	Watt, G; Giacaman, R; Zurayk, H				Watt, Graham; Giacaman, Rita; Zurayk, Huda		LPHA Steering Grp	Palestinian health research	LANCET			English	Editorial Material									[Watt, Graham] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland; [Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, West Bank, Israel; [Zurayk, Huda] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon	University of Glasgow; Birzeit University; American University of Beirut	Watt, G (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland.	graham.watt@glasgow.ac.uk	Husseini, Abdullatif/E-8377-2015	Husseini, Abdullatif/0000-0001-8767-5956				Abu-Rmeileh NME, 2012, EUR J PUBLIC HEALTH, V22, P732, DOI 10.1093/eurpub/ckr131; Al Barqouni LN, 2010, LANCET, V376, P68, DOI 10.1016/S0140-6736(10)60812-4; Palestinian Central Bureau of Statistics, 2013, 65 ANN PAL NAKB DES; United Nations Relief and Works Agency for Palestine Refugees in the Near East, PAL REF; [No title captured]	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					E6	E8		10.1016/S0140-6736(13)62234-5	http://dx.doi.org/10.1016/S0140-6736(13)62234-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24315726				2022-12-28	WOS:000330212600002
J	Fairchild, AL; Bayer, R; Colgrove, J				Fairchild, Amy L.; Bayer, Ronald; Colgrove, James			The Renormalization of Smoking? E-Cigarettes and the Tobacco "Endgame"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NICOTINE DELIVERY-SYSTEMS; POLICY	Whereas some experts welcome e-cigarettes as a pathway to reducing tobacco use, others characterize them as dangerous products that could undermine efforts to denormalize smoking. But the goal of eliminating the risks of smoking is not incompatible with e-cigarette use. Electronic cigarettes, or e-cigarettes battery-operated nicotine-delivery devices that mimic the look and feel of smoking by vaporizing a liquid solution such as propylene glycol appeared in European and American markets less than a decade ago. Sales have reached $650 million a year in Europe and are projected to reach $1.7 billion in the United States in 2013. Though these figures are a small fraction of sales figures for traditional cigarettes, e-cigarettes represent a substantial market achievement; indeed, some people predict that they may eventually eclipse tobacco cigarettes. But e-cigarettes are the subject of a public health dispute that ...	[Fairchild, Amy L.; Bayer, Ronald; Colgrove, James] Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				Chapman S, 2013, TOB CONTROL, V22, P33, DOI 10.1136/tobaccocontrol-2012-050767; Grana RA, 2011, TOB CONTROL, V20, P425, DOI 10.1136/tc.2011.043778; Henningfield JE, 2010, TOB CONTROL, V19, P89, DOI 10.1136/tc.2009.035279; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Sweanor D, 2007, INT J DRUG POLICY, V18, P70, DOI 10.1016/j.drugpo.2006.11.013	5	224	227	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2014	370	4					293	295		10.1056/NEJMp1313940	http://dx.doi.org/10.1056/NEJMp1313940			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HP	24350902				2022-12-28	WOS:000330036200002
J	Baron, J; Campbell, WC; DeMille, D; Doyle, JM; Gabrielse, G; Gurevich, YV; Hess, PW; Hutzler, NR; Kirilov, E; Kozyryev, I; O'Leary, BR; Panda, CD; Parsons, MF; Petrik, ES; Spaun, B; Vutha, AC; West, AD				Baron, J.; Campbell, W. C.; DeMille, D.; Doyle, J. M.; Gabrielse, G.; Gurevich, Y. V.; Hess, P. W.; Hutzler, N. R.; Kirilov, E.; Kozyryev, I.; O'Leary, B. R.; Panda, C. D.; Parsons, M. F.; Petrik, E. S.; Spaun, B.; Vutha, A. C.; West, A. D.		ACME Collaboration	Order of Magnitude Smaller Limit on the Electric Dipole Moment of the Electron	SCIENCE			English	Article							SEARCH; ATOMS	The Standard Model of particle physics is known to be incomplete. Extensions to the Standard Model, such as weak-scale supersymmetry, posit the existence of new particles and interactions that are asymmetric under time reversal (T) and nearly always predict a small yet potentially measurable electron electric dipole moment (EDM), d(e), in the range of 10(-27) to 10(-30) e.cm. The EDM is an asymmetric charge distribution along the electron spin ((S) over right arrow) that is also asymmetric under T. Using the polar molecule thorium monoxide, we measured d(e) = (-2.1 +/- 3.7(stat) +/- 2.5(syst)) x 10(-29) e.cm. This corresponds to an upper limit of vertical bar d(e)vertical bar < 8.7 x 10(-29) e.cm with 90% confidence, an order of magnitude improvement in sensitivity relative to the previous best limit. Our result constrains T-violating physics at the TeV energy scale.	[Baron, J.; Doyle, J. M.; Gabrielse, G.; Gurevich, Y. V.; Hess, P. W.; Hutzler, N. R.; Panda, C. D.; Parsons, M. F.; Petrik, E. S.; Spaun, B.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Campbell, W. C.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [DeMille, D.; Kirilov, E.; Kozyryev, I.; O'Leary, B. R.; West, A. D.] Yale Univ, Dept Phys, New Haven, CT 06511 USA; [Vutha, A. C.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada	Harvard University; University of California System; University of California Los Angeles; Yale University; York University - Canada	DeMille, D (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06511 USA.	acme@physics.harvard.edu; acme@physics.harvard.edu; acme@physics.harvard.edu	kirilov, emil/J-6038-2018; Parsons, Maxwell/GWC-8748-2022	kirilov, emil/0000-0003-0878-8296; Vutha, Amar/0000-0002-1250-2927; Campbell, Wesley/0000-0003-1578-906X; West, Adam/0000-0003-4098-0165; Hess, Paul/0000-0003-2985-4221; West, Elizabeth/0000-0003-4249-0370; Hutzler, Nicholas/0000-0002-5203-3635	NSF; Precision Measurement Grants Program of the National Institute of Standards and Technology; Office of Science Graduate Fellowship Program, U.S. Department of Energy; Division Of Physics [0855575] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Precision Measurement Grants Program of the National Institute of Standards and Technology; Office of Science Graduate Fellowship Program, U.S. Department of Energy; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by NSF and the Precision Measurement Grants Program of the National Institute of Standards and Technology. We thank M. Reece and M. Schwartz for discussions and S. Cotreau, J. MacArthur, and S. Sansone for technical support. P. W. H. was supported in part by the Office of Science Graduate Fellowship Program, U.S. Department of Energy. The authors declare no competing financial interests.	BARR SM, 1993, INT J MOD PHYS A, V8, P209, DOI 10.1142/S0217751X93000096; BERNREUTHER W, 1991, REV MOD PHYS, V63, P313, DOI 10.1103/RevModPhys.63.313; BERRY HG, 1977, APPL OPTICS, V16, P3200, DOI 10.1364/AO.16.003200; Bickman S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.023418; Campbell WC, 2013, EPJ WEB CONF, V57, DOI 10.1051/epjconf/20135702004; Commins Eugene D., 2010, Lepton Dipole Moments, P519, DOI 10.1142/9789814271844_0014; Curtiss JH, 1941, ANN MATH STAT, V12, P409, DOI 10.1214/aoms/1177731679; Dzuba VA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052108; Eckel S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052130; Eisenbach S., 1993, P SOC PHOTO-OPT INS, V1972, P19; Engel J, 2013, PROG PART NUCL PHYS, V71, P21, DOI 10.1016/j.ppnp.2013.03.003; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Fortson N, 2003, PHYS TODAY, V56, P33, DOI 10.1063/1.1595052; GRAY HR, 1978, OPT LETT, V3, P218, DOI 10.1364/OL.3.000218; Griffith WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.101601; Hutzler NR, 2012, CHEM REV, V112, P4803, DOI 10.1021/cr200362u; Hutzler NR, 2011, PHYS CHEM CHEM PHYS, V13, P18976, DOI 10.1039/c1cp20901a; Khriplovich I. B., 1997, CP VIOLATION STRANGE; Kirilov E, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013844; KOZLOV MG, 1995, J PHYS B-AT MOL OPT, V28, P1933, DOI 10.1088/0953-4075/28/10/008; Maxwell SE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.173201; Meyer ER, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010502; PLAYER MA, 1970, J PHYS PT B ATOM M P, V3, P1620, DOI 10.1088/0022-3700/3/12/007; Pospelov M, 2005, ANN PHYS-NEW YORK, V318, P119, DOI 10.1016/j.aop.2005.04.002; Regan BC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.071805; SANDARS PGH, 1965, PHYS LETT, V14, P194, DOI 10.1016/0031-9163(65)90583-4; Skripnikov LV, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4843955; Vutha AC, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.034502; Vutha AC, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/7/074007	31	738	743	2	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					269	272		10.1126/science.1248213	http://dx.doi.org/10.1126/science.1248213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24356114	Green Accepted, Green Submitted			2022-12-28	WOS:000329718600028
J	Joseph, CG; Darrah, E; Shah, AA; Skora, AD; Casciola-Rosen, LA; Wigley, FM; Boin, F; Fava, A; Thoburn, C; Kinde, I; Jiao, YC; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Rosen, A				Joseph, Christine G.; Darrah, Erika; Shah, Ami A.; Skora, Andrew D.; Casciola-Rosen, Livia A.; Wigley, Fredrick M.; Boin, Francesco; Fava, Andrea; Thoburn, Chris; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Rosen, Antony			Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer	SCIENCE			English	Article							CD4(+) T-CELLS; ANTIGENS; EXPRESSION; MUTATIONS	Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Scleroderma is an autoimmune connective tissue disease in which patients make antibodies to a limited group of autoantigens, including RPC1, encoded by the POLR3A gene. As patients with scleroderma and antibodies against RPC1 are at increased risk for cancer, we hypothesized that the "foreign" antigens in this autoimmune disease are encoded by somatically mutated genes in the patients' incipient cancers. Studying cancers from scleroderma patients, we found genetic alterations of the POLR3A locus in six of eight patients with antibodies to RPC1 but not in eight patients without antibodies to RPC1. Analyses of peripheral blood lymphocytes and serum suggested that POLR3A mutations triggered cellular immunity and cross-reactive humoral immune responses. These results offer insight into the pathogenesis of scleroderma and provide support for the idea that acquired immunity helps to control naturally occurring cancers.	[Joseph, Christine G.; Skora, Andrew D.; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ludwig Ctr, Baltimore, MD 21287 USA; [Joseph, Christine G.; Skora, Andrew D.; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Darrah, Erika; Shah, Ami A.; Casciola-Rosen, Livia A.; Wigley, Fredrick M.; Boin, Francesco; Fava, Andrea; Rosen, Antony] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21224 USA; [Thoburn, Chris] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Div Immunol, Baltimore, MD 21287 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Kinzler, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ludwig Ctr, Baltimore, MD 21287 USA.	kinzlke@jhmi.edu; vogelbe@jhmi.edu; arosen@jhmi.edu	Thoburn, Christopher J/U-9170-2017; Boin, Francesco/T-3186-2017; Fava, Andrea/AAF-8515-2019; Boin, Francesco/AAI-1471-2021	Thoburn, Christopher J/0000-0001-7743-9183; Fava, Andrea/0000-0001-6738-4836; Jiao, Yuchen/0000-0001-7917-8810; Boin, Francesco/0000-0003-4840-3063; Darrah, Erika/0000-0003-1119-0279	Virginia; D. K. Ludwig Fund for Cancer Research; Donald B. and Dorothy L. Stabler Foundation; Scleroderma Research Foundation; Rheumatology Research Foundation Career Development Bridge Funding Award; NIH [K23 AR061439, P30-AR053503, CA43460, CA 57345, CA 62924]; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA043460, R01CA057345, R37CA043460, R37CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503, K23AR061439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Donald B. and Dorothy L. Stabler Foundation; Scleroderma Research Foundation; Rheumatology Research Foundation Career Development Bridge Funding Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Ptak, N. Silliman. L. Dobbyn, J. Schaeffer, and M. Sampedro for expert technical assistance and J. Wu for advice on capturing. These studies were supported by The Virginia and D. K. Ludwig Fund for Cancer Research, The Donald B. and Dorothy L. Stabler Foundation, the Scleroderma Research Foundation, the Rheumatology Research Foundation Career Development Bridge Funding Award, and NIH grants K23 AR061439, P30-AR053503, CA43460, CA 57345, and CA 62924.	Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Ding ZC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890178; Doyle HA, 2005, ANN NY ACAD SCI, V1050, P1, DOI 10.1196/annals.1313.001; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gaudin C, 1999, J IMMUNOL, V162, P1730; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; Jackson KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00263; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; LIN RH, 1991, J EXP MED, V173, P1433, DOI 10.1084/jem.173.6.1433; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MAMULA MJ, 1994, J IMMUNOL, V152, P1453; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Quezada SA, 2013, BRIT J CANCER, V108, P1560, DOI 10.1038/bjc.2013.117; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shah AA, 2011, CURR OPIN RHEUMATOL, V23, P530, DOI 10.1097/BOR.0b013e32834a5081; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Tatsis E, 1999, ARTHRITIS RHEUM-US, V42, P751, DOI 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	36	273	282	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					152	157		10.1126/science.1246886	http://dx.doi.org/10.1126/science.1246886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24310608	Green Accepted			2022-12-28	WOS:000329440800034
J	Kumar, MS; Armenteros-Monterroso, E; East, P; Chakravorty, P; Matthews, N; Winslow, MM; Downward, J				Kumar, Madhu S.; Armenteros-Monterroso, Elena; East, Philip; Chakravorty, Probir; Matthews, Nik; Winslow, Monte M.; Downward, Julian			RETRACTED: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression (Retracted article. See vol. 523, 2015)	NATURE			English	Article; Retracted Publication							TGF-BETA; MESSENGER-RNAS; EXPRESSION DATA; GENE; ADENOCARCINOMA; BINDING; LET-7; OVEREXPRESSION; TRANSFORMATION; INHIBITOR	Non-small-cell lung cancer (NSCLC) is the most prevalent histological cancer subtype worldwide(1). As the majority of patients present with invasive, metastatic disease(2), it is vital to understand the basis for lung cancer progression. Hmga2 is highly expressed in metastatic lung adenocarcinoma, in which it contributes to cancer progression and metastasis(3-6). Here we show that Hmga2 promotes lung cancer progression in mouse and human cells by operating as a competing endogenous RNA (ceRNA)(7-11) for the let-7 microRNA (miRNA) family. Hmga2 can promote the transformation of lung cancer cells independent of protein-coding function but dependent upon the presence of let-7 sites; this occurs without changes in the levels of let-7 isoforms, suggesting that Hmga2 affects let-7 activity by altering miRNA targeting. These effects are also observed in vivo, where Hmga2 ceRNA activity drives lung cancer growth, invasion and dissemination. Integrated analysis of miRNA target prediction algorithms and metastatic lung cancer gene expression data reveals the TGF-beta co-receptor Tgfbr3 (ref. 12) as a putative target of Hmga2 ceRNA function. Tgfbr3 expression is regulated by the Hmga2 ceRNA through differential recruitment to Argonaute 2 (Ago2), and TGF-beta signalling driven by Tgfbr3 is important for Hmga2 to promote lung cancer progression. Finally, analysis of NSCLC-patient gene-expression data reveals that HMGA2 and TGFBR3 are coordinately regulated in NSCLC-patient material, a vital corollary to ceRNA function. Taken together, these results suggest that Hmga2 promotes lung carcinogenesis both as a protein-coding gene and as a non-coding RNA; such dual-function regulation of gene-expression networks reflects a novel means by which oncogenes promote disease progression.	[Kumar, Madhu S.; Armenteros-Monterroso, Elena; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [East, Philip; Chakravorty, Probir] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Matthews, Nik] Canc Res UK London Res Inst, Adv Sequencing Facil, London WC2A 3LY, England; [Winslow, Monte M.] Stanford Univ, Sch Med, Stanford Canc Inst, Dept Genet,Dept Pathol, Stanford, CA 94305 USA; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Stanford Cancer Institute; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk		Downward, Julian/0000-0002-2331-4729	Cancer Research UK; European Commission [259770]; Worldwide Cancer Research [13-0142] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Worldwide Cancer Research	We thank the laboratory of T. Jacks for providing the 482N1 and 368T1 lung cancer cell lines and the laboratories of P. A. Sharp and P. Chambon for providing the KPD sarcoma cell lines. We thank the LRI FACS Facility for the BrdU analyses and the LRI Biological Resources Unit for assistance with the animal studies. We thank M. S. Ebert and E. De Bruin for critical review of the manuscript. M. S. K. is a Long-Term Fellow of the Human Frontier Science Program and the European Molecular Biology Organization. This work was funded by Cancer Research UK and by the European Commission's Seventh Framework Programme (FP7/2007-2013) under the grant agreement Lungtarget (project no. 259770).	Brants JR, 2004, FEBS LETT, V569, P277, DOI 10.1016/j.febslet.2004.05.075; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Liau SS, 2007, BRIT J CANCER, V96, P993, DOI 10.1038/sj.bjc.6603654; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]	34	220	238	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					212	+		10.1038/nature12785	http://dx.doi.org/10.1038/nature12785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24305048	Green Accepted			2022-12-28	WOS:000329441500038
J	Hviid, A; Melbye, M; Pasternak, B				Hviid, Anders; Melbye, Mads; Pasternak, Bjorn			Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIDEPRESSANT USE; DANISH; DEPRESSION; FETAL	BackgroundStudies have raised concern about an association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and an increased risk of autism spectrum disorders in the offspring. MethodsWe conducted a cohort study of all singleton live births in Denmark from 1996 through 2005 (626,875 births), with follow-up through 2009. Using Danish population registries, we linked information on maternal use of SSRIs before and during pregnancy, autism spectrum disorders diagnosed in the offspring, and a range of potential confounders. We used a survival analysis of the time to diagnosis in the offspring with Poisson regression to estimate rate ratios of autism spectrum disorders according to maternal use of SSRIs. ResultsDuring 5,057,282 person-years of follow-up, we identified 3892 cases of autism spectrum disorder (incidence rate, 77.0 per 100,000 person-years). A total of 52 cases during 42,400 person-years of follow-up involved offspring of women who were exposed to SSRIs during their pregnancy (incidence rate, 122.6 per 100,000 person-years). As compared with no use of SSRIs both before and during pregnancy, use during pregnancy was not associated with a significantly increased risk of autism spectrum disorders (fully adjusted rate ratio, 1.20; 95% confidence interval [CI], 0.90 to 1.61). Among women who received SSRIs before pregnancy but not during pregnancy, the corresponding fully adjusted rate ratio was 1.46 (95% CI, 1.17 to 1.81). ConclusionsWe did not detect a significant association between maternal use of SSRIs during pregnancy and autism spectrum disorder in the offspring. On the basis of the upper boundary of the confidence interval, our study could not rule out a relative risk up to 1.61, and therefore the association warrants further study. (Funded by the Danish Health and Medicines Authority.)	[Hviid, Anders; Melbye, Mads; Pasternak, Bjorn] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	aii@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785	Danish Health and Medicines Authority	Danish Health and Medicines Authority	Supported by the Danish Health and Medicines Authority.	Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Grzeskowiak LE, 2011, DRUG SAFETY, V34, P1027, DOI 10.2165/11593130-000000000-00000; Harrell HF., 2001, REGRESSION MODELING; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Jorgensen Maiken Thyregod, 2003, Ugeskr Laeger, V165, P447; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Oberlander TF, 2012, J ADOLESCENT HEALTH, V51, pS9, DOI 10.1016/j.jadohealth.2012.04.009; Parner ET, 2011, J AUTISM DEV DISORD, V41, P1601, DOI 10.1007/s10803-011-1186-0; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Tuccori M, 2009, CLIN THER, V31, P1426, DOI 10.1016/j.clinthera.2009.07.009; [No title captured]	24	131	132	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2406	2415		10.1056/NEJMoa1301449	http://dx.doi.org/10.1056/NEJMoa1301449			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24350950				2022-12-28	WOS:000328586000008
J	Brockmann, D; Helbing, D				Brockmann, Dirk; Helbing, Dirk			The Hidden Geometry of Complex, Network-Driven Contagion Phenomena	SCIENCE			English	Article							SPREAD; FORECAST	The global spread of epidemics, rumors, opinions, and innovations are complex, network-driven dynamic processes. The combined multiscale nature and intrinsic heterogeneity of the underlying networks make it difficult to develop an intuitive understanding of these processes, to distinguish relevant from peripheral factors, to predict their time course, and to locate their origin. However, we show that complex spatiotemporal patterns can be reduced to surprisingly simple, homogeneous wave propagation patterns, if conventional geographic distance is replaced by a probabilistically motivated effective distance. In the context of global, air-traffic-mediated epidemics, we show that effective distance reliably predicts disease arrival times. Even if epidemiological parameters are unknown, the method can still deliver relative arrival times. The approach can also identify the spatial origin of spreading processes and successfully be applied to data of the worldwide 2009 H1N1 influenza pandemic and 2003 SARS epidemic.	[Brockmann, Dirk] Robert Koch Inst, D-13353 Berlin, Germany; [Brockmann, Dirk] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Brockmann, Dirk] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Brockmann, Dirk] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Helbing, Dirk] Swiss Fed Inst Technol, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Helbing, Dirk] Swiss Fed Inst Technol, Risk Ctr, CH-8092 Zurich, Switzerland	Robert Koch Institute; Humboldt University of Berlin; Northwestern University; Northwestern University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Brockmann, D (corresponding author), Robert Koch Inst, Seestr 10, D-13353 Berlin, Germany.	dirk.brockmann@hu-berlin.de			Volkswagen Foundation; ETH project "Systemic Risks, Systemic Solutions" (CHIRP II project) [ETH 48 12-1]	Volkswagen Foundation(Volkswagen); ETH project "Systemic Risks, Systemic Solutions" (CHIRP II project)	D.B. thanks W. Kath, D. Grady, W. H. Grond, O. Woolley-Meza, and A. Bentley for fruitful discussions and comments and W. Moers, B. May, and FuturICT for inspiration. We thank R. Brune for contributions during the early phase of the project and for work on the origin reconstruction and C. Thiemann for the development of the SPaTo network visualization tool (www.spato.net). Global mobility data was provided by OAG (www.oag.com), prevalence data of H1N1 and SARS by the WHO (www.who.int), and EHEC data by the RKI-Survstat (www3.rki.de/SurvStat/). This work was supported by the Volkswagen Foundation (project: "Bioinvasion and epidemic spread in complex transportation networks") and partially supported by the ETH project "Systemic Risks, Systemic Solutions" (CHIRP II project ETH 48 12-1).	Abbott EJ., 1933, Mech. Eng, V55, P569; Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; ANDERSON JE, 1979, AM ECON REV, V69, P106; ANDERSON R M, 1991; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brockmann D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178301; Brockmann D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.170601; Brunet E, 1997, PHYS REV E, V56, P2597, DOI 10.1103/PhysRevE.56.2597; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Grady D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1847; Hollingsworth TD, 2007, EMERG INFECT DIS, V13, P1288, DOI 10.3201/eid1309.070081; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Lokhov A. Y., 2013, INFERRING ORIGIN EPI; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; McLean AR., 2005, SARS CASE STUDY EMER, DOI [10.1093/shm/hki055, DOI 10.1093/SHM/HKI055]; Moore M, 2003, INT J HYG ENVIR HEAL, V206, P269, DOI 10.1078/1438-4639-00223; Murray J.D, 2005, MATH BIOL; NOBLE JV, 1974, NATURE, V250, P726, DOI 10.1038/250726a0; Pinto PC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.068702; Robert-Koch-Institute, 2012, SURVST; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Woolley-Meza O, 2011, EUR PHYS J B, V84, P589, DOI 10.1140/epjb/e2011-20208-9; World Health Organization, GLOB AL RESP; World Heath Organization, 2013, FLUNET	39	692	736	16	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1337	1342		10.1126/science.1245200	http://dx.doi.org/10.1126/science.1245200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337289				2022-12-28	WOS:000328196000041
J	Kumar, R				Kumar, Rajeev			The Science hoax: poor journalology reflects poor training in peer review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									All India Inst Med Sci, Dept Urol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Kumar, R (corresponding author), All India Inst Med Sci, Dept Urol, New Delhi 110029, India.	rajeev02@gmail.com	Kumar, Rakesh/ABD-1065-2020; Kumar, Rajeev/I-2338-2016	Kumar, Rakesh/0000-0001-7664-0803; Kumar, Rajeev/0000-0002-0783-1101				Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5975; Rice C., 2013, OPEN ACCESS PUBLISHI	3	7	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2013	347								f7465	10.1136/bmj.f7465	http://dx.doi.org/10.1136/bmj.f7465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZU	24336454				2022-12-28	WOS:000328575600006
J	Bui, KH; von Appen, A; DiGuilio, AL; Ori, A; Sparks, L; Mackmull, MT; Bock, T; Hagen, W; Andres-Pons, A; Glavy, JS; Beck, M				Bui, Khanh Huy; von Appen, Alexander; DiGuilio, Amanda L.; Ori, Alessandro; Sparks, Lenore; Mackmull, Marie-Therese; Bock, Thomas; Hagen, Wim; Andres-Pons, Amparo; Glavy, Joseph S.; Beck, Martin			Integrated Structural Analysis of the Human Nuclear Pore Complex Scaffold	CELL			English	Article							CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; DOMAIN TOPOLOGY; NUCLEOPORIN; MEMBRANE; PHOSPHORYLATION; COMPONENTS; PROTEINS	The nuclear pore complex (NPC) is a fundamental component of all eukaryotic cells that facilitates nucleocytoplasmic exchange of macromolecules. It is assembled from multiple copies of about 30 nucleoporins. Due to its size and complex composition, determining the structure of the NPC is an enormous challenge, and the overall architecture of the NPC scaffold remains elusive. In this study, we have used an integrated approach based on electron tomography, single-particle electron microscopy, and crosslinking mass spectrometry to determine the structure of a major scaffold motif of the human NPC, the Nup107 subcomplex, in both isolation and integrated into the NPC. We show that 32 copies of the Nup107 subcomplex assemble into two reticulated rings, one each at the cytoplasmic and nuclear face of the NPC. This arrangement may explain how changes of the diameter are realized that would accommodate transport of huge cargoes.	[Bui, Khanh Huy; von Appen, Alexander; Ori, Alessandro; Sparks, Lenore; Mackmull, Marie-Therese; Bock, Thomas; Hagen, Wim; Andres-Pons, Amparo; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [DiGuilio, Amanda L.; Glavy, Joseph S.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA	European Molecular Biology Laboratory (EMBL); Stevens Institute of Technology	Glavy, JS (corresponding author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, 507 River St, Hoboken, NJ 07030 USA.	jglavy@stevens.edu; martin.beck@embl.de	Ori, Alessandro/B-7067-2011; Thomas, Bock/I-2444-2017; Lemke, Edward A/J-3337-2015; Ori, Alessandro/M-8586-2019; Beck, Martin/B-5589-2011	Ori, Alessandro/0000-0002-3046-0871; Thomas, Bock/0000-0001-7448-3162; Lemke, Edward A/0000-0002-0634-0503; Ori, Alessandro/0000-0002-3046-0871; Beck, Martin/0000-0002-7397-1321; von Appen, Alexander/0000-0001-6528-2123; Andres-Pons, Amparo/0000-0001-5801-4024; Bui, Khanh Huy/0000-0003-2814-9889; Hagen, Wim/0000-0001-6229-2692; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Mackmull, Marie-Therese/0000-0003-2928-1144; Glavy, Joseph/0000-0003-3716-3965	Swiss National Science Foundation; European Molecular Biology Organization, and Marie Curie Actions; Alexander von Humboldt Foundation and Marie Curie Actions; Robert Crooks Stanley Fellowship at Stevens Institute of Technology; European Research Council [309271-NPCAtlas]; EMBL's mechanical workshop	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization, and Marie Curie Actions; Alexander von Humboldt Foundation and Marie Curie Actions(Alexander von Humboldt Foundation); Robert Crooks Stanley Fellowship at Stevens Institute of Technology; European Research Council(European Research Council (ERC)European Commission); EMBL's mechanical workshop	We thank Drs. Katja Beck and Edward A. Lemke for critical advice, reading of the manuscript, and numerous insightful discussions. We thank Drs. Carsten Sachse, Virginia VanDelinder, Thomas Cattabiani, and Iain Mattaj for critical reading of the manuscript; Ulrike Kutay for reagents; Peer Bork, Tommy E. White, Jan Kosinski, and John Briggs for critical advice. We gratefully acknowledge support from EMBL's mechanical workshop, electron microscopy and proteomics core facilities, and the centre for statistical data analysis and, in particular, want to thank James Riches, Drs. Jeroen Krijgsveld, and Bernd Klaus. K.H.B was supported by postdoctoral fellowships from the Swiss National Science Foundation, the European Molecular Biology Organization, and Marie Curie Actions. A.O. was supported by postdoctoral fellowships from the Alexander von Humboldt Foundation and Marie Curie Actions. A.L.D. was supported by the Robert Crooks Stanley Fellowship at Stevens Institute of Technology. M.B. acknowledges funding by the European Research Council (309271-NPCAtlas).	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Antonin W, 2011, NUCLEUS-AUSTIN, V2, P87, DOI 10.4161/nucl.2.2.14637; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; GOLDBERG MW, 1993, J CELL SCI, V106, P261; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kampmann M, 2011, NAT STRUCT MOL BIOL, V18, P643, DOI 10.1038/nsmb.2056; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Sachdev R, 2012, MOL BIOL CELL, V23, P740, DOI 10.1091/mbc.E11-09-0761; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	52	241	244	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1233	1243		10.1016/j.cell.2013.10.055	http://dx.doi.org/10.1016/j.cell.2013.10.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315095	Bronze			2022-12-28	WOS:000328271100009
J	Kulkarni, AD; Jamieson, DJ; Jones, HW; Kissin, DM; Gallo, MF; Macaluso, M; Adashi, EY				Kulkarni, Aniket D.; Jamieson, Denise J.; Jones, Howard W., Jr.; Kissin, Dmitry M.; Gallo, Maria F.; Macaluso, Maurizio; Adashi, Eli Y.			Fertility Treatments and Multiple Births in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED-REPRODUCTIVE-TECHNOLOGY; OUTCOMES; PREGNANCIES; INFERTILITY; EMBRYO; HEALTH; RATES	BackgroundThe advent of fertility treatments has led to an increase in the rate of multiple births in the United States. However, the trends in and magnitude of the contribution of fertility treatments to the increase are uncertain. MethodsWe derived the rates of multiple births after natural conception from data on distributions of all births from 1962 through 1966 (before fertility treatments were available). Publicly available data on births from 1971 through 2011 were used to determine national multiple birth rates, and data on in vitro fertilization (IVF) from 1997 through 2011 were used to estimate the annual proportion of multiple births that were attributable to IVF and to non-IVF fertility treatments, after adjustment for maternal age. Trends in multiple births were examined starting from 1998, the year when clinical practice guidelines for IVF were developed with an aim toward reducing the incidence of multiple births. ResultsWe estimated that by 2011, a total of 36% of twin births and 77% of triplet and higher-order births resulted from conception assisted by fertility treatments. The observed incidence of twin births increased by a factor of 1.9 from 1971 to 2009. The incidence of triplet and higher-order births increased by a factor of 6.7 from 1971 to 1998 and decreased by 29% from 1998 to 2011. This decrease coincided with a 70% reduction in the transfer of three or more embryos during IVF (P<0.001) and a 33% decrease in the proportion of triplet and higher-order births attributable to IVF (P<0.001). ConclusionsOver the past four decades, the increased use of fertility treatments in the United States has been associated with a substantial rise in the rate of multiple births. The rate of triplet and higher-order births has declined over the past decade in the context of a reduction in the transfer of three or more embryos during IVF. (Funded by the Centers for Disease Control and Prevention.)	[Kulkarni, Aniket D.; Jamieson, Denise J.; Kissin, Dmitry M.; Gallo, Maria F.] Ctr Dis Control & Prevent, Womens Hlth & Fertil Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Jones, Howard W., Jr.] Johns Hopkins Sch Med, Baltimore, MD USA; [Jones, Howard W., Jr.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Macaluso, Maurizio] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Medicine; Eastern Virginia Medical School; Cincinnati Children's Hospital Medical Center; Brown University	Kulkarni, AD (corresponding author), Ctr Dis Control & Prevent, Womens Hlth & Fertil Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop F-74, Atlanta, GA 30341 USA.	eof0@cdc.gov	Macaluso, Maurizio/J-2076-2015	Macaluso, Maurizio/0000-0002-2977-9690; Gallo, Maria/0000-0002-9411-4767; Jamieson, Denise/0000-0003-2597-1201	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Centers for Disease Control and Prevention.	Adashi Eli Y, 2003, Reprod Biomed Online, V7, P515; Adashi EY, 2011, JAMA-J AM MED ASSOC, V306, P1135, DOI 10.1001/jama.2011.1249; [Anonymous], 2009, ASSISTED REPRODUCTIV; [Anonymous], 1998, PRACTICE COMMITTEE O; Baerwald AR, 2012, HUM REPROD UPDATE, V18, P73, DOI 10.1093/humupd/dmr039; Barton SE, 2011, HUM REPROD, V26, P2750, DOI 10.1093/humrep/der221; Beemsterboer SN, 2006, HUM REPROD, V21, P1531, DOI 10.1093/humrep/del009; Birmingham AL, 2012, MULTIPLE PREGNANCY A; Blake DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002118.pub3; Bortolus R, 1999, HUM REPROD UPDATE, V5, P179, DOI 10.1093/humupd/5.2.179; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; Cantineau AE, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.PUB2; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P535; Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Division of Reproductive Health, ASSISTED REPRODUCTIV; Centers for Disease Control and Prevention National Center for Health Statistics, DATASETS AND RELATED; Collins John, 2007, Reprod Biomed Online, V15 Suppl 3, P35; Cook JL, 2011, J OBSTET GYNAECOL CA, V33, P609, DOI 10.1016/S1701-2163(16)34909-X; Dickey RP, 2007, FERTIL STERIL, V88, P1554, DOI 10.1016/j.fertnstert.2007.01.112; Dickey RP, 2009, FERTIL STERIL, V91, P1, DOI 10.1016/j.fertnstert.2008.08.008; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Fritz MA, 2009, FERTIL STERIL, V92, P1518, DOI 10.1016/j.fertnstert.2009.08.059; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Jain T, 2005, FERTIL STERIL, V84, P221, DOI 10.1016/j.fertnstert.2005.01.118; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Kissin DM, 2011, JAMA-J AM MED ASSOC, V306, P2564, DOI 10.1001/jama.2011.1843; Kresowik JD, 2011, FERTIL STERIL, V96, P1367, DOI 10.1016/j.fertnstert.2011.09.007; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; MacKay AR, 2006, OBSTET GYNECOL, V107, P563, DOI 10.1097/01.AOG.0000200045.91015.c6; Pfeifer S, 2012, FERTIL STERIL, V97, P835, DOI 10.1016/j.fertnstert.2011.11.050; Pfeifer S, 2012, FERTIL STERIL, V97, P825, DOI 10.1016/j.fertnstert.2011.11.048; Reddy UM, 2005, OBSTET GYNECOL, V105, P593, DOI 10.1097/01.AOG.0000153491.09525.dd; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Ryan GL, 2004, FERTIL STERIL, V81, P500, DOI 10.1016/j.fertnstert.2003.05.035; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Schieve LA, 2009, AM J EPIDEMIOL, V170, P1396, DOI 10.1093/aje/kwp281; Stone J, 2002, AM J OBSTET GYNECOL, V187, P1163, DOI 10.1067/mob.2002.126988; Sunderam Saswati, 2009, Morbidity and Mortality Weekly Report, V58, P1; Sutcliffe AG, 2006, EARLY HUM DEV, V82, P379, DOI 10.1016/j.earlhumdev.2006.03.007; Templeton A, 2004, AM J OBSTET GYNECOL, V190, P894, DOI 10.1016/j.ajog.2004.02.017; Wimalasundera RC, 2010, SEMIN FETAL NEONAT M, V15, P327, DOI 10.1016/j.siny.2010.08.002	41	169	178	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2218	2225		10.1056/NEJMoa1301467	http://dx.doi.org/10.1056/NEJMoa1301467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304051				2022-12-28	WOS:000327801100008
J	Mundell, CG; Kopac, D; Arnold, DM; Steele, IA; Gomboc, A; Kobayashi, S; Harrison, RM; Smith, RJ; Guidorzi, C; Virgili, FJ; Melandri, A; Japelj, J				Mundell, C. G.; Kopac, D.; Arnold, D. M.; Steele, I. A.; Gomboc, A.; Kobayashi, S.; Harrison, R. M.; Smith, R. J.; Guidorzi, C.; Virgili, F. J.; Melandri, A.; Japelj, J.			Highly polarized light from stable ordered magnetic fields in GRB 120308A	NATURE			English	Article							GAMMA-RAY BURSTS; OPTICAL POLARIZATION; AFTERGLOW; EMISSION; SHOCK; RECONNECTION; MODEL; JETS	After the initial burst of gamma-rays that defines a gamma-ray burst (GRB), expanding ejecta collide with the circumburst medium and begin to decelerate at the onset of the afterglow, during which a forward shock travels outwards and a reverse shock propagates backwards into the oncoming collimated flow, or 'jet'(1,2). Light from the reverse shock should be highly polarized if the jet's magnetic field is globally ordered and advected from the central engine(3,4), with a position angle that is predicted to remain stable in magnetized baryonic jet models(5) or vary randomly with time if the field is produced locally by plasma or magnetohydrodynamic instabilities(6,7). Degrees of linear polarization of P approximate to 10 per cent in the optical band have previously been detected in the early afterglow(6,8), but the lack of temporal measurements prevented definitive tests of competing jet models(9-14). Hours to days after the gamma-ray burst, polarization levels are low (P<4 per cent), when emission from the shocked ambient medium dominates(15-17). Here we report the detection of P=28(-4)(+4) per cent in the immediate afterglow of Swift gamma-ray burst GRB 120308A, four minutes after its discovery in the gamma-ray band, decreasing to P = 16(-4)(+5) per cent over the subsequent ten minutes. The polarization position angle remains stable, changing by no more than 15 degrees over this time, with a possible trend suggesting gradual rotation and ruling out plasma or magnetohydrodynamic instabilities. Instead, the polarization properties show that GRBs contain magnetized baryonic jets with large-scale uniform fields that can survive long after the initial explosion.	[Mundell, C. G.; Arnold, D. M.; Steele, I. A.; Kobayashi, S.; Harrison, R. M.; Smith, R. J.; Virgili, F. J.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Kopac, D.; Gomboc, A.; Japelj, J.] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Gomboc, A.] Ctr Excellence SPACE SI, Ljubljana 1000, Slovenia; [Guidorzi, C.] Univ Ferrara, Dept Phys, I-44122 Ferrara, Italy; [Melandri, A.] Brera Astron Observ, INAF, I-23807 Merate, LC, Italy	Liverpool John Moores University; University of Ljubljana; University of Ferrara; Istituto Nazionale Astrofisica (INAF)	Mundell, CG (corresponding author), Liverpool John Moores Univ, Astrophys Res Inst, IC2,Liverpool Sci Pk,146 Brownlow Hill, Liverpool L3 5RF, Merseyside, England.	c.mundell@ljmu.ac.uk		Guidorzi, Cristiano/0000-0001-6869-0835; Melandri, Andrea/0000-0002-2810-2143; Virgili, Fabio/0000-0002-9691-8742	Royal Society; Wolfson Foundation; Science and Technology Facilities Council; Slovenian Research Agency; Centre of Excellence for Space Sciences and Technologies SPACE-SI; European Union; European Regional Development Fund; Republic of Slovenia, Ministry of Education, Science and Sport; STFC [ST/I505821/1, ST/J001465/1, ST/J500732/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J500732/1, ST/J001465/1, ST/I505821/1] Funding Source: researchfish	Royal Society(Royal Society of London); Wolfson Foundation; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence for Space Sciences and Technologies SPACE-SI; European Union(European Commission); European Regional Development Fund(European Commission); Republic of Slovenia, Ministry of Education, Science and Sport; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Liverpool Telescope is operated by Liverpool John Moores University at the Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. C.G.M. acknowledges support from the Royal Society, the Wolfson Foundation and the Science and Technology Facilities Council. A. G. acknowledges funding from the Slovenian Research Agency and from the Centre of Excellence for Space Sciences and Technologies SPACE-SI, an operation partly financed by the European Union, European Regional Development Fund and Republic of Slovenia, Ministry of Education, Science and Sport.	Baumgartner W. H., 2012, GCN CIRC, V13017; Beuermann K, 1999, ASTRON ASTROPHYS, V352, pL26; Bikmaev I., 2012, GCN CIRC, V13030; Clarke D, 2002, ASTRON ASTROPHYS, V383, P360, DOI 10.1051/0004-6361:20011717; Covino S, 1999, ASTRON ASTROPHYS, V348, pL1; Cucchiara A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/154; Granot J, 2003, ASTROPHYS J, V594, pL83, DOI 10.1086/378733; Granot J, 2012, MON NOT R ASTRON SOC, V421, P2467, DOI 10.1111/j.1365-2966.2012.20474.x; Greiner J, 2003, NATURE, V426, P157, DOI 10.1038/nature02077; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; Harrison R, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/101; Komissarov SS, 2012, MON NOT R ASTRON SOC, V422, P326, DOI 10.1111/j.1365-2966.2012.20609.x; Lazzati D, 2004, ASTRON ASTROPHYS, V422, P121, DOI 10.1051/0004-6361:20035951; Lyutikov M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/119; Lyutikov M, 2003, MON NOT R ASTRON SOC, V346, P540, DOI 10.1046/j.1365-2966.2003.07110.x; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Mundell CG, 2007, SCIENCE, V315, P1822, DOI 10.1126/science.1138484; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Steele IA, 2010, PROC SPIE, V7735, DOI 10.1117/12.856842; Steele IA, 2009, NATURE, V462, P767, DOI 10.1038/nature08590; Tchekhovskoy A, 2008, MON NOT R ASTRON SOC, V388, P551, DOI 10.1111/j.1365-2966.2008.13425.x; Uehara T, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/1/L6; Virgili F., 2012, GCN CIRC, V13018; Wiersema K, 2012, MON NOT R ASTRON SOC, V426, P2, DOI 10.1111/j.1365-2966.2012.20943.x; Yonetoku D, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L1; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363; Zhang B, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/90	27	92	93	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					119	+		10.1038/nature12814	http://dx.doi.org/10.1038/nature12814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305162				2022-12-28	WOS:000327851700042
J	Raven, K				Raven, Kathleen			How sexual harassment changed the way I work	NATURE			English	Editorial Material												kathraven@gmail.com							0	0	0	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					9	9		10.1038/504009a	http://dx.doi.org/10.1038/504009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264BK	24305117	Bronze			2022-12-28	WOS:000327851700004
J	Toettcher, JE; Weiner, OD; Lim, WA				Toettcher, Jared E.; Weiner, Orion D.; Lim, Wendell A.			Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module	CELL			English	Article							KINASE PATHWAY; GROWTH-FACTOR; LIVING CELLS; ERK; ACTIVATION; FEEDBACK; NETWORK; COMPLEX; TRANSLOCATION; TRANSDUCTION	The complex, interconnected architecture of cell-signaling networks makes it challenging to disentangle how cells process extracellular information to make decisions. We have developed an optogenetic approach to selectively activate isolated intracellular signaling nodes with light and use this method to follow the flow of information from the signaling protein Ras. By measuring dose and frequency responses in single cells, we characterize the precision, timing, and efficiency with which signals are transmitted from Ras to Erk. Moreover, we elucidate how a single pathway can specify distinct physiological outcomes: by combining distinct temporal patterns of stimulation with proteomic profiling, we identify signaling programs that differentially respond to Ras dynamics, including a paracrine circuit that activates STAT3 only after persistent (>1 hr) Ras activation. Optogenetic stimulation provides a powerful tool for analyzing the intrinsic transmission properties of pathway modules and identifying how they dynamically encode distinct outcomes.	[Toettcher, Jared E.; Lim, Wendell A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Toettcher, Jared E.; Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Toettcher, Jared E.; Weiner, Orion D.; Lim, Wendell A.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiner, OD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	orion.weiner@ucsf.edu; lim@cmp.ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	Cancer Research Institute Postdoctoral Fellowship; NIH [GM096164, GM55040, GM62583, PN2EY016546, P50GM081879, GM084040]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM096164, R01GM062583, P50GM081879, R01GM084040] Funding Source: NIH RePORTER	Cancer Research Institute Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. El-Samad, D. Sivak, and members of the Lim and Weiner labs. This work was supported by a Cancer Research Institute Postdoctoral Fellowship (J.E.T.); NIH grant GM096164 (W.A.L. and O.D.W.); the Howard Hughes Medical Institute and NIH grants GM55040, GM62583, PN2EY016546, and P50GM081879 (W.A.L.); and NIH grant GM084040 (O.D.W.).	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; BISHOP JM, 1994, COLD SPRING HARB SYM, V59, P165, DOI 10.1101/SQB.1994.059.01.020; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Davies MA, 2012, CLIN CANCER RES, V18, P1120, DOI 10.1158/1078-0432.CCR-11-2436; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Oppenheim A.V., 1997, SIGNALS SYSTEMS; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rusnati M, 2009, SENSORS-BASEL, V9, P6471, DOI 10.3390/s90806471; Samoilov M, 2002, J PHYS CHEM A, V106, P10205, DOI 10.1021/jp025846z; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241	46	346	351	3	99	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1422	1434		10.1016/j.cell.2013.11.004	http://dx.doi.org/10.1016/j.cell.2013.11.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315106	Green Accepted, Bronze			2022-12-28	WOS:000328271100023
J	Curtis, JR; Back, AL; Ford, DW; Downey, L; Shannon, SE; Doorenbos, AZ; Kross, EK; Reinke, LF; Feemster, LC; Edlund, B; Arnold, RW; O'Connor, K; Engelberg, RA				Curtis, J. Randall; Back, Anthony L.; Ford, Dee W.; Downey, Lois; Shannon, Sarah E.; Doorenbos, Ardith Z.; Kross, Erin K.; Reinke, Lynn F.; Feemster, Laura C.; Edlund, Barbara; Arnold, Richard W.; O'Connor, Kim; Engelberg, Ruth A.			Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; EARLY PALLIATIVE CARE; CELL LUNG-CANCER; DYING PATIENTS; PHYSICIAN COMMUNICATION; CHRONIC DISEASE; MENTAL-HEALTH; MEDICAL-CARE; END; PERSPECTIVES	IMPORTANCE Communication about end-of-life care is a core clinical skill. Simulation-based training improves skill acquisition, but effects on patient-reported outcomes are unknown. OBJECTIVE To assess the effects of a communication skills intervention for internal medicine and nurse practitioner trainees on patient- and family-reported outcomes. DESIGN, SETTING, AND PARTICIPANTS Randomized trial conducted with 391 internal medicine and 81 nurse practitioner trainees between 2007 and 2013 at the University of Washington and Medical University of South Carolina. INTERVENTION Participants were randomized to an 8-session, simulation-based, communication skills intervention (N = 232) or usual education (N = 240). MAIN OUTCOMES AND MEASURES Primary outcome was patient- reported quality of communication (QOC; mean rating of 17 items rated from 0-10, with 0 = poor and 10 = perfect). Secondary outcomes were patient- reported quality of end-of-life care (QEOLC; mean rating of 26 items rated from 0-10) and depressive symptoms (assessed using the 8-item Personal Health Questionnaire [PHQ-8]; range, 0-24, higher scores worse) and family-reported QOC and QEOLC. Analyses were clustered by trainee. RESULTS There were 1866 patient ratings (44% response) and 936 family ratings (68% response). The intervention was not associated with significant changes in QOC or QEOLC. Mean values for postintervention patient QOC and QEOLC were 6.5 (95% CI, 6.2 to 6.8) and 8.3 (95% CI, 8.1 to 8.5) respectively, compared with 6.3 (95% CI, 6.2 to 6.5) and 8.3 (95% CI, 8.1 to 8.4) for control conditions. After adjustment, comparing intervention with control, there was no significant difference in the QOC score for patients (difference, 0.4 points [95% CI, -0.1 to 0.9]; P = .15) or families (difference, 0.1 [95% CI, -0.8 to 1.0]; P = .81). There was no significant difference in QEOLC score for patients (difference, 0.3 points [95% CI, -0.3 to 0.8]; P = .34) or families (difference, 0.1 [95% CI, -0.7 to 0.8]; P = .88). The intervention was associated with significantly increased depression scores among patients of postintervention trainees (mean score, 10.0 [95% CI, 9.1 to 10.8], compared with 8.8 [95% CI, 8.4 to 9.2]) for control conditions; adjusted model showed an intervention effect of 2.2 (95% CI, 0.6 to 3.8; P = .006). CONCLUSIONS AND RELEVANCE Among internal medicine and nurse practitioner trainees, simulation-based communication training compared with usual education did not improve quality of communication about end-of-life care or quality of end-of-life care but was associated with a small increase in patients' depressive symptoms. These findings raise questions about skills transfer from simulation training to actual patient care and the adequacy of communication skills assessment.	[Curtis, J. Randall; Downey, Lois; Kross, Erin K.; Feemster, Laura C.; Engelberg, Ruth A.] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Dept Med, Seattle, WA 98104 USA; [Curtis, J. Randall; Shannon, Sarah E.; Doorenbos, Ardith Z.; Reinke, Lynn F.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98104 USA; [Back, Anthony L.] Univ Washington, Dept Med, Div Med Oncol, Seattle Canc Care Alliance, Seattle, WA 98104 USA; [Back, Anthony L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Ford, Dee W.] Med Univ S Carolina, Dept Med, Div Pulm & Crit Care, Charleston, SC USA; [Reinke, Lynn F.; Feemster, Laura C.] VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, Seattle, WA USA; [Edlund, Barbara] Med Univ S Carolina, Coll Nursing, Charleston, SC USA; [Arnold, Richard W.; O'Connor, Kim] Univ Washington, Dept Med, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Medical University of South Carolina; University of Washington; University of Washington Seattle	Curtis, JR (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Box 359762, Seattle, WA 98104 USA.	jrc@u.washington.edu		Curtis, J. Randall/0000-0001-9529-845X; Shannon, Sarah E/0000-0001-8492-8743	National Institute of Nursing Research of the National Institutes of Health [R01NR009987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR009987] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by the National Institute of Nursing Research of the National Institutes of Health (R01NR009987).	Alexander SC, 2006, ACAD MED, V81, P1008, DOI 10.1097/01.ACM.0000242580.83851.ad; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bays AM, 2014, J PALLIAT MED, V17, P159, DOI 10.1089/jpm.2013.0318; Carline JD, 2003, J PAIN SYMPTOM MANAG, V25, P19, DOI 10.1016/S0885-3924(02)00537-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayton JM, 2012, J PALLIAT MED, V15, P585, DOI 10.1089/jpm.2011.0292; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; Curtis JR, 2002, CHEST, V122, P356, DOI 10.1378/chest.122.1.356; Curtis JR, 2001, J GEN INTERN MED, V16, P41; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Engelberg R, 2006, J PALLIAT MED, V9, P1086, DOI 10.1089/jpm.2006.9.1086; Engelberg RA, 2010, J PAIN SYMPTOM MANAG, V39, P951, DOI 10.1016/j.jpainsymman.2009.11.313; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fiscella K, 2007, ANN FAM MED, V5, P151, DOI 10.1370/afm.643; Frosch DL, 2010, J AM GERIATR SOC, V58, P1496, DOI 10.1111/j.1532-5415.2010.02980.x; Fryer-Edwards K, 2006, ACAD MED, V81, P638, DOI 10.1097/01.ACM.0000232414.43142.45; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Gysels M, 2005, SUPPORT CARE CANCER, V13, P356, DOI 10.1007/s00520-004-0732-0; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Hopman WM, 2009, CHRONIC DIS CAN, V29, P108; Jackson VA, 2011, J PALLIAT MED, V14, P775, DOI 10.1089/jpm.2010.0493; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2003, PSYCHOSOM MED, V65, P764, DOI 10.1097/01.PSY.0000079379.39918.17; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McBurney CR, 2002, PHARMACOTHERAPY, V22, P1616, DOI 10.1592/phco.22.17.1616.34121; Reeder BA, 2008, J PHYS ACT HEALTH, V5, P74, DOI 10.1123/jpah.5.1.74; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Shilling V, 2003, PSYCHO-ONCOL, V12, P599, DOI 10.1002/pon.731; Szmuilowicz E, 2012, J PALLIAT MED, V15, P768, DOI 10.1089/jpm.2011.0446; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wenrich MD, 2003, J PAIN SYMPTOM MANAG, V25, P236, DOI 10.1016/S0885-3924(02)00694-2; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	41	274	278	7	102	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2271	2281		10.1001/jama.2013.282081	http://dx.doi.org/10.1001/jama.2013.282081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	262OV	24302090	Green Accepted, Bronze			2022-12-28	WOS:000327746300012
J	Haist, SA; Katsufrakis, PJ; Dillon, GF				Haist, Steven A.; Katsufrakis, Peter J.; Dillon, Gerard F.			The Evolution of the United States Medical Licensing Examination (USMLE) Enhancing Assessment of Practice-Related Competencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIMULATION		[Haist, Steven A.; Katsufrakis, Peter J.; Dillon, Gerard F.] Natl Board Med Examiners, Philadelphia, PA 19104 USA		Haist, SA (corresponding author), Natl Board Med Examiners, Test Dev Serv, 3750 Market St, Philadelphia, PA 19104 USA.	shaist@nbme.org						ANDERSON MB, 1994, TEACH LEARN MED, V6, P15, DOI DOI 10.1080/10401339409539637; Clauser B. E., 2006, ED MEASUREMENT, P701; Cook DA, 2013, ACAD MED, V88, P872, DOI 10.1097/ACM.0b013e31828ffdcf; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Raymond MR, 2011, ACAD MED, V86, pS60, DOI 10.1097/ACM.0b013e31822a70ff; Rothman A, 2002, INT HDB RES MED ED, P613; Spencer AL, 2008, ACAD MED, V83, P662, DOI 10.1097/ACM.0b013e318178356b	7	26	29	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2245	2246		10.1001/jama.2013.282328	http://dx.doi.org/10.1001/jama.2013.282328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302081				2022-12-28	WOS:000327746300003
J	Jakes, AD; Bhandari, S				Jakes, Adam D.; Bhandari, Sunil			RATIONAL TESTING Investigating polyuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; PRIMARY-CARE; POPULATION; PREVALENCE		[Jakes, Adam D.] Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England; [Bhandari, Sunil] Hull & East Yorkshire Hosp NHS Trust, Renal Unit, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bhandari, Sunil] Hull York Med Sch, Kingston Upon Hull HU3 2JZ, Yorks, England	University of Leeds; University of Hull; University of York - UK	Bhandari, S (corresponding author), Hull & East Yorkshire Hosp NHS Trust, Renal Unit, Kingston Upon Hull HU3 2JZ, N Humberside, England.	Sunil.bhandari@hey.nhs.uk		bhandari, sunil/0000-0002-0996-9622				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Bayliss P., 1993, MED INT, V2, P189; Car J, 2006, BMJ-BRIT MED J, V332, P94, DOI 10.1136/bmj.332.7533.94; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Diabetes UK, 2012, DIAB UK 2012 APR 201; Dundas Brian, 2007, Curr Psychiatry Rep, V9, P236, DOI 10.1007/s11920-007-0025-7; Ertugrul DT, 2008, J NATL MED ASSOC, V100, P401, DOI 10.1016/S0027-9684(15)31272-4; Frolich AF, 1998, DAN MED BULL, V45, P436; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Koutkia P, 2001, NEW ENGL J MED, V345, P66, DOI 10.1056/NEJM200107053450115; McKeigue PM, 2000, LANCET, V355, P486; ROY D, 1987, J AM COLL CARDIOL, V9, P509, DOI 10.1016/S0735-1097(87)80042-6; Saborio P, 2000, Pediatr Rev, V21, P122, DOI 10.1542/pir.21-4-122; Silverberg SJ, 2008, PRIMER METABOLIC BON, P302; St John A, 2006, AM J CLIN PATHOL, V126, P428, DOI 10.1309/C69RW1BT7E4QAFPV; World Health Organization, 2011, US GLYC HAEM HBA1C D	17	0	1	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f6772	10.1136/bmj.f6772	http://dx.doi.org/10.1136/bmj.f6772			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297973				2022-12-28	WOS:000328146700001
J	Liao, JM				Liao, Joshua M.			Eulogy	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Dept Internal Med, Brigham & Womens Hosp, Boston, MA 02467 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liao, JM (corresponding author), Harvard Univ, Sch Med, Dept Internal Med, Brigham & Womens Hosp, Boston, MA 02467 USA.	jmliao@partners.org							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1775	1776		10.1016/S0140-6736(13)62537-4	http://dx.doi.org/10.1016/S0140-6736(13)62537-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24298610				2022-12-28	WOS:000327540700015
J	Wellings, K; Jones, KG; Mercer, CH; Tanton, C; Clifton, S; Datta, J; Copas, AJ; Erens, B; Gibson, LJ; Macdowall, W; Sonnenberg, P; Phelps, A; Johnson, AM				Wellings, Kaye; Jones, Kyle G.; Mercer, Catherine H.; Tanton, Clare; Clifton, Soazig; Datta, Jessica; Copas, Andrew J.; Erens, Bob; Gibson, Lorna J.; Macdowall, Wendy; Sonnenberg, Pam; Phelps, Andrew; Johnson, Anne M.			The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	LANCET			English	Article							UNINTENDED PREGNANCY; WOMEN; CONTRACEPTION; FERTILITY; INTENTION; ABORTION; DEPRESSION; CATEGORIES; BIRTH; RATES	Background Unplanned pregnancy is a key public health indicator. We describe the prevalence of unplanned pregnancy, and associated factors, in a general population sample in Britain (England, Scotland, and Wales). Method We did a probability sample survey, the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), of 15 162 men and women aged 16-74 years in Britain, including 5686 women of child-bearing age (16-44 years) who were included in the pregnancy analysis, between Sept 6, 2010, and Aug 31, 2012. We describe the planning status of pregnancies with known outcomes in the past year, and report the annual population prevalence of unplanned pregnancy, using a validated, multicriteria, multi-outcome measure (the London Measure of Unplanned Pregnancy). We set the findings in the context of secular trends in reproductive health-related events, and patterns across the life course. Findings 9.7% of women aged 16-44 years had pregnancies with known outcome in the year before interview, of which 16.2% (95% CI 13.1-19.9) scored as unplanned, 29.0% (25.2-33.2) as ambivalent, and 54.8% (50.3-59.2) as planned, giving an annual prevalence estimate for unplanned pregnancy of 1.5% (1.2-1.9). Pregnancies in women aged 16-19 years were most commonly unplanned (45.2% [30.8-60.5]). However, most unplanned pregnancies were in women aged 20-34 years (62.4% [50.2-73.2]). Factors strongly associated with unplanned pregnancy were first sexual intercourse before 16 years of age (age-adjusted odds ratio 2.85 [95% CI 1.77-4.57], current smoking (2.47 [1.46-4.18]), recent use of drugs other than cannabis (3.41 [1.64-7.11]), and lower educational attainment. Unplanned pregnancy was also associated with lack of sexual competence at first sexual intercourse (1.90 [1.14-3.08]), reporting higher frequency of sex (2.11 [1.25-3.57] for five or more times in the past 4 weeks), receiving sex education mainly from a non-school-based source (1.84 [1.12-3.00]), and current depression (1.96 [1.10-3.47]). Interpretation The increasing intervals between first sexual intercourse, cohabitation, and childbearing means that, on average, women in Britain spend about 30 years of their life needing to avert an unplanned pregnancy. Our data off er scope for primary prevention aimed at reducing the rate of unplanned conceptions, and secondary prevention aimed at modification of health behaviours and health disorders in unplanned pregnancy that might be harmful for mother and child.	[Wellings, Kaye; Datta, Jessica; Erens, Bob; Gibson, Lorna J.; Macdowall, Wendy] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Jones, Kyle G.; Mercer, Catherine H.; Tanton, Clare; Clifton, Soazig; Copas, Andrew J.; Erens, Bob; Sonnenberg, Pam; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Clifton, Soazig; Erens, Bob; Phelps, Andrew] NatCen Social Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), Ctr Sexual & Reprod Hlth Res, Dept Publ Hlth & Policy, 15 Tavistock Pl, London WC1H 9SH, England.	kaye.wellings@lshtm.ac.uk	Weatherburn, Peter/AAC-2701-2019	Johnson, Anne/0000-0003-1330-7100; Clifton, Soazig/0000-0002-4171-0805; Erens, Robert/0000-0002-3054-504X; Tanton, Clare/0000-0002-4612-1858; Macdowall, Wendy/0000-0001-5868-8336; Mercer, Catherine/0000-0002-4220-5034; Jones, Kyle/0000-0002-7127-1612; Copas, Andrew/0000-0001-8968-5963; Sonnenberg, Pam/0000-0002-1067-1583; Erens, Bob/0000-0002-4430-954X	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [MET-11-19-101, NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Cameron ST, 2013, CONTRACEPTION, V88, P128, DOI 10.1016/j.contraception.2012.10.032; Campbell A A, 2000, Matern Child Health J, V4, P163, DOI 10.1023/A:1009519329226; Carson C, 2013, FERTIL STERIL, V99, P456, DOI 10.1016/j.fertnstert.2012.10.029; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2013, CONTRACEPTION, V87, P126, DOI 10.1016/j.contraception.2012.12.005; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Font-Ribera L, 2008, J URBAN HEALTH, V85, P125, DOI 10.1007/s11524-007-9233-z; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gipson JD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4996; Goto A, 2002, SOC SCI MED, V54, P1065, DOI 10.1016/S0277-9536(01)00081-8; Hale GE, 2009, BEST PRACT RES CL OB, V23, P7, DOI 10.1016/j.bpobgyn.2008.10.001; Harrison Ayanna T., 2012, Morbidity and Mortality Weekly Report, V61, P25; Joyce T, 2000, Matern Child Health J, V4, P171, DOI 10.1023/A:1009571313297; Kavanaugh ML, 2009, PERSPECT SEX REPRO H, V41, P238, DOI 10.1363/4123809; Krause EL, 2012, MED ANTHROPOL Q, V26, P361, DOI 10.1111/j.1548-1387.2012.01223.x; Kuroki LM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.049; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Lanzi RG, 2009, J CHILD ADOL PS NURS, V22, P194, DOI 10.1111/j.1744-6171.2009.00199.x; Luker KC, 1999, FAM PLANN PERSPECT, V31, P248, DOI 10.2307/2991574; Mercer CH, 2013, LANCET; Miller WB, 2013, POP STUD-J DEMOG, V67, P25, DOI 10.1080/00324728.2012.738823; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Mosher WD, 2012, INTENDED UNINTENDED, V55; Office for National Statistics, 2010, STAT OCC CLASS 2010, V1-3; Oringanje C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005215.pub2; Payne R. A., 2012, Health Statistics Quarterly, P22; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6763; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1363/3509403; Santelli JS, 2009, STUD FAMILY PLANN, V40, P87, DOI 10.1111/j.1728-4465.2009.00192.x; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Schwartz A, 2010, WOMEN HEALTH ISS, V20, P371, DOI 10.1016/j.whi.2010.06.005; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Speizer IS, 2004, PERSPECT SEX REPRO H, V36, P198; United Nations Population Fund, STAT WORLD POP 1997; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4	45	252	257	2	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1807	1816		10.1016/S0140-6736(13)62071-1	http://dx.doi.org/10.1016/S0140-6736(13)62071-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286786	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000327540700025
J	Hertzfeld, HR; Pace, SN				Hertzfeld, Henry R.; Pace, Scott N.			International Cooperation on Human Lunar Heritage	SCIENCE			English	Editorial Material									[Hertzfeld, Henry R.; Pace, Scott N.] George Washington Univ, Elliott Sch Int Affairs, Inst Space Policy, Washington, DC 20052 USA	George Washington University	Hertzfeld, HR (corresponding author), George Washington Univ, Elliott Sch Int Affairs, Inst Space Policy, Washington, DC 20052 USA.	hrh@gwu.edu							0	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1049	1050		10.1126/science.1243607	http://dx.doi.org/10.1126/science.1243607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288319				2022-12-28	WOS:000327518600041
J	Kirsner, RS; Margolis, DJ				Kirsner, Robert S.; Margolis, David J.			Stockings before bandages: an option for venous ulcers	LANCET			English	Editorial Material							LEG ULCERS		[Kirsner, Robert S.] Univ Miami, Leonard M Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Kirsner, Robert S.] Univ Miami, Leonard M Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Margolis, David J.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Margolis, David J.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kirsner, RS (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	rkirsner@med.miami.edu						Ashby RL, 2014, LANCET, V383, P871, DOI 10.1016/S0140-6736(13)62368-5; Herschthal Jordana, 2008, Surg Technol Int, V17, P77; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Meissner MH, 2007, J VASC SURG, V46, p4S, DOI 10.1016/j.jvs.2007.09.043; O'Meara S, 2009, COCHRANE DB SYST REV, V1, P1; Purwins S, 2010, INT WOUND J, V7, P97, DOI 10.1111/j.1742-481X.2010.00660.x; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.111633; Gonzalez-Consuegra RV, 2011, J ADV NURS, V67, P926, DOI 10.1111/j.1365-2648.2010.05568.x; Yim E, 2013, JAMA DERMATOL, DOI [10.1001/jamadermatol.2013.6723, DOI 10.1001/JAMADERMAT0L.2013.6723]	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					850	851		10.1016/S0140-6736(13)62557-X	http://dx.doi.org/10.1016/S0140-6736(13)62557-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3FC	24315523				2022-12-28	WOS:000332399500006
J	Hagen, S; Stark, D; Glazener, C; Dickson, S; Barry, S; Elders, A; Frawley, H; Galea, MP; Logan, J; McDonald, A; McPherson, G; Moore, KH; Norrie, J; Walker, A; Wilson, D				Hagen, Suzanne; Stark, Diane; Glazener, Cathryn; Dickson, Sylvia; Barry, Sarah; Elders, Andrew; Frawley, Helena; Galea, Mary P.; Logan, Janet; McDonald, Alison; McPherson, Gladys; Moore, Kate H.; Norrie, John; Walker, Andrew; Wilson, Don		POPPY Trial Collaborators	Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial	LANCET			English	Article							SHORT-FORM; SYMPTOMS	Background Pelvic organ prolapse is common and is strongly associated with childbirth and increasing age. Women with prolapse are often advised to do pelvic floor muscle exercises, but evidence supporting the benefits of such exercises is scarce. We aimed to establish the effectiveness of one-to-one individualised pelvic floor muscle training for reducing prolapse symptoms. Methods We did a parallel-group, multicentre, randomised controlled trial at 23 centres in the UK, one in New Zealand, and one in Australia, between June 22, 2007, and April 9, 2010. Female outpatients with newly-diagnosed, symptomatic stage I, II, or III prolapse were randomly assigned (1:1), by remote computer allocation with minimsation, to receive an individualised programme of pelvic floor muscle training or a prolapse lifestyle advice leaflet and no muscle training (control group). Outcome assessors, and investigators who were gynaecologists at trial sites, were masked to group allocation; the statistician was masked until after data analysis. Our primary endpoint was participants' self-report of prolapse symptoms at 12 months. Analysis was by intention-to-treat analysis. This trial is registered, number ISRCTN35911035. Findings 447 eligible patients were randomised to the intervention group (n=225) or the control group (n=222). 377 (84%) participants completed follow-up for questionnaires at 6 months and 295 (66%) for questionnaires at 12 months. Women in the intervention group reported fewer prolapse symptoms (ie, a significantly greater reduction in the pelvic organ prolapse symptom score [POP-SS]) at 12 months than those in the control group (mean reduction in POP-SS from baseline 3.77 [SD 5.62] vs 2.09 [5.39]; adjusted difference 1.52, 95% CI 0.46-2.59; p=0.0053). Findings were robust to missing data. Eight adverse events (six vaginal symptoms, one case of back pain, and one case of abdominal pain) and one unexpected serious adverse event, all in women from the intervention group, were regarded as unrelated to the intervention or to participation in the study. Interpretation One-to-one pelvic floor muscle training for prolapse is effective for improvement of prolapse symptoms. Long-term benefits should be investigated, as should the effects in specific subgroups.	[Hagen, Suzanne; Dickson, Sylvia; Logan, Janet] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland; [Stark, Diane] Leicester Royal Infirm, Clin 2, Leicester, Leics, England; [Glazener, Cathryn; Elders, Andrew] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [McDonald, Alison; McPherson, Gladys; Norrie, John] Univ Aberdeen, Hlth Serv Res Unit, Ctr Healthcare Randomised Trials, Aberdeen, Scotland; [Barry, Sarah; Walker, Andrew] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Frawley, Helena] Univ Melbourne, Melbourne Sch Hlth Sci, Dept Physiotherapy, Melbourne, Vic 3010, Australia; [Galea, Mary P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Moore, Kate H.] St George Hosp, Dept Urogynaecol, Pelv Floor & Bladder Unit, Kogarah, NSW, Australia; [Wilson, Don] Dunedin Sch Med, Dept Obstet & Gynaecol, Dunedin, New Zealand	Glasgow Caledonian University; University of Leicester; University of Aberdeen; University of Aberdeen; University of Glasgow; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; St George Hospital; University of Otago	Hagen, S (corresponding author), Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland.	s.hagen@gcu.ac.uk	Galea, Mary/F-4242-2010; Frawley, Helena C/B-9840-2017; Walker, Andrew/ABF-6771-2020; Elders, Andrew/N-4195-2015	Galea, Mary/0000-0003-0045-7978; Frawley, Helena C/0000-0002-7126-6979; Elders, Andrew/0000-0003-4172-4702; Moore, Kate/0000-0001-6947-9839; Barry, Sarah J.E./0000-0003-3039-8729; HAGEN, SUZANNE/0000-0002-9741-9160	Chief Scientist Office of the Scottish Government Health and Social Care Directorates; New Zealand Lottery Board; National Health and Medical Research Council (Australia); Chief Scientist Office (CSO) of the Scottish Government [CZH/4/377]; CSO; Chief Scientist Office [NMAHP2, HSRU1, CZH/4/377] Funding Source: researchfish	Chief Scientist Office of the Scottish Government Health and Social Care Directorates; New Zealand Lottery Board; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Chief Scientist Office (CSO) of the Scottish Government; CSO; Chief Scientist Office	Chief Scientist Office of the Scottish Government Health and Social Care Directorates, New Zealand Lottery Board, and National Health and Medical Research Council (Australia).; The UK component of the trial was funded by the Chief Scientist Office (CSO) of the Scottish Government (project number CZH/4/377) and is summarised online. The Nursing, Midwifery and Allied Health Professions Research Unit and the Health Services Research Unit are also funded by the CSO. The views expressed in this publication are those of the investigators and not necessarily those of the CSO. We also acknowledge funding for the international components from the National Health and Medical Research Council (Australia) and the New Zealand Lottery Board. We accept full responsibility for the research. We thank all the women who willingly participated in the POPPY trial and completed their questionnaires and attended physiotherapy and gynaecology appointments; the staff at each of our centres for recruiting, motivating and treating our participants; the POPPY trial office staff in the UK (Kim Stewart and Lucy Pyart); those who administered the trial in Dunedin (Gaye Ellis) and Sydney (Wendy Allen) and members of the trial steering committee and data monitoring committee for giving their time in advising the trial team throughout the work.	Abrams P, 2013, INCONTINENCE; Allahdin S, 2008, J OBSTET GYNAECOL, V28, P427, DOI 10.1080/01443610802150077; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Bo K., 1995, INT UROGYNECOL J, V6, P282, DOI [10.1007/BF01901527, DOI 10.1007/BF01901527]; Bradley CS, 2007, OBSTET GYNECOL, V109, P848, DOI 10.1097/01.AOG.0000255977.91296.5d; Braekken IH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.037; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; C&G Medicare, 2010, CLUB PESS; Curtis L., 2009, UNIT COSTS HLTH SOCI; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dumoulin C, 2010, COCHRANE DB SYST REV, V1; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Ghroubi S., 2008, Annales de Readaptation et de Medecine Physique, V51, P96, DOI 10.1016/j.annrmp.2007.11.002; Hagen S, 2010, NEUROUROL URODYNAM, V29, P1055; Hagen S, 2009, BJOG-INT J OBSTET GY, V116, P25, DOI 10.1111/j.1471-0528.2008.01903.x; Hagen S, 2004, PHYSIOTHERAPY, V90, P19; Hagen S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003882.pub4; Hagen S, 2009, INT UROGYNECOL J, V20, P45, DOI 10.1007/s00192-008-0726-4; Handa VL, 2004, AM J OBSTET GYNECOL, V190, P27, DOI 10.1016/j.ajog.2003.07.017; Health and Social Care Information Centre, 2011, HOSP EP STAT ADM PAT; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Information Services Division, 2010, SCOTT HLTH SERV COST; Joint Formulary Committee, 2011, BRIT NATL FORMULARY; Kashyap R, 2013, INT J GYNECOL OBSTET, V121, P69, DOI 10.1016/j.ijgo.2012.11.012; Laycock J., 2001, PHYSIOTHERAPY, V87, P631, DOI [10.1016/s0031-9406(05)61108-x, DOI 10.1016/S0031-9406(05)61108-X]; Miedel A, 2011, INT UROGYNECOL J, V22, P461, DOI 10.1007/s00192-010-1305-z; Miedel A, 2009, OBSTET GYNECOL, V113, P1089, DOI 10.1097/AOG.0b013e3181a11a85; Mouritsen L, 2003, INT UROGYNECOL J PEL, V14, P122, DOI 10.1007/s00192-002-1024-1; National Institute for Health & Clinical Excellence, 2006, UR INC MAN UR INC WO; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Piya-Anant Manee, 2003, Journal of the Medical Association of Thailand, V86, P509; R Development Core Team, 2012, R LANG ENV STAT COMP; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; SLIEKERTENHOVE MC, 2009, AM J OBSTET GYNECOL, V200; Stupp L, 2011, INT UROGYNECOL J, V22, P1233, DOI 10.1007/s00192-011-1428-x; Su YS, 2011, J STAT SOFTW, V45, P1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wu JM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.046	39	123	134	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					796	806		10.1016/S0140-6736(13)61977-7	http://dx.doi.org/10.1016/S0140-6736(13)61977-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24290404	Green Accepted, Green Submitted			2022-12-28	WOS:000332398700026
J	Trobaugh, DW; Gardner, CL; Sun, CQ; Haddow, AD; Wang, EY; Chapnik, E; Mildner, A; Weaver, SC; Ryman, KD; Klimstra, WB				Trobaugh, Derek W.; Gardner, Christina L.; Sun, Chengqun; Haddow, Andrew D.; Wang, Eryu; Chapnik, Elik; Mildner, Alexander; Weaver, Scott C.; Ryman, Kate D.; Klimstra, William B.			RNA viruses can hijack vertebrate microRNAs to suppress innate immunity	NATURE			English	Article							EASTERN EQUINE ENCEPHALITIS; INTERFERON SENSITIVITY; MESSENGER-RNA; PROTEIN; REPLICATION; EMERGENCE; INFECTION	Currently, there is little evidence for a notable role of the vertebrate microRNA (miRNA) system in the pathogenesis of RNA viruses(1). This is primarily attributed to the ease with which these viruses mutate to disrupt recognition and growth suppression by host miRNAs(2,3). Here we report that the haematopoietic-cell-specific miRNA miR-142-3p potently restricts the replication of the mosquito-borne North American eastern equine encephalitis virus in myeloid-lineage cells by binding to sites in the 3' non-translated region of its RNA genome. However, by limiting myeloid cell tropism and consequent innate immunity induction, this restriction directly promotes neurologic disease manifestations characteristic of eastern equine encephalitis virus infection in humans. Furthermore, the region containing the miR-142-3p binding sites is essential for efficient virus infection of mosquito vectors. We propose that RNA viruses can adapt to use antiviral properties of vertebrate miRNAs to limit replication in particular cell types and that this restriction can lead to exacerbation of disease severity.	[Trobaugh, Derek W.; Gardner, Christina L.; Sun, Chengqun; Ryman, Kate D.; Klimstra, William B.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Trobaugh, Derek W.; Gardner, Christina L.; Sun, Chengqun; Ryman, Kate D.; Klimstra, William B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Haddow, Andrew D.; Wang, Eryu; Weaver, Scott C.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Haddow, Andrew D.; Wang, Eryu; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Chapnik, Elik] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Mildner, Alexander] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Weizmann Institute of Science; Weizmann Institute of Science	Klimstra, WB (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.	klimstra@pitt.edu	mildner, alexander/AFK-2161-2022; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022; Trobaugh, Derek W./H-8044-2019; Weaver, Scott C/D-6490-2011; Mildner, Alexander/ABG-6122-2020; Haddow, Andrew/C-5902-2008	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Trobaugh, Derek W./0000-0002-7312-0260; Weaver, Scott C/0000-0001-8016-8556; Haddow, Andrew/0000-0002-8957-2608	National Institutes of Health (NIH) [AI049820-10, AI060525-08, AI083383, AI095436]; National Institute of Allergy and Infectious Diseases through the Pacific Northwest Regional Centers for Excellence in Biodefense and Emerging Infectious Diseases Research [U54 AI081680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049820, U54AI081680, T32AI060525, R01AI095436, R01AI083383] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases through the Pacific Northwest Regional Centers for Excellence in Biodefense and Emerging Infectious Diseases Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Dunn for excellent technical support, and M. Diamond for reading of the manuscript. This work was supported by National Institutes of Health (NIH) training grants AI049820-10 and AI060525-08 (D. W. T.), research grants AI083383 and AI095436 (W. B. K.) and a Project Grant (K. D. R.) from National Institute of Allergy and Infectious Diseases through the Pacific Northwest Regional Centers for Excellence in Biodefense and Emerging Infectious Diseases Research (U54 AI081680). The views expressed are those of the authors and do not necessarily represent the views of the NIH.	Aguilar PV, 2008, J VIROL, V82, P4920, DOI 10.1128/JVI.02514-07; Anishchenko M, 2004, J VIROL, V78, P1, DOI 10.1128/JVI.78.1.1-8.2004; Armstrong PM, 2013, NEW ENGL J MED, V368, P1670, DOI 10.1056/NEJMp1213696; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; Griffin D, 2006, FIELDS VIROLOGY, P1023; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Silverman MA, 2013, EMERG INFECT DIS, V19, P194, DOI 10.3201/eid1902.120039; Sun C., 2013, J VIROL; Tesfay MZ, 2008, J VIROL, V82, P2620, DOI 10.1128/JVI.01784-07; Thomas JM, 2003, J VIROL, V77, P5598, DOI 10.1128/JVI.77.10.5598-5606.2003; Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12	31	141	144	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					245	+		10.1038/nature12869	http://dx.doi.org/10.1038/nature12869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24352241	Green Accepted			2022-12-28	WOS:000331107700043
J	Hanahan, D				Hanahan, Douglas			Rethinking the war on cancer	LANCET			English	Article							DRUG-RESISTANCE; THERAPY; CELLS	Some 40 years ago a metaphor was posed that cancer was such an insidious adversary that a declaration of war on the disease was justified. Although this statement was a useful inspiration for enlistment of resources, despite extraordinary progress in our understanding of disease pathogenesis, in most cases and for most forms of cancer this war has not been won. A second metaphor was about magic bullets-targeted therapies based on knowledge of mechanisms that were envisaged to strike with devastating consequences for the disease. The reality, however, is that targeted therapies are generally not curative or even enduringly effective, because of the adaptive and evasive resistance strategies developed by cancers under attack. In this Series paper, I suggest that, much like in modern warfare, the war on cancer needs to have a battlespace vision.	Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hanahan, D (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, SV 2816 Batiment SV,Stn 19, CH-1015 Lausanne, Switzerland.	dh@epfl.ch	damiani, chiara/R-4256-2016					Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; De Palma M, 2012, MOL ONCOL, V6, P111, DOI 10.1016/j.molonc.2012.01.011; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Johnson S. E., 1995, DOMINANT BATTLESPACE; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Leaf C, 2004, FORTUNE, V149, P76; Leaf C., 2013, THE TRUTH IN SMALL D; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Rehman FL, 2010, NAT REV CLIN ONCOL, V7, P718, DOI 10.1038/nrclinonc.2010.172; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Roulston A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004113; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Varmus H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005899; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Vogelstein B, 2012, SCI TRANSL MED, V4; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	29	165	173	2	91	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					558	563		10.1016/S0140-6736(13)62226-6	http://dx.doi.org/10.1016/S0140-6736(13)62226-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KH	24351321				2022-12-28	WOS:000331136400032
J	Schwefel, D; Groom, HCT; Boucherit, VC; Christodoulou, E; Walker, PA; Stoye, JP; Bishop, KN; Taylor, IA				Schwefel, David; Groom, Harriet C. T.; Boucherit, Virginie C.; Christodoulou, Evangelos; Walker, Philip A.; Stoye, Jonathan P.; Bishop, Kate N.; Taylor, Ian A.			Structural basis of lentiviral subversion of a cellular protein degradation pathway	NATURE			English	Article							RESTRICTION FACTOR SAMHD1; E3 UBIQUITIN LIGASE; HIV-1 INFECTION; VIRUS; TRANSDUCTION; ARCHITECTURE; INHIBITION; NUCLEAR; USURPS; CYCLE	Lentiviruses contain accessory genes that have evolved to counteract the effects of host cellular defence proteins that inhibit productive infection. One such restriction factor, SAMHD1, inhibits human immunodeficiency virus (HIV)-1 infection ofmyeloid-lineage cells(1,2) as well as resting CD4(+) T cells(3,4) by reducing the cellular deoxynucleoside 5'-triphosphate (dNTP) concentration to a level at which the viral reverse transcriptase cannot function(5,6). In other lentiviruses, including HIV-2 and related simian immunodeficiency viruses (SIVs), SAMHD1 restriction is overcome by the action of viral accessory protein x (Vpx) or the related viral protein r (Vpr) that target and recruit SAMHD1 for proteasomal degradation(7,8). The molecular mechanism by which these viral proteins are able to usurp the host cell's ubiquitination machinery to destroy the cell's protection against these viruses has not been defined. Here we present the crystal structure of a ternary complex of Vpx with the human E3 ligase substrate adaptor DCAF1 and the carboxy-terminal region of human SAMHD1. Vpx is made up of a three-helical bundle stabilized by a zinc finger motif, and wraps tightly around the disc-shaped DCAF1 molecule to present a new molecular surface. This adapted surface is then able to recruit SAMHD1 via its C terminus, making it a competent substrate for the E3 ligase to mark for proteasomal degradation. The structure reported here provides a molecular description of how a lentiviral accessory protein is able to subvert the cell's normal protein degradation pathway to inactivate the cellular viral defence system.	[Schwefel, David; Christodoulou, Evangelos; Walker, Philip A.; Taylor, Ian A.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Groom, Harriet C. T.; Boucherit, Virginie C.; Stoye, Jonathan P.; Bishop, Kate N.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Taylor, IA (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, Mill Hill, London NW7 1AA, England.	itaylor@nimr.mrc.ac.uk		Christodoulou, Evangelos/0000-0001-8464-1558; Stoye, Jonathan/0000-0003-3377-323X	Diamond Light Source for synchrotron access [7707]; UK Medical Research Council [U117565647, U117592729, U117512710]; Wellcome Trust [084955]; EMBO; European Commission [GA-2010-267146]; MRC [MC_U117565647, MC_U117512710, MC_U117592729] Funding Source: UKRI; Medical Research Council [MC_U117565647, MC_U117512710, MC_U117592729] Funding Source: researchfish	Diamond Light Source for synchrotron access; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Haire and R. Ogrodowicz for help with crystallization, I. Jones for the provision of the modified A. californica baculovirus bacmid, BAC10:1629<INF>KO</INF>, S. Smerdon and S. Gamblin for comments on the manuscript. We gratefully acknowledge the Diamond Light Source for synchrotron access (grant no. 7707). This work was supported by the UK Medical Research Council, file references U117565647 (I. A. T.), U117592729 (K.N.B.) and U117512710 (J.P.S.); the Wellcome Trust, ref. 084955 (K. N. B.); and by an EMBO long-term fellowship co-funded by the European Commission Marie Curie Actions (EMBOCOFUND2010, GA-2010-267146) (D.S.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barnitz RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024924; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	42	85	88	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					234	+		10.1038/nature12815	http://dx.doi.org/10.1038/nature12815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24336198	Green Accepted			2022-12-28	WOS:000329441500042
J	Talin, AA; Centrone, A; Ford, AC; Foster, ME; Stavila, V; Haney, P; Kinney, RA; Szalai, V; El Gabaly, F; Yoon, HP; Leonard, F; Allendorf, MD				Talin, A. Alec; Centrone, Andrea; Ford, Alexandra C.; Foster, Michael E.; Stavila, Vitalie; Haney, Paul; Kinney, R. Adam; Szalai, Veronika; El Gabaly, Farid; Yoon, Heayoung P.; Leonard, Francois; Allendorf, Mark D.			Tunable Electrical Conductivity in Metal-Organic Framework Thin-Film Devices	SCIENCE			English	Article							CHARGE-TRANSFER; MECHANISM	We report a strategy for realizing tunable electrical conductivity in metal-organic frameworks (MOFs) in which the nanopores are infiltrated with redox-active, conjugated guest molecules. This approach is demonstrated using thin-film devices of the MOF Cu-3(BTC)(2) (also known as HKUST-1; BTC, benzene-1,3,5-tricarboxylic acid) infiltrated with the molecule 7,7,8,8-tetracyanoquinododimethane (TCNQ). Tunable, air-stable electrical conductivity over six orders of magnitude is achieved, with values as high as 7 siemens per meter. Spectroscopic data and first-principles modeling suggest that the conductivity arises from TCNQ guest molecules bridging the binuclear copper paddlewheels in the framework, leading to strong electronic coupling between the dimeric Cu subunits. These ohmically conducting porous MOFs could have applications in conformal electronic devices, reconfigurable electronics, and sensors.	[Talin, A. Alec; Ford, Alexandra C.; Foster, Michael E.; Stavila, Vitalie; El Gabaly, Farid; Leonard, Francois; Allendorf, Mark D.] Sandia Natl Labs, Livermore, CA 94551 USA; [Talin, A. Alec; Centrone, Andrea; Haney, Paul; Kinney, R. Adam; Szalai, Veronika; Yoon, Heayoung P.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Centrone, Andrea; Kinney, R. Adam; Yoon, Heayoung P.] Univ Maryland, Maryland Nanoctr, College Pk, MD 20742 USA	United States Department of Energy (DOE); Sandia National Laboratories; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Talin, AA (corresponding author), Sandia Natl Labs, Livermore, CA 94551 USA.	aatalin@sandia.gov; mdallen@sandia.gov	Centrone, Andrea/H-5541-2013; Stavila, Vitalie/B-6464-2008	Centrone, Andrea/0000-0002-2919-3366; Stavila, Vitalie/0000-0003-0981-0432; Szalai, Veronika/0000-0002-1115-2849	Laboratory Directed Research and Development Program at Sandia National Laboratories; U.S. Department of Energy (DOE) SunShot Program; U.S. DOE National Nuclear Security Administration [DE-AC04-94AL85000]; Science of Precision Multifunctional Nanostructures for Electrical Energy Storage (NEES), an Energy Frontier Research Center; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DESC0001160]; Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE [DE-AC04-94AL85000]; University of Maryland [70NANB10H193]; National Institute of Standards and Technology Center for Nanoscale Science and Technology through the University of Maryland [70NANB10H193]	Laboratory Directed Research and Development Program at Sandia National Laboratories; U.S. Department of Energy (DOE) SunShot Program; U.S. DOE National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); Science of Precision Multifunctional Nanostructures for Electrical Energy Storage (NEES), an Energy Frontier Research Center; U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE(United States Department of Energy (DOE)); University of Maryland; National Institute of Standards and Technology Center for Nanoscale Science and Technology through the University of Maryland	We thank S. T. Meek for organic synthesis in this work and D. Ruzmetov for help in fabrication. This work was supported by the Laboratory Directed Research and Development Program at Sandia National Laboratories and the U.S. Department of Energy (DOE) SunShot Program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. DOE National Nuclear Security Administration under contract DE-AC04-94AL85000. A. A. T. was supported by the Science of Precision Multifunctional Nanostructures for Electrical Energy Storage (NEES), an Energy Frontier Research Center funded by the U.S. DOE, Office of Science, Office of Basic Energy Sciences under award DESC0001160. F. E. G. was supported by the Office of Basic Energy Sciences, Division of Materials and Engineering Sciences, U.S. DOE, under contract DE-AC04-94AL85000. A. C., R. A. K., and H.P.Y. acknowledge support under the Cooperative Research Agreement between the University of Maryland and the National Institute of Standards and Technology Center for Nanoscale Science and Technology, award 70NANB10H193, through the University of Maryland.	ABELES B, 1975, PHYS REV LETT, V35, P247, DOI 10.1103/PhysRevLett.35.247; Brunschwig BS, 2002, CHEM SOC REV, V31, P168, DOI 10.1039/b008034i; CHAPPELL JS, 1981, J AM CHEM SOC, V103, P2442, DOI 10.1021/ja00399a066; Chui SSY, 1999, SCIENCE, V283, P1148, DOI 10.1126/science.283.5405.1148; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Gandara F, 2012, CHEM-EUR J, V18, P10595, DOI 10.1002/chem.201103433; Heintz RA, 1999, INORG CHEM, V38, P144, DOI 10.1021/ic9812095; Hendon CH, 2012, PHYS CHEM CHEM PHYS, V14, P13120, DOI 10.1039/c2cp41099k; INZELT G, 1983, J PHYS CHEM-US, V87, P4592, DOI 10.1021/j100246a012; Kobayashi Y, 2010, CHEM MATER, V22, P4120, DOI 10.1021/cm101238m; MATSUZAKI S, 1980, SOLID STATE COMMUN, V33, P403, DOI 10.1016/0038-1098(80)90429-9; MELBY LR, 1962, J AM CHEM SOC, V84, P3374, DOI 10.1021/ja00876a029; Miyasaka H, 2010, J AM CHEM SOC, V132, P1532, DOI 10.1021/ja909489s; Poppl A, 2008, J PHYS CHEM C, V112, P2678, DOI 10.1021/jp7100094; POTEMBER RS, 1979, APPL PHYS LETT, V34, P405, DOI 10.1063/1.90814; Shekhah O, 2009, ANGEW CHEM INT EDIT, V48, P5038, DOI 10.1002/anie.200900378; Shimomura S, 2011, J MATER CHEM, V21, P5537, DOI 10.1039/c1jm10208g; Stavila V, 2012, CHEM SCI, V3, P1531, DOI 10.1039/c2sc20065a; Wee LH, 2012, J MATER CHEM, V22, P13742, DOI 10.1039/c2jm31536j; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yakovenko AA, 2013, J APPL CRYSTALLOGR, V46, P346, DOI 10.1107/S0021889812050935	21	868	882	90	1852	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					66	69		10.1126/science.1246738	http://dx.doi.org/10.1126/science.1246738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24310609				2022-12-28	WOS:000329162000048
J	Prufer, K; Racimo, F; Patterson, N; Jay, F; Sankararaman, S; Sawyer, S; Heinze, A; Renaud, G; Sudmant, PH; de Filippo, C; Li, H; Mallick, S; Dannemann, M; Fu, QM; Kircher, M; Kuhlwilm, M; Lachmann, M; Meyer, M; Ongyerth, M; Siebauer, M; Theunert, C; Tandon, A; Moorjani, P; Pickrell, J; Mullikin, JC; Vohr, SH; Green, RE; Hellmann, I; Johnson, PLF; Blanche, H; Cann, H; Kitzman, JO; Shendure, J; Eichler, EE; Lein, ES; Bakken, TE; Golovanova, LV; Doronichev, VB; Shunkov, MV; Derevianko, AP; Viola, B; Slatkin, M; Reich, D; Kelso, J; Paabo, S				Pruefer, Kay; Racimo, Fernando; Patterson, Nick; Jay, Flora; Sankararaman, Sriram; Sawyer, Susanna; Heinze, Anja; Renaud, Gabriel; Sudmant, Peter H.; de Filippo, Cesare; Li, Heng; Mallick, Swapan; Dannemann, Michael; Fu, Qiaomei; Kircher, Martin; Kuhlwilm, Martin; Lachmann, Michael; Meyer, Matthias; Ongyerth, Matthias; Siebauer, Michael; Theunert, Christoph; Tandon, Arti; Moorjani, Priya; Pickrell, Joseph; Mullikin, James C.; Vohr, Samuel H.; Green, Richard E.; Hellmann, Ines; Johnson, Philip L. F.; Blanche, Helene; Cann, Howard; Kitzman, Jacob O.; Shendure, Jay; Eichler, Evan E.; Lein, Ed S.; Bakken, Trygve E.; Golovanova, Liubov V.; Doronichev, Vladimir B.; Shunkov, Michael V.; Derevianko, Anatoli P.; Viola, Bence; Slatkin, Montgomery; Reich, David; Kelso, Janet; Paeaebo, Svante			The complete genome sequence of a Neanderthal from the Altai Mountains	NATURE			English	Article							MEZMAISKAYA CAVE; DENISOVA CAVE; DNA-SEQUENCES; GREAT APE; ANCIENT; HOMININ; ADMIXTURE; ANCESTRY; HISTORY	We present a high-quality genome sequence of a Neanderthal woman from Siberia. We show that her parents were related at the level of half-siblings and that mating among close relatives was common among her recent ancestors. We also sequenced the genome of a Neanderthal from the Caucasus to low coverage. An analysis of the relationships and population history of available archaic genomes and 25 present-day human genomes shows that several gene flow events occurred among Neanderthals, Denisovans and early modern humans, possibly including gene flow into Denisovans from an unknown archaic group. Thus, interbreeding, albeit of low magnitude, occurred among many hominin groups in the Late Pleistocene. In addition, the high-quality Neanderthal genome allows us to establish a definitive list of substitutions that became fixed in modern humans after their separation from the ancestors of Neanderthals and Denisovans.	[Pruefer, Kay; Sawyer, Susanna; Heinze, Anja; Renaud, Gabriel; de Filippo, Cesare; Dannemann, Michael; Fu, Qiaomei; Kircher, Martin; Kuhlwilm, Martin; Lachmann, Michael; Meyer, Matthias; Ongyerth, Matthias; Siebauer, Michael; Theunert, Christoph; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Racimo, Fernando; Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Patterson, Nick; Sankararaman, Sriram; Li, Heng; Mallick, Swapan; Tandon, Arti; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sankararaman, Sriram; Mallick, Swapan; Tandon, Arti; Moorjani, Priya; Pickrell, Joseph; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sudmant, Peter H.; Kircher, Martin; Kitzman, Jacob O.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Fu, Qiaomei] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Mallick, Swapan] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Mallick, Swapan] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Vohr, Samuel H.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Hellmann, Ines] Max F Perutz Labs, Math & Biosci Grp, Campus Vienna Bioctr 5, A-1030 Vienna, Austria; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Blanche, Helene; Cann, Howard] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lein, Ed S.; Bakken, Trygve E.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Golovanova, Liubov V.; Doronichev, Vladimir B.] ANO Lab Prehist 14 Linia 3 11, St Petersburg 199034, Russia; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Inst Archaeol & Ethnog, Palaeolith Dept, Siberian Branch, Novosibirsk 630090, Russia; [Viola, Bence] Max Planck Inst Evolutionare Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Max Planck Society; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Santa Cruz; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Emory University; Foundation Jean Dausset-CEPH; Howard Hughes Medical Institute; Allen Institute for Brain Science; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Max Planck Society; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Slatkin, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	slatkin@berkeley.edu; reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Liubov, Golovanova V./Q-2995-2016; Bakken, Trygve E./R-4622-2017; Shunkov, Mikhail V./Q-6576-2016; Kelso, Janet/N-1812-2019; Kircher, Martin/H-6909-2019; Kircher, Martin/HDL-9392-2022; Ganesh, Dunna Sai/AGX-5170-2022; Derevianko, Anatoly P./Q-5975-2016; Li, Heng/D-9344-2011; Shendure, Jay/AAU-3684-2021	Bakken, Trygve E./0000-0003-3373-7386; Shunkov, Mikhail V./0000-0003-1388-2308; Kelso, Janet/0000-0002-3618-322X; Kircher, Martin/0000-0001-9278-5471; Derevianko, Anatoly P./0000-0003-1156-8331; Li, Heng/0000-0003-4874-2874; Vohr, Samuel/0000-0002-4338-3756; Renaud, Gabriel/0000-0002-0630-027X; Golovanova, Liubov/0000-0002-6099-4081; Shendure, Jay/0000-0002-1516-1865; Sudmant, Peter/0000-0002-9573-8248; Doronichev, Vladimir/0000-0003-0198-0250; Green, Richard/0000-0003-0516-5827; Viola, Bence/0000-0001-8052-707X; Kitzman, Jacob/0000-0002-6145-882X; jay, flora/0000-0001-5884-4730; Racimo, Fernando/0000-0002-5025-2607; Kuhlwilm, Martin/0000-0002-0115-1797; Sawyer, Susanna/0000-0002-8477-6089	NSF [1032255]; NIH [GM100233, HG002385, R01-GM40282]; National Genome Research Institute (NHGRI) [HG006283]; Harvard University Science of the Human Past Program; HHMI International Student Fellowship; Paul G. Allen Family Foundation; Presidential Innovation Fund of the Max Planck Society; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, R01HG002385, ZIBHG000196, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282, R01GM100233] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Genome Research Institute (NHGRI); Harvard University Science of the Human Past Program; HHMI International Student Fellowship; Paul G. Allen Family Foundation; Presidential Innovation Fund of the Max Planck Society; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hammer, C. Winkler and W. Klitz for sharing DNA samples; W. Huttner and his group, B. Peter, J. G. Schraiber and M. A. Yang for helpful discussions; and A. Lewis and R. Qiu for technical assistance. N.P. and D. R. are grateful for the chance to discuss these results with Peter Waddell who independently found evidence of a deeply diverged hominin admixing into the Denisova genome. D. R. and E. E. E. are Howard Hughes Medical Institute Investigators. D. R. and N.P. were supported by NSF grant number 1032255 and NIH grant GM100233; E. E. E. by NIH grant HG002385; J. S. by grant HG006283 from the National Genome Research Institute (NHGRI); S. S. by a post-doctoral fellowship from the Harvard University Science of the Human Past Program; F. J. and M. S. in part by a grant from the NIH (R01-GM40282); P. H. S. by an HHMI International Student Fellowship. We thank the team at the NIH Intramural Sequencing Center and Alice Young in particular, for generating some of the sequence reported here. This research was supported in part by the Paul G. Allen Family Foundation. Major funding support came from the Presidential Innovation Fund of the Max Planck Society.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gabunia L, 2001, EVOL ANTHROPOL, V10, P158, DOI 10.1002/evan.1030; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Golovanova LV, 1999, CURR ANTHROPOL, V40, P77, DOI 10.1086/515805; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Mednikova MB, 2011, ARCHAEOL ETHNOL ANTH, V39, P129, DOI 10.1016/j.aeae.2011.06.017; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Skinner AR, 2005, APPL RADIAT ISOTOPES, V62, P219, DOI 10.1016/j.apradiso.2004.08.008; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Waddell P. J., 2012, PREPRINT; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang CR, 2013, NAT NEUROSCI, V16, P532, DOI 10.1038/nn.3365; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	46	1151	1191	56	783	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					43	+		10.1038/nature12886	http://dx.doi.org/10.1038/nature12886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24352235	Green Accepted, Green Submitted			2022-12-28	WOS:000329163300020
J	Elert, E				Elert, Emily			CALLING CELLS TO ARMS	NATURE			English	Editorial Material																			0	9	22	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S2	S3		10.1038/504S2a	http://dx.doi.org/10.1038/504S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352361	Bronze			2022-12-28	WOS:000328575300002
J	Hsiao, EY; McBride, SW; Hsien, S; Sharon, G; Hyde, ER; McCue, T; Codelli, JA; Chow, J; Reisman, SE; Petrosino, JF; Patterson, PH; Mazmanian, SK				Hsiao, Elaine Y.; McBride, Sara W.; Hsien, Sophia; Sharon, Gil; Hyde, Embriette R.; McCue, Tyler; Codelli, Julian A.; Chow, Janet; Reisman, Sarah E.; Petrosino, Joseph F.; Patterson, Paul H.; Mazmanian, Sarkis K.			Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders	CELL			English	Article							GASTROINTESTINAL DYSFUNCTION; SPECTRUM DISORDERS; GUT MICROBIOTA; AUTISM; CHILDREN; BRAIN; MOUSE; ACTIVATION; MICROFLORA; PREGNANCY	Neurodevelopmental disorders, including autism spectrum disorder (ASD), are defined by core behavioral impairments; however, subsets of individuals display a spectrum of gastrointestinal (GI) abnormalities. We demonstrate GI barrier defects and microbiota alterations in the maternal immune activation (MIA) mouse model that is known to display features of ASD. Oral treatment of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters microbial composition, and ameliorates defects in communicative, stereotypic, anxiety-like and sensorimotor behaviors. MIA offspring display an altered serum metabolomic profile, and B. fragilis modulates levels of several metabolites. Treating naive mice with a metabolite that is increased by MIA and restored by B. fragilis causes certain behavioral abnormalities, suggesting that gut bacterial effects on the host metabolome impact behavior. Taken together, these findings support a gut-microbiome-brain connection in a mouse model of ASD and identify a potential probiotic therapy for GI and particular behavioral symptoms in human neurodevelopmental disorders.	[Hsiao, Elaine Y.; McBride, Sara W.; Hsien, Sophia; Sharon, Gil; Chow, Janet; Patterson, Paul H.; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Hsiao, Elaine Y.; Codelli, Julian A.; Reisman, Sarah E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hyde, Embriette R.; McCue, Tyler; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagenom & Microbiome Res, Houston, TX 77030 USA	California Institute of Technology; California Institute of Technology; Baylor College of Medicine	Hsiao, EY (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	ehsiao@caltech.edu; php@caltech.edu; sarkis@caltech.edu	Petrosino, Joseph F./AAF-1621-2019; Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Sharon, Gil/0000-0002-4605-9943; Hsien, Sophia/0000-0002-1662-9378	Caltech Innovation Fellowship; Autism Speaks Weatherstone Fellowship; NIH/NRSA Predoctoral Fellowship; Human Frontiers Science Program Fellowship; DOD Graduate Fellowship; NSF Graduate Research Fellowship; Autism Speaks Trailblazer Award; Caltech Innovation Initiative; Caltech Grubstake Awards; Congressionally Directed Medical Research Award; Weston Havens Award; Callie D. McGrath Charitable Foundation; NIMH [MH100556]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER	Caltech Innovation Fellowship; Autism Speaks Weatherstone Fellowship; NIH/NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program Fellowship(Human Frontier Science Program); DOD Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Autism Speaks Trailblazer Award; Caltech Innovation Initiative; Caltech Grubstake Awards; Congressionally Directed Medical Research Award; Weston Havens Award; Callie D. McGrath Charitable Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Reyna Sauza, Jaime Rodriguez, and Taren Thron for caring for the animals; Dr. Michael Fischbach (UCSF) for advising on pathways of 4EPS and indolepyruvate synthesis; Dr. Nadim Ajami (Baylor) for providing helpful comments on the manuscript; Greg Donaldson (Caltech) for conducting experiments on microbial viability; Dr. Kym Faull (UCLA) for conducting pilot GC/MS experiments; Dr. Alessio Fasano (Massachusetts General) for conducting pilot microbiota sequencing experiments; and Dr. Jerrold Turner (U Chicago) for providing histological analysis of intestinal sections. This work was supported by a Caltech Innovation Fellowship (to E.Y.H.), Autism Speaks Weatherstone Fellowship (to E.Y.H.), NIH/NRSA Predoctoral Fellowship (to E.Y.H.), Human Frontiers Science Program Fellowship (to G. S.), DOD Graduate Fellowship (to J.A.C.), NSF Graduate Research Fellowship (to J.A.C.), Autism Speaks Trailblazer Award (to P. H. P. and S. K. M.), Caltech Innovation Initiative (to P. H. P. and S. K. M.), Caltech Grubstake Awards (to P. H. P. and S. K. M), Congressionally Directed Medical Research Award (to P. H. P. and S. K. M.), Weston Havens Award (to P. H. P. and S. K. M.), Callie D. McGrath Charitable Foundation awards (to P. H. P.) and NIMH grant MH100556 (to P. H. P. and S.K.M.).	Abdallah MW, 2013, WORLD J BIOL PSYCHIA, V14, P528, DOI 10.3109/15622975.2011.639803; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Altieri L, 2011, BIOMARKERS, V16, P252, DOI 10.3109/1354750X.2010.548010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amaral FA, 2008, P NATL ACAD SCI USA, V105, P2193, DOI 10.1073/pnas.0711891105; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Boukthir Samir, 2010, Tunis Med, V88, P685; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Bull G, 2003, MED SCI MONITOR, V9, P422; Campanozzi A, 2007, BRAIN DEV-JPN, V29, P25, DOI 10.1016/j.braindev.2006.05.008; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Coury DL, 2012, PEDIATRICS, V130, pS160, DOI 10.1542/peds.2012-0900N; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ibrahim SH, 2009, PEDIATRICS, V124, P680, DOI 10.1542/peds.2008-2933; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Lafaye A, 2004, J MASS SPECTROM, V39, P655, DOI 10.1002/jms.635; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Motil KJ, 2012, J PEDIATR GASTR NUTR, V55, P292, DOI 10.1097/MPG.0b013e31824b6159; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Rao A. Ravishankar, 2009, P1; Robertson MA, 2008, J AUTISM DEV DISORD, V38, P1066, DOI 10.1007/s10803-007-0482-1; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585	65	1880	2031	39	725	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1451	1463		10.1016/j.cell.2013.11.024	http://dx.doi.org/10.1016/j.cell.2013.11.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24315484	Green Accepted, Bronze			2022-12-28	WOS:000328693300004
J	Gonzalez, EB				Gonzalez, Emilio B.			Review: Glucosamine (sulfate or hydrochloride) does not reduce pain in knee or hip osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHONDROITIN SULFATE; DOUBLE-BLIND; PLACEBO; COMBINATION		Univ Texas Med Branch, UTMB Hlth, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Gonzalez, EB (corresponding author), Univ Texas Med Branch, UTMB Hlth, Galveston, TX 77555 USA.							Bruyere O, 2007, DRUG AGING, V24, P573, DOI 10.2165/00002512-200724070-00005; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Gabay C, 2011, ARTHRITIS RHEUM-US, V63, P3383, DOI 10.1002/art.30574; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Sawitzke AD, 2010, ANN RHEUM DIS, V69, P1459, DOI 10.1136/ard.2009.120469	5	1	2	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC8	10.7326/0003-4819-159-12-201312170-02008	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343413				2022-12-28	WOS:000329735300007
J	Shekelle, P				Shekelle, Paul			Fixed-dose combination pills reduced SBP and LDL-C in patients with, or at high risk for, cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									West Los Angeles VA Med Ctr, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center	Shekelle, P (corresponding author), West Los Angeles VA Med Ctr, Los Angeles, CA USA.							Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC9	10.7326/0003-4819-159-12-201312170-02009	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343414				2022-12-28	WOS:000329735300008
J	Pipis, M; Dehabadi, M; Matthews, E; Gould, L				Pipis, Menelaos; Dehabadi, Mohammad; Matthews, Emma; Gould, Lawrence			10-MINUTE CONSULTATION Tremor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pipis, Menelaos] Watford Dist Gen Hosp, Accident & Emergency Dept, Watford WD18 0HB, England; [Dehabadi, Mohammad] Watford Dist Gen Hosp, Ophthalmol Dept, Watford WD18 0HB, England; [Matthews, Emma] Natl Hosp Neurol & Neurosurg, Dept Neurol, London WC1N 3BG, England; [Gould, Lawrence] Stanmore Med Ctr, London, England	Watford General Hospital; Watford General Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Pipis, M (corresponding author), Watford Dist Gen Hosp, Accident & Emergency Dept, Watford WD18 0HB, England.	mpipis@hotmail.com	Matthews, Emma/AAH-6518-2020	Matthews, Emma/0000-0002-3810-306X				[Anonymous], TREMOR; National Institute of Neurological Disorders and Stroke, 2012, TERM FACT SHEET	2	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f7200	10.1136/bmj.f7200	http://dx.doi.org/10.1136/bmj.f7200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336002				2022-12-28	WOS:000328575200006
J	Zineh, I; Pacanowski, M; Woodcock, J				Zineh, Issam; Pacanowski, Michael; Woodcock, Janet			Pharmacogenetics and Coumarin Dosing - Recalibrating Expectations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY		[Zineh, Issam; Pacanowski, Michael; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Zineh, I (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							[Anonymous], COUM WARF SOD PACK I; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; FLAY BR, 1986, PREV MED, V15, P451, DOI 10.1016/0091-7435(86)90024-1; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261	4	50	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2273	2275		10.1056/NEJMp1314529	http://dx.doi.org/10.1056/NEJMp1314529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328463				2022-12-28	WOS:000328156300002
J	Canup, R				Canup, Robin			Lunar conspiracies	NATURE			English	Editorial Material							GIANT IMPACT; MOON; ISOTOPES; EARTH		SW Res Inst, Planetary Sci Directorate, Boulder, CO USA		Canup, R (corresponding author), SW Res Inst, Planetary Sci Directorate, Boulder, CO USA.	robin@boulder.swri.edu						Armytage RMG, 2012, GEOCHIM COSMOCHIM AC, V77, P504, DOI 10.1016/j.gca.2011.10.032; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Salmon J, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/83; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	10	7	8	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					27	29		10.1038/504027a	http://dx.doi.org/10.1038/504027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24312956	Bronze			2022-12-28	WOS:000327851700013
J	Cohen, D				Cohen, Deborah			DRUG REGULATION FDA official: "clinical trial system is broken"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROSIGLITAZONE		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.							[Anonymous], 2013, FORBES; Burton TM, 2013, WALL STREET J; Center for Drug Evaluation and Research, MED REV; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6727; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Dombrowski C., 2013, PINK SHEET      0617; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Neale T., 2013, MEDPAGE TODAY   0805; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tucker ME, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3769	11	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2013	347								f6980	10.1136/bmj.f6980	http://dx.doi.org/10.1136/bmj.f6980			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DX	24309077				2022-12-28	WOS:000328150000003
J	Liao, MF; Cao, EH; Julius, D; Cheng, YF				Liao, Maofu; Cao, Erhu; Julius, David; Cheng, Yifan			Structure of the TRPV1 ion channel determined by electron cryo-microscopy	NATURE			English	Article							HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; VOLTAGE; PORE; RECEPTOR; VISUALIZATION; SELECTIVITY; MUTATIONS; REVEALS; SYSTEM	Transient receptor potential (TRP) channels are sensors for a wide range of cellular and environmental signals, but elucidating how these channels respond to physical and chemical stimuli has been hampered by a lack of detailed structural information. Here we exploit advances in electron cryo-microscopy to determine the structure of a mammalian TRP channel, TRPV1, at 3.4 angstrom resolution, breaking the side-chain resolution barrier for membrane proteins without crystallization. Like voltage-gated channels, TRPV1 exhibits four-fold symmetry around a central ion pathway formed by transmembrane segments 5-6 (S5-S6) and the intervening pore loop, which is flanked by S1-S4 voltage-sensor-like domains. TRPV1 has a wide extracellular 'mouth' with a short selectivity filter. The conserved 'TRP domain' interacts with the S4-S5 linker, consistent with its contribution to allosteric modulation. Subunit organization is facilitated by interactions among cytoplasmic domains, including amino-terminal ankyrin repeats. These observations provide a structural blueprint for understanding unique aspects of TRP channel function.	[Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA; [Cao, Erhu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.julius@ucsf.edu; ycheng@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, R01NS065071, R01NS047723]; National Science Foundation [DBI-0960271]; University of California, San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Li for assistance with data acquisition using TF30 Polara and K2 Summit camera, S. Zhou and D. King for help with protein microsequencing and J.P Armache, C. Bohlen, J. Cordero-Morales and J. Osteen for discussion and reading of the manuscript. This work was supported by grants from the National Institutes of Health (R01GM098672 and S10RR026814 to Y.C. and R01NS065071 and R01NS047723 to D. J.), the National Science Foundation (DBI-0960271 to D. Agard and Y.C.) and the University of California, San Francisco Program for Breakthrough Biomedical Research (Y.C.). E. C. was a fellow of the Damon Runyon Cancer Research Foundation.	Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Boukalova S, 2013, BBA-MOL CELL RES, V1833, P520, DOI 10.1016/j.bbamcr.2012.11.017; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Inada H, 2012, BIOCHEMISTRY-US, V51, P6195, DOI 10.1021/bi300279b; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	55	1107	1159	46	591	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					107	+		10.1038/nature12822	http://dx.doi.org/10.1038/nature12822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305160	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000327851700040
J	Macdowall, W; Gibson, LJ; Tanton, C; Mercer, CH; Lewis, R; Clifton, S; Field, N; Datta, J; Mitchell, KR; Sonnenberg, P; Erens, B; Copas, AJ; Phelps, A; Prah, P; Johnson, AM; Wellings, K				Macdowall, Wendy; Gibson, Lorna J.; Tanton, Clare; Mercer, Catherine H.; Lewis, Ruth; Clifton, Soazig; Field, Nigel; Datta, Jessica; Mitchell, Kirstin R.; Sonnenberg, Pam; Erens, Bob; Copas, Andrew J.; Phelps, Andrew; Prah, Philip; Johnson, Anne M.; Wellings, Kaye			Lifetime prevalence, associated factors, and circumstances of non-volitional sex in women and men in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; TRANSMITTED INFECTIONS; DOMESTIC VIOLENCE; HEALTH; RISK; BEHAVIOR; RAPE; MULTICOUNTRY; ASSAULT	Background Sexual violence is increasingly recognised as a public health issue. Information about prevalence, associated factors, and consequences for health in the population of Britain (England, Scotland, and Wales) is scarce. The third National Survey of Sexual Health Attitudes and Lifestyles (Natsal-3) is the first of the Natsal surveys to include questions about sexual violence and the first population-based survey in Britain to explore the issue outside the context of crime. Methods Between Sept 6, 2010, and Aug 31, 2012, we did a probability sample survey of women and men aged 16-74 years living in Britain. We asked participants about their experience of sex against their will since age 13 years and the circumstances surrounding the most recent occurrence. We explored associations between ever experiencing non-volitional sex and a range of sociodemographic, health, and behavioural factors. We used logistic regression to estimate age-adjusted odds ratios to analyse factors associated with the occurrence of completed non-volitional sex in women and men. Findings We interviewed 15 162 people. Completed non-volitional sex was reported by 9.8% (95% CI 9.0-10.5) of women and 1.4% (1.1-1.7) of men. Median age (interdecile range) at most recent occurrence was 18 years (14-32) for women and 16 years (13-30) for men. Completed non-volitional sex varied by family structure and, in women, by age, education, and area-level deprivation. It was associated with poor health, longstanding illness or disability, and treatment for mental health conditions, smoking, and use of non-prescription drugs in the past year in both sexes, and with binge drinking in women. Completed non-volitional sex was also associated with reporting of first heterosexual intercourse before 16 years of age, same-sex experience, more lifetime sexual partners, ever being diagnosed with a sexually transmitted infection, and low sexual function in both sexes, and, in women, with abortion and pregnancy outcome before 18 years of age. In most cases, the person responsible was known to the individual, although the nature of the relationship differed by age at most recent occurrence. Participants who were younger at interview were more likely to have told someone about the event and to have reported it to the police than were older participants. Interpretation These data provide the first population prevalence estimates of non-volitional sex in Britain. We showed it to be mainly an experience of young age and strongly associated with a range of adverse health outcomes in both women and men.	[Macdowall, Wendy; Gibson, Lorna J.; Lewis, Ruth; Datta, Jessica; Mitchell, Kirstin R.; Wellings, Kaye] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Ctr Sexual & Reprod Hlth Res, London WC1H 9SH, England; [Erens, Bob] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Tanton, Clare; Mercer, Catherine H.; Clifton, Soazig; Field, Nigel; Sonnenberg, Pam; Erens, Bob; Copas, Andrew J.; Prah, Philip; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Macdowall, W (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Ctr Sexual & Reprod Hlth Res, 15-17 Tavistock Pl, London WC1H 9SH, England.	wendy.macdowall@lshtm.ac.uk	Weatherburn, Peter/AAC-2701-2019; Lewis, Ruth/K-2833-2019; Field, Nigel/ABG-3948-2020	Erens, Bob/0000-0002-4430-954X; Copas, Andrew/0000-0001-8968-5963; Johnson, Anne/0000-0003-1330-7100; Mercer, Catherine/0000-0002-4220-5034; Mitchell, Kirstin/0000-0002-4409-6601; Tanton, Clare/0000-0002-4612-1858; Macdowall, Wendy/0000-0001-5868-8336; Lewis, Ruth/0000-0002-6768-6188; Sonnenberg, Pam/0000-0002-1067-1583; Erens, Robert/0000-0002-3054-504X; Prah, Philip/0000-0002-4742-9686; Field, Nigel/0000-0002-2825-6652; Clifton, Soazig/0000-0002-4171-0805	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244, CL-2010-18-010] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	[Anonymous], 2005, RESP RESP STRAT ACT; [Anonymous], 2001, STRAT FRAM PROM SEX; Bajekal Madhavi, 2006, Health Stat Q, P42; Bajos N., 2012, SEXUALITY FRANCE PRA; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Black M.C., 2011, NATL INTIMATE PARTNE; Bondurant B, 2001, VIOLENCE AGAINST WOM, V7, P294, DOI 10.1177/10778010122182451; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; Coxell A, 1999, BMJ-BRIT MED J, V318, P846, DOI 10.1136/bmj.318.7187.846; Creighton CD, 2012, J FORENSIC LEG MED, V19, P35, DOI 10.1016/j.jflm.2011.10.007; Dartnall E, 2013, BEST PRACT RES CL OB, V27, P3, DOI 10.1016/j.bpobgyn.2012.08.002; Department of Health, 2001, NAT STRAT SEX HLTH H; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Erens B, METHODOLOGY 3 BRIT N; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fisher BS, 2009, VIOLENCE AGAINST WOM, V15, P133, DOI 10.1177/1077801208329391; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2011, B WORLD HEALTH ORGAN, V89, P2, DOI 10.2471/BLT.10.085217; Goodman LA, 1997, SCHIZOPHRENIA BULL, V23, P685, DOI 10.1093/schbul/23.4.685; Hagemann-White C, 2001, VIOLENCE AGAINST WOM, V7, P732, DOI 10.1177/10778010122182712; HICKSON FCI, 1994, ARCH SEX BEHAV, V23, P281, DOI 10.1007/BF01541564; HM Government, 2013, CAL END VIOL WOM GIR; HM Government, 2012, GOV ALC STRAT; Home Office, 2010, STERN REV; Hutchinson D., 2011, LOOKED CHILDREN TALK; Jina R, 2013, BEST PRACT RES CL OB, V27, P15, DOI 10.1016/j.bpobgyn.2012.08.012; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; Johnson AM, 1994, NATL SURVEY SEXUAL A; Khalifeh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055952; Khalifeh H, 2013, AM J PUBLIC HEALTH, V103, P462, DOI 10.2105/AJPH.2012.300723; KOSS MP, 1993, J INTERPERS VIOLENCE, V8, P198, DOI 10.1177/088626093008002004; McLean IA, 2013, BEST PRACT RES CL OB, V27, P39, DOI 10.1016/j.bpobgyn.2012.08.006; Mercer CH, 2013, LANCET; Mitchell KR, 2012, EUR J EPIDEMIOL, V27, P409, DOI 10.1007/s10654-012-9697-3; Office for National Statistics, 2013, FOC VIOL CRIM SEX OF; Payne R. A., 2012, Health Statistics Quarterly, P22; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Rickert VI, 2002, CURR OPIN OBSTET GYN, V14, P495, DOI 10.1097/00001703-200210000-00009; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Walters ML, 2013, NATL INTIMATE PARTNE, DOI Atlanta, GA; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; Wellings K, 1994, SEXUAL BEHAV BRITAIN; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2021, VIOL WOM PREV EST 20	49	85	86	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1845	1855		10.1016/S0140-6736(13)62300-4	http://dx.doi.org/10.1016/S0140-6736(13)62300-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286789	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000327540700028
J	Nelson, ER; Wardell, SE; Jasper, JS; Park, S; Suchindran, S; Howe, MK; Carver, NJ; Pillai, RV; Sullivan, PM; Sondhi, V; Umetani, M; Geradts, J; McDonnell, DP				Nelson, Erik R.; Wardell, Suzanne E.; Jasper, Jeff S.; Park, Sunghee; Suchindran, Sunil; Howe, Matthew K.; Carver, Nicole J.; Pillai, Ruchita V.; Sullivan, Patrick M.; Sondhi, Varun; Umetani, Michihisa; Geradts, Joseph; McDonnell, Donald P.			27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology	SCIENCE			English	Article							STEROL 27-HYDROXYLASE; CHOLESTEROL; ESTROGEN; RISK; PROGRESSION; METABOLISM; INDUCTION; OXYSTEROL; OBESITY; MODEL	Hypercholesterolemia is a risk factor for estrogen receptor (ER)-positive breast cancers and is associated with a decreased response of tumors to endocrine therapies. Here, we show that 27-hydroxycholesterol (27HC), a primary metabolite of cholesterol and an ER and liver X receptor (LXR) ligand, increases ER-dependent growth and LXR-dependent metastasis in mouse models of breast cancer. The effects of cholesterol on tumor pathology required its conversion to 27HC by the cytochrome P450 oxidase CYP27A1 and were attenuated by treatment with CYP27A1 inhibitors. In human breast cancer specimens, CYP27A1 expression levels correlated with tumor grade. In high-grade tumors, both tumor cells and tumor-associated macrophages exhibited high expression levels of the enzyme. Thus, lowering circulating cholesterol levels or interfering with its conversion to 27HC may be a useful strategy to prevent and/or treat breast cancer.	[Nelson, Erik R.; Wardell, Suzanne E.; Jasper, Jeff S.; Park, Sunghee; Howe, Matthew K.; Carver, Nicole J.; Pillai, Ruchita V.; McDonnell, Donald P.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Suchindran, Sunil] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA; [Sullivan, Patrick M.] Duke Univ, Sch Med, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Sondhi, Varun; Umetani, Michihisa] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Sondhi, Varun; Umetani, Michihisa] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Geradts, Joseph] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	McDonnell, DP (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	donald.mcdonnell@duke.edu	Nelson, Erik/U-2697-2019; Nelson, Erik/B-5158-2013; Umetani, Michi/AAP-3964-2020	Nelson, Erik/0000-0002-8887-1905; Nelson, Erik/0000-0002-8887-1905; Umetani, Michi/0000-0001-8474-7088; Jasper, Jeff/0000-0003-3941-0018	NIH [K99CA172357, R37DK048807]; U.S. Department of Defense (DOD) [BC085585, DOD BC094960]; NATIONAL CANCER INSTITUTE [T32CA059365, K99CA172357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048807] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the NIH [grants K99CA172357 (E.R.N.) and R37DK048807 (D.P.M.)] and the U.S. Department of Defense (DOD) [grants BC085585 (E.R.N.) and DOD BC094960 (D.P.M.)]. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or DOD. Expression profiling data on 27HC in MCF7 cells were uploaded to Gene Expression Omnibus (GEO) (accession no. GSE46924) and were part of a larger study (GEO accession no. GSE35428).	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; BOYD NF, 1990, JNCI-J NATL CANCER I, V82, P460, DOI 10.1093/jnci/82.6.460; Capasso I, 2010, CANCER BIOL THER, V10, P1240, DOI 10.4161/cbt.10.12.13473; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Connor CE, 2001, CANCER RES, V61, P2917; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; DuSell CD, 2010, ENDOCRINOLOGY, V151, P3675, DOI 10.1210/en.2010-0080; FERRARONI M, 1993, INT J EPIDEMIOL, V22, P772, DOI 10.1093/ije/22.5.772; Gerber JG, 2005, JAIDS-J ACQ IMM DEF, V39, P307, DOI 10.1097/01.qai.0000167156.44980.33; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Karuna R, 2011, ATHEROSCLEROSIS, V214, P448, DOI 10.1016/j.atherosclerosis.2010.10.042; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8; Nelson ER, 2011, ENDOCRINOLOGY, V152, P4691, DOI 10.1210/en.2011-1298; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	26	504	518	11	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1094	1098		10.1126/science.1241908	http://dx.doi.org/10.1126/science.1241908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288332	Green Accepted			2022-12-28	WOS:000327518600057
J	Ramos-Casals, M; Brito-Zeron, P; Lopez-Guillermo, A; Khamashta, MA; Bosch, X				Ramos-Casals, Manuel; Brito-Zeron, Pilar; Lopez-Guillermo, Armando; Khamashta, Munther A.; Bosch, Xavier			Adult haemophagocytic syndrome	LANCET			English	Article							EPSTEIN-BARR-VIRUS; RENAL-TRANSPLANT RECIPIENTS; B-CELL LYMPHOMA; DISSEMINATED INTRAVASCULAR COAGULATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVATED FACTOR-VII; BONE-MARROW; CLINICAL-FEATURES; INTRAVENOUS IMMUNOGLOBULIN; CYCLOSPORINE-A	Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ damage-mainly reported in paediatric patients, but reports of adult presentation are increasing. Analysis of the genetic and molecular pathophysiology of these syndromes have improved the understanding of the crosstalk between lymphocytes and histiocytes and their regulatoty mechanisms. Clinical presentations with a broad differential diagnosis, and often life-threatening outcome, complicate the management, which might include supportive intensive care, immunosuppressive and biological treatments, or haemopoietic stem cell transplantation. Insufficient knowledge of these syndromes could contribute to poor prognosis. Early diagnosis is essential to initiate appropriate treatment and improve the quality of life and survival of patients with this challenging disorder.	[Ramos-Casals, Manuel; Brito-Zeron, Pilar] Univ Barcelona, IDIBAPS, Hosp Clin,Josep Font Lab Autoimmune Dis CELLEX, Dept Autoimmune Dis,Inst Clin Med & Dermatol, E-08036 Barcelona, Spain; [Bosch, Xavier] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Internal Med,Inst Clin Med & Dermatol, E-08036 Barcelona, Spain; [Lopez-Guillermo, Armando] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Haematol,Inst Clin Malalties Hematol & Oncol, E-08036 Barcelona, Spain; [Khamashta, Munther A.] Kings Coll Univ, St Thomas Hosp, Rayne Inst, Lupus Res Unit, London, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, Dept Internal Med, E-08036 Barcelona, Spain.	xavbosch@clinic.ub.es	Lopez-Guillermo, Armando/Z-5684-2019; brito zeron, pilar/L-6551-2014	brito zeron, pilar/0000-0003-1016-5055; Ramos-Casals, Manuel/0000-0001-5709-6734	Josep Font Research Fellow Award, Hospital Clinic, Barcelona, Spain	Josep Font Research Fellow Award, Hospital Clinic, Barcelona, Spain	PB-Z is supported by the Josep Font Research Fellow Award, Hospital Clinic, Barcelona, Spain. We thank David Buss for his technical assistance.	Ahn JS, 2010, AM J HEMATOL, V85, P719, DOI 10.1002/ajh.21795; Akamatsu N, 2006, TRANSPL P, V38, P1425, DOI 10.1016/j.transproceed.2006.02.089; Aleem A, 2005, CLIN LAB HAEMATOL, V27, P395, DOI 10.1111/j.1365-2257.2005.00728.x; Allory Y, 2001, AM J SURG PATHOL, V25, P865, DOI 10.1097/00000478-200107000-00004; Arceci RJ, 2008, CURR OPIN HEMATOL, V15, P359, DOI 10.1097/MOH.0b013e3282f97f88; Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Asci G, 2006, J NEPHROL, V19, P322; Balamuth NJ, 2007, J PEDIAT HEMATOL ONC, V29, P569, DOI 10.1097/MPH.0b013e3180f61be3; Gonzalez MJB, 2008, EUR J INTERN MED, V19, P150, DOI 10.1016/j.ejim.2007.05.007; Bauer MP, 2009, CLIN INFECT DIS, V49, P1540, DOI [10.1086/644731, 10.1086/644730]; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; BELL MD, 1992, J FORENSIC SCI, V37, P1407; Biank VF, 2011, J PEDIATR-US, V159, P808, DOI 10.1016/j.jpeds.2011.04.045; Bosman G, 2009, NETH J MED, V67, P364; Brastianos PK, 2006, LANCET INFECT DIS, V6, P447, DOI 10.1016/S1473-3099(06)70524-2; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Buyse S, 2010, INTENS CARE MED, V36, P1695, DOI 10.1007/s00134-010-1936-z; Canna SW, 2012, CURR OPIN RHEUMATOL, V24, P113, DOI 10.1097/BOR.0b013e32834dd37e; Castillo L, 2009, PEDIATR CRIT CARE ME, V10, P387, DOI 10.1097/PCC.0b013e3181a1ae08; Celkan T, 2007, PEDIATR HEMAT ONCOL, V24, P117, DOI 10.1080/08880010601094102; Chen M, 2012, BLOOD, V119, P127, DOI 10.1182/blood-2011-06-363994; Chiossone L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00239; Chung HJ, 2010, INT J LAB HEMATOL, V32, P239, DOI 10.1111/j.1751-553X.2009.01177.x; Cohen JI, 2009, ANN ONCOL, V20, P1472, DOI 10.1093/annonc/mdp064; Coman T, 2003, J CLIN APHERESIS, V18, P129, DOI 10.1002/jca.10056; Creput C, 2008, INTENS CARE MED, V34, P1177, DOI 10.1007/s00134-008-1111-y; de Kerguenec C, 2001, AM J GASTROENTEROL, V96, P852, DOI 10.1016/S0002-9270(00)02425-4; Demirkan F, 2001, LEUKEMIA LYMPHOMA, V42, P1401, DOI 10.3109/10428190109097769; Dhote R, 2003, ARTHRIT RHEUM-ARTHR, V49, P633, DOI 10.1002/art.11368; Emmenegger U, 2005, SWISS MED WKLY, V135, P299; Emmenegger U, 2002, J CLIN ONCOL, V20, P599, DOI 10.1200/JCO.2002.20.2.599; Fardet L, 2010, BRIT J DERMATOL, V162, P547, DOI 10.1111/j.1365-2133.2009.09549.x; Fardet L, 2010, AIDS, V24, P1299, DOI 10.1097/QAD.0b013e328339e55b; Filipovich AH, 2011, CURR OPIN ALLERGY CL, V11, P512, DOI 10.1097/ACI.0b013e32834c22f5; Florena AM, 2002, VIRCHOWS ARCH, V441, P335, DOI 10.1007/s00428-002-0661-6; Fukaya S, 2008, RHEUMATOLOGY, V47, P1686, DOI 10.1093/rheumatology/ken342; Garcia-Hejl C, 2008, PATHOL BIOL, V56, P314, DOI 10.1016/j.patbio.2008.01.003; Goel S, 2012, ANN CLIN LAB SCI, V42, P21; Gupta A, 2008, PEDIATR BLOOD CANCER, V50, P192, DOI 10.1002/pbc.21441; Han AR, 2007, ANN HEMATOL, V86, P493, DOI 10.1007/s00277-007-0278-6; Han SM, 2008, J CHIN MED ASSOC, V71, P210, DOI 10.1016/S1726-4901(08)70106-0; Hanai M, 1997, Rinsho Ketsueki, V38, P682; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P675, DOI 10.1111/j.1651-2227.1991.tb11928.x; Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.3.CO;2-Y; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Henzan T, 2006, AM J HEMATOL, V81, P59, DOI 10.1002/ajh.20462; Imajoh Masayuki, 2012, J Med Virol, V84, P940, DOI 10.1002/jmv.23299; Imashuku S, 2001, J CLIN ONCOL, V19, P2665, DOI 10.1200/JCO.2001.19.10.2665; Imashuku S, 2003, MED PEDIATR ONCOL, V41, P103, DOI 10.1002/mpo.10314; Ino Kazuko, 2010, Rinsho Ketsueki, V51, P258; Ishii E, 2007, INT J HEMATOL, V86, P58, DOI 10.1532/IJH97.07012; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Kaito K, 1997, EUR J HAEMATOL, V59, P247; Karras A, 2004, TRANSPLANTATION, V77, P238, DOI 10.1097/01.TP.0000107285.86939.37; KIKUTA H, 1995, BRIT J HAEMATOL, V90, P971, DOI 10.1111/j.1365-2141.1995.tb05232.x; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Kuwata K, 2006, SHOCK, V25, P344, DOI 10.1097/01.shk.0000209520.82377.41; Lambotte O, 2006, MEDICINE, V85, P169, DOI 10.1097/01.md.0000224708.62510.d1; Larroche C, 2000, ANN MED INTERNE, V151, P533; Lin TF, 2011, PEDIATR BLOOD CANCER, V56, P154, DOI 10.1002/pbc.22774; Lykens JE, 2011, BLOOD, V118, P618, DOI 10.1182/blood-2010-12-324533; Maakaroun NR, 2010, REV MED VIROL, V20, P93, DOI 10.1002/rmv.638; Machaczka M, 2011, LEUKEMIA LYMPHOMA, V52, P613, DOI 10.3109/10428194.2010.551153; Machaczka M, 2010, NAT REV CLIN ONCOL, V7, P1, DOI 10.1038/nrclinonc.2010.40-c1; Majluf-Cruz A, 1998, LEUKEMIA RES, V22, P893, DOI 10.1016/S0145-2126(98)00083-6; Marsh RA, 2013, PEDIATR BLOOD CANCER, V60, P101, DOI 10.1002/pbc.24188; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; Nagai K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014173; Nakamura Itaru, 2009, Kansenshogaku Zasshi, V83, P60; Nakano M, 2000, Rinsho Shinkeigaku, V40, P34; Nakatsuka A, 2007, INTERNAL MED, V46, P495, DOI 10.2169/internalmedicine.46.6294; Niece JA, 2010, PEDIATR BLOOD CANCER, V54, P424, DOI 10.1002/pbc.22359; Ohshima K, 1999, PATHOL INT, V49, P533, DOI 10.1046/j.1440-1827.1999.00921.x; Okamoto M, 2009, INTERNAL MED, V48, P775, DOI 10.2169/internalmedicine.48.1677; Omagari K, 1997, AM J MED SCI, V314, P403, DOI 10.1097/00000441-199712000-00009; Orbach H, 2004, SEMIN ARTHRITIS RHEU, V34, P593, DOI 10.1016/j.semarthrit.2004.06.003; Park JH, 2004, J KOREAN MED SCI, V19, P137, DOI 10.3346/jkms.2004.19.1.137; Prendki V, 2011, AM J SURG PATHOL, V35, P337, DOI 10.1097/PAS.0b013e318209c681; Quesnel B, 1997, BRIT J HAEMATOL, V97, P508; RISDALL RJ, 1979, CANCER, V44, P993, DOI 10.1002/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5; Risma K, 2012, CURR OPIN PEDIATR, V24, P9, DOI 10.1097/MOP.0b013e32834ec9c1; Roschewski M, 2012, BEST PRACT RES CL HA, V25, P75, DOI 10.1016/j.beha.2012.01.005; Rouphael NG, 2007, LANCET INFECT DIS, V7, P814, DOI 10.1016/S1473-3099(07)70290-6; Barbon SR, 2009, MED CLIN-BARCELONA, V133, P74, DOI 10.1016/j.medcli.2008.09.026; Sano T, 2007, INT J CLIN ONCOL, V12, P59, DOI 10.1007/s10147-006-0627-9; Schaer DJ, 2005, EUR J HAEMATOL, V74, P6, DOI 10.1111/j.1600-0609.2004.00318.x; Schleinitz N, 2002, AM J MED, V112, P593, DOI 10.1016/S0002-9343(02)01066-5; Scott RB, 1939, LANCET, V2, P194; Seo YI, 2007, KOREAN J LAB MED, V27, P244, DOI 10.3343/kjlm.2007.27.4.244; Shimazaki C, 2001, INTERNAL MED, V40, P878, DOI 10.2169/internalmedicine.40.878; Shin HJ, 2008, J KOREAN MED SCI, V23, P439, DOI 10.3346/jkms.2008.23.3.439; Sieni E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044649; Stephan F, 1997, CLIN INFECT DIS, V25, P1159, DOI 10.1086/516086; Strauss R, 2004, CRIT CARE MED, V32, P1316, DOI 10.1097/01.CCM.0000127779.24232.15; Strout MP, 2010, NAT REV CLIN ONCOL, V7, P415, DOI 10.1038/nrclinonc.2010.40; Sumegi J, 2013, BLOOD, V121, pE14, DOI 10.1182/blood-2012-05-425769; Sumegi J, 2011, BLOOD, V117, pE151, DOI 10.1182/blood-2010-08-300046; Switala JR, 2012, J PEDIAT HEMATOL ONC, V34, pE89, DOI 10.1097/MPH.0b013e31824227b9; Tabata C, 2012, ANN HEMATOL, V91, P63, DOI 10.1007/s00277-011-1239-7; Tabata R, 2011, ANN HEMATOL, V90, P1365, DOI 10.1007/s00277-011-1187-2; Takagi S, 2009, BRIT J HAEMATOL, V147, P543, DOI 10.1111/j.1365-2141.2009.07863.x; Takahashi N, 2001, INT J HEMATOL, V74, P209, DOI 10.1007/BF02982007; Takahashi N, 2001, INT J HEMATOL, V74, P303, DOI 10.1007/BF02982065; Takahashi N, 2008, MOD RHEUMATOL, V18, P72, DOI 10.1007/s10165-007-0006-z; Takahashi S, 2007, EUR J DERMATOL, V17, P242; Takizawa Y, 2009, SCAND J RHEUMATOL, V38, P492, DOI 10.3109/03009740902971221; Tamura K, 2008, PEDIATR BLOOD CANCER, V51, P662, DOI 10.1002/pbc.21660; Tateishi Y, 2009, TRANSFUS APHER SCI, V40, P33, DOI 10.1016/j.transci.2008.11.001; Teramura T, 2002, LEUKEMIA LYMPHOMA, V43, P173, DOI 10.1080/10428190210176; Thompson PA, 2009, PEDIATR BLOOD CANCER, V52, P621, DOI 10.1002/pbc.21838; Tong HY, 2008, LEUKEMIA LYMPHOMA, V49, P81, DOI 10.1080/10428190701713630; Tseng YT, 2011, J MICROBIOL IMMUNOL, V44, P191, DOI 10.1016/j.jmii.2011.01.027; Tsuda H, 1997, LEUKEMIA LYMPHOMA, V28, P73, DOI 10.3109/10428199709058333; Tsuda H, 1996, AM J HEMATOL, V53, P285, DOI 10.1002/(SICI)1096-8652(199612)53:4<285::AID-AJH21>3.0.CO;2-A; Tsujimura Akane, 2006, Rinsho Ketsueki, V47, P1387; Tzeng HE, 2007, J FORMOS MED ASSOC, V106, pS55, DOI 10.1016/S0929-6646(09)60354-5; Valentin SM, 2010, AM J DERMATOPATH, V32, P716, DOI 10.1097/DAD.0b013e3181d775cf; Wang S, 2004, AM J HEMATOL, V77, P391, DOI 10.1002/ajh.20202; Wang Yi-Ni, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P1379; Wang Zhao, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P1064; Wang Z, 2009, INT J HEMATOL, V90, P501, DOI 10.1007/s12185-009-0391-5; Watabe R, 2000, ANN HEMATOL, V79, P581, DOI 10.1007/s002770000188; Watanabe H, 2012, MOD RHEUMATOL, V22, P284, DOI 10.1007/s10165-011-0491-y; Wolter M, 2002, ANN DERMATOL VENER, V129, P320; Xu XJ, 2012, J PEDIATR-US, V160, P984, DOI 10.1016/j.jpeds.2011.11.046; Yavuz A, 2004, TRANSPL P, V36, P120, DOI 10.1016/j.transproceed.2003.11.052; Zhang KJ, 2011, BLOOD, V118, P5794, DOI 10.1182/blood-2011-07-370148; Zhuang JL, 2011, CHINESE MED J-PEKING, V124, P3189, DOI 10.3760/cma.j.issn.0366-6999.2011.19.043; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	132	689	749	2	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1503	1516		10.1016/S0140-6736(13)61048-X	http://dx.doi.org/10.1016/S0140-6736(13)61048-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24290661				2022-12-28	WOS:000335325800031
J	Mony, BM; MacGregor, P; Ivens, A; Rojas, F; Cowton, A; Young, J; Horn, D; Matthews, K				Mony, Binny M.; MacGregor, Paula; Ivens, Alasdair; Rojas, Federico; Cowton, Andrew; Young, Julie; Horn, David; Matthews, Keith			Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei	NATURE			English	Article							PROTEIN-KINASE; CELL-CYCLE; STAGE DIFFERENTIATION; AFRICAN TRYPANOSOMES; LIFE-CYCLE; EXPRESSION; VIRULENCE; MALARIA; FORMS; TRANSMISSION	The protozoan parasites Trypanosoma brucei spp. cause important human and livestock diseases in sub-Saharan Africa. In mammalian blood, two developmental forms of the parasite exist: proliferative 'slender' forms and arrested 'stumpy' forms that are responsible for transmission to tsetse flies. The slender to stumpy differentiation is a density-dependent response that resembles quorum sensing in microbial systems and is crucial for the parasite life cycle, ensuring both infection chronicity and disease transmission(1). This response is triggered by an elusive 'stumpy induction factor' (SIF) whose intracellular signalling pathway is also uncharacterized. Laboratory-adapted (monomorphic) trypanosome strains respond inefficiently to SIF but can generate forms with stumpy characteristics when exposed to cell-permeable cAMP and AMP analogues. Exploiting this, we have used a genome-wide RNA interference library screen to identify the signalling components driving stumpy formation. In separate screens, monomorphic parasites were exposed to 8-(4-chlorophenylthio)-cAMP(pCPT-cAMP) or 8-pCPT-2'-O-methyl-5'-AMP to select cells that were unresponsive to these signals and hence remained proliferative. Genome-wide Ion Torrent based RNAi target sequencing identified cohorts of genes implicated in each step of the signalling pathway, from purine metabolism, through signal transducers (kinases, phosphatases) to gene expression regulators. Genes at each step were independently validated in cells naturally capable of stumpy formation, confirming their role in density sensing in vivo. The putative RNA-binding protein, RBP7, was required for normal quorum sensing and promoted cell-cycle arrest and transmission competence when overexpressed. This study reveals that quorum sensing signalling in trypanosomes shares similarities to fundamental quiescence pathways in eukaryotic cells, its components providing targets for quorum-sensing interference-based therapeutics.	[Mony, Binny M.; MacGregor, Paula; Ivens, Alasdair; Rojas, Federico; Cowton, Andrew; Young, Julie; Matthews, Keith] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Horn, David] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Edinburgh; University of Dundee	Matthews, K (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.	keith.matthews@ed.ac.uk	Rojas, Federico/AAG-6220-2020	Rojas, Federico/0000-0002-7018-2861; Ivens, Al/0000-0002-0112-3876; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184; Horn, David/0000-0001-5173-9284; MacGregor, Paula/0000-0003-0919-3745	Wellcome Trust [088293MA, 095831MA, 100320/Z/12/Z]; BBSRC [BB/I004602/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004602/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Wellcome Trust Programme grant (088293MA) to K.M. and by a Wellcome Trust strategic award (095831MA) to the Centre for Immunity, Infection and Evolution. D.H. is supported by a Wellcome Trust senior investigator award (100320/Z/12/Z). We thank M. Chase-Topping for statistical support.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; ALSFORD S, 2011, GENOME RES; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Barquilla A, 2012, P NATL ACAD SCI USA, V109, P14399, DOI 10.1073/pnas.1210465109; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; Gjini E, 2010, AM NAT, V176, P424, DOI 10.1086/656276; Goldenberg S, 2011, ADV PARASIT, V75, P285, DOI 10.1016/B978-0-12-385863-4.00013-7; Gould MK, 2013, ANTIMICROB AGENTS CH, V57, P4882, DOI 10.1128/AAC.00508-13; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Li ZY, 2006, EXP CELL RES, V312, P3504, DOI 10.1016/j.yexcr.2006.07.022; MacGregor P, 2013, MOL BIOCH PARASITOL; MacGregor P, 2012, NUCLEIC ACIDS RES, V40, P7705, DOI 10.1093/nar/gks533; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Matthews KR, 2011, SCIENCE, V331, P1149, DOI 10.1126/science.1198077; MATTHEWS KR, 1995, J CELL SCI, V108, P2231; Pfister DD, 2006, EUKARYOT CELL, V5, P1126, DOI 10.1128/EC.00094-06; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Robertson M, 1912, P R SOC LOND B-CONTA, V85, P241, DOI 10.1098/rspb.1912.0048; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Souza GM, 1998, DEVELOPMENT, V125, P2291; Tasker M, 2000, MOL BIOL CELL, V11, P1905, DOI 10.1091/mbc.11.5.1905; Vassella E, 1997, MOL BIOCHEM PARASIT, V90, P381, DOI 10.1016/S0166-6851(97)00171-0; Vassella E, 1997, J CELL SCI, V110, P2661; Vassella E, 2001, MOL MICROBIOL, V41, P33, DOI 10.1046/j.1365-2958.2001.02471.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	41	142	143	6	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					681	+		10.1038/nature12864	http://dx.doi.org/10.1038/nature12864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24336212	Green Accepted			2022-12-28	WOS:000330321000041
J	Sackett, CA				Sackett, Charles A.			QUANTUM PHYSICS An atomic SQUID	NATURE			English	Editorial Material							GASES		Univ Virginia, Dept Phys, Charlottesville, VA 22904 USA	University of Virginia	Sackett, CA (corresponding author), Univ Virginia, Dept Phys, Charlottesville, VA 22904 USA.	sackett@virginia.edu	Sackett, Charles/AAD-1452-2019	Sackett, Charles/0000-0001-6741-0571				Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Clarke J., 2004, SQUID HDB, V1; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Ryu C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.205301; Wright KC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025302	5	4	4	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					166	167		10.1038/nature12846	http://dx.doi.org/10.1038/nature12846			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24352238				2022-12-28	WOS:000329441500026
J	McGee, H				McGee, Harold			A festive ferment	NATURE			English	Editorial Material												harold@curiouscook.com							0	3	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					372	374		10.1038/504372a	http://dx.doi.org/10.1038/504372a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352277	Bronze			2022-12-28	WOS:000328575300030
J	Christakis, DA; Zimmerman, FJ				Christakis, Dimitri A.; Zimmerman, Frederick J.			Rethinking Reanalysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BONE MORPHOGENETIC PROTEIN-2; METAANALYSIS; FUSION		[Christakis, Dimitri A.] Seattle Childrens Res Inst, Seattle, WA USA; [Zimmerman, Frederick J.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	Seattle Children's Hospital; University of California System; University of California Los Angeles	Christakis, DA (corresponding author), Univ Washington, Dept Pediat, 1100 Olive Way,Ste 500, Seattle, WA 98101 USA.	dimitri.christakis@seattlechildrens.org	Zimmerman, Frederick/AAM-5432-2020	Zimmerman, Frederick/0000-0002-4163-9893				Attfield MD, 2012, JNCI-J NATL CANCER I, V104, P869, DOI 10.1093/jnci/djs035; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Meier B., 2011, NY TIMES, pB5; NIH, FIN NIH STAT SHAR RE; Rosenstock L, 2002, AM J PUBLIC HEALTH, V92, P14, DOI 10.2105/AJPH.92.1.14; Rowland Christopher, 2013, BOSTON GLOBE; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Weaver, 2013, WALL STR J	9	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2499	2500		10.1001/jama.2013.281337	http://dx.doi.org/10.1001/jama.2013.281337			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346985				2022-12-28	WOS:000328503600015
J	McLean, AR				McLean, Angela R.			Coming to an Airport Near You	SCIENCE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	McLean, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	angela.mclean@zoo.ox.ac.uk						Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Cliff AD, 2009, EMERGENCE REEMERGENC; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; McLean AR, 2004, PHILOS T R SOC B, V359, P1047, DOI 10.1098/rstb.2004.1488; Scarry R., 1968, WHAT DO PEOPLE DO AL	9	1	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1330	1331		10.1126/science.1247830	http://dx.doi.org/10.1126/science.1247830			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	268UL	24337285				2022-12-28	WOS:000328196000036
J	Pereira, IAC				Pereira, Ines A. C.			An Enzymatic Route to H-2 Storage	SCIENCE			English	Editorial Material							ELECTRON BIFURCATION; FORMATE; FERREDOXIN; CO2		Univ Nova Lisboa, ITQB Antonio Xavier, Bacterial Energy Metab Lab, P-2780157 Oeiras, Portugal	Universidade Nova de Lisboa	Pereira, IAC (corresponding author), Univ Nova Lisboa, ITQB Antonio Xavier, Bacterial Energy Metab Lab, Av Republ, P-2780157 Oeiras, Portugal.	ipereira@itqb.unl.pt	Pereira, Inês/C-2748-2009	Pereira, Inês/0000-0003-3283-4520				Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Costa KC, 2010, P NATL ACAD SCI USA, V107, P11050, DOI 10.1073/pnas.1003653107; Crable Bryan R, 2011, Enzyme Res, V2011, P532536, DOI 10.4061/2011/532536; da Silva SM, 2013, MICROBIOL-SGM, V159, P1760, DOI 10.1099/mic.0.067868-0; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Jiang HL, 2010, CHEMSUSCHEM, V3, P541, DOI 10.1002/cssc.201000023; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Sousa FL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0088; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12	14	15	17	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1329	1330		10.1126/science.1247698	http://dx.doi.org/10.1126/science.1247698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337284				2022-12-28	WOS:000328196000035
J	Martinez-Garcia, MA; Capote, F; Campos-Rodriguez, F; Lloberes, P; de Atauri, MJD; Somoza, M; Masa, JF; Gonzalez, M; Sacristan, L; Barbe, F; Duran-Cantolla, J; Aizpuru, F; Manas, E; Barreiro, B; Mosteiro, M; Cebrian, JJ; de la Pena, M; Garcia-Rio, F; Maimo, A; Zapater, J; Hernandez, C; SanMarti, NG; Montserrat, JM				Martinez-Garcia, Miguel-Angel; Capote, Francisco; Campos-Rodriguez, Francisco; Lloberes, Patricia; Diaz de Atauri, Maria Josefa; Somoza, Maria; Masa, Juan F.; Gonzalez, Monica; Sacristan, Lirios; Barbe, Ferran; Duran-Cantolla, Joaquin; Aizpuru, Felipe; Manas, Eva; Barreiro, Bienvenido; Mosteiro, Mar; Cebrian, Juan J.; de la Pena, Monica; Garcia-Rio, Francisco; Maimo, Andres; Zapater, Jordi; Hernandez, Concepcion; SanMarti, Nuria Grau; Montserrat, Josep Maria			Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension The HIPARCO Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; METAANALYSIS; DIAGNOSIS; HYPOPNEA; THERAPY; ASSOCIATION; PREVALENCE; PROGNOSIS; FEATURES; IMPACT	IMPORTANCE More than 70% of patients with resistant hypertension have obstructive sleep apnea (OSA). However, there is little evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with resistant hypertension. OBJECTIVE To assess the effect of CPAP treatment on blood pressure values and nocturnal blood pressure patterns in patients with resistant hypertension and OSA. DESIGN, SETTING, AND PARTICIPANTS Open-label, randomized, multicenter clinical trial of parallel groups with blinded end point design conducted in 24 teaching hospitals in Spain involving 194 patients with resistant hypertension and an apnea-hypopnea index (AHI) of 15 or higher. Data were collected from June 2009 to October 2011. INTERVENTIONS CPAP or no therapy while maintaining usual blood pressure control medication. MAIN OUTCOMES AND MEASURES The primary end point was the change in 24-hour mean blood pressure after 12 weeks. Secondary end points included changes in other blood pressure values and changes in nocturnal blood pressure patterns. Both intention-to-treat (ITT) and per-protocol analyses were performed. RESULTS A total of 194 patients were randomly assigned to receive CPAP (n = 98) or no CPAP (control; n = 96). The mean AHI was 40.4 (SD, 18.9) and an average of 3.8 antihypertensive drugs were taken per patient. Baseline 24-hour mean blood pressure was 103.4 mm Hg; systolic blood pressure (SBP), 144.2 mm Hg; and diastolic blood pressure (DBP), 83 mm Hg. At baseline, 25.8% of patients displayed a dipper pattern (a decrease of at least 10% in the average nighttime blood pressure compared with the average daytime blood pressure). The percentage of patients using CPAP for 4 or more hours per day was 72.4%. When the changes in blood pressure over the study period were compared between groups by ITT, the CPAP group achieved a greater decrease in 24-hour mean blood pressure (3.1 mm Hg [95% CI, 0.6 to 5.6]; P = .02) and 24-hour DBP (3.2 mm Hg [95% CI, 1.0 to 5.4]; P = .005), but not in 24-hour SBP (3.1 mm Hg [95% CI, -0.6 to 6.7]; P = .10) compared with the control group. Moreover, the percentage of patients displaying a nocturnal blood pressure dipper pattern at the 12-week follow-up was greater in the CPAP group than in the control group (35.9% vs 21.6%; adjusted odds ratio [OR], 2.4 [95% CI, 1.2 to 5.1]; P = .02). There was a significant positive correlation between hours of CPAP use and the decrease in 24-hour mean blood pressure (r = 0.29, P = .006), SBP (r = 0.25; P = .02), and DBP (r = 0.30, P = .005). CONCLUSIONS AND RELEVANCE Among patients with OSA and resistant hypertension, CPAP treatment for 12 weeks compared with control resulted in a decrease in 24-hour mean and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern. Further research is warranted to assess longer-term health outcomes.	[Martinez-Garcia, Miguel-Angel] Hosp Univ & Politecnico La Fe, Resp Dept, Valencia, Spain; [Capote, Francisco] Hosp Univ Virgen Rocio, Resp Dept, Seville, Spain; [Campos-Rodriguez, Francisco] Hosp Univ Valme, Resp Dept, Seville, Spain; [Lloberes, Patricia] Hosp Univ Vall Hebron, Resp Dept, Barcelona, Spain; [Diaz de Atauri, Maria Josefa] Hosp Univ 12 Octubre, Resp Dept, Madrid, Spain; [Somoza, Maria] Consorcio Sanitario Terrassa, Resp Dept, Barcelona, Spain; [Masa, Juan F.] Hosp Univ San Pedro Alcantara, Resp Dept, Caceres, Spain; [Gonzalez, Monica] Hosp Univ Marques Valdecilla, Resp Dept, Santander, Spain; [Sacristan, Lirios] Hosp Villajoyosa, Resp Dept, Alicante, Spain; [Barbe, Ferran] IRB Lleida, Lleida, Spain; [Duran-Cantolla, Joaquin] BioAraba Res Inst, Vitoria, Spain; [Duran-Cantolla, Joaquin] Hosp Univ Araba, Clin Res Unit, Vitoria, Spain; [Manas, Eva] Hosp Univ Ramon & Cajal, Resp Dept, Madrid, Spain; [Barreiro, Bienvenido] Hosp Univ Mutua Terrassa, Resp Dept, Barcelona, Spain; [Mosteiro, Mar] Hosp Univ Xeral, Resp Dept, Vigo, Spain; [Mosteiro, Mar] Hosp Univ Xeral, Resp Dept, Vigo, Spain; [Cebrian, Juan J.] Hosp Costa Sol, Resp Dept, Malaga, Spain; [de la Pena, Monica] Hosp Univ Son Espases, Resp Dept, Palma de Mallorca, Spain; [Garcia-Rio, Francisco] Hosp Univ La Paz, Resp Dept, IdiPAZ, Madrid, Spain; [Maimo, Andres] Hosp Son Llatzer, Resp Dept, Palma de Mallorca, Spain; [Zapater, Jordi] Hosp Igualada, Resp Dept, Barcelona, Spain; [Hernandez, Concepcion] Hosp Univ Palmas, Resp Dept, Gran Canaria, Spain; [SanMarti, Nuria Grau] Hosp Mar, Resp Dept, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; Virgen del Rocio University Hospital; Hospital Valme; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; Hospital Universitario Marques de Valdecilla (HUMV); Bioaraba Health Research Institute; University Hospital of Araba; Hospital Universitario Ramon y Cajal; Hospital Universitario Mutua Terrassa; Hospital Universitari Son Espases; Hospital Universitario La Paz; Hospital Universitari Son Llatzer; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Martinez-Garcia, MA (corresponding author), Hosp Univ & Politecn La Fe, Serv Neumol, Bulevar Sur S-N, E-46026 Valenicia, Spain.	mianmartinezgarcia@gmail.com	GONZALEZ, MONICA/AAM-4033-2021; Lloberes Canadell, Patricia/F-9707-2014; Cantolla, Joaquin Duran/B-6996-2015; Grilo-Reina, Antonio/S-8097-2018; Garcia-Rio, Francisco/AAC-9981-2020; mañas, pedro/F-1441-2015; Mañas, Eva/AGV-9568-2022; IBIS, SUEÑO/I-2520-2016; de la Torre, Manuel Sanchez/B-5578-2009; Barbé, Ferran/A-5988-2010; Martinez-Garcia, Miguel/AAA-6349-2019; Carmona-Bernal, Carmen/C-9429-2015; Capote, Francisco/E-9954-2015; Caballero Eraso, Candela/F-1455-2015	GONZALEZ, MONICA/0000-0003-1516-0181; Lloberes Canadell, Patricia/0000-0002-1595-8225; Grilo-Reina, Antonio/0000-0002-3702-2540; Mañas, Eva/0000-0003-2107-3316; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Barbé, Ferran/0000-0002-2340-8928; Martinez-Garcia, Miguel/0000-0002-7321-1891; Saracho, Ramon/0000-0002-7849-5440; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Campos-Rodriguez, Francisco/0000-0002-2632-3073; Garcia-Rio, Francisco/0000-0002-7227-2238; Gomez, Ricardo/0000-0001-9267-304X; EMBID, Cristina/0000-0002-3691-917X; Egea, Carlos/0000-0002-7618-7444; de la Pena, Monica/0000-0003-3276-776X	Philips-Respironics; Sociedad Espanola de Neumologia; Instituto de Salud Carlos III; Sociedad Valenciana de Neumologia	Philips-Respironics; Sociedad Espanola de Neumologia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad Valenciana de Neumologia	The study received a grant from Philips-Respironics, Sociedad Espanola de Neumologia, Instituto de Salud Carlos III, and Sociedad Valenciana de Neumologia.	Alajmi M, 2007, LUNG, V185, P67, DOI 10.1007/s00408-006-0117-x; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5991; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Franklin SS, 1997, CIRCULATION, V96, P308; Grote L, 2000, J HYPERTENS, V18, P679, DOI 10.1097/00004872-200018060-00004; Gugger M, 1997, EUR RESPIR J, V10, P587; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; HAYNES RB, 1976, LANCET, V1, P1265; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Hein H, 2002, AM J RESP CRIT CARE, V165, P305, DOI 10.1164/ajrccm.165.2.correspondence_a; Hui DS, 2006, THORAX, V61, P1083, DOI 10.1136/thx.2006.064063; Lloberes P, 2010, J SLEEP RES, V19, P597, DOI 10.1111/j.1365-2869.2010.00839.x; Logan AG, 2003, EUR RESPIR J, V21, P241, DOI 10.1183/09031936.03.00035402; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marrone O, 2011, CLIN EXP HYPERTENS, V33, P373, DOI 10.3109/10641963.2010.531853; Martinez-Garcia MA, 2007, EUR RESPIR J, V29, P951, DOI 10.1183/09031936.00048606; Martinez-Garcia MA, 2006, ARCH BRONCONEUMOL, V42, P14, DOI 10.1157/13083275; Masa JF, 2004, AM J RESP CRIT CARE, V170, P1218, DOI 10.1164/rccm.200312-1787OC; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Pavlova MK, 2008, SLEEP, V31, P241, DOI 10.1093/sleep/31.2.241; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Sanders Mark H, 2008, Proc Am Thorac Soc, V5, P161, DOI 10.1513/pats.200709-150MG; Schwartz SW, 2012, SLEEP, V35, P1585, DOI 10.5665/sleep.2218; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	412	433	1	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2407	2415		10.1001/jama.2013.281250	http://dx.doi.org/10.1001/jama.2013.281250			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327037	Bronze, Green Published			2022-12-28	WOS:000328030900021
J	Jamison, DT; Summers, LH; Alleyne, G; Arrow, KJ; Berkley, S; Binagwaho, A; Bustreo, F; Evans, D; Feachem, RGA; Frenk, J; Ghosh, G; Goldie, SJ; Guo, Y; Gupta, S; Horton, R; Kruk, ME; Mahmoud, A; Mohohlo, LK; Ncube, M; Pablos-Mendez, A; Reddy, KS; Saxenian, H; Soucat, A; Ulltveit-Moe, KH; Yamey, G				Jamison, Dean T.; Summers, Lawrence H.; Alleyne, George; Arrow, Kenneth J.; Berkley, Seth; Binagwaho, Agnes; Bustreo, Flavia; Evans, David; Feachem, Richard G. A.; Frenk, Julio; Ghosh, Gargee; Goldie, Sue J.; Guo, Yan; Gupta, Sanjeev; Horton, Richard; Kruk, Margaret E.; Mahmoud, Adel; Mohohlo, Linah K.; Ncube, Mthuli; Pablos-Mendez, Ariel; Reddy, K. Srinath; Saxenian, Helen; Soucat, Agnes; Ulltveit-Moe, Karene H.; Yamey, Gavin			Global health 2035: a world converging within a generation	LANCET			English	Review							SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; INCOME COUNTRIES; LIFE EXPECTANCY; 21 REGIONS; CARE; MORTALITY; DISEASE; BURDEN		[Jamison, Dean T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Summers, Lawrence H.] Harvard Univ, Cambridge, MA 02138 USA; [Frenk, Julio; Goldie, Sue J.] Harvard Univ, Harvard Sch Publ Hlth, Cambridge, MA 02138 USA; [Alleyne, George] Univ W Indies, Kingston 7, Jamaica; [Arrow, Kenneth J.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Arrow, Kenneth J.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Berkley, Seth] GAVI Alliance, Execut Off, Geneva, Switzerland; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Bustreo, Flavia] WHO, Family Womens & Childrens Hlth, Geneva, Switzerland; [Evans, David] WHO, Dept Hlth Syst Financing, Geneva, Switzerland; [Feachem, Richard G. A.; Yamey, Gavin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ghosh, Gargee] Bill & Melinda Gates Fdn, Washington, DC USA; [Guo, Yan] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Gupta, Sanjeev] Int Monetary Fund, Fiscal Affairs Dept, Washington, DC 20431 USA; [Horton, Richard] Lancet, London, England; [Kruk, Margaret E.] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY USA; [Mahmoud, Adel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Mahmoud, Adel] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Mohohlo, Linah K.] Bank Botswana, Gaborone, Botswana; [Pablos-Mendez, Ariel] African Dev Bank Grp, Tunis, Tunisia; [Pablos-Mendez, Ariel] US Agcy Int Dev, Bur Global Hlth, Washington, DC USA; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Saxenian, Helen] Results Dev Inst, Washington, DC USA; [Ulltveit-Moe, Karene H.] Univ Oslo, Dept Econ, Oslo, Norway	University of Washington; University of Washington Seattle; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University West Indies Mona Jamaica; Stanford University; Stanford University; World Health Organization; World Health Organization; University of California System; University of California San Francisco; Bill & Melinda Gates Foundation; Peking University; International Monetary Fund; Columbia University; Princeton University; Princeton University; African Development Bank Group (AfDB); United States Agency for International Development (USAID); Public Health Foundation of India; University of Oslo	Yamey, G (corresponding author), Global Hlth Grp, Evidence Policy Initiat, 50 Beale St,Suite 1200,Box 1224, San Francisco, CA 94105 USA.	yameyg@globalhealth.ucsf.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432; Reddy, K Srinath/0000-0003-3416-3548	Bill & Melinda Gates Foundation (Seattle, WA, USA); NORAD (Oslo, Norway); DCPN project; Bill & Melinda Gates Foundation at the Department of Global Health of the University of Washington (Seattle, WA, USA); Harvard Global Health Institute (Cambridge, MA, USA); UK Department for International Development (London, UK)	Bill & Melinda Gates Foundation (Seattle, WA, USA)(Bill & Melinda Gates Foundation); NORAD (Oslo, Norway); DCPN project; Bill & Melinda Gates Foundation at the Department of Global Health of the University of Washington (Seattle, WA, USA); Harvard Global Health Institute (Cambridge, MA, USA); UK Department for International Development (London, UK)	The two main funders of the Commission were the Bill & Melinda Gates Foundation (Seattle, WA, USA) and NORAD (Oslo, Norway). Additional funding came from the DCPN project funded by the Bill & Melinda Gates Foundation and based at the Department of Global Health of the University of Washington (Seattle, WA, USA), the Harvard Global Health Institute (Cambridge, MA, USA), and the UK Department for International Development (London, UK). The funding covered travel, accommodation, and meals for the Commission meetings, as well as development of background papers and research assistant time; additionally, the three members of the writing team (GY, DTJ, and HS) were reimbursed for their writing time from grants. The grants were managed by the Center for Disease Dynamics, Economics & Policy (Washington, DC, USA). GG is the Director of Development Policy and Finance at the Bill & Melinda Gates Foundation, and SJG is the Faculty Director of the Harvard Global Health Institute; the contributions of these two commissioners are documented in the contributors statement. Representatives of NORAD were invited to attend commission meetings, and participated in the Oslo meeting, but had no role in the drafting of the report. The DCPN project co-sponsored a meeting with the Commission and the Harvard Global Health Institute about the role of policy measures in reducing the incidence of non-communicable diseases; editors of the third edition of Disease Control Priorities in Developing Countries (DCP3), a core component of DCPN, provided background working papers that informed the Commission report; and DCP3 editors and authors commented on an early draft of the report. DTJ, co-chair of the Commission, is Principal Investigator and an editor for DCP3.	Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Acemoglu D, 2007, J POLIT ECON, V115, P925, DOI 10.1086/529000; Africa Progress Panel, 2013, 2013 AFR PROGR REP E; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; Aldy JE, 2013, DESIGNING ENERGY ENV; Alkire BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034595; Alleyne GA, 2002, EC GROWTH POVERY RED; [Anonymous], 2006, B WORLD HEALTH ORGAN, V84, P850; [Anonymous], 2012, LANCET, V380, P859, DOI 10.1016/S0140-6736(12)61485-8; [Anonymous], 1993, Lancet, V342, P63; [Anonymous], 2004, WORLD REP ROAD TRAFF; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], 2004, PRIVATE HLTH INSURAN; [Anonymous], 2012, SAV LIV CREAT IMPAC; [Anonymous], 2004, HUM RES HLTH OV CRIS; [Anonymous], 2011, HLTH NUTR POPULATION; [Anonymous], 2013, MDR TB XDR TB; [Anonymous], 2013, ECONOMIST; Arrow KJ, 2012, ENVIRON DEV ECON, V17, P317, DOI 10.1017/S1355770X12000137; AVERT, HIV AIDS IND; Baicker K, 2011, J ECON PERSPECT, V25, P47, DOI 10.1257/jep.25.2.47; BARNUM H, 1987, SOC SCI MED, V24, P833, DOI 10.1016/0277-9536(87)90184-5; Barrett S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0149; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Baumgartner J, 2012, GLOB HEART, V7, P243, DOI 10.1016/j.gheart.2012.06.018; Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563; Berman P., 2000, DECADE HLTH SECTOR R; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Blanchet N, 2013, GLOB COLL ACT HLTH W; Bloom D. E., 2004, Finance & Development, V41, P10; Bloom David E., 2009, 15137 NAT BUR EC RES; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695; Bloom DE, 1997, J ECONOMETRICS, V77, P105, DOI 10.1016/S0304-4076(96)01808-8; Bloom DE, MANSONS TROPICAL DIS; Bloom DE, 2011, GLOBAL BURDEN NONCOM; Bloomberg MR., 2013, NY TIMES; BOBADILLA JL, 1994, B WORLD HEALTH ORGAN, V72, P653; BOBADILLA JL, 1993, DIS CONTROL PRIORITI, P51; Bonfrer I, 2013, LANCET, V381, P19; Bosch M, 2012, TAKING STOCK 9 YEARS; Bourguignon F, 2002, AM ECON REV, V92, P727, DOI 10.1257/00028280260344443; Brundtland GH, 2002, WORK GROUP 2 GLOB PU; Brundtland GH, 1999, MESS DIRECTOR GEN; Bukhman G, 2011, PIH GUIDE CHRONIC CA; Calsyn M, 2012, ALT FEE FOR SERV PAY; Cameron TA, 2010, REV ENV ECON POLICY, V4, P161, DOI 10.1093/reep/req010; Center for Global Development, 2012, VAL MON AG GLOB HLTH; Central Office of Information, 1948, LEAFL PREP MIN HLTH; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chen JY, 2010, AM J MANAG CARE, V16, pE11; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cheng T.-M., 2012, EC PUBLIC HLTH CARE, P253; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Clements B, 2012, EC PUBLIC HEALTHCARE; Clift C., 2013, IDENTIFYING SUSTAINA; Coady D., 2012, EC PUBLIC HLTH CARE, P3; Collier P., 2007, BOTTOM BILLION WHY P; COSTELLO A, 1993, LANCET, V342, P440, DOI 10.1016/0140-6736(93)92857-P; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Crafts N, 2004, MACROECONOMICS OF HIV/AIDS, P182; Croghan TW, 2006, MILBANK Q, V84, P333, DOI 10.1111/j.1468-0009.2006.00450.x; Cropper M, 1110 RES FUT; D?az Y., 2013, IMPACT UNIVERSAL COV; DAVIS K, 1956, AM ECON REV, V46, P305; Deaton A, 2008, DEVELOPMENT ECONOMICS THROUGH THE DECADES: A CRITICAL LOOK AT 30 YEARS OF THE WORLD DEVELOPMENT REPORT, P105; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; del Rio C, 2002, AIDS, V16, P1445, DOI 10.1097/00002030-200207260-00001; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Downs SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1139; Dybul M, 2012, HOOVER I POLICY REV; Easterlin RA, 1999, EUR REV ECON HIST, V3, P257, DOI 10.1017/S1361491699000131; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; Eggleston KN, 2012, J ECON PERSPECT, V26, P137, DOI 10.1257/jep.26.3.137; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Elovainio R., 2013, RAISING SPENDING DOM; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Feachem RGA, 1992, HLTH ADULTS DEV WORL; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; Figueras J., 2005, PURCHASING IMPROVE H; Fink G, 2013, URBANIZATION CHILD M; Finkelstein A, 2005, NBER WORKING PAPER S, V11609; Fogel RW, 1997, HDB POPULATION FAM A, V1A, P483; Frakt A., 2013, ALMOST ANY COST CATA; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Futures Institute, 2011, ONE HLTH TOOL; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; Glassman A, 2011, GLOBAL HLTH NEW BOTT; Goldie SJ, 2013, RES DEV; Guillet P, 2001, B WORLD HEALTH ORGAN, V79, P998; Guilmoto CZ, 2012, DEMOGRAPHY, V49, P77, DOI 10.1007/s13524-011-0083-7; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Gutteridge WE, 2006, T ROY SOC TROP MED H, V100, pS21, DOI 10.1016/j.trstmh.2006.02.013; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Hecht R, 2012, RETHINKHIV: SMARTER WAYS TO INVEST IN ENDING HIV IN SUB-SAHARAN AFRICA, P299; Hernández-Torres Jinneth, 2008, Rev. salud pública, V10, P18, DOI 10.1590/S0124-00642008000100003; Hill K, 2013, ADOLESCENT MORTALITY; Horwitz A., 1987, COMP PUBLIC HLTH COS; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hsia RY, 2012, HEALTH POLICY PLANN, V27, P234, DOI 10.1093/heapol/czr023; IFPMA (International Federation of Pharmaceutical Manufacturers and Associations), 2012, PHARM R D PROJ DISC; Ijsselmuiden C, 2006, WHY HLTH RES; India UNICEF, 2013, WORLD AIDS DAY MOR P; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2012 E; Institute of Medicine, ACC PROGR OB PREV SO; Institute of Medicine Committee on Issues and Priorities for New Vaccine Development Division of Health Promotion and Disease Prevention, 1985, NEW VACC DEV EST PRI, V1; International Monetary Fund, 2013, EN SUBS REF LESS IMP; Jamison D. T., 1984, CHINA HLTH SECTOR; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jamison DT, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P67; Jamison Dean T., 2003, Food and Nutrition Bulletin, V24, P145; Jamison DT, 2013, HOW MUCH HAVE GLOBAL PROBLEMS COST THE WORLD?: A SCORECARD FROM 1900 TO 2050, P207; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Jamison DT, 2004, 21 DIS CONTR PRIOR; Jayasinghe KSA, 1998, SOC SCI MED, V47, P1619, DOI 10.1016/S0277-9536(98)00110-5; Jha P, 2012, TOB TAX WIN WIN MEAS; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011; Krivelli E, 2010, IMF WORKING PAPER; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Kruk ME, 2010, SOC SCI MED, V70, P904, DOI 10.1016/j.socscimed.2009.11.025; KUHN L, 1990, S AFR MED J, V77, P471; Kydland FE, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P701; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Larson N, 2009, MENU LABELING DOES P; Leatherman S., 2010, PERFORMANCE MEASUREM, P114; Lee Joy Li-Yueh, 2012, Am J Manag Care, V18, pe429; Lee K, 2006, PLOS MED, V3, P1080, DOI 10.1371/journal.pmed.0030228; Legge D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6877; Lightfoot N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f364; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Limwattananon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S6; Liu J, 2013, LANCET GLOB HEALTH, V1, pE2, DOI 10.1016/S2214-109X(13)70002-0; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; LOPEZ A D, 1990, World Health Statistics Quarterly, V43, P91; LOPEZ AD, 1993, DIS CONTROL PRIORITI, P35; Mackey TK, 2012, HEALTH POLICY, V107, P66, DOI 10.1016/j.healthpol.2012.04.006; Mahbubani Kishore, 2013, GREAT CONVERGENCE AS; Mahoney RT, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-33; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Misra R., 2006, DIS CONTROL PRIORITI; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Moon S, DRAFT CHATHAM HOUSE; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Moran M, 2012, NEGLETED DIS RES DEV; Moran M, 2013, HDB GLOBAL HLTH POLI; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; MORROW R, 1981, INT J EPIDEMIOL, V10, P73, DOI 10.1093/ije/10.1.73; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1826; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nelson TF, 2013, AM J PREV MED, V45, P19, DOI 10.1016/j.amepre.2013.03.008; Nordhaus WD, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P9; Norheim OF, 2013, ESTIMATED IMAPCT LIF; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Organisation for Economic Co-operation and Development, 2013, HLTH STAT; Oxley H, 2009, ACHIEVING BETTER VAL, P79; Pablos-Mendez A, 2012, COST DIS WHY COMPUTE, P94; PEARSON TA, 1993, DIS CONTROL PRIORITI, P577; Pedrique B, 2012, DRUG VACCINE PIPELIN; Philipson TJ, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P315; PISON G, 1993, INT J EPIDEMIOL, V22, P72, DOI 10.1093/ije/22.1.72; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rivera J, 2012, WORLD NUTR, V3; Roberts MJ., 2004, GETTING HLTH REFORM; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Roll Back Malaria, 2011, GLOB MAL ACT PLAN; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Rottingen JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001219; Rowden R, 2013, HEALTH HUM RIGHTS, V15, P175; Ruger JP, 2006, INT PUBLIC HLTH DIS, P601; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Sandy LG, 2013, HEALTH AFFAIR, V32, P1440, DOI 10.1377/hlthaff.2012.1082; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schieber GJ, 1997, INNOVATIONS HLTH CAR, P266; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Seddoh A, 2013, INV CAS NEGL TROP DI; Sekhri N, 2006, INT J HEALTH PLAN M, V21, P357, DOI 10.1002/hpm.857; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Smith PC, 2013, HEALTH ECON, V22, P180, DOI 10.1002/hec.2774; Specter Michael, 2005, NEW YORKER; Stabile M, 2013, HEALTH AFFAIR, V32, P643, DOI 10.1377/hlthaff.2012.1252; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Strauss J, 1998, J ECON LIT, V36, P766; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Suhrcke M, 2012, HLTH SYSTEMS HLTH WE; Taskforce on Innovative International Financing for Health Systems, 2009, CONSTR SCAL COSTS WO; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; The Global Health Group, 2011, MAINT GAINS GLOB MAL; The International Health Partnership, ONE HLTH TOOL; Thomas D, 2002, B WORLD HEALTH ORGAN, V80, P106; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1597; Towse A, 2004, BRIT MED J, V328, P103, DOI 10.1136/bmj.328.7431.103; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; UN Inter-agency Group for Maternal Mortality Estimation, 2012, TRENDS MAT MORT 1990; UN Univ. Int. Hum. Dimens. Program. Glob. Change/UN Environ. Program, 2012, INCL WEALTH REP 2012; UNAIDS, 2012, REP GLOB AIDS EP 201; United Nations, 2002, UN SESS CHILDR GUEST; United Nations Department of Economic and Social Affairs Population Division, WORLD URB PROSP 2011; United Nations Development Programme, 2013, HUM DEV REP 2013; United Nations Development Programme, 1994, HUM DEV REP 1994 NEW; United Nations-Department of Economic and Social Affairs (DESA), 2011, SEX DIFF CHILDH MORT; Usher D, 1973, MEASUEMENT EC SOCIAL; Vallin J, 2009, POPUL DEV REV, V35, P159, DOI 10.1111/j.1728-4457.2009.00264.x; van der Gaag J, 2008, NEW PAR HLTH SECT DE; Verguet S, 2013, 4 U WASH; Verguet S, HLTH EC IN PRESS; Verguet S, 2014, HEALTH POLICY PLANN, V29, P151, DOI 10.1093/heapol/czs143; Victora C, 2013, SELECTED ANAL INEQUA; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Walz J., 2011, BRAVE NEW WORLD LIT; Wang Jenny Qu, 2013, ASIAS ROLE GOVERNING, P39; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Wen M, 2012, J GERONTOL A-BIOL, V67, P1219, DOI 10.1093/gerona/gls094; Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2013, GLOB HEALTH EST SUMM; WHO, 2013, EVERY CHILD STRENGHT; WHO, NAT HLTH ACC DAT; WHO, 2011, SCAL ACT NONC DIS MU; WHO, 2008, CLOSING GAP GEN HEAL; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2010, 11 GEN PROGR WORK; WHO, 2012, ESS INT COMM GUID RE; *WHO AD HOC COMM H, 1996, INV HLTH RES DEV; WILLIAMSON JG, 1984, POP STUD-J DEMOG, V38, P157, DOI 10.2307/2174361; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Bank, 2012, MEX SYST SOC PROT HL; *WORLD BANK, 1993, WORLD DEV REP; World Bank, 2012, WORLD DEV IND 2012; World Health Organisation, 2011, PREV CONTR NCDS PRIO; World Health Organization, 2011, AB DECL 10 YEARS; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2013, WORLD HLTH STAT; World Health Organization, 2013, INV MENT HLTH EV ACT; World Health Organization, 2001, MACR HLTH INV HLTH E; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049; ZECKHAUSER R, 1976, LAW CONTEMP PROBL, V40, P5, DOI 10.2307/1191310	265	713	726	6	244	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1898	1955		10.1016/S0140-6736(13)62105-4	http://dx.doi.org/10.1016/S0140-6736(13)62105-4			58	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309475				2022-12-28	WOS:000328222400033
J	Kansagara, D; Dyer, E; Englander, H; Fu, RW; Freeman, M; Kagen, D				Kansagara, Devan; Dyer, Edward; Englander, Honora; Fu, Rongwei; Freeman, Michele; Kagen, David			Treatment of Anemia in Patients With Heart Disease A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; BLOOD-CELL TRANSFUSION; INTRAVENOUS FERRIC CARBOXYMALTOSE; CLINICAL-PRACTICE GUIDELINE; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; DARBEPOETIN-ALPHA; IRON-DEFICIENCY; DOUBLE-BLIND	Background: The benefits of anemia treatment in patients with heart disease are uncertain. Purpose: To evaluate the benefits and harms of treatments for anemia in adults with heart disease. Data Sources: MEDLINE, EMBASE, and Cochrane databases; clinical trial registries; reference lists; and technical advisors. Study Selection: English-language trials of blood transfusions, iron, or erythropoiesis-stimulating agents in adults with anemia and congestive heart failure or coronary heart disease and observational studies of transfusion. Data Extraction: Data on study design, population characteristics, hemoglobin levels, and health outcomes were extracted. Trials were assessed for quality. Data Synthesis: Low-strength evidence from 6 trials and 26 observational studies suggests that liberal transfusion protocols do not improve short-term mortality rates compared with less aggressive protocols (combined relative risk among trials, 0.94 [95% CI, 0.61 to 1.42]; I-2 = 16.8%), although decreased mortality rates occurred in a small trial of patients with the acute coronary syndrome (1.8% vs. 13.0%; P = 0.032). Moderate-strength evidence from 3 trials of intravenous iron found improved short-term exercise tolerance and quality of life in patients with heart failure. Moderate- to high-strength evidence from 17 trials of erythropoiesis-stimulating agent therapy found they offered no consistent benefits, but their use may be associated with harms, such as venous thromboembolism. Limitations: Few trials have examined transfusions in patients with heart disease, and observational studies are potentially confounded by indication. Data supporting iron use come mainly from 1 large trial, and long-term effects are unknown. Conclusion: Higher transfusion thresholds do not consistently improve mortality rates, but large trials are needed. Intravenous iron may help to alleviate symptoms in patients with heart failure and iron deficiency and also warrants further study. Erythropoiesis-stimulating agents do not seem to benefit patients with mild to moderate anemia and heart disease and may be associated with serious harms.	[Kansagara, Devan] Portland VA Med Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Kansagara, D (corresponding author), Portland VA Med Ctr, Mailcode RD71,3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA.	kansagar@ohsu.edu			U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs.	Aggarwal C, 2011, CORONARY ARTERY DIS, V22, P194, DOI 10.1097/MCA.0b013e328342cd81; Alexander KP, 2008, AM HEART J, V155, P1047, DOI 10.1016/j.ahj.2008.01.009; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Aronson D, 2008, AM J CARDIOL, V102, P115, DOI 10.1016/j.amjcard.2008.03.027; Athar MK, 2011, J CRIT CARE, V26, P335, DOI 10.1016/j.jcrc.2010.08.008; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; BELLINGHIERI G, 1994, CONTRIB NEPHROL, V106, P135; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2008, NEW ENGL J MED, V358, P433, DOI 10.1056/NEJMc076523; Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x; Bursi F, 2009, EUR J VASC ENDOVASC, V37, P311, DOI 10.1016/j.ejvs.2008.12.002; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Comin-Colet J, 2013, EUR HEART J, V34, P30, DOI 10.1093/eurheartj/ehr504; Comin-Colet J, 2009, J CARD FAIL, V15, P727, DOI 10.1016/j.cardfail.2009.05.010; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; da Silveira AD, 2008, CORONARY ARTERY DIS, V19, P21, DOI 10.1097/MCA.0b013e3282f27c0a; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doyle BJ, 2008, JACC-CARDIOVASC INTE, V1, P202, DOI 10.1016/j.jcin.2007.12.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Felker GM, 2004, J AM COLL CARDIOL, V44, P959, DOI 10.1016/j.jacc.2004.05.070; Garty M, 2009, AM HEART J, V158, P653, DOI 10.1016/j.ahj.2009.08.001; Gerber DR, 2008, CRIT CARE MED, V36, P1068, DOI 10.1097/CCM.0b013e318169251f; Ghali JK, 2008, CIRCULATION, V117, P526, DOI 10.1161/CIRCULATIONAHA.107.698514; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Gonzalez-Costello J, 2010, EUR J HEART FAIL, V12, P1159, DOI 10.1093/eurjhf/hfq165; Gutzwiller FS, 2012, EUR J HEART FAIL, V14, P782, DOI 10.1093/eurjhf/hfs083; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herbert PC, 2001, ANASTH INTENSIV NOTF, V36, pS94; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Jani SM, 2007, CLIN CARDIOL, V30, P49, DOI 10.1002/clc.20236; Jolicoeur EM, 2009, EUR HEART J, V30, P2575, DOI 10.1093/eurheartj/ehp279; Kansagara D, 2011, TREATMENT ANEMIA PAT; Kao DP, 2011, AM J CARDIOL, V107, P69, DOI 10.1016/j.amjcard.2010.08.046; Kim P, 2007, CLIN CARDIOL, V30, P35, DOI 10.1002/clc.20231; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Komajda M, 2006, EUR HEART J, V27, P1440, DOI 10.1093/eurheartj/ehl012; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Kourea K, 2008, EUR J CARDIOV PREV R, V15, P365, DOI 10.1097/HJR.0b013e3282f849d0; Lyseng-Williamson KA, 2009, DRUGS, V69, P739, DOI 10.2165/00003495-200969060-00007; Maluenda G, 2009, AM J CARDIOL, V104, P1069, DOI 10.1016/j.amjcard.2009.06.006; Maluenda G, 2009, J AM COLL CARDIOL, V53, pA84; Maluenda G, 2009, J AM COLL CARDIOL, V53, pA72; Malyszko J, 2010, ISR MED ASSOC J, V12, P489; Mancini DM, 2003, CIRCULATION, V107, P294, DOI 10.1161/01.CIR.0000044914.42696.6A; Nikolsky E, 2009, JACC-CARDIOVASC INTE, V2, P624, DOI 10.1016/j.jcin.2009.05.004; Norris S, 2010, METHODS GUIDE COMP E; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P1178, DOI 10.1016/j.jclinepi.2010.04.027; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Palazzuoli A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.005; Palazzuoli A, 2009, J CARDIOVASC PHARM, V53, P462, DOI 10.1097/FJC.0b013e3181a6ac38; Palazzuoli A, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.022; Parissis JT, 2009, AM J CARDIOL, V103, P1134, DOI 10.1016/j.amjcard.2008.12.041; Parissis JT, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2008.01.016; Pfeffer MA, 2009, AM J KIDNEY DIS, V54, P59, DOI 10.1053/j.ajkd.2009.04.008; Ponikowski P, 2007, J AM COLL CARDIOL, V49, P753, DOI 10.1016/j.jacc.2006.11.024; Qunibi WY, 2011, NEPHROL DIAL TRANSPL, V26, P1599, DOI 10.1093/ndt/gfq613; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singla I, 2007, AM J CARDIOL, V99, P1119, DOI 10.1016/j.amjcard.2006.11.056; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Szczech LA, 2010, KIDNEY INT, V77, P239, DOI 10.1038/ki.2009.415; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; van Veldhuisen DJ, 2007, EUR HEART J, V28, P2208, DOI 10.1093/eurheartj/ehm328; Wells G., NEWCASTLE OTTAWA SCA; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yang G, 2005, J AM COLL CARDIOL, V46, P1490, DOI 10.1016/j.jacc.2005.06.072; Yatskar L, 2007, CATHETER CARDIO INTE, V69, P961, DOI 10.1002/ccd.21087	81	42	43	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					746	+		10.7326/0003-4819-159-11-201312030-00007	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00007			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297191				2022-12-28	WOS:000328731000004
J	Park, IU; Peacey, MW; Munafo, MR				Park, In-Uck; Peacey, Mike W.; Munafo, Marcus R.			Modelling the effects of subjective and objective decision making in scientific peer review	NATURE			English	Article							PUBLISHED RESEARCH; RELIABILITY; SCIENCE; TRIALS; FALSE	The objective of science is to advance knowledge, primarily in two interlinked ways: circulating ideas, and defending or criticizing the ideas of others. Peer review acts as the gatekeeper to these mechanisms. Given the increasing concern surrounding the reproducibility of much published research(1), it is critical to understand whether peer review is intrinsically susceptible to failure, or whether other extrinsic factors are responsible that distort scientists' decisions. Here we show that even when scientists are motivated to promote the truth, their behaviour may be influenced, and even dominated, by information gleaned from their peers' behaviour, rather than by their personal dispositions. This phenomenon, known as herding, subjects the scientific community to an inherent risk of converging on an incorrect answer and raises the possibility that, under certain conditions, science may not be self-correcting. We further demonstrate that exercising some subjectivity in reviewer decisions, which serves to curb the herding process, can be beneficial for the scientific community in processing available information to estimate truth more accurately. By examining the impact of different models of reviewer decisions on the dynamic process of publication, and thereby on eventual aggregation of knowledge, we provide a new perspective on the ongoing discussion of how the peer-review process may be improved.	[Park, In-Uck; Peacey, Mike W.] Univ Bristol, Dept Econ, Bristol BS8 1TN, Avon, England; [Park, In-Uck] Sungkyunkwan Univ, Dept Econ, Seoul 110745, South Korea; [Peacey, Mike W.] Univ Bath, Dept Econ, Bath BA2 7AY, Avon, England; [Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol BS8 1BN, Avon, England; [Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Bristol BS8 1TU, Avon, England; [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TU, Avon, England	University of Bristol; Sungkyunkwan University (SKKU); University of Bath; University of Bristol; University of Bristol; University of Bristol	Munafo, MR (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol BS8 1BN, Avon, England.	marcus.munafo@bristol.ac.uk	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X	Economics and Social Research Council UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research under the UK Clinical Research Collaboration; Economic and Social Research Council [ES/H005331/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish; ESRC [ES/H005331/1] Funding Source: UKRI; MRC [MC_UU_12013/6] Funding Source: UKRI	Economics and Social Research Council UK; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under the UK Clinical Research Collaboration; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by an Economics and Social Research Council UK PhD studentship to M.W.P. M.R.M. is a member of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The authors are grateful to S. Murphy for her assistance in coding the meta-analysis study abstracts, and to A. Bird and G. Huxley for their comments on earlier drafts of this manuscript.	Almenberg J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008500; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Barnes B., 1996, SCI KNOWLEDGE SOCIOL; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Billingsley P., 1995, PROBABILITY MEASURE; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Brembs B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00291; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Davey Smith G., 2005, BIOPSYCHOSOCIAL MED, P77; EDWARDS AWF, 1986, J HERED, V77, P138, DOI 10.1093/oxfordjournals.jhered.a110192; Freeses J, 2008, INTERGENERATIONAL CA, P145; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Ioannidis JPA, 2012, J PSYCHOSOM RES, V73, P408, DOI 10.1016/j.jpsychores.2012.09.014; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Pfeiffer T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005996; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Yong E, 2012, NATURE, V487, P18, DOI 10.1038/487018a	29	60	61	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					93	+		10.1038/nature12786	http://dx.doi.org/10.1038/nature12786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	303BA	24305052				2022-12-28	WOS:000330648100038
J	Maures, TJ; Booth, LN; Benayoun, BA; Izrayelit, Y; Schroeder, FC; Brunet, A				Maures, Travis J.; Booth, Lauren N.; Benayoun, Berenice A.; Izrayelit, Yevgeniy; Schroeder, Frank C.; Brunet, Anne			Males Shorten the Life Span of C. elegans Hermaphrodites via Secreted Compounds	SCIENCE			English	Article							LARVAL DEVELOPMENT; CAENORHABDITIS; PHEROMONE; LONGEVITY; EVOLUTION; INSULIN	How an individual's longevity is affected by the opposite sex is still largely unclear. In the nematode Caenorhabditis elegans, the presence of males accelerated aging and shortened the life span of individuals of the opposite sex (hermaphrodites), including long-lived or sterile hermaphrodites. The male-induced demise could occur without mating and required only exposure of hermaphrodites to medium in which males were once present. Such communication through pheromones or other diffusible substances points to a nonindividual autonomous mode of aging regulation. The male-induced demise also occurred in other species of nematodes, suggesting an evolutionary conserved process whereby males may induce the disposal of the opposite sex to save resources for the next generation or to prevent competition from other males.	[Maures, Travis J.; Booth, Lauren N.; Benayoun, Berenice A.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Brunet, Anne] Glenn Labs Biol Aging Stanford, Stanford, CA 94305 USA	Stanford University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	abrunet1@stanford.edu	Benayoun, Bérénice A./K-7048-2012	Benayoun, Bérénice A./0000-0002-7401-4777; Schroeder, Frank/0000-0002-4420-0237	Glenn Foundation for Medical Research; Helen Hay Whitney Foundation; Stanford Dean's Fellowship [R01GM088290, T32GM008500];  [R01AG031198];  [DP1AG044848];  [F32AG37254];  [T32HG000044]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM088290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031198, F32AG037254, DP1AG044848] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Helen Hay Whitney Foundation; Stanford Dean's Fellowship; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Brunet laboratory, S. Kim, A. Fire, and A. Villeneuve for helpful suggestions and J. Lim and S. Zimmerman for critical reading of the manuscript. We thank N. Kosovilka and the Protein and Nucleic Acid Facility facility for the microarray experiments and T. Stiernagle from the Caenorhabditis Genetics Center. Supported by R01AG031198, DP1AG044848, the Glenn Foundation for Medical Research (A. B.), postdoctoral fellowship F32AG37254 (T. J. M.), T32HG000044 and the Helen Hay Whitney Foundation (L. N. B.), Stanford Dean's Fellowship (BAB), R01GM088290 (F. C. S.), and T32GM008500 (Y.I.).	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gems D, 2000, GENETICS, V154, P1597; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Ludewig AH, 2013, P NATL ACAD SCI USA, V110, P5522, DOI 10.1073/pnas.1214467110; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; van Swinderen B, 2002, GENETICS, V161, P109	30	100	104	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					541	544		10.1126/science.1244160	http://dx.doi.org/10.1126/science.1244160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24292626	Green Accepted			2022-12-28	WOS:000330343700047
J	Adams, K				Adams, Keith			Genomic Clues to the Ancestral Flowering Plant	SCIENCE			English	Editorial Material							HORIZONTAL TRANSFER; ANGIOSPERM; GENES		Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Adams, K (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	keitha@mail.ubc.ca						Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Bergthorsson U, 2004, P NATL ACAD SCI USA, V101, P17747, DOI 10.1073/pnas.0408336102; Chamala S, 2013, SCIENCE, V342, P1516, DOI 10.1126/science.1241130; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Vekemans D, 2012, MOL BIOL EVOL, V29, P3793, DOI 10.1093/molbev/mss183	8	6	6	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1456	1457		10.1126/science.1248709	http://dx.doi.org/10.1126/science.1248709			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357306				2022-12-28	WOS:000328644300039
J	Harris, SE; Bellino, M				Harris, Stephen E.; Bellino, Marissa			DNA Barcoding from NYC to Belize	SCIENCE			English	Editorial Material									[Harris, Stephen E.] CUNY, Grad Ctr, Program Ecol Evolutionary Biol & Behav, New York, NY 10016 USA; [Harris, Stephen E.; Bellino, Marissa] Petters Res Inst, Biodivers Ctr Belize, Dangriga, Belize; [Bellino, Marissa] CUNY, Grad Ctr, Program Urban Educ, New York, NY 10016 USA	City University of New York (CUNY) System; City University of New York (CUNY) System	Harris, SE (corresponding author), CUNY, Grad Ctr, Program Ecol Evolutionary Biol & Behav, New York, NY 10016 USA.	harris.stephen.e@gmail.com						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Cox CE, 2013, CONSERV LETT, V6, P132, DOI 10.1111/j.1755-263X.2012.00286.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hoskins SG, 2007, GENETICS, V176, P1381, DOI 10.1534/genetics.107.071183; Micklos D, 2011, SCIENCE, V334, P1657, DOI 10.1126/science.1197074; Santschi L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001471	6	8	9	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1462	1463		10.1126/science.1230006	http://dx.doi.org/10.1126/science.1230006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	274ZI	24357310				2022-12-28	WOS:000328644300043
J	Klampfl, T; Gisslinger, H; Harutyunyan, AS; Nivarthi, H; Rumi, E; Milosevic, JD; Them, NCC; Berg, T; Gisslinger, B; Pietra, D; Chen, D; Vladimer, GI; Bagienski, K; Milanesi, C; Casetti, IC; Sant'Antonio, E; Ferretti, V; Elena, C; Schischlik, F; Cleary, C; Six, M; Schalling, M; Schonegger, A; Bock, C; Malcovati, L; Pascutto, C; Superti-Furga, G; Cazzola, M; Kralovics, R				Klampfl, Thorsten; Gisslinger, Heinz; Harutyunyan, Ashot S.; Nivarthi, Harini; Rumi, Elisa; Milosevic, Jelena D.; Them, Nicole C. C.; Berg, Tiina; Gisslinger, Bettina; Pietra, Daniela; Chen, Doris; Vladimer, Gregory I.; Bagienski, Klaudia; Milanesi, Chiara; Casetti, Ilaria Carola; Sant'Antonio, Emanuela; Ferretti, Virginia; Elena, Chiara; Schischlik, Fiorella; Cleary, Ciara; Six, Melanie; Schalling, Martin; Schoenegger, Andreas; Bock, Christoph; Malcovati, Luca; Pascutto, Cristiana; Superti-Furga, Giulio; Cazzola, Mario; Kralovics, Robert			Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; GAIN-OF-FUNCTION; PRIMARY MYELOFIBROSIS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC MODEL; PREDICT SURVIVAL; COMPETING RISKS; JAK2; DISORDERS	Background Approximately 50 to 60% of patients with essential thrombocythemia or primary myelofibrosis carry a mutation in the Janus kinase 2 gene (JAK2), and an additional 5 to 10% have activating mutations in the thrombopoietin receptor gene (MPL). So far, no specific molecular marker has been identified in the remaining 30 to 45% of patients. MethodsWe performed whole-exome sequencing to identify somatically acquired mutations in six patients who had primary myelofibrosis without mutations in JAK2 or MPL. Resequencing of CALR, encoding calreticulin, was then performed in cohorts of patients with myeloid neoplasms. ResultsSomatic insertions or deletions in exon 9 of CALR were detected in all patients who underwent whole-exome sequencing. Resequencing in 1107 samples from patients with myeloproliferative neoplasms showed that CALR mutations were absent in polycythemia vera. In essential thrombocythemia and primary myelofibrosis, CALR mutations and JAK2 and MPL mutations were mutually exclusive. Among patients with essential thrombocythemia or primary myelofibrosis with nonmutated JAK2 or MPL, CALR mutations were detected in 67% of those with essential thrombocythemia and 88% of those with primary myelofibrosis. A total of 36 types of insertions or deletions were identified that all cause a frameshift to the same alternative reading frame and generate a novel C-terminal peptide in the mutant calreticulin. Overexpression of the most frequent CALR deletion caused cytokine-independent growth in vitro owing to the activation of signal transducer and activator of transcription 5 (STAT5) by means of an unknown mechanism. Patients with mutated CALR had a lower risk of thrombosis and longer overall survival than patients with mutated JAK2. ConclusionsMost patients with essential thrombocythemia or primary myelofibrosis that was not associated with a JAK2 or MPL alteration carried a somatic mutation in CALR. The clinical course in these patients was more indolent than that in patients with the JAK2 V617F mutation. (Funded by the MPN Research Foundation and Associazione Italiana per la Ricerca sul Cancro.)	[Klampfl, Thorsten; Harutyunyan, Ashot S.; Nivarthi, Harini; Milosevic, Jelena D.; Them, Nicole C. C.; Berg, Tiina; Chen, Doris; Vladimer, Gregory I.; Bagienski, Klaudia; Schischlik, Fiorella; Cleary, Ciara; Six, Melanie; Schoenegger, Andreas; Bock, Christoph; Superti-Furga, Giulio; Kralovics, Robert] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Gisslinger, Heinz; Gisslinger, Bettina; Schalling, Martin; Kralovics, Robert] Med Univ Vienna, Div Hematol & Blood Coagulat, Dept Internal Med 1, Vienna, Austria; [Rumi, Elisa; Pietra, Daniela; Milanesi, Chiara; Casetti, Ilaria Carola; Sant'Antonio, Emanuela; Ferretti, Virginia; Elena, Chiara; Malcovati, Luca; Pascutto, Cristiana; Cazzola, Mario] Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Dept Hematol Oncol, Pavia, Italy; [Malcovati, Luca; Cazzola, Mario] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Pavia	Kralovics, R (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT25-3, A-1090 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Superti-Furga, Giulio/F-4755-2015; Rumi, Elisa/J-7424-2016; Ferretti, Virginia/ABA-6196-2021; Cazzola, Mario/AAQ-8854-2021; Feenstra, Jelena D Milosevic/K-2114-2012; Schalling, Martin/F-1518-2015; Pietra, Daniela/F-3931-2016; Superti-Furga, Giulio/AAE-5681-2019; Malcovati, Luca/CAJ-1695-2022; Bock, Christoph/AAE-7618-2019; Vladimer, Gregory/X-4547-2018; Harutyunyan, Ashot S/M-3528-2014	Superti-Furga, Giulio/0000-0002-0570-1768; Rumi, Elisa/0000-0002-7572-9504; Ferretti, Virginia/0000-0003-0130-915X; Cazzola, Mario/0000-0001-6984-8817; Feenstra, Jelena D Milosevic/0000-0001-7420-3298; Schalling, Martin/0000-0001-5011-2922; Pietra, Daniela/0000-0002-6575-8766; Malcovati, Luca/0000-0002-1460-1611; Bock, Christoph/0000-0001-6091-3088; Vladimer, Gregory/0000-0003-4205-7585; Harutyunyan, Ashot S/0000-0002-9050-9315; Kralovics, Robert/0000-0002-6997-8539; Klampfl, Thorsten/0000-0002-6666-9773; CASETTI, ILARIA CAROLA/0000-0001-5232-9543; milanesi, chiara/0000-0003-0391-4126; ELENA, CHIARA/0000-0002-0058-7142; Chen, Doris/0000-0001-8835-0280	MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro [1005]	MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Supported by grants from the MPN Research Foundation (to Dr. Kralovics) and Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5 per Mille, project 1005, to Dr. Cazzola).	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Carbuccia N, 2009, LEUKEMIA, V23, P2183, DOI 10.1038/leu.2009.141; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Harutyunyan A, 2011, NEW ENGL J MED, V364, P488, DOI 10.1056/NEJMc1012718; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lasho TL, 2012, BLOOD, V120, P4168, DOI 10.1182/blood-2012-05-429696; Malcovati L, 2009, BLOOD, V114, P3538, DOI 10.1182/blood-2009-05-222331; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Passamonti F, 2012, BLOOD, V120, P1197, DOI 10.1182/blood-2012-01-403279; Passamonti F, 2011, BLOOD, V117, P2813, DOI 10.1182/blood-2010-11-316810; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rumi E, 2013, BLOOD, V121, P4388, DOI 10.1182/blood-2013-02-486050; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405	32	1304	1378	5	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2379	2390		10.1056/NEJMoa1311347	http://dx.doi.org/10.1056/NEJMoa1311347			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24325356	Bronze			2022-12-28	WOS:000328586000006
J	Threapleton, DE; Greenwood, DC; Evans, CEL; Cleghorn, CL; Nykjaer, C; Woodhead, C; Cade, JE; Gale, CP; Burley, VJ				Threapleton, Diane E.; Greenwood, Darren C.; Evans, Charlotte E. L.; Cleghorn, Christine L.; Nykjaer, Camilla; Woodhead, Charlotte; Cade, Janet E.; Gale, Christopher P.; Burley, Victoria J.			Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MEASUREMENT ERROR; CARBOHYDRATE INTAKE; CEREAL FIBER; REDUCED RISK; MORTALITY; NUTRITION; MEN; HEALTH; CANCER	Objective To investigate dietary fibre intake and any potential dose-response association with coronary heart disease and cardiovascular disease. Design Systematic review of available literature and dose-response meta-analysis of cohort studies using random effects models. Data sources The Cochrane Library, Medline, Medline in-process, Embase, CAB Abstracts, ISI Web of Science, BIOSIS, and hand searching. Eligibility criteria for studies Prospective studies reporting associations between fibre intake and coronary heart disease or cardiovascular disease, with a minimum follow-up of three years and published in English between 1 January 1990 and 6 August 2013. Results 22 cohort study publications met inclusion criteria and reported total dietary fibre intake, fibre subtypes, or fibre from food sources and primary events of cardiovascular disease or coronary heart disease. Total dietary fibre intake was inversely associated with risk of cardiovascular disease (risk ratio 0.91 per 7 g/day (95% confidence intervals 0.88 to 0.94)) and coronary heart disease (0.91 (0.87 to 0.94)). There was evidence of some heterogeneity between pooled studies for cardiovascular disease (I-2= 45% (0% to 74%)) and coronary heart disease (I-2= 33% (0% to 66%)). Insoluble fibre and fibre from cereal and vegetable sources were inversely associated with risk of coronary heart disease and cardiovascular disease. Fruit fibre intake was inversely associated with risk of cardiovascular disease. Conclusions Greater dietary fibre intake is associated with a lower risk of both cardiovascular disease and coronary heart disease. Findings are aligned with general recommendations to increase fibre intake. The differing strengths of association by fibre type or source highlight the need for a better understanding of the mode of action of fibre components.	[Threapleton, Diane E.; Evans, Charlotte E. L.; Cleghorn, Christine L.; Nykjaer, Camilla; Woodhead, Charlotte; Cade, Janet E.; Burley, Victoria J.] Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds LS2 9JT, W Yorkshire, England; [Greenwood, Darren C.; Gale, Christopher P.] Univ Leeds, Ctr Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Burley, VJ (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds LS2 9JT, W Yorkshire, England.	v.j.burley@leeds.ac.uk	Threapleton, Diane/AAP-8205-2021; Greenwood, Darren C/C-3220-2008; Cade, Janet E/G-4250-2016; Evans, Charlotte/L-7735-2015	Threapleton, Diane/0000-0002-5884-3372; Greenwood, Darren C/0000-0001-7035-3096; Cade, Janet E/0000-0003-3421-0121; Burley, Victoria/0000-0003-0282-2932; Gale, Chris/0000-0003-4732-382X; Nykjaer, Camilla/0000-0002-8648-9972; Evans, Charlotte/0000-0002-4065-4397	Department of Health for England; Kellogg Marketing and Sales Company (UK); Danone	Department of Health for England; Kellogg Marketing and Sales Company (UK); Danone(Danone Nutricia)	The main systematic review was funded by the Department of Health for England. The update review was conducted primarily by DET, whose PhD studentship is sponsored by Kellogg Marketing and Sales Company (UK). Funding bodies played no part in article selection, analysis, interpretation; or decision to publish. Kellogg Marketing and Sales Company (UK) sponsored the main author studentship. One author is in receipt of an unrelated project grant from Danone. Funders played no part in article selection, analysis, interpretation, or decision to publish.	Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Allender S, 2008, EUROPEAN CARDIOVASCU; [American Institute for Cancer Research World Cancer Research Fund], 2007, 2 EXP REP FOOD NUTR; Appleby PN, 1999, AM J CLIN NUTR, V70, p525S, DOI 10.1093/ajcn/70.3.525s; Baer HJ, 2011, AM J EPIDEMIOL, V173, P319, DOI 10.1093/aje/kwq368; Bates B., 2008, NATL DIET NUTR SURVE; Bazzano LA, 2003, ARCH INTERN MED, V163, P1897, DOI 10.1001/archinte.163.16.1897; Bernstein AM, 2011, EUR J EPIDEMIOL, V26, P877, DOI 10.1007/s10654-011-9626-x; Buyken AE, 2010, AM J CLIN NUTR, V92, P634, DOI 10.3945/ajcn.2010.29390; Chuang SC, 2012, AM J CLIN NUTR, V96, P164, DOI 10.3945/ajcn.111.028415; COMA, 1994, NUTR ASP CARD DIS; *COMA, 1991, DIET REF VAL FOOD EN; Crowe FL, 2012, EUR J CLIN NUTR, V66, P950, DOI 10.1038/ejcn.2012.51; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Drogan D, 2007, J NUTR, V137, P1961, DOI 10.1093/jn/137.8.1961; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eshak ES, 2010, J NUTR, V140, P1445, DOI 10.3945/jn.110.122358; FEHILY AM, 1993, BRIT J NUTR, V69, P303, DOI 10.1079/BJN19930035; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hauner H, 2012, ANN NUTR METAB, V60, P1, DOI 10.1159/000335326; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; James SL, 2003, INTERN MED J, V33, P291, DOI 10.1046/j.1445-5994.2003.00404.x; Kaushik S, 2009, STROKE, V40, P206, DOI 10.1161/STROKEAHA.108.513812; Kipnis V, 2003, AM J EPIDEMIOL, V158, P25, DOI 10.1093/aje/kwg094; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Kipnis V, 2008, J NATL CANCER I, V100, P1658, DOI 10.1093/jnci/djn408; KNEKT P, 1994, AM J EPIDEMIOL, V139, P1180, DOI 10.1093/oxfordjournals.aje.a116964; Kokubo Y, 2011, EUR J CLIN NUTR, V65, P1233, DOI 10.1038/ejcn.2011.100; Laaksonen DE, 2005, ARCH INTERN MED, V165, P193, DOI 10.1001/archinte.165.2.193; Larsson SC, 2009, EUR J CLIN NUTR, V63, P1016, DOI 10.1038/ejcn.2009.16; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Liu SM, 2002, J AM COLL CARDIOL, V39, P49, DOI 10.1016/S0735-1097(01)01695-3; Lunn J, 2007, NUTR BULL, V32, P21, DOI 10.1111/j.1467-3010.2007.00616.x; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mozaffarian D, 2003, JAMA-J AM MED ASSOC, V289, P1659, DOI 10.1001/jama.289.13.1659; Orsini N, 2011, STATA J, V11, P1; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Pietinen P, 1996, CIRCULATION, V94, P2720, DOI 10.1161/01.CIR.94.11.2720; PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; StataCorp, 2011, STAT STAT SOFTW REL, P173; Streppel MT, 2008, AM J CLIN NUTR, V88, P1119, DOI 10.1093/ajcn/88.4.1119; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Threapleton DE, 2013, EUR J EPIDEMIOL, V28, P335, DOI 10.1007/s10654-013-9799-6; Todd S, 1999, AM J EPIDEMIOL, V150, P1073, DOI 10.1093/oxfordjournals.aje.a009931; Townsend N, 2012, CORONARY HEART DIS S; TROWELL H, 1972, AM J CLIN NUTR, V25, P926; Truswell AS, 2002, EUR J CLIN NUTR, V56, P1, DOI 10.1038/sj.ejcn.1601283; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Van Horn L, 2008, J AM DIET ASSOC, V108, P287, DOI 10.1016/j.jada.2007.10.050; Wallstrom P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031637; Ward HA, 2012, EUR J CLIN NUTR, V66, P296, DOI 10.1038/ejcn.2011.184; Wells G., 2013, NEWCASTLE OTTAWA SCA; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325	63	376	389	7	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f6879	10.1136/bmj.f6879	http://dx.doi.org/10.1136/bmj.f6879			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355537	Green Published, hybrid			2022-12-28	WOS:000328824300001
J	Downie, A; Williams, CM; Henschke, N; Hancock, MJ; Ostelo, RWJG; de Vet, HCW; Macaskill, P; Irwig, L; van Tulder, MW; Koes, BW; Maher, CG				Downie, Aron; Williams, Christopher M.; Henschke, Nicholas; Hancock, Mark J.; Ostelo, Raymond W. J. G.; de Vet, Henrica C. W.; Macaskill, Petra; Irwig, Les; van Tulder, Maurits W.; Koes, Bart W.; Maher, Christopher G.			Red flags to screen for malignancy and fracture in patients with low back pain: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUMBAR SPINE FILMS; DIAGNOSTIC-TESTS; PRIMARY-CARE; EUROPEAN GUIDELINES; AMERICAN-COLLEGE; TEST ACCURACY; HEALTH-CARE; MANAGEMENT; RADIOGRAPHY; DISEASE	Objective To review the evidence on diagnostic accuracy of red flag signs and symptoms to screen for fracture or malignancy in patients presenting with low back pain to primary, secondary, or tertiary care. Design Systematic review. Data sources Medline, OldMedline, Embase, and CINAHL from earliest available up to 1 October 2013. Inclusion criteria Primary diagnostic studies comparing red flags for fracture or malignancy to an acceptable reference standard, published in any language. Review methods Assessment of study quality and extraction of data was conducted by three independent assessors. Diagnostic accuracy statistics and post-test probabilities were generated for each red flag. Results We included 14 studies (eight from primary care, two from secondary care, four from tertiary care) evaluating 53 red flags; only five studies evaluated combinations of red flags. Pooling of data was not possible because of index test heterogeneity. Many red flags in current guidelines provide virtually no change in probability of fracture or malignancy or have untested diagnostic accuracy. The red flags with the highest post-test probability for detection of fracture were older age (9%, 95% confidence interval 3% to 25%), prolonged use of corticosteroid drugs (33%, 10% to 67%), severe trauma (11%, 8% to 16%), and presence of a contusion or abrasion (62%, 49% to 74%). Probability of spinal fracture was higher when multiple red flags were present (90%, 34% to 99%). The red flag with the highest post-test probability for detection of spinal malignancy was history of malignancy (33%, 22% to 46%). Conclusions While several red flags are endorsed in guidelines to screen for fracture or malignancy, only a small subset of these have evidence that they are indeed informative. These findings suggest a need for revision of many current guidelines.	[Downie, Aron; Williams, Christopher M.; Henschke, Nicholas; Maher, Christopher G.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Downie, Aron] Macquarie Univ, Fac Sci, Sydney, NSW 2109, Australia; [Henschke, Nicholas] Heidelberg Univ, Inst Publ Hlth, D-69115 Heidelberg, Germany; [Hancock, Mark J.] Macquarie Univ, Fac Human Sci, Sydney, NSW 2109, Australia; [Ostelo, Raymond W. J. G.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands; [de Vet, Henrica C. W.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Macaskill, Petra] Sch Publ Hlth, Screening & Test Evaluat Program STEP, Sydney, NSW, Australia; [Irwig, Les] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [van Tulder, Maurits W.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Koes, Bart W.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands	George Institute for Global Health; University of Sydney; Macquarie University; Ruprecht Karls University Heidelberg; Macquarie University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Sydney; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Downie, A (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201, Sydney, NSW 2050, Australia.	adownie@georgeinstitute.org.au	Henschke, Nicholas/C-2975-2014; Downie, Aron/I-3971-2013; Koes, Bart w/K-4614-2016; Maher, Christopher/AAC-6267-2019; Williams, Christopher M/A-2395-2011; Williams, Christopher M/AAU-7946-2021; van Tulder, Maurits/AAB-9785-2022; Ostelo, Raymond/GSE-2602-2022	Henschke, Nicholas/0000-0002-9624-2519; Downie, Aron/0000-0002-9888-3854; Koes, Bart w/0000-0002-0450-9969; Maher, Christopher/0000-0002-1628-7857; Williams, Christopher M/0000-0001-8896-0978; Williams, Christopher M/0000-0001-8896-0978; van Tulder, Maurits/0000-0002-7589-8471; Macaskill, Petra/0000-0001-5879-6193; Hancock, Mark/0000-0002-9277-5377; Ostelo, Raymond/0000-0001-7679-7210; de Vet, Henrica/0000-0002-5454-2804				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; [Anonymous], 2012, REV MAN REVMAN VERS; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bachmann LM, 2003, BRIT MED J, V326, P393; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Cook C, 2012, PAIN PRACT, V12, P426, DOI 10.1111/j.1533-2500.2011.00519.x; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deeks JJ., 2009, COCHRANE DATABASE SY; DEYO RA, 1986, J GEN INTERN MED, V1, P20, DOI 10.1007/BF02596320; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2013, NEW ENGL J MED, V368, P1056, DOI 10.1056/NEJMe1215599; Donner-Banzhoff N, 2006, FAM PRACT, V23, P682, DOI 10.1093/fampra/cml049; FRAZIER LM, 1989, ARCH INTERN MED, V149, P47, DOI 10.1001/archinte.149.1.47; Friedrich M, 2007, WIEN KLIN WOCHENSCHR, V119, P189, DOI 10.1007/s00508-006-0754-3; GIBSON M, 1992, ARCH EMERG MED, V9, P28; Government of Western Australia Department of Health, 2013, DIAGN IM PATHW LOW B; Henschke N, 2010, COCHRANE DB SYST REV; Henschke N, 2010, COCHRANE DB SYST REV, V9; Henschke N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008686.pub2; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Jacobson AF, 1997, ARCH INTERN MED, V157, P105, DOI 10.1001/archinte.157.1.105; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Khoo LAL, 2003, CLIN RADIOL, V58, P606, DOI 10.1016/S0009-9260(03)00173-9; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Laerum Even, 2007, Tidsskr Nor Laegeforen, V127, P2706; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Michaleff ZA, 2012, CAN MED ASSOC J, V184, pE867, DOI 10.1503/cmaj.120675; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Health and Medical Research Council, 2004, EV BAS MAN AC MUSC P; National Institute for Health and Care Excelence, 2009, NICE CLIN KNOWL SUMM; National Institute for Health and Care Excelence, 2013, LOW BACK PAIN EARL M; Negrini S, 2006, Eura Medicophys, V42, P151; PATRICK JD, 1983, ANN EMERG MED, V12, P84, DOI 10.1016/S0196-0644(83)80378-3; Poitras S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-54; Reinus WR, 1998, AM J ROENTGENOL, V170, P443, DOI 10.2214/ajr.170.2.9456961; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; Roman M, 2010, J MAN MANIP THER, V18, P44, DOI 10.1179/106698110X12595770849641; SCAVONE JG, 1981, JAMA-J AM MED ASSOC, V246, P1105, DOI 10.1001/jama.246.10.1105; Steurer J, 2002, BRIT MED J, V324, P824, DOI 10.1136/bmj.324.7341.824; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; van den Bosch MAAJ, 2004, CLIN RADIOL, V59, P69, DOI 10.1016/j.crad.2003.08.012; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Waddell G, 2004, BACK PAIN REVOLUTION; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Williams CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008643.pub2; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	51	145	146	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f7095	10.1136/bmj.f7095	http://dx.doi.org/10.1136/bmj.f7095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335669	Green Published, hybrid			2022-12-28	WOS:000328575000003
J	Lane, R				Lane, Richard			Dean Jamison: putting economics at the heart of global health	LANCET			English	Biographical-Item																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1871	1871		10.1016/S0140-6736(13)62613-6	http://dx.doi.org/10.1016/S0140-6736(13)62613-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24315167				2022-12-28	WOS:000328222400016
J	Kruglov, AA; Grivennikov, SI; Kuprash, DV; Winsauer, C; Prepens, S; Seleznik, GM; Eberl, G; Littman, DR; Heikenwalder, M; Tumanov, AV; Nedospasov, SA				Kruglov, Andrey A.; Grivennikov, Sergei I.; Kuprash, Dmitry V.; Winsauer, Caroline; Prepens, Sandra; Seleznik, Gitta Maria; Eberl, Gerard; Littman, Dan R.; Heikenwalder, Mathias; Tumanov, Alexei V.; Nedospasov, Sergei A.			Nonredundant Function of Soluble LT alpha(3) Produced by Innate Lymphoid Cells in Intestinal Homeostasis	SCIENCE			English	Article							B-CELLS; GUT; GENERATION; RESPONSES; MICE	Immunoglobulin A (IgA) production at mucosal surfaces contributes to protection against pathogens and controls intestinal microbiota composition. However, mechanisms regulating IgA induction are not completely defined. We show that soluble lymphotoxin alpha (sLT alpha(3)) produced by ROR gamma t(+) innate lymphoid cells (ILCs) controls T cell-dependent IgA induction in the lamina propria via regulation of T cell homing to the gut. By contrast, membrane-bound lymphotoxin beta (LT alpha(1)beta(2)) produced by ROR gamma t(+) ILCs is critical for T cell-independent IgA induction in the lamina propria via control of dendritic cell functions. Ablation of LT alpha in ROR gamma t(+) cells abrogated IgA production in the gut and altered microbiota composition. Thus, soluble and membrane-bound lymphotoxins produced by ILCs distinctly organize adaptive immune responses in the gut and control commensal microbiota composition.	[Kruglov, Andrey A.; Winsauer, Caroline; Prepens, Sandra; Nedospasov, Sergei A.] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Kruglov, Andrey A.; Kuprash, Dmitry V.; Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Kruglov, Andrey A.; Kuprash, Dmitry V.; Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA; [Kuprash, Dmitry V.; Nedospasov, Sergei A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Seleznik, Gitta Maria; Heikenwalder, Mathias] Univ Zurich Hosp, Inst Clin Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Eberl, Gerard] Inst Pasteur, F-75724 Paris, France; [Eberl, Gerard] Inst Pasteur, Dept Biotechnol, CNRS, Unite Rech Associee 1961, F-75724 Paris, France; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany; [Tumanov, Alexei V.] Trudeau Inst, Saranac Lake, NY 12983 USA	Deutsches Rheuma-Forschungszentrum (DRFZ); Lomonosov Moscow State University; Lomonosov Moscow State University; Fox Chase Cancer Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Zurich; University Zurich Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Howard Hughes Medical Institute; New York University; New York University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Trudeau Institute	Kruglov, AA (corresponding author), German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany.	andrey_krugloff@mail.ru; sergei@nedos.net	Nedospasov, Sergei/Q-7319-2016; Kuprash, Dmitry/O-4899-2015; Kruglov, Andrey/AAP-2023-2021; Heikenwalder, Mathias/AAA-2269-2020; Tumanov, Alexei/AAR-1607-2021; Kruglov, Andrey A/F-7543-2017; Grivennikov, Sergei/AAE-7365-2019; Eberl, Gerard/A-1160-2013; Nedospasov, Sergei/L-1990-2015; Nedospasov, Sergei/C-3043-2018	Kuprash, Dmitry/0000-0002-1488-4148; Tumanov, Alexei/0000-0001-6042-0152; Kruglov, Andrey A/0000-0002-4597-2087; Grivennikov, Sergei/0000-0003-2987-0555; Eberl, Gerard/0000-0002-1119-5638	Deutsche Forschungsgemeinschaft [SFB633 A13, NE1466/2-1]; MCB Program of the Russian Academy of Sciences; Crohn's and Colitis Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MCB Program of the Russian Academy of Sciences; Crohn's and Colitis Foundation	We thank S. Fillatreau, J. Gommerman, A. Rudensky, and F. Melchers for useful discussions and critiques; K. Holden-Dye for editing of the manuscript; L. Drutskaya, K. Horn, M. Drutskaya, and D. Schlienz for expert technical support throughout the project; H. Schafer, S. Gruczek, and M. Ohde for excellent animal husbandry; the members of the German Rheumatism Research Center Flow Cytometry Core Facility (T. Kaiser, J. Kirsch) for help with FACS analysis and cell sorting; H. Hecker-Kia, H. Schliemann, and T. Geske for antibody preparation; and J. Hirscher for help with figure preparation. Supported by Deutsche Forschungsgemeinschaft grants (SFB633 A13 and NE1466/2-1) and the MCB Program of the Russian Academy of Sciences (S.A.N. and D. V. K.), and the Crohn's and Colitis Foundation (A. V. T.). Bacterial 16S rRNA pyrosequencing reads have been deposited in the NCBI Short Read Archive database with accession numbers SRX362155, SRX362156, SRX362157, and SRX362158. Author contributions: A. A. K. and S.A.N. designed research; A. A. K., D. V. K., S. I. G., S. P., C. W., G. M. S., M. H., and A. V. T. performed experiments; D. R. L. and G. E. provided ROR gamma t-Cre animals and discussed the data; and A. A. K. and S.A.N. wrote the manuscript.	Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Liepinsh DJ, 2006, MOL CELL BIOL, V26, P4214, DOI 10.1128/MCB.01751-05; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newberry RD, 2002, J IMMUNOL, V168, P4988, DOI 10.4049/jimmunol.168.10.4988; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	29	180	193	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1243	1246		10.1126/science.1243364	http://dx.doi.org/10.1126/science.1243364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311691				2022-12-28	WOS:000327857900050
J	Mani, A; Mullainathan, S; Shafir, E; Zhao, JY				Mani, Anandi; Mullainathan, Sendhil; Shafir, Eldar; Zhao, Jiaying			Response to Comment on "Poverty Impedes Cognitive Function"	SCIENCE			English	Editorial Material								Wicherts and Scholten criticized our study on statistical and psychometric grounds. We show that (i) using a continuous income variable, the interaction between income, and experimental manipulation remains reliable across our experiments; (ii) our results in the cognitive control task do not appear driven by ceiling effects; and (iii) our observed post-harvest improvement is robust to the presence of learning.	[Mani, Anandi] Univ Warwick, Dept Econ, Coventry CV4 7AL, W Midlands, England; [Mullainathan, Sendhil] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Shafir, Eldar] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Shafir, Eldar] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08540 USA; [Zhao, Jiaying] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Zhao, Jiaying] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z4, Canada	University of Warwick; Harvard University; Princeton University; Princeton University; University of British Columbia; University of British Columbia	Zhao, JY (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	jiayingz@psych.ubc.ca	Shafir, Eldar/H-9957-2014					Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Iyengar SS, 2006, PSYCHOL SCI, V17, P143, DOI 10.1111/j.1467-9280.2006.01677.x; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Seamon JG, 1998, PSYCHOL SCI, V9, P20, DOI 10.1111/1467-9280.00004; Wicherts JM, 2013, SCIENCE, V342, DOI 10.1126/science.1246680	8	15	15	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163								10.1126/science.1246799	http://dx.doi.org/10.1126/science.1246799			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264DT	24311666				2022-12-28	WOS:000327857900021
J	Schmidt, D				Schmidt, Dominic			Evolution of Vertebrate Transcriptional Regulator Binding	SCIENCE			English	Editorial Material									LEK Consulting, London SW1X 7JL, England		Schmidt, D (corresponding author), LEK Consulting, 40 Grosvenor Pl, London SW1X 7JL, England.	dominic.schmidt@cantab.net			Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	14	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163								10.1126/science.1247569	http://dx.doi.org/10.1126/science.1247569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311678				2022-12-28	WOS:000327857900033
J	Suchowski, H; O'Brien, K; Wong, ZJ; Salandrino, A; Yin, XB; Zhang, X				Suchowski, Haim; O'Brien, Kevin; Wong, Zi Jing; Salandrino, Alessandro; Yin, Xiaobo; Zhang, Xiang			Phase Mismatch-Free Nonlinear Propagation in Optical Zero-Index Materials	SCIENCE			English	Article							NEGATIVE-INDEX; 2ND-HARMONIC GENERATION; METAMATERIALS	Phase matching is a critical requirement for coherent nonlinear optical processes such as frequency conversion and parametric amplification. Phase mismatch prevents microscopic nonlinear sources from combining constructively, resulting in destructive interference and thus very low efficiency. We report the experimental demonstration of phase mismatch-free nonlinear generation in a zero-index optical metamaterial. In contrast to phase mismatch compensation techniques required in conventional nonlinear media, the zero index eliminates the need for phase matching, allowing efficient nonlinear generation in both forward and backward directions. We demonstrate phase mismatch-free nonlinear generation using intrapulse four-wave mixing, where we observed a forward-to-backward nonlinear emission ratio close to unity. The removal of phase matching in nonlinear optical metamaterials may lead to applications such as multidirectional frequency conversion and entangled photon generation.	[Suchowski, Haim; O'Brien, Kevin; Wong, Zi Jing; Salandrino, Alessandro; Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011; Wong, Zi Jing/AGP-9517-2022; Suchowski, Haim/GZL-5700-2022; Salandrino, Alessandro/U-8022-2019; Yin, Xiaobo/A-4142-2011; Salandrino, Alessandro/B-5898-2011	Salandrino, Alessandro/0000-0002-8643-9764; Zhang, Xiang/0000-0002-3272-894X; Wong, Zi Jing/0000-0003-0746-3473	U.S. Department of Energy, Office of Basic Energy Sciences through the Materials Sciences Division of Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Fulbright Foundation	U.S. Department of Energy, Office of Basic Energy Sciences through the Materials Sciences Division of Lawrence Berkeley National Laboratory; Fulbright Foundation	Supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-05CH11231 through the Materials Sciences Division of Lawrence Berkeley National Laboratory. H. S. and Z.J.W. acknowledge partial support by the Fulbright Foundation. We thank the Molecular Foundry, Lawrence Berkeley National Laboratory, for technical support in nanofabrication.	Argyropoulos C, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045129; Arie A, 2010, LASER PHOTONICS REV, V4, P355, DOI 10.1002/lpor.200910006; ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Barnett SM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070401; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Canalias C, 2007, NAT PHOTONICS, V1, P459, DOI 10.1038/nphoton.2007.137; Dani KM, 2009, NANO LETT, V9, P3565, DOI 10.1021/nl9017644; Dudovich N, 2002, NATURE, V418, P512, DOI 10.1038/nature00933; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Gu XH, 1998, J OPT SOC AM B, V15, P1561, DOI 10.1364/JOSAB.15.001561; Hum DS, 2007, CR PHYS, V8, P180, DOI 10.1016/j.crhy.2006.10.022; Minovich A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3695165; O'Brien K, 2012, OPT LETT, V37, P4089, DOI 10.1364/OL.37.004089; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Popov AK, 2006, APPL PHYS B-LASERS O, V84, P131, DOI 10.1007/s00340-006-2167-4; Popov AK, 2006, OPT LETT, V31, P2169, DOI 10.1364/OL.31.002169; Popov AK, 2009, OPT LETT, V34, P1165, DOI 10.1364/OL.34.001165; Reinhold J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115401; Roke S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115106; Rose A, 2011, OPT MATER EXPRESS, V1, P1232; Rose A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063902; Scalora M, 2006, OPT EXPRESS, V14, P4746, DOI 10.1364/OE.14.004746; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Tang SW, 2011, OPT EXPRESS, V19, P18283, DOI 10.1364/OE.19.018283; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; VESELAGO VG, 1967, FIZ TVERD TELA+, V8, P2854; Vesseur EJR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.013902	29	218	221	13	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1223	1226		10.1126/science.1244303	http://dx.doi.org/10.1126/science.1244303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311687				2022-12-28	WOS:000327857900045
J	Victora, GD				Victora, Gabriel D.			Stop, Go, and Evolve	SCIENCE			English	Editorial Material							GERMINAL CENTER; DYNAMICS; MUTATION; BROAD; CELLS; LIGHT		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Victora, GD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	victora@wi.mit.edu		Victora, Gabriel/0000-0001-8807-348X				BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Janeway Jr C. A., 2001, IMMUNOBIOLOGY IMMUNE; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0	18	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163								10.1126/science.1247567	http://dx.doi.org/10.1126/science.1247567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311676				2022-12-28	WOS:000327857900031
J	Markson, JS; Piechura, JR; Puszynska, AM; O'Shea, EK				Markson, Joseph S.; Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.			Circadian Control of Global Gene Expression by the Cyanobacterial Master Regulator RpaA	CELL			English	Article							ELONGATUS PCC 7942; SYNECHOCOCCUS-ELONGATUS; TRANSCRIPTIONAL REGULATION; OUTPUT PATHWAYS; CELL-DIVISION; IN-VITRO; CLOCK; PHOSPHORYLATION; OSCILLATOR; RHYTHM	The cyanobacterial circadian clock generates genome-wide transcriptional oscillations and regulates cell division, but the underlying mechanisms are not well understood. Here, we show that the response regulator RpaA serves as the master regulator of these clock outputs. Deletion of rpaA abrogates gene expression rhythms globally and arrests cells in a dawn-like expression state. Although rpaA deletion causes core oscillator failure by perturbing clock gene expression, rescuing oscillator function does not restore global expression rhythms. We show that phosphorylated RpaA regulates the expression of not only clock components, generating feedback on the core oscillator, but also a small set of circadian effectors that, in turn, orchestrate genome-wide transcriptional rhythms. Expression of constitutively active RpaA is sufficient to switch cells from a dawn-like to a dusk-like expression state as well as to block cell division. Hence, complex global circadian phenotypes can be generated by controlling the phosphorylation of a single transcription factor.	[Markson, Joseph S.; Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Markson, Joseph S.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu		Markson, Joseph/0000-0002-3167-3887	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Vikram Vijayan for the 48 hr wild-type gene expression time course and for code, technical assistance, and discussion; Andrian Gutu for Phos-tag western blots; and Andrian Gutu, Xu Zhou, Abbas Rizvi, Brian Zid, Michael Rust (University of Chicago), Guogang Dong (UCSD), and Susan Golden (UCSD) for discussion and advice. We thank Richard Losick, Bodo Stern, and Andrian Gutu for comments on the manuscript and Takao Kondo (Nagoya University) and Susan Golden for plasmids and strains. This work was supported by the Howard Hughes Medical Institute.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Edery I, 2011, GENE DEV, V25, P2321, DOI 10.1101/gad.180984.111; Gutu A, 2013, MOL CELL, V50, P288, DOI 10.1016/j.molcel.2013.02.022; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Joshua S, 2005, BBA-BIOENERGETICS, V1709, P58, DOI 10.1016/j.bbabio.2005.06.005; Kim YI, 2012, P NATL ACAD SCI USA, V109, P17765, DOI 10.1073/pnas.1216401109; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kutsuna S, 2005, MOL MICROBIOL, V57, P1474, DOI 10.1111/j.1365-2958.2005.04781.x; Marbouty M, 2009, J BACTERIOL, V191, P6178, DOI 10.1128/JB.00723-09; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Moronta-Barrios F, 2012, MICROBIOL-SGM, V158, P1229, DOI 10.1099/mic.0.057679-0; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Murayama Y, 2008, J BACTERIOL, V190, P1691, DOI 10.1128/JB.01693-07; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nakajima M, 2010, FEBS LETT, V584, P898, DOI 10.1016/j.febslet.2010.01.016; Nakamichi N, 2012, P NATL ACAD SCI USA, V109, P17123, DOI 10.1073/pnas.1205156109; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Paddock ML, 2013, P NATL ACAD SCI USA, V110, pE3849, DOI 10.1073/pnas.1315170110; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; Vijayan V, 2013, J BACTERIOL, V195, P665, DOI 10.1128/JB.02012-12; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	42	90	92	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1396	1408		10.1016/j.cell.2013.11.005	http://dx.doi.org/10.1016/j.cell.2013.11.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315105	Green Accepted, Bronze			2022-12-28	WOS:000328271100021
J	Watt, G; Giacaman, R; Zurayk, H; Horton, R				Watt, Graham; Giacaman, Rita; Zurayk, Huda; Horton, Richard		LPHA Steering Grp	Progress of The Lancet Palestinian Health Alliance	LANCET			English	Editorial Material									[Watt, Graham] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland; [Giacaman, Rita] Birzeit Univ, Inst Community & Publ Hlth, West Bank, Israel; [Zurayk, Huda] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Glasgow; Birzeit University; American University of Beirut	Watt, G (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland.	graham.watt@glasgow.ac.uk	Husseini, Abdullatif/E-8377-2015	Husseini, Abdullatif/0000-0001-8767-5956					0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					E5	E6		10.1016/S0140-6736(13)62233-3	http://dx.doi.org/10.1016/S0140-6736(13)62233-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	24315727				2022-12-28	WOS:000330212600001
J	Grotzinger, JP; Sumner, DY; Kah, LC; Stack, K; Gupta, S; Edgar, L; Rubin, D; Lewis, K; Schieber, J; Mangold, N; Milliken, R; Conrad, PG; DesMarais, D; Farmer, J; Siebach, K; Calef, F; Hurowitz, J; McLennan, SM; Ming, D; Vaniman, D; Crisp, J; Vasavada, A; Edgett, KS; Malin, M; Blake, D; Gellert, R; Mahaffy, P; Wiens, RC; Maurice, S; Grant, JA; Wilson, S; Anderson, RC; Beegle, L; Arvidson, R; Hallet, B; Sletten, RS; Rice, M; Bell, J; Griffes, J; Ehlmann, B; Anderson, RB; Bristow, TF; Dietrich, WE; Dromart, G; Eigenbrode, J; Fraeman, A; Hardgrove, C; Herkenhoff, K; Jandura, L; Kocurek, G; Lee, S; Leshin, LA; Leveille, R; Limonadi, D; Maki, J; McCloskey, S; Meyer, M; Minitti, M; Newsom, H; Oehler, D; Okon, A; Palucis, M; Parker, T; Rowland, S; Schmidt, M; Squyres, S; Steele, A; Stolper, E; Summons, R; Treiman, A; Williams, R; Yingst, A				Grotzinger, J. P.; Sumner, D. Y.; Kah, L. C.; Stack, K.; Gupta, S.; Edgar, L.; Rubin, D.; Lewis, K.; Schieber, J.; Mangold, N.; Milliken, R.; Conrad, P. G.; DesMarais, D.; Farmer, J.; Siebach, K.; Calef, F., III; Hurowitz, J.; McLennan, S. M.; Ming, D.; Vaniman, D.; Crisp, J.; Vasavada, A.; Edgett, K. S.; Malin, M.; Blake, D.; Gellert, R.; Mahaffy, P.; Wiens, R. C.; Maurice, S.; Grant, J. A.; Wilson, S.; Anderson, R. C.; Beegle, L.; Arvidson, R.; Hallet, B.; Sletten, R. S.; Rice, M.; Bell, J., III; Griffes, J.; Ehlmann, B.; Anderson, R. B.; Bristow, T. F.; Dietrich, W. E.; Dromart, G.; Eigenbrode, J.; Fraeman, A.; Hardgrove, C.; Herkenhoff, K.; Jandura, L.; Kocurek, G.; Lee, S.; Leshin, L. A.; Leveille, R.; Limonadi, D.; Maki, J.; McCloskey, S.; Meyer, M.; Minitti, M.; Newsom, H.; Oehler, D.; Okon, A.; Palucis, M.; Parker, T.; Rowland, S.; Schmidt, M.; Squyres, S.; Steele, A.; Stolper, E.; Summons, R.; Treiman, A.; Williams, R.; Yingst, A.		MSL Sci Team	A Habitable Fluvio-Lacustrine Environment at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							SEDIMENTARY-ROCKS; MERIDIANI-PLANUM; WATER ACTIVITY; LIFE; BASIN; HYDROGEN; DEPOSITS; ORIGIN; SOIL; DUST	The Curiosity rover discovered fine-grained sedimentary rocks, which are inferred to represent an ancient lake and preserve evidence of an environment that would have been suited to support a martian biosphere founded on chemolithoautotrophy. This aqueous environment was characterized by neutral pH, low salinity, and variable redox states of both iron and sulfur species. Carbon, hydrogen, oxygen, sulfur, nitrogen, and phosphorus were measured directly as key biogenic elements; by inference, phosphorus is assumed to have been available. The environment probably had a minimum duration of hundreds to tens of thousands of years. These results highlight the biological viability of fluvial-lacustrine environments in the post-Noachian history of Mars.	[Grotzinger, J. P.; Stack, K.; Siebach, K.; Rice, M.; Griffes, J.; Ehlmann, B.; Stolper, E.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Kah, L. C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Edgar, L.; Farmer, J.; Bell, J., III; Minitti, M.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Rubin, D.] US Geol Survey, Santa Cruz, CA 95060 USA; [Lewis, K.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Schieber, J.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Mangold, N.] LPGN CNRS UMR6112, LPGN, F-44322 Nantes, France; [Mangold, N.] Univ Nantes, F-44322 Nantes, France; [Milliken, R.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Conrad, P. G.; Mahaffy, P.; Eigenbrode, J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [DesMarais, D.; Blake, D.; Bristow, T. F.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Calef, F., III; Crisp, J.; Vasavada, A.; Anderson, R. C.; Beegle, L.; Ehlmann, B.; Jandura, L.; Lee, S.; Limonadi, D.; Maki, J.; McCloskey, S.; Okon, A.; Parker, T.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hurowitz, J.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D.; Oehler, D.] NASA, Lyndon B Johnson Space Ctr, Jacobs Technol, Houston, TX 77058 USA; [Vaniman, D.; Williams, R.; Yingst, A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Edgett, K. S.; Malin, M.; Hardgrove, C.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Wiens, R. C.] Los Alamos Natl Lab, Los Alamos, NM 87544 USA; [Maurice, S.] Univ Toulouse, CNRS, IRAP, F-31400 Toulouse, France; [Grant, J. A.; Wilson, S.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Arvidson, R.; Fraeman, A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Hallet, B.; Sletten, R. S.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Anderson, R. B.; Herkenhoff, K.] US Geol Survey, Flagstaff, AZ 86001 USA; [Dietrich, W. E.; Palucis, M.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Kocurek, G.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Leveille, R.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Meyer, M.] NASA Headquarters, Washington, DC 20546 USA; [Newsom, H.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Rowland, S.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Schmidt, M.] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; [Squyres, S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Summons, R.] MIT, Dept Earth & Planetary Sci, Cambridge, MA 02139 USA; [Treiman, A.] Lunar & Planetary Inst, Houston, TX 77058 USA	California Institute of Technology; University of California System; University of California Davis; University of Tennessee System; University of Tennessee Knoxville; Imperial College London; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey; Princeton University; Indiana University System; Indiana University Bloomington; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Le Mans Universite; Nantes Universite; Universite d'Angers; Nantes Universite; Brown University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Guelph; United States Department of Energy (DOE); Los Alamos National Laboratory; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Smithsonian Institution; Washington University (WUSTL); University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley; Ecole Normale Superieure de Lyon (ENS de LYON); University of Texas System; University of Texas Austin; Rensselaer Polytechnic Institute; Canadian Space Agency; National Aeronautics & Space Administration (NASA); University of New Mexico; University of Hawaii System; University of Hawaii Manoa; Brock University; Cornell University; Carnegie Institution for Science; Massachusetts Institute of Technology (MIT)	Grotzinger, JP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	grotz@gps.caltech.edu	szopa, cyril/C-6865-2015; Rodriguez-Manfredi, Jose/L-8001-2014; FABRE, Cécile/B-5827-2012; Lemmon, Mark T/E-9983-2010; Beegle, Luther/AAU-5538-2021; Gomez-Elvira, Javier/K-5829-2014; Rodriguez-Manfredi, Jose/AAG-9826-2021; Zorzano, María-Paz/F-2184-2015; Harri, Ari-Matti/C-7142-2012; Blanco, Juan Jose/E-3627-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Teinturier, Samuel/AAS-8663-2020; Prats, Benito/F-9467-2019; Malakhov, Alexey Vladimirovich/F-7953-2017; Glavin, Daniel P/D-6194-2012; Stipp, Susan L.S./B-8494-2019; Crisp, Joy/H-8287-2016; Martin-Torres, Javier/G-6329-2015; Farmer, Jack D/B-9343-2019; De Pablo, Miguel Ángel/J-6442-2014; Gómez, Felipe/L-7315-2014; Dworkin, Jason P./C-9417-2012; Ramos, Miguel/K-2230-2014; GEFFROY, Claude/AAB-9152-2019; Stack Morgan, Kathryn/AGY-7985-2022; Benna, Mehdi/F-3489-2012; Kah, Linda C/J-3754-2019; Navarro-González, Rafael/D-1748-2009; Sumner, Dawn Y/E-8744-2011; Balic-Zunic, Tonci/A-6362-2013; Floyd, Melissa/D-4626-2012; Summons, Roger Everett/AAL-3789-2020; Eigenbrode, Jennifer L/D-4651-2012; Hayes, Alexander G/P-2024-2014; Steele, Andrew/A-3573-2013; Vicenzi, Edward/T-9430-2017	szopa, cyril/0000-0002-0090-4056; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; FABRE, Cécile/0000-0001-8627-4050; Lemmon, Mark T/0000-0002-4504-5136; Gomez-Elvira, Javier/0000-0002-9068-9846; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Zorzano, María-Paz/0000-0002-4492-9650; Harri, Ari-Matti/0000-0001-8541-2802; Blanco, Juan Jose/0000-0002-8666-0696; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Teinturier, Samuel/0000-0003-1755-9524; Prats, Benito/0000-0003-3869-3351; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Glavin, Daniel P/0000-0001-7779-7765; Stipp, Susan L.S./0000-0001-7009-643X; Crisp, Joy/0000-0002-3202-4416; Martin-Torres, Javier/0000-0001-6479-2236; De Pablo, Miguel Ángel/0000-0002-4496-2741; Gómez, Felipe/0000-0001-9977-7060; Dworkin, Jason P./0000-0002-3961-8997; Ramos, Miguel/0000-0003-3648-6818; GEFFROY, Claude/0000-0002-2731-9658; Kah, Linda C/0000-0001-7172-2033; Navarro-González, Rafael/0000-0002-6078-7621; Sumner, Dawn Y/0000-0002-7343-2061; Balic-Zunic, Tonci/0000-0003-1687-1233; Eigenbrode, Jennifer L/0000-0003-3089-1986; Hayes, Alexander G/0000-0001-6397-2630; Steele, Andrew/0000-0001-9643-2841; Vicenzi, Edward/0000-0003-2085-6546; Fraeman, Abigail/0000-0003-4017-5158; Rubin, David/0000-0003-1169-1452; Rice, Melissa/0000-0002-8370-4139; McLennan, Scott/0000-0003-4259-7178; Grant, John/0000-0001-8276-1281; Siebach, Kirsten/0000-0002-6628-6297; Williams, Rebecca/0000-0003-1571-6952; Edgett, Kenneth/0000-0001-7197-5751; Johnson, Jeffrey/0000-0002-5586-4901; Wilson, Sharon/0000-0001-8872-8546; Beegle, Luther/0000-0002-4944-4353; Gupta, Sanjeev/0000-0001-6415-1332	NASA; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005169/1, ST/J005339/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We are indebted to the MSL Project engineering and management teams for their exceptionally skilled and diligent efforts in making the mission as effective as possible and enhancing science operations. We are also grateful to all those MSL Science Team members who participated in tactical and strategic operations. Without the support of both the engineering and science teams, the data presented here could not have been collected. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Data presented in this paper are archived in the Planetary Data System (pds.nasa.gov).	Anderson R. B., 2010, MARS, V5, P76, DOI [DOI 10.1555/MARS.2010.0004, 10.1555/mars.2010.0004]; Andrews-Hanna JC, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003709; Aspler LB, 2004, PRECAMBRIAN RES, V129, P225, DOI 10.1016/j.precamres.2003.10.004; Attewell P., 1976, PRINCIPLES ENG GEOLO, P1045, DOI [10.1007/978-94-009-5707-7, DOI 10.1007/978-94-009-5707-7]; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Bell III J. F., 2008, MARTIAN SURFACE COMP; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bridges NT, 2012, SOC SEDIMENT GEOL SP, V102, P169; Bristow TF, 2011, CLAY CLAY MINER, V59, P339, DOI 10.1346/CCMN.2011.0590401; CHRISTENSEN PR, 1986, J GEOPHYS RES-SOLID, V91, P3533, DOI 10.1029/JB091iB03p03533; COLLINSON JD, 1983, SEDIMENT GEOL, V34, P145, DOI 10.1016/0037-0738(83)90084-2; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Cosgrove JW, 2001, AAPG BULL, V85, P737; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; ElTabakh M, 1997, SEDIMENTOLOGY, V44, P767, DOI 10.1046/j.1365-3091.1997.d01-47.x; Fairen AG, 2010, P NATL ACAD SCI USA, V107, P12095, DOI 10.1073/pnas.1002889107; Fendrihan S, 2012, GEOBIOLOGY, V10, P424, DOI 10.1111/j.1472-4669.2012.00337.x; Fisher JA, 2007, SEDIMENT GEOL, V195, P55, DOI 10.1016/j.sedgeo.2006.07.005; Fraeman AA, 2013, GEOLOGY, V41, P1103, DOI 10.1130/G34613.1; Fralick P., 2012, SEPM SPECIAL PUBLICA, V102; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Furniss G, 1998, J SEDIMENT RES, V68, P104, DOI 10.2110/jsr.68.104; Gottschalk G., 1994, MICROBIAL METABOLISM; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Grotzinger J. P., 2012, SEPM SPECIAL PUBLICA, V102; Grotzinger J.P., 2000, CARBONATE SEDIMENTAT, P3, DOI [DOI 10.2110/PEC.00.67.0003, 10.2110/pec.00.67.0003]; Grotzinger J, 2009, NAT GEOSCI, V2, P231, DOI 10.1038/ngeo480; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Hurst A, 2003, GEOL SOC SPEC PUBL, V216, P123, DOI 10.1144/GSL.SP.2003.216.01.09; Hurst A, 2011, EARTH-SCI REV, V106, P215, DOI 10.1016/j.earscirev.2011.02.004; Huuse M., 2007, AM ASS PETROLEUM GEO, V87; Irwin RP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002460; James H. L., 1982, MIN DEP EV BIOSPH DA, V3; Kane IA, 2010, MAR PETROL GEOL, V27, P1200, DOI 10.1016/j.marpetgeo.2010.02.009; Kieffer H., 1992, MARS; Kim JD, 2013, P NATL ACAD SCI USA, V110, P10073, DOI 10.1073/pnas.1308958110; Kish A, 2009, ENVIRON MICROBIOL, V11, P1066, DOI 10.1111/j.1462-2920.2008.01828.x; Klein H. P., 1977, Journal of Geophysical Research, V82, P4677, DOI 10.1029/JS082i028p04677; Knoll AH, 2006, ELEMENTS, V2, P169, DOI 10.2113/gselements.2.3.169; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Lopez-Archilla AI, 2001, MICROB ECOL, V41, P20; MACDONALD GA, 1953, AM J SCI, V251, P169, DOI 10.2475/ajs.251.3.169; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mangold N, 2009, GEOMORPHOLOGIE, P23; MCCORMICK DS, 1993, J SEDIMENT PETROL, V63, P398; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Meslin PY, 2013, SCIENCE, V341, DOI 10.1126/science.1238670; Milliken RE, 2008, GEOLOGY, V36, P847, DOI 10.1130/G24967A.1; Milliken RE, 2010, PHILOS MAG, V90, P2293, DOI 10.1080/14786430903575132; Milman-Barris MS, 2008, CONTRIB MINERAL PETR, V155, P739, DOI 10.1007/s00410-007-0268-7; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002791; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Nealson KH, 1999, PHILOS T R SOC B, V354, P1923, DOI 10.1098/rstb.1999.0532; OYAMA VI, 1977, NATURE, V265, P110, DOI 10.1038/265110a0; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PLUMMER PS, 1981, J SEDIMENT PETROL, V51, P1147; Pollock MD, 2006, J SEDIMENT RES, V76, P310, DOI 10.2110/jsr.2006.021; Potter PE, 2005, MUD MUDSTONES; Pratt BR, 1998, SEDIMENT GEOL, V117, P1, DOI 10.1016/S0037-0738(98)00023-2; Ross JA, 2011, SEDIMENTOLOGY, V58, P1693, DOI 10.1111/j.1365-3091.2011.01230.x; Rossi M, 2003, J BACTERIOL, V185, P3683, DOI 10.1128/JB.185.13.3683-3689.2003; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Sarna-Wojcicki A, 1981, US GEOLOGICAL SURVEY, V1250, P577; Schlegel HG, 1993, GEN MICROBIOLOGY, V7th; Schmidt M. E., 2013, LUNAR PLANET SCI C; Schoonen MAA, 2001, ASTROBIOLOGY, V1, P133, DOI 10.1089/153110701753198909; SCHRAUZER GN, 1976, J AM CHEM SOC, V98, P3508, DOI 10.1021/ja00428a019; SMITH ND, 1972, J SEDIMENT PETROL, V42, P624; Sousa DZ, 2013, APPL ENVIRON MICROB, V79, P4239, DOI 10.1128/AEM.00035-13; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Stetter KO, 1999, FEBS LETT, V452, P22, DOI 10.1016/S0014-5793(99)00663-8; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; Summers DP, 2012, ASTROBIOLOGY, V12, P107, DOI 10.1089/ast.2011.0646; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Winston D., 1977, FLUVIAL SEDIMENTOLOG, V5, P343; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	90	295	299	8	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1242777	10.1126/science.1242777	http://dx.doi.org/10.1126/science.1242777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324272	Green Submitted, Green Accepted			2022-12-28	WOS:000330039300002
J	Brown, KR				Brown, Kenneth R.			Probing the Electron	SCIENCE			English	Editorial Material									[Brown, Kenneth R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Brown, Kenneth R.] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA; [Brown, Kenneth R.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Brown, KR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	ken.brown@chemistry.gatech.edu	Brown, Kenneth/E-5844-2010	Brown, Kenneth/0000-0001-7716-1425				Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Commins E. D., 1999, ADV ATOM MOL OPT PHY, V40, P1; Leanhardt AE, 2011, J MOL SPECTROSC, V270, P1, DOI 10.1016/j.jms.2011.06.007; Loh H, 2013, SCIENCE, V342, P1220, DOI 10.1126/science.1243683	7	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					255	256		10.1126/science.1246820	http://dx.doi.org/10.1126/science.1246820			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	289YN	24356111				2022-12-28	WOS:000329718600021
J	Ravindran, R; Khan, N; Nakaya, HI; Li, SZ; Loebbermann, J; Maddur, MS; Park, Y; Jones, DP; Chappert, P; Davoust, J; Weiss, DS; Virgin, HW; Ron, D; Pulendran, B				Ravindran, Rajesh; Khan, Nooruddin; Nakaya, Helder I.; Li, Shuzhao; Loebbermann, Jens; Maddur, Mohan S.; Park, Youngja; Jones, Dean P.; Chappert, Pascal; Davoust, Jean; Weiss, David S.; Virgin, Herbert W.; Ron, David; Pulendran, Bali			Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation	SCIENCE			English	Article							INITIATION-FACTOR 2-ALPHA; YELLOW-FEVER VACCINE; CD8(+) T-CELLS; TRANSLATIONAL CONTROL; AUTOPHAGY; KINASE; STRESS; MICE; RNA; PHOSPHORYLATION	The yellow fever vaccine YF-17D is one of the most successful vaccines ever developed in humans. Despite its efficacy and widespread use in more than 600 million people, the mechanisms by which it stimulates protective immunity remain poorly understood. Recent studies using systems biology approaches in humans have revealed that YF-17D-induced early expression of general control nonderepressible 2 kinase (GCN2) in the blood strongly correlates with the magnitude of the later CD8(+) T cell response. We demonstrate a key role for virus-induced GCN2 activation in programming dendritic cells to initiate autophagy and enhanced antigen presentation to both CD4(+) and CD8(+) T cells. These results reveal an unappreciated link between virus-induced integrated stress response in dendritic cells and the adaptive immune response.	[Ravindran, Rajesh; Khan, Nooruddin; Nakaya, Helder I.; Li, Shuzhao; Loebbermann, Jens; Maddur, Mohan S.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Khan, Nooruddin] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500046, Andhra Pradesh, India; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Park, Youngja] Korea Univ, Coll Pharm, Seoul 339700, South Korea; [Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA; [Chappert, Pascal; Davoust, Jean] INSERM, U1013, Paris, France; [Chappert, Pascal; Davoust, Jean] Univ Paris 05, Sorbonne Paris Cite, F-75743 Paris 15, France; [Weiss, David S.] Emory Univ, Div Infect Dis, Dept Med, Atlanta, GA 30329 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ron, David] Univ Cambridge, Cambridge Metab Res Labs, Cambridge CB2 0QQ, England; [Ron, David] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	Emory University; University of Hyderabad; Emory University; Korea University; Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Emory University; Washington University (WUSTL); University of Cambridge; University of Cambridge	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Davoust, Jean/ABB-6720-2020; Nakaya, Helder/AAF-1738-2020; Loebbermann, Jens/K-8327-2014; Khan, Nooruddin/AAF-5417-2019; Maddur, Mohan/E-4763-2015; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Davoust, Jean/0000-0002-3098-7665; Maddur, Mohan/0000-0002-7085-1762; Ron, David/0000-0002-3014-5636; chappert, pascal/0000-0002-9799-4608; Virgin, Herbert/0000-0001-8580-7628; Li, Shuzhao/0000-0002-7386-2539; Pulendran, Bali/0000-0001-6517-4333	U.S. National Institutes of Health [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01 AI50025]; Bill & Melinda Gates Foundation; Wellcome Trust [084812/Z/08/Z]; NIH [U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, R37AI048638, N01AI050025, U19AI057266, R56AI048638, U54AI057157, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the U.S. National Institutes of Health (grants R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, and N01 AI50025) and from the Bill & Melinda Gates Foundation to B. P., a Wellcome Trust Principal Research Fellowship (084812/Z/08/Z) to D. R, and NIH grant U54 AI057160 to H. W. V. We thank B. Cervasi and K. Gill for help with sorting and D. Levesque, D. Bonenberger, and colleagues for animal husbandry. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Martinez J, 2013, CELL METAB, V17, P895, DOI 10.1016/j.cmet.2013.05.012; McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Sood R, 2000, GENETICS, V154, P787; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11	31	150	159	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					313	317		10.1126/science.1246829	http://dx.doi.org/10.1126/science.1246829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24310610	Green Accepted			2022-12-28	WOS:000329718600040
J	Roth, L; Saur, J; Retherford, KD; Strobel, DF; Feldman, PD; McGrath, MA; Nimmo, F				Roth, Lorenz; Saur, Joachim; Retherford, Kurt D.; Strobel, Darrell F.; Feldman, Paul D.; McGrath, Melissa A.; Nimmo, Francis			Transient Water Vapor at Europa's South Pole	SCIENCE			English	Article							SUBSURFACE OCEAN; ATMOSPHERE; CONSTRAINTS; SIMULATION; ENCELADUS; EMISSION; GANYMEDE; PLUMES	In November and December 2012, the Hubble Space Telescope (HST) imaged Europa's ultraviolet emissions in the search for vapor plume activity. We report statistically significant coincident surpluses of hydrogen Lyman-alpha and oxygen OI 130.4-nanometer emissions above the southern hemisphere in December 2012. These emissions were persistently found in the same area over the 7 hours of the observation, suggesting atmospheric inhomogeneity; they are consistent with two 200-km-high plumes of water vapor with line-of-sight column densities of about 10(20) per square meter. Nondetection in November 2012 and in previous HST images from 1999 suggests varying plume activity that might depend on changing surface stresses based on Europa's orbital phases. The plume was present when Europa was near apocenter and was not detected close to its pericenter, in agreement with tidal modeling predictions.	[Roth, Lorenz; Retherford, Kurt D.] SW Res Inst, San Antonio, TX 78238 USA; [Roth, Lorenz; Saur, Joachim] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany; [Strobel, Darrell F.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Strobel, Darrell F.; Feldman, Paul D.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [McGrath, Melissa A.] NASA, Marshall Space Flight Ctr, Huntsville, AL USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	Southwest Research Institute; University of Cologne; Johns Hopkins University; Johns Hopkins University; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz	Roth, L (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	lorenz.roth@swri.edu	Strobel, Darrell5/AAO-6643-2021; Saur, Joachim/V-6780-2019	Strobel, Darrell5/0000-0002-0944-8675; Saur, Joachim/0000-0003-1413-1231; Roth, Lorenz/0000-0003-0554-4691; Retherford, Kurt/0000-0001-9470-150X	NASA through Space Telescope Science Institute [GO-13040, NAS5-26555]	NASA through Space Telescope Science Institute(Space Telescope Science Institute)	This work is based on HST observations available at the NASA Mikulski Archive for Space Telescopes. Support for program number GO-13040 was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, under contract NAS5-26555; and by Verbundforschung Astronomie und Astrophysik.	Barth CA, 1997, GEOPHYS RES LETT, V24, P2147, DOI 10.1029/97GL01927; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Cassidy TA, 2007, ICARUS, V191, P755, DOI 10.1016/j.icarus.2007.04.033; Fagents SA, 2000, ICARUS, V144, P54, DOI 10.1006/icar.1999.6254; Fagents SA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002128; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Hansen CJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047415; Hedman MM, 2013, NATURE, V500, P182, DOI 10.1038/nature12371; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; Makarov OP, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2002JA009353; McGrath M. A., 2009, EUROPA, P485; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Phillips CB, 2000, J GEOPHYS RES-PLANET, V105, P22579, DOI 10.1029/1999JE001139; Plainaki C, 2012, ICARUS, V218, P956, DOI 10.1016/j.icarus.2012.01.023; Rathbun JA, 2010, ICARUS, V210, P763, DOI 10.1016/j.icarus.2010.07.017; Roth L, 2011, ICARUS, V214, P495, DOI 10.1016/j.icarus.2011.05.014; Saur J, 1998, J GEOPHYS RES-PLANET, V103, P19947, DOI 10.1029/97JE03556; Saur J, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/153; Schmidt BE, 2011, NATURE, V479, P502, DOI 10.1038/nature10608; Shematovich VI, 2005, ICARUS, V173, P480, DOI 10.1016/j.icarus.2004.08.013; Smyth WH, 2006, ICARUS, V181, P510, DOI 10.1016/j.icarus.2005.10.019; Spencer JR, 1999, SCIENCE, V284, P1514, DOI 10.1126/science.284.5419.1514; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; Zhang J, 2003, ICARUS, V163, P182, DOI 10.1016/S0019-1035(03)00050-2	25	288	289	2	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					171	174		10.1126/science.1247051	http://dx.doi.org/10.1126/science.1247051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24336567				2022-12-28	WOS:000329440800039
J	Jenner, K				Jenner, Katharine			Hospital food can be improved only by legislation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												k.jenner@qmul.ac.uk						Campaign for Better Hospital Food, 2013, 20 YEARS HOSP FOOD F; Department for Environment, 2013, SUST DEV GOV FOOD CA; Department of Health, 2012, REP DIET SOD INT; Devlin K, 2010, TELEGRAPH; Francis R, 2013, MIDST NHS FDN TRUST; Leach RM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f801; Soil Association, 2011, 1 AID HOSP FOOD; Surman W., 2010, FARMERS GUARDIA 0519	8	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7300	10.1136/bmj.f7300	http://dx.doi.org/10.1136/bmj.f7300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355539				2022-12-28	WOS:000328824300004
J	Yaffe, K; Falvey, C; Harris, TB; Newman, A; Satterfield, S; Koster, A; Ayonayon, H; Simonsick, E				Yaffe, Kristine; Falvey, Cherie; Harris, Tamara B.; Newman, Anne; Satterfield, Suzanne; Koster, Annemarie; Ayonayon, Hilsa; Simonsick, Eleanor		Hlth ABC Study	Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; RACIAL-DIFFERENCES; AFRICAN-AMERICANS; WHITE DIFFERENCES; LIMITED LITERACY; TEST-SCORES; DECLINE; HEALTH; EDUCATION; PREVALENCE	Objective To examine whether observed differences in dementia rates between black and white older people living in the community could be explained by measures of socioeconomic status (income, financial adequacy, education, and literacy) and health related factors. Design Prospective cohort study. Setting General community from two clinic sites in the United States (Pittsburgh, Pennsylvania and Memphis, Tennessee). Participants 2457 older people (mean age 73.6 years; 1019 (41.5%) black; 1233 (50.2%) women), dementia-free at baseline, in the Health, Aging, and Body Composition study. Main outcome measure Dementia was determined over 12 years (ending January 2011) by prescribed dementia drugs, hospital records, and decline in global cognitive scores. The influence of socioeconomic status and health related factors on dementia rates was examined in a series of Cox proportional hazard models in which these variables were added sequentially in covariate blocks. Results Over follow-up, 449 (18.3%) participants developed dementia. Black participants were more likely than white participants to develop dementia (211 (20.7%) v 238 (16.6%), P<0.001; unadjusted hazard ratio 1.44, 95% confidence interval 1.20 to 1.74). The hazard ratio lessened somewhat after adjustment for demographics, apolipoprotein E e4, comorbidities, and lifestyle factors (1.37, 1.12 to 1.67) but was greatly reduced and no longer statistically significant when socioeconomic status was added (1.09, 0.87 to 1.37). Conclusion These findings suggest that differences in the burden of risk factors, especially socioeconomic status, may contribute to the higher rates of dementia seen among black compared with white older people. Strategies aimed at reducing these disparities may favorably affect the incidence of dementia.	[Yaffe, Kristine] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Falvey, Cherie] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Newman, Anne] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Aging & Populat Hlth, Pittsburgh, PA 15261 USA; [Satterfield, Suzanne] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Koster, Annemarie] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Simonsick, Eleanor] NIA, Clin Res Branch, Harbor Hosp, Baltimore, MD 21225 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; Maastricht University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yaffe, K (corresponding author), Univ Calif San Francisco, 4150 Clement St,Box 181, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu	Newman, Anne B./C-6408-2013; Koster, Annemarie/E-7438-2010; Simonsick, Eleanor/W-6864-2019	Newman, Anne B./0000-0002-0106-1150; Koster, Annemarie/0000-0003-1583-7391; 	National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; NINR [R01-NR012459]; NIH, National Institute on Aging; American Health Assistance Foundation [A201-0029]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG028050, K24AG031155, N01AG062103, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging (NIA) contract Nos N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106; NIA grant No R01-AG028050; NINR grant No R01-NR012459. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, and a grant from the American Health Assistance Foundation, grant number A201-0029. The Intramural Research Program of the NIA participated in the design and conduct of the study.	Adelman S, 2011, BRIT J PSYCHIAT, V199, P119, DOI 10.1192/bjp.bp.110.086405; Adelman S, 2009, INT J GERIATR PSYCH, V24, P657, DOI 10.1002/gps.2186; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes LL, 2012, NEUROLOGY, V79, P2321, DOI 10.1212/WNL.0b013e318278b607; Beckie TM, 2012, BIOL RES NURS, V14, P311, DOI 10.1177/1099800412455688; Chin AL, 2012, J INT NEUROPSYCH SOC, V18, P277, DOI 10.1017/S1355617711001688; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Davis T C, 1993, Fam Med, V25, P391; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fors S, 2009, J GERONTOL B-PSYCHOL, V64, P750, DOI 10.1093/geronb/gbp029; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Haas SA, 2012, J GERONTOL B-PSYCHOL, V67, P238, DOI 10.1093/geronb/gbr155; Hemingway H, 1997, AM J PUBLIC HEALTH, V87, P1484, DOI 10.2105/AJPH.87.9.1484; Honer WG, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.38; Jefferson AL, 2011, J AM GERIATR SOC, V59, P1403, DOI 10.1111/j.1532-5415.2011.03499.x; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; Koster A, 2005, ANN EPIDEMIOL, V15, P564, DOI 10.1016/j.annepidem.2005.02.008; Lee HB, 2012, AGING MENT HEALTH, V16, P372, DOI 10.1080/13607863.2011.609533; Lee S, 2003, AM J EPIDEMIOL, V157, P712, DOI 10.1093/aje/kwg042; Livak Kenneth J, 2003, Methods Mol Biol, V212, P129; Loewenstein DA, 2007, DEMENT GERIATR COGN, V23, P82, DOI 10.1159/000097304; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Moody-Ayers SY, 2005, J GERONTOL A-BIOL, V60, P933, DOI 10.1093/gerona/60.7.933; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sachs-Ericsson N, 2005, AM J GERIAT PSYCHIAT, V13, P968, DOI 10.1176/appi.ajgp.13.11.968; Sawyer K, 2009, GERONTOLOGY, V55, P32, DOI 10.1159/000137666; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Shadlen MF, 2006, J AM GERIATR SOC, V54, P898, DOI 10.1111/j.1532-5415.2006.00747.x; Sudore RL, 2006, J AM GERIATR SOC, V54, P770, DOI 10.1111/j.1532-5415.2006.00691.x; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Szklo M, 2008, EPIDEMIOLOGY BASICS; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thorpe RJ, 2012, ANN BEHAV MED, V43, P29, DOI 10.1007/s12160-011-9335-4; Thorpe RJ, 2011, J GERONTOL A-BIOL, V66, P1114, DOI 10.1093/gerona/glr102; Whitfield KE, 2000, J AGING HEALTH, V12, P69, DOI 10.1177/089826430001200104; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995	47	183	183	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7051	10.1136/bmj.f7051	http://dx.doi.org/10.1136/bmj.f7051			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	277MS	24355614	hybrid, Green Published			2022-12-28	WOS:000328824300003
J	Zhou, F; Lin, QB; Zhu, LH; Ren, YL; Zhou, KN; Shabek, N; Wu, FQ; Mao, HB; Dong, W; Gan, L; Ma, WW; Gao, H; Chen, J; Yang, C; Wang, D; Tan, JJ; Zhang, X; Guo, XP; Wang, JL; Jiang, L; Liu, X; Chen, WQ; Chu, JF; Yan, CY; Ueno, K; Ito, S; Asami, T; Cheng, ZJ; Wang, J; Lei, CL; Zhai, HQ; Wu, CY; Wang, HY; Zheng, N; Wan, JM				Zhou, Feng; Lin, Qibing; Zhu, Lihong; Ren, Yulong; Zhou, Kunneng; Shabek, Nitzan; Wu, Fuqing; Mao, Haibin; Dong, Wei; Gan, Lu; Ma, Weiwei; Gao, He; Chen, Jun; Yang, Chao; Wang, Dan; Tan, Junjie; Zhang, Xin; Guo, Xiuping; Wang, Jiulin; Jiang, Ling; Liu, Xi; Chen, Weiqi; Chu, Jinfang; Yan, Cunyu; Ueno, Kotomi; Ito, Shinsaku; Asami, Tadao; Cheng, Zhijun; Wang, Jie; Lei, Cailin; Zhai, Huqu; Wu, Chuanyin; Wang, Haiyang; Zheng, Ning; Wan, Jianmin			D14-SCFD3-dependent degradation of D53 regulates strigolactone signalling	NATURE			English	Article							BOX PROTEIN TIR1; GENE-EXPRESSION; ARABIDOPSIS; RICE; PERCEPTION; OUTGROWTH; MAX2; GERMINATION; INHIBITION; KARRIKIN	Strigolactones (SLs), a newly discovered class of carotenoid-derived phytohormones, are essential for developmental processes that shape plant architecture and interactions with parasitic weeds and symbiotic arbuscular mycorrhizal fungi. Despite the rapid progress in elucidating the SL biosynthetic pathway, the perception and signalling mechanisms of SL remain poorly understood. Here we show that DWARF 53 (D53) acts as a repressor of SL signalling and that SLs induce its degradation. We find that the rice (Oryza sativa) d53 mutant, which produces an exaggerated number of tillers compared to wild-type plants, is caused by a gain-of-function mutation and is insensitive to exogenous SL treatment. The D53 gene product shares predicted features with the class I Clp ATPase proteins and can form a complex with the a/b hydrolase protein DWARF 14 (D14) and the F-box protein DWARF 3 (D3), two previously identified signalling components potentially responsible for SL perception. We demonstrate that, in a D14- and D3-dependent manner, SLs induce D53 degradation by the proteasome and abrogate its activity in promoting axillary bud outgrowth. Our combined genetic and biochemical data reveal that D53 acts as a repressor of the SL signalling pathway, whose hormone-induced degradation represents a key molecular link between SL perception and responses.	[Zhou, Feng; Zhu, Lihong; Zhou, Kunneng; Gao, He; Yang, Chao; Jiang, Ling; Liu, Xi; Wan, Jianmin] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Zhou, Feng; Lin, Qibing; Ren, Yulong; Wu, Fuqing; Dong, Wei; Gan, Lu; Ma, Weiwei; Chen, Jun; Wang, Dan; Tan, Junjie; Zhang, Xin; Guo, Xiuping; Wang, Jiulin; Cheng, Zhijun; Wang, Jie; Lei, Cailin; Zhai, Huqu; Wu, Chuanyin; Wang, Haiyang; Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Shabek, Nitzan; Mao, Haibin; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Shabek, Nitzan; Mao, Haibin; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Chen, Weiqi; Chu, Jinfang; Yan, Cunyu] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [Ueno, Kotomi; Ito, Shinsaku; Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Tokyo	Wan, JM (corresponding author), Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	wanghaiyang@caas.cn; nzheng@u.washington.edu; wanjm@njau.edu.cn	Zhu, Li/GXH-9801-2022; Shabek, Nitzan/AAG-7521-2019; Cheng, Zhijun/HDN-7780-2022; Lin, Qibing/AAG-3882-2021; Ren, Yulong/HHC-8217-2022	Shabek, Nitzan/0000-0002-2190-5955; Yan, Cunyu/0000-0002-3603-2421; Zhou, Feng/0000-0002-1305-3756	National Transgenic Science and Technology Program [2011ZX08009-003]; 863 National High-tech R&D Program of China [2012AA101100, 2012AA10A301]; Jiangsu Province 333 Program [BRA2012126]; National Natural Science Foundation of China [90917017]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0929100] Funding Source: National Science Foundation	National Transgenic Science and Technology Program; 863 National High-tech R&D Program of China(National High Technology Research and Development Program of China); Jiangsu Province 333 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank T. Omura for providing the d53 mutant, and Z.-Y. Wang and C. Lin for reading of the manuscript. We also thank X. Li for providing the d3 mutant, W. Liu for providing the htd2 mutant and I. Takamure for providing the d10, d17 and d27 mutants. This work was supported by the National Transgenic Science and Technology Program (2011ZX08009-003), 863 National High-tech R&D Program of China (2012AA101100, 2012AA10A301), Jiangsu Province 333 Program (BRA2012126) and National Natural Science Foundation of China (90917017). N.Z. is a Howard Hughes Medical Institute investigator and is supported by the National Science Foundation.	Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Beveridge CA, 2000, PLANT GROWTH REGUL, V32, P193, DOI 10.1023/A:1010718020095; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Iwata N., 1977, JPN J BREED S1, V27, P250; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Liu WZ, 2009, PLANTA, V230, P649, DOI 10.1007/s00425-009-0975-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stanga JP, 2013, PLANT PHYSIOL, V163, P318, DOI 10.1104/pp.113.221259; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang YH, 2011, CURR OPIN PLANT BIOL, V14, P94, DOI 10.1016/j.pbi.2010.11.002; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Wei LR, 2006, J INTEGR PLANT BIOL, V48, P447, DOI 10.1111/j.1744-7909.2006.00248.x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	50	491	562	26	450	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					406	+		10.1038/nature12878	http://dx.doi.org/10.1038/nature12878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24336215	Green Accepted, Green Submitted			2022-12-28	WOS:000328575300045
J	Shiroma, EJ; Freedson, PS; Trost, SG; Lee, IM				Shiroma, Eric J.; Freedson, Patty S.; Trost, Stewart G.; Lee, I-Min			Patterns of Accelerometer-Assessed Sedentary Behavior in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADULTS		[Shiroma, Eric J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Freedson, Patty S.] Univ Massachusetts, Amherst, MA 01003 USA; [Trost, Stewart G.] Univ Queensland, Brisbane, Qld, Australia; [Lee, I-Min] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Amherst; University of Queensland; Harvard University; Harvard Medical School	Shiroma, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, 900 Commonwealth Ave,3rd Floor, Boston, MA 02215 USA.	ericshiroma@mail.harvard.edu	Lee, I-Min/ABD-5409-2021; Shiroma, Eric/AAV-5487-2021; Trost, Stewart G/B-5948-2012	Shiroma, Eric/0000-0003-4920-2642; Trost, Stewart G/0000-0001-9587-3944	NCI NIH HHS [CA047988, R01 CA121005, CA121005, R01 CA154647, R01 CA047988, CA154647] Funding Source: Medline; NHLBI NIH HHS [HL080467, HL099355, HL007575, T32 HL007575, RC1 HL099557, HL099557, R01 HL080467, RC1 HL099355, R01 HL043851] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154647, R01CA121005, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, RC1HL099355, RC1HL099557, T32HL007575, R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332	6	89	90	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2562	2563		10.1001/jama.2013.278896	http://dx.doi.org/10.1001/jama.2013.278896			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346993	Bronze, Green Accepted			2022-12-28	WOS:000328503600027
J	Ryan, JF; Pang, K; Schnitzler, CE; Nguyen, AD; Moreland, RT; Simmons, DK; Koch, BJ; Francis, WR; Havlak, P; Smith, SA; Putnam, NH; Haddock, SHD; Dunn, CW; Wolfsberg, TG; Mullikin, JC; Martindale, MQ; Baxevanis, AD				Ryan, Joseph F.; Pang, Kevin; Schnitzler, Christine E.; Anh-Dao Nguyen; Moreland, R. Travis; Simmons, David K.; Koch, Bernard J.; Francis, Warren R.; Havlak, Paul; Smith, Stephen A.; Putnam, Nicholas H.; Haddock, Steven H. D.; Dunn, Casey W.; Wolfsberg, Tyra G.; Mullikin, James C.; Martindale, Mark Q.; Baxevanis, Andreas D.		NISC Comparative Sequencing Progra	The Genome of the Ctenophore Mnemiopsis leidyi and Its Implications for Cell Type Evolution	SCIENCE			English	Article							HOMEOBOX GENES; METAZOAN; ORIGIN; EXPRESSION; REVEALS; ULTRASTRUCTURE; INSIGHTS; SYSTEM; TREE	An understanding of ctenophore biology is critical for reconstructing events that occurred early in animal evolution. Toward this goal, we have sequenced, assembled, and annotated the genome of the ctenophore Mnemiopsis leidyi. Our phylogenomic analyses of both amino acid positions and gene content suggest that ctenophores rather than sponges are the sister lineage to all other animals. Mnemiopsis lacks many of the genes found in bilaterian mesodermal cell types, suggesting that these cell types evolved independently. The set of neural genes in Mnemiopsis is similar to that of sponges, indicating that sponges may have lost a nervous system. These results present a newly supported view of early animal evolution that accounts for major losses and/or gains of sophisticated cell types, including nerve and muscle cells.	[Ryan, Joseph F.; Schnitzler, Christine E.; Anh-Dao Nguyen; Moreland, R. Travis; Koch, Bernard J.; Wolfsberg, Tyra G.; Mullikin, James C.; Baxevanis, Andreas D.] NHGRI, Genome Technol Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Ryan, Joseph F.; Pang, Kevin] Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Simmons, David K.; Martindale, Mark Q.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Francis, Warren R.; Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Havlak, Paul; Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77098 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr, NIH, Rockville, MD 20852 USA; [Smith, Stephen A.; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Smith, Stephen A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Bergen; State University System of Florida; University of Florida; Monterey Bay Aquarium Research Institute; Rice University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Brown University; University of Michigan System; University of Michigan	Baxevanis, AD (corresponding author), NHGRI, Genome Technol Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	andy@mail.nih.gov	Wolfsberg, Tyra/D-8296-2017; Smith, Stephen/AAE-8623-2019; Putnam, Nicholas/B-9968-2008	Wolfsberg, Tyra/0000-0001-5646-9455; Smith, Stephen/0000-0003-2035-9531; Francis, Warren/0000-0003-3473-4726; Ryan, Joseph/0000-0001-5478-0522; Dunn, Casey/0000-0003-0628-5150; Baxevanis, Andy/0000-0002-5370-0014; Putnam, Nicholas/0000-0002-1315-782X	National Human Genome Research Institute (NHGRI), NIH; NASA; NSF; Sars International Centre for Marine Molecular Biology; University of Bergen; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIAHG000140, ZIBHG000196] Funding Source: NIH RePORTER; Office Of The Director [1158629] Funding Source: National Science Foundation	National Human Genome Research Institute (NHGRI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Sars International Centre for Marine Molecular Biology; University of Bergen; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by the Intramural Research Program of the National Human Genome Research Institute (NHGRI), NIH. This work was also supported in part by NASA and NSF grants to M. Q. M. J.F.R. received additional support from the Sars International Centre for Marine Molecular Biology and the University of Bergen. We thank A. Young, B. Schmidt, N. Gurson, R. Legaspi, B. Novotny, and R. Blakesley, who were responsible for the sequencing performed at the NIH Intramural Sequencing Center (NISC); A. Prasad, D. Gildea, N. Trivedi, A. Yun, K. Siewert, D. Leja, S. Bond, and G. Bouffard at NHGRI; A. Hejnol, D. Chourrout, L. Leclere, G. Richards, F. Rentzsch, C. Martin, H. Hausen, S. Henriet, S. Church, and S9 at Sars; B. Vellutini for the photo of M. leidyi used in Fig. 1A; W. Browne for access to additional RNA-seq data from early developmental stages of M. leidyi; J. Lehmann for supplying an updated near intron pair matrix; C. Trapnell for help with the Bowtie short-read aligner and Cufflinks transcript assembly program; M. Srivastava for phylogenetic data sets and advice; I. Ruiz-Trillo and the Origins of Multicellularity Sequencing Project, Broad Institute of Harvard and MIT for use of their genomic data; D. Rokhsar and the Joint Genome Institute for use of their genomic data; and other researchers whose publicly available sequence data were used in this study. The views expressed in this paper do not necessarily reflect the views of those acknowledged. We dedicate this manuscript to the pioneering work of the late Sebastian Beroe of the Stazione Zoologica in Naples. The authors declare no competing financial interests. The genome sequence data can be accessed from GenBank as project accession AGCP00000000 and from http://research.nhgri.nih.gov/mnemiopsis/. Contributions are as follows: genome and RNA-seq sequencing and assembly: NISC and J. C. M.; annotation: J. F. R., K. P., C. E. S., P. H., N. H. P., A.-D.N., R. T. M., B. J. K., and T. G. W.; analysis: J. F. R., K. P., C. E. S., D. K. S., B. J. K., P. H., N. H. P., M. Q. M., and A. D. B.; additional ctenophore data: S. H. D. H. and W. R. F.; phylogenetics: J. F. R., S. A. S., and C. W. D.; writing: J. F. R., K. P., C. E. S., D. K. S., R. T. M., C. W. D., M. Q. M., and A. D. B.; project design and coordination: J. F. R., M. Q. M., and A.D.B.	ANCTIL M, 1985, CELL TISSUE RES, V242, P333; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Farrar N., 2013, 2013 SOC INT COMP BI; FREEMAN G, 1973, DEV BIOL, V31, P61, DOI 10.1016/0012-1606(73)90321-7; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory T. R., ANIMAL GENOME SIZE D; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harbison G.R., 1985, Systematics Association Special Volume Series, P78; Hay-Schmidt A, 2000, P ROY SOC B-BIOL SCI, V267, P1071, DOI 10.1098/rspb.2000.1111; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Henry JQ, 2000, DEV BIOL, V227, P720, DOI 10.1006/dbio.2000.9903; HERNANDE.ML, 1973, J NEUROCYTOL, V2, P249, DOI 10.1007/BF01104029; Jager M, 2011, J EXP ZOOL PART B, V316B, P171, DOI 10.1002/jez.b.21386; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Layden MJ, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-12; Lehmann J, 2013, MOL PHYLOGENET EVOL, V66, P811, DOI 10.1016/j.ympev.2012.11.012; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; MACKIE GO, 1988, ZOOMORPHOLOGY, V107, P319, DOI 10.1007/BF00312216; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427; Martindale MQ, 1997, DEVELOPMENT, V124, P1999; Martindale MQ, 2002, MOL PHYLOGENET EVOL, V24, P358, DOI 10.1016/S1055-7903(02)00208-7; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Pang K., 2008, CSH PROTOC, DOI DOI 10.1101/PDB.PROT5085; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Pang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024152; Pang K, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-10; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-3; REVERBERI G., 1963, ACTA EMBRYOL MORPHOL EXPTL, V6, P175; Ryan J. F., 2013, BAA PL TOOL EVALUATE; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Simmons DK, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-2; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621	53	449	456	3	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1336	+		10.1126/science.1242592	http://dx.doi.org/10.1126/science.1242592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337300	Green Accepted, Green Submitted			2022-12-28	WOS:000328196000040
J	Dowrick, C; Frances, A				Dowrick, Christopher; Frances, Allen			TOO MUCH MEDICINE Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAJOR DEPRESSION; PRIMARY-CARE; ANTIDEPRESSANTS; SEVERITY; DISORDER; DIAGNOSIS; SYMPTOMS; EFFICACY; SUPPORT; DOCTORS		[Dowrick, Christopher] Univ Liverpool, Liverpool L69 3GL, Merseyside, England; [Frances, Allen] Duke Univ, Med Ctr, Durham, NC USA	University of Liverpool; Duke University	Dowrick, C (corresponding author), Univ Liverpool, Liverpool L69 3GL, Merseyside, England.	cfd@liv.ac.uk						Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Barbui C, 2011, BRIT J PSYCHIAT, V198, P11, DOI 10.1192/bjp.bp.109.076448; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bower P, 2013, BMJ-BRIT MED J, V346, pf540; Brown WA, 2007, ACTA PSYCHIAT SCAND, V115, P125, DOI 10.1111/j.1600-0447.2007.00970.x; Brugha T, 2009, ADULT PSYCHIAT MORBI; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; Callahan C.M., 2005, REINVENTING DEPRESSI; Dowrick C, 2000, PSYCHOL MED, V30, P413, DOI 10.1017/S0033291799001531; Dowrick C, 2013, PROGRAMME GRANTS APP, V1, P1; Dowrick C, 2009, DEPRESSION; FEINBERG M, 1984, ARCH GEN PSYCHIAT, V41, P1080; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frances A., 2013, SAVING NORMAL, DOI Morrow; Friedman RA, 2012, NEW ENGL J MED, V366, P1855, DOI 10.1056/NEJMp1201794; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gold PW, 2013, MOL PSYCHIATR, V18, P632, DOI 10.1038/mp.2013.5; Gotzsche P.C., 2013, DEADLY MED ORG CRIME; Gunn J, 2013, J AFFECT DISORDERS, V148, P338, DOI 10.1016/j.jad.2012.12.021; Hacking Ian, 1999, SOCIAL CONSTRUCTION, P22; Healy David, 2004, LET THEM EAT PROZAC; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hetrick SE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub3; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Kendler KS, 2008, AM J PSYCHIAT, V165, P1449, DOI 10.1176/appi.ajp.2008.07111757; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khin NA, 2011, J CLIN PSYCHIAT, V72, P464, DOI 10.4088/JCP.10m06191; KIRK SA, 1994, J MIND BEHAV, V15, P71; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kokanovic R, 2010, SOCIOL HEALTH ILL, V32, P511, DOI 10.1111/j.1467-9566.2009.01228.x; Maxwell M, 2005, CHRONIC ILLN, V1, P61, DOI 10.1179/174239505X19617; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Nemeroff CB, 2007, CNS SPECTRUMS, V12, P4; Nielsen Margrethe, 2011, Int J Risk Saf Med, V23, P125, DOI 10.3233/JRS-2011-0526; Parker G, 2013, ACTA PSYCHIAT SCAND, V128, P88, DOI 10.1111/acps.12110; Pratt L.A., 2011, NCHS DATA BRIEF; Singleton N., 2001, PSYCHIAT MORBIDITY A; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Avendonk Marielle J P, 2012, Ned Tijdschr Geneeskd, V156, pA5101; Vasiliadis HM, 2013, CAN J PSYCHIAT, V58, P201, DOI 10.1177/070674371305800405; Wakefield, 2007, LOSS SADNESS PSYCHIA; Wakefield JC, 2013, ACTA PSYCHIAT SCAND, V127, P159, DOI 10.1111/j.1600-0447.2012.01898.x; Wakefield JC, 2013, WORLD PSYCHIATRY, V12, P44, DOI 10.1002/wps.20015; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wierzbicka A, 2003, ETHOS, V31, P577, DOI 10.1525/eth.2003.31.4.577	51	92	92	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7140	10.1136/bmj.f7140	http://dx.doi.org/10.1136/bmj.f7140			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273ZI	24322400				2022-12-28	WOS:000328574400007
J	Jorgensen, WL				Jorgensen, William L.			Foundations of Biomolecular Modeling	CELL			English	Editorial Material							PROTEIN CONFORMATIONS; MOLECULAR-MECHANICS; SIMULATION; COMPUTER; SYSTEMS		Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Jorgensen, WL (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	william.jorgensen@yale.edu	/AAW-1187-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032136] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44616, R01 AI044616] Funding Source: Medline; NIGMS NIH HHS [R01 GM032136, GM32136] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLINGER NL, 1973, J AM CHEM SOC, V95, P3893, DOI 10.1021/ja00793a012; Allinger NL, 2011, J COMPUT AID MOL DES, V25, P295, DOI 10.1007/s10822-011-9422-4; BIXON M, 1967, TETRAHEDRON, V23, P769, DOI 10.1016/0040-4020(67)85023-3; HAGLER AT, 1978, P NATL ACAD SCI USA, V75, P554, DOI 10.1073/pnas.75.2.554; HONIG B, 1971, NATURE, V229, P558, DOI 10.1038/229558a0; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; Lafitte T, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4819786; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; LIFSON S, 1968, J CHEM PHYS, V49, P5116, DOI 10.1063/1.1670007; NEMETHY G, 1977, Quarterly Reviews of Biophysics, V10, P239; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014	14	25	25	0	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1199	1202		10.1016/j.cell.2013.11.023	http://dx.doi.org/10.1016/j.cell.2013.11.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315087	Green Accepted, Bronze			2022-12-28	WOS:000328271100001
J	Kost, RG; Lee, LM; Yessis, J; Wesley, RA; Henderson, DK; Coller, BS				Kost, Rhonda G.; Lee, Laura M.; Yessis, Jennifer; Wesley, Robert A.; Henderson, David K.; Coller, Barry S.			Assessing Participant-Centered Outcomes to Improve Clinical Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCEPTION		[Kost, Rhonda G.; Coller, Barry S.] Rockefeller Univ, New York, NY 10021 USA; [Lee, Laura M.; Wesley, Robert A.; Henderson, David K.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Yessis, Jennifer] Univ Waterloo, Propel Ctr Populat Hlth Impact, Waterloo, ON N2L 3G1, Canada	Rockefeller University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Waterloo	Kost, RG (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.				NCATS NIH HHS [UL1 TR000043] Funding Source: Medline; NCRR NIH HHS [UL1 RR024143] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Klitzman R, 2012, SCIENCE, V335, P1576, DOI 10.1126/science.1217225; Kost RG, 2011, CTS-CLIN TRANSL SCI, V4, P403, DOI 10.1111/j.1752-8062.2011.00349.x; Leshner AI, 2013, CSTA PROGRAM NIH OPP; Yessis JL, 2012, CTS-CLIN TRANSL SCI, V5, P452, DOI 10.1111/j.1752-8062.2012.00443.x	5	35	35	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2179	2181		10.1056/NEJMp1311461	http://dx.doi.org/10.1056/NEJMp1311461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263II	24304050	Green Accepted			2022-12-28	WOS:000327801100004
J	Mossinger, J; White, M; Goymer, P				Mossinger, Juliane; White, Michael; Goymer, Patrick			Untitled	NATURE			English	Editorial Material														Goymer, Patrick/0000-0002-2789-9373					0	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					35	35		10.1038/504035a	http://dx.doi.org/10.1038/504035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264BK	24305145	Bronze			2022-12-28	WOS:000327851700022
J	Bjerrum, L; Currea, GCC; Llor, C; Lindbaek, M				Bjerrum, Lars; Cordoba Currea, Gloria Cristina; Llor, Carlos; Lindbaek, Morten			Lower threshold for rapid antigen detection testing in patients with sore throats would reduce antibiotic use	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							ACUTE PHARYNGITIS		[Bjerrum, Lars; Cordoba Currea, Gloria Cristina] Univ Copenhagen, Dept Publ Hlth, Sect & Res Unit Gen Practice, DK-1014 Copenhagen K, Denmark; [Llor, Carlos] Univ Rovira & Virgili, Primary Care Ctr Jaume 1, Tarragona 43005, Spain; [Lindbaek, Morten] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, N-0317 Oslo, Norway	University of Copenhagen; Universitat Rovira i Virgili; University of Oslo	Bjerrum, L (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect & Res Unit Gen Practice, DK-1014 Copenhagen K, Denmark.	lbjerrum@sund.ku.dk	Bjerrum, Lars/ABD-2019-2020	Bjerrum, Lars/0000-0003-0969-0063; Cordoba, Gloria/0000-0002-2609-0468; Llor, Carl/0000-0001-6644-717X				Chiappini E, 2011, CLIN THER, V33, P48, DOI 10.1016/j.clinthera.2011.02.001; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018	4	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2013	347								f7055	10.1136/bmj.f7055	http://dx.doi.org/10.1136/bmj.f7055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GN	24286986				2022-12-28	WOS:000327795500002
J	Wise, J				Wise, Jacqui			Polypharmacy: a necessary evil The rise of patients taking four or more drugs is an aspect of modern medicine that requires some urgent attention, finds a new report. Jacqui Wise examines its recommendations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Guthrie B, 2012, PRIM HEALTH CARE RES, V13, P45; Health and Social Care Information Centre, 2012, PRESCR DISP COMM STA; The King's Fund, 2013, POL MED OPT MAK IT S	3	40	43	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2013	347								f7033	10.1136/bmj.f7033	http://dx.doi.org/10.1136/bmj.f7033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GN	24286985				2022-12-28	WOS:000327795500001
J	Gendron, CM; Kuo, TH; Harvanek, ZM; Chung, BY; Yew, JY; Dierick, HA; Pletcher, SD				Gendron, Christi M.; Kuo, Tsung-Han; Harvanek, Zachary M.; Chung, Brian Y.; Yew, Joanne Y.; Dierick, Herman A.; Pletcher, Scott D.			Drosophila Life Span and Physiology Are Modulated by Sexual Perception and Reward	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SENSORY PERCEPTION; EVOLUTION; MELANOGASTER; DEPRIVATION; OLFACTION; COURTSHIP; LONGEVITY; STRESS; GENE	Sensory perception can modulate aging and physiology across taxa. We found that perception of female sexual pheromones through a specific gustatory receptor expressed in a subset of foreleg neurons in male fruit flies, Drosophila melanogaster, rapidly and reversibly decreases fat stores, reduces resistance to starvation, and limits life span. Neurons that express the reward-mediating neuropeptide F are also required for pheromone effects. High-throughput whole-genome RNA sequencing experiments revealed a set of molecular processes that were affected by the activity of the longevity circuit, thereby identifying new candidate cell-nonautonomous aging mechanisms. Mating reversed the effects of pheromone perception; therefore, life span may be modulated through the integrated action of sensory and reward circuits, and healthy aging may be compromised when the expectations defined by sensory perception are discordant with ensuing experience.	[Gendron, Christi M.; Harvanek, Zachary M.; Chung, Brian Y.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Gendron, Christi M.; Harvanek, Zachary M.; Chung, Brian Y.; Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Kuo, Tsung-Han; Dierick, Herman A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Harvanek, Zachary M.] Univ Michigan, Med Scientist Training Program, Taubman Med Lib, Ann Arbor, MI 48109 USA; [Yew, Joanne Y.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; University of Michigan System; University of Michigan; National University of Singapore; National University of Singapore	Gendron, CM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Biomed Sci & Res Bldg, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Harvanek, Zachary M/GPJ-9798-2022; Yew, Joanne/D-6562-2014	Harvanek, Zachary/0000-0003-3702-1051; Chung, Brian/0000-0002-6423-5226	NIH [R01AG030593, TR01AG043972, R01AG023166, T32AG000114, T32GM007863, T32GM008322]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Ruth L. Kirschstein National Research Service Award from the National Institute on Aging [F32AG042253]; Glenn/AFAR Scholarship for Research in the Biology of Aging; NSF [IOS-1119473]; Alexander von Humboldt Foundation; Singapore National Research Foundation [RF001-363]; National Institute on Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102279, T32GM008322, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, P30AG013283, R01AG023166, R01AG043972, F32AG042253, R01AG030593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Ruth L. Kirschstein National Research Service Award from the National Institute on Aging; Glenn/AFAR Scholarship for Research in the Biology of Aging; NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Pletcher laboratory for Drosophila husbandry, N. Linford for comments on the revision, P. J. Lee for figure illustration, and members of the Dierick and Pletcher laboratories for suggestions on experiments and comments on the manuscript. Supported by NIH grants R01AG030593, TR01AG043972, and R01AG023166, the Glenn Foundation, the American Federation for Aging Research, and the Ellison Medical Foundation (S. D. P.); Ruth L. Kirschstein National Research Service Award F32AG042253 from the National Institute on Aging (B.Y.C.); NIH grant T32AG000114 (B.Y.C.); NIH grants T32GM007863 and T32GM008322 (Z.M.H.), a Glenn/AFAR Scholarship for Research in the Biology of Aging (Z.M.H.); NSF grant IOS-1119473 (H. A. D.); and the Alexander von Humboldt Foundation and Singapore National Research Foundation grant RF001-363 (J.Y.Y.). This work made use of the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging, funded by National Institute on Aging grant P30-AG-013283. RNA-seq expression data are provided in table S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no competing interests. C. M. G., T.-H. K., Z.M.H., and S. D. P. conceived and designed the experiments; C. M. G., T.-H. K., Z.M.H., B.Y.C., J.Y.Y., H. A. D., and S. D. P. performed the experiments; C. M. G., T.-H. K., Z.M.H., B.Y.C., J.Y.Y., and S. D. P. analyzed the data; and C. M. G., T.-H. K., J.Y.Y., H. A. D., and S. D. P. wrote the paper.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashburner M., 2004, DROSOPHILA LAB HDB; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; KALRA SP, 1988, SYNAPSE, V2, P254, DOI 10.1002/syn.890020313; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Linford NJ, 2011, ANNU REV CELL DEV BI, V27, P759, DOI 10.1146/annurev-cellbio-092910-154240; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020	25	90	91	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					544	548		10.1126/science.1243339	http://dx.doi.org/10.1126/science.1243339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24292624	Green Accepted			2022-12-28	WOS:000330343700048
J	Rouskin, S; Zubradt, M; Washietl, S; Kellis, M; Weissman, JS				Rouskin, Silvi; Zubradt, Meghan; Washietl, Stefan; Kellis, Manolis; Weissman, Jonathan S.			Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo	NATURE			English	Article							SECONDARY STRUCTURE; DIMETHYL SULFATE; PROTEIN RESPONSE; WEB SERVER; TRANSLATION; PREDICTION; RIBOSOME; YEAST; THERMOSENSOR; DEGRADATION	RNA has a dual role as an informational molecule and a direct effector of biological tasks. The latter function is enabled by RNA's ability to adopt complex secondary and tertiary folds and thus has motivated extensive computational(1,2) and experimental(3-8) efforts for determining RNA structures. Existing approaches for evaluating RNA structure have been largely limited to in vitro systems, yet the thermodynamic forces which drive RNA folding in vitro may not be sufficient to predict stable RNA structures in vivo(5). Indeed, the presence of RNA-binding proteins and ATP-dependent helicases can influence which structures are present inside cells. Here we present an approach for globally monitoring RNA structure in native conditions in vivo with single-nucleotide precision. This method is based on in vivo modification with dimethyl sulphate (DMS), which reacts with unpaired adenine and cytosine residues(9), followed by deep sequencing to monitor modifications. Our data from yeast and mammalian cells are in excellent agreement with known messenger RNA structures and with the high-resolution crystal structure of the Saccharomyces cerevisiae ribosome(10). Comparison between in vivo and in vitro data reveals that in rapidly dividing cells there are vastly fewer structured mRNA regions in vivo than in vitro. Even thermostable RNA structures are often denatured in cells, highlighting the importance of cellular processes in regulating RNA structure. Indeed, analysis of mRNA structure under ATP-depleted conditions in yeast shows that energy-dependent processes strongly contribute to the predominantly unfolded state of mRNAs inside cells. Our studies broadly enable the functional analysis of physiological RNA structures and reveal that, in contrast to the Anfinsen view of protein folding whereby the structure formed is the most thermodynamically favourable, thermodynamics have an incomplete role in determining mRNA structure in vivo.	[Rouskin, Silvi; Zubradt, Meghan; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biol,Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Washietl, Stefan; Kellis, Manolis] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Washietl, Stefan; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Washietl, Stefan; Kellis, Manolis] Broad Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biol,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Rouskin, Silvi/0000-0003-2042-6642; Weissman, Jonathan/0000-0003-2445-670X	Center for RNA Systems Biology; Howard Hughes Medical Institute; National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Andino, M. Bassik, J. Doudna, J. Dunn, T. Faust, N. Stern-Ginossar, C. Gross, C. Guthrie, N. Ingolia, C. Jan, M. Kampmann, D. Koller, G.W. Li, S. Mortimer, E. Oh, C. Pop and members of the Weissman laboratory for discussions; J. Stewart-Ornstein and O. Brandman for plasmids; C. Chu, N. Ingolia and J. Lund for sequencing help. This research was supported by the Center for RNA Systems Biology (J.S.W.), the Howard Hughes Medical Institute (J.S.W.), and the National Science Foundation (M.Z.).	Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; Cordero P, 2012, BIOCHEMISTRY-US, V51, P7037, DOI 10.1021/bi3008802; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; HASTINGS C, 1947, ANN MATH STAT, V18, P413, DOI 10.1214/aoms/1177730388; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; INOUE T, 1985, P NATL ACAD SCI USA, V82, P648, DOI 10.1073/pnas.82.3.648; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kortmann J, 2011, NUCLEIC ACIDS RES, V39, P2855, DOI 10.1093/nar/gkq1252; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Li SS, 2013, NUCLEIC ACIDS RES, V41, P3022, DOI 10.1093/nar/gkt057; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Memczak S., 2013, NATURE; Meyer M, 2011, MOL CELL, V43, P1033, DOI 10.1016/j.molcel.2011.07.030; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ouyang ZQ, 2013, GENOME RES, V23, P377, DOI 10.1101/gr.138545.112; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wells SE, 2000, METHOD ENZYMOL, V318, P479; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; ZAUG AJ, 1995, RNA, V1, P363; Ziehler W.A., 2001, CURR PROTOC NUCL ACI, V6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	543	556	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					701	+		10.1038/nature12894	http://dx.doi.org/10.1038/nature12894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24336214	Green Accepted, Green Submitted			2022-12-28	WOS:000330321000045
J	Hassler, DM; Zeitlin, C; Wimmer-Schweingruber, RF; Ehresmann, B; Rafkin, S; Eigenbrode, JL; Brinza, DE; Weigle, G; Bottcher, S; Bohm, E; Burmeister, S; Guo, JN; Kohler, J; Martin, C; Reitz, G; Cucinotta, FA; Kim, MH; Grinspoon, D; Bullock, MA; Posner, A; Gomez-Elvira, J; Vasavada, A; Grotzinger, JP				Hassler, Donald M.; Zeitlin, Cary; Wimmer-Schweingruber, Robert F.; Ehresmann, Bent; Rafkin, Scot; Eigenbrode, Jennifer L.; Brinza, David E.; Weigle, Gerald; Boettcher, Stephan; Boehm, Eckart; Burmeister, Soenke; Guo, Jingnan; Koehler, Jan; Martin, Cesar; Reitz, Guenther; Cucinotta, Francis A.; Kim, Myung-Hee; Grinspoon, David; Bullock, Mark A.; Posner, Arik; Gomez-Elvira, Javier; Vasavada, Ashwin; Grotzinger, John P.		MSL Sci Team	Mars' Surface Radiation Environment Measured with the Mars Science Laboratory's Curiosity Rover	SCIENCE			English	Article							IONIZING-RADIATION; MARTIAN SOIL; ORIGIN; RISKS; SPACE; BIOSIGNATURES; DESTRUCTION; PERCHLORATE; MODEL; CO2	The Radiation Assessment Detector (RAD) on the Mars Science Laboratory's Curiosity rover began making detailed measurements of the cosmic ray and energetic particle radiation environment on the surface of Mars on 7 August 2012. We report and discuss measurements of the absorbed dose and dose equivalent from galactic cosmic rays and solar energetic particles on the martian surface for similar to 300 days of observations during the current solar maximum. These measurements provide insight into the radiation hazards associated with a human mission to the surface of Mars and provide an anchor point with which to model the subsurface radiation environment, with implications for microbial survival times of any possible extant or past life, as well as for the preservation of potential organic biosignatures of the ancient martian environment.	[Hassler, Donald M.; Zeitlin, Cary; Ehresmann, Bent; Rafkin, Scot; Bullock, Mark A.] SW Res Inst, Boulder, CO 80302 USA; [Wimmer-Schweingruber, Robert F.; Boettcher, Stephan; Boehm, Eckart; Burmeister, Soenke; Guo, Jingnan; Koehler, Jan; Martin, Cesar] Univ Kiel, D-24118 Kiel, Germany; [Eigenbrode, Jennifer L.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Brinza, David E.; Vasavada, Ashwin; Grotzinger, John P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Weigle, Gerald] SW Res Inst, San Antonio, TX 78238 USA; [Reitz, Guenther] German Aerosp Ctr DLR, D-51147 Cologne, Germany; [Cucinotta, Francis A.] Univ Nevada, Las Vegas, NV 89154 USA; [Kim, Myung-Hee] Univ Space Res Assoc, Houston, TX 77058 USA; [Grinspoon, David] Denver Museum Nat & Sci, Denver, CO 80205 USA; [Posner, Arik] NASA Headquarters, Washington, DC 20546 USA; [Gomez-Elvira, Javier] Ctr Astrobiol INTA CSIC, Madrid 28850, Spain	University of Kiel; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; Helmholtz Association; German Aerospace Centre (DLR); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Hassler, DM (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	hassler@boulder.swri.edu	Reitz, Guenther/ABC-8921-2021; Franz, Heather B/F-3508-2012; Stipp, Susan L.S./B-8494-2019; Glavin, Daniel P/D-6194-2012; Martin-Torres, Javier/G-6329-2015; Teinturier, Samuel/AAS-8663-2020; Harri, Ari-Matti/C-7142-2012; Balic-Zunic, Tonci/A-6362-2013; Gomez-Elvira, Javier/K-5829-2014; De Pablo, Miguel Ángel/J-6442-2014; Muller, Jan-Peter/Q-8886-2019; Nikiforov, Sergei/ABI-1265-2020; Navarro-González, Rafael/D-1748-2009; Guo, Jingnan/ABB-3749-2021; Hayes, Alexander G/P-2024-2014; Eigenbrode, Jennifer L/D-4651-2012; FABRE, Cécile/B-5827-2012; Dworkin, Jason P./C-9417-2012; Wimmer-Schweingruber, Robert/AAQ-5794-2021; Blanco, Juan Jose/E-3627-2014; Lemmon, Mark T/E-9983-2010; GEFFROY, Claude/AAB-9152-2019; Cucinotta, Francis/AAZ-5941-2020; szopa, cyril/C-6865-2015; Zorzano, María-Paz/F-2184-2015; Ramos, Miguel/K-2230-2014; IMPMC, ROCKS @/U-8478-2017; Benna, Mehdi/F-3489-2012; Avalos, Juan Jose Blanco/AAB-9447-2021; Rodriguez-Manfredi, Jose/AAG-9826-2021; Gómez, Felipe/L-7315-2014; Rodriguez-Manfredi, Jose/L-8001-2014; Prats, Benito/F-9467-2019; Muñoz, Guillermo M/L-6370-2014; Gasnault, Olivier/F-4327-2010; Malakhov, Alexey/F-7953-2017; Steele, Andrew/A-3573-2013	Stipp, Susan L.S./0000-0001-7009-643X; Glavin, Daniel P/0000-0001-7779-7765; Martin-Torres, Javier/0000-0001-6479-2236; Teinturier, Samuel/0000-0003-1755-9524; Harri, Ari-Matti/0000-0001-8541-2802; Balic-Zunic, Tonci/0000-0003-1687-1233; Gomez-Elvira, Javier/0000-0002-9068-9846; De Pablo, Miguel Ángel/0000-0002-4496-2741; Muller, Jan-Peter/0000-0002-5077-3736; Nikiforov, Sergei/0000-0002-7221-8602; Navarro-González, Rafael/0000-0002-6078-7621; Guo, Jingnan/0000-0002-8707-076X; Hayes, Alexander G/0000-0001-6397-2630; Eigenbrode, Jennifer L/0000-0003-3089-1986; FABRE, Cécile/0000-0001-8627-4050; Dworkin, Jason P./0000-0002-3961-8997; Wimmer-Schweingruber, Robert/0000-0002-7388-173X; Blanco, Juan Jose/0000-0002-8666-0696; Lemmon, Mark T/0000-0002-4504-5136; GEFFROY, Claude/0000-0002-2731-9658; szopa, cyril/0000-0002-0090-4056; Zorzano, María-Paz/0000-0002-4492-9650; Ramos, Miguel/0000-0003-3648-6818; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Gómez, Felipe/0000-0001-9977-7060; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Muñoz, Guillermo M/0000-0001-7003-7368; Gasnault, Olivier/0000-0002-6979-9012; Malakhov, Alexey/0000-0003-4292-7077; Matthia, Daniel/0000-0003-1507-0143; Steele, Andrew/0000-0001-9643-2841	NASA under Jet Propulsion Laboratory (JPL) [1273039]; Deutsches Zentrum fur Luft-und Raumfahrt (DLR); DLR's Space Administration [50QM0501, 50 QM1201]; NASA; UK Space Agency [ST/I003118/1] Funding Source: researchfish	NASA under Jet Propulsion Laboratory (JPL); Deutsches Zentrum fur Luft-und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR's Space Administration; NASA(National Aeronautics & Space Administration (NASA)); UK Space Agency	This paper is dedicated to Dr. Michael J. Wargo at NASA HQ, who passed away unexpectedly on 4 August 2013. Mike was Chief Exploration Scientist in the Human Exploration and Operations Mission Directorate (HEOMD) and an enthusiastic supporter of collaborative projects between Science and Exploration. He was a strong supporter of RAD and a valuable member of both the science and exploration communities. He was a good friend and a wonderful human being, and he will be greatly missed. RAD is supported by NASA under Jet Propulsion Laboratory (JPL) subcontract 1273039 to Southwest Research Institute and in Germany by Deutsches Zentrum fur Luft-und Raumfahrt (DLR) and DLR's Space Administration grant numbers 50QM0501 and 50 QM1201 to the Christian Albrechts University, Kiel. Part of this research was carried out at JPL, California Institute of Technology, under a contract with NASA. We extend sincere gratitude to J. Simmonds and J. Crisp at JPL; G. Allen, M. Meyer, C. Moore, V. Friedensen, and R. Williams at NASA HQ; and H. Witte at DLR in Germany for their unwavering support of RAD over the years. The authors also thank the reviewers for their careful and thoughtful comments and suggestions. The data used in this paper are archived in the NASA Planetary Data System's Planetary Plasma Interactions (PPI) node at the University of California, Los Angeles. The archival volume includes the full binary raw data files, detailed descriptions of the structures therein, and higher-level data products in human-readable form. The PPI node is hosted at http://ppi.pds.nasa.gov.	Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; [Anonymous], 1991, Ann ICRP, V21, P1; Baumstark-Khan, 2001, ASTROBIOLOGY QUEST C, P260; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; Cane HV, 2010, AIP CONF PROC, V1216, P687, DOI 10.1063/1.3395960; Cane HV, 2000, SPACE SCI REV, V93, P55, DOI 10.1023/A:1026532125747; Catling DC, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003425; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; Court RW, 2007, GEOCHIM COSMOCHIM AC, V71, P2547, DOI 10.1016/j.gca.2007.03.001; Cucinotta F, 2013, 2013217375 NASA; Cucinotta FA, 2002, J RADIAT RES, V43, pS35; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2007, RADIAT ENVIRON BIOPH, V46, P101, DOI 10.1007/s00411-007-0099-y; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2011, RADIAT RES, V176, P102, DOI 10.1667/RR2540.1; Dartnell LR, 2007, BIOGEOSCIENCES, V4, P545, DOI 10.5194/bg-4-545-2007; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Dartnell LR, 2012, ANAL BIOANAL CHEM, V403, P131, DOI 10.1007/s00216-012-5829-6; Dartnell LR, 2011, ASTROBIOLOGY, V11, P997, DOI 10.1089/ast.2011.0663; Dartnell LR, 2011, ASTROBIOLOGY, V11, P551, DOI 10.1089/ast.2010.0528; De Angelis G, 2004, ADV SPACE RES, V34, P1328, DOI 10.1016/j.asr.2003.09.059; Drake B. G., 2010, AER C 2010 IEEE, P1, DOI [DOI 10.1109/AERO.2010.5446736, 10.1109/AERO.2010.5446736]; Ehresmann B, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016616; Ehresmann B., 2012, THESIS CHRISTIAN ALB; Gerakines PA, 2013, ASTROBIOLOGY, V13, P647, DOI 10.1089/ast.2012.0943; Glavin DP, 2013, J GEOPHYS RES-PLANET, V118, P1955, DOI 10.1002/jgre.20144; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; Gomez-Elvira J, 2012, SPACE SCI REV, V170, P583, DOI 10.1007/s11214-012-9921-1; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Hess VF, 1912, PHYS Z, V13, P1084; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KAHN R, 1985, ICARUS, V62, P175, DOI 10.1016/0019-1035(85)90116-2; Kamide Y, 2013, SPACE WEATHER, V11, P140, DOI 10.1002/swe.20045; Kim M.-H. Y., 2012, AGU M SAN FRANC; Kim MHY, 2009, ADV SPACE RES, V44, P1428, DOI 10.1016/j.asr.2009.07.028; Kim YS, 2013, J AM CHEM SOC, V135, P4910, DOI 10.1021/ja3122922; Kminek G, 2006, EARTH PLANET SC LETT, V245, P1, DOI 10.1016/j.epsl.2006.03.008; Lammer H., 2002, ASTROBIOLOGY QUEST C; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317; Nealy J. E., 1993, 3300 NASA; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Onsager TG, 1996, P SOC PHOTO-OPT INS, V2812, P281, DOI 10.1117/12.254075; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Pavlov AA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052166; Pavlov AK, 2002, PLANET SPACE SCI, V50, P669, DOI 10.1016/S0032-0633(01)00113-1; Pizzarello S., 2006, METEORITES EARLY SOL, P625; Quinn RC, 2013, ASTROBIOLOGY, V13, P515, DOI 10.1089/ast.2013.0999; Saganti PB, 2004, SPACE SCI REV, V110, P143, DOI 10.1023/B:SPAC.0000021010.20082.1a; Schneider S. I., 2009, ASP C SERIES, V420; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Simonsen L, 1990, 2979 NASA; Simonsen L.C., 1991, 3079 NASA; SIMPSON JA, 1983, ANNU REV NUCL PART S, V33, P323, DOI 10.1146/annurev.ns.33.120183.001543; Slaba TC, 2010, RADIAT MEAS, V45, P173, DOI 10.1016/j.radmeas.2010.01.005; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Task Group on the Biological Effects of Space Radiation National Research Council, 1996, RAD HAZ CREWS INT MI; von Rosenvinge TT, 2008, SPACE SCI REV, V136, P391, DOI 10.1007/s11214-007-9300-5; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wilson J. W., 1995, 3495 NASA STI PROGR; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	68	389	396	8	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1244797	10.1126/science.1244797	http://dx.doi.org/10.1126/science.1244797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324275	Green Published, Green Accepted			2022-12-28	WOS:000330039300005
J	Ming, DW; Archer, PD; Glavin, DP; Eigenbrode, JL; Franz, HB; Sutter, B; Brunner, AE; Stern, JC; Freissinet, C; McAdam, AC; Mahaffy, PR; Cabane, M; Coll, P; Campbell, JL; Atreya, SK; Niles, PB; Bell, JF; Bish, DL; Brinckerhoff, WB; Buch, A; Conrad, PG; Des Marais, DJ; Ehlmann, BL; Fairen, AG; Farley, K; Flesch, GJ; Francois, P; Gellert, R; Grant, JA; Grotzinger, JP; Gupta, S; Herkenhoff, KE; Hurowitz, JA; Leshin, LA; Lewis, KW; McLennan, SM; Miller, KE; Moersch, J; Morris, RV; Navarro-Gonzalez, R; Pavlov, AA; Perrett, GM; Pradler, I; Squyres, SW; Summons, RE; Steele, A; Stolper, EM; Sumner, DY; Szopa, C; Teinturier, S; Trainer, MG; Treiman, AH; Vaniman, DT; Vasavada, AR; Webster, CR; Wray, JJ; Yingst, RA				Ming, D. W.; Archer, P. D., Jr.; Glavin, D. P.; Eigenbrode, J. L.; Franz, H. B.; Sutter, B.; Brunner, A. E.; Stern, J. C.; Freissinet, C.; McAdam, A. C.; Mahaffy, P. R.; Cabane, M.; Coll, P.; Campbell, J. L.; Atreya, S. K.; Niles, P. B.; Bell, J. F., III; Bish, D. L.; Brinckerhoff, W. B.; Buch, A.; Conrad, P. G.; Des Marais, D. J.; Ehlmann, B. L.; Fairen, A. G.; Farley, K.; Flesch, G. J.; Francois, P.; Gellert, R.; Grant, J. A.; Grotzinger, J. P.; Gupta, S.; Herkenhoff, K. E.; Hurowitz, J. A.; Leshin, L. A.; Lewis, K. W.; McLennan, S. M.; Miller, K. E.; Moersch, J.; Morris, R. V.; Navarro-Gonzalez, R.; Pavlov, A. A.; Perrett, G. M.; Pradler, I.; Squyres, S. W.; Summons, R. E.; Steele, A.; Stolper, E. M.; Sumner, D. Y.; Szopa, C.; Teinturier, S.; Trainer, M. G.; Treiman, A. H.; Vaniman, D. T.; Vasavada, A. R.; Webster, C. R.; Wray, J. J.; Yingst, R. A.		MSL Sci Team	Volatile and Organic Compositions of Sedimentary Rocks in Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							MARTIAN SOIL; PERCHLORATE; HYDROGEN; DIOXIDE; SURFACE; ANALOG	H2O, CO2, SO2, O-2, H-2, H2S, HCl, chlorinated hydrocarbons, NO, and other trace gases were evolved during pyrolysis of two mudstone samples acquired by the Curiosity rover at Yellowknife Bay within Gale crater, Mars. H2O/OH-bearing phases included 2:1 phyllosilicate(s), bassanite, akaganeite, and amorphous materials. Thermal decomposition of carbonates and combustion of organic materials are candidate sources for the CO2. Concurrent evolution of O-2 and chlorinated hydrocarbons suggests the presence of oxychlorine phase(s). Sulfides are likely sources for sulfur-bearing species. Higher abundances of chlorinated hydrocarbons in the mudstone compared with Rocknest windblown materials previously analyzed by Curiosity suggest that indigenous martian or meteoritic organic carbon sources may be preserved in the mudstone; however, the carbon source for the chlorinated hydrocarbons is not definitively of martian origin.	[Ming, D. W.; Niles, P. B.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Archer, P. D., Jr.; Sutter, B.] Jacobs, Houston, TX 77058 USA; [Glavin, D. P.; Eigenbrode, J. L.; Franz, H. B.; Brunner, A. E.; Stern, J. C.; Freissinet, C.; McAdam, A. C.; Mahaffy, P. R.; Brinckerhoff, W. B.; Conrad, P. G.; Pavlov, A. A.; Trainer, M. G.] NASA, Goddard Space Flight Ctr, Planetary Environments Lab, Greenbelt, MD 20771 USA; [Franz, H. B.] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA; [Brunner, A. E.] Univ Maryland, Dept Astron, Ctr Res & Explorat Space Sci & Technol, College Pk, MD 20742 USA; [Freissinet, C.] NASA, Goddard Space Flight Ctr, NASA Postdoctoral Program, Greenbelt, MD 20771 USA; [Cabane, M.] Univ Versailles St Quentin, Univ Paris 06, Lab Atmospheres, UMR CNRS 8970, F-75005 Paris, France; [Coll, P.; Francois, P.; Szopa, C.; Teinturier, S.] Univ Paris Diderot, Univ Paris Est Creteil, Lab Interuniv Syst Atmospher, F-94000 Creteil, France; [Coll, P.; Francois, P.; Szopa, C.; Teinturier, S.] CNRS, F-94000 Creteil, France; [Campbell, J. L.; Gellert, R.; Perrett, G. M.; Pradler, I.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Atreya, S. K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Bell, J. F., III] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Bish, D. L.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Buch, A.] Ecole Cent Paris, Lab Genie Procedes & Mat, F-92295 Chatenay Malabry, France; [Des Marais, D. J.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Ehlmann, B. L.; Farley, K.; Grotzinger, J. P.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ehlmann, B. L.; Flesch, G. J.; Vasavada, A. R.; Webster, C. R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Fairen, A. G.; Squyres, S. W.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Herkenhoff, K. E.] US Geol Survey, Flagstaff, AZ 86001 USA; [Hurowitz, J. A.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Lewis, K. W.] Princeton Univ, Princeton, NJ 08544 USA; [Miller, K. E.; Summons, R. E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Moersch, J.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Vaniman, D. T.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wray, J. J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Guelph; University of Michigan System; University of Michigan; Arizona State University; Arizona State University-Tempe; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Smithsonian Institution; Imperial College London; United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Princeton University; Massachusetts Institute of Technology (MIT); University of Tennessee System; University of Tennessee Knoxville; Universidad Nacional Autonoma de Mexico; Carnegie Institution for Science; University of California System; University of California Davis; University System of Georgia; Georgia Institute of Technology	Ming, DW (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA.	douglas.w.ming@nasa.gov	Moersch, Jeffrey E/F-7189-2010; Benna, Mehdi/F-3489-2012; Bish, David/AAY-7618-2020; Lemmon, Mark T/E-9983-2010; Eigenbrode, Jennifer L/D-4651-2012; Ramos, Miguel/K-2230-2014; Brinckerhoff, William/F-3453-2012; Farley, Kenneth/AAE-7735-2020; Steele, Andrew/A-3573-2013; Summons, Roger Everett/AAL-3789-2020; Rodriguez-Manfredi, Jose/L-8001-2014; Muller, Jan-Peter/Q-8886-2019; Prats, Benito/F-9467-2019; Wray, James J/B-8457-2008; Dworkin, Jason P./C-9417-2012; Zorzano, María-Paz/F-2184-2015; De Pablo, Miguel Ángel/J-6442-2014; Harri, Ari-Matti/C-7142-2012; Hayes, Alexander G/P-2024-2014; Sumner, Dawn Y/E-8744-2011; Webster, Chris/M-9315-2019; Martin-Torres, Javier/G-6329-2015; Blanco, Juan Jose/E-3627-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Franz, Heather B/F-3508-2012; Teinturier, Samuel/AAS-8663-2020; szopa, cyril/C-6865-2015; Glavin, Daniel P/D-6194-2012; Gómez, Felipe/L-7315-2014; Gomez-Elvira, Javier/K-5829-2014; Stern, Jennifer/E-3135-2012; Navarro-González, Rafael/D-1748-2009; Rodriguez-Manfredi, Jose/AAG-9826-2021; Stipp, Susan L.S./B-8494-2019; Balic-Zunic, Tonci/A-6362-2013; FABRE, Cécile/B-5827-2012; GEFFROY, Claude/AAB-9152-2019; Trainer, Melissa G/E-1477-2012; Vicenzi, Edward/T-9430-2017; McAdam, Amy/E-1556-2012; Gasnault, Olivier/F-4327-2010; Malakhov, Alexey/F-7953-2017	Moersch, Jeffrey E/0000-0003-3433-9419; Lemmon, Mark T/0000-0002-4504-5136; Eigenbrode, Jennifer L/0000-0003-3089-1986; Ramos, Miguel/0000-0003-3648-6818; Brinckerhoff, William/0000-0001-5121-2634; Steele, Andrew/0000-0001-9643-2841; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Muller, Jan-Peter/0000-0002-5077-3736; Prats, Benito/0000-0003-3869-3351; Wray, James J/0000-0001-5559-2179; Dworkin, Jason P./0000-0002-3961-8997; Zorzano, María-Paz/0000-0002-4492-9650; De Pablo, Miguel Ángel/0000-0002-4496-2741; Harri, Ari-Matti/0000-0001-8541-2802; Hayes, Alexander G/0000-0001-6397-2630; Sumner, Dawn Y/0000-0002-7343-2061; Martin-Torres, Javier/0000-0001-6479-2236; Blanco, Juan Jose/0000-0002-8666-0696; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Teinturier, Samuel/0000-0003-1755-9524; szopa, cyril/0000-0002-0090-4056; Glavin, Daniel P/0000-0001-7779-7765; Gómez, Felipe/0000-0001-9977-7060; Gomez-Elvira, Javier/0000-0002-9068-9846; Stern, Jennifer/0000-0002-0162-8807; Navarro-González, Rafael/0000-0002-6078-7621; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Stipp, Susan L.S./0000-0001-7009-643X; Balic-Zunic, Tonci/0000-0003-1687-1233; FABRE, Cécile/0000-0001-8627-4050; GEFFROY, Claude/0000-0002-2731-9658; Gupta, Sanjeev/0000-0001-6415-1332; Vicenzi, Edward/0000-0003-2085-6546; Buch, Arnaud/0000-0002-2097-7252; Wilson, Sharon/0000-0001-8872-8546; McAdam, Amy/0000-0001-9120-2991; Gasnault, Olivier/0000-0002-6979-9012; McLennan, Scott/0000-0003-4259-7178; Johnson, Jeffrey/0000-0002-5586-4901; Malakhov, Alexey/0000-0003-4292-7077; Grant, John/0000-0001-8276-1281; Farley, Kenneth/0000-0002-7846-7546; Campbell, John/0000-0002-6752-3493	National Aeronautics and Space Administration (NASA); French Space Agency (CNES); Canadian Space Agency; UK Space Agency; NASA ROSES MSL Participating Scientist Program; UK Space Agency [ST/I003118/1, ST/J005169/1] Funding Source: researchfish	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); French Space Agency (CNES)(Centre National D'etudes Spatiales); Canadian Space Agency(Canadian Space Agency); UK Space Agency; NASA ROSES MSL Participating Scientist Program; UK Space Agency	We are indebted to the Mars Science Laboratory Project engineering and management teams for making this mission possible and enhancing science operations. Much of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration (NASA). NASA provided support for the development of SAM. Data from these SAM experiments are archived in the Planetary Data System (pds.nasa.gov). Essential contributions to the successful operation of SAM on Mars and the acquisition of this data were provided by the SAM development, operations, and testbed teams. Development and operation of the SAM and APXS instruments were also supported by funds from the French Space Agency (CNES) and the Canadian Space Agency. Work in the UK was funded by the UK Space Agency. B. L. E., J.L.E., K. F., D. P. G., J.E.G., K. E. M., S. M. M., J.M., P.B.N., and R. E. S. acknowledge funding support from the NASA ROSES MSL Participating Scientist Program.	Anderson MS, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4757861; Archer P.D., 2013, PLANETARY SCI, V2, P2, DOI [10.1186/2191-2521-2-2, DOI 10.1186/2191-2521-2-2]; ARUTYUNOV VS, 1991, KINET CATAL+, V32, P1112; Baba A. A., 2011, J APPL SCI TECHNOL, V16, P104; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; BIEMANN K, 1976, SCIENCE, V194, P72, DOI 10.1126/science.194.4260.72; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Biemann K, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003869; BIGHAM JM, 2002, SOIL MINERALOGY ENV; BINNS D, 1991, J CHEM PHYS, V95, P4940, DOI 10.1063/1.461710; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; Cannon KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051952; Flynn GJ, 1996, EARTH MOON PLANETS, V72, P469, DOI 10.1007/BF00117551; Gellert R., 2013, 44 LUN PLAN SCI C HO; Glavin DP, 2013, J GEOPHYS RES-PLANET, V118, P1955, DOI 10.1002/jgre.20144; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Hanley J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051239; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; INGRAHAM TR, 1972, CAN METALL QUART, V11, P407, DOI 10.1179/000844372795257575; Janchen J, 2009, ICARUS, V200, P463, DOI 10.1016/j.icarus.2008.12.006; Kminek G, 2006, EARTH PLANET SC LETT, V245, P1, DOI 10.1016/j.epsl.2006.03.008; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; MARVIN GG, 1945, IND ENG CHEM, V17, P474, DOI 10.1021/i560144a004; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; -Mikuli AM, 2008, J THERM ANAL CALORIM, V91, P529, DOI 10.1007/s10973-007-8511-z; Ming D. W., 2009, 40 LUN PLAN SCI C HO; Navarro-Gonzalez R, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003880; Navarro-Gonzalez R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003599; Nealson KH, 1999, PHILOS T R SOC B, V354, P1923, DOI 10.1098/rstb.1999.0532; Potter PE, 2005, MUD MUDSTONES; Quinn RC, 1999, ORIGINS LIFE EVOL B, V29, P59, DOI 10.1023/A:1006506022182; RUDLOFF WK, 1970, J PHYS CHEM-US, V74, P3317, DOI 10.1021/j100712a002; Schwertmann U., 2007, IRON OXIDES LAB PREP; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Steele A, 2012, AM MINERAL, V97, P1256, DOI 10.2138/am.2012.4148; Steininger H, 2012, PLANET SPACE SCI, V71, P9, DOI 10.1016/j.pss.2012.06.015; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Sutter B, 2012, ICARUS, V218, P290, DOI 10.1016/j.icarus.2011.12.002; The National Institute of Standards and Technology/Environmental Protection Agency/National Institutes of Health (NIST/EPA/NIH) Mass Spectral Database, 2011, MASS SPECTR DAT NIST; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Yen AS, 2000, SCIENCE, V289, P1909, DOI 10.1126/science.289.5486.1909; Zent AP, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003001	47	268	270	11	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1245267	10.1126/science.1245267	http://dx.doi.org/10.1126/science.1245267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324276	Green Submitted, Green Accepted			2022-12-28	WOS:000330039300006
J	Spottiswoode, CN				Spottiswoode, Claire N.			How Cooperation Defeats Cheats	SCIENCE			English	Editorial Material							BROOD PARASITISM; BIRDS; EVOLUTION; HISTORY; HOSTS		[Spottiswoode, Claire N.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Spottiswoode, Claire N.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa	University of Cambridge; National Research Foundation - South Africa; University of Cape Town	Spottiswoode, CN (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	cns26@cam.ac.uk			BBSRC [BB/J014109/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014109/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Boland CRJ, 2002, EMU, V102, P9, DOI 10.1071/MU01039; Cambray E., 2014, AFRICAN BIRDLIFE, V2, P70; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cockburn A, 2011, CURR BIOL, V21, pR195, DOI 10.1016/j.cub.2011.01.044; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Feeney WE, 2013, SCIENCE, V342, P1506, DOI 10.1126/science.1240039; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Kilner RM, 2011, BIOL REV, V86, P836, DOI 10.1111/j.1469-185X.2010.00173.x; ROBERTSON RJ, 1976, CONDOR, V78, P166, DOI 10.2307/1366851	11	1	1	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1452	1453		10.1126/science.1247758	http://dx.doi.org/10.1126/science.1247758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357303				2022-12-28	WOS:000328644300036
J	Gravitz, L				Gravitz, Lauren			Cancer Immunotherapy	NATURE			English	Editorial Material																			0	36	36	7	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S1	S1		10.1038/504S1a	http://dx.doi.org/10.1038/504S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352357	Bronze			2022-12-28	WOS:000328575300001
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Fasten your seatbelts for integrated care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2721; Northern Ireland Health and Social Care Board, 2013, TRANSFORMING YOUR CA; Timmins N., 2013, THE FOUR UK HEALTH S	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2013	347								f7487	10.1136/bmj.f7487	http://dx.doi.org/10.1136/bmj.f7487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277LV	24342776				2022-12-28	WOS:000328821800021
J	Weatheritt, RJ; Babu, MM				Weatheritt, Robert J.; Babu, M. Madan			The Hidden Codes That Shape Protein Evolution	SCIENCE			English	Editorial Material									[Weatheritt, Robert J.; Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Weatheritt, RJ (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	rweather@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	Weatheritt, Robert/0000-0003-3716-1783	Medical Research Council [MC_U105185859] Funding Source: Medline; MRC [MC_U105185859] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; Nirenberg M, 2004, TRENDS BIOCHEM SCI, V29, P46, DOI 10.1016/j.tibs.2003.11.009; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; Warnecke T, 2009, BIOCHEM SOC T, V37, P756, DOI 10.1042/BST0370756	14	27	28	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1325	1326		10.1126/science.1248425	http://dx.doi.org/10.1126/science.1248425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337281	Green Accepted			2022-12-28	WOS:000328196000032
J	DeCaen, PG; Delling, M; Vien, TN; Clapham, DE				DeCaen, Paul G.; Delling, Markus; Vien, Thuy N.; Clapham, David E.			Direct recording and molecular identification of the calcium channel of primary cilia	NATURE			English	Article							CA2+ CHANNEL; TRP; CURRENTS; CELLS	A primary cilium is a solitary, slender, non-motile protuberance of structured microtubules (9+0) enclosed by plasma membrane(1). Housing components of the cell division apparatus between cell divisions, primary cilia also serve as specialized compartments for calcium signalling(2) and hedgehog signalling pathways(3). Specialized sensory cilia such as retinal photoreceptors and olfactory cilia use diverse ion channels(4-7). An ion current has been measured from primary cilia of kidney cells(8), but the responsible genes have not been identified. The polycystin proteins (PC and PKD), identified in linkage studies of polycystic kidney disease(9), are candidate channels divided into two structural classes: 11-transmembrane proteins (PKD1, PKD1L1 and PKD1L2) remarkable for a large extracellular amino terminus of putative cell adhesion domains and a G-protein-coupled receptor proteolytic site, and the 6-transmembrane channel proteins (PKD2, PKD2L1 and PKD2L2; TRPPs). Evidence indicates that the PKD1 proteins associate with the PKD2 proteins via coiled-coil domains(10-12). Here we use a transgenic mouse in which only cilia express a fluorophore and use it to record directly from primary cilia, and demonstrate that PKD1L1 and PKD2L1 form ion channels at high densities in several cell types. In conjunction with an accompanying manuscript(2), we show that the PKD1L1-PKD2L1 heteromeric channel establishes the cilia as a unique calcium compartment within cells that modulates established hedgehog pathways.	[DeCaen, Paul G.; Delling, Markus; Clapham, David E.] Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Vien, Thuy N.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Neurosci, Boston, MA 02111 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Tufts University; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, 320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu		Clapham, David/0000-0002-4459-9428	NIH [T32 HL007572, P30 HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.G.D. was supported by NIH T32 HL007572. Animal work was, in part, supported by NIH P30 HD18655 to the IDDRC of Boston Children's Hospital. We thank B. Navarro, N. Blair, J. Doerner, S. Febvay, and the members of the Clapham laboratory for advice and assistance.	Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kleene N. K., 2012, CILIA, V1, P1; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Raychowdhury MK, 2005, J BIOL CHEM, V280, P34718, DOI 10.1074/jbc.M507793200; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhu J, 2011, P NATL ACAD SCI USA, V108, P10133, DOI 10.1073/pnas.1017669108	29	198	206	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					315	+		10.1038/nature12832	http://dx.doi.org/10.1038/nature12832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336289	Green Accepted, Green Submitted			2022-12-28	WOS:000328121500044
J	Sanchez, A; Golding, I				Sanchez, Alvaro; Golding, Ido			Genetic Determinants and Cellular Constraints in Noisy Gene Expression	SCIENCE			English	Review							TRANSCRIPTION; REVEALS; INITIATION; PROMOTERS; DYNAMICS; KINETICS	In individual cells, transcription is a random process obeying single-molecule kinetics. Often, it occurs in a bursty, intermittent manner. The frequency and size of these bursts affect the magnitude of temporal fluctuations in messenger RNA and protein content within a cell, creating variation or "noise" in gene expression. It is still unclear to what degree transcriptional kinetics are specific to each gene and determined by its promoter sequence. Alternative scenarios have been proposed, in which the kinetics of transcription are governed by cellular constraints and follow universal rules across the genome. Evidence from genome-wide noise studies and from systematic perturbations of promoter sequences suggest that both scenarios-namely gene-specific versus genome-wide regulation of transcription kinetics-may be present to different degrees in bacteria, yeast, and animal cells.	[Sanchez, Alvaro] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Golding, Ido] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Harvard University; Baylor College of Medicine; Rice University; University of Illinois System; University of Illinois Urbana-Champaign	Sanchez, A (corresponding author), Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA.	sanchez@rowland.harvard.edu; golding@bcm.edu	Sanchez, Alvaro/AAW-2304-2021	Sanchez, Alvaro/0000-0002-2292-5608	Rowland Institute at Harvard; U.S. National Institutes of Health [R01 GM082837]; U.S. National Science Foundation [082265, PHY-1147498]; Welch Foundation [Q-1759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1147498] Funding Source: National Science Foundation	Rowland Institute at Harvard; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We apologize to our colleagues whose work could not be cited because of space limitations. We thank the following for sharing data and insights with us: A. Bar-Even, N. Barkai, A. Boettiger, M. Dadiani, A. Depace, T. Gregor, J. Kondev, D. Larson, R. Philips, A. Raj, E. Segal, and D. Zenklusen. I. G. thanks his laboratory members for help preparing the manuscript. Work in the Sanchez lab is supported by a Junior Fellowship from the Rowland Institute at Harvard. Work in the Golding lab is supported by the U.S. National Institutes of Health grant R01 GM082837, U.S. National Science Foundation grants 082265 (Physics Frontiers Center: Center for the Physics of Living Cells) and PHY-1147498 (CAREER), and Welch Foundation grant Q-1759. The authors declare no conflicts of interest.	Bai L, 2010, DEV CELL, V18, P544, DOI 10.1016/j.devcel.2010.02.007; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; BREMER H, 1995, BBA-GENE STRUCT EXPR, V1262, P15, DOI 10.1016/0167-4781(95)00042-F; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Dadiani M, 2013, GENOME RES, V23, P966, DOI 10.1101/gr.149096.112; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Murphy KF, 2010, NUCLEIC ACIDS RES, V38, P2712, DOI 10.1093/nar/gkq091; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zopf CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003161	40	279	282	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1188	1193		10.1126/science.1242975	http://dx.doi.org/10.1126/science.1242975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311680	Green Accepted			2022-12-28	WOS:000327857900035
J	Archer, SL				Archer, Stephen L.			Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PULMONARY ARTERIAL-HYPERTENSION; PARKINSONS-DISEASE; MITOFUSIN 2; ENDOPLASMIC-RETICULUM; EMBRYONIC-DEVELOPMENT; ENZYMATIC-ACTIVITY; MAMMALIAN-CELLS; S-NITROSYLATION; GTPASE DRP1; PINK1	Mitochondria fuse and divide in response to cell demands and environment. Alterations in mitochondrial dynamics underlie various human diseases, including cancer and neurologic and cardiovascular diseases. Defining the alterations may identify potential therapeutic targets. Mitochondria are mobile organelles that exist in dynamic networks. They continuously join by the process of fusion and divide by the process of fission. Mitochondria are derived from eubacterial endosymbionts that are capable of aerobic respiration; this finding was proposed independently by Merezhkovsky in 1905 and by Margulis in 1967.(1) First described as bioblasts by Altmann in 1890, it was Benda's 1898 observation of their heterogeneous morphologic features, sometimes ball-shaped and other times linear, that inspired the name mitochondrion, from the Greek words mitos (meaning thread) and chondrion (meaning granule).(2) Lewis and Lewis's 1914 observations established the field of mitochondrial ...	Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Rm 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071115] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071115] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Inoue-Yamauchi A, 2012, BIOCHEM BIOPH RES CO, V421, P81, DOI 10.1016/j.bbrc.2012.03.118; Ishihara N, 2013, ANTIOXID REDOX SIGN, V19, P389, DOI 10.1089/ars.2012.4830; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1295, DOI 10.1001/archneurol.2011.225; Knoll AH, 2012, P NATL ACAD SCI USA, V109, P1022, DOI 10.1073/pnas.1120472109; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nakamura T, 2010, APOPTOSIS, V15, P1354, DOI 10.1007/s10495-010-0476-x; O'Rourke B, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00007; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rojo M, 2002, J CELL SCI, V115, P1663; Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Semenza GL, 2011, NEW ENGL J MED, V365, P968; Sharp WW, 2003, FASEB J; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2010, AUTOPHAGY, V6, P405, DOI 10.4161/auto.6.3.11245; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	102	632	663	9	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2236	2251		10.1056/NEJMra1215233	http://dx.doi.org/10.1056/NEJMra1215233			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304053				2022-12-28	WOS:000327801100010
J	Betley, JN; Cao, ZFH; Ritola, KD; Sternson, SM				Betley, J. Nicholas; Cao, Zhen Fang Huang; Ritola, Kimberly D.; Sternson, Scott M.			Parallel, Redundant Circuit Organization for Homeostatic Control of Feeding Behavior	CELL			English	Article							IN-VIVO; NEURONAL POPULATIONS; HYPOTHALAMUS; HORMONE; NUCLEUS; POMC; CONNECTIONS; PATHWAY; SWITCH; MICE	Neural circuits for essential natural behaviors are shaped by selective pressure to coordinate reliable execution of flexible goal-directed actions. However, the structural and functional organization of survival-oriented circuits is poorly understood due to exceptionally complex neuroanatomy. This is exemplified by AGRP neurons, which are a molecularly defined population that is sufficient to rapidly coordinate voracious food seeking and consumption behaviors. Here, we use cell-type-specific techniques for neural circuit manipulation and projection-specific anatomical analysis to examine the organization of this critical homeostatic circuit that regulates feeding. We show that AGRP neuronal circuits use a segregated, parallel, and redundant output configuration. AGRP neuron axon projections that target different brain regions originate from distinct subpopulations, several of which are sufficient to independently evoke feeding. The concerted anatomical and functional analysis of AGRP neuron projection populations reveals a constellation of core forebrain nodes, which are part of an extended circuit that mediates feeding behavior.	[Betley, J. Nicholas; Cao, Zhen Fang Huang; Ritola, Kimberly D.; Sternson, Scott M.] HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), HHMI, Janelia Farm Res Campus, 19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org			Howard Hughes Medical Institute; HHMI Janelia Farm Graduate Scholar program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Farm Graduate Scholar program	This research was funded by the Howard Hughes Medical Institute. Z.F.H.C. was funded by the HHMI Janelia Farm Graduate Scholar program. We thank A. Wardlaw, K. Morris, and J. Rouchard for mouse breeding, genotyping, and viral injections; M. Copeland for histology; S. Supekar and E. Betley for executing automated bouton counting; S. Brenner-Morton and T. Jessell for Islet1(2) antibody; M. Myers for Lepr-IRES-Cre mice; E. Callaway for rabies viral reagents.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Diano S, 1998, J NEUROENDOCRINOL, V10, P731, DOI 10.1046/j.1365-2826.1998.00204.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hess WR, 1957, FUNCTIONAL ORG DIENC; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; KELLY J, 1977, PHARMACOL BIOCHEM BE, V7, P537, DOI 10.1016/0091-3057(77)90250-7; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P517, DOI 10.1016/0031-9384(88)90153-9; KOW LM, 1977, BRAIN RES, V123, P75, DOI 10.1016/0006-8993(77)90644-8; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; KUYPERS HGJM, 1977, NEUROSCI LETT, V6, P127, DOI 10.1016/0304-3940(77)90007-6; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Napadow V, 2013, CEREB CORTEX, V23, P806, DOI 10.1093/cercor/bhs073; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; ROELING TAP, 1994, NEUROSCIENCE, V59, P1001, DOI 10.1016/0306-4522(94)90302-6; Shin JW, 2008, J COMP NEUROL, V511, P628, DOI 10.1002/cne.21870; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Tinbergen N, 1989, STUDY INSTINCT; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wittmann G, 2009, J COMP NEUROL, V515, P313, DOI 10.1002/cne.22017; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2012, P NATL ACAD SCI USA, V109, P3155, DOI 10.1073/pnas.1120501109; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	41	364	369	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1337	1350		10.1016/j.cell.2013.11.002	http://dx.doi.org/10.1016/j.cell.2013.11.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315102	Green Accepted, Bronze			2022-12-28	WOS:000328271100017
J	Khabbaz, RF				Khabbaz, Rima F.			Still Learning From SARS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; INFECTION; OUTBREAK		Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Khabbaz, RF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop D12, Atlanta, GA 30333 USA.	rfk1@cdc.gov						[Anonymous], 2008, INT HLTH REG; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Relman DA, 2013, JAMA-J AM MED ASSOC, V309, P1531, DOI 10.1001/jama.2013.3678; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; World Health Organization, 2003, GLOB AL RESP GAR SUM; World Health Organization, 2011, PAND INFL A H1N1 DON; World Health Organization, 2013, GLOB AL RESP GAR MER	10	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					780	+		10.7326/0003-4819-159-11-201312030-00011	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297195				2022-12-28	WOS:000328731000008
J	Tinkle, S				Tinkle, Sally			Learn from other initiatives	NATURE			English	Editorial Material									Sci & Technol Policy Inst, Washington, DC USA		Tinkle, S (corresponding author), Sci & Technol Policy Inst, Washington, DC USA.		Barnard, Amanda/A-7340-2011	Barnard, Amanda/0000-0002-4784-2382					0	6	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					463	463						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24298569				2022-12-28	WOS:000327464200015
J	James, PA				James, P. A.			2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Correction													James, Paul/ABB-2761-2020	Dennison Himmelfarb, Cheryl/0000-0003-1918-4316				James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427	1	4251	4548	9	124	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1809	1809		10.1001/jama.2013.284427	http://dx.doi.org/10.1001/jama.2013.284427			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24352797	Bronze			2022-12-28	WOS:000335382300033
J	Kahn, SE; Cooper, ME; Del Prato, S				Kahn, Steven E.; Cooper, Mark E.; Del Prato, Stefano			Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future	LANCET			English	Review							BETA-CELL FUNCTION; GLUCAGON-LIKE PEPTIDE-1; LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; FIBROBLAST GROWTH-FACTORS; INSULIN-TREATED PATIENTS; ACTING BASAL INSULIN; ALL-CAUSE MORTALITY	Glucose metabolism is normally regulated by a feedback loop including islet beta cells and insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of beta-cell response. If insulin resistance is present, beta cells maintain normal glucose tolerance by increasing insulin output. Only when beta cells cannot release sufficient insulin in the presence of insulin resistance do glucose concentrations rise. Although beta-cell dysfunction has a clear genetic component, environmental changes play an essential part. Modern research approaches have helped to establish the important role that hexoses, aminoacids, and fatty acids have in insulin resistance and beta-cell dysfunction, and the potential role of changes in the microbiome. Several new approaches for treatment have been developed, but more effective therapies to slow progressive loss of beta-cell function are needed. Recent findings from clinical trials provide important information about methods to prevent and treat type 2 diabetes and some of the adverse effects of these interventions. However, additional long-term studies of drugs and bariatric surgery are needed to identify new ways to prevent and treat type 2 diabetes and thereby reduce the harmful effects of this disease.	[Kahn, Steven E.] Univ Washington, VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Cooper, Mark E.] Baker IDI Heart & Diabet Inst, Diabet Div, Melbourne, Vic, Australia; [Del Prato, Stefano] Univ Pisa, Sch Med, Dept Clin & Expt Med, I-56100 Pisa, Italy	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Baker Heart and Diabetes Institute; University of Pisa	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA.	skahn@uw.edu	Del Prato, Stefano/K-3405-2016; Cooper, Mark/AAC-5326-2020; Del+Prato, Stefano/AAC-9197-2021	Del Prato, Stefano/0000-0002-5388-0270; Kahn, Steven/0000-0001-7307-9002	US Department of Veterans Affairs; NIH [DK-017047]; National Health and Medical Research Council of Australia; Italian Ministry of Education and Research [2010YK7Z5K_006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SEK is supported partly by the US Department of Veterans Affairs and NIH grant DK-017047. MEC is supported by an Australia Fellowship from the National Health and Medical Research Council of Australia. SDP was supported by grant 2010YK7Z5K_006 from the Italian Ministry of Education and Research.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P403, DOI 10.1517/13543770902762893; Arslanian S, 2013, DIABETES CARE, V36, P1749, DOI 10.2337/dc12-2393; ASMAL AC, 1984, DRUGS, V28, P62, DOI 10.2165/00003495-198428010-00004; Barbarroja N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048155; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bergenstal RM, 2012, DIABETES CARE, V35, P2140, DOI 10.2337/dc12-0060; BERTHOUD HR, 1979, ENDOCRINOLOGY, V105, P146, DOI 10.1210/endo-105-1-146; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; BROWNLEE M, 1979, SCIENCE, V206, P1190, DOI 10.1126/science.505005; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Bunck MC, 2011, DIABETES CARE, V34, P2041, DOI 10.2337/dc11-0291; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Card JW, 2011, AM J PHYSIOL-GASTR L, V301, pG956, DOI 10.1152/ajpgi.00107.2011; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; CHEN M, 1988, J CLIN ENDOCR METAB, V67, P951, DOI 10.1210/jcem-67-5-951; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Conti R, 2011, DIABETES, V60, P644, DOI 10.2337/db10-0346; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; DINARELLO CA, 1992, INT J TISSUE REACT, V14, P65; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Elbein SC, 1999, J CLIN ENDOCR METAB, V84, P1398, DOI 10.1210/jc.84.4.1398; European Medicines Agency, 2013, ASS REP GLP 1 BAS TH; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Fradkin JE, 2012, NEW ENGL J MED, V367, P1177, DOI 10.1056/NEJMp1208169; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Garber AJ, 2012, LANCET, V379, P1498, DOI 10.1016/S0140-6736(12)60205-0; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Gathercole LL, 2013, ENDOCR REV, V34, P525, DOI 10.1210/er.2012-1050; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2013, DIABETES CARE, V36, P1266, DOI 10.2337/dc12-1311; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goedecke JH, 2006, CLIN ENDOCRINOL, V65, P81, DOI 10.1111/j.1365-2265.2006.02552.x; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Gorter Kees J, 2012, BMJ Clin Evid, V2012; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Haffner S, 2005, DIABETES, V54, pA1; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Hemmingsen Bianca, 2011, BMJ, V343, pd6898, DOI 10.1136/bmj.d6898; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Himsworth HP, 1936, LANCET, V1, P127; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Holt RIG, 2010, DIABETES OBES METAB, V12, P1048, DOI 10.1111/j.1463-1326.2010.01304.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; International Diabetes Federation, IDF DIAB ATL UPD 201; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1992, J CLIN ENDOCR METAB, V74, P1336, DOI 10.1210/jc.74.6.1336; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2013, DIABETES, V62, P2178, DOI 10.2337/db13-0520; Kahn SE, 2011, DIABETES, V60, P1552, DOI 10.2337/db10-1392; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Keating S, 2013, CLIN GENET, V84, P1, DOI 10.1111/cge.12121; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lamos EM, 2013, EXPERT OPIN DRUG MET, V9, P763, DOI 10.1517/17425255.2013.791282; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Levitsky LL, 2013, DIABETES CARE, V36, P1772, DOI 10.2337/dc12-2387; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindblad U, 2011, DIABETES OBES METAB, V13, P185, DOI 10.1111/j.1463-1326.2010.01331.x; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu JW, 2012, DIABETES, V61, P2199, DOI 10.2337/db12-0052; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luotola K, 2011, J INTERN MED, V269, P322, DOI 10.1111/j.1365-2796.2010.02294.x; Lynch J, 2013, DIABETES CARE, V36, P1735, DOI 10.2337/dc12-2420; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Ma YM, 2011, MOL CELL BIOCHEM, V357, P65, DOI 10.1007/s11010-011-0876-4; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marina AL, 2012, DIABETES CARE, V35, P1119, DOI 10.2337/dc11-2050; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; MEINERT CL, 1970, DIABETES, V19, P789; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Meyer-Gerspach AC, 2013, J CLIN ENDOCR METAB, V98, P3351, DOI 10.1210/jc.2012-4109; MILLER RE, 1981, ENDOCR REV, V2, P471, DOI 10.1210/edrv-2-4-471; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; Monami M, 2011, EXP DIABETES RES, DOI 10.1155/2011/215764; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nadeau KJ, DIABETES CA IN PRESS; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicol LE, 2013, J ENDOCRINOL, V217, P207, DOI 10.1530/JOE-12-0424; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; PERLEY M, 1966, DIABETES, V15, P867, DOI 10.2337/diab.15.12.867; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Pfutzner Andreas, 2010, J Diabetes Sci Technol, V4, P706; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; PORTE D, 1969, ARCH INTERN MED, V123, P252, DOI 10.1001/archinte.123.3.252; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quddusi S, 2003, DIABETES CARE, V26, P791, DOI 10.2337/diacare.26.3.791; Rachman J, 1997, DIABETOLOGIA, V40, P205, DOI 10.1007/s001250050664; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Rosenstock J, 2013, DIABETES CARE, V36, P522, DOI 10.2337/dc12-0067; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Siekmeier R, 2008, J PHYSIOL PHARMACOL, V59, P81; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tan TM, 2013, DIABETES, V62, P1131, DOI 10.2337/db12-0797; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; The University Group Diabetes Program, 1970, DIABETES S2, V19, P747; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tschop MH, 2012, DIABETES, V61, P1309, DOI 10.2337/db12-0272; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; Varewijck AJ, 2013, DIABETES, V62, P2539, DOI 10.2337/db12-1773; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; WARD WK, 1985, DIABETES, V34, P861, DOI 10.2337/diabetes.34.9.861; WARD WK, 1984, DIABETES CARE, V7, P491, DOI 10.2337/diacare.7.5.491; Weinstock RS, 2013, DIABETES CARE, V36, P1758, DOI 10.2337/dc12-2388; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Wynne K, 2006, INT J OBESITY, V30, P1729, DOI 10.1038/sj.ijo.0803344; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Younk LM, 2011, EXPERT OPIN PHARMACO, V12, P1439, DOI 10.1517/14656566.2011.581663; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333; Ziesmer AE, 2012, ENDOCR PRACT, V18, P34, DOI 10.4158/EP11043.OR; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5	202	921	971	10	392	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1068	1083		10.1016/S0140-6736(13)62154-6	http://dx.doi.org/10.1016/S0140-6736(13)62154-6			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24315620	Green Accepted			2022-12-28	WOS:000333521200033
J	Lu, G; Middleton, RE; Sun, HH; Naniong, M; Ott, CJ; Mitsiades, CS; Wong, KK; Bradner, JE; Kaelin, WG				Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.			The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins	SCIENCE			English	Article							B-CELL LYMPHOMA; MULTIPLE-MYELOMA; MAMMALIAN-CELLS; EXPRESSION; POMALIDOMIDE; DIFFERENTIATION; THALIDOMIDE; IDENTIFICATION; SURVIVAL; TARGET	Thalidomide-like drugs such as lenalidomide are clinically important treatments for multiple myeloma and show promise for other B cell malignancies. The biochemical mechanisms underlying their antitumor activity are unknown. Thalidomide was recently shown to bind to, and inhibit, the cereblon ubiquitin ligase. Cereblon loss in zebrafish causes fin defects reminiscent of the limb defects seen in children exposed to thalidomide in utero. Here we show that lenalidomide-bound cereblon acquires the ability to target for proteasomal degradation two specific B cell transcription factors, Ikaros family zinc finger proteins 1 and 3 (IKZF1 and IKZF3). Analysis of myeloma cell lines revealed that loss of IKZF1 and IKZF3 is both necessary and sufficient for lenalidomide's therapeutic effect, suggesting that the antitumor and teratogenic activities of thalidomide-like drugs are dissociable.	[Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Wong, Kwok-Kin] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu		wong, kwok kin/0000-0001-6323-235X	NIH; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation; Celgene, the manufacturer of lenalidomide and pomalidomide; NATIONAL CANCER INSTITUTE [R01CA076120, R01CA068490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Multiple Myeloma Research Foundation; Celgene, the manufacturer of lenalidomide and pomalidomide; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Vidal and A. MacWilliams at Dana-Farber Cancer Institute for the ORF cDNA collection and for help with recombination cloning. This work was supported by a grant (W. G. K.) and F32 fellowship (G. L.) from NIH. C.J.O. is supported by a Leukemia and Lymphoma Society Fellowship award, and J.E.B. and C. S. M. are supported by the Multiple Myeloma Research Foundation. W. G. K. is a Howard Hughes Medical Institute Investigator. C. S. M. has received consulting fees from Celgene, the manufacturer of lenalidomide and pomalidomide. The primary and secondary luciferase screen data are presented in the supplementary materials.	Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Broyl A, 2013, BLOOD, V121, P624, DOI 10.1182/blood-2012-06-438101; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Heintel D, 2013, BRIT J HAEMATOL, V161, P695, DOI 10.1111/bjh.12338; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kastner P, 2013, AM J BLOOD RES, V3, P1; Laubach J, 2011, ANNU REV MED, V62, P249, DOI 10.1146/annurev-med-070209-175325; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martiniani Roberta, 2012, Adv Hematol, V2012, P842945, DOI 10.1155/2012/842945; Merkenschlager M, 2010, FEBS LETT, V584, P4910, DOI 10.1016/j.febslet.2010.09.042; Monticelli S, 2012, NAT IMMUNOL, V13, P719, DOI 10.1038/ni.2377; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Richardson PG, 2009, J CLIN ONCOL, V27, P5713, DOI 10.1200/JCO.2009.22.2679; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang LH, 2013, BRIT J HAEMATOL, V160, P487, DOI 10.1111/bjh.12172; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	29	887	949	12	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					305	309		10.1126/science.1244917	http://dx.doi.org/10.1126/science.1244917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24292623	Green Accepted			2022-12-28	WOS:000329718600038
J	Costantino, L; Sotiriou, SK; Rantala, JK; Magin, S; Mladenov, E; Helleday, T; Haber, JE; Iliakis, G; Kallioniemi, OP; Halazonetis, TD				Costantino, Lorenzo; Sotiriou, Sotirios K.; Rantala, Juha K.; Magin, Simon; Mladenov, Emil; Helleday, Thomas; Haber, James E.; Iliakis, George; Kallioniemi, Olli P.; Halazonetis, Thanos D.			Break-Induced Replication Repair of Damaged Forks Induces Genomic Duplications in Human Cells	SCIENCE			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-POLYMERASE DELTA; INSTABILITY	In budding yeast, one-ended DNA double-strand breaks (DSBs) and damaged replication forks are repaired by break-induced replication (BIR), a homologous recombination pathway that requires the Pol32 subunit of DNA polymerase delta. DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals. In a cyclin E overexpression model of DNA replication stress, POLD3, the human ortholog of POL32, was required for cell cycle progression and processive DNA synthesis. Segmental genomic duplications induced by cyclin E overexpression were also dependent on POLD3, as were BIR-mediated recombination events captured with a specialized DSB repair assay. We propose that BIR repairs damaged replication forks in mammals, accounting for the high frequency of genomic duplications in human cancers.	[Costantino, Lorenzo; Sotiriou, Sotirios K.; Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland; [Rantala, Juha K.] VTT Tech Res Ctr Finland, Turku 20521, Finland; [Magin, Simon; Mladenov, Emil; Iliakis, George] Univ Duisburg Essen, Sch Med, Inst Med Radiat Biol, D-45122 Essen, Germany; [Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Kallioniemi, Olli P.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki 00140, Finland	University of Geneva; VTT Technical Research Center Finland; University of Duisburg Essen; Karolinska Institutet; Brandeis University; Brandeis University; University of Helsinki	Halazonetis, TD (corresponding author), Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland.	thanos.halazonetis@unige.ch	Magin, Simon/GRJ-8271-2022; Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Magin, Simon/0000-0002-6173-1304; Sotiriou, Sotirios/0000-0003-4690-0568; Helleday, Thomas/0000-0002-7384-092X; Rantala, Juha/0000-0002-4999-5585; Costantino, Lorenzo/0000-0002-4230-485X	European Commission; Swiss National Science Foundation; German Federal Ministry of Education and Research; European Space Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R37GM020056] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Space Agency(European Space AgencyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bartek for the U2OS cells inducibly overexpressing cyclin E and J. Stark for the systems to monitor SDSA and SSA. This work was supported by the European Commission Projects GENICA (T. D. H. and O.P.K.) and ONIDDAC (T. D. H.), the Swiss National Science Foundation (T. D. H.), the German Federal Ministry of Education and Research (G. I.), and the European Space Agency (G. I.). siRNA screening data has been deposited in PubChem (accession no. AID 720710).	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kanel DP, 2012, PLOS GENET, V8, P447, DOI 10.1371/journal.pgen.1002659; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; McBride DJ, 2012, J PATHOL, V227, P446, DOI 10.1002/path.4042; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076	29	312	314	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					88	91		10.1126/science.1243211	http://dx.doi.org/10.1126/science.1243211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24310611	Green Accepted			2022-12-28	WOS:000329162000054
J	Xie, XS				Xie, X. Sunney			Enzyme Kinetics, Past and Present	SCIENCE			English	Editorial Material							MOLECULES		[Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China	Harvard University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu						Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Cornish-Bowden A, 2013, FEBS LETT, V587, P2711, DOI 10.1016/j.febslet.2013.07.035; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Fersht A., 1997, STRUCTURE MECH PROTE; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Ge H, 2012, PHYS REP, V510, P87, DOI 10.1016/j.physrep.2011.09.001; Hill TL, 2004, FREE ENERGY TRANSDUC; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Michaelis L, 1913, BIOCHEM Z, V49, P333; Min W, 2006, J PHYS CHEM B, V110, P20093, DOI 10.1021/jp065187g; Sakmann B., 1995, SINGLE CHANNEL RECOR; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911	14	60	63	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1457	1459		10.1126/science.1248859	http://dx.doi.org/10.1126/science.1248859			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357307				2022-12-28	WOS:000328644300040
J	Weaver, M				Weaver, Meaghann			Recognizing Pride	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weaver, Meaghann] St Judes Children Res Hosp, Memphis, TN USA	St Jude Children's Research Hospital	Weaver, M (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2505	2506		10.1001/jama.2013.283714	http://dx.doi.org/10.1001/jama.2013.283714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346986				2022-12-28	WOS:000328503600018
J	Roensch, K; Tazaki, A; Chara, O; Tanaka, EM				Roensch, Kathleen; Tazaki, Akira; Chara, Osvaldo; Tanaka, Elly M.			Progressive Specification Rather than Intercalation of Segments During Limb Regeneration	SCIENCE			English	Article							PATTERN-FORMATION; VERTEBRATE LIMB; PROXIMODISTAL IDENTITY; GENE-EXPRESSION; AMPHIBIAN LIMB; AXOLOTL LIMBS; VITAMIN-A; CELLS; BUD; ESTABLISHMENT	An amputated salamander limb regenerates the correct number of segments. Models explaining limb regeneration were largely distinct from those for limb development, despite the presence of common patterning molecules. Intercalation has been an important concept to explain salamander limb regeneration, but clear evidence supporting or refuting this model was lacking. In the intercalation model, the first blastema cells acquire fingertip identity, creating a gap in positional identity that triggers regeneration of the intervening region from the stump. We used HOXA protein analysis and transplantation assays to show that axolotl limb blastema cells acquire positional identity in a proximal-to-distal sequence. Therefore, intercalation is not the primary mechanism for segment formation during limb regeneration in this animal. Patterning in development and regeneration uses similar mechanisms.	[Roensch, Kathleen; Tazaki, Akira; Tanaka, Elly M.] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany; [Roensch, Kathleen; Tazaki, Akira; Tanaka, Elly M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Chara, Osvaldo] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Chara, Osvaldo] Consejo Nacl Invest Cient & Tecn, Inst Phys Liquids & Biol Syst, RA-1033 Buenos Aires, DF, Argentina; [Chara, Osvaldo] Univ La Plata, La Plata, Argentina	German Research Foundation (DFG); Technische Universitat Dresden; Max Planck Society; Technische Universitat Dresden; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany.	elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010; Chara, Osvaldo/T-2798-2019	Chara, Osvaldo/0000-0002-0868-2507; Tazaki, Akira/0000-0002-7151-0089; Tanaka, Elly/0000-0003-4240-2158	central funds of the Max Planck Institute for Cell Biology and Genetics; Center for Regenerative Therapies; Human Frontiers Science Program;  [DFG-SFB655];  [DFG TA274/2];  [DFG TA274/5]	central funds of the Max Planck Institute for Cell Biology and Genetics; Center for Regenerative Therapies; Human Frontiers Science Program(Human Frontier Science Program); ; ; 	We are grateful to H. Andreas, J. Michling, B. Gruhl, S. Moegel, and M. Armstead for animal care; M. Tipsword and D. Drechsel for antibody production; D. Gardiner for unpublished HoxA11 fragment; F. Martin for initial cloning attempts; and J. Rink, J. Currie, and A. Gavalas for comments. National Center for Biotechnology Information accession numbers of axolotl genes are as follows: HoxA9, JX975067; HoxA11, JX975068; HoxA13, JX975069. Grant support came from DFG-SFB655: From Cells to Tissues (DFG TA274/2), DFG TA274/5, central funds of the Max Planck Institute for Cell Biology and Genetics and the Center for Regenerative Therapies, and Human Frontiers Science Program (E. M. T.). A. T. and E. M. T. designed, conceived experiments, and analyzed data. K. R. and A. T. performed experimental work and analyzed data. O.C. developed and performed image analysis. K.R., A.T., and E.M.T. prepared the manuscript. The authors claim no competing interests.	Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; BOHN H, 1970, ROUX ARCH DEV BIOL, V165, P303; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; BUTLER EG, 1955, J NATL CANCER I, V15, P877; CRAWFORD K, 1988, DEVELOPMENT, V104, P703; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; FABER J., 1960, ARCH BIOL, V71, P1; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; MADEN M, 1977, J THEOR BIOL, V69, P735, DOI 10.1016/0022-5193(77)90379-4; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P139; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; MITTENTHAL JE, 1981, DEV BIOL, V88, P15, DOI 10.1016/0012-1606(81)90215-3; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Nelson CE, 1996, DEVELOPMENT, V122, P1449; PESCITELLI MJ, 1980, DEV BIOL, V79, P255, DOI 10.1016/0012-1606(80)90115-3; Rosello-Diez A, 2011, DEV DYNAM, V240, P1203, DOI 10.1002/dvdy.22635; SAXENA S, 1977, INDIAN J EXP BIOL, V15, P435; STOCUM DL, 1975, DEV BIOL, V45, P112, DOI 10.1016/0012-1606(75)90246-8; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Towers M, 2012, CURR OPIN CELL BIOL, V24, P181, DOI 10.1016/j.ceb.2011.11.005; Wada N, 2003, DEV BIOL, V264, P550, DOI 10.1016/j.ydbio.2003.08.019; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	36	62	62	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1375	1379		10.1126/science.1241796	http://dx.doi.org/10.1126/science.1241796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337297				2022-12-28	WOS:000328196000052
J	Hoogduijn, MJ; van den Beukel, JC; Wiersma, LCM; Ijzer, J				Hoogduijn, Martin J.; van den Beukel, Johanna C.; Wiersma, Lidewij C. M.; Ijzer, Jooske			CHRISTMAS 2013: RESEARCH Morphology and size of stem cells from mouse and whale: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE	Objective To compare the morphology and size of stem cells from two mammals of noticeably different body size. Design Observational study. Setting The Netherlands. Participants A humpback whale (Megaptera novaeangliae) and a laboratory mouse (Mus musculus). Main outcome measures Morphology and size of mesenchymal stem cells from adipose tissue. Results Morphologically, mesenchymal stem cells of the mouse and whale are indistinguishable. The average diameter of 50 mesenchymal stem cells from the mouse was 28 (SD 0.86) mu m and 50 from the whale was 29 (SD 0.71) mu m. The difference in cell size between the species was not statistically significant. Although the difference in bodyweight between the species is close to two million-fold, the mesenchymal stem cells of each were of similar size. Conclusions The mesenchymal stem cells of whales and mice are alike, in both morphology and size.	[Hoogduijn, Martin J.; van den Beukel, Johanna C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Wiersma, Lidewij C. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Ijzer, Jooske] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University	Hoogduijn, MJ (corresponding author), Dept Internal Med, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	m.hoogduijn@erasmusmc.nl						Comoli P, 2008, NEPHROL DIAL TRANSPL, V23, P1196, DOI 10.1093/ndt/gfm740; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Fink T, 2011, STEM CELL RES, V7, P89, DOI 10.1016/j.scr.2011.03.003; Franquesa M, 2013, TRANSPLANTATION, V96, P234, DOI 10.1097/TP.0b013e318298f9fa; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; PARRY DA, 1949, Q J MICROSC SCI, V90, P13; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143	10	14	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f6833	10.1136/bmj.f6833	http://dx.doi.org/10.1136/bmj.f6833			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336001	Green Published, hybrid			2022-12-28	WOS:000328575200002
J	Barends, CRM; Absalom, AR				Barends, Clemens R. M.; Absalom, Anthony R.			Tied up in science: unknotting an old anaesthetic problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barends, Clemens R. M.; Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, NL-9713 AV Groningen, Netherlands	University of Groningen	Barends, CRM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, NL-9713 AV Groningen, Netherlands.	clemensbarends@gmail.com	Absalom, Anthony/GPG-1582-2022	Absalom, Anthony/0000-0001-7563-9157				Adams C. C., 2004, KNOT BOOK ELEMENTARY; [Anonymous], 2013, SPONTANEOUS KNOTTING; Raymer DM, 2007, P NATL ACAD SCI USA, V104, P16432, DOI 10.1073/pnas.0611320104	3	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f6735	10.1136/bmj.f6735	http://dx.doi.org/10.1136/bmj.f6735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335667				2022-12-28	WOS:000328575000001
J	Streicker, DG				Streicker, Daniel G.			From Persistence to Cross-Species Emergence of a Viral Zoonosis	SCIENCE			English	Editorial Material							RABIES VIRUS; ESTABLISHMENT; TRANSMISSION; BATS		Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Streicker, DG (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.	daniel.streicker@glasgow.ac.uk		Streicker, Daniel/0000-0001-7475-2705	Wellcome Trust [102507] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Streicker DG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002720; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	9	7	7	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1185	1186		10.1126/Science.1247566	http://dx.doi.org/10.1126/Science.1247566			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311675				2022-12-28	WOS:000327857900030
J	Cao, EH; Liao, MF; Cheng, YF; Julius, D				Cao, Erhu; Liao, Maofu; Cheng, Yifan; Julius, David			TRPV1 structures in distinct conformations reveal activation mechanisms	NATURE			English	Article							SPECIES-SPECIFIC SENSITIVITY; C-TYPE INACTIVATION; CAPSAICIN RECEPTOR; ION-CHANNEL; K+ CHANNEL; TARANTULA TOXIN; VOLTAGE-SENSOR; SELECTIVITY; BINDING; DOMAIN	Transient receptor potential (TRP) channels are polymodal signal detectors that respond to a wide range of physical and chemical stimuli. Elucidating how these channels integrate and convert physiological signals into channel opening is essential to understanding how they regulate cell excitability under normal and pathophysiological conditions. Here we exploit pharmacological probes (a peptide toxin and small vanilloid agonists) to determine structures of two activated states of the capsaicin receptor, TRPV1. A domain (consisting of transmembrane segments 1-4) that moves during activation of voltage-gated channels remains stationary in TRPV1, highlighting differences in gating mechanisms for these structurally related channel superfamilies. TRPV1 opening is associated with major structural rearrangements in the outer pore, including the pore helix and selectivity filter, as well as pronounced dilation of a hydrophobic constriction at the lower gate, suggesting a dual gating mechanism. Allosteric coupling between upper and lower gates may account for rich physiological modulation exhibited by TRPV1 and other TRP channels.	[Cao, Erhu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; david.julius@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, R01NS065071, R01NS047723]; National Science Foundation [DBI-0960271]; University of California, San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Li for assistant in data acquisition using TF30 Polara and K2 Summit camera, and J.P Armache, C. Bohlen, J. Cordero-Morales and J. Osteen for discussion and reading of the manuscript. This work was supported by grants from the National Institutes of Health (R01GM098672 and S10RR026814 to Y.C. and R01NS065071 and R01NS047723 to D. J.), the National Science Foundation (DBI-0960271 to D. Agard and Y.C.) and the University of California, San Francisco Program for Breakthrough Biomedical Research (Y.C.). E. C. was a fellow of the Damon Runyon Cancer Research Foundation.	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Dai J, 2010, J HUM GENET, V55, P400, DOI 10.1038/jhg.2010.37; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Latorre Ramon, 2007, P287; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Papakosta M, 2011, J BIOL CHEM, V286, P39663, DOI 10.1074/jbc.M111.273581; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	55	699	728	33	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					113	+		10.1038/nature12823	http://dx.doi.org/10.1038/nature12823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305161	Green Submitted, Green Accepted			2022-12-28	WOS:000327851700041
J	Walsh, CM; Fung, M; Ginsburg, S				Walsh, Catharine M.; Fung, Many; Ginsburg, Shiphra			Publication of Results of Abstracts Presented at Medical Education Conferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Walsh, Catharine M.; Ginsburg, Shiphra] Univ Toronto, Wilson Ctr, Toronto, ON, Canada; [Fung, Many] Univ Toronto, Toronto, ON, Canada	University of Toronto; University of Toronto	Ginsburg, S (corresponding author), Wilson Ctr Res Educ, 600 Univ Ave,Ste 433, Toronto, ON M5G 1X5, Canada.	shiphra.ginsburg@utoronto.ca	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650; Walsh, Catharine/0000-0003-3928-703X	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Boyer EL, 1990, SCHOLARSHIP RECONSID; Sackett DL, 2000, EVIDENCE BASED MEDIC; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Simpson D, 2007, MED EDUC, V41, P1002, DOI 10.1111/j.1365-2923.2007.02844.x; Yoon U, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-47	5	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2307	2309		10.1001/jama.2013.281671	http://dx.doi.org/10.1001/jama.2013.281671			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302094	Bronze			2022-12-28	WOS:000327746300016
J	Miller, JF; Neufang, M; Solway, A; Brandt, A; Trippel, M; Mader, I; Hefft, S; Merkow, M; Polyn, SM; Jacobs, J; Kahana, MJ; Schulze-Bonhage, A				Miller, Jonathan F.; Neufang, Markus; Solway, Alec; Brandt, Armin; Trippel, Michael; Mader, Irina; Hefft, Stefan; Merkow, Max; Polyn, Sean M.; Jacobs, Joshua; Kahana, Michael J.; Schulze-Bonhage, Andreas			Neural Activity in Human Hippocampal Formation Reveals the Spatial Context of Retrieved Memories	SCIENCE			English	Article							PLACE CELLS; PATH-INTEGRATION; THETA RHYTHM; FREE-RECALL; SEARCH; NAVIGATION; NEURONS; PATTERNS; MODEL; TIME	In many species, spatial navigation is supported by a network of place cells that exhibit increased firing whenever an animal is in a certain region of an environment. Does this neural representation of location form part of the spatiotemporal context into which episodic memories are encoded? We recorded medial temporal lobe neuronal activity as epilepsy patients performed a hybrid spatial and episodic memory task. We identified place-responsive cells active during virtual navigation and then asked whether the same cells activated during the subsequent recall of navigation-related memories without actual navigation. Place-responsive cell activity was reinstated during episodic memory retrieval. Neuronal firing during the retrieval of each memory was similar to the activity that represented the locations in the environment where the memory was initially encoded.	[Miller, Jonathan F.; Jacobs, Joshua] Drexel Univ, Philadelphia, PA 19104 USA; [Neufang, Markus; Brandt, Armin; Trippel, Michael; Mader, Irina; Hefft, Stefan; Schulze-Bonhage, Andreas] Univ Med Ctr, Epilepsy Ctr, Freiburg, Germany; [Solway, Alec; Merkow, Max; Polyn, Sean M.; Kahana, Michael J.] Univ Penn, Philadelphia, PA 19104 USA	Drexel University; University of Freiburg; University of Pennsylvania	Kahana, MJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	kahana@psych.upenn.edu; andreas.schulze-bonhage@uniklinik-freiburg.de	Schulze-Bonhage, Andreas/AAJ-3107-2020; Jacobs, Joshua/E-9500-2013	Jacobs, Joshua/0000-0003-1807-6882	NIH [MH-061975]; Brain and Behavior Research Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 780-TP3]; Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany) [BCNT TP B3]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975, R01MH055687] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was sponsored by NIH grant MH-061975, the Brain and Behavior Research Foundation, German Research Foundation (Deutsche Forschungsgemeinschaft) grant SFB 780-TP3, and Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany) grant BCNT TP B3. We are most grateful to J. Stein and H. Urbach for help with localizing electrode locations in postoperative magnetic resonance imaging. We thank the patients and their families for their participation in this research.	[Anonymous], 1983, CANADIAN PSYCHOL; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Howard MW, 2012, HIPPOCAMPUS, V22, P1833, DOI 10.1002/hipo.22018; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Manning JR, 2012, J NEUROSCI, V32, P8871, DOI 10.1523/JNEUROSCI.5321-11.2012; Manning JR, 2011, P NATL ACAD SCI USA, V108, P12893, DOI 10.1073/pnas.1015174108; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miller JF, 2013, J EXP PSYCHOL LEARN, V39, P773, DOI 10.1037/a0029684; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	29	184	186	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1111	1114		10.1126/science.1244056	http://dx.doi.org/10.1126/science.1244056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288336	Green Accepted			2022-12-28	WOS:000327518600062
J	Forrester, A; Slade, K				Forrester, Andrew; Slade, Karen			Preventing self-harm and suicide in prisoners: job half done	LANCET			English	Editorial Material									[Forrester, Andrew] South London & Maudsley NHS Fdn Trust, London, England; [Forrester, Andrew] Kings Coll London, Inst Psychiat, London, England; [Forrester, Andrew] HM Prison Brixton, Mental Hlth In Reach Team, London SW2 5XF, England; [Slade, Karen] Nottingham Trent Univ, Sch Social Sci, Coll Business Law & Social Sci, Nottingham, England	South London & Maudsley NHS Trust; University of London; King's College London; Nottingham Trent University	Forrester, A (corresponding author), South London & Maudsley NHS Fdn Trust, London, England.	andrew.forrester1@nhs.net	Slade, Karen/P-2426-2019	Slade, Karen/0000-0002-7442-4805; Forrester, Andrew/0000-0003-2510-1249				Birmingham L, 1999, BRIT MED J, V319, P853, DOI 10.1136/bmj.319.7213.853; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Felthous AR, 2011, J FORENSIC SCI, V56, P1541, DOI 10.1111/j.1556-4029.2011.01858.x; Hawton K, 2014, LANCET, V383, P1147, DOI 10.1016/S0140-6736(13)62118-2; Her Majesty's Inspectorate of Prisons for England and Wales, 1999, SUIC IS EV THEM REV; Marzano L, 2011, J FORENSIC PSYCHI PS, V22, P863, DOI 10.1080/14789949.2011.617465; Rivlin A, 2013, PSYCHOL CRIME LAW, V19, P305, DOI 10.1080/1068316X.2011.631540; Slade K, 2014, CRISIS, V35, P82, DOI 10.1027/0227-5910/a000236; UK Ministry of Justice, 2013, MAN PRIS RISK HARM S; UK Ministry of Justice, 2013, MIN JUST STAT B; UK Ministry of Justice, 2013, SAF CUST STAT DEATHS; Walmsley R, 2011, WORLD PRISON POPULAT	12	22	22	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1109	1111		10.1016/S0140-6736(13)62571-4	http://dx.doi.org/10.1016/S0140-6736(13)62571-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24351323	Green Accepted, hybrid			2022-12-28	WOS:000333956000009
J	Kirschner, N; Ginsburg, J; Sulmasy, LS				Kirschner, Neil; Ginsburg, Jack; Sulmasy, Lois Snyder		Hlth Public Policy Comm Amer Coll	Prescription Drug Abuse: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							PAIN		[Kirschner, Neil; Ginsburg, Jack; Sulmasy, Lois Snyder] Amer Coll Physicians, Philadelphia, PA USA	American College of Physicians	Kirschner, N (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	nkirschner@acponline.org		Arora, Vineet/0000-0002-4745-7599				Centers for Disease Control and Prevention, 2013, OP DRIV CONT INCR DR; Centers for Disease Control and Prevention, 2010, NSDUH SER H; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Furrow BR, 2001, J LAW MED ETHICS, V29, P28; Girion Lisa, 2012, LOS ANGELES TIMES; Government Accountability Office, 2011, GAO12115; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Lembke A, 2012, NEW ENGL J MED, V367, P1580, DOI 10.1056/NEJMp1208498; National Institute of Drug Abuse, 2011, COMM AB PRESCR DRUGS; National Institute on Drug Abuse, 2013, TOP BRIEF DRUG AB PR; National Institute on Drug Abuse, 2011, RES REP PRESCR DRUGS; Partnership for a Drug-Free America and MetLife Foundation, 2011, 2010 PARTN ATT TRACK; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H	14	48	48	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					198	+		10.7326/M13-2209	http://dx.doi.org/10.7326/M13-2209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA2VE	24323199				2022-12-28	WOS:000330951500007
J	Monroe, KM; Yang, ZY; Johnson, JR; Geng, X; Doitsh, G; Krogan, NJ; Greene, WC				Monroe, Kathryn M.; Yang, Zhiyuan; Johnson, Jeffrey R.; Geng, Xin; Doitsh, Gilad; Krogan, Nevan J.; Greene, Warner C.			IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells Abortively Infected with HIV	SCIENCE			English	Article							INNATE IMMUNE SENSOR; GMP-AMP SYNTHASE; INFLAMMASOME; TRANSCRIPTION; ACTIVATION; INDUCTION	The progressive depletion of quiescent "bystander" CD4 T cells, which are nonpermissive to HIV infection, is a principal driver of the acquired immunodeficiency syndrome (AIDS). These cells undergo abortive infection characterized by the cytosolic accumulation of incomplete HIV reverse transcripts. These viral DNAs are sensed by an unidentified host sensor that triggers an innate immune response, leading to caspase-1 activation and pyroptosis. Using unbiased proteomic and targeted biochemical approaches, as well as two independent methods of lentiviral short hairpin RNA-mediated gene knockdown in primary CD4 T cells, we identify interferon-gamma-inducible protein 16 (IFI16) as a host DNA sensor required for CD4 T cell death due to abortive HIV infection. These findings provide insights into a key host pathway that plays a central role in CD4 T cell depletion during disease progression to AIDS.	[Monroe, Kathryn M.; Yang, Zhiyuan; Johnson, Jeffrey R.; Geng, Xin; Doitsh, Gilad; Krogan, Nevan J.; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Johnson, Jeffrey R.; Krogan, Nevan J.; Greene, Warner C.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Krogan, Nevan J.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu			University of California San Francisco-Gladstone Center for AIDS Research (CFAR); NIH [P30 AI027763, R21 AI102782, U19 AI096113, 1DP1036502, P50 GM082250, P01 AI090935, P50 GM081879]; Gladstone Institutes; A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, P30AI027763, R21AI102782, P01AI090935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, P50GM081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036502] Funding Source: NIH RePORTER	University of California San Francisco-Gladstone Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for technical assistance from the Gladstone Flow Core, including M. Cavrois, M. Gesner, and J. Tawney. We thank M. Spindler for the generous gift of the pSicoR-mCherry vector, and D. N. Levy for the NLENG1 and D116N plasmids. Efavirenz and azidothymidine were obtained from the AIDS Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH. We thank L. Chavez, I. Munoz-Arias, and N. Byers for technical advice; T. Johnson for technical assistance; G. Howard and A. L. Lucido for editorial assistance; J.C.W. Carroll for graphic arts; and R. Givens and S. Cammack for administrative assistance. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. A patent application has been filed (U.S. provisional serial number 61/511,023) regarding the identification of abortive HIV infection as a driver of CD4 T cell depletion involving the activation by IFI16 of caspase-1 in inflammasomes leading to pyroptosis, an intensely inflammatory form of programmed cell death. This work was made possible with support from the University of California San Francisco-Gladstone Center for AIDS Research (CFAR), an NIH-funded program (P30 AI027763), with additional funding from the Gladstone Institutes. This work was also supported by NIH R21 AI102782, U19 AI096113 (Martin Delaney CARE Collaboratory), and 1DP1036502 to W.C.G. and NIH P50 GM082250, P01 AI090935, and P50 GM081879 to N.J.K. N.J.K. is a Keck Young Investigator. K.M.M. is an A. P. Giannini Fellow supported by the A. P. Giannini Foundation.	Agosto LM, 2009, J VIROL, V83, P8153, DOI 10.1128/JVI.00220-09; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bobadilla S, 2013, GENE THER, V20, P514, DOI 10.1038/gt.2012.61; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633	30	333	345	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					428	432		10.1126/science.1243640	http://dx.doi.org/10.1126/science.1243640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24356113	Green Accepted			2022-12-28	WOS:000330039300052
J	Roy, MG; Livraghi-Butrico, A; Fletcher, AA; McElwee, MM; Evans, SE; Boerner, RM; Alexander, SN; Bellinghausen, LK; Song, AS; Petrova, YM; Tuvim, MJ; Adachi, R; Romo, I; Bordt, AS; Bowden, MG; Sisson, JH; Woodruff, PG; Thornton, DJ; Rousseau, K; De la Garza, MM; Moghaddam, SJ; Karmouty-Quintana, H; Blackburn, MR; Drouin, SM; Davis, CW; Terrell, KA; Grubb, BR; O'Neal, WK; Flores, SC; Cota-Gomez, A; Lozupone, CA; Donnelly, JM; Watson, AM; Hennessy, CE; Keith, RC; Yang, IV; Barthel, L; Henson, PM; Janssen, WJ; Schwartz, DA; Boucher, RC; Dickey, BF; Evans, CM				Roy, Michelle G.; Livraghi-Butrico, Alessandra; Fletcher, Ashley A.; McElwee, Melissa M.; Evans, Scott E.; Boerner, Ryan M.; Alexander, Samantha N.; Bellinghausen, Lindsey K.; Song, Alfred S.; Petrova, Youlia M.; Tuvim, Michael J.; Adachi, Roberto; Romo, Irlanda; Bordt, Andrea S.; Bowden, M. Gabriela; Sisson, Joseph H.; Woodruff, Prescott G.; Thornton, David J.; Rousseau, Karine; De la Garza, Maria M.; Moghaddam, Seyed J.; Karmouty-Quintana, Harry; Blackburn, Michael R.; Drouin, Scott M.; Davis, C. William; Terrell, Kristy A.; Grubb, Barbara R.; O'Neal, Wanda K.; Flores, Sonia C.; Cota-Gomez, Adela; Lozupone, Catherine A.; Donnelly, Jody M.; Watson, Alan M.; Hennessy, Corinne E.; Keith, Rebecca C.; Yang, Ivana V.; Barthel, Lea; Henson, Peter M.; Janssen, William J.; Schwartz, David A.; Boucher, Richard C.; Dickey, Burton F.; Evans, Christopher M.			Muc5b is required for airway defence	NATURE			English	Article							MUCOCILIARY CLEARANCE; CYSTIC-FIBROSIS; OTITIS-MEDIA; CLARA CELLS; MUCIN; DISEASE; ASTHMA; EXPRESSION; MICE; LUNG	Respiratory surfaces are exposed to billions of particulates and pathogens daily. A protective mucus barrier traps and eliminates them through mucociliary clearance (MCC)(1,2). However, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numerous respiratory diseases(1). MUC5AC and MUC5B are evolutionarily conserved genes that encode structurally related mucin glycoproteins, the principal macromolecules in airway mucus(1,3). Genetic variants are linked to diverse lung diseases(4-6), but specific roles for MUC5AC and MUC5B in MCC, and the lasting effects of their inhibition, are unknown. Here we show that mouse Muc5b (but not Muc5ac) is required for MCC, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable. Muc5b deficiency caused materials to accumulate in upper and lower airways. This defect led to chronic infection by multiple bacterial species, including Staphylococcus aureus, and to inflammation that failed to resolve normally(7). Apoptotic macrophages accumulated, phagocytosis was impaired, and interleukin-23 (IL-23) production was reduced in Muc5b(-/-) mice. By contrast, in mice that transgenically overexpress Muc5b, macrophage functions improved. Existing dogma defines mucous phenotypes in asthma and chronic obstructive pulmonary disease (COPD) as driven by increased MUC5AC, with MUC5B levels either unaffected or increased in expectorated sputum(1,8). However, in many patients, MUC5B production at airway surfaces decreases by as much as 90%(9-11). By distinguishing a specific role for Muc5b in MCC, and by determining its impact on bacterial infections and inflammation in mice, our results provide a refined framework for designing targeted therapies to control mucin secretion and restore MCC.	[Roy, Michelle G.; McElwee, Melissa M.; Evans, Scott E.; Alexander, Samantha N.; Bellinghausen, Lindsey K.; Song, Alfred S.; Petrova, Youlia M.; Tuvim, Michael J.; Adachi, Roberto; Romo, Irlanda; De la Garza, Maria M.; Moghaddam, Seyed J.; Dickey, Burton F.; Evans, Christopher M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Livraghi-Butrico, Alessandra; Davis, C. William; Terrell, Kristy A.; Grubb, Barbara R.; O'Neal, Wanda K.; Boucher, Richard C.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Fletcher, Ashley A.; Flores, Sonia C.; Cota-Gomez, Adela; Lozupone, Catherine A.; Donnelly, Jody M.; Watson, Alan M.; Hennessy, Corinne E.; Keith, Rebecca C.; Yang, Ivana V.; Barthel, Lea; Henson, Peter M.; Janssen, William J.; Schwartz, David A.; Evans, Christopher M.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Boerner, Ryan M.; Karmouty-Quintana, Harry; Blackburn, Michael R.; Drouin, Scott M.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX 77030 USA; [Romo, Irlanda] Inst Tecnol & Estudios Super Monterrey, Monterrey 64849, Nuevo Leon, Mexico; [Bordt, Andrea S.; Bowden, M. Gabriela] Texas A&M Hlth Sci Ctr, Houston, TX 77030 USA; [Bowden, M. Gabriela] Univ Houston Downtown, Houston, TX 77002 USA; [Sisson, Joseph H.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [Woodruff, Prescott G.] Univ Calif San Francisco, San Francisco, CA 27599 USA; [Thornton, David J.; Rousseau, Karine] Univ Manchester, Manchester M13 9PT, Lancs, England; [Barthel, Lea; Henson, Peter M.; Janssen, William J.] Natl Jewish Hlth, Denver, CO 80206 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health Science Center Houston; Tecnologico de Monterrey; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Houston System; University of Houston; University of Houston Downtown; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Francisco; University of Manchester; National Jewish Health	Evans, CM (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	Christopher.Evans@ucdenver.edu	Moghaddam, Seyed Javad/A-9701-2014; Yang, Ivana V/P-3059-2018; Lozupone, Catherine/AAD-9317-2020; , BRIC Small Animal Imaging Facility/AEV-1023-2022; Karmouty-Quintana, Harry/ABC-9144-2020	Moghaddam, Seyed Javad/0000-0002-5350-307X; Yang, Ivana V/0000-0002-1018-489X; , BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Karmouty-Quintana, Harry/0000-0003-4753-9823; Keith, Rebecca/0000-0001-9660-5909; Cota-Gomez, Adela/0000-0001-7607-6122; Adachi, Roberto/0000-0002-0146-0768; Tuvim, Michael/0000-0001-8126-7716; Blackburn, Michael/0000-0002-1394-9966; Thornton, David/0000-0001-7148-1970; Evans, Christopher/0000-0001-5600-7314; Evans, Scott/0000-0003-4503-0644	National Institutes of Health [R01 HL080396, R01 AA008769, R01 HL109517, R01 HL114381, R01 HL097000, P01 HL108808, P01 HL110873, P50 HL107168, P30DK065988]; Medical Research Council [G1000450]; Cystic Fibrosis Foundation [06IO, RDP R026-CR11]; National Institutes of Health Cancer Center [CA016672, CA046934];  [CA016086]; MRC [G1000450] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA046934, P30CA016086, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109517, R01HL117976, P01HL107202, R01HL114381, R01HL097000, DP2HL123229, R01HL095372, R01HL080396, R01HL097591, P50HL107168, P01HL108808, P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988, K01DK090285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank F. Ttofali, D. Harper, D. Raclawska, V. Mdoe, C. Ramsey and J. Parker-Thornburg for their assistance. We also thank K. Naff and the MD Anderson Cancer Center Department of Veterinary Medicine and Surgery for support in animal care. This work was supported by the National Institutes of Health Grants R01 HL080396 (C.M.E.); R01 AA008769 (J.H.S.), R01 HL109517 (W.J.J.); R01 HL114381 (P.M.H.); R01 HL097000 (B.F.D.), P01 HL108808, P01 HL110873, P50 HL107168, P30DK065988 (R.C.B.), Medical Research Council Grant G1000450 (D.J.T.) and Cystic Fibrosis Foundation Grants 06IO (C.M.E.) and RDP R026-CR11 (R.C.B.). Additional support was provided by National Institutes of Health Cancer Center Support Grants CA016672 for the MD Anderson Cancer Center and CA046934 for the University of Colorado transgenic mouse facilities; by CA016086 for the UNC Biomedical Research Imaging Center Small Animal Imaging Facility, and for the UNC Michael Hooker Microscopy Facility funded by an anonymous private donor.	Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Coote K, 2004, EXP LUNG RES, V30, P59, DOI 10.1080/01902140490252885; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillard P, 2007, AM J RESP CRIT CARE, V175, P1250, DOI 10.1164/rccm.200701-049OC; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hendley JO, 2002, NEW ENGL J MED, V347, P1169, DOI 10.1056/NEJMcp010944; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamio K, 2005, AM J RESP CRIT CARE, V171, P949, DOI 10.1164/rccm.200409-1168OC; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lee TA, 2007, J GEN INTERN MED, V22, P62, DOI 10.1007/s11606-007-0118-3; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marsh DG, 1997, NAT GENET, V15, P389; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; ORIORDAN TG, 1992, AM REV RESPIR DIS, V146, P598, DOI 10.1164/ajrccm/146.3.598; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Ward PP, 2003, MOL CELL BIOL, V23, P178, DOI 10.1128/MCB.23.1.178-185.2003; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	51	469	482	9	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					412	+		10.1038/nature12807	http://dx.doi.org/10.1038/nature12807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24317696	Green Accepted			2022-12-28	WOS:000329621800045
J	Kynaston-Pearson, F; Ashmore, AM; Malak, TT; Rombach, I; Taylor, A; Beard, D; Arden, NK; Price, A; Prieto-Alhambra, D; Judge, A; Carr, AJ; Glyn-Jones, S				Kynaston-Pearson, F.; Ashmore, A. M.; Malak, T. T.; Rombach, I.; Taylor, A.; Beard, D.; Arden, N. K.; Price, A.; Prieto-Alhambra, D.; Judge, A.; Carr, A. J.; Glyn-Jones, S.			Primary hip replacement prostheses and their evidence base: systematic review of literature	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL DEVICES; JOINT; RISK; ASR	Objective To determine the extent to which prostheses with no readily available evidence to support their use are being implanted in primary total hip arthroplasty. Design Systematic review of the literature. Data sources The 9th annual report of the National Joint Registry of England and Wales (NJR) was analysed to identify prostheses with an Orthopaedic Data Evaluation Panel rating of "unclassified" or "pre-entry" used in primary total hip arthroplasty in 2011. A systematic review of those prostheses was carried out using PubMed, Cochrane, Embase, OVID, and Google databases. Study selection Prostheses used in primary total hip arthroplasty as published in the NJR's 9th annual report were analysed. Only literature that included the name of the prosthesis was included. Literature yielded in the search results was excluded if it reported animal, non-orthopaedic, non-total hip arthroplasty, or non-device related studies. Results The systematic review found that 24% (57/235) of all hip replacement implants available to surgeons in the UK have no evidence for their clinical effectiveness. It also shows that 10 617 (7.8%) of the 136 593 components used in primary hip replacements in 2011 were implanted without readily identifiable evidence of clinical effectiveness. These comprised 157 cemented stems (0.5% of 34 655 implanted), 936 (2.8% of 33 367) uncemented stems, 1732 (7.1% of 24 349) cemented cups, and 7577 (17.1% of 44 222) uncemented cups. Conclusions This study shows that a considerable proportion of prostheses available to orthopaedic surgeons have no readily available evidence of clinical effectiveness to support their use. Concern exists about the current system of device regulation, and the need for a revised process for introducing new orthopaedic devices is highlighted.	[Kynaston-Pearson, F.] Univ Hosp Birmingham NHS Fdn Trust, Old Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Ashmore, A. M.; Malak, T. T.; Rombach, I.; Taylor, A.; Beard, D.; Arden, N. K.; Price, A.; Prieto-Alhambra, D.; Judge, A.; Carr, A. J.; Glyn-Jones, S.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford OX3 7FF, England; [Arden, N. K.; Judge, A.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Birmingham; University of Oxford; University of Southampton	Glyn-Jones, S (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Ctr, Oxford OX3 7LD, England.	sion.glyn-jones@ndorms.ox.ac.uk		Beard, David/0000-0001-7884-6389; Judge, Andrew/0000-0003-3015-0432; Prieto-Alhambra, Daniel/0000-0002-3950-6346	NIHR Musculoskeletal Biomedical Research Unit, University of Oxford; National Institute for Health Research [NF-SI-0611-10216] Funding Source: researchfish	NIHR Musculoskeletal Biomedical Research Unit, University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	Support was received from the NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, to provide staff, resources, and consumables.	Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; de Steiger RN, 2011, J BONE JOINT SURG AM, V93A, P2287, DOI [10.2106/JBJS.J.01727, 10.2106/JBJSJ.01727]; Di Mario C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3021; Dias J., 2012, RESTORING YOUR MOBIL; European Commission, 2011, EXPL INN HEALTHC THE; European Commission Enterprise and Industry, NOT BOD; Foster RL, 2012, J SPEC PEDIATR NURS, V17, P1, DOI 10.1111/j.1744-6155.2011.00319.x; Fraser AG, 2011, EUR HEART J, V32, P1673, DOI 10.1093/eurheartj/ehr171; Glyn-Jones S, 2009, J BONE JOINT SURG BR, V91B, P1566, DOI 10.1302/0301-620X.91B12.22287; Hauptfleisch J, 2006, J BONE JOINT SURG BR, V88B, P179, DOI 10.1302/0301-620X.88B2.17055; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126; MURRAY DW, 1995, J BONE JOINT SURG BR, V77B, P520, DOI 10.1302/0301-620X.77B4.7615593; National Institute for Health and Clinical Excellence, 2000, GUID SEL PROSTH PRIM; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2012, 9 NAT JOINT REG ENGL; Nelissen Rob G H H, 2011, J Bone Joint Surg Am, V93 Suppl 3, P62, DOI 10.2106/JBJS.K.00907; NHS, ODEP CRIT; OCEBM levels of evidence working group, OXF 2011 LEV EV; Roy N, 2002, ACTA ORTHOP SCAND, V73, P400, DOI 10.1080/00016470216328; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Sorrel S, 2006, MED DEVICE DEV US EU; Wilmshurst P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2822	22	37	38	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f6956	10.1136/bmj.f6956	http://dx.doi.org/10.1136/bmj.f6956			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355538	Green Published, hybrid			2022-12-28	WOS:000328824300002
J	Wong, HY; Houben, CH				Wong, Hei Yi; Houben, Christoph Heinrich			Beans and Beaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 12-year-old girl presented with a 1-week history of constipation with one episode of vomiting. Initially, she had generalized abdominal pain. On admission, she reported having intermittent bilateral loin pain. A 12-year-old girl presented with a 1-week history of constipation with one episode of vomiting. Initially, she had generalized abdominal pain. On admission, she reported having intermittent bilateral loin pain. She had no history of preexisting gastrointestinal disturbances. On physical examination, the abdomen was distended but soft with an empty rectum. The supine abdominal radiograph (Panel A) showed a large bowel dilatation, called the coffee-bean sign, with a cleft in the center (arrows) representing torsion of the sigmoid mesentery. Insertion of a rectal tube released a large volume of gas and a small amount of mucus. The contrast enema radiograph ...	[Wong, Hei Yi; Houben, Christoph Heinrich] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Wong, HY (corresponding author), Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China.	chhouben@web.de							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25								10.1056/NEJMicm1304303	http://dx.doi.org/10.1056/NEJMicm1304303			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24350973				2022-12-28	WOS:000328586000002
J	Brown, R; Lip, GYH				Brown, Richard; Lip, Gregory Y. H.			PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; CARDIOGENIC-SHOCK		[Brown, Richard; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Birmingham	Brown, R (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.							Jensen LO, 2012, EUROINTERVENTION, V8, P456, DOI 10.4244/EIJV8I4A72; Mylotte D, 2013, JACC-CARDIOVASC INTE, V6, P115, DOI 10.1016/j.jcin.2012.10.006; Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596; Steg PG, 2012, EUR HEART J, V33, P2569	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC3	10.7326/0003-4819-159-12-201312170-02003	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343408				2022-12-28	WOS:000329735300002
J	Chen, Z; Wang, JN; Ma, GX; Zhang, YS				Chen, Zhu; Wang, Jin-Nan; Ma, Guo-Xia; Zhang, Yan-Shen			China tackles the health effects of air pollution	LANCET			English	Editorial Material									[Chen, Zhu] Chinese Med Assoc, Beijing, Peoples R China; [Chen, Zhu] Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jin-Nan] Chinese Acad Environm Planning, Beijing 100012, Peoples R China; [Ma, Guo-Xia; Zhang, Yan-Shen] Chinese Acad Environm Planning, Ctr Environm Risk & Damage Assessment, Beijing, Peoples R China	Chinese Academy of Sciences	Wang, JN (corresponding author), Chinese Acad Environm Planning, Beijing 100012, Peoples R China.	wangjn@caep.org.cn						[Anonymous], 2013, NATL MED J CHINA, DOI DOI 10.2307/20066129; Chen RenJie, 2010, China Environmental Science, V30, P410; National Office for Cancer Prevention and Control National Center for Cancer Registries Bureau of Disease Prevention and Control Ministry of Health, 2008, CANC DEATH REP CHIN; Wang JN, 2012, CHINESE ENV POLICY, V8, P1; World Bank, 2007, COST POLLUTION CHINA; World Health Organization, 2009, COUNTR PROF ENV BURD; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yu F, 2012, REPORT CHINAS ENV EC	8	271	306	10	179	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1959	1960		10.1016/S0140-6736(13)62064-4	http://dx.doi.org/10.1016/S0140-6736(13)62064-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24332069				2022-12-28	WOS:000328223700007
J	Koo, BC; Lee, YH; Moon, DS; Yoon, SC; Raymond, JC				Koo, Bon-Chul; Lee, Yong-Hyun; Moon, Dae-Sik; Yoon, Sung-Chul; Raymond, John C.			Phosphorus in the Young Supernova Remnant Cassiopeia A	SCIENCE			English	Article							A SUPERNOVA; 3-DIMENSIONAL STRUCTURE; INFRARED-SPECTROSCOPY; CHEMICAL EVOLUTION; MASSIVE STARS; DUST; ORIGIN; AGE	Phosphorus (P-31), which is essential for life, is thought to be synthesized in massive stars and dispersed into interstellar space when these stars explode as supernovae (SNe). Here, we report on near-infrared spectroscopic observations of the young SN remnant Cassiopeia A, which show that the abundance ratio of phosphorus to the major nucleosynthetic product iron (Fe-56) in SN material is up to 100 times the average ratio of the Milky Way, confirming that phosphorus is produced in SNe. The observed range is compatible with predictions from SN nucleosynthetic models but not with the scenario in which the chemical elements in the inner SN layers are completely mixed by hydrodynamic instabilities during the explosion.	[Koo, Bon-Chul; Lee, Yong-Hyun; Yoon, Sung-Chul] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Moon, Dae-Sik] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Moon, Dae-Sik] CALTECH, Space Radiat Lab, Pasadena, CA 91125 USA; [Raymond, John C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Seoul National University (SNU); University of Toronto; California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Koo, BC (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea.	koo@astro.snu.ac.kr		Raymond, John/0000-0002-7868-1622	National Research Foundation of Korea (NRF) [NRF-2011-0007223, NRF-2010-616-C00020]; Ministry of Education, Science and Technology; Korean Federation of Science and Technology Societies (KOFST); Natural Science and Engineering Research Council of Canada	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Federation of Science and Technology Societies (KOFST)(Korean Federation of Science & Technology Societies (KOFST)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Basic Science Research (NRF-2011-0007223) and International Cooperation in Science and Technology (NRF-2010-616-C00020) programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, and also by the Korean Federation of Science and Technology Societies (KOFST). D.-S.M. acknowledges support from the the Natural Science and Engineering Research Council of Canada. We thank M. Muno for his help in observations and J.-J. Lee for providing the Chandra 1Ms x-ray images.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Barlow MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014585; Cescutti G, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118188; Chieffi A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/21; DeLaney T, 2010, ASTROPHYS J, V725, P2038, DOI 10.1088/0004-637X/725/2/2038; Fesen RA, 2006, ASTROPHYS J, V645, P283, DOI 10.1086/504254; Gerardy CL, 2001, ASTRON J, V121, P2781, DOI 10.1086/320393; Hwang U, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/130; Kifonidis K, 2003, ASTRON ASTROPHYS, V408, P621, DOI 10.1051/0004-6361:20030863; Kobayashi C, 2006, ASTROPHYS J, V653, P1145, DOI 10.1086/508914; Krause O, 2008, SCIENCE, V320, P1195, DOI 10.1126/science.1155788; Lebouteiller V, 2005, ASTRON ASTROPHYS, V443, P509, DOI 10.1051/0004-6361:20053448; Lee J.-J., 2013, ARXIV13043973; Nozawa T, 2010, ASTROPHYS J, V713, P356, DOI 10.1088/0004-637X/713/1/356; Oliva E, 2001, ASTRON ASTROPHYS, V369, pL5, DOI 10.1051/0004-6361:20010214; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; Rho J, 2008, ASTROPHYS J, V673, P271, DOI 10.1086/523835; Sibthorpe B, 2010, ASTROPHYS J, V719, P1553, DOI 10.1088/0004-637X/719/2/1553; Thorstensen JR, 2001, ASTRON J, V122, P297, DOI 10.1086/321138; VANDENBERGH S, 1971, ASTROPHYS J, V165, P457, DOI 10.1086/150913; West C, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/75; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1994, ASTROPHYS J, V429, P300, DOI 10.1086/174319; Young PA, 2006, ASTROPHYS J, V640, P891, DOI 10.1086/500108	26	44	44	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1346	1348		10.1126/science.1243823	http://dx.doi.org/10.1126/science.1243823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337291	Green Accepted, Green Submitted			2022-12-28	WOS:000328196000043
J	Shoemaker, JK; Schrag, DP; Molina, MJ; Ramanathan, V				Shoemaker, J. K.; Schrag, D. P.; Molina, M. J.; Ramanathan, V.			What Role for Short-Lived Climate Pollutants in Mitigation Policy?	SCIENCE			English	Editorial Material							EMISSIONS; CARBON		[Shoemaker, J. K.; Schrag, D. P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Molina, M. J.] Univ Calif San Diego, Dept Phys Chem, La Jolla, CA 92093 USA; [Ramanathan, V.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ramanathan, V.] TERI Univ, UNESCO, New Delhi 110070, DL, India	Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; TERI University	Schrag, DP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	schrag@eps.harvard.edu	Shoemaker, Joel Kevin/L-2682-2013	Shoemaker, Joel Kevin/0000-0002-6794-5979				Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Archer D, 2008, CLIMATIC CHANGE, V90, P283, DOI 10.1007/s10584-008-9413-1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fuglestvedt JS, 2003, CLIMATIC CHANGE, V58, P267, DOI 10.1023/A:1023905326842; Hu AX, 2013, NAT CLIM CHANGE, V3, P730, DOI [10.1038/nclimate1869, 10.1038/NCLIMATE1869]; Kriegler E, 2009, P NATL ACAD SCI USA, V106, P5041, DOI 10.1073/pnas.0809117106; LASHOF DA, 1990, NATURE, V344, P529, DOI 10.1038/344529a0; Molina M, 2009, P NATL ACAD SCI USA, V106, P20616, DOI 10.1073/pnas.0902568106; Ramanathan V., 2013, BLACK CARBON REGIONA; Ramanathan V, 2010, P NATL ACAD SCI USA, V107, P8055, DOI 10.1073/pnas.1002293107; Shindell D., 2013, MILKEN I REV, V2013, P36; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smith SJ, 2013, P NATL ACAD SCI USA, V110, P14202, DOI 10.1073/pnas.1308470110; UN Environment Programme/World Meteorological Organization, 2011, INT ASS BLACK CARB T; Wallack JS, 2009, FOREIGN AFF, V88, P105	15	71	71	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1323	1324		10.1126/science.1240162	http://dx.doi.org/10.1126/science.1240162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	268UL	24337280				2022-12-28	WOS:000328196000031
J	Driskell, RR; Lichtenberger, BM; Hoste, E; Kretzschmar, K; Simons, BD; Charalambous, M; Ferron, SR; Herault, Y; Pavlovic, G; Ferguson-Smith, AC; Watt, FM				Driskell, Ryan R.; Lichtenberger, Beate M.; Hoste, Esther; Kretzschmar, Kai; Simons, Ben D.; Charalambous, Marika; Ferron, Sacri R.; Herault, Yann; Pavlovic, Guillaume; Ferguson-Smith, Anne C.; Watt, Fiona M.			Distinct fibroblast lineages determine dermal architecture in skin development and repair	NATURE			English	Article							STEM-CELLS; PAPILLA CELLS; BETA-CATENIN; MOUSE SKIN; IN-VIVO; REGENERATION; DIFFERENTIATION; EPIDERMIS; RECRUITMENT; ACTIVATION	Fibroblasts are the major mesenchymal cell type in connective tissue and deposit the collagen and elastic fibres of the extracellular matrix (ECM)(1). Even within a single tissue, fibroblasts exhibit considerable functional diversity, but it is not known whether this reflects the existence of a differentiation hierarchy or is a response to different environmental factors. Here we show, using transplantation assays and lineage tracing in mice, that the fibroblasts of skin connective tissue arise from two distinct lineages. One forms the upper dermis, including the dermal papilla that regulates hair growth and the arrector pili muscle, which controls piloerection. The other forms the lower dermis, including the reticular fibroblasts that synthesize the bulk of the fibrillar ECM, and the preadipocytes and adipocytes of the hypodermis. The upper lineage is required for hair follicle formation. In wounded adult skin, the initial wave of dermal repair is mediated by the lower lineage and upper dermal fibroblasts are recruited only during re-epithelialization. Epidermal beta-catenin activation stimulates the expansion of the upper dermal lineage, rendering wounds permissive for hair follicle formation. Our findings explain why wounding is linked to formation of ECM-rich scar tissue that lacks hair follicles(2-4). They also forma platform for discovering fibroblast lineages in other tissues and for examining fibroblast changes in ageing and disease.	[Driskell, Ryan R.; Lichtenberger, Beate M.; Kretzschmar, Kai] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Driskell, Ryan R.; Lichtenberger, Beate M.; Hoste, Esther; Kretzschmar, Kai; Watt, Fiona M.] Kings Coll London, Ctr Stem Cells & Regenerat Med, Guys Hosp, London SE1 9RT, England; [Hoste, Esther] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Simons, Ben D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Charalambous, Marika; Ferron, Sacri R.; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Herault, Yann; Pavlovic, Guillaume] Inst Clin Souris, F-67404 Illkrich Graffenstaden, France	University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Watt, FM (corresponding author), Kings Coll London, Ctr Stem Cells & Regenerat Med, Guys Hosp, 28th Floor,Tower Wing, London SE1 9RT, England.	fiona.watt@kcl.ac.uk	Pavlovic, Guillaume/C-9907-2013; Hoste, Esther/M-9926-2014; Kretzschmar, Kai/F-1174-2013; Hoste, Esther/AAG-2218-2020; Simons, Benjamin/AAY-8920-2020; Ferrón, Sacri R./I-2958-2015; Watt, Fiona/AHB-0226-2022; Lichtenberger, Beate M./AAD-1717-2019; Herault, Yann/B-5500-2012	Pavlovic, Guillaume/0000-0001-9122-4592; Hoste, Esther/0000-0002-3181-431X; Kretzschmar, Kai/0000-0002-4745-6684; Hoste, Esther/0000-0002-3181-431X; Simons, Benjamin/0000-0002-3875-7071; Ferrón, Sacri R./0000-0003-0854-8575; Watt, Fiona/0000-0001-9151-5154; Lichtenberger, Beate M./0000-0001-6882-0257; Herault, Yann/0000-0001-7049-6900; Ferguson-Smith, Anne/0000-0002-7608-5894; Charalambous, Marika/0000-0002-1684-5783; Driskell, Ryan/0000-0001-7673-2564	Wellcome Trust; Medical Research Council (MRC); European Union; FEBS long-term fellowship; MRC; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust; MRC [MR/J001597/1, G0600796] Funding Source: UKRI; Medical Research Council [G0600796, MR/J001597/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); FEBS long-term fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (F. M. W., A.C.F.-S.), the Medical Research Council (MRC) (F. M. W., A.C.F.-S.) and the European Union FP7 programme: TUMIC (F. M. W.), HEALING (F. M. W.) and EpigeneSys (A.C.F.-S.). B. M. L. is the recipient of a FEBS long-term fellowship. K. K. is the recipient of a MRC PhD Studentship. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London (KCL) and King's College Hospital NHS Foundation Trust. Input from M. Mastrogiannaki, A. Reimer and B. Trappmann is gratefully acknowledged. The authors also thank J. Connelly and G. Theocharidis for providing tissue, KCL core staff, in particular J. Castle, C. Pearce and D. Cooper, for technical support, and J. Harris and the Nikon Imaging Centre at KCL for expert assistance.	Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Driskell RR, 2012, J INVEST DERMATOL, V132, P1084, DOI 10.1038/jid.2011.428; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Egawa G, 2009, J INVEST DERMATOL, V129, P2386, DOI 10.1038/jid.2009.105; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Janson DG, 2012, J INVEST DERMATOL, V132, P2565, DOI 10.1038/jid.2012.192; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Lesko MH, 2013, DEV BIOL, V382, P15, DOI 10.1016/j.ydbio.2013.08.004; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; SHAH M, 1994, J CELL SCI, V107, P1137; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; VANEXAN RJ, 1984, AM J ANAT, V169, P149, DOI 10.1002/aja.1001690204	30	674	698	34	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					277	+		10.1038/nature12783	http://dx.doi.org/10.1038/nature12783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336287	Green Submitted, Green Accepted			2022-12-28	WOS:000328121500036
J	Gobel, CH; Gobel, A; Gobel, H				Goebel, Carl H.; Goebel, Anna; Goebel, Hartmut			CHRISTMAS 2013: MEDICAL HISTORIES "Compulsive plague! pain without end!" How Richard Wagner played out his migraine in the opera Siegfried	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goebel, Carl H.; Goebel, Anna; Goebel, Hartmut] Kiel Headache & Pain Ctr, D-24149 Kiel, Germany; [Goebel, Carl H.] Inst Neurosci & Med INM 3, Julich, Germany; [Goebel, Carl H.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Goebel, Anna] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany	University of Cologne; University of Kiel; Schleswig Holstein University Hospital	Gobel, CH (corresponding author), Kiel Headache & Pain Ctr, Heikendorfer Weg 9-27, D-24149 Kiel, Germany.	hg@schmerzklinik.de	Göbel, Hartmut/AAE-4719-2020					Crotogino J, 2001, HEADACHE, V41, P40, DOI 10.1046/j.1526-4610.2001.111006040.x; Eggebrecht HH, 1996, TERMINOLOGIE MUSIKAL; Franken FH, 2004, KRANKHEITEN GROSSER; Glasenapp CF, 1905, LEBEN R WAGNERS 6 BU; Gobel H, 2013, FRANKFURTER ALLG, V181, P27; Gould GM, 1903, LANCET, V162, P306; Haenchen H., 2013, WERKTREUE INTERPRETA; Otte A, 2008, KERNERS KRANKHEITEN; Wagner C, 1977, TAGEBUCHER; Wagner C., 1976, TAGEBUCHER; Wagner R., 1911, MEIN LEBEN; [No title captured]	12	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f6952	10.1136/bmj.f6952	http://dx.doi.org/10.1136/bmj.f6952			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336305				2022-12-28	WOS:000328575200004
J	Watanabe, S; Rost, BR; Camacho-Perez, M; Davis, MW; Sohl-Kielczynski, B; Rosenmund, C; Jorgensen, EM				Watanabe, Shigeki; Rost, Benjamin R.; Camacho-Perez, Marcial; Davis, M. Wayne; Soehl-Kielczynski, Berit; Rosenmund, Christian; Jorgensen, Erik M.			Ultrafast endocytosis at mouse hippocampal synapses	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; TRANSMITTER RELEASE; AUTAPTIC CULTURES; FUSION; MEMBRANE; EXOCYTOSIS; TRANSMISSION; RETRIEVAL; MECHANISM	To sustain neurotransmission, synaptic vesicles and their associated proteins must be recycled locally at synapses. Synaptic vesicles are thought to be regenerated approximately 20 s after fusion by the assembly of clathrin scaffolds or in approximately 1 s by the reversal of fusion pores via 'kiss-and-run' endocytosis. Here we use optogenetics to stimulate cultured hippocampal neurons with a single stimulus, rapidly freeze them after fixed intervals and examine the ultrastructure using electron microscopy-'flash-and-freeze' electron microscopy. Docked vesicles fuse and collapse into the membrane within 30 ms of the stimulus. Compensatory endocytosis occurs within 50 to 100 ms at sites flanking the active zone. Invagination is blocked by inhibition of actin polymerization, and scission is blocked by inhibiting dynamin. Because intact synaptic vesicles are not recovered, this form of recycling is not compatible with kiss-and-run endocytosis; moreover, it is 200-fold faster than clathrin-mediated endocytosis. It is likely that 'ultrafast endocytosis' is specialized to restore the surface area of the membrane rapidly.	[Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rost, Benjamin R.; Camacho-Perez, Marcial; Soehl-Kielczynski, Berit; Rosenmund, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	christian.rosenmund@charite.de; jorgensen@biology.utah.edu	Rosenmund, Christian/AAC-3596-2020; Rost, Benjamin/AHD-2242-2022	Rosenmund, Christian/0000-0002-3905-2444; Rost, Benjamin/0000-0003-1906-0081; Davis, Mikel/0000-0003-1867-1593; Watanabe, Shigeki/0000-0001-7580-8141; Camacho Perez, Marcial/0000-0002-2367-1259	EMBO; US National Institutes of Health [NS034307]; European Research Council [249939 SYNVGLUT]; German Research Council [EXC 257, SFB 665, SFB958]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307, R37NS034307] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Lorenz and A. Muenster-Wandowski for providing access to electron microscopes. We would like to thank P. Hegemann and F. Schneider for providing the Cheta TC construct, A. Felies for cell cultures, B. Brokowski for generating lentivirus, E. Hujber for image processing and freezing calculations, C. Ebeling for calculating the time constant for synaptic vesicle collapse, and J. Iwasa for drawing the model figure. We would like to thank C. Tomova and Leica Microsystems for providing us with technical details of the controller of the high-pressure freezer for precise temporal control of light stimulation. We thank EMBO for providing the travel funds (S. W.). The research was funded by the US National Institutes of Health (NS034307; E. M. J.), European Research Council grant (249939 SYNVGLUT; C. R.), and German Research Council grants (EXC 257, SFB 665, SFB958; C. R.). E. M. J. is an Investigator of the Howard Hughes Medical Institute and is an Alexander von Humboldt Scholar.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CECCARELLI B, 1972, J CELL BIOL, V54, P30, DOI 10.1083/jcb.54.1.30; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeno-Hikichi Y, 2011, J NEUROSCI, V31, P1093, DOI 10.1523/JNEUROSCI.2800-10.2011; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Rost BR, 2010, EUR J NEUROSCI, V32, P939, DOI 10.1111/j.1460-9568.2010.07387.x; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Teng HB, 1999, J NEUROSCI, V19, P4855; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104	54	323	323	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					242	+		10.1038/nature12809	http://dx.doi.org/10.1038/nature12809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305055	Green Accepted			2022-12-28	WOS:000328121500029
J	Coiera, E; Collins, S; Kuziemsky, C				Coiera, Enrico; Collins, Sarah; Kuziemsky, Craig			A unified model of patient safety (or "Who froze my cheese?")	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Coiera, Enrico] Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia; [Collins, Sarah] Harvard Univ, Sch Med, Clin Informat Partners eCare, Partners Healthcare Syst, Boston, MA USA; [Collins, Sarah] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kuziemsky, Craig] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada	University of New South Wales Sydney; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; University of Ottawa	Coiera, E (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia.	e.coiera@unsw.edu.au		Coiera, Enrico/0000-0002-6444-6584				[Anonymous], 1941, IND ACCIDENT PREVENT; Braithwaite J, 2005, J ROY SOC MED, V98, P542, DOI 10.1258/jrsm.98.12.542; Braithwaite J, 2010, J ROY SOC MED, V103, P219, DOI 10.1258/jrsm.2010.100032; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f7273	10.1136/bmj.f7273	http://dx.doi.org/10.1136/bmj.f7273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335670				2022-12-28	WOS:000328575000004
J	Shen, L; Shah, BR; Reyes, EM; Thomas, L; Wojdyla, D; Diem, P; Leiter, LA; Charbonnel, B; Mareev, V; Horton, ES; Haffner, SM; Soska, V; Holman, R; Bethel, MA; Schaper, F; Sun, JL; McMurray, JJV; Califf, RM; Krum, H				Shen, Lan; Shah, Bimal R.; Reyes, Eric M.; Thomas, Laine; Wojdyla, Daniel; Diem, Peter; Leiter, Lawrence A.; Charbonnel, Bernard; Mareev, Viacheslav; Horton, Edward S.; Haffner, Steven M.; Soska, Vladimir; Holman, Rury; Bethel, M. Angelyn; Schaper, Frank; Sun, Jie-Lena; McMurray, John J. V.; Califf, Robert M.; Krum, Henry			Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR MORBIDITY; ANTIHYPERTENSIVE DRUGS; PRIMARY PREVENTION; RANDOMIZED-TRIAL; BLOOD-PRESSURE; MELLITUS; THERAPY; HYPERTENSION; MORTALITY; NATEGLINIDE	Objective To examine the degree to which use of beta blockers, statins, and diuretics in patients with impaired glucose tolerance and other cardiovascular risk factors is associated with new onset diabetes. Design Reanalysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Setting NAVIGATOR trial. Participants Patients who at baseline (enrolment) were treatment naive to beta blockers (n=5640), diuretics (n=6346), statins (n=6146), and calcium channel blockers (n=6294). Use of calcium channel blocker was used as a metabolically neutral control. Main outcome measures Development of new onset diabetes diagnosed by standard plasma glucose level in all participants and confirmed with glucose tolerance testing within 12 weeks after the increased glucose value was recorded. The relation between each treatment and new onset diabetes was evaluated using marginal structural models for causal inference, to account for time dependent confounding in treatment assignment. Results During the median five years of follow-up, beta blockers were started in 915 (16.2%) patients, diuretics in 1316 (20.7%), statins in 1353 (22.0%), and calcium channel blockers in 1171 (18.6%). After adjusting for baseline characteristics and time varying confounders, diuretics and statins were both associated with an increased risk of new onset diabetes (hazard ratio 1.23, 95% confidence interval 1.06 to 1.44, and 1.32, 1.14 to 1.48, respectively), whereas beta blockers and calcium channel blockers were not associated with new onset diabetes (1.10, 0.92 to 1.31, and 0.95, 0.79 to 1.13, respectively). Conclusions Among people with impaired glucose tolerance and other cardiovascular risk factors and with serial glucose measurements, diuretics and statins were associated with an increased risk of new onset diabetes, whereas the effect of beta blockers was non-significant.	[Shen, Lan; Shah, Bimal R.; Reyes, Eric M.; Thomas, Laine; Wojdyla, Daniel; Sun, Jie-Lena; Califf, Robert M.] Duke Clin Res Inst, Durham, NC USA; [Shen, Lan] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Diem, Peter] Univ Bern, Univ Hosp, Dept Endocrinol Diabet & Clin Nutr, CH-3012 Bern, Switzerland; [Leiter, Lawrence A.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Charbonnel, Bernard] Univ Hosp, Dept Endocrinol, Nantes, France; [Mareev, Viacheslav] Moscow MV Lomonosov State Univ, Moscow, Russia; [Horton, Edward S.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Haffner, Steven M.; Bethel, M. Angelyn] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; [Soska, Vladimir] Masaryk Univ, Clin Internal Med 2, Brno, Czech Republic; [Soska, Vladimir] Masaryk Univ, Fac Med, Dept Biochem, Brno, Czech Republic; [Holman, Rury] Churchill Hosp, Oxford OX3 7LJ, England; [Schaper, Frank] Tech Univ Dresden, Ctr Clin Studies Metab & Endocrinol Knowledge & T, Dresden, Germany; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Krum, Henry] Monash Univ, Alfred Hosp, Sch Publ Hlth & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia	Duke University; Shanghai Jiao Tong University; University of Bern; University Hospital of Bern; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Nantes Universite; CHU de Nantes; Lomonosov Moscow State University; Harvard University; Joslin Diabetes Center, Inc.; University of Oxford; Masaryk University Brno; Masaryk University Brno; University of Oxford; Technische Universitat Dresden; University of Glasgow; Florey Institute of Neuroscience & Mental Health; Monash University	Krum, H (corresponding author), Monash Univ, Alfred Hosp, Sch Publ Hlth & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@monash.edu	mcmurray, John/B-2467-2013; Diem, Peter/A-7650-2008; Leiter, Lawrence/AAG-4059-2020; Mareev, Viacheslav Yurivich/Q-1375-2017	mcmurray, John/0000-0002-6317-3975; Diem, Peter/0000-0002-1190-9880; Mareev, Viacheslav Yurivich/0000-0002-7285-2048				[Anonymous], 1981, LANCET, V2, P539; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Carter BL, 2008, HYPERTENSION, V52, P30, DOI 10.1161/HYPERTENSIONAHA.108.114389; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; FDA, 2013, FDA DRUG SAF COMM IM; Freeman DJ, 2001, CIRCULATION, V103, P357; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hernan MA, 1999, BIOMETRICS, V55, P1316; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Krum H, 2010, CARDIOVASC THER, V28, P124, DOI 10.1111/j.1755-5922.2010.00146.x; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Neugebauer R, 2012, PHARMACOEPIDEM DR S, V21, P99, DOI 10.1002/pds.3253; PEDERSEN TR, 1994, LANCET, V344, P1383; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; SKARFORS ET, 1989, BRIT MED J, V298, P1147, DOI 10.1136/bmj.298.6681.1147; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; Taylor EN, 2006, DIABETES CARE, V29, P1065, DOI 10.2337/dc05-2366	29	59	64	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f6745	10.1136/bmj.f6745	http://dx.doi.org/10.1136/bmj.f6745			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZI	24322398	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000328574400002
J	Horton, R; Lo, S				Horton, Richard; Lo, Selina			Investing in health: why, what, and three reflections	LANCET			English	Editorial Material									[Horton, Richard; Lo, Selina] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Jamison DT, 2013, LANCET; The World Bank, 1993, WORLD DEVELOPMENT RE	2	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1859	1861		10.1016/S0140-6736(13)62330-2	http://dx.doi.org/10.1016/S0140-6736(13)62330-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309474				2022-12-28	WOS:000328222400009
J	Levenson, JE; Kaul, DR; Saint, S; Nallamothu, BK; Gurm, HS				Levenson, Joshua E.; Kaul, Daniel R.; Saint, Sanjay; Nallamothu, Brahmajee K.; Gurm, Hitinder S.			A Shocking Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FULMINANT MYOCARDITIS; DIAGNOSIS; OUTCOMES	A 20-year-old female college student presented in the winter with a 2-week history of fatigue, cough, sinus congestion, and rhinorrhea, followed by 2 days of vomiting, diarrhea, and abdominal pain. ForewordIn this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.StageA 20-year-old female college student presented with a 2-week history of fatigue, cough, sinus congestion, and rhinorrhea, followed by 2 days of vomiting, diarrhea, and abdominal pain. The patient's initial symptoms began during her end-of-semester winter examination period; she knew many people who had been ill with similar symptoms, including fatigue and upper respiratory symptoms. The patient was recovering when she began to have nonbilious, nonbloody emesis and frequent, loose, nonbloody bowel movements. ResponseUpper respiratory tract symptoms, particularly when they occur in the winter and involve a number of contacts, are suggestive of a community-acquired respiratory virus, such ...	[Levenson, Joshua E.; Saint, Sanjay] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kaul, Daniel R.] Univ Michigan, Div Infect Dis, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Gurm, Hitinder S.] Univ Michigan, Div Cardiol, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Ann Arbor Vet Affairs VA Hosp Outcomes Program Ex, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Ann Arbor VA Ctr Clin Management & Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Levenson, JE (corresponding author), 3116G Taubman Ctr,SPC 5368, Ann Arbor, MI 48109 USA.	levenson@med.umich.edu	Saint, Sanjay/AAF-5126-2019	Gurm, Hitinder/0000-0002-1646-0218; Levenson, Joshua/0000-0001-6940-524X	Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for board membership from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2012, INFLUENZA RES TREAT; Atluri P, 2013, EUR J CARDIO-THORAC, V43, P379, DOI 10.1093/ejcts/ezs242; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Felker GM, 2000, J AM COLL CARDIOL, V36, P227, DOI 10.1016/S0735-1097(00)00690-2; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Krumholz HM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f547; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Pankuweit S, 2012, HEART FAIL REV; Takeuchi I, 2010, CIRC J, V74, P2758, DOI 10.1253/circj.CJ-10-0354; Ukimura A, 2010, CIRC J, V74, P2193, DOI 10.1253/circj.CJ-10-0452	14	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2253	2258		10.1056/NEJMcps1301587	http://dx.doi.org/10.1056/NEJMcps1301587			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304055				2022-12-28	WOS:000327801100012
J	Deane, RP; Murphy, DJ				Deane, Richard P.; Murphy, Deirdre J.			Student Attendance and Academic Performance in Undergraduate Obstetrics/Gynecology Clinical Rotations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LECTURE ATTENDANCE; MEDICAL-SCHOOL; ABSENTEEISM	IMPORTANCE Student attendance is thought to be an important factor in the academic performance of medical students, in addition to having important regulatory, policy, and financial implications for medical educators. However, this relationship has not been well evaluated within clinical learning environments. OBJECTIVE To evaluate the relationship between student attendance and academic performance in a medical student obstetrics/gynecology clinical rotation. DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study of student attendance at clinical and tutorial-based activities during a full academic year (September 2011 to June 2012) within a publicly funded university teaching hospital in Dublin, Ireland. Students were expected to attend 64 activities (26 clinical activities and 38 tutorial-based activities) but attendance was not mandatory. All 147 fourth-year medical students who completed an 8-week obstetrics/gynecology rotation were included. EXPOSURES Student attendance at clinical and tutorial-based activities, recorded using a paper-based logbook. MAIN OUTCOMES AND MEASURES The overall examination score (out of a possible 200 points) was obtained using an 11-station objective structured clinical examination (40 points), an end-of-year written examination comprising 50 multiple-choice questions (40 points) and 6 short-answer questions (40 points), and an end-of-year long-case clinical/oral examination (80 points). Students were required to have an overall score of 100 points (50%) and a minimum of 40 points in the long-case clinical/oral examination (50%) to pass. RESULTS The mean attendance rate was 89% (range, 39%-100% [SD, 11%], n = 57/64 activities). Male students (84% attendance, P = .001) and students who failed an end-of-year examination previously (84% attendance, P = .04) had significantly lower rates. There was a positive correlation between attendance and overall examination score (r = 0.59 [95% CI, 0.44-0.70]; P < .001). Both clinical attendance (r = 0.50 [95% CI, 0.32-0.64]; P < .001) and tutorial-based attendance (r = 0.57 [95% CI, 0.40-0.70]; P < .001) were positively correlated with overall examination score. The associations persisted after controlling for confounding factors of student sex, age, country of origin, previous failure in an end-of-year examination, and the timing of the rotation during the academic year. Distinction grades (overall score of >= 60%) were present only among students with attendance rates of 80% or higher. The odds of a distinction grade increased with each 10% increase in attendance (adjusted odds ratio, 5.52; 95% CI, 2.17-14.00). The majority of failure grades (6/10 students; 60%) occurred in students with attendance rates lower than 80%. The adjusted odds ratio for failure with attendance rates of 80% or higher was 0.11 (95% CI, 0.02-0.72). CONCLUSIONS AND RELEVANCE Among fourth-year medical students completing an 8-week obstetrics/gynecology clinical rotation, attendance at clinical and tutorial-based activities was positively correlated with overall examination scores. Further research is needed to understand whether the relationship is causal, and whether improving attendance rates can improve academic performance.	[Deane, Richard P.; Murphy, Deirdre J.] Univ Dublin, Coombe Women & Infants Univ Hosp, Trinity Coll, Dept Obstet & Gynecol, Dublin, Ireland	Trinity College Dublin	Deane, RP (corresponding author), Coombe Women & Infants Univ Hosp, Dublin 8, Ireland.	deaneri@tcd.ie		Murphy, Deirdre/0000-0001-6074-6718; Deane, Richard/0000-0002-7178-1145	Department of Obstetrics and Gynecology, Trinity College, University of Dublin	Department of Obstetrics and Gynecology, Trinity College, University of Dublin	Internal funding from the Department of Obstetrics and Gynecology, Trinity College, University of Dublin.	BinSaeed AA, 2006, J INT ASSOC MED SCI, V19, P155; Chan WP, 2009, ANN ACAD MED SINGAP, V38, P237; Cohall D. H., 2012, CARIBBEAN TEACHING S, V2, P115; Cortright RN, 2011, ADV PHYSIOL EDUC, V35, P416, DOI 10.1152/advan.00021.2011; Dhaliwal U, 2003, NATL MED J INDIA, V16, P34; Fernandes L., 2008, J INT ASS MED SCI ED, V18, P62; Flournoy D J, 1984, J Okla State Med Assoc, V77, P20; FOGLEMAN BS, 1983, J MED EDUC, V58, P904; GLANZ K, 1984, J MED EDUC, V59, P516; Hamdi A., 2006, J INT ASS MED SCI ED, V16, P27; Hamdy H, 2006, MED TEACH, V28, P103, DOI 10.1080/01421590600622723; Hammen C. S., 1994, American Journal of Physiology, V267, pS105; Hidayat L, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe7618; Horton DM, 2012, ADV PHYSIOL EDUC, V36, P108, DOI 10.1152/advan.00111.2011; Khan Habib-ullah, 2003, J Ayub Med Coll Abbottabad, V15, P56; Millis RM, 2009, ADV PHYSIOL EDUC, V33, P139, DOI 10.1152/advan.00028.2009; O'Brien B, 2007, ACAD MED, V82, P970, DOI 10.1097/ACM.0b013e31814a4fd5; Office of the Senior Lecturer Trinity College University of Dublin., TCD MARKING SCHEME; Richards AJ, 2013, ACAD MED, V88, P434, DOI 10.1097/ACM.0b013e3182854f3f; RIGGS JW, 1994, OBSTET GYNECOL, V84, P311; SADE RM, 1982, J MED EDUC, V57, P191; Schieffler Danny A Jr, 2012, Perm J, V16, P10; Smith LB, 2012, MED EDUC, V46, P137, DOI 10.1111/j.1365-2923.2011.04182.x; THOMPSON JL, 1974, J MED EDUC, V49, P963	24	37	39	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2282	2288		10.1001/jama.2013.282228	http://dx.doi.org/10.1001/jama.2013.282228			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302091				2022-12-28	WOS:000327746300013
J	Kahn, SR; Shapiro, S; Wells, PS; Rodger, MA; Kovacs, MJ; Anderson, DR; Tagalakis, V; Houweling, AH; Ducruet, T; Holcroft, C; Johri, M; Solymoss, S; Miron, MJ; Yeo, E; Smith, R; Schulman, S; Kassis, J; Kearon, C; Chagnon, I; Wong, T; Demers, C; Hanmiah, R; Kaatz, S; Selby, R; Rathbun, S; Desmarais, S; Opatrny, L; Ortel, TL; Ginsberg, JS				Kahn, Susan R.; Shapiro, Stan; Wells, Philip S.; Rodger, Marc A.; Kovacs, Michael J.; Anderson, David R.; Tagalakis, Vicky; Houweling, Adrielle H.; Ducruet, Thierry; Holcroft, Christina; Johri, Mira; Solymoss, Susan; Miron, Marie-Jose; Yeo, Erik; Smith, Reginald; Schulman, Sam; Kassis, Jeannine; Kearon, Clive; Chagnon, Isabelle; Wong, Turnly; Demers, Christine; Hanmiah, Rajendar; Kaatz, Scott; Selby, Rita; Rathbun, Suman; Desmarais, Sylvie; Opatrny, Lucie; Ortel, Thomas L.; Ginsberg, Jeffrey S.		SOX Trial Investigators	Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial	LANCET			English	Article							DEEP VENOUS THROMBOSIS; QUALITY-OF-LIFE; VEIN THROMBOSIS; DETERMINANTS; DISEASE; VILLALTA; OUTCOMES; BURDEN; SCALE; LEG	Background Post-thrombotic syndrome (PTS) is a common and burdensome complication of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression stockings (ECS) to prevent PTS were small, single-centre studies without placebo control. We aimed to assess the efficacy of ECS, compared with placebo stockings, for the prevention of PTS. Methods We did a multicentre randomised placebo-controlled trial of active versus placebo ECS used for 2 years to prevent PTS after a first proximal DVT in centres in Canada and the USA. Patients were randomly assigned to study groups with a web-based randomisation system. Patients presenting with a first symptomatic, proximal DVT were potentially eligible to participate. They were excluded if the use of compression stockings was contraindicated, they had an expected lifespan of less than 6 months, geographical inaccessibility precluded return for follow-up visits, they were unable to apply stockings, or they received thrombolytic therapy for the initial treatment of acute DVT. The primary outcome was PTS diagnosed at 6 months or later using Ginsberg's criteria (leg pain and swelling of >= 1 month duration). We used a modified intention to treat Cox regression analysis, supplemented by a prespecified per-protocol analysis of patients who reported frequent use of their allocated treatment. This study is registered with ClinicalTrials.gov, number NCT00143598, and Current Controlled Trials, number ISRCTN71334751. Findings From 2004 to 2010, 410 patients were randomly assigned to receive active ECS and 396 placebo ECS. The cumulative incidence of PTS was 14.2% in active ECS versus 12.7% in placebo ECS (hazard ratio adjusted for centre 1.13, 95% CI 0.73-1.76; p=0.58). Results were similar in a prespecified per-protocol analysis of patients who reported frequent use of stockings. Interpretation ECS did not prevent PTS after a first proximal DVT, hence our findings do not support routine wearing of ECS after DVT.	[Kahn, Susan R.; Shapiro, Stan; Tagalakis, Vicky; Houweling, Adrielle H.; Ducruet, Thierry] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Shapiro, Stan] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3T 1E2, Canada; [Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada; [Wells, Philip S.; Rodger, Marc A.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Rodger, Marc A.] Univ Ottawa, Dept Med, Div Hematol, Thrombosis Program, Ottawa, ON, Canada; [Kovacs, Michael J.] London Hlth Sci Ctr, Div Hematol, London, ON, Canada; [Anderson, David R.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Anderson, David R.] Capital Hlth, Halifax, NS, Canada; [Holcroft, Christina] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Holcroft, Christina] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Johri, Mira] Univ Montreal Hosp Res Ctr, Int Hlth Unit, Montreal, PQ, Canada; [Johri, Mira] Univ Montreal, Fac Med, Dept Hlth Adm, Montreal, PQ H3C 3J7, Canada; [Chagnon, Isabelle] Univ Montreal, Dept Med, Hop Sacre Coeur, Montreal, PQ H3C 3J7, Canada; [Solymoss, Susan] Montreal Gen Hosp, Div Hematol, Montreal, PQ H3G 1A4, Canada; [Solymoss, Susan] St Marys Hosp, Montreal, PQ, Canada; [Opatrny, Lucie] St Marys Hosp, Profess Serv, Montreal, PQ, Canada; [Miron, Marie-Jose] Hop Notre Dame de Bon Secours, Dept Med, Montreal, PQ H2L 4K8, Canada; [Yeo, Erik] Univ Hlth Network, Div Hematol, Toronto, ON, Canada; [Smith, Reginald] Victoria Heart Inst Fdn, Div Cardiol, Victoria, BC, Canada; [Smith, Reginald] Victoria Heart Inst Fdn, Div Thrombosis, Victoria, BC, Canada; [Schulman, Sam; Kearon, Clive; Ginsberg, Jeffrey S.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Schulman, Sam] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Schulman, Sam] Karolinska Inst, Stockholm, Sweden; [Kassis, Jeannine] Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ, Canada; [Wong, Turnly] Univ Manitoba, Dept Med, St Boniface Gen Hosp, Winnipeg, MB, Canada; [Demers, Christine] CHU Quebec, Div Hematol, Quebec City, PQ, Canada; [Hanmiah, Rajendar] St Josephs Hosp, Div Gen Internal Med, Hamilton, ON, Canada; [Kaatz, Scott] Hurley Med Ctr, Flint, MI USA; [Selby, Rita] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Selby, Rita] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON, Canada; [Selby, Rita] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Rathbun, Suman] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Desmarais, Sylvie] Hop Pierre Boucher, Dept Med, Longueuil, PQ, Canada; [Ortel, Thomas L.] Duke Univ, Med Ctr, Div Hematol, Durham, NC USA	McGill University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; London Health Sciences Centre; Dalhousie University; Tufts Medical Center; Tufts University; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; McMaster University; Karolinska Institutet; Universite de Montreal; University of Manitoba; Children's Hospital Research Institute of Manitoba; Laval University; McGill University; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Oklahoma System; University of Oklahoma Health Sciences Center; Duke University	Kahn, SR (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, 3755 Cote Ste Catherine Room H420-1, Montreal, PQ H3T 1E2, Canada.	susan.kahn@mcgill.ca	Tagalakis, Vicky/E-1932-2015; Lazo-Langner, Alejandro/E-6993-2011; Johri, Mira/D-5104-2013; Kovacs, Michael/G-3315-2011; Schulman, Sam/I-7559-2019; ginsberg, jeffrey s/ABC-1065-2020	Lazo-Langner, Alejandro/0000-0001-6869-8431; Johri, Mira/0000-0001-5642-787X; Schulman, Sam/0000-0002-8512-9043; Anderson, David/0000-0003-0845-1722; Rodger, Marc/0000-0001-8166-3487	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	[Anonymous], 1994, HAEMOSTASIS S1; Aschwanden M, 2008, J VASC SURG, V47, P1015, DOI 10.1016/j.jvs.2008.01.008; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Cohen JM, 2012, CHEST, V141, P308, DOI 10.1378/chest.11-1175; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; GINSBERG JS, 1989, ARCH INTERN MED, V149, P2255, DOI 10.1001/archinte.149.10.2255; GINSBERG JS, 1991, RADIOLOGY, V181, P651, DOI 10.1148/radiology.181.3.1947076; Ginsberg JS, 2001, ARCH INTERN MED, V161, P2105, DOI 10.1001/archinte.161.17.2105; Guanella R, 2011, J THROMB HAEMOST, V9, P2397, DOI 10.1111/j.1538-7836.2011.04516.x; Henke PK, 2011, J VASC SURG, V53, P500, DOI 10.1016/j.jvs.2010.08.050; Hrobjartsson A, 2013, CAN MED ASSOC J, V185, pE201, DOI 10.1503/cmaj.120744; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kahn SR, 2006, J THROMB HAEMOST, V4, P907, DOI 10.1111/j.1538-7836.2006.01824.x; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2003, J THROMB HAEMOST, V1, P500, DOI 10.1046/j.1538-7836.2003.00098.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn Susan R, 2007, BMC Cardiovasc Disord, V7, P21, DOI 10.1186/1471-2261-7-21; Kahn SR, 2006, J CLIN EPIDEMIOL, V59, P1049, DOI 10.1016/j.jclinepi.2005.10.016; Kahn SR, 2009, BLOOD, V114, P4624, DOI 10.1182/blood-2009-07-199174; Lamping DL, 2003, J VASC SURG, V37, P410, DOI 10.1067/mva.2003.152; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Sibbald B, 2004, CAN MED ASSOC J, V171, P1027, DOI 10.1503/cmaj.1041606; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; van Korlaar I, 2003, THROMB HAEMOSTASIS, V90, P27; Ware J, 1994, SF 36 PHYS MENTAL SU	34	315	333	3	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					880	888		10.1016/S0140-6736(13)61902-9	http://dx.doi.org/10.1016/S0140-6736(13)61902-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3FC	24315521				2022-12-28	WOS:000332399500028
J	Cruchaga, C; Karch, CM; Jin, SC; Benitez, BA; Cai, YF; Guerreiro, R; Harari, O; Norton, J; Budde, J; Bertelsen, S; Jeng, AT; Cooper, B; Skorupa, T; Carrell, D; Levitch, D; Hsu, S; Choi, J; Ryten, M; Sassi, C; Bras, J; Gibbs, JR; Hernandez, DG; Lupton, MK; Powell, J; Forabosco, P; Ridge, PG; Corcoran, CD; Tschanz, JT; Norton, MC; Munger, RG; Schmutz, C; Leary, M; Demirci, FY; Bamne, MN; Wang, XB; Lopez, OL; Ganguli, M; Medway, C; Turton, J; Lord, J; Braae, A; Barber, I; Brown, K; Pastor, P; Lorenzo-Betancor, O; Brkanac, Z; Scott, E; Topol, E; Morgan, K; Rogaeva, E; Singleton, AB; Hardy, J; Kamboh, MI; St George-Hyslop, P; Cairns, N; Morris, JC; Kauwe, JSK; Goate, AM				Cruchaga, Carlos; Karch, Celeste M.; Jin, Sheng Chih; Benitez, Bruno A.; Cai, Yefei; Guerreiro, Rita; Harari, Oscar; Norton, Joanne; Budde, John; Bertelsen, Sarah; Jeng, Amanda T.; Cooper, Breanna; Skorupa, Tara; Carrell, David; Levitch, Denise; Hsu, Simon; Choi, Jiyoon; Ryten, Mina; Sassi, Celeste; Bras, Jose; Gibbs, J. Raphael; Hernandez, Dena G.; Lupton, Michelle K.; Powell, John; Forabosco, Paola; Ridge, Perry G.; Corcoran, Christopher D.; Tschanz, Joann T.; Norton, Maria C.; Munger, Ronald G.; Schmutz, Cameron; Leary, Maegan; Demirci, F. Yesim; Bamne, Mikhil N.; Wang, Xingbin; Lopez, Oscar L.; Ganguli, Mary; Medway, Christopher; Turton, James; Lord, Jenny; Braae, Anne; Barber, Imelda; Brown, Kristelle; Pastor, Pau; Lorenzo-Betancor, Oswaldo; Brkanac, Zoran; Scott, Erick; Topol, Eric; Morgan, Kevin; Rogaeva, Ekaterina; Singleton, Andrew B.; Hardy, John; Kamboh, M. Ilyas; St George-Hyslop, Peter; Cairns, Nigel; Morris, John C.; Kauwe, John S. K.; Goate, Alison M.		UKBEC; Alzheimers Res UK ARUK Consortium	Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease	NATURE			English	Article							NETWORK ANALYSIS; ASSOCIATION; EXPRESSION; TREM2; AGE; DIAGNOSIS; DEMENTIA; INSIGHTS; MUTATION; BRAIN	Genome-wide association studies (GWAS) have identified several risk variants for late-onset Alzheimer's disease (LOAD)(1,2). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants, not detected by GWAS, are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk, we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. Gene-based burden analyses in 4,387 cases and controls of European descent and 302 African American cases and controls, with complete sequence data for PLD3, reveal that several variants in this gene increase risk for Alzheimer's disease in both populations. PLD3 is highly expressed in brain regions that are vulnerable to Alzheimer's disease pathology, including hippocampus and cortex, and is expressed at significantly lower levels in neurons from Alzheimer's disease brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-beta precursor protein (APP) and extracellular A beta 42 and A beta 40 (the 42- and 40-residue isoforms of the amyloid-beta peptide), and knockdown of PLD3 leads to a significant increase in extracellular A beta 42 and A beta 40. Together, our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for disease or other complex traits.	[Cruchaga, Carlos; Karch, Celeste M.; Jin, Sheng Chih; Benitez, Bruno A.; Cai, Yefei; Harari, Oscar; Norton, Joanne; Budde, John; Bertelsen, Sarah; Jeng, Amanda T.; Cooper, Breanna; Skorupa, Tara; Carrell, David; Levitch, Denise; Hsu, Simon; Choi, Jiyoon; Goate, Alison M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Cruchaga, Carlos; Karch, Celeste M.; Cairns, Nigel; Goate, Alison M.] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO 63110 USA; [Guerreiro, Rita; Ryten, Mina; Sassi, Celeste; Bras, Jose; Gibbs, J. Raphael; Hernandez, Dena G.; Hardy, John] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Guerreiro, Rita; Sassi, Celeste; Gibbs, J. Raphael; Hernandez, Dena G.; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Lupton, Michelle K.; Powell, John] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Lupton, Michelle K.] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia; [Forabosco, Paola] CNR, Ist Genet Popolaz, I-07100 Sassari, Italy; [Ridge, Perry G.; Schmutz, Cameron; Leary, Maegan; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Corcoran, Christopher D.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Corcoran, Christopher D.; Tschanz, Joann T.; Norton, Maria C.] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA; [Tschanz, Joann T.; Norton, Maria C.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Norton, Maria C.; Munger, Ronald G.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA; [Munger, Ronald G.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Demirci, F. Yesim; Bamne, Mikhil N.; Wang, Xingbin; Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Kamboh, M. Ilyas] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Kamboh, M. Ilyas] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15261 USA; [Ganguli, Mary] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; [Medway, Christopher; Turton, James; Lord, Jenny; Braae, Anne; Barber, Imelda; Brown, Kristelle; Morgan, Kevin] Univ Nottingham, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Pastor, Pau; Lorenzo-Betancor, Oswaldo] Univ Navarra, Ctr Appl Med Res, Neurogenet Lab, Div Neurosci, Navarra 31008, Spain; [Pastor, Pau] Univ Navarra, Sch Med, Clin Univ Navarra, Dept Neurol, Pamplona 31008, Spain; [Pastor, Pau] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Brkanac, Zoran] Univ Washington, Seattle, WA 98104 USA; [Scott, Erick; Topol, Eric] Scripps Res Inst, La Jolla, CA 92037 USA; [Rogaeva, Ekaterina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0XY, England; [Cairns, Nigel; Morris, John C.] Washington Univ, St Louis, MO 63110 USA; [Morris, John C.; Goate, Alison M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Morris, John C.; Goate, Alison M.] Washington Univ, Knight ADRC, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; QIMR Berghofer Medical Research Institute; Consiglio Nazionale delle Ricerche (CNR); Brigham Young University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Nottingham; University of Navarra; University of Navarra; CIBERNED; Instituto de Salud Carlos III; University of Washington; University of Washington Seattle; Scripps Research Institute; University of Toronto; University of Cambridge; University of Cambridge; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cruchaga, C (corresponding author), Washington Univ, Dept Psychiat, 425 South Euclid Ave, St Louis, MO 63110 USA.	ccruchaga@wustl.edu	MORAN, CATHERINE L/C-9539-2015; Pickering-Brown, Stuart/D-4008-2009; Cairns, Nigel/AAB-9713-2020; Bras, Jose MT/A-1428-2011; Powell, John F/G-4412-2011; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009; Guerreiro, Rita J L/A-1327-2011; Cruchaga, Carlos/ABF-4065-2020; Forabosco, Paola/AAM-5540-2021; Pastor, Pau/C-9834-2009; Saito, Takashi/G-2563-2015; Trabzuni, Daniah/AAI-2037-2021; Benitez, Bruno A./E-7116-2014; Lord, Jenny/GYJ-1039-2022; Gibbs, J. Raphael/A-3984-2010; Weale, Michael E/F-2587-2010; Trabzuni, Daniah M/C-4034-2012; Lord, Jenny/AAR-5643-2021; Lorenzo-Betancor, Oswaldo/J-2753-2019; Kauwe, John/AAC-6646-2021; Fazli, Ghazal/AAE-8320-2022; Ryten, Mina/Q-8419-2016; Smith, Anthony D./A-4233-2010; Kehoe, Patrick/P-8760-2018	Pickering-Brown, Stuart/0000-0003-1561-6054; Cairns, Nigel/0000-0001-9858-3344; Powell, John F/0000-0001-6124-439X; Hardy, John/0000-0002-3122-0423; Cruchaga, Carlos/0000-0002-0276-2899; Pastor, Pau/0000-0002-7493-8777; Saito, Takashi/0000-0002-9659-9251; Trabzuni, Daniah/0000-0003-4826-9570; Benitez, Bruno A./0000-0002-2699-3878; Gibbs, J. Raphael/0000-0002-6985-0658; Weale, Michael E/0000-0003-4593-1186; Trabzuni, Daniah M/0000-0003-4826-9570; Lord, Jenny/0000-0002-0539-9343; Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; Kauwe, John/0000-0001-8641-2468; Smith, Anthony D./0000-0002-1095-6722; Goate, Alison/0000-0002-0576-2472; Bras, Jose/0000-0001-8186-0333; FORABOSCO, PAOLA/0000-0002-2006-2693; Todd, Stephen/0000-0002-2312-9195; Turton, James/0000-0003-2681-0477; Guerreiro, Rita/0000-0001-5879-3486; Kehoe, Patrick/0000-0002-7542-1139; St George-Hyslop, Peter/0000-0003-0796-7209; Hooper, Nigel/0000-0002-5811-3484; Jin, Sheng Chih/0000-0002-5777-7262; Hsu, Simon/0000-0002-0799-3549; McGuinness, Bernadette/0000-0002-7028-5633; Ramasamy, Adaikalavan/0000-0002-7598-2892; Lupton, Michelle/0000-0002-7274-7299; Budde, John/0000-0001-7778-7276; Demirci, F. Yesim/0000-0001-6907-9843; Kamboh, M. Ilyas/0000-0002-3453-1438; Karch, Celeste/0000-0002-6854-5547; Topol, Eric/0000-0002-1478-4729; Lowe, James/0000-0002-9856-1599; Morgan, Kevin/0000-0002-8217-2396	National Institutes of Health [P30-NS069329, R01-AG044546, R01-AG035083, RO1-AG11380, RO1-AG18712, RO1-AG21136, R01-AG042611]; Alzheimer Association [NIRG-11-200110]; Barnes Jewish Foundation; American Federation for Aging Research; BrightFocus Foundation Alzheimer's Disease Research Grant [A2013359S]; Genentech; Pfizer; NIH [P50 AG05681, P01 AG03991, P01 AG026276, R01039700, AG041718, AG030653, AG005133, AG07562, AG023652]; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [ZO1 AG000950-11]; Alzheimer's Association [MNIRG-11-205368]; Alzheimer's Research UK (ARUK); NINDS [ZO1 AG000950-10]; Wellcome Trust/MRC [WT089698]; Big Lottery; ARUK; ASvia ABBUK Ltd.; NIHR Queen Square Dementia BRU; BRC NIHR; Canadian Institutes of Health Research; Wellcome Trust; Medical Research Council; National Institute of Health Research; Ontario Research Fund; Alzheimer Society of Ontario; UK Medical Research Council through the MRC Sudden Death Brain Bank; Department of Health of the Government of Navarra, Spain [13085, 3/2008]; UTE project FIMA, Spain; NIA [R01AG21136];  [U24AG21886];  [U24: 5U24AG026395];  [1R01AG041797];  [G0901254];  [G0802462]; MRC [MC_G1000734, G1100695, MR/L016400/1, G0802189, MR/K01417X/1, G0901254, MC_G1000735, G0802462] Funding Source: UKRI; Alzheimers Research UK [ART-BIG2009-1, ARUK-NCG2014A-1, ARUK-NCG2012B-1, ART-PhD2010-5, ARUK-PG2014-2, ART-SB2010A-1, ARUK-TRFUS2012-3, ARUK-TRFUS2012-1] Funding Source: researchfish; Medical Research Council [G0802189, G1100695, G0802462, MC_G1000734, MR/K01417X/1, G0901254, MC_G1000735, MR/L016400/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017, ACF-2007-18-011] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041718, R01AG021136, P01AG026276, R01AG044546, R01AG039700, R01AG035083, P50AG005133, ZIAAG000950, K01AG046374, R01AG030653, R01AG041797, RF1AG044546, P50AG005681, R01AG011380, R01AG018712, R01AG007562, R01AG042611, P01AG003991, U24AG021886, Z01AG000950, U24AG026395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Barnes Jewish Foundation; American Federation for Aging Research; BrightFocus Foundation Alzheimer's Disease Research Grant(BrightFocus Foundation); Genentech(Roche HoldingGenentech); Pfizer(Pfizer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Big Lottery; ARUK(Alzheimer's Research UK (ARUK)); ASvia ABBUK Ltd.; NIHR Queen Square Dementia BRU; BRC NIHR; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Ontario Research Fund; Alzheimer Society of Ontario; UK Medical Research Council through the MRC Sudden Death Brain Bank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health of the Government of Navarra, Spain; UTE project FIMA, Spain; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Frohman for providing us with PLD1- and PLD2-WT constructs as well as constructs for the inactive mutations in these genes. This work was supported by grants from the National Institutes of Health (P30-NS069329, R01-AG044546 and R01-AG035083), the Alzheimer Association (NIRG-11-200110) and Barnes Jewish Foundation. This research was conducted while C.C. was a recipient of a New Investigator Award in Alzheimer's Disease from the American Federation for Aging Research. C.C. is a recipient of a BrightFocus Foundation Alzheimer's Disease Research Grant (A2013359S). Sequencing of some of the families included in this study was supported by Genentech and Pfizer. The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991 and P01 AG026276. This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, project ZO1 AG000950-11. Samples from the National Cell Repository for Alzheimer's Disease (NCRAD) and NIA-LOAD, which receives government support under a cooperative agreement (U24AG21886; U24: 5U24AG026395 and 1R01AG041797), were used in this study. We thank our contributors, including the Alzheimer's Disease Centers, that collected samples used in this study, as well as participants and their families, whose help and participation made this work possible. The Cache County Study is supported by National Institutes of Health, RO1-AG11380, RO1-AG18712 and RO1-AG21136. Genotyping and analysis conducted at Brigham Young University was funded by grants from the National Institutes of Health R01-AG042611 and the Alzheimer's Association (MNIRG-11-205368) to J.S.K.K. The sequencing at University of Washington was supported by NIH R01039700 (Z.B.). The sequencing for the NIA-UK samples was supported by the Alzheimer's Research UK (ARUK), by an anonymous donor, by the NINDS (ZO1 AG000950-10), by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC), by the Big Lottery (to K.M.) and by a fellowship from ARUK to R.G; Some samples and pathological diagnoses were provided by the MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research, jointly funded from ARUK and ASvia ABBUK Ltd. This work was also supported by the NIHR Queen Square Dementia BRU and BRC NIHR grant mechanisms. The sample recruitment and genetic studies at University of Pittsburgh are funded by NIH grants AG041718, AG030653, AG005133, AG07562 and AG023652. The Toronto sample studies are funded by Canadian Institutes of Health Research, Wellcome Trust, Medical Research Council, National Institute of Health, National Institute of Health Research, Ontario Research Fund and Alzheimer Society of Ontario (to P.S.G.-H.). The Nottingham Laboratory (K.M.) is funded by ARUK and Big Lottery. ARUK is supported by the UK Medical Research Council through the MRC Sudden Death Brain Bank (C.S.) and by a Project Grant (G0901254) and Training Fellowship (G0802462 to M.R.). P.P. receives funds from the Department of Health of the Government of Navarra, Spain (13085 and 3/2008) and from the UTE project FIMA, Spain. J.T.T. receives funds from the NIA (R01AG21136).	Benitez BA, 2013, NEW ENGL J MED, V369, P1567, DOI 10.1056/NEJMc1306509; Benitez BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003685; Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Bertram L., 2013, ALZGENE DATABASE; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cruchaga C., 2013, NEURON; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harms M, 2013, JAMA NEUROL, V70, P736, DOI 10.1001/2013.jamaneurol.537; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin SC, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt137; Jonsson T., 2013, N ENGL J MED; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Osisami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033341; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	47	312	324	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					550	+		10.1038/nature12825	http://dx.doi.org/10.1038/nature12825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24336208	Green Accepted			2022-12-28	WOS:000329995000040
J	Stefansson, H; Meyer-Lindenberg, A; Steinberg, S; Magnusdottir, B; Morgen, K; Arnarsdottir, S; Bjornsdottir, G; BragiWalters, G; Jonsdottir, GA; Doyle, OM; Tost, H; Grimm, O; Kristjansdottir, S; Snorrason, H; Davidsdottir, SR; Gudmundsson, LJ; Jonsson, GF; Stefansdottir, B; Helgadottir, I; Haraldsson, M; Jonsdottir, B; Thygesen, JH; Schwarz, AJ; Didriksen, M; Stensbol, TB; Brammer, M; Kapur, S; Halldorsson, JG; Hreidarsson, S; Saemundsen, E; Sigurdsson, E; Stefansson, K				Stefansson, Hreinn; Meyer-Lindenberg, Andreas; Steinberg, Stacy; Magnusdottir, Brynja; Morgen, Katrin; Arnarsdottir, Sunna; Bjornsdottir, Gyda; BragiWalters, G.; Jonsdottir, Gudrun A.; Doyle, Orla M.; Tost, Heike; Grimm, Oliver; Kristjansdottir, Solveig; Snorrason, Heimir; Davidsdottir, Solveig R.; Gudmundsson, Larus J.; Jonsson, Gudbjorn F.; Stefansdottir, Berglind; Helgadottir, Isafold; Haraldsson, Magnus; Jonsdottir, Birna; Thygesen, Johan H.; Schwarz, Adam J.; Didriksen, Michael; Stensbol, Tine B.; Brammer, Michael; Kapur, Shitij; Halldorsson, Jonas G.; Hreidarsson, Stefan; Saemundsen, Evald; Sigurdsson, Engilbert; Stefansson, Kari			CNVs conferring risk of autism or schizophrenia affect cognition in controls	NATURE			English	Article							SPATIAL WORKING-MEMORY; RECURRENT MICRODELETIONS; GLOBAL ASSESSMENT; DEFICITS; 16P11.2; METAANALYSIS; PSYCHOSIS; RELATIVES; 15Q11.2	In a small fraction of patients with schizophrenia or autism, alleles of copy-number variants (CNVs) in their genomes are probably the strongest factors contributing to the pathogenesis of the disease. These CNVs may provide an entry point for investigations into the mechanisms of brain function and dysfunction alike. They are not fully penetrant and offer an opportunity to study their effects separate from that of manifest disease. Here we show in an Icelandic sample that a few of the CNVs clearly alter fecundity (measured as the number of children by age 45). Furthermore, we use various tests of cognitive function to demonstrate that control subjects carrying the CNVs perform at a level that is between that of schizophrenia patients and population controls. The CNVs do not all affect the same cognitive domains, hence the cognitive deficits that drive or accompany the pathogenesis vary from one CNV to another. Controls carrying the chromosome 15q11.2 deletion between breakpoints 1 and 2 (15q11.2(BP1-BP2) deletion) have a history of dyslexia and dyscalculia, even after adjusting for IQ in the analysis, and the CNV only confers modest effects on other cognitive traits. The 15q11.2(BP1-BP2) deletion affects brain structure in a pattern consistent with both that observed during first-episode psychosis in schizophrenia and that of structural correlates in dyslexia.	[Stefansson, Hreinn; Steinberg, Stacy; Arnarsdottir, Sunna; Bjornsdottir, Gyda; BragiWalters, G.; Jonsdottir, Gudrun A.; Kristjansdottir, Solveig; Snorrason, Heimir; Gudmundsson, Larus J.; Jonsson, Gudbjorn F.; Stefansdottir, Berglind; Stefansson, Kari] deCODE Genet Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland; [Meyer-Lindenberg, Andreas; Morgen, Katrin; Tost, Heike; Grimm, Oliver] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Magnusdottir, Brynja; Arnarsdottir, Sunna; Davidsdottir, Solveig R.; Helgadottir, Isafold; Haraldsson, Magnus; Sigurdsson, Engilbert] Natl Univ Hosp Reykjavik, Dept Psychiat, Landspitali, IS-101 Reykjavik, Iceland; [Doyle, Orla M.; Brammer, Michael; Kapur, Shitij] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Haraldsson, Magnus; Halldorsson, Jonas G.; Saemundsen, Evald; Sigurdsson, Engilbert] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonsdottir, Birna] Rontgen Domus, IS-101 Reykjavik, Iceland; [Thygesen, Johan H.] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, DK-4000 Roskilde, Denmark; [Schwarz, Adam J.] Eli Lilly & Co, Tailored Therapeut, Lilly Res Labs, Lilly Corp Ctr DC 1940, Indianapolis, IN 46285 USA; [Didriksen, Michael; Stensbol, Tine B.] H Lundbeck & Co AS, DK-2500 Valby, Denmark; [Hreidarsson, Stefan; Saemundsen, Evald] State Diagnost & Counselling Ctr, IS-200 Kopavogur, Iceland	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of London; King's College London; University of Iceland; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Eli Lilly; Lundbeck Corporation	Stefansson, K (corresponding author), deCODE Genet Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland.	A.Meyer-Lindenberg@zi-mannheim.de; kstefans@decode.is	/ABD-6198-2020; Stefansson, Kari/AAE-7187-2019; Magnusdottir, Brynja/AAH-3482-2019; Sigurdsson, Engilbert/D-2486-2014; Doyle, Orla/B-7839-2012; Tost, med. Dr. phil. Heike/AAX-8305-2020; Walters, G. Bragi/L-4215-2013; Meyer-Lindenberg, Andreas/H-1076-2011	Magnusdottir, Brynja/0000-0002-6131-7269; Sigurdsson, Engilbert/0000-0001-9404-7982; Walters, G. Bragi/0000-0002-5415-6487; Grimm, Oliver/0000-0002-0767-0301; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Thygesen, Johan H/0000-0002-7479-3459; Kapur, Shitij/0000-0002-2231-2924; Stefansson, Hreinn/0000-0002-9331-6666; Doyle, Orla/0000-0002-6964-0140; Bjornsdottir, Gyda/0000-0002-8100-0306	Innovative Medicines Initiative Joint Undertaking [115008]; European Union; EU [PsychDPC (GA 286213)]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0701748] Funding Source: researchfish; MRC [G0701748] Funding Source: UKRI	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EU(European Commission); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to the participants and we thank the research nurses and staff at the Krokhals recruitment centre and roentgentechnicians at Rontgen Domus. We also thank the staff at deCODE genetics core facilities and all our colleagues for their important contribution to this work. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115008 of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EU funded FP7-People-2011-IAPP grant PsychDPC (GA 286213).	Arnone D, 2008, SCHIZOPHR RES, V101, P124, DOI 10.1016/j.schres.2008.01.005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benton AL., 1983, MULTILINGUAL APHASIA; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bjornsdottir G., 2013, J LEARN DISABIL; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; DIORIO D, 1993, J NEUROSCI, V13, P3839; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Feigenbaum JD, 1996, NEUROPSYCHOLOGIA, V34, P163, DOI 10.1016/0028-3932(95)00107-7; Golden C.J., 1978, STROOP COLOR WORD TE; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; HALL RCW, 1995, PSYCHOSOMATICS, V36, P416, DOI 10.1016/S0033-3182(95)71656-5; Haukka J, 2003, AM J PSYCHIAT, V160, P460, DOI 10.1176/appi.ajp.160.3.460; Heaton R.K., 1993, WISCONSIN CARD SORTI; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kirov G., 2013, BIOL PSYCHIAT; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lefly DL, 2000, J LEARN DISABIL-US, V33, P286, DOI 10.1177/002221940003300306; Linkersdorfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043122; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MEINS W, 1995, PSYCHIAT PRAX, V22, P206; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Rund BR, 1998, SCHIZOPHRENIA BULL, V24, P425, DOI 10.1093/oxfordjournals.schbul.a033337; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tan GM, 2009, SCHIZOPHR RES, V115, P173, DOI 10.1016/j.schres.2009.09.010; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; World Health Organization, 2008, ICD 10 INT STAT CLAS	48	433	440	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					361	+		10.1038/nature12818	http://dx.doi.org/10.1038/nature12818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24352232				2022-12-28	WOS:000329621800034
J	Wolfe, SM				Wolfe, Sidney M.			Escalating criminal and civil violations: pharma has corporate integrity? Not really Sidney M Wolfe looks at the system that should, but does not, deter drug companies from breaking the	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC USA.	Swolfe@citizen.org						Almashat S, 2012, PHARM IND CRIMINAL C; [Anonymous], 2012, CNN MONEY; GlaxoSmithKline, ANN REP 2012; US Department of Health and Human Services and Department of Justice, 2004, HLTH CAR FRAUD AB CO; US Department of Justice, 2012, GLAXOSMITHKLINE PLEA; US Department of Justice, 2004, WARN LAMB PAY 430 MI; US Department of Justice, 2002, DRUG GIANT PFIZ 2 SU	7	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2013	347								f7507	10.1136/bmj.f7507	http://dx.doi.org/10.1136/bmj.f7507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MI	24353156				2022-12-28	WOS:000328823300004
J	Kolias, TJ				Kolias, Theodore J.			Dabigatran increased bleeding and stroke compared with warfarin after mechanical heart valve implantation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kolias, TJ (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC6	10.7326/0003-4819-159-12-201312170-02006	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343411				2022-12-28	WOS:000329735300005
J	Barker, D; Barker, M; Fleming, T; Lampl, M				Barker, David; Barker, Mary; Fleming, Tom; Lampl, Michelle			Support mothers to secure future public health	NATURE			English	Editorial Material							CARDIOVASCULAR-DISEASE; WOMEN		[Barker, David; Barker, Mary] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton SO9 5NH, Hants, England; [Barker, David] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA; [Fleming, Tom] Univ Southampton, Ctr Biol Sci, Southampton SO9 5NH, Hants, England; [Lampl, Michelle] Ctr Study Human Hlth, Atlanta, GA USA; [Lampl, Michelle] Emory Univ, Atlanta, GA 30322 USA	University of Southampton; Oregon Health & Science University; University of Southampton; Emory University	Barker, D (corresponding author), Emory Univ, Ctr Study Human Hlth, Atlanta, GA 30322 USA.	meb@mrc.soton.ac.uk	Lampl, Michelle L/B-1619-2013	Barker, Mary/0000-0003-2976-0217	BBSRC [BB/I001840/1, BB/F007450/1] Funding Source: UKRI; MRC [MC_UP_A620_1017, G0100558, MC_UU_12011/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007450/1] Funding Source: Medline; Medical Research Council [MC_UP_A620_1017, MC_UU_12011/4, G0100558] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/I001840/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Barker DJP, 2013, PLACENTA, V34, P841, DOI 10.1016/j.placenta.2013.07.063; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1997, BRIT MED BULL, V53, P96; BARKER DJP, 1989, NATURE, V338, P371, DOI 10.1038/338371a0; Barker M, 2008, PUBLIC HEALTH NUTR, V11, P1229, DOI 10.1017/S136898000800178X; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648	10	60	62	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					209	211		10.1038/504209a	http://dx.doi.org/10.1038/504209a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	267TQ	24350368	Bronze			2022-12-28	WOS:000328121500014
J	Spence, D				Spence, Des			What is the point of doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7380	10.1136/bmj.f7380	http://dx.doi.org/10.1136/bmj.f7380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24327056				2022-12-28	WOS:000328574700010
J	Guo, YM; Li, SS; Tian, ZX; Pan, XC; Zhang, JL; Williams, G				Guo, Yuming; Li, Shanshan; Tian, Zhaoxing; Pan, Xiaochuan; Zhang, Jinliang; Williams, Gail			The burden of air pollution on years of life lost in Beijing, China, 2004-08: retrospective regression analysis of daily deaths	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY-ROOM VISITS; DAILY MORTALITY; TIME-SERIES; FINE; AGE; ASSOCIATION; DISEASE; CITIES; SEX	Objectives To better understand the burden of air pollution on deaths, we examined the effects of air pollutants on years of life lost (YLL) in Beijing, China. Design Retrospective regression analysis using daily time series. Setting 8 urban districts in Beijing, China. Participants 80 515 deaths (48 802 male, 31 713 female) recorded by the Beijing death classification system during 2004-08. Main outcome measures Associations between daily YLL and ambient air pollutants (particulate matter with aerodynamic diameter < 2.5 mu m (PM2.5), PM10, SO2, and NO2), after adjusting for long term trends, seasonality, day of the week, and weather conditions. We also examined mortality risk related to air pollutants. Results Mean concentrations of daily PM2.5, PM10, SO2 and NO2 were 105.1 mu g/m(3), 144.6 mu g/m(3), 48.6 mu g/m(3), and 64.2 mu g/m(3), respectively. All air pollutants had significant effects on years of life lost when we used single pollutant models. An interquartile range (IQR) increase in PM2.5, PM10, SO2, and NO2 was related to YLL increases of 15.8, 15.8, 16.2, and 15.1 years, respectively. The effects of air pollutants on YLL appeared acutely and lasted for two days (lag 0-1); these effects associated with an IQR increase in PM2.5 were greater in women than men (11.1 (95% confidence interval 4.7 to 17.5) v 4.7 (-2.9 to 12.3) YLL) and in people aged up to 65 years than those older than 65 years (12.0 (2.9 to 21) v 3.8 (-0.9 to 8.6) YLL). The mortality risk associated with an IQR increase in PM2.5 was greater for people older than 65 years (2.5% (95% confidence interval 0.6% to 4.5%) increase of mortality) than those aged up to 65 years (0.7% (-0.8% to 2.2%)). Conclusions YLL provides a complementary measure for examining the effect of air pollutants on mortality. Increased YLL are associated with increased air pollution. This study highlights the need to reduce air pollution in Beijing, China, to protect the health of the population.	[Guo, Yuming; Li, Shanshan; Williams, Gail] Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld 4006, Australia; [Tian, Zhaoxing] Peking Univ, Hosp 3, Emergency Dept, Beijing 100191, Peoples R China; [Pan, Xiaochuan] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100871, Peoples R China; [Zhang, Jinliang] Chinese Res Inst Environm Sci, Environm Stand Inst, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	University of Queensland; Peking University; Peking University; Chinese Research Academy of Environmental Sciences	Guo, YM (corresponding author), Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	y.guo1@uq.edu.au; tjtzx@126.com	Williams, Gail/S-8833-2019; Guo, Yuming/I-8353-2018	Williams, Gail/0000-0002-4822-5263; Guo, Yuming/0000-0002-1766-6592; Li, Shanshan/0000-0002-9021-8470	National Natural Science Foundation of China [81172745]; Australia National Health and Medical Research Council [APP1030259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by the National Natural Science Foundation of China (# 81172745), and the Australia National Health and Medical Research Council (# APP1030259).	Anderson HR, 1996, BMJ-BRIT MED J, V312, P665; [Anonymous], 2010, R LANG ENV STAT COMP; Bell ML, 2004, ANNU REV PUBL HEALTH, V25, P247, DOI 10.1146/annurev.publhealth.25.102802.124329; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Chen RJ, 2012, ENVIRON RES, V118, P101, DOI 10.1016/j.envres.2012.07.003; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Davis MC, 1999, ANN BEHAV MED, V21, P83, DOI 10.1007/BF02895038; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Guo YM, 2009, SCI TOTAL ENVIRON, V407, P4826, DOI 10.1016/j.scitotenv.2009.05.022; Johnston FH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8446; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu LQ, 2013, ENVIRON RES, V121, P52, DOI 10.1016/j.envres.2012.10.009; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Qiu H, 2013, ATMOS ENVIRON, V64, P296, DOI 10.1016/j.atmosenv.2012.09.060; Roosli M, 2005, INT J EPIDEMIOL, V34, P1029, DOI 10.1093/ije/dyi106; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; WEHNER B, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/2004GL021596; Wen M, 2007, J GEN INTERN MED, V22, P1674, DOI 10.1007/s11606-007-0400-4; WHO, 2006, INDIAN J MED RES; World Health Organization, 2010, LIF TABL WHO MEMB ST; Yue D, 2009, J GEOPHYS RES, V114, P1; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712	31	163	171	8	95	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7139	10.1136/bmj.f7139	http://dx.doi.org/10.1136/bmj.f7139			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZI	24322399	Green Published, hybrid			2022-12-28	WOS:000328574400006
J	Jessup, S				Jessup, Stuart			Patient perspective: mild depression must not be ignored	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stuart.jessup@hotmail.co.uk						Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Wiles N, 2013, LANCET, V381, P375, DOI 10.1016/S0140-6736(12)61552-9	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7225	10.1136/bmj.f7225	http://dx.doi.org/10.1136/bmj.f7225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZI	24322401				2022-12-28	WOS:000328574400010
J	Wang, KL; Kinoshita, M				Wang, Kelin; Kinoshita, Masataka			Dangers of Being Thin and Weak	SCIENCE			English	Editorial Material							TOHOKU; STRESS; FAULTS		[Wang, Kelin] Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; [Kinoshita, Masataka] JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Wang, KL (corresponding author), Nat Resources Canada, Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada.	kelin.wang@nrcan-rncan.gc.ca		Kinoshita, Masataka/0000-0003-1144-3651				Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Hasegawa A, 2012, EARTH PLANET SC LETT, V355, P231, DOI 10.1016/j.epsl.2012.08.042; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Hu Y, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005724; Kozdon JE, 2013, B SEISMOL SOC AM, V103, P1275, DOI 10.1785/0120120136; Lin WR, 2013, SCIENCE, V339, P687, DOI 10.1126/science.1229379; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Obana K, 2013, EARTH PLANET SC LETT, V382, P111, DOI 10.1016/j.epsl.2013.09.007; Rowe CD, 2013, GEOLOGY, V41, P991, DOI 10.1130/G34556.1; Shipton ZK, 2006, GEOPHYS MONOGR SER, V170, P217, DOI 10.1029/170GM22; Ujiie K, 2013, SCIENCE, V342, P1211, DOI 10.1126/science.1243485; Wang KL, 1999, GEOPHYS RES LETT, V26, P2307, DOI 10.1029/1999GL900528	14	9	10	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1178	1180		10.1126/science.1246518	http://dx.doi.org/10.1126/science.1246518			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311671				2022-12-28	WOS:000327857900026
J	Catic, A; Suh, CY; Hill, CT; Daheron, L; Henkel, T; Orford, KW; Dombkowski, DM; Liu, T; Liu, XS; Scadden, DT				Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Daheron, Laurence; Henkel, Theresa; Orford, Keith W.; Dombkowski, David M.; Liu, Tao; Liu, X. Shirley; Scadden, David T.			Genome-wide Map of Nuclear Protein Degradation Shows NCoR1 Turnover as a Key to Mitochondrial Gene Regulation	CELL			English	Article							TRANSCRIPTIONAL ACTIVATION; LIGASE SIAH2; CREB; PROTEOLYSIS; REPRESSION; HYPOXIA; ADIPOGENESIS; EXPRESSION; RECEPTORS; CHROMATIN	Transcription factor activity and turnover are functionally linked, but the global patterns by which DNA-bound regulators are eliminated remain poorly understood. We established an assay to define the chromosomal location of DNA-associated proteins that are slated for degradation by the ubiquitin-proteasome system. The genome-wide map described here ties proteolysis in mammalian cells to active enhancers and to promoters of specific gene families. Nuclear-encoded mitochondrial genes in particular correlate with protein elimination, which positively affects their transcription. We show that the nuclear receptor corepressor NCoR1 is a key target of proteolysis and physically interacts with the transcription factor CREB. Proteasome inhibition stabilizes NCoR1 in a site-specific manner and restrains mitochondrial activity by repressing CREB-sensitive genes. In conclusion, this functional map of nuclear proteolysis links chromatin architecture with local protein stability and identifies proteolytic derepression as highly dynamic in regulating the transcription of genes involved in energy metabolism.	[Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Henkel, Theresa; Orford, Keith W.; Dombkowski, David M.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Daheron, Laurence; Henkel, Theresa; Orford, Keith W.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Catic, Andre; Daheron, Laurence; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Henkel, Theresa] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Dombkowski, David M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Catic, A (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	catic@post.harvard.edu; david_scadden@harvard.edu	Liu, Tao/AAO-6310-2021; Liu, Tao/G-3585-2010	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0003-0446-9001; Catic, Andre/0000-0002-3572-7598	Margaret Dammann Eisner Foundation; National Institute on Aging [K01-AG036744]; NIH [DK050234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG036744] Funding Source: NIH RePORTER	Margaret Dammann Eisner Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Carlota Dao, Laura Prickett-Rice, Kat Folz-Donahue, Meredith Weglarz, Katherine Kulig, Christa Buecker, Hsu-Hsin Chen, Mark Borowsky, Caroline Woo, Youn-Kyoung Lee, Alison Brown, and Vance Morgan for support. T.H. is a fellow of the German National Academic Foundation. A.C. appreciates mentorship by Daniel Finley, Robert Kingston, Derrick Rossi, and Ron Kohanski (NIH/NIA). A.C. is an Irvington Fellow of the Cancer Research Institute and is supported by the Margaret Dammann Eisner Foundation and by National Institute on Aging grant K01-AG036744. D.T.S. is supported by NIH grant DK050234. We thank the reviewers for constructive suggestions and apologize for references we could not include.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriegenburg F, 2008, CELL, V135, P355, DOI 10.1016/j.cell.2008.08.032; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rubenstein EM, 2010, CELL CYCLE, V9, P4282, DOI 10.4161/cc.9.21.13741; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	38	38	38	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1380	1395		10.1016/j.cell.2013.11.016	http://dx.doi.org/10.1016/j.cell.2013.11.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315104	Green Accepted, Bronze			2022-12-28	WOS:000328271100020
J	Caudron, F; Barral, Y				Caudron, Fabrice; Barral, Yves			A Super-Assembly of Whi3 Encodes Memory of Deceptive Encounters by Single Cells during Yeast Courtship	CELL			English	Article							ALPHA-FACTOR PHEROMONE; SACCHAROMYCES-CEREVISIAE; MATING PHEROMONE; MAPK PATHWAYS; APLYSIA CPEB; G1 CYCLINS; PRION; GENE; PROTEINS; RNA	Cellular behavior is frequently influenced by the cell's history, indicating that single cells may memorize past events. We report that budding yeast permanently escape pheromone-induced cell-cycle arrest when experiencing a deceptive mating attempt, i.e., not reaching their putative partner within reasonable time. This acquired behavior depends on super-assembly and inactivation of the G1/S inhibitor Whi3, which liberates the G1 cyclin Cln3 from translational inhibition. Super-assembly of Whi3 is a slow response to pheromone, driven by polyQ and polyN domains, counteracted by Hsp70, and stable over generations. Unlike prion aggregates, Whi3 super-assemblies are not inherited mitotically but segregate to the mother cell. We propose that such polyQ- and polyN-based elements, termed here mnemons, act as cellular memory devices to encode previous environmental conditions.	[Caudron, Fabrice; Barral, Yves] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Caudron, Fabrice/AAE-3039-2021	Caudron, Fabrice/0000-0001-5159-1507; Barral, Yves/0000-0002-0989-3373	European Research Council	European Research Council(European Research Council (ERC)European Commission)	We would like to thank R. Dechant and M. Peter for help with cell-size measurements; M. Bayer for the 3GFP construct; B. Futcher, E. Gari, and B. Errede for strains and plasmids; the Light Microscopy and Screening Center of ETH Zurich for microscopy support; U. Kutay, P. Meraldi, R. Kroschewski, C. Weirich, and A.M. Farcas for critical reading of the manuscript; and S. Alberti, P. Picotti, Y. Feng, M. Krzyzanowski, and the whole Barral group for discussions. F.C. and Y.B. are supported by a grant of the European Research Council to Y.B.	ACHSTETTER T, 1989, MOL CELL BIOL, V9, P4507, DOI 10.1128/MCB.9.10.4507; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arkowitz RA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001958; Blackwell E, 2003, MOL CELL BIOL, V23, P1135, DOI 10.1128/MCB.23.4.1135-1150.2003; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Dohlman HG, 2009, PROG MOL BIOL TRANSL, V86, P1, DOI 10.1016/S1877-1173(09)86001-8; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Erdman S, 2001, GENETICS, V159, P919; Gari E, 2001, GENE DEV, V15, P2803; Guthrie C., 2004, GUIDE YEAST GENETICS, P933; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HAGEN DC, 1986, P NATL ACAD SCI USA, V83, P1418, DOI 10.1073/pnas.83.5.1418; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; Jin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001763; Kabani M, 2011, PRION, V5, P277, DOI [10.4161/pri.5.4.18070, 10.4161/pri.18070]; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kilian AE, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P296; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; MOORE SA, 1984, J BIOL CHEM, V259, P1004; Nash RS, 2001, GENETICS, V157, P1469; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; STRAZDIS JR, 1983, NATURE, V305, P543, DOI 10.1038/305543a0; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568	51	98	99	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1244	1257		10.1016/j.cell.2013.10.046	http://dx.doi.org/10.1016/j.cell.2013.10.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315096	Bronze			2022-12-28	WOS:000328271100010
J	Elia, N; Ott, C; Lippincott-Schwartz, J				Elia, Natalie; Ott, Carolyn; Lippincott-Schwartz, Jennifer			Incisive Imaging and Computation for Cellular Mysteries: Lessons from Abscission	CELL			English	Review							STRUCTURED ILLUMINATION MICROSCOPY; ESCRT-III; FLUORESCENCE MICROSCOPY; PERICENTRIOLAR MATERIAL; CYTOKINETIC ABSCISSION; INTERCELLULAR BRIDGE; MAMMALIAN-CELLS; FINAL STAGES; MIDBODY; RESOLUTION	The final cleavage event that terminates cell division, abscission of the small, dense intercellular bridge, has been particularly challenging to resolve. Here, we describe imaging innovations that helped answer long-standing questions about the mechanism of abscission. We further explain how computational modeling of high-resolution data was employed to test hypotheses and generate additional insights. We present the model that emerges from application of these complimentary approaches. Similar experimental strategies will undoubtedly reveal exciting details about other underresolved cellular structures.	[Elia, Natalie] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Elia, Natalie] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel; [Ott, Carolyn; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Ben Gurion University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Elia, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	elianat@post.bgu.ac.il; jlippin@helix.nih.gov			Marie Curie Intergration grant (CIG); Israel Science foundadtion (ISF); EU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER	Marie Curie Intergration grant (CIG); Israel Science foundadtion (ISF); EU(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Erin Fincher and Nicole Jonas from the NICHD Unit on Computer Support Services for creating the graphics used in the figures. We also thank Christian Hellriegel (Zeiss), and members of the Lippincott-Schwartz laboratory, Schuyler VanEngelenberg, Prabuddha Sengupta, Angelika Rambold, and Bennet Waxse for helpful comments on the text. N.E. is supported by the Marie Curie Intergration grant (CIG), EU and by the Israel Science foundadtion (ISF).	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Capalbo L, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120070; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Dobro MJ, 2013, MOL BIOL CELL, V24, P2319, DOI 10.1091/mbc.E12-11-0785; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Echard A, 2012, CYTOSKELETON, V69, P893, DOI 10.1002/cm.21067; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Elad N, 2011, J CELL SCI, V124, P207, DOI 10.1242/jcs.073486; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Fridman K, 2012, NAT REV MOL CELL BIO, V13, P736, DOI 10.1038/nrm3453; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hadders MA, 2012, P NATL ACAD SCI USA, V109, P17424, DOI 10.1073/pnas.1206839109; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Lafaurie-Janvore J, 2013, SCIENCE, V339, P1625, DOI 10.1126/science.1233866; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lekomtsev S, 2012, NATURE, V492, P276, DOI 10.1038/nature11773; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Luders J, 2012, NAT CELL BIOL, V14, P1126, DOI 10.1038/ncb2617; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; MULLINS JM, 1973, TISSUE CELL, V5, P47, DOI 10.1016/S0040-8166(73)80005-9; Neto H, 2013, MOL BIOL CELL, V24, P3663, DOI 10.1091/mbc.E13-06-0302; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Patterson GH, 2009, SEMIN CELL DEV BIOL, V20, P886, DOI 10.1016/j.semcdb.2009.08.006; Pe'er T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057532; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Schiel JA, 2010, THESCIENTIFICWORLDJO, V10, P1424, DOI 10.1100/tsw.2010.129; Sengupta P, 2012, DEV CELL, V23, P1092, DOI 10.1016/j.devcel.2012.09.022; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Stehbens S, 2012, METHOD ENZYMOL, V504, P293, DOI 10.1016/B978-0-12-391857-4.00015-X; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/NMETH.2025, 10.1038/nmeth.2025]; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	65	31	31	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1220	1231		10.1016/j.cell.2013.11.011	http://dx.doi.org/10.1016/j.cell.2013.11.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315094	Bronze, Green Accepted			2022-12-28	WOS:000328271100008
J	Phillips, R				Phillips, Rob			The Feynman Lectures on Physics	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Phillips, R (corresponding author), CALTECH, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu							0	5	5	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					30	31		10.1038/504030a	http://dx.doi.org/10.1038/504030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264BK	24305137	Bronze			2022-12-28	WOS:000327851700014
J	Marsh, K; Snow, RW				Marsh, K; Snow, RW			30 years of science and technology: The example of malaria	LANCET			English	Article									JOHN RADCLIFFE HOSP, NUFFIELD DEPT MED, OXFORD OX3 9DU, ENGLAND; KEMRI, WELLCOME TRUST COLLABORAT PROGRAMME, NAIROBI, KENYA	University of Oxford	Marsh, K (corresponding author), KEMRI, CRC, KILIFI UNIT, POB 230, KILIFI, KENYA.		Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [033340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON J, 1996, 7 PRISM WELLC TRUST; BERENDT AR, 1994, PARASITOLOGY, V108, pS19, DOI 10.1017/S0031182000075685; Butler D, 1997, NATURE, V386, P535, DOI 10.1038/42306; Clark I A, 1992, Immunol Ser, V56, P365; CRAMPTON JM, 1994, ADV PARASIT, V34, P1, DOI 10.1016/S0065-308X(08)60135-9; ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0; Marsh K, 1996, ANN TROP MED PARASIT, V90, P395, DOI 10.1080/00034983.1996.11813068; PATARROYO ME, 1988, NATURE, V332, P158, DOI 10.1038/332158a0; Plowe CV, 1995, ADV EXP MED BIOL, V390, P197; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weatherall DJ, 1996, CIBA F SYMP, V197, P300; [No title captured]	15	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN	1997	349			3			1	2						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG041	24293742				2022-12-28	WOS:A1997XG04100002
J	van Bon, L; Affandi, AJ; Broen, J; Christmann, RB; Marijnissen, RJ; Stawski, L; Farina, GA; Stifano, G; Mathes, AL; Cossu, M; York, M; Collins, C; Wenink, M; Huijbens, R; Hesselstrand, R; Saxne, T; DiMarzio, M; Wuttge, D; Agarwal, SK; Reveille, JD; Assassi, S; Mayes, M; Deng, Y; Drenth, JPH; de Graaf, J; den Heijer, M; Kallenberg, CGM; Bijl, M; Loof, A; van den Berg, WB; Joosten, LAB; Smith, V; de Keyser, F; Scorza, R; Lunardi, C; van Riel, PLCM; Vonk, M; van Heerde, W; Meller, S; Homey, B; Beretta, L; Roest, M; Trojanowska, M; Lafyatis, R; Radstake, TRDJ				van Bon, L.; Affandi, A. J.; Broen, J.; Christmann, R. B.; Marijnissen, R. J.; Stawski, L.; Farina, G. A.; Stifano, G.; Mathes, A. L.; Cossu, M.; York, M.; Collins, C.; Wenink, M.; Huijbens, R.; Hesselstrand, R.; Saxne, T.; DiMarzio, M.; Wuttge, D.; Agarwal, S. K.; Reveille, J. D.; Assassi, S.; Mayes, M.; Deng, Y.; Drenth, J. P. H.; de Graaf, J.; den Heijer, M.; Kallenberg, C. G. M.; Bijl, M.; Loof, A.; van den Berg, W. B.; Joosten, L. A. B.; Smith, V.; de Keyser, F.; Scorza, R.; Lunardi, C.; van Riel, P. L. C. M.; Vonk, M.; van Heerde, W.; Meller, S.; Homey, B.; Beretta, L.; Roest, M.; Trojanowska, M.; Lafyatis, R.; Radstake, T. R. D. J.			Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUPUS-ERYTHEMATOSUS; REVISED CRITERIA; SCLERODERMA SKIN; I INTERFERONS; DISEASE; CELLS; PLATELET-FACTOR-4; CLASSIFICATION; ASSOCIATION; ACTIVATION	BackgroundPlasmacytoid dendritic cells have been implicated in the pathogenesis of systemic sclerosis through mechanisms beyond the previously suggested production of type I interferon. MethodsWe isolated plasmacytoid dendritic cells from healthy persons and from patients with systemic sclerosis who had distinct clinical phenotypes. We then performed proteome-wide analysis and validated these observations in five large cohorts of patients with systemic sclerosis. Next, we compared the results with those in patients with systemic lupus erythematosus, ankylosing spondylitis, and hepatic fibrosis. We correlated plasma levels of CXCL4 protein with features of systemic sclerosis and studied the direct effects of CXCL4 in vitro and in vivo. ResultsProteome-wide analysis and validation showed that CXCL4 is the predominant protein secreted by plasmacytoid dendritic cells in systemic sclerosis, both in circulation and in skin. The mean (SD) level of CXCL4 in patients with systemic sclerosis was 25,6242652 pg per milliliter, which was significantly higher than the level in controls (92.577.9 pg per milliliter) and than the level in patients with systemic lupus erythematosus (1346 +/- 1011 pg per milliliter), ankylosing spondylitis (1368 +/- 1162 pg per milliliter), or liver fibrosis (1668 +/- 1263 pg per milliliter). CXCL4 levels correlated with skin and lung fibrosis and with pulmonary arterial hypertension. Among chemokines, only CXCL4 predicted the risk and progression of systemic sclerosis. In vitro, CXCL4 down-regulated expression of transcription factor FLI1, induced markers of endothelial-cell activation, and potentiated responses of toll-like receptors. In vivo, CXCL4 induced the influx of inflammatory cells and skin transcriptome changes, as in systemic sclerosis. ConclusionsLevels of CXCL4 were elevated in patients with systemic sclerosis and correlated with the presence and progression of complications, such as lung fibrosis and pulmonary arterial hypertension. (Funded by the Dutch Arthritis Association and others.)	[van Bon, L.; Affandi, A. J.; Broen, J.; Christmann, R. B.; Stawski, L.; Farina, G. A.; Stifano, G.; Mathes, A. L.; York, M.; Collins, C.; DiMarzio, M.; Trojanowska, M.; Lafyatis, R.; Radstake, T. R. D. J.] Boston Univ Sch, Arthrit Ctr, Boston, MA USA; [Deng, Y.] Boston Univ Sch, Flow Cytometry Core Facil, Boston, MA USA; [van Bon, L.; Affandi, A. J.; Broen, J.; Marijnissen, R. J.; Cossu, M.; Wenink, M.; Huijbens, R.; van den Berg, W. B.; Radstake, T. R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Rheumatol, Utrecht, Netherlands; [van Bon, L.; Affandi, A. J.; Broen, J.; Marijnissen, R. J.; Cossu, M.; Wenink, M.; Huijbens, R.; van den Berg, W. B.; Radstake, T. R. D. J.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Roest, M.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Res Lab, Utrecht, Netherlands; [Drenth, J. P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [de Graaf, J.; Joosten, L. A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [den Heijer, M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Loof, A.; van Heerde, W.] Radboud Univ Nijmegen, Med Ctr, Cent Hematol Lab, NL-6525 ED Nijmegen, Netherlands; [van Riel, P. L. C. M.; Vonk, M.] Univ Med Ctr Nijmegen, Dept Rheumatol, Nijmegen, Netherlands; [Kallenberg, C. G. M.; Bijl, M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Cossu, M.; Scorza, R.; Beretta, L.] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Referral Ctr System Autoimmune Dis, Milan, Italy; [Lunardi, C.] Univ Verona, I-37100 Verona, Italy; [Hesselstrand, R.; Saxne, T.; Wuttge, D.] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; [Agarwal, S. K.; Reveille, J. D.; Assassi, S.; Mayes, M.] Univ Texas Hlth Sci Ctr Houston, Div Rheumatol, Dept Internal Med, Houston, TX 77030 USA; [Smith, V.; de Keyser, F.] Ghent Univ Hosp, Ghent, Belgium; [Meller, S.; Homey, B.] Univ Dusseldorf, Dept Dermatol, Dusseldorf, Germany	Boston University; Boston University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Verona; Lund University; Skane University Hospital; University of Texas System; University of Texas Health Science Center Houston; Ghent University; Ghent University Hospital; Heinrich Heine University Dusseldorf	Radstake, TRDJ (corresponding author), Univ Med Ctr Utrecht, Lab Translat Immunol, Dept Rheumatol & Clin Immunol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	t.r.d.j.radstake@umcutrecht.nl	de Graaf, J./H-8038-2014; Joosten, Leo AB/H-3138-2015; Meller, Stephan/GYA-5568-2022; den Heijer, Martin/J-8036-2015; van Heerde, Waander/L-4357-2015; Vonk, M.C./L-4726-2015; Drenth, J.P.H./H-8025-2014; Farina, Giuseppina/B-1800-2019; Drenth, Joost/V-7436-2019; van Riel, P.L.C.M./H-8082-2014; Beretta, Lorenzo/AAB-8605-2019; van den Berg, W.B./H-8010-2014; Marijnissen, Renoud/M-5541-2013	Joosten, Leo AB/0000-0001-6166-9830; den Heijer, Martin/0000-0003-3620-5617; van Heerde, Waander/0000-0001-7101-8775; Vonk, M.C./0000-0002-2266-9907; Farina, Giuseppina/0000-0002-3948-6920; Beretta, Lorenzo/0000-0002-6529-6258; Marijnissen, Renoud/0000-0002-6836-675X; Affandi, Alsya/0000-0003-0859-2322	Dutch Arthritis Association; Netherlands Organization for Scientific Research; Niels Stensen Foundation; European Research Council; European Community's FP6; National Institute of Arthritis and Musculoskeletal and Skin Diseases [IP50AR060780]; German Research Foundation; European Union; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062721, P30AR061271, K23AR061436, R01AR042334, T32AR007598, P50AR060780, R01AR055258, R01AR051089] Funding Source: NIH RePORTER	Dutch Arthritis Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Niels Stensen Foundation; European Research Council(European Research Council (ERC)European Commission); European Community's FP6(European Commission); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by awards from the Dutch Arthritis Association (to Dr. Radstake), the Netherlands Organization for Scientific Research (to Drs. Radstake and Affandi), the Niels Stensen Foundation (to Dr. Radstake), the European Research Council (to Dr. Radstake), the European Community's FP6 (to Drs. Hesselstrand and Saxne), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant no. IP50AR060780, to Dr. Lafyatis), and the German Research Foundation and the European Union (to Dr. Homey).	Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Antonelli A, 2008, RHEUMATOLOGY, V47, P45, DOI 10.1093/rheumatology/kem313; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Distler O, 1999, RHEUMATOL INT, V19, P39, DOI 10.1007/s002960050098; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Farina G, 2011, ANN RHEUM DIS, V70, P544, DOI 10.1136/ard.2010.132464; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Gourh P, 2009, ARTHRITIS RHEUM-US, V60, P3794, DOI 10.1002/art.24958; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; Hasegawa M, 2011, CLIN RHEUMATOL, V30, P231, DOI 10.1007/s10067-010-1610-4; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Holewijn S, 2009, J CLIN ENDOCR METAB, V94, P2893, DOI 10.1210/jc.2009-0084; KAHALEH MB, 1981, ANN INTERN MED, V94, P482, DOI 10.7326/0003-4819-94-4-482; Kim D, 2008, ARTHRITIS RHEUM-US, V58, P2163, DOI 10.1002/art.23486; Kodera M, 2005, ARTHRITIS RHEUM-US, V52, P2889, DOI 10.1002/art.21257; Kowal-Bielecka O, 2005, ANN RHEUM DIS, V64, P484, DOI 10.1136/ard.2004.022970; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Lafyatis R, 2009, CURR OPIN RHEUMATOL, V21, P617, DOI 10.1097/BOR.0b013e32832fd69e; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1972, J EXP MED, V135, P1351, DOI 10.1084/jem.135.6.1351; Liu CY, 2005, J IMMUNOL, V174, P2680, DOI 10.4049/jimmunol.174.5.2680; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005981; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Romagnani P, 2005, J ALLERGY CLIN IMMUN, V116, P1372, DOI 10.1016/j.jaci.2005.09.035; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Scheja A, 2001, ARTHRITIS RES, V3, P178, DOI 10.1186/ar295; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; vanderHeijde D, 1997, J RHEUMATOL, V24, P2225; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435	39	275	278	8	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2014	370	5					433	443		10.1056/NEJMoa1114576	http://dx.doi.org/10.1056/NEJMoa1114576			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303AA	24350901	Green Accepted, Green Published			2022-12-28	WOS:000330645400008
J	Comin, R; Frano, A; Yee, MM; Yoshida, Y; Eisaki, H; Schierle, E; Weschke, E; Sutarto, R; He, F; Soumyanarayanan, A; He, Y; Le Tacon, M; Elfimov, IS; Hoffman, JE; Sawatzky, GA; Keimer, B; Damascelli, A				Comin, R.; Frano, A.; Yee, M. M.; Yoshida, Y.; Eisaki, H.; Schierle, E.; Weschke, E.; Sutarto, R.; He, F.; Soumyanarayanan, A.; He, Yang; Le Tacon, M.; Elfimov, I. S.; Hoffman, Jennifer E.; Sawatzky, G. A.; Keimer, B.; Damascelli, A.			Charge Order Driven by Fermi-Arc Instability in Bi2Sr2-xLaxCuO6+delta	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTOR; QUASI-PARTICLE STATES; T-C SUPERCONDUCTOR; PSEUDOGAP STATE; BI2SR2CACU2O8+DELTA; CA2-XNAXCUO2CL2; BREAKING; SYMMETRY	The understanding of the origin of superconductivity in cuprates has been hindered by the apparent diversity of intertwining electronic orders in these materials. We combined resonant x-ray scattering (REXS), scanning-tunneling microscopy (STM), and angle-resolved photoemission spectroscopy (ARPES) to observe a charge order that appears consistently in surface and bulk, and in momentum and real space within one cuprate family, Bi2Sr2-xLaxCuO6+delta. The observed wave vectors rule out simple antinodal nesting in the single-particle limit but match well with a phenomenological model of a many-body instability of the Fermi arcs. Combined with earlier observations of electronic order in other cuprate families, these findings suggest the existence of a generic charge-ordered state in underdoped cuprates and uncover its intimate connection to the pseudogap regime.	[Comin, R.; Elfimov, I. S.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Frano, A.; Le Tacon, M.; Keimer, B.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Frano, A.; Schierle, E.; Weschke, E.] Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany; [Yee, M. M.; Soumyanarayanan, A.; He, Yang; Hoffman, Jennifer E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Yoshida, Y.; Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Sutarto, R.; He, F.] Univ Saskatchewan, Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Elfimov, I. S.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Harvard University; National Institute of Advanced Industrial Science & Technology (AIST); University of Saskatchewan; University of British Columbia	Damascelli, A (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	damascelli@physics.ubc.ca	Comin, Riccardo/H-7731-2016; He, Feizhou/G-8493-2015; He, Yang/E-7772-2015; , Le Tacon Matthieu/D-8023-2011; damascelli, andrea/P-6329-2014; Yoshida, Yoshiyuki/L-6221-2018; Soumyanarayanan, Anjan/C-9023-2013; Eisaki, Hiroshi/F-6317-2018; Hoffman, Jennifer E/H-4334-2011; Weschke, Eugen/J-4404-2013; Schierle, Enrico/J-4356-2013	Comin, Riccardo/0000-0002-1069-9973; He, Feizhou/0000-0002-3125-1406; , Le Tacon Matthieu/0000-0002-5838-3724; damascelli, andrea/0000-0001-9895-2226; Yoshida, Yoshiyuki/0000-0001-7998-1873; Soumyanarayanan, Anjan/0000-0003-2680-6005; Eisaki, Hiroshi/0000-0002-8299-6416; Hoffman, Jennifer E/0000-0003-2752-5379; Weschke, Eugen/0000-0002-2141-0944; Keimer, Bernhard/0000-0001-5220-9023; Schierle, Enrico/0000-0002-6981-2301	Max Planck-UBC Centre for Quantum Materials; Killam, Alfred P. Sloan, Alexander von Humboldt; National Sciences and Engineering Research Council (NSERC)'s Steacie Memorial Fellowships; Canada Research Chairs Program; NSERC; Canada Foundation for Innovation (CFI); Canadian Institute for Advanced Research Quantum Materials; U.S. NSF [DMR-0847433]; A*STAR fellowship; CFI; National Research Council; Canadian Institute for Health Research; Government of Saskatchewan; WD Canada; University of Saskatchewan; Direct For Mathematical & Physical Scien [0847433] Funding Source: National Science Foundation	Max Planck-UBC Centre for Quantum Materials; Killam, Alfred P. Sloan, Alexander von Humboldt; National Sciences and Engineering Research Council (NSERC)'s Steacie Memorial Fellowships; Canada Research Chairs Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institute for Advanced Research Quantum Materials; U.S. NSF(National Science Foundation (NSF)); A*STAR fellowship(Agency for Science Technology & Research (A*STAR)); CFI(Canada Foundation for Innovation); National Research Council; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Government of Saskatchewan; WD Canada; University of Saskatchewan; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge S. A. Kivelson, A.-M. Tremblay, S. Sachdev, E. H. da Silva Neto, and A. Yazdani for discussions. This work was supported by the Max Planck-UBC Centre for Quantum Materials, the Killam, Alfred P. Sloan, Alexander von Humboldt, and National Sciences and Engineering Research Council (NSERC)'s Steacie Memorial Fellowships (A. D.), the Canada Research Chairs Program (A. D., G. A. S.), NSERC, Canada Foundation for Innovation (CFI), and Canadian Institute for Advanced Research Quantum Materials. J.E.H. acknowledges support from the U.S. NSF grant DMR-0847433. A. S. was funded by the A*STAR fellowship. M.M.Y. was funded by an NSERC fellowship. Part of the research described in this paper was performed at the Canadian Light Source, which is funded by the CFI, NSERC, National Research Council, Canadian Institute for Health Research, the Government of Saskatchewan, WD Canada, and the University of Saskatchewan.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Ando Y, 2000, PHYS REV B, V61, P14956, DOI 10.1103/PhysRevB.61.R14956; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Bonn DA, 2006, NAT PHYS, V2, P159, DOI 10.1038/nphys248; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Dean MPM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.147001; Eder R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205137; Fournier D, 2010, NAT PHYS, V6, P905, DOI [10.1038/NPHYS1763, 10.1038/nphys1763]; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Hashimoto M, 2010, NAT PHYS, V6, P414, DOI 10.1038/NPHYS1632; He RH, 2011, SCIENCE, V331, P1579, DOI 10.1126/science.1198415; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Inosov DS, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.172505; James AJA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100508; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kawasaki S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.137002; King PDC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.127005; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; Robertson JA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134507; Rosen JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2977; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501; Zimmermann M., 1998, EPL-EUROPHYS LETT, V41, P629	34	440	444	10	366	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					390	392		10.1126/science.1242996	http://dx.doi.org/10.1126/science.1242996			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24356115	Green Submitted			2022-12-28	WOS:000330039300040
J	Dolgin, E				Dolgin, Elie			CANCER VACCINES Material breach	NATURE			English	Editorial Material																		Ali OA, 2011, PHARM RES-DORDR, V28, P1074, DOI 10.1007/s11095-010-0361-x; Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Kwong B, 2013, CANCER RES, V73, P1547, DOI 10.1158/0008-5472.CAN-12-3343; Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]; Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008; Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003	7	6	6	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S16	S17		10.1038/504S16a	http://dx.doi.org/10.1038/504S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352360				2022-12-28	WOS:000328575300008
J	Roh, EK; Vleugels, RA; Hoang, MP				Roh, Ellen K.; Vleugels, Ruth Ann; Hoang, Mai P.			Case 39-2013: A 57-Year-Old Woman with Painful Bullous Skin Lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PEMPHIGUS ERYTHEMATOSUS; CLINICAL-FEATURES; DIAGNOSIS; FOLIACEUS; VULGARIS	A 57-year-old woman was admitted to the hospital because of a 19-month history of recurrent painful bullous and erosive skin lesions. Multiple skin-biopsy specimens had yielded diverse diagnoses. A diagnostic procedure was performed. Presentation of CaseDr. Amir Aboutalebi (Dermatology): A 57-year-old woman was admitted to this hospital because of recurrent painful bullous and erosive skin lesions. Approximately 19 months before admission, 1 week after the patient had begun taking citalopram, the development of oral erosions, tongue swelling, and urticarial lesions, approximately 1 cm in diameter, on her torso occurred. These symptoms were followed during the next several weeks by joint pain and swelling in her hands, fatigue, and low-grade fevers. Citalopram was stopped, and antihistamines were prescribed, which the patient reported that she did not take for religious reasons; during the next ...	[Roh, Ellen K.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Hoang, Mai P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Vleugels, Ruth Ann] Harvard Univ, Brigham & Womens Hosp, Dept Dermatol, Sch Med, Boston, MA 02115 USA; [Roh, Ellen K.; Vleugels, Ruth Ann] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hoang, Mai P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roh, EK (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.				WorldCare Clinical	WorldCare Clinical	Dr. Roh reports receiving consulting fees from WorldCare Clinical. No other potential conflict of interest relevant to this article was reported.	AMERIAN ML, 1984, J AM ACAD DERMATOL, V10, P215, DOI 10.1016/S0190-9622(84)70025-9; [Anonymous], 2011, NEW ENGL J MED, V364, P957; [Anonymous], 2011, N ENGL J MED, V364, P1450; CHORZELSKI T, 1968, BRIT J DERMATOL, V80, P211, DOI 10.1111/j.1365-2133.1968.tb11961.x; Deschamps P, 1984, Photodermatol, V1, P38; Diab M, 2008, INT J DERMATOL, V47, P1317, DOI 10.1111/j.1365-4632.2008.03682.x; Goldberg I, 1999, INT J DERMATOL, V38, P888, DOI 10.1046/j.1365-4362.1999.00836.x; Gupta MT, 2004, BRIT J DERMATOL, V150, P163, DOI 10.1111/j.1365-2133.2004.05754.x; Hacker-Foegen MK, 2003, J INVEST DERMATOL, V121, P1373, DOI 10.1111/j.1523-1747.2003.12608.x; James KA, 2011, DERMATOL CLIN, V29, P405, DOI 10.1016/j.det.2011.03.012; Lamoreux MR, 2006, AM FAM PHYSICIAN, V74, P1883; Malik M, 2006, J AM ACAD DERMATOL, V55, P699, DOI 10.1016/j.jaad.2006.04.052; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Scheinfeld NS, 2003, CUTIS, V71, P303; Sebaratnam DF, 2011, DERMATOL CLIN, V29, P649, DOI 10.1016/j.det.2011.06.002; Senear FE, 1926, ARCH DERM SYPHILOL, V13, P1761; Shadid Nadia H, 2007, Int J Dermatol, V46 Suppl 3, P30, DOI 10.1111/j.1365-4632.2007.03508.x; Venugopal SS, 2011, DERMATOL CLIN, V29, P373, DOI 10.1016/j.det.2011.03.004	18	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2438	2449		10.1056/NEJMcpc1215967	http://dx.doi.org/10.1056/NEJMcpc1215967			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24350953				2022-12-28	WOS:000328586000012
J	Hicks, C; Makary, M				Hicks, Caitlin; Makary, Martin			A prophet to modern medicine: Ernest Amory Codman Caitlin Hicks and Martin Makary describe the life of the pioneer of healthcare registries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hicks, Caitlin] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Makary, Martin] Johns Hopkins Univ Hosp, Dept Surg, Halsted 610, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Makary, M (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mmakary1@jhmi.edu	Hicks, Caitlin/E-8849-2012	Hicks, Caitlin/0000-0001-7638-1936				Brand RA, 2009, CLIN ORTHOP RELAT R, V467, P2763, DOI 10.1007/s11999-009-1047-8; Codman E, 1926, SURG GYNECOL OBSTET, V42, P381; Codman E, 1924, B AM COLL SURG, V8, p34e8; Codman EA, 1918, STUDY HOSP EFFICIENC; Codman Ernest Amory, 2007, AM NATL BIOGRAPHY; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Mallon WJ, 2000, EA CODMAN END RESULT; Swensen SJ, 2008, CHEST, V133, P233, DOI 10.1378/chest.07-2101	8	8	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2013	347								f7368	10.1136/bmj.f7368	http://dx.doi.org/10.1136/bmj.f7368			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MI	24353099				2022-12-28	WOS:000328823300001
J	Tunis, SR				Tunis, Sean R.			CHRISTMAS 2013: AGGRAVATIONS Lack of evidence for clinical and health policy decisions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TECHNOLOGY-ASSESSMENT		Ctr Med Technol Policy, Baltimore, MD 21202 USA		Tunis, SR (corresponding author), Ctr Med Technol Policy, 401 East Pratt St,Suite 631, Baltimore, MD 21202 USA.	sean.tunis@cmtpnet.org						Abernethy AP, 2010, TECHNOLOGY ASSESSMEN; Balas E A, 2000, Yearb Med Inform, P65; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Krumholz HM, 2012, ANN INTERN MED, V157, P446, DOI 10.7326/0003-4819-157-6-201209180-00519; Raftery J, 2013, LANCET, V382, P1278, DOI 10.1016/S0140-6736(13)61724-9; Tunis SR, 2012, J CLIN ONCOL, V30, P4256, DOI 10.1200/JCO.2012.42.6338; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	7	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2013	347								f7155	10.1136/bmj.f7155	http://dx.doi.org/10.1136/bmj.f7155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277LV	24343113				2022-12-28	WOS:000328821800001
J	Keaney, JJ; Groarke, JD; Galvin, Z; McGorrian, C; McCann, HA; Sugrue, D; Keelan, E; Galvin, J; Blake, G; Mahon, NG; O'Neill, J				Keaney, John J.; Groarke, John D.; Galvin, Zita; McGorrian, Catherine; McCann, Hugh A.; Sugrue, Declan; Keelan, Edward; Galvin, Joseph; Blake, Gavin; Mahon, Niall G.; O'Neill, James			CHRISTMAS 2013: RESEARCH The Brady Bunch? New evidence for nominative determinism in patients' health: retrospective, population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MUTATION; TRAFFICKING; MODULATION	Objective To ascertain whether a name can influence a person's health, by assessing whether people with the surname "Brady" have an increased prevalence of bradycardia. Design Retrospective, population based cohort study. Setting One university teaching hospital in Dublin, Ireland. Participants People with the surname "Brady" in Dublin, determined through use of an online telephone directory. Main outcome measure Prevalence of participants who had pacemakers inserted for bradycardia between 1 January 2007 and 28 February 2013. Results 579 (0.36%) of 161 967 people who were listed on the Dublin telephone listings had the surname "Brady." The proportion of pacemaker recipients was significantly higher among Bradys (n= 8, 1.38%) than among non-Bradys (n= 991, 0.61%; P= 0.03). The unadjusted odds ratio (95% confidence interval) for pacemaker implantation among individuals with the surname Brady compared with individuals with other surnames was 2.27 (1.13 to 4.57). Conclusions Patients named Brady are at increased risk of needing pacemaker implantation compared with the general population. This finding shows a potential role for nominative determinism in health.	[Keaney, John J.; Groarke, John D.; McGorrian, Catherine; McCann, Hugh A.; Sugrue, Declan; Keelan, Edward; Galvin, Joseph; Blake, Gavin; Mahon, Niall G.; O'Neill, James] Mater Misericordiae Univ Hosp, Cardiol Dept, Dublin 7, Ireland; [Galvin, Zita] Mater Misericordiae Univ Hosp, Liver Ctr, Dublin 7, Ireland; [Keelan, Edward; Galvin, Joseph; O'Neill, James] James Connolly Mem Hosp, Dublin, Ireland; [O'Neill, James] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Mater Misericordiae University Hospital; University College Dublin; Mater Misericordiae University Hospital; University College Dublin; Royal College of Surgeons - Ireland	Keaney, JJ (corresponding author), Mater Misericordiae Univ Hosp, Cardiol Dept, Dublin 7, Ireland.	jkeaney@mgh.harvard.edu		Mahon, Niall/0000-0002-2872-2297				Ache JM, 2012, J NEUROPHYSIOL, V107, P2756, DOI 10.1152/jn.01072.2011; Arun B, 2009, BRIT J DERMATOL, V160, P197, DOI [10.1111/j.1365-2133.2008.08873.x, 10.1111/j.1365-2133.2008.08877.x]; Bomtempo CAS, 1998, J HYPERTENS, V16, P1797, DOI 10.1097/00004872-199816120-00013; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Caligiorne SM, 1996, BRAIN RES, V720, P183, DOI 10.1016/0006-8993(95)01498-5; Davis NF, 2012, J UROLOGY, V188, P1828, DOI 10.1016/j.juro.2012.07.040; El-Mallakh RS, 2004, BIPOLAR DISORD, V6, P87, DOI 10.1046/j.1399-5618.2003.00080.x; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; Feedback Hoyland J., 1994, NEW SCI; Fountain AG, 1998, REV GEOPHYS, V36, P299, DOI 10.1029/97RG03579; HARARI H, 1973, J EDUC PSYCHOL, V65, P222, DOI 10.1037/h0034978; HARTE MT, 1988, CHEST, V93, P339, DOI 10.1378/chest.93.2.339; Highfield R., 2011, LONDON EVENING  0324; Izrailtyan I, 1997, CARDIOVASC RES, V33, P641, DOI 10.1016/S0008-6363(96)00267-2; Jung C.G., 1973, SYNCHRONICITY ACAUSA; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Loro JF, 1998, FUNDAM CLIN PHARM, V12, P77, DOI 10.1111/j.1472-8206.1998.tb00927.x; Luscri G, 1998, PSYCHOL REP, V82, P1023, DOI 10.2466/PR0.82.3.1023-1026; NAKANO J, 1965, ARCH INT PHARMACOD T, V157, P1; NAKASHIMA A, 1982, EUR J PHARMACOL, V81, P479, DOI 10.1016/0014-2999(82)90113-3; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Papapoulos S, 2012, J BONE MINER RES, V27, P694, DOI 10.1002/jbmr.1479; Pelham BW, 2002, J PERS SOC PSYCHOL, V82, P469, DOI 10.1037//0022-3514.82.4.469; Potts JM, 2012, PAIN, V153, P755, DOI 10.1016/j.pain.2011.10.005; RIBUOT C, 1993, AM J PHYSIOL, V265, pH876, DOI 10.1152/ajpheart.1993.265.3.H876; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Snowman D., 1993, POLE POSITIONS POLAR; SPLATT AJ, 1981, BRIT J UROL, V53, P263, DOI 10.1111/j.1464-410X.1981.tb06102.x; Spray CJ, 1997, ASSESSING RECREATION; STASZEWSKABARCZAK J, 1976, CARDIOVASC RES, V10, P314, DOI 10.1093/cvr/10.3.314; Sun K, 2012, J MATER CHEM, V22, P24155, DOI 10.1039/c2jm35221d; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200	33	2	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f6627	10.1136/bmj.f6627	http://dx.doi.org/10.1136/bmj.f6627			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336304	Green Published, hybrid			2022-12-28	WOS:000328575200001
J	Padhi, S; Bullock, I; Li, L; Stroud, M				Padhi, Smita; Bullock, Ian; Li, Lilian; Stroud, Mike		Guideline Dev Grp	Intravenous fluid therapy for adults in hospital: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Padhi, Smita; Bullock, Ian; Li, Lilian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stroud, Mike] Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England	Royal College of Physicians; University of Southampton; University Hospital Southampton NHS Foundation Trust	Padhi, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	smita.padhi@rcplondon.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796; Nolan, Jerry/0000-0003-3141-3812; Wonderling, David/0000-0003-0315-6273				[Anonymous], AC ILL PAT HOSP REC; *NAT CONF ENQ PER, 1999, EXTR AG 1999 REP NAT; National Confidential Enquiry into Perioperative Deaths, 2011, KNOW RISK REV PER CA; National Institute for Health and Care Excellence, 2013, INTR FLUID THER AD H; Resuscitation Council UK, 2011, ADV LIF SUPP; Royal College of Physicians, 2017, NATL EARL WARN SCOR	6	38	43	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7073	10.1136/bmj.f7073	http://dx.doi.org/10.1136/bmj.f7073			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24326887				2022-12-28	WOS:000328574700002
J	Hathaway, DH; Upton, L; Colegrove, O				Hathaway, David H.; Upton, Lisa; Colegrove, Owen			Giant Convection Cells Found on the Sun	SCIENCE			English	Article							SOLAR CONVECTION; SUPERGRANULES; ROTATION; SURFACE; PROBES	Heat is transported through the outermost 30% of the Sun's interior by overturning convective motions. These motions are evident at the Sun's surface in the form of two characteristic cellular structures: granules and supergranules (similar to 1000 and similar to 30,000 kilometers across, respectively). The existence of much larger cells has been suggested by both theory and observation for more than 45 years. We found evidence for giant cellular flows that persist for months by tracking the motions of supergranules. As expected from the effects of the Sun's rotation, the flows in these cells are clockwise around high pressure in the north and counterclockwise in the south and transport angular momentum toward the equator, maintaining the Sun's rapid equatorial rotation.	[Hathaway, David H.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Upton, Lisa] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Upton, Lisa] Univ Alabama, Dept Space Sci, Huntsville, AL 35899 USA; [Colegrove, Owen] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Vanderbilt University; University of Alabama System; University of Alabama Huntsville; University of Rochester	Hathaway, DH (corresponding author), NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA.	david.hathaway@nasa.gov		Upton, Lisa/0000-0003-0621-4803	NASA; NASA Heliophysics Supporting Research and Technology (SRT) Program; NASA Living With a Star (LWS) Program; University of Alabama in Huntsville by funds from NSF [AGS-1157027]; Directorate For Geosciences [1157027] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA Heliophysics Supporting Research and Technology (SRT) Program; NASA Living With a Star (LWS) Program(National Aeronautics & Space Administration (NASA)); University of Alabama in Huntsville by funds from NSF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The SDO/HMI data described in this paper are archived at http://jsoc.stanford.edu. The SDO/HMI project is supported by NASA grant to Stanford University. D. H. H. was supported by a grant from the NASA Heliophysics Supporting Research and Technology (SR&T) Program to NASA/MSFC. L. U. was supported by a grant from the NASA Living With a Star (LWS) Program to NASA/MSFC. O.C. was supported as a Research Experience for Undergraduates (REU) summer student at the University of Alabama in Huntsville by funds from NSF grant AGS-1157027.	Beck JG, 1998, NATURE, V394, P653, DOI 10.1038/29245; BUMBA V, 1970, SOL PHYS, V14, P80, DOI 10.1007/BF00240162; Elliott JR, 2000, ASTROPHYS J, V533, P546, DOI 10.1086/308643; GILMAN PA, 1979, ASTROPHYS J, V231, P284, DOI 10.1086/157191; Hanasoge SM, 2010, ASTROPHYS J LETT, V712, pL98, DOI 10.1088/2041-8205/712/1/L98; HART AB, 1956, MON NOT R ASTRON SOC, V116, P38, DOI 10.1093/mnras/116.1.38; Hathaway DH, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/84; Hathaway DH, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/1/L13; Hathaway DH, 2000, SOL PHYS, V193, P299, DOI 10.1023/A:1005200809766; Hathaway DH, 1996, SCIENCE, V272, P1306, DOI 10.1126/science.272.5266.1306; LEIGHTON RB, 1962, ASTROPHYS J, V135, P474, DOI 10.1086/147285; Lisle JP, 2004, ASTROPHYS J, V608, P1167, DOI 10.1086/420691; Miesch MS, 2008, ASTROPHYS J, V673, P557, DOI 10.1086/523838; November L.J., 1987, NASACP, V2483, P121; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; SIMON GW, 1968, Z ASTROPHYS, V69, P435; SNODGRASS HB, 1984, ASTROPHYS J, V284, P848, DOI 10.1086/162468; van Ballegooijen AA, 1998, ASTROPHYS J, V501, P866, DOI 10.1086/305823	18	59	59	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1217	1219		10.1126/science.1244682	http://dx.doi.org/10.1126/science.1244682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311685	Green Submitted			2022-12-28	WOS:000327857900043
J	Ujiie, K; Tanaka, H; Saito, T; Tsutsumi, A; Mori, JJ; Kameda, J; Brodsky, EE; Chester, FM; Eguchi, N; Toczko, S				Ujiie, Kohtaro; Tanaka, Hanae; Saito, Tsubasa; Tsutsumi, Akito; Mori, James J.; Kameda, Jun; Brodsky, Emily E.; Chester, Frederick M.; Eguchi, Nobuhisa; Toczko, Sean		Expedition 343 Scientist; Expedition 343T Scientist	Low Coseismic Shear Stress on the Tohoku-Oki Megathrust Determined from Laboratory Experiments	SCIENCE			English	Article							ZONE; TEMPERATURE; FRICTION; RUPTURE	Large coseismic slip was thought to be unlikely to occur on the shallow portions of plate-boundary thrusts, but the 11 March 2011 Tohoku-Oki earthquake [moment magnitude (M-w) = 9.0] produced huge displacements of similar to 50 meters near the Japan Trench with a resultant devastating tsunami. To investigate the mechanisms of the very large fault movements, we conducted high-velocity (1.3 meters per second) friction experiments on samples retrieved from the plate-boundary thrust associated with the earthquake. The results show a small stress drop with very low peak and steady-state shear stress. The very low shear stress can be attributed to the abundance of weak clay (smectite) and thermal pressurization effects, which can facilitate fault slip. This behavior provides an explanation for the huge shallow slip that occurred during the earthquake.	[Ujiie, Kohtaro; Tanaka, Hanae; Saito, Tsubasa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ujiie, Kohtaro] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Tsutsumi, Akito] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan; [Kameda, Jun] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan; [Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA; [Chester, Frederick M.] Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX 77843 USA; [Eguchi, Nobuhisa; Toczko, Sean] Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Yokohama, Kanagawa, Japan	University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University; Kyoto University; Hokkaido University; University of California System; University of California Santa Cruz; Texas A&M University System; Texas A&M University College Station; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Ujiie, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	kujiie@geol.tsukuba.ac.jp	Toy, Virginia/F-9912-2014; Brodsky, Emily/B-9139-2014; Chester, Frederick/X-4706-2019; Chester, Frederick M/U-6789-2017; Sample, James/A-9622-2015	Toy, Virginia/0000-0002-7621-2064; Chester, Frederick M/0000-0001-7665-3647; Kirkpatrick, James/0000-0001-7504-6968; Brodsky, Emily/0000-0002-6855-6860; Ishikawa, Tsuyoshi/0000-0003-2886-7282	U.S. Science Support Program of IODP; Ministry of Education, Culture, Sports, Science and Technology of Japan [21107005]; Gordon and Betty Moore Foundation; Grants-in-Aid for Scientific Research [21107004] Funding Source: KAKEN	U.S. Science Support Program of IODP; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	For this research, we used samples and data provided by the IODP (www.iodp.org/access-data-and-samples). We thank all drilling and logging operation staff on board the D/V Chikyu during Expedition 343 and 343T. We acknowledge two anonymous reviewers for their thoughtful reviews. Part of this work was supported by the U.S. Science Support Program of IODP. K. U. was supported by grant 21107005 (Ministry of Education, Culture, Sports, Science and Technology of Japan). E. E. B was supported by the Gordon and Betty Moore Foundation.	[Anonymous], 1980, SIT 436 JAP TRENCH 1, V56; [Anonymous], 1980, SIT 436 JAP TRENCH 1, V57; Bilek SL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015215; Boutareaud S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032554; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Ferri F, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008338; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Haines SH, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005866; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; Kinoshita M, 2009, P INTEGRATED OCEAN D, V314, DOI [10.2204/iodp.proc.314315316.123.2009, DOI 10.2204/IODP.PROC.314315316.133.2009, 10.2204/iodp.proc.314315316.133.2009]; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; Maltman A., 1997, P ODP SCI RESULTS, V156, P279, DOI DOI 10.2973/ODP.PROC.SR.156.037.1997.C0LLEGE; MASE CW, 1987, J GEOPHYS RES-SOLID, V92, P6249, DOI 10.1029/JB092iB07p06249; Moore JC, 2001, GEOLOGY, V29, P183, DOI 10.1130/0091-7613(2001)029<0183:ULOTSZ>2.0.CO;2; Mori J.J., 2012, IODP SCI PROSP, V343, DOI [/10.2204/iodp.sp.343.2012, DOI 10.2204/IODP.SP.343.2012, 10.2204/iodp.sp.343.2012, DOI 10.2204/I0DP.SP.343.2012]; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; SIBSON RH, 1973, NATURE-PHYS SCI, V243, P66, DOI 10.1038/physci243066a0; Skinner B. J., 1966, GEOL SOC AM MEM, DOI [rg/10.1130/MEM97-p75, 10.1130/MEM97-p75]; Tobin H, 2001, GEOLOGY, V29, P907, DOI 10.1130/0091-7613(2001)029<0907:SIMPAI>2.0.CO;2; Ujiie K, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL046002; Wang KY, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006411	25	187	192	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1211	1214		10.1126/science.1243485	http://dx.doi.org/10.1126/science.1243485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311683				2022-12-28	WOS:000327857900041
J	Roederer, M				Roederer, Mario			Leonard Herzenberg (1931-2013) OBITUARY	NATURE			English	Biographical-Item									[Roederer, Mario] US Natl Inst Allergy & Infect Dis, ImmunoTechnol Sect, Vaccine Res Ctr, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), US Natl Inst Allergy & Infect Dis, ImmunoTechnol Sect, Vaccine Res Ctr, Bethesda, MD USA.	roederer@nih.gov	Roederer, Mario/G-1887-2011					HERZENBERG L, PUBLICATION LIST	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					34	34		10.1038/504034a	http://dx.doi.org/10.1038/504034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305144	Bronze			2022-12-28	WOS:000327851700021
J	Mackie, SL; Mallen, CD				Mackie, Sarah L.; Mallen, Christian D.			Polymyalgia rheumatica	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ERYTHROCYTE SEDIMENTATION-RATE; GIANT-CELL ARTERITIS; TEMPORAL ARTERITIS; DISEASE-ACTIVITY; FOLLOW-UP; CLASSIFICATION CRITERIA; PLASMA VISCOSITY; BHPR GUIDELINES; DOUBLE-BLIND; ONSET		[Mackie, Sarah L.] Univ Leeds, Chapel Allerton Hosp, Natl Inst Hlth Res Leeds Musculoskeletal Biomed R, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England; [Mallen, Christian D.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England	Chapel Allerton Hospital; University of Leeds; Keele University	Mackie, SL (corresponding author), Univ Leeds, Chapel Allerton Hosp, Natl Inst Hlth Res Leeds Musculoskeletal Biomed R, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England.	s.l.mackie@leeds.ac.uk		Mallen, Christian/0000-0002-2677-1028	National Institute for Health Research [CL-2009-02-002, NIHR-CS-012-016] Funding Source: researchfish; Department of Health [NIHR-CS-012-016] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Adizie T, 2012, INT J CLIN PRACT, V66, P906, DOI 10.1111/j.1742-1241.2012.02981.x; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aydeniz A, 2012, RHEUMATOL INT, V32, P1357, DOI 10.1007/s00296-010-1394-5; Belloli L, 2008, JCR-J CLIN RHEUMATOL, V14, P59, DOI 10.1097/RHU.0b013e318163c373; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Camellino D, 2012, RHEUMATOLOGY, V51, P77, DOI 10.1093/rheumatology/keq450; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Cantini F, 2004, SEMIN ARTHRITIS RHEU, V33, P294, DOI 10.1016/j.semarthrit.2003.09.008; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Caporali R, 2001, ANN RHEUM DIS, V60, P1021, DOI 10.1136/ard.60.11.1021; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Cimmino MA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-94; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Dasgupta B, 1998, BRIT J RHEUMATOL, V37, P189; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Dasgupta B, 2010, RHEUMATOLOGY, V49, P1594, DOI 10.1093/rheumatology/keq039a; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; Do-Nguyen D, 2013, OPEN ACCESS RHEUMATO, V5, P33, DOI 10.2147/OARRR.S38443; Dolan AL, 1997, ARTHRITIS RHEUM, V40, P2022, DOI 10.1002/art.1780401115; Falsetti P, 2011, SCAND J RHEUMATOL, V40, P57, DOI 10.3109/03009742.2010.486766; FAUCHALD P, 1972, ANN INTERN MED, V77, P845, DOI 10.7326/0003-4819-77-6-845; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gonzalez-Gay MA, 1999, J RHEUMATOL, V26, P1326; Gonzalez-Gay MA, 2000, J RHEUMATOL, V27, P2179; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay MA, 2001, J RHEUMATOL, V28, P122; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P317, DOI 10.1001/archinte.157.3.317; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hoes JN, 2009, ANN RHEUM DIS, V68, P1833, DOI 10.1136/ard.2008.100008; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; HUTCHINSON RM, 1977, J CLIN PATHOL, V30, P345, DOI 10.1136/jcp.30.4.345; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; Kanfer EJ, 1997, J ROY SOC MED, V90, P16, DOI 10.1177/014107689709000106; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kreiner F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3140; KYLE V, 1989, ANN RHEUM DIS, V48, P658, DOI 10.1136/ard.48.8.658; Leeb BF, 2004, ANN RHEUM DIS, V63, P1279, DOI 10.1136/ard.2003.011379; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Macchioni P, 2013, SEMIN ARTHRITIS RHEU; Mackie SL, 2010, RHEUMATOLOGY, V49, P716, DOI 10.1093/rheumatology/kep395; Mazzantini M, 2012, J RHEUMATOL, V39, P552, DOI 10.3899/jrheum.110851; McCarthy EM, 2013, RHEUMATOLOGY, V52, P465, DOI 10.1093/rheumatology/kes294; McGonagle D, 2001, J RHEUMATOL, V28, P1837; Meliconi R, 1996, ARTHRITIS RHEUM-US, V39, P1199, DOI 10.1002/art.1780390719; Myklebust G, 2001, SCAND J RHEUMATOL, V30, P260; Narvaez J, 1999, J RHEUMATOL, V26, P1945; National Institute for Health and Care Excellence, 2013, OST PREV FRAG FRACT; NOBUNAGA M, 1989, JPN J MED, V28, P452, DOI 10.2169/internalmedicine1962.28.452; Olivieri I, 2007, RHEUMATOL INT, V27, P927, DOI 10.1007/s00296-007-0331-8; Pease CT, 2005, J RHEUMATOL, V32, P1043; Pego-Reigosa JM, 2005, ARTHRIT RHEUM-ARTHR, V53, P931, DOI 10.1002/art.21585; Pountain G, 1997, BRIT J RHEUMATOL, V36, P508; Quick V, 2012, J ROY COLL PHYS EDIN, V42, P341, DOI 10.4997/JRCPE.2012.413; Sakellariou G, 2013, CLIN EXP RHEUMATOL, V31, P1; Salvarani C, 2008, ANN RHEUM DIS, V67, P758, DOI 10.1136/ard.2007.084723; SALVARANI C, 1987, CLIN EXP RHEUMATOL, V5, P205; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Salvarani C, 2007, ANN INTERN MED, V146, P631, DOI 10.7326/0003-4819-146-9-200705010-00005; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Straub RH, 2000, RHEUMATOLOGY, V39, P624, DOI 10.1093/rheumatology/39.6.624; Strehl C, 2011, CLIN EXP RHEUMATOL, V29, pS13; Weyand CM, 1999, ARCH INTERN MED, V159, P577, DOI 10.1001/archinte.159.6.577; Zacharski LR, 1976, BRIT J HOSP MED, V16, P53	66	12	12	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2013	347								f6937	10.1136/bmj.f6937	http://dx.doi.org/10.1136/bmj.f6937			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DF	24301266				2022-12-28	WOS:000328147900002
J	Richards-Kortum, R; Oden, M				Richards-Kortum, Rebecca; Oden, Maria			Devices for Low-Resource Health Care	SCIENCE			English	Editorial Material							TECHNOLOGIES; RATES		[Richards-Kortum, Rebecca; Oden, Maria] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, 6100 Main St, Houston, TX 77005 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467	NCI NIH HHS [R21CA156704-02] Funding Source: Medline; NIBIB NIH HHS [R03EB013973-03] Funding Source: Medline; PHS HHS [U54A1057156-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA156704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB013973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brown J., 2013, LOW COST HIGHLY EFFE; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Ersdal HL, 2013, SEMIN FETAL NEONAT M, V18, P373, DOI 10.1016/j.siny.2013.07.001; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Matthews P., 2012, AFRICA UK ENG DEV PA; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Sinha SR, 2011, NEW ENGL J MED, V365, P779, DOI 10.1056/NEJMp1108040; WHO, 2010, MED DEV MAN MISM OUT	15	27	28	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1055	1057		10.1126/science.1243473	http://dx.doi.org/10.1126/science.1243473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288323				2022-12-28	WOS:000327518600045
J	Zuo, WW; Lough, AJ; Li, YF; Morris, RH				Zuo, Weiwei; Lough, Alan J.; Li, Young Feng; Morris, Robert H.			Amine(imine)diphosphine Iron Catalysts for Asymmetric Transfer Hydrogenation of Ketones and Imines	SCIENCE			English	Article							N-N-P; COMPLEXES; MECHANISM; ACETOPHENONE; REDUCTION; RUTHENIUM; AMINES	A rational approach is needed to design hydrogenation catalysts that make use of Earth-abundant elements to replace the rare elements such as ruthenium, rhodium, and palladium that are traditionally used. Here, we validate a prior mechanistic hypothesis that partially saturated amine(imine)diphosphine ligands (P-NH-N-P) activate iron to catalyze the asymmetric reduction of the polar bonds of ketones and imines to valuable enantiopure alcohols and amines, with isopropanol as the hydrogen donor, at turnover frequencies as high as 200 per second at 28 degrees C. We present a direct synthetic approach to enantiopure ligands of this type that takes advantage of the iron(lI) ion as a template. The catalytic mechanism is elucidated by the spectroscopic detection of iron hydride and amide intermediates.	[Zuo, Weiwei; Lough, Alan J.; Li, Young Feng; Morris, Robert H.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto	Morris, RH (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	rmorris@chem.utoronto.ca	Morris, Robert H/R-8760-2016	Morris, Robert H/0000-0002-7574-9388; Li, Young Feng/0000-0002-0510-5587	NSERC; University of Toronto; Green Centre Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto(University of Toronto); Green Centre Canada	Supported by NSERC Discovery and RTI grants (R.H.M.), the University of Toronto, and a proof-of-principle grant from the Green Centre Canada. We thank D. Prokopchuk for DFT calculations, A. Mikhailine for preceding work and for providing a phosphonium dimer compound, and T. Burrow and D. Burns for NMR support. Crystallographic data for 2b are available free of charge from the Cambridge Crystallographic Data Centre under reference number 954477. R.H.M. is listed as an inventor on a patent filed in relation to the work described herein.	Abdur-Rashid K, 2002, J AM CHEM SOC, V124, P15104, DOI 10.1021/ja016817p; Baratta W, 2010, ORGANOMETALLICS, V29, P3563, DOI 10.1021/om1004918; Basolo F., 1967, MECH INORGANIC REACT, V2; Bell S, 2006, SCIENCE, V311, P642, DOI 10.1126/science.1121977; Brands KMJ, 2003, J AM CHEM SOC, V125, P2129, DOI 10.1021/ja027458g; John JM, 2013, J AM CHEM SOC, V135, P8578, DOI 10.1021/ja401294q; Junge K, 2011, CHEM COMMUN, V47, P4849, DOI 10.1039/c0cc05733a; Knowles WS, 2007, ACCOUNTS CHEM RES, V40, P1238, DOI 10.1021/ar7000809; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lagaditis PO, 2011, J AM CHEM SOC, V133, P9662, DOI 10.1021/ja202375y; Liu TB, 2013, NAT CHEM, V5, P228, DOI [10.1038/nchem.1571, 10.1038/NCHEM.1571]; Mikhailine AA, 2008, INORG CHEM, V47, P6587, DOI 10.1021/ic800884c; Mikhailine AA, 2012, ORG LETT, V14, P4638, DOI 10.1021/ol302079q; Mikhailine AA, 2012, J AM CHEM SOC, V134, P12266, DOI 10.1021/ja304814s; Mikhailine AA, 2010, INORG CHEM, V49, P11039, DOI 10.1021/ic101548j; Morris RH, 2009, CHEM SOC REV, V38, P2282, DOI 10.1039/b806837m; Noyori R, 2001, ANGEW CHEM INT EDIT, V40, P40, DOI 10.1002/1521-3773(20010105)40:1<40::AID-ANIE40>3.0.CO;2-5; NUGENT WA, 1993, SCIENCE, V259, P479, DOI 10.1126/science.259.5094.479; Prokopchuk DE, 2012, ORGANOMETALLICS, V31, P7375, DOI 10.1021/om300572v; Rautenstrauch V, 2003, CHEM-EUR J, V9, P4954, DOI 10.1002/chem.200304884; Sandoval CA, 2003, J AM CHEM SOC, V125, P13490, DOI 10.1021/ja030272c; Sues PE, 2011, ORGANOMETALLICS, V30, P4418, DOI 10.1021/om2005172; Tondreau AM, 2012, SCIENCE, V335, P567, DOI 10.1126/science.1214451; Zhou SL, 2010, ANGEW CHEM INT EDIT, V49, P8121, DOI 10.1002/anie.201002456	24	368	374	18	441	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1080	1083		10.1126/science.1244466	http://dx.doi.org/10.1126/science.1244466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288329				2022-12-28	WOS:000327518600053
J	Vafai, SB; Mootha, VK				Vafai, Scott B.; Mootha, Vamsi K.			A Common Pathway for a Rare Disease?	SCIENCE			English	Editorial Material							MITOCHONDRIAL DISEASE; MTOR		[Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Howard Hughes Med Inst, Boston, MA 02114 USA; [Vafai, Scott B.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Vafai, Scott B.; Mootha, Vamsi K.] Broad Inst, Boston, MA 02141 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Vafai, SB (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA.	vamsi@hms.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bird MJ, 2014, BBA-GEN SUBJECTS, V1840, P1380, DOI 10.1016/j.bbagen.2013.10.017; Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707	11	19	19	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1453	1454		10.1126/science.1248449	http://dx.doi.org/10.1126/science.1248449			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357304				2022-12-28	WOS:000328644300037
J	Kelly, CR; Rabbani, LE				Kelly, Christopher R.; Rabbani, LeRoy E.			Pulmonary-Artery Catheterization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONTROLLED-TRIAL; HEART	Pulmonary-artery catheterization aids the diagnosis and management of numerous cardiovascular illnesses. This video demonstrates the insertion of a pulmonary-artery catheter. Standard Pulmonary-Artery Catheter.The pulmonary-artery catheter is generally 110 cm long and 7 or 8 French in diameter. An air-filled syringe (A) is used to inflate the balloon at the catheter tip (inset). An accessory infusion port (B) is present in most catheters and connects to a lumen 30 cm from the catheter tip (arrow). The distal port (C) connects to a lumen at the catheter tip and is used to measure all pressures during catheter insertion. The proximal port (D) connects to an additional lumen 30 cm from the catheter tip and is used to monitor right atrial pressures once the catheter tip is in the pulmonary artery. A thermistor wire extends from the catheter tip to an electronic connector (E) and is used to measure cardiac output by means of thermodilution.	New York Presbyterian Hosp, New York, NY USA; Columbia Univ, Med Ctr, New York, NY 10032 USA	NewYork-Presbyterian Hospital; Columbia University	Kelly, CR (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Med, 177 Ft Washington Ave,Rm 6C-12, New York, NY 10032 USA.	crk2002@columbia.edu						ARDS Network, 2006, N ENGL J MED, V354, P2213; Davidson CJ, 2007, BRAUNWALDS HEART DIS, V1, P439; FORRESTER JS, 1972, AM HEART J, V83, P306, DOI 10.1016/0002-8703(72)90429-2; Fragou M, 2011, CRIT CARE MED, V39, P1607, DOI 10.1097/CCM.0b013e318218a1ae; KEARNEY TJ, 1995, CHEST, V108, P1349, DOI 10.1378/chest.108.5.1349; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902	9	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25								10.1056/NEJMvcm1212416	http://dx.doi.org/10.1056/NEJMvcm1212416			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24350972				2022-12-28	WOS:000328586000001
J	D'Silva, J				D'Silva, Jeetha			Can India save its Parsi community with assisted reproduction? The size of the Zoroastrian population is in sharp decline, reports Jeetha D'Silva, so the federal government has decided to fund advocacy and in vitro fertilisation in the hope of bucking the trend	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						Bharat S, 2008, DEMOGRAPHIC TRANSITI; Chakrabarty R., 2013, TIMES INDIA     0924; Government of India Ministry of Minority Affairs, 2013, JIYO PARS CENTR SECT; Shroff Z, 2011, DEM RES, V25, P555; Shroff Zubin, 2011, DEM RES, V25, P547; UNESCO Parsi-Zoroastrian Project, DEM	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2013	347								f7530	10.1136/bmj.f7530	http://dx.doi.org/10.1136/bmj.f7530			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MI	24353102				2022-12-28	WOS:000328823300005
J	Keating, P; Cambrosio, A				Keating, Peter; Cambrosio, Alberto			The art of medicine 21st-century oncology: a tangled web	LANCET			English	Editorial Material									[Keating, Peter] Univ Quebec, Ctr Interuniv Rech Sci & Technol, Montreal, PQ H3C 3P1, Canada; [Keating, Peter] Univ Quebec, Dept Hist, Montreal, PQ H3C 3P1, Canada; [Cambrosio, Alberto] McGill Univ, Dept Social Studies Med, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; McGill University	Keating, P (corresponding author), Univ Quebec, Ctr Interuniv Rech Sci & Technol, Montreal, PQ H3C 3P1, Canada.	keating.peter@uqam.ca		Keating, Peter/0000-0001-7236-9761					0	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					E45	E46		10.1016/S0140-6736(13)62660-4	http://dx.doi.org/10.1016/S0140-6736(13)62660-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24350356	Green Submitted			2022-12-28	WOS:000328223700002
J	Hurley, R				Hurley, Richard			Who cares for the nine million displaced people of Syria?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Hurley, R (corresponding author), BMJ, London, England.	rhurley@bmj.com							0	5	5	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7374	10.1136/bmj.f7374	http://dx.doi.org/10.1136/bmj.f7374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24326890	Bronze, Green Published			2022-12-28	WOS:000328574700007
J	Kirwan, ML; Megonigal, JP				Kirwan, Matthew L.; Megonigal, J. Patrick			Tidal wetland stability in the face of human impacts and sea-level rise	NATURE			English	Review							GULF-OF-MEXICO; SALT-MARSH; COASTAL WETLANDS; CARBON ACCUMULATION; MISSISSIPPI DELTA; SURFACE-ELEVATION; ORGANIC-MATTER; VEGETATION; SEDIMENT; CLIMATE	Coastal populations and wetlands have been intertwined for centuries, whereby humans both influence and depend on the extensive ecosystem services that wetlands provide. Although coastal wetlands have long been considered vulnerable to sea-level rise, recent work has identified fascinating feedbacks between plant growth and geomorphology that allow wetlands to actively resist the deleterious effects of sea-level rise. Humans alter the strength of these feedbacks by changing the climate, nutrient inputs, sediment delivery and subsidence rates. Whether wetlands continue to survive sea-level rise depends largely on how human impacts interact with rapid sea-level rise, and socio-economic factors that influence transgression into adjacent uplands.	[Kirwan, Matthew L.] Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	William & Mary; Virginia Institute of Marine Science; Smithsonian Institution; Smithsonian Environmental Research Center	Kirwan, ML (corresponding author), Virginia Inst Marine Sci, POB 1346,1375 Greate Rd, Gloucester Point, VA 23062 USA.	kirwan@vims.edu		Megonigal, Patrick/0000-0002-2018-7883	U.S.G.S. Global Change Research Program; Virginia Coast Reserve Long Term Ecological Research Program [NSF DEB-0621014]; Division Of Environmental Biology [0950080] Funding Source: National Science Foundation	U.S.G.S. Global Change Research Program(United States Geological Survey); Virginia Coast Reserve Long Term Ecological Research Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The U.S.G.S. Global Change Research Program and the Virginia Coast Reserve Long Term Ecological Research Program (NSF DEB-0621014) supported this work financially. We thank G. Guntenspergen for conversations that enhanced this work.	Alber M, 2008, ESTUAR COAST SHELF S, V80, P1, DOI 10.1016/j.ecss.2008.08.009; Anisfeld SC, 2012, ESTUAR COAST, V35, P201, DOI 10.1007/s12237-011-9440-4; Balduff, 2007, THESIS U MARYLAND; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bauer DM, 2004, CONSERV BIOL, V18, P401, DOI 10.1111/j.1523-1739.2004.00367.x; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Carniello L, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001157; Charles H, 2009, ECOL APPL, V19, P1758, DOI 10.1890/08-0172.1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Coleman JM, 2008, J COASTAL RES, V24, P1, DOI 10.2112/05-0607.1; Craft C, 2007, LIMNOL OCEANOGR, V52, P1220, DOI 10.4319/lo.2007.52.3.1220; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Cronin TM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031318; D'Alpaos A, 2012, ECOHYDROLOGY, V5, P550, DOI 10.1002/eco.279; D'Alpaos A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000537; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Davis RA, 2003, MAR GEOL, V200, P103, DOI 10.1016/S0025-3227(03)00179-8; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Engelhart SE, 2012, QUATERNARY SCI REV, V54, P12, DOI 10.1016/j.quascirev.2011.09.013; Fagherazzi S, 2006, P NATL ACAD SCI USA, V103, P8337, DOI 10.1073/pnas.0508379103; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; French J, 2006, MAR GEOL, V235, P119, DOI 10.1016/j.margeo.2006.10.009; Friedrichs C. T., 2001, J COASTAL RES, V27, P6; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Giri C, 2008, J BIOGEOGR, V35, P519, DOI 10.1111/j.1365-2699.2007.01806.x; Howes NC, 2010, P NATL ACAD SCI USA, V107, P14014, DOI 10.1073/pnas.0914582107; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P680, DOI 10.1111/j.1365-2486.2009.01976.x; Kearney MS., 2002, EOS T AM GEOPHYS UN, V83, P173, DOI [10.1029/2002EO000112, DOI 10.1029/2002EO000112]; Kemp AC, 2011, P NATL ACAD SCI USA, V108, P11017, DOI 10.1073/pnas.1015619108; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan M, 2009, QUATERNARY SCI REV, V28, P1801, DOI 10.1016/j.quascirev.2009.02.022; Kirwan ML, 2012, NATURE, V489, P550, DOI 10.1038/nature11440; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2011, GEOLOGY, V39, P507, DOI 10.1130/G31789.1; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032681; Kolker AS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049458; Kolker AS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043874; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Larsen LG, 2011, GEOMORPHOLOGY, V126, P279, DOI 10.1016/j.geomorph.2010.03.015; Larsen LG, 2010, AM NAT, V176, pE66, DOI 10.1086/655215; Li YX, 2012, EARTH PLANET SC LETT, V315, P41, DOI 10.1016/j.epsl.2011.05.034; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marani M, 2004, J MARINE SYST, V51, P191, DOI 10.1016/j.jmarsys.2004.05.012; Marani M, 2013, P NATL ACAD SCI USA, V110, P3259, DOI 10.1073/pnas.1218327110; Marion C, 2009, ESTUAR COAST SHELF S, V83, P475, DOI 10.1016/j.ecss.2009.03.039; Mariotti G, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005892; Mariotti G, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001326; Mattheus CR, 2010, ESTUAR COAST SHELF S, V88, P365, DOI 10.1016/j.ecss.2010.04.016; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Morris J.T., 2012, RECARBONIZATION BIOS, P517; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mozdzer TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042794; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Nicholls R.J., 1995, GEOJOURNAL, V37, P369, DOI [10.1007/BF00814018, DOI 10.1007/BF00814018]; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Poulter B, 2009, PLANT ECOL, V202, P55, DOI 10.1007/s11258-008-9465-3; RAMPINO MR, 1981, GEOLOGY, V9, P63, DOI 10.1130/0091-7613(1981)9<63:EGOHTM>2.0.CO;2; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Smith SM, 2009, NORTHEAST NAT, V16, P183, DOI 10.1656/045.016.0203; Stedman S.M., 2008, STATUS TRENDS WETLAN; Stevenson J.C., 2009, HUMAN IMPACTS SALT M, P171; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Temmerman S, 2003, EARTH SURF PROC LAND, V28, P739, DOI 10.1002/esp.495; Temmerman S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050502; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Turner RE, 2011, ESTUAR COAST, V34, P1084, DOI 10.1007/s12237-010-9341-y; Turner RE, 1997, ESTUARIES, V20, P1, DOI 10.2307/1352716; Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583; Tweel AW, 2012, LIMNOL OCEANOGR, V57, P18, DOI 10.4319/lo.2012.57.1.0018; van der Wal D, 2004, GEOMORPHOLOGY, V61, P373, DOI 10.1016/j.geomorph.2004.02.005; Visscher P.T., 2003, BIOGEOCHEMISTRY, V8, P317, DOI DOI 10.1016/B0-08-043751-6/08132-9; Weston NB, 2011, BIOGEOCHEMISTRY, V102, P135, DOI 10.1007/s10533-010-9427-4; Yang SL, 2011, GLOBAL PLANET CHANGE, V75, P14, DOI 10.1016/j.gloplacha.2010.09.006; Yang SL, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000271	99	984	1036	73	906	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					53	60		10.1038/nature12856	http://dx.doi.org/10.1038/nature12856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305148				2022-12-28	WOS:000327851700025
J	Page, L				Page, Leigh			HEALTH INSURANCE EXCHANGES What insurance exchanges mean for physicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												leighpage@comcast.net						Kaiser Family Foundation, HLTH INS COV AD 19 6; Medical Group Management Association, 2013, ACA INS EXCH IMPL; Medical Society of the State of New York, 2013, NEW YORKS HLTH INS E; Terhune C, 2013, LOS ANGELES TIMES; Watchdog.org, 2013, US NEWS WORLD REPORT	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f7163	10.1136/bmj.f7163	http://dx.doi.org/10.1136/bmj.f7163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297997				2022-12-28	WOS:000328146700005
J	Adamala, K; Szostak, JW				Adamala, Katarzyna; Szostak, Jack W.			Nonenzymatic Template-Directed RNA Synthesis Inside Model Protocells	SCIENCE			English	Article							CITRATE	Efforts to recreate a prebiotically plausible protocell, in which RNA replication occurs within a fatty acid vesicle, have been stalled by the destabilizing effect of Mg2+ on fatty acid membranes. Here we report that the presence of citrate protects fatty acid membranes from the disruptive effects of high Mg2+ ion concentrations while allowing RNA copying to proceed, while also protecting single-stranded RNA from Mg2+-catalyzed degradation. This combination of properties has allowed us to demonstrate the chemical copying of RNA templates inside fatty acid vesicles, which in turn allows for an increase in copying efficiency by bathing the vesicles in a continuously refreshed solution of activated nucleotides.	[Adamala, Katarzyna; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; [Adamala, Katarzyna; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Adamala, Katarzyna] Univ Roma Tre, Dipartimento Biol, Rome, Italy	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Roma Tre University	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Adamala, Kate/0000-0003-1066-7207	NASA [NNX07AJ09G]	NASA(National Aeronautics & Space Administration (NASA))	We thank A. Engelhart, C. Hentrich, A. Larsen, N. Kamat, and A. Bjorkbom for discussions and help with manuscript preparation and A. Gifford for help with vesicle leakage experiments. This work was supported in part by NASA Exobiology grant NNX07AJ09G. J.W.S. is an investigator of the Howard Hughes Medical Institute. Raw data are presented in the supplementary materials. The instructions for assembling the Liposome Dialyzer are available at http://molbio.mgh.harvard.edu/szostakweb/.	Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Butch C, 2013, J AM CHEM SOC, V135, P13440, DOI 10.1021/ja405103r; Covington AK, 2009, J SOLUTION CHEM, V38, P1449, DOI 10.1007/s10953-009-9459-3; Deamer DW, 2005, TOP CURR CHEM, V259, P1, DOI 10.1007/b136806; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; JOHNSON CK, 1965, ACTA CRYSTALLOGR, V18, P1004, DOI 10.1107/S0365110X6500244X; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Mansy SS, 2008, P NATL ACAD SCI USA, V105, P13351, DOI 10.1073/pnas.0805086105; Szostak J. W., 2012, J SYST CHEM, V3, P2, DOI [10.1186/1759-2208-3-2, DOI 10.1186/1759-2208-3-2]; WALSER M, 1961, J PHYS CHEM-US, V65, P159, DOI 10.1021/j100819a045	12	196	203	5	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1098	1100		10.1126/science.1241888	http://dx.doi.org/10.1126/science.1241888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288333	Green Accepted			2022-12-28	WOS:000327518600058
J	Chapman, CR				Chapman, Clark R.			Calibrating Asteroid Impact	SCIENCE			English	Editorial Material									SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Chapman, CR (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	cchapman@boulder.swri.edu						Boslough MBE, 2008, INT J IMPACT ENG, V35, P1441, DOI 10.1016/j.ijimpeng.2008.07.053; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; National Research Council, 2010, DEFENDING PLANET EAR; Near-Earth Object Science Definition Team, 2003, STUDY TO DETERMINE T; Popova OP, 2013, SCIENCE, V342, P1069, DOI 10.1126/science.1242642; Tonry JL, 2011, PUBL ASTRON SOC PAC, V123, P58, DOI 10.1086/657997	7	5	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1051	1052		10.1126/science.1246250	http://dx.doi.org/10.1126/science.1246250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288320				2022-12-28	WOS:000327518600042
J	McLennan, SM; Anderson, RB; Bell, JF; Bridges, JC; Calef, F; Campbell, JL; Clark, BC; Clegg, S; Conrad, P; Cousin, A; Des Marais, DJ; Dromart, G; Dyar, MD; Edgar, LA; Ehlmann, BL; Fabre, C; Forni, O; Gasnault, O; Gellert, R; Gordon, S; Grant, JA; Grotzinger, JP; Gupta, S; Herkenhoff, KE; Hurowitz, JA; King, PL; Le Mouelic, S; Leshin, LA; Leveille, R; Lewis, KW; Mangold, N; Maurice, S; Ming, DW; Morris, RV; Nachon, M; Newsom, HE; Ollila, AM; Perrett, GM; Rice, MS; Schmidt, ME; Schwenzer, SP; Stack, K; Stolper, EM; Sumner, DY; Treiman, AH; VanBommel, S; Vaniman, DT; Vasavada, A; Wiens, RC; Yingst, RA				McLennan, S. M.; Anderson, R. B.; Bell, J. F., III; Bridges, J. C.; Calef, F., III; Campbell, J. L.; Clark, B. C.; Clegg, S.; Conrad, P.; Cousin, A.; Des Marais, D. J.; Dromart, G.; Dyar, M. D.; Edgar, L. A.; Ehlmann, B. L.; Fabre, C.; Forni, O.; Gasnault, O.; Gellert, R.; Gordon, S.; Grant, J. A.; Grotzinger, J. P.; Gupta, S.; Herkenhoff, K. E.; Hurowitz, J. A.; King, P. L.; Le Mouelic, S.; Leshin, L. A.; Leveille, R.; Lewis, K. W.; Mangold, N.; Maurice, S.; Ming, D. W.; Morris, R. V.; Nachon, M.; Newsom, H. E.; Ollila, A. M.; Perrett, G. M.; Rice, M. S.; Schmidt, M. E.; Schwenzer, S. P.; Stack, K.; Stolper, E. M.; Sumner, D. Y.; Treiman, A. H.; VanBommel, S.; Vaniman, D. T.; Vasavada, A.; Wiens, R. C.; Yingst, R. A.		MSL Sci Team	Elemental Geochemistry of Sedimentary Rocks at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							CHEMCAM INSTRUMENT SUITE; CLAY MINERAL FORMATION; SILICICLASTIC SEDIMENTS; ROVER; PETROGENESIS; PROVENANCE; CHEMISTRY; PROFILES; HISTORY; ONTARIO	Sedimentary rocks examined by the Curiosity rover at Yellowknife Bay, Mars, were derived from sources that evolved from an approximately average martian crustal composition to one influenced by alkaline basalts. No evidence of chemical weathering is preserved, indicating arid, possibly cold, paleoclimates and rapid erosion and deposition. The absence of predicted geochemical variations indicates that magnetite and phyllosilicates formed by diagenesis under low-temperature, circumneutral pH, rock-dominated aqueous conditions. Analyses of diagenetic features (including concretions, raised ridges, and fractures) at high spatial resolution indicate that they are composed of iron-and halogen-rich components, magnesium-iron-chlorine-rich components, and hydrated calcium sulfates, respectively. Composition of a cross-cutting dike-like feature is consistent with sedimentary intrusion. The geochemistry of these sedimentary rocks provides further evidence for diverse depositional and diagenetic sedimentary environments during the early history of Mars.	[McLennan, S. M.; Hurowitz, J. A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Anderson, R. B.; Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Bell, J. F., III; Edgar, L. A.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Bridges, J. C.] Univ Leicester, Dept Phys & Astron, Space Res Ctr, Leicester LE1 7RH, Leics, England; [Calef, F., III; Ehlmann, B. L.; Vasavada, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Campbell, J. L.; Gellert, R.; Perrett, G. M.; VanBommel, S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Clegg, S.; Cousin, A.] Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; [Conrad, P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Des Marais, D. J.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Dyar, M. D.] Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA; [Ehlmann, B. L.; Grotzinger, J. P.; Rice, M. S.; Stack, K.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Fabre, C.] Fac Sci, CNRS Georesources, UMR 7359, F-54506 Vandoeuvre Les Nancy, France; [Forni, O.; Gasnault, O.] Univ Toulouse, IRAP, UPS OMP CNRS, F-31028 Toulouse 4, France; [Gordon, S.; Newsom, H. E.; Ollila, A. M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Sci, Washington, DC 20560 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [King, P. L.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Le Mouelic, S.; Mangold, N.; Nachon, M.] LPGN CNRS UMR 6112, Lab Planetol & Geodynam, F-4432 Nantes, France; [Le Mouelic, S.; Mangold, N.; Nachon, M.] Univ Nantes, F-4432 Nantes, France; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Leveille, R.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Lewis, K. W.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Maurice, S.] Observ Midi Pyrenees, F-31400 Toulouse, France; [Ming, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Schmidt, M. E.] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; [Schwenzer, S. P.] Open Univ, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Treiman, A. H.] Lunar Planetary Sci Inst, Houston, TX 77058 USA; [Vaniman, D. T.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wiens, R. C.] Los Alamos Natl Lab, Int Space & Response Div, Los Alamos, NM 87545 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; University of Leicester; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Guelph; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Ecole Normale Superieure de Lyon (ENS de LYON); Mount Holyoke College; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of New Mexico; Smithsonian Institution; Imperial College London; Australian National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Rensselaer Polytechnic Institute; Canadian Space Agency; Princeton University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brock University; Open University - UK; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory	McLennan, SM (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	scott.mclennan@stonybrook.edu	Ramos, Miguel/K-2230-2014; Stack Morgan, Kathryn/AGY-7985-2022; Teinturier, Samuel/AAS-8663-2020; Benna, Mehdi/F-3489-2012; Dworkin, Jason P./C-9417-2012; szopa, cyril/C-6865-2015; Hayes, Alexander G/P-2024-2014; Navarro-González, Rafael/D-1748-2009; Balic-Zunic, Tonci/A-6362-2013; Sumner, Dawn Y/E-8744-2011; Zorzano, María-Paz/F-2184-2015; Schwenzer, Susanne P/H-6992-2019; Romeral Planelló, Julio J./T-1788-2017; Rodriguez-Manfredi, Jose/L-8001-2014; Gomez-Elvira, Javier/K-5829-2014; Prats, Benito/F-9467-2019; Harri, Ari-Matti/C-7142-2012; Muller, Jan-Peter/Q-8886-2019; Franz, Heather B/F-3508-2012; King, Penelope/A-1791-2011; Blanco, Juan Jose/E-3627-2014; Steele, Andrew/A-3573-2013; Avalos, Juan Jose Blanco/AAB-9447-2021; GEFFROY, Claude/AAB-9152-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Lemmon, Mark T/E-9983-2010; FABRE, Cécile/B-5827-2012; Gómez, Felipe/L-7315-2014; Glavin, Daniel P/D-6194-2012; Stipp, Susan L.S./B-8494-2019; De Pablo, Miguel Ángel/J-6442-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Martin-Torres, Javier/G-6329-2015; Gasnault, Olivier/F-4327-2010; Vicenzi, Edward/T-9430-2017	Ramos, Miguel/0000-0003-3648-6818; Teinturier, Samuel/0000-0003-1755-9524; Dworkin, Jason P./0000-0002-3961-8997; szopa, cyril/0000-0002-0090-4056; Hayes, Alexander G/0000-0001-6397-2630; Navarro-González, Rafael/0000-0002-6078-7621; Balic-Zunic, Tonci/0000-0003-1687-1233; Sumner, Dawn Y/0000-0002-7343-2061; Zorzano, María-Paz/0000-0002-4492-9650; Schwenzer, Susanne P/0000-0002-9608-0759; Romeral Planelló, Julio J./0000-0002-2205-067X; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Gomez-Elvira, Javier/0000-0002-9068-9846; Prats, Benito/0000-0003-3869-3351; Harri, Ari-Matti/0000-0001-8541-2802; Muller, Jan-Peter/0000-0002-5077-3736; King, Penelope/0000-0002-8364-9168; Blanco, Juan Jose/0000-0002-8666-0696; Steele, Andrew/0000-0001-9643-2841; Avalos, Juan Jose Blanco/0000-0002-8666-0696; GEFFROY, Claude/0000-0002-2731-9658; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Lemmon, Mark T/0000-0002-4504-5136; FABRE, Cécile/0000-0001-8627-4050; Gómez, Felipe/0000-0001-9977-7060; Glavin, Daniel P/0000-0001-7779-7765; Stipp, Susan L.S./0000-0001-7009-643X; De Pablo, Miguel Ángel/0000-0002-4496-2741; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Martin-Torres, Javier/0000-0001-6479-2236; Gasnault, Olivier/0000-0002-6979-9012; Vicenzi, Edward/0000-0003-2085-6546; Clegg, Sam/0000-0002-0338-0948; Wilson, Sharon/0000-0001-8872-8546; Gupta, Sanjeev/0000-0001-6415-1332; Johnson, Jeffrey/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Rice, Melissa/0000-0002-8370-4139; Campbell, John/0000-0002-6752-3493; Grant, John/0000-0001-8276-1281; Le Mouelic, Stephane/0000-0001-5260-1367	French Space Agency; NASA; CNES; Canadian Space Agency; NSERC (Canada); United Kingdom Space Agency (UK); Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/J005169/1, ST/I003118/1] Funding Source: researchfish	French Space Agency(Centre National D'etudes Spatiales); NASA(National Aeronautics & Space Administration (NASA)); CNES(Centre National D'etudes Spatiales); Canadian Space Agency(Canadian Space Agency); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United Kingdom Space Agency (UK); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Much of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Development and operation of the ChemCam and APXS instruments were also supported by funds from the French Space Agency, CNES, and the Canadian Space Agency. Organizations supporting research include NASA, the Canadian Space Agency, NSERC (Canada), and the United Kingdom Space Agency (UK). Chemical data presented here are derived from archived data sets in the NASA Planetary Data System (PDS), http://pds-geosciences.wustl.edu/missions/msl. We are grateful to the MSL engineering and management teams for making the mission and this scientific investigation possible and to science team members who contributed to mission operations. S. M. M. thanks Lamont-Doherty Earth Observatory of Columbia University, and especially S. Hemming, for hospitality during a sabbatical when the manuscript was being prepared.	Basaltic Volcanism Study Project, 1981, BAS VOLC TERR PLAN; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Chan LH, 2002, EARTH PLANET SC LETT, V201, P187, DOI 10.1016/S0012-821X(02)00707-0; Chan MA, 2007, GEOFLUIDS, V7, P356, DOI 10.1111/j.1468-8123.2007.00187.x; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Fedo CM, 1997, PRECAMBRIAN RES, V84, P17, DOI 10.1016/S0301-9268(96)00058-7; Gellert R., 2013, LUNAR PLANET SCI C, V44; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Grotzinger J. P., 2012, SEPM SPEC PUBL, V12; Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002515; Hurowitz JA, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002391; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002795; Hutchison R., 2004, METEORITES PETROLOGI; King PL, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002482; Knoll AH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002949; Lu FH, 2002, CHEM GEOL, V192, P149, DOI 10.1016/S0009-2541(02)00009-8; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Martinez NC, 2010, GEOLOGY, V38, P159, DOI 10.1130/G30487.1; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; McGlynn IO, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003861; McGlynn IO, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003712; McLennan S., 2008, MARTIAN SURFACE COMP, P541, DOI [DOI 10.1017/CBO9780511536076.025, 10.1017/CBO9780511536076.025]; McLennan S.M., 1993, PROCESSES CONTROLLIN, V285, P21; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; Melosh H.J., 2011, PLANETARY SURFACE PR, DOI 10.1017/CBO9780511977848; MICHALOPOULOS P, 1995, SCIENCE, V270, P614, DOI 10.1126/science.270.5236.614; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Naumov MV, 2005, GEOFLUIDS, V5, P165, DOI 10.1111/j.1468-8123.2005.00092.x; Nekvasil H, 2009, METEORIT PLANET SCI, V44, P853, DOI 10.1111/j.1945-5100.2009.tb00773.x; Nesbitt HW, 2009, PRECAMBRIAN RES, V174, P16, DOI 10.1016/j.precamres.2009.06.006; Nesbitt H.W., 2003, GEOCHEMISTRY SEDIMEN, V4, P39; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Nesbitt HW, 1996, J GEOL, V104, P525, DOI 10.1086/629850; NESBITT HW, 1992, AM J SCI, V292, P740, DOI 10.2475/ajs.292.10.740; Nesbitt HW, 1996, SEDIMENTOLOGY, V43, P341, DOI 10.1046/j.1365-3091.1996.d01-12.x; Ollila A. M., 2013, LUNAR PLANET SCI C, V44; Saha S, 2010, SEDIMENT GEOL, V228, P1, DOI 10.1016/j.sedgeo.2010.03.009; Schmidt M. E., 2013, LUNAR PLANET SCI C; SLINGERLAND R, 1986, ANNU REV EARTH PL SC, V14, P113, DOI 10.1146/annurev.ea.14.050186.000553; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres S. W., 2005, SEDIMENTARY GEOLOGY; STAMATELOPOULOUSEYMOUR K, 1980, CAN J EARTH SCI, V17, P1576, DOI 10.1139/e80-164; STEWART AD, 1993, T ROY SOC EDIN-EARTH, V84, P73, DOI 10.1017/S0263593300005939; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; SUTTNER LJ, 1986, J SEDIMENT PETROL, V56, P329; Taylor S.R., 1985, CONTINENTAL CRUST IT; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Tosca NJ, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003700; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Wang A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002516; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; Yen AS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002797; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Young GM, 1999, GEOL SOC AM BULL, V111, P264, DOI 10.1130/0016-7606(1999)111<0264:PAPOTG>2.3.CO;2; Young GM, 1998, J SEDIMENT RES, V68, P448, DOI 10.2110/jsr.68.448	62	230	235	9	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1244734	10.1126/science.1244734	http://dx.doi.org/10.1126/science.1244734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324274	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000330039300004
J	Meyer, M; Fu, QM; Aximu-Petri, A; Glocke, I; Nickel, B; Arsuaga, JL; Martinez, I; Gracia, A; de Castro, JMB; Carbonell, E; Paabo, S				Meyer, Matthias; Fu, Qiaomei; Aximu-Petri, Ayinuer; Glocke, Isabelle; Nickel, Birgit; Arsuaga, Juan-Luis; Martinez, Ignacio; Gracia, Ana; Maria Bermudez de Castro, Jose; Carbonell, Eudald; Paeaebo, Svante			A mitochondrial genome sequence of a hominin from Sima de los Huesos	NATURE			English	Article							MIDDLE-PLEISTOCENE SITE; DNA; ATAPUERCA; ANCIENT; SIERRA; EVOLUTION; (SIERRA; SPAIN).; CAVE; ALIGNMENT	Excavations of a complex of caves in the Sierra de Atapuerca in northern Spain have unearthed hominin fossils that range in age from the early Pleistocene to the Holocene(1). One of these sites, the 'Sima de los Huesos' ('pit of bones'), has yielded the world's largest assemblage of Middle Pleistocene hominin fossils(2,3), consisting of at least 28 individuals(4) dated to over 300,000 years ago(5). The skeletal remains share a number of morphological features with fossils classified as Homo heidelbergensis and also display distinct Neanderthal-derived traits(6-8). Here we determine an almost complete mitochondrial genome sequence of a hominin from Sima de los Huesos and show that it is closely related to the lineage leading to mitochondrial genomes of Denisovans(9,10), an eastern Eurasian sister group to Neanderthals. Our results pave the way for DNA research on hominins from the Middle Pleistocene.	[Meyer, Matthias; Fu, Qiaomei; Aximu-Petri, Ayinuer; Glocke, Isabelle; Nickel, Birgit; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Arsuaga, Juan-Luis; Martinez, Ignacio; Gracia, Ana] Univ Complutense Madrid, Inst Salud Carlos III, Ctr Invest Evoluc & Comportamiento Humanos, Madrid 28029, Spain; [Arsuaga, Juan-Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain; [Martinez, Ignacio; Gracia, Ana] Univ Alcala, Dept Geog & Geol, Area Paleontol, Madrid 28871, Spain; [Maria Bermudez de Castro, Jose] Ctr Nacl Invest Evoluc Humana, Burgos 09002, Spain; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43007, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Dept Hist & Hist Art, Area Prehist, Tarragona 43002, Spain	Max Planck Society; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Complutense University of Madrid; Instituto de Salud Carlos III; Complutense University of Madrid; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de	Carbonell, Eudald/G-3003-2015	Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Arsuaga, Juan Luis/0000-0001-5361-2295; martinez, ignacio/0000-0002-1835-9199	Max Planck ?Society; Presidential Innovation Fund; Junta de Castilla y Leon; Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion [CGL2009-12703-C03]; Spanish Ministerio de Economia y Competitividad [CGL2012-38434-C03]	Max Planck ?Society(Max Planck SocietyFoundation CELLEX); Presidential Innovation Fund; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government)	We thank J. Dabney, M. Dannemann, C. de Filippo, S. Lippold, K. Prufer, M. Slatkin, M. Stiller, C. Valdiosera and B. Viola for discussions and comments on the manuscript; G. Renaud and U. Stenzel for help with sequence data processing; B. Hober and A. Weihmann for performing the sequencing runs; M. Gansauge, P. Korlevic, R. Rodriguez and I. Urena for help in the laboratory; M. Schreiber for help with graphics; J. Trueba for providing the fossil image; M. Cruz Ortega for restoration of the fossil and the rest of the members of the Sima de los Huesos excavation team ?for decades of continuous efforts. Genetics work was funded by the Max Planck ?Society and its Presidential Innovation Fund. Field work at the Sierra de Atapuerca sites is funded by the Junta de Castilla y Leon and the Fundacion Atapuerca. ?Research was supported by Spanish Ministerio de Ciencia e Innovacion (project CGL2009-12703-C03) and Spanish Ministerio de Economia y Competitividad (project CGL2012-38434-C03).	Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; ARSUAGA JL, 1993, NATURE, V362, P534, DOI 10.1038/362534a0; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Arsuaga JL, 1997, SCIENCE, V277, P1086, DOI 10.1126/science.277.5329.1086; Bischoff JL, 1997, J HUM EVOL, V33, P129, DOI 10.1006/jhev.1997.0130; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; deCastro JMB, 1997, J HUM EVOL, V33, P333, DOI 10.1006/jhev.1997.0110; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Arsuaga JL, 2010, P NATL ACAD SCI USA, V107, P8910, DOI 10.1073/pnas.0914614107; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martinez I, 1997, J HUM EVOL, V33, P283, DOI 10.1006/jhev.1997.0155; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ortega AI, 2013, GEOMORPHOLOGY, V196, P122, DOI 10.1016/j.geomorph.2012.05.031; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stone AC, 2010, PHILOS T R SOC B, V365, P3277, DOI 10.1098/rstb.2010.0096; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Valdiosera C, 2006, BIOL LETT-UK, V2, P601, DOI 10.1098/rsbl.2006.0515; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	51	318	328	5	267	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					403	+		10.1038/nature12788	http://dx.doi.org/10.1038/nature12788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24305051	Green Accepted			2022-12-28	WOS:000329621800043
J	Walker, J; Darer, JD; Elmore, JG; Delbanco, T				Walker, Jan; Darer, Jonathan D.; Elmore, Joann G.; Delbanco, Tom			The Road toward Fully Transparent Medical Records	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walker, Jan; Delbanco, Tom] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; [Walker, Jan; Delbanco, Tom] Harvard Univ, Sch Med, Boston, MA USA; [Darer, Jonathan D.] Geisinger Hlth Syst, Danville, PA USA; [Elmore, Joann G.] Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Geisinger Health System; Harborview Medical Center; University of Washington; University of Washington Seattle	Walker, J (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA.				NCRR NIH HHS [UL1 RR025014] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Elias P., 2013, ROAD SHARED OFFICE V; SHENKIN BN, 1973, NEW ENGL J MED, V289, P688, DOI 10.1056/NEJM197309272891311	3	65	65	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					6	8		10.1056/NEJMp1310132	http://dx.doi.org/10.1056/NEJMp1310132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24304001				2022-12-28	WOS:000329354100004
J	Budenholzer, B				Budenholzer, Brian			HPV vaccination reduced cytologic abnormalities compared with control vaccination in young women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									ECU Brody Sch Med, Greenville, NC USA		Budenholzer, B (corresponding author), ECU Brody Sch Med, Greenville, NC USA.							Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC4	10.7326/0003-4819-159-12-201312170-02004	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343409				2022-12-28	WOS:000329735300003
J	Fox, NC; Petersen, RC				Fox, Nick C.; Petersen, Ronald C.			The G8 Dementia Research Summit-a starter for eight?	LANCET			English	Editorial Material							TRIAL		[Fox, Nick C.] UCL Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Petersen, Ronald C.] Mayo Clin, Coll Med, Dept Neurol, Alzheimers Dis Res Ctr, Rochester, MN USA	University of London; University College London; Mayo Clinic	Fox, NC (corresponding author), UCL Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1N 3BG, England.	n.fox@ucl.ac.uk	Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009	Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X	Alzheimers Research UK [ARUK-Network2011-6-ICE] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR))		Alzheimer's Disease International, 2013, WORLD ALZH REP 2013; Alzheimer's Research Trust, 2010, DEM 2010 EC BURD DEM; Department of Health, 2013, DEM CHALL FIGHT BACK; Department of Health Foreign and Commonwealth Office Prime Minister's Office, 2013, UK HOST G8 DEM SUMM; Eichler HG, 2013, NEW ENGL J MED, V369, P1577, DOI 10.1056/NEJMp1310771; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Luengo-Fernandez R, 2012, EUR J NEUROL, V19, P149, DOI 10.1111/j.1468-1331.2011.03500.x; Nakanishi M, 2014, ALZHEIMERS DEMENT, V10, P468, DOI 10.1016/j.jalz.2013.06.005; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007	10	27	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1968	1969		10.1016/S0140-6736(13)62426-5	http://dx.doi.org/10.1016/S0140-6736(13)62426-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24332306				2022-12-28	WOS:000328223700012
J	Crabtree, KN; Talipov, MR; Martinez, O; O'Connor, GD; Khursan, SL; McCarthy, MC				Crabtree, Kyle N.; Talipov, Marat R.; Martinez, Oscar, Jr.; O'Connor, Gerard D.; Khursan, Sergey L.; McCarthy, Michael C.			Detection and Structure of HOON: Microwave Spectroscopy Reveals an O-O Bond Exceeding 1.9 angstrom	SCIENCE			English	Article							AB-INITIO; ELECTRONIC-STRUCTURE; IMINE PEROXIDE; NH X; SPECTRUM; HONO; MATRIX; NO	Nitric oxide (NO) reacts with hydroxyl radicals (OH) in the gas phase to produce nitrous acid, HONO, but essentially nothing is known about the isomeric nitrosyl-O-hydroxide (HOON), owing to its perceived instability. We report the detection of gas-phase HOON in a supersonic molecular beam by Fourier transform microwave spectroscopy and a precise determination of its molecular structure by further spectroscopic analysis of its H-2, N-15, and O-18 isotopologs. HOON contains the longest O-O bond in any known molecule (1.9149 +/- 0.0005 angstrom) and appears surprisingly stable, with an abundance roughly 3% that of HONO in our experiments.	[Crabtree, Kyle N.; Martinez, Oscar, Jr.; O'Connor, Gerard D.; McCarthy, Michael C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Talipov, Marat R.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA; [Khursan, Sergey L.] Russian Acad Sci, Ufa Sci Ctr, Inst Organ Chem, Ufa 450054, Russia	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Marquette University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Ufa Institute of Chemistry	McCarthy, MC (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	mccarthy@cfa.harvard.edu	Talipov, Marat R./M-1615-2017; O'Connor, Gerard/M-1612-2016; Khursan, Sergey/F-6262-2016	Talipov, Marat R./0000-0002-7559-9666; O'Connor, Gerard/0000-0003-1831-9186; Khursan, Sergey/0000-0003-1879-944X; McCarthy, Michael/0000-0001-9142-0008	CfA Postdoctoral Fellowship from the Smithsonian Astrophysical Observatory; NSF [CHE-1058063]; National Science Foundation [OCI-0923037]; Acquisition of a Parallel Computing Cluster and Storage for the Marquette University Grid (MUGrid); Acquisition of a Linux Cluster [CBET-0521602]; Division Of Chemistry [1058063] Funding Source: National Science Foundation	CfA Postdoctoral Fellowship from the Smithsonian Astrophysical Observatory; NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Acquisition of a Parallel Computing Cluster and Storage for the Marquette University Grid (MUGrid); Acquisition of a Linux Cluster; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	K.N.C. has been supported by a CfA Postdoctoral Fellowship from the Smithsonian Astrophysical Observatory. The work in Cambridge is supported by NSF grant CHE-1058063. Calculations were funded by National Science Foundation awards OCI-0923037, MRI: Acquisition of a Parallel Computing Cluster and Storage for the Marquette University Grid (MUGrid), and CBET-0521602, Acquisition of a Linux Cluster to Support College-Wide Research and Teaching Activities. We thank C. A. Gottlieb for helpful discussions and E. S. Palmer for technical assistance.	Asatryan R, 2007, INT J CHEM KINET, V39, P378, DOI 10.1002/kin.20247; Bean BD, 2003, J PHYS CHEM A, V107, P6974, DOI 10.1021/jp034407c; DeKock RL, 2004, J PHYS CHEM A, V108, P2893, DOI 10.1021/jp036809q; FUENO T, 1992, THEOR CHIM ACTA, V82, P299, DOI 10.1007/BF01113260; HUET TR, 1990, J MOL SPECTROSC, V144, P32, DOI 10.1016/0022-2852(90)90306-B; KOPUT J, 1995, CHEM PHYS LETT, V236, P516, DOI 10.1016/0009-2614(95)00246-Z; Laursen SL, 1998, J AM CHEM SOC, V120, P12583, DOI 10.1021/ja970749i; Le Picard SD, 2010, SCIENCE, V328, P1258, DOI 10.1126/science.1184459; Li X, 2012, ATMOS CHEM PHYS, V12, P1497, DOI 10.5194/acp-12-1497-2012; Maier G, 2000, CHEM-EUR J, V6, P800, DOI 10.1002/(SICI)1521-3765(20000303)6:5<800::AID-CHEM800>3.0.CO;2-7; McCarthy MC, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3673875; Miller Y, 2006, J PHYS CHEM A, V110, P5342, DOI 10.1021/jp0559940; NAKAMURA S, 1987, J AM CHEM SOC, V109, P4142, DOI 10.1021/ja00248a003; Nizkorodov SA, 2002, J PHYS CHEM A, V106, P855, DOI [10.1021/jp013598l, 10.1021/jp0135981]; Polak R, 2004, CHEM PHYS, V303, P73, DOI 10.1016/j.chemphys.2004.04.027; Raston PL, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764298; Stanton JF, 2000, INT REV PHYS CHEM, V19, P61, DOI 10.1080/014423500229864; STUHL F, 1972, J CHEM PHYS, V57, P3671, DOI 10.1063/1.1678825; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Suma K, 2005, SCIENCE, V308, P1885, DOI 10.1126/science.1112233; Talipov MR, 2013, J PHYS CHEM A, V117, P679, DOI 10.1021/jp3110858; Talipov MR, 2009, J PHYS CHEM A, V113, P6468, DOI 10.1021/jp902527a; Troe J, 2001, INT J CHEM KINET, V33, P878, DOI 10.1002/kin.10019; Varandas AJC, 2012, J CHEM THEORY COMPUT, V8, P428, DOI 10.1021/ct200773b; Zhang JY, 2006, J PHYS CHEM A, V110, P6898, DOI 10.1021/jp0556512; Zhang N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038999	26	21	22	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1354	1357		10.1126/science.1244180	http://dx.doi.org/10.1126/science.1244180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337293				2022-12-28	WOS:000328196000046
J	Leconte, J; Forget, F; Charnay, B; Wordsworth, R; Pottier, A				Leconte, Jeremy; Forget, Francois; Charnay, Benjamin; Wordsworth, Robin; Pottier, Alizee			Increased insolation threshold for runaway greenhouse processes on Earth-like planets	NATURE			English	Article							GENERAL-CIRCULATION MODEL; HABITABLE ZONES; CLIMATE; ATMOSPHERE; TEMPERATURES; SCATTERING; WATER; EQUILIBRIUM; SENSITIVITY; SIMULATION	The increase in solar luminosity over geological timescales should warm the Earth's climate, increasing water evaporation, which will in turn enhance the atmospheric greenhouse effect. Above a certain critical insolation, this destabilizing greenhouse feedback can 'run away' until the oceans have completely evaporated(1-4). Through increases in stratospheric humidity, warming may also cause evaporative loss of the oceans to space before the runaway greenhouse state occurs(5,6). The critical insolation thresholds for these processes, however, remain uncertain because they have so far been evaluated using one-dimensional models that cannot account for the dynamical and cloud feedback effects that are key stabilizing features of the Earth's climate. Here we use a three-dimensional global climate model to show that the insolation threshold for the runaway greenhouse state to occur is about 375 W m(-2), which is significantly higher than previously thought(6,7). Our model is specifically developed to quantify the climate response of Earth-like planets to increased insolation in hot and extremely moist atmospheres. In contrast with previous studies, we find that clouds have a destabilizing feedback effect on the long-term warming. However, subsident, unsaturated regions created by the Hadley circulation have a stabilizing effect that is strong enough to shift the runaway greenhouse limit to higher values of insolation than are inferred from one-dimensional models. Furthermore, because of wavelength-dependent radiative effects, the stratosphere remains sufficiently cold and dry to hamper the escape of atmospheric water, even at large fluxes. This has strong implications for the possibility of liquid water existing on Venus early in its history, and extends the size of the habitable zone around other stars.	[Leconte, Jeremy; Forget, Francois; Charnay, Benjamin; Pottier, Alizee] Inst Pierre Simon Laplace, Meteorol Dynam Lab, F-75252 Paris, France; [Wordsworth, Robin] Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Chicago	Leconte, J (corresponding author), Inst Pierre Simon Laplace, Meteorol Dynam Lab, 4 Pl Jussieu,BP 99, F-75252 Paris, France.	jeremy.leconte@lmd.jussieu.fr			Region Ile-de-France; Div Atmospheric & Geospace Sciences [0933936] Funding Source: National Science Foundation	Region Ile-de-France(Region Ile-de-France); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank our referees, J. Kasting and Y. Abe, for their thorough review, and A. Spiga and F. Selsis for discussions. This work was supported by grants from Region Ile-de-France.	Abe Y, 2011, ASTROBIOLOGY, V11, P443, DOI 10.1089/ast.2010.0545; ARKING A, 1972, J ATMOS SCI, V29, P937, DOI 10.1175/1520-0469(1972)029<0937:TIOLSA>2.0.CO;2; BORYSOW A, 1986, ASTROPHYS J, V311, P1043, DOI 10.1086/164841; BOUCHER O, 1995, J GEOPHYS RES-ATMOS, V100, P16395, DOI 10.1029/95JD01382; BUCHOLTZ A, 1995, APPL OPTICS, V34, P2765, DOI 10.1364/AO.34.002765; Charnay B, 2013, J GEOPHYS RES-ATMOS, V118, P10414, DOI 10.1002/jgrd.50808; Clough S., 1989, ATMOS RES, V23, P229, DOI DOI 10.1016/0169-8095(89)90020-3; Forget F, 1998, ICARUS, V131, P302, DOI 10.1006/icar.1997.5874; Forget F, 2013, ICARUS, V222, P81, DOI 10.1016/j.icarus.2012.10.019; Frierson DMW, 2007, J ATMOS SCI, V64, P1959, DOI 10.1175/JAS3935.1; Goldblatt C, 2013, NAT GEOSCI, V6, P661, DOI [10.1038/NGEO1892, 10.1038/ngeo1892]; Goldblatt C, 2012, PHILOS T R SOC A, V370, P4197, DOI 10.1098/rsta.2012.0004; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; HANSEN JE, 1974, SPACE SCI REV, V16, P527, DOI 10.1007/BF00168069; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; Ishiwatari M, 2002, J ATMOS SCI, V59, P3223, DOI 10.1175/1520-0469(2002)059<3223:ANSOAO>2.0.CO;2; KASTING JF, 1984, ICARUS, V57, P335, DOI 10.1016/0019-1035(84)90122-2; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; Komabayashi M., 1967, J METEOR SOC JAPAN, V45, P137, DOI [10.2151/jmsj1965.45.1_137, DOI 10.2151/JMSJ1965.45.1_137]; Le Hir G, 2013, CLIM PAST DISCUSS, V9, P1509; Le Trent H., 1991, CLIM DYNAM, V5, P175, DOI 10.1007/BF00251808; Leconte J, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321042; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; NAKAJIMA S, 1992, J ATMOS SCI, V49, P2256, DOI 10.1175/1520-0469(1992)049<2256:ASOTGE>2.0.CO;2; Pierrehumbert RT, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/1/L8; Pierrehumbert R. T., 2010, PRINCIPLES PLANETARY, P289; PIERREHUMBERT RT, 1995, J ATMOS SCI, V52, P1784, DOI 10.1175/1520-0469(1995)052<1784:TRFATL>2.0.CO;2; Richard C, 2012, J QUANT SPECTROSC RA, V113, P1276, DOI 10.1016/j.jqsrt.2011.11.004; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Selsis F, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116654; Sherwood SC, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012585; Simpson G.C., 1927, MEM R METEOROL SOC, V11, P69; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287; VAN LEER B, 1977, J COMPUT PHYS, V23, P276, DOI [10.1016/0021-9991(77)90095-X, 10.1016/0021-9991(77)90094-8]; Wolf ET, 2013, ASTROBIOLOGY, V13, P656, DOI 10.1089/ast.2012.0936; Wordsworth R, 2013, ICARUS, V222, P1, DOI 10.1016/j.icarus.2012.09.036; Wordsworth RD, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/154; Wordsworth RD, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L48; Yang J, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L45	45	180	181	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					268	+		10.1038/nature12827	http://dx.doi.org/10.1038/nature12827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336285	Green Accepted, Green Submitted			2022-12-28	WOS:000328121500034
J	Berger, TG; Shive, M; Harper, GM				Berger, Timothy G.; Shive, Melissa; Harper, G. Michael			Pruritus in the Older Patient A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHRONIC ECZEMATOUS ERUPTIONS; ULTRAVIOLET-B PHOTOTHERAPY; QUALITY-OF-LIFE; IRON-DEFICIENCY; SKIN DISEASES; ITCH; MANAGEMENT; SYMPTOM; MANIFESTATION; PREVALENCE	IMPORTANCE Pruritus is a common problem among elderly people and, when severe, causes as much discomfort as chronic pain. Little evidence supports pruritus treatment, limiting therapeutic possibilities and resulting in challenging management problems. OBJECTIVES To present the evidence on the etiology, diagnosis, and treatment of pruritus in the elderly and, using the best available evidence, provide an approach for generalist physicians caring for older patients with pruritus. EVIDENCE REVIEW PubMed and EMBASE databases were searched (1946-August 2013). The Cochrane Database of Systematic Reviews and the Agency for Healthcare Research and Quality Systematic Review Data Repository were also searched from their inception to August 2013. References from retrieved articles were evaluated. FINDINGS More than 50% of elderly patients have xerosis (dry skin). Xerosis treatment should be included in the initial therapy for pruritus in all elderly patients. Calcium channel blockers and hydrochlorothiazide are important causes of pruritic skin eruptions in older patients. Neuropathic pruritus is infrequently considered but may cause localized itching (especially in the genital area) and generalized truncal pruritus (especially in patients with diabetes mellitus). Certain skin conditions are more common in elderly patients, including scabies, bullous pemphigoid, transient acantholytic dermatosis, and mycosis fungoides, and should be considered in elderly patients with pruritus. CONCLUSIONS AND RELEVANCE It is important to evaluate elderly patients for dermatological, systemic, and neurological etiologies of itch. A simple-to-apply diagnostic and therapeutic algorithm can be used. Xerosis, drug reactions, and neuropathy should be considered when evaluating pruritus.	[Berger, Timothy G.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Shive, Melissa] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Harper, G. Michael] Univ Calif San Francisco, Dept Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Berger, TG (corresponding author), Univ Calif San Francisco, Dept Dermatol, 1701 Divisadero St,4th Floor,POB 0316, San Francisco, CA 94143 USA.	bergert@derm.ucsf.edu			SCAN Foundation	SCAN Foundation	The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Andersen F, 2004, EXOG DERMATOL, V3, P30; Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; BEAUREGARD S, 1987, ARCH DERMATOL, V123, P1638, DOI 10.1001/archderm.123.12.1638; Bergasa NV, 2008, CLIN LIVER DIS, V12, P219, DOI 10.1016/j.cld.2007.11.009; Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P113, DOI 10.1016/j.sder.2011.04.002; Bingham LG, 2009, J AM ACAD DERMATOL, V60, P792, DOI 10.1016/j.jaad.2008.12.043; Burgess Ian F, 2003, Nurs Times, V99, P44; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Centers for Medicare & Medicaid Services, PHYS FEE SCHED; Choi EH, 2007, J INVEST DERMATOL, V127, P2847, DOI 10.1038/sj.jid.5700913; Cohen AD, 2005, J AM ACAD DERMATOL, V52, P61, DOI 10.1016/j.jaad.2004.04.039; da Costa D., 1997, BMJ-BRIT MED J, V315, P463; De Ridder D, 2010, J NEUROSURG, V113, P118, DOI 10.3171/2009.9.JNS09620; Decock S, 2012, J HEPATOL, V57, P637, DOI 10.1016/j.jhep.2012.04.023; Drucker AM, 2011, DRUG SAFETY, V34, P821, DOI 10.2165/11592780-000000000-00000; DUPONT C, 1984, DERMATOLOGICA, V169, P348, DOI 10.1159/000249626; Fargo MV, 2012, AM FAM PHYSICIAN, V85, P624; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Furue M, 2013, ACTA DERM-VENEREOL, V93, P214, DOI 10.2340/00015555-1446; GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919; Gutman AB, 2005, ARCH DERMATOL, V141, P1556, DOI 10.1001/archderm.141.12.1556; Joly P, 2007, J INVEST DERMATOL, V127, P2766, DOI 10.1038/sj.jid.5701018; Kini SP, 2011, ARCH DERMATOL, V147, P1153, DOI 10.1001/archdermatol.2011.178; KLIGMAN AM, 1979, INT J DERMATOL, V18, P23, DOI 10.1111/j.1365-4362.1979.tb01905.x; Ko MJ, 2011, BRIT J DERMATOL, V165, P633, DOI 10.1111/j.1365-2133.2011.10448.x; Ko MJ, 2013, EUR J DERMATOL, V23, P688, DOI 10.1684/ejd.2013.2100; Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x; Lay Chorng-Jang, 2011, J Clin Med Res, V3, P72, DOI 10.4021/jocmr520w; LEWIECKI EM, 1976, JAMA-J AM MED ASSOC, V236, P2319, DOI 10.1001/jama.236.20.2319; MacLean J, 2010, AUST FAM PHYSICIAN, V39, P366; Markell KW, 2010, SURG CLIN N AM, V90, P125, DOI 10.1016/j.suc.2009.09.007; Matterne U, 2011, ACTA DERM-VENEREOL, V91, P674, DOI 10.2340/00015555-1159; de Francisco AM, 2012, AM J CARDIOL, V110, P1552, DOI 10.1016/j.amjcard.2012.08.027; Paul C, 2011, DERMATOLOGY, V223, P260, DOI 10.1159/000334631; Pei AYS, 2001, PEDIATR DERMATOL, V18, P343, DOI 10.1046/j.1525-1470.2001.01952.x; Petavy-Catala C, 2001, ACTA DERM-VENEREOL, V81, P209; Reich A, 2011, CLIN DERMATOL, V29, P15, DOI 10.1016/j.clindermatol.2010.07.002; Reich A, 2009, ACTA DERM-VENEREOL, V89, P236, DOI 10.2340/00015555-0650; SALEM HH, 1982, BRIT MED J, V285, P91, DOI 10.1136/bmj.285.6335.91; Shive M, 2013, J AM ACAD DERMATOL, V69, P550, DOI 10.1016/j.jaad.2013.05.029; Solak Y, 2012, NEPHROLOGY, V17, P710, DOI 10.1111/j.1440-1797.2012.01655.x; Steinhoff M, 2011, SEMIN CUTAN MED SURG, V30, P127, DOI 10.1016/j.sder.2011.05.001; Stellon Anthony, 2002, Acupunct Med, V20, P186; Summers EM, 2013, JAMA DERMATOL, V149, P814, DOI 10.1001/jamadermatol.2013.511; Tefferi A, 2002, BLOOD, V99, P2627, DOI 10.1182/blood.V99.7.2627; Teoh YL, 2012, J AM ACAD DERMATOL, V66, pAB11; Tey HL, 2010, ACTA DERM-VENEREOL, V90, P227, DOI 10.2340/00015555-0867; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VALSECCHI R, 1983, ARCH DERMATOL, V119, P630, DOI 10.1001/archderm.119.8.630; Verhoeven EWM, 2008, ACTA DERM-VENEREOL, V88, P211, DOI 10.2340/00015555-0452; VICKERS CFH, 1973, BRIT J DERMATOL, V89, P10; Weisshaar E, 2008, ACTA DERM-VENEREOL, V88, P195, DOI 10.2340/00015555-0410; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wilson MMG, 2001, J GERONTOL A-BIOL, V56, pM424, DOI 10.1093/gerona/56.7.M424; Yalcin B, 2006, INT J DERMATOL, V45, P672, DOI 10.1111/j.1365-4632.2005.02607.x; Yamaoka H, 2010, DIABETES CARE, V33, P150, DOI 10.2337/dc09-0632; Yilmaz S, 2010, J DERMATOL, V37, P662, DOI 10.1111/j.1346-8138.2010.00830.x; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Zachariae R, 2012, ACTA DERM-VENEREOL, V92, P508, DOI 10.2340/00015555-1221; Zylicz Z, 2003, J PAIN SYMPTOM MANAG, V26, P1105, DOI 10.1016/j.jpainsymman.2003.05.004	60	69	73	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2443	2450		10.1001/jama.2013.282023	http://dx.doi.org/10.1001/jama.2013.282023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327039				2022-12-28	WOS:000328030900025
J	Clark, H				Clark, Helen			Towards a more robust investment framework for health	LANCET			English	Editorial Material							HIV; PREVENTION; UGANDA; CANCER; BREAST		United Nations Dev Programme, New York, NY 10017 USA		Clark, H (corresponding author), United Nations Dev Programme, New York, NY 10017 USA.	helen.clark@undp.org						[Anonymous], 2013, ADDR SOC DET NONC DI; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Brown AE, 2013, HIV MED, V14, P563, DOI 10.1111/hiv.12066; Gakwaya A, 2008, BRIT J CANCER, V99, P63, DOI 10.1038/sj.bjc.6604435; Grady D, 2013, NY TIMES; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Jamison DT, 2013, LANCET; Koon KP, 2013, BREAST, V22, P138, DOI 10.1016/j.breast.2012.12.017; Medecins Sans Frontieres, 2008, UNT WEB ANT PRIC RED; Roll Back Malaria Partnership UNDP, 2013, MULT ACT FRAM MAL; UN, 2013, 68 SESS GEN ASS NEW; WHO Secretariat of the Pacific Community C-POND UNDP, 2013, TRAD AGR NON COMM DI; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2006, WHO HOUS EN DAT	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					E36	E37		10.1016/S0140-6736(13)62335-1	http://dx.doi.org/10.1016/S0140-6736(13)62335-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309478				2022-12-28	WOS:000328222400003
J	Lazarus, MB; Jiang, JY; Kapuria, V; Bhuiyan, T; Janetzko, J; Zandberg, WF; Vocadlo, DJ; Herr, W; Walker, S				Lazarus, Michael B.; Jiang, Jiaoyang; Kapuria, Vaibhav; Bhuiyan, Tanja; Janetzko, John; Zandberg, Wesley F.; Vocadlo, David J.; Herr, Winship; Walker, Suzanne			HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase	SCIENCE			English	Article							CELL FACTOR-I; REPEAT DOMAIN; GLYCOSYLATION; COMPLEX; PROTEINS; NUCLEAR	Host cell factor-1 (HCF-1), a transcriptional co-regulator of human cell-cycle progression, undergoes proteolytic maturation in which any of six repeated sequences is cleaved by the nutrient-responsive glycosyltransferase, O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT). We report that the tetratricopeptide-repeat domain of O-GlcNAc transferase binds the carboxyl-terminal portion of an HCF-1 proteolytic repeat such that the cleavage region lies in the glycosyltransferase active site above uridine diphosphate-GlcNAc. The conformation is similar to that of a glycosylation-competent peptide substrate. Cleavage occurs between cysteine and glutamate residues and results in a pyroglutamate product. Conversion of the cleavage site glutamate into serine converts an HCF-1 proteolytic repeat into a glycosylation substrate. Thus, protein glycosylation and HCF-1 cleavage occur in the same active site.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kapuria, Vaibhav; Bhuiyan, Tanja; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Zandberg, Wesley F.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Lazarus, Michael B.; Janetzko, John] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; University of Lausanne; Simon Fraser University; Harvard University; Simon Fraser University	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch; Suzanne_Walker@hms.harvard.edu	Zandberg, Wesley/AAX-5568-2021; Janetzko, John/AAQ-2602-2021; Herr, Winship/E-6491-2012; Vocadlo, David J/E-5508-2014	Janetzko, John/0000-0003-1604-2515; Herr, Winship/0000-0002-3606-4546; Vocadlo, David J/0000-0001-6897-5558; Lazarus, Michael/0000-0002-6738-2563; Kapuria, Vaibhav/0000-0003-1514-419X	National Institutes of Health (NIH) [R01GM094263]; Swiss National Science Foundation (SNSF) [31003A_130829]; University of Lausanne; Natural Sciences and Engineering Research Council of Canada (NSERC); Simon Fraser University; European Molecular Biology Organization (EMBO); NSERC PGS-M; D3; E. W. R. Steacie Memorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); University of Lausanne; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NSERC PGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); D3; E. W. R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM094263 to S. W., Swiss National Science Foundation (SNSF) grant 31003A_130829 and the University of Lausanne to W. H., and the Natural Sciences and Engineering Research Council of Canada (NSERC) and Simon Fraser University to D.J.V. M. B. L. is a Merck Fellow of the Helen Hay Whitney Foundation. V. K. is an European Molecular Biology Organization (EMBO) long-term fellowship recipient. J.J. is an NSERC PGS-M and D3 fellowship recipient. D.J.V. is a recipient of an E. W. R. Steacie Memorial Fellowship and holds a Canada Research Chair in Chemical Glycobiology. We thank A. Heroux (B.N.L.) for assistance with x-ray data collection. We thank V. Zoete for helpful discussions and M. Bogyo for reading the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with accession nos. 4N39, 4N3A, 4N3B, and 4N3C.	Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KHAN SA, 1982, J BIOL CHEM, V257, P1864; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; TWARDZIK DR, 1972, P NATL ACAD SCI USA, V69, P274, DOI 10.1073/pnas.69.1.274; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711	25	122	123	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1235	1239		10.1126/science.1243990	http://dx.doi.org/10.1126/science.1243990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311690	Green Accepted			2022-12-28	WOS:000327857900048
J	Straneo, F; Heimbach, P				Straneo, Fiammetta; Heimbach, Patrick			North Atlantic warming and the retreat of Greenland's outlet glaciers	NATURE			English	Review							SEA-LEVEL RISE; ICE-SHEET; JAKOBSHAVN ISBRAE; EAST GREENLAND; CLIMATE-CHANGE; TIDEWATER GLACIERS; SUBPOLAR GYRE; LABRADOR SEA; OCEAN; VARIABILITY	Mass loss from the Greenland ice sheet quadrupled over the past two decades, contributing a quarter of the observed global sea-level rise. Increased submarine melting is thought to have triggered the retreat of Greenland's outlet glaciers, which is partly responsible for the ice loss. However, the chain of events and physical processes remain elusive. Recent evidence suggests that an anomalous inflow of subtropical waters driven by atmospheric changes, multidecadal natural ocean variability and a long-term increase in the North Atlantic's upper ocean heat content since the 1950s all contributed to a warming of the subpolar North Atlantic. This led, in conjunction with increased runoff, to enhanced submarine glacier melting. Future climate projections raise the potential for continued increases in warming and ice-mass loss, with implications for sea level and climate.	[Straneo, Fiammetta] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA; [Heimbach, Patrick] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Straneo, F (corresponding author), Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA.	fstraneo@whoi.edu	Heimbach, Patrick/K-3530-2013	Heimbach, Patrick/0000-0003-3925-6161; Straneo, Fiammetta/0000-0002-1735-2366	US CLIVAR; Estimating the Circulation and Climate of the Oceans (ECCO) project; NASA; NSF; DOE; NOAA; WHOI's OCCI; Directorate For Geosciences [0909373, 1129746] Funding Source: National Science Foundation; Division Of Ocean Sciences [1550290] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1118473, 1023499] Funding Source: National Science Foundation	US CLIVAR; Estimating the Circulation and Climate of the Oceans (ECCO) project; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); WHOI's OCCI; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Part of the work discussed here benefited from discussions within the US CLIVAR Working Group on Greenland Ice Sheet-Ocean Interactions (GRISO). US CLIVAR and its sponsoring agencies are thanked for supporting a workshop on this subject held in Beverly, Massachusetts, from June 4-7, 2013. P. H. gratefully acknowledges core support through the Estimating the Circulation and Climate of the Oceans (ECCO) project, and supplemental funding from NASA, NSF, DOE and NOAA. F.S. gratefully acknowledges funding from NSF, NASA and WHOI's OCCI.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Andresen CS, 2012, NAT GEOSCI, V5, P37, DOI [10.1038/ngeo1349, 10.1038/NGEO1349]; Bamber J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052552; Bersch M, 2007, OCEAN DYNAM, V57, P223, DOI 10.1007/s10236-007-0104-7; Bjork AA, 2012, NAT GEOSCI, V5, P427, DOI [10.1038/NGEO1481, 10.1038/ngeo1481]; Box JE, 2009, J CLIMATE, V22, P4029, DOI 10.1175/2009JCLI2816.1; Chhak KC, 2009, J PHYS OCEANOGR, V39, P162, DOI 10.1175/2008JPO3972.1; Christoffersen P, 2011, CRYOSPHERE, V5, P701, DOI 10.5194/tc-5-701-2011; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Clift PD., 2011, EOS T AM GEOPHYS UN, V92, P205, DOI [10.1029/2011EO240006, DOI 10.1029/2011EO240006, 10.1029/2011EO370001, DOI 10.1029/2011EO370001]; Dickson R, 2007, PROG OCEANOGR, V73, P210, DOI 10.1016/j.pocean.2006.12.003; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Gelderloos R, 2011, J PHYS OCEANOGR, V41, P2102, DOI 10.1175/JPO-D-11-054.1; Gillet-Chaulet F, 2012, CRYOSPHERE, V6, P1561, DOI 10.5194/tc-6-1561-2012; Hakkinen S, 2013, J GEOPHYS RES-OCEANS, V118, P3670, DOI 10.1002/jgrc.20268; Hakkinen S, 2011, SCIENCE, V334, P655, DOI 10.1126/science.1205683; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Hall DK, 2013, GEOPHYS RES LETT, V40, P2114, DOI 10.1002/grl.50240; Hanna E, 2013, INT J CLIMATOL, V33, P862, DOI 10.1002/joc.3475; Hanna E, 2013, NATURE, V498, P51, DOI 10.1038/nature12238; Hanna E, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016387; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Holland DM, 1999, J PHYS OCEANOGR, V29, P1787, DOI 10.1175/1520-0485(1999)029<1787:MTIOIA>2.0.CO;2; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, J GLACIOL, V57, P389, DOI 10.3189/002214311796905631; Hu AX, 2013, J CLIMATE, V26, P3087, DOI 10.1175/JCLI-D-12-00102.1; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jenkins A, 2011, J PHYS OCEANOGR, V41, P2279, DOI 10.1175/JPO-D-11-03.1; Johnson HL, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006519; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002110; Khan SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042460; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Lindstrom E., 2012, IOCINF1284; Lloyd J, 2011, GEOLOGY, V39, P867, DOI 10.1130/G32076.1; Lohmann K, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039166; Lorbacher K, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007733; Lozier MS, 2008, SCIENCE, V319, P800, DOI 10.1126/science.1146436; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; MANABE S, 1980, J GEOPHYS RES-OCEANS, V85, P5529, DOI 10.1029/JC085iC10p05529; Marsh R, 2010, OCEAN SCI, V6, P749, DOI 10.5194/os-6-749-2010; Mitrovica JX, 2011, GEOPHYS J INT, V187, P729, DOI 10.1111/j.1365-246X.2011.05090.x; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Mortensen J, 2013, J GEOPHYS RES-OCEANS, V118, P1382, DOI 10.1002/jgrc.20134; Mortensen J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006528; Motyka RJ, 2003, ANN GLACIOL, V36, P57, DOI 10.3189/172756403781816374; Motyka RJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001632; Mugford RI, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001735; Myers P. G., 2013, J PHYS OCEANOGR; Myers PG, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030419; Nick FM, 2013, NATURE, V497, P235, DOI 10.1038/nature12068; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Nowicki S, 2013, J GEOPHYS RES-EARTH, V118, P1025, DOI 10.1002/jgrf.20076; O'Leary M, 2013, CRYOSPHERE, V7, P119, DOI 10.5194/tc-7-119-2013; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Podrasky D, 2012, J GLACIOL, V58, P1212, DOI 10.3189/2012JoG12J065; Polyakov IV, 2012, J CLIMATE, V25, P8362, DOI 10.1175/JCLI-D-12-00266.1; Polyakov IV, 2005, J CLIMATE, V18, P4562, DOI 10.1175/JCLI3548.1; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Reverdin G, 2010, J CLIMATE, V23, P4571, DOI 10.1175/2010JCLI3493.1; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2010, NAT GEOSCI, V3, P187, DOI 10.1038/NGEO765; Salcedo-Castro J, 2011, CONT SHELF RES, V31, P1396, DOI 10.1016/j.csr.2011.06.002; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Sciascia R, 2013, J GEOPHYS RES-OCEANS, V118, P2492, DOI 10.1002/jgrc.20142; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Sole A, 2008, CRYOSPHERE, V2, P205, DOI 10.5194/tc-2-205-2008; Stammer D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004079; Stammer D, 2013, ANNU REV MAR SCI, V5, P21, DOI 10.1146/annurev-marine-121211-172406; Straneo F, 2013, B AM METEOROL SOC, V94, P1131, DOI 10.1175/BAMS-D-12-00100.1; Straneo F, 2012, ANN GLACIOL, V53, P202, DOI 10.3189/2012AoG60A059; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Sutherland DA, 2008, PROG OCEANOGR, V78, P58, DOI 10.1016/j.pocean.2007.09.006; Sutherland DA, 2013, J GEOPHYS RES-OCEANS, V118, P847, DOI 10.1029/2012JC008354; Sutherland DA, 2012, ANN GLACIOL, V53, P50, DOI 10.3189/2012AoG60A050; Thomas RH, 2004, J GLACIOL, V50, P57, DOI 10.3189/172756504781830321; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Vage K, 2011, DEEP-SEA RES PT I, V58, P590, DOI 10.1016/j.dsr.2011.03.001; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Vieli A, 2011, SURV GEOPHYS, V32, P437, DOI 10.1007/s10712-011-9132-4; Visbeck M., 2003, N ATLANTIC OSCILLATI, V134, P113, DOI DOI 10.1029/134GM06; Weijer W, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051611; Williams R. G., 2013, J CLIMATOL; Woollings T, 2012, NAT GEOSCI, V5, P313, DOI [10.1038/ngeo1438, 10.1038/NGEO1438]; Woollings T, 2008, Q J ROY METEOR SOC, V134, P1635, DOI 10.1002/qj.310; Wouters B, 2013, NAT GEOSCI, V6, P613, DOI [10.1038/ngeo1874, 10.1038/NGEO1874]; Wunsch C., 2013, OCEAN CIRCULATION CL, P553, DOI [DOI 10.1016/B978-0-12-391851-2.00021-0, 10.1016/B978-0-12-391851-2.00021-0]; Wunsch C, 2013, P NATL ACAD SCI USA, V110, P4435, DOI 10.1073/pnas.1302536110; Xu Y, 2013, GEOPHYS RES LETT, V40, P4648, DOI 10.1002/grl.50825; Xu Y, 2012, ANN GLACIOL, V53, P229, DOI 10.3189/2012AoG60A139; Yashayaev I, 2007, PROG OCEANOGR, V73, P242, DOI 10.1016/j.pocean.2007.04.015; Yin JJ, 2011, NAT GEOSCI, V4, P524, DOI [10.1038/ngeo1189, 10.1038/NGEO1189]; Zweng MM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003093	100	267	272	20	279	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					36	43		10.1038/nature12854	http://dx.doi.org/10.1038/nature12854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305146				2022-12-28	WOS:000327851700023
J	Sinsky, CA; Beasley, JW				Sinsky, Christine A.; Beasley, John W.			Texting While Doctoring: A Patient Safety Hazard	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Associates Clin, Dubuque, IA USA; Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Sinsky, CA (corresponding author), Med Assoc Clin & Hlth Plans, Dept Internal Med, 1000 Langworthy St, Dubuque, IA 52001 USA.	csinsky1@mahealthcare.com						Anderson Peter, 2008, Fam Pract Manag, V15, P35; Beasley JW, 2011, J AM BOARD FAM MED, V24, P745, DOI 10.3122/jabfm.2011.06.100255; Centers for Medicare & Medicaid Services, EHR INC PROGR STAG 2; Governor's Highway Safety Association, 2013, DISTR DRIV LAWS; Harman JS, 2012, J GEN INTERN MED, V27, P962, DOI 10.1007/s11606-012-2001-0; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Macy Jr Josiah, 2011, TEAM BAS COMP BUILD; Olson R. L., 2009, DRIVER DISTRACTION C; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Zheng K, 2010, J AM MED INFORM ASSN, V17, P454, DOI 10.1136/jamia.2010.004440	10	17	17	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					782	+		10.7326/0003-4819-159-11-201312030-00012	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297196				2022-12-28	WOS:000328731000009
J	Politi, MC; Dizon, DS; Frosch, DL; Kuzemchak, MD; Stiggelbout, AM				Politi, Mary C.; Dizon, Don S.; Frosch, Dominick L.; Kuzemchak, Marie D.; Stiggelbout, Anne M.			Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER-PATIENTS; SUPPORT INTERVENTIONS; HEALTH-PROFESSIONALS; BREAST-CANCER; PATIENTS WANT; INVOLVEMENT; INFORMATION; PHYSICIANS; DIFFICULT; OPTIONS		[Politi, Mary C.; Kuzemchak, Marie D.] Washington Univ, Sch Med, Div Publ Hlth Sci, Dept Surg, St Louis, MO 63112 USA; [Dizon, Don S.] Massachusetts Gen Hosp, Ctr Canc, Gillette Ctr Gynecol Oncol, Boston, MA USA; [Dizon, Don S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Frosch, Dominick L.] Gordon & Betty Moore Fdn, Patient Care Program, Palo Alto, CA USA; [Frosch, Dominick L.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Frosch, Dominick L.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Stiggelbout, Anne M.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands	Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Palo Alto Medical Foundation Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Politi, MC (corresponding author), Washington Univ, Sch Med, Div Publ Hlth Sci, Dept Surg, 660 South Euclid Ave,Campus Box 8100, St Louis, MO 63112 USA.	mpoliti@wustl.edu	Stiggelbout, Anne M/D-2293-2018; Dizon, Don Steven/I-3634-2019	Stiggelbout, Anne M/0000-0002-6293-4509; Dizon, Don Steven/0000-0001-6541-9580; Politi, Mary/0000-0001-9103-6495				Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Benbassat J, 1998, BEHAV MED, V24, P81, DOI 10.1080/08964289809596384; Caldon LJM, 2011, HEALTH EXPECT, V14, P133, DOI 10.1111/j.1369-7625.2010.00633.x; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Edwards A, 2006, HEALTH EXPECT, V9, P307, DOI 10.1111/j.1369-7625.2006.00401.x; Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922; Elwyn G, 1999, BRIT MED J, V319, P753, DOI 10.1136/bmj.319.7212.753; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, MED DECIS MAKING, V30, P701, DOI 10.1177/0272989X10386231; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Fowler FJ, 2013, JAMA INTERN MED, V173, P1215, DOI 10.1001/jamainternmed.2013.6172; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Graham ID, 2003, PATIENT EDUC COUNS, V50, P279, DOI 10.1016/S0738-3991(03)00050-8; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Hawley ST, 2007, PATIENT EDUC COUNS, V65, P387, DOI 10.1016/j.pec.2006.09.010; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; Lanz NK, 2004, J CLIN ONCOL, V22, P3091, DOI 10.1200/JCO.2004.09.069; LEGARE F, 2010, COCHRANE DB SYST REV, V5; Legare F, 2012, PATIENT EDUC COUNS, V88, P159, DOI 10.1016/j.pec.2012.01.002; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Livaudais JC, 2013, J GEN INTERN MED, V28, P630, DOI 10.1007/s11606-012-2274-3; Mazur DJ, 1997, J GEN INTERN MED, V12, P114, DOI 10.1046/j.1525-1497.1997.00016.x; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Politi MC, 2011, J EVAL CLIN PRACT, V17, P579, DOI 10.1111/j.1365-2753.2010.01549.x; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Shepherd HL, 2011, PATIENT EDUC COUNS, V84, P379, DOI 10.1016/j.pec.2011.07.022; Stacey D, 2008, CA-CANCER J CLIN, V58, P293, DOI 10.3322/CA.2008.0006; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Street RL, 2011, J GEN INTERN MED, V26, P21, DOI 10.1007/s11606-010-1453-3; Swainston K, 2012, BRIT J HEALTH PSYCH, V17, P155, DOI 10.1111/j.2044-8287.2011.02028.x; Towle A, 2006, HEALTH EXPECT, V9, P321, DOI 10.1111/j.1369-7625.2006.00404.x; van Tol-Geerdink JJ, 2006, INT J RADIAT ONCOL, V66, P1105, DOI 10.1016/j.ijrobp.2006.07.001; Wetzels R, 2004, PATIENT EDUC COUNS, V53, P183, DOI 10.1016/S0738-3991(03)00145-9; Wrede-Sach Jennifer, 2013, Int J Family Med, V2013, P478498, DOI 10.1155/2013/478498	38	72	74	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								F7066	10.1136/bmj.f7066	http://dx.doi.org/10.1136/bmj.f7066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268CV	24297974	Green Submitted			2022-12-28	WOS:000328146700003
J	Herwig, P; Zawatzky, K; Grieser, M; Heber, O; Jordon-Thaden, B; Krantz, C; Novotny, O; Repnow, R; Schurig, V; Schwalm, D; Vager, Z; Wolf, A; Trapp, O; Kreckel, H				Herwig, Philipp; Zawatzky, Kerstin; Grieser, Manfred; Heber, Oded; Jordon-Thaden, Brandon; Krantz, Claude; Novotny, Oldrich; Repnow, Roland; Schurig, Volker; Schwalm, Dirk; Vager, Zeev; Wolf, Andreas; Trapp, Oliver; Kreckel, Holger			Imaging the Absolute Configuration of a Chiral Epoxide in the Gas Phase	SCIENCE			English	Article							MOLECULES; RESOLUTION	In chemistry and biology, chirality, or handedness, refers to molecules that exist in two spatial configurations that are incongruent mirror images of one another. Almost all biologically active molecules are chiral, and the correct determination of their absolute configuration is essential for the understanding and the development of processes involving chiral molecules. Anomalous x-ray diffraction and vibrational optical activity measurements are broadly used to determine absolute configurations of solid or liquid samples. Determining absolute configurations of chiral molecules in the gas phase is still a formidable challenge. Here we demonstrate the determination of the absolute configuration of isotopically labeled (R,R)-2,3-dideuterooxirane by foil-induced Coulomb explosion imaging of individual molecules. Our technique provides unambiguous and direct access to the absolute configuration of small gas-phase species, including ions and molecular fragments.	[Herwig, Philipp; Grieser, Manfred; Jordon-Thaden, Brandon; Krantz, Claude; Novotny, Oldrich; Repnow, Roland; Schwalm, Dirk; Wolf, Andreas; Kreckel, Holger] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Zawatzky, Kerstin; Trapp, Oliver] Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany; [Heber, Oded; Schwalm, Dirk; Vager, Zeev] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Novotny, Oldrich] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Schurig, Volker] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Weizmann Institute of Science; Columbia University; Eberhard Karls University of Tubingen	Trapp, O (corresponding author), Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany.	trapp@oci.uni-heidelberg.de; holger.kreckel@mpi-hd.mpg.de	Kreckel, Holger/F-4969-2010; Wolf, Andreas/O-4440-2017; Novotny, Oldrich/K-6691-2013; Trapp, Oliver/AAB-9707-2019; Trapp, Oliver/A-2114-2014	Kreckel, Holger/0000-0003-0511-0738; Wolf, Andreas/0000-0003-1198-9013; Novotny, Oldrich/0000-0003-2520-343X; Trapp, Oliver/0000-0002-3594-5181; 	Max-Planck Society; Ruprecht-Karls Universitat Heidelberg; NASA; NSF; European Research Council [StG 307163, StG 258740]; Weizmann Institute	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Ruprecht-Karls Universitat Heidelberg; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Weizmann Institute	This work was supported by the Max-Planck Society and the Ruprecht-Karls Universitat Heidelberg. O.N. was supported, in part, by grants from NASA and the NSF. H.K. and O.T. were supported by the European Research Council under Grant Agreements StG 307163 and StG 258740, respectively. D.S. acknowledges support by the Weizmann Institute through the Joseph Meyerhoff program. We thank B. F. Straub for support in the quantum-chemical calculations and F. Rominger for x-ray structure analysis. We thank G. Helmchen and H. Wadepohl for helpful discussions. We are grateful for the support from the Max-Planck-Institut fur Kernphysik accelerator staff, and we thank O. Koschorreck for assistance with the CEI detector electronics. Metrical parameters for the crystal structures of compounds [triphenylsilyl propargyl alcohol, 2, (S,S)-3 and (S,S)-4] are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC 964292, CCDC 964293, CCDC 964294, and CCDC 964295, respectively.	ADDADI L, 1982, NATURE, V296, P21, DOI 10.1038/296021a0; Barron LD, 2010, CHEM PHYS LETT, V492, P199, DOI 10.1016/j.cplett.2010.03.090; BARRON LD, 1973, J AM CHEM SOC, V95, P603, DOI 10.1021/ja00783a058; BERKOVITCHYELLIN Z, 1982, NATURE, V296, P27, DOI 10.1038/296027a0; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; EVANS D, 1965, NATURE, V208, P1203, DOI 10.1038/2081203b0; Fang HB, 1998, J PHYS CHEM B, V102, P7311, DOI 10.1021/jp981960z; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Freedman TB, 2003, CHIRALITY, V15, P743, DOI 10.1002/chir.10287; GAO Y, 1987, J AM CHEM SOC, V109, P5765, DOI 10.1021/ja00253a032; Haesler J, 2007, NATURE, V446, P526, DOI 10.1038/nature05653; He YA, 2011, APPL SPECTROSC, V65, P699, DOI 10.1366/11-06321; Herwig P, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.062513; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Jordon-Thaden B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.193003; Klyne W., 1978, ATLAS STEREOCHEMISTR, V2; Klyne W., 1978, ATLAS STEREOCHEMISTR, V1; Lammich L, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062904; NIKOLAEV VS, 1965, SOV PHYS USPEKHI, V8, P269, DOI 10.1070/PU1965v008n02ABEH003043; PARIKH JR, 1967, J AM CHEM SOC, V89, P5505, DOI 10.1021/ja00997a067; Pitzer M, 2013, SCIENCE, V341, P1096, DOI 10.1126/science.1240362; SCHWAB JM, 1986, J CHEM SOC CHEM COMM, P872, DOI 10.1039/c39860000872; SCHWAB JM, 1989, J AM CHEM SOC, V111, P1057, DOI 10.1021/ja00185a041; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; STEPHENS PJ, 1985, J PHYS CHEM-US, V89, P748, DOI 10.1021/j100251a006; VAGER Z, 1989, SCIENCE, V244, P426, DOI 10.1126/science.244.4903.426; Wester R, 2002, J CHEM PHYS, V116, P7000, DOI 10.1063/1.1461812; Wester R, 1998, NUCL INSTRUM METH A, V413, P379, DOI 10.1016/S0168-9002(98)00553-1	28	98	97	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1084	1086		10.1126/science.1246549	http://dx.doi.org/10.1126/science.1246549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288330				2022-12-28	WOS:000327518600054
J	Kronke, J; Udeshi, ND; Narla, A; Grauman, P; Hurst, SN; McConkey, M; Svinkina, T; Heckl, D; Comer, E; Li, XY; Ciarlo, C; Hartman, E; Munshi, N; Schenone, M; Schreiber, SL; Carr, SA; Ebert, BL				Kroenke, Jan; Udeshi, Namrata D.; Narla, Anupama; Grauman, Peter; Hurst, Slater N.; McConkey, Marie; Svinkina, Tanya; Heckl, Dirk; Comer, Eamon; Li, Xiaoyu; Ciarlo, Christie; Hartman, Emily; Munshi, Nikhil; Schenone, Monica; Schreiber, Stuart L.; Carr, Steven A.; Ebert, Benjamin L.			Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells	SCIENCE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; UBIQUITIN LIGASE; IKAROS GENE; TRANSCRIPTION FACTOR; AIOLOS; LYMPHOMA; DIFFERENTIATION; IDENTIFICATION; POMALIDOMIDE; ACTIVATION	Lenalidomide is a drug with clinical efficacy in multiple myeloma and other B cell neoplasms, but its mechanism of action is unknown. Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. IKZF1 and IKZF3 are essential transcription factors in multiple myeloma. A single amino acid substitution of IKZF3 conferred resistance to lenalidomide-induced degradation and rescued lenalidomide-induced inhibition of cell growth. Similarly, we found that lenalidomide-induced interleukin-2 production in T cells is due to depletion of IKZF1 and IKZF3. These findings reveal a previously unknown mechanism of action for a therapeutic agent: alteration of the activity of an E3 ubiquitin ligase, leading to selective degradation of specific targets.	[Kroenke, Jan; Narla, Anupama; Grauman, Peter; Hurst, Slater N.; McConkey, Marie; Heckl, Dirk; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Udeshi, Namrata D.; Svinkina, Tanya; Comer, Eamon; Li, Xiaoyu; Ciarlo, Christie; Hartman, Emily; Schenone, Monica; Schreiber, Stuart L.; Carr, Steven A.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Munshi, Nikhil] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Ebert, BL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	bebert@partners.org	Carr, Steven A./AAH-8366-2019; Heckl, Dirk/GMW-5407-2022; Munshi, Nikhil/ABE-2338-2021	Kronke, Jan/0000-0002-4649-0506	NIH [R01HL082945, P01 CA108631]; Leukemia and Lymphoma Society Scholar Award; Evans Foundation grant; Starr Cancer Consortium; SPARC consortium; National Human Genome Research Institute [RL1-HG004671]; German Research Foundation (DFG) [Kr-3886/1-1]; German Cancer Aid; Celgene; NATIONAL CANCER INSTITUTE [P01CA155258, P50CA100707, P01CA108631, P01CA078378] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Evans Foundation grant; Starr Cancer Consortium; SPARC consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y.-T. Tai (Dana-Faber Cancer Institute) for technical assistance with primary multiple myeloma samples. This work was supported by funding from the NIH (R01HL082945, P01 CA108631), a Leukemia and Lymphoma Society Scholar Award, an Evans Foundation grant, and a grant from the Starr Cancer Consortium to B. L. E. In addition, the work was supported by a grant from the SPARC consortium and by an National Human Genome Research Institute (RL1-HG004671) initiative in genome-based drug discovery. J.K. was supported by the German Research Foundation (DFG, Kr-3886/1-1). D. H. was supported by the German Cancer Aid. B. L. E. and N.M. have received consulting fees from Celgene. The authors (J.K., N.D.U., S. A. C., and B. L. E.) and the Broad Institute have filed a patent application (number 61/902,066) pertaining to the prediction of therapeutic response to lenalidomide and related compounds.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Chanan-Khan A, 2006, J CLIN ONCOL, V24, P5343, DOI 10.1200/JCO.2005.05.0401; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Habermann TM, 2009, BRIT J HAEMATOL, V145, P344, DOI 10.1111/j.1365-2141.2009.07626.x; Haslett PAJ, 1998, J EXP MED, V187, P1885, DOI 10.1084/jem.187.11.1885; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nuckel H, 2009, BRIT J HAEMATOL, V144, P268, DOI 10.1111/j.1365-2141.2008.07442.x; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	27	998	1074	27	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					301	305		10.1126/science.1244851	http://dx.doi.org/10.1126/science.1244851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24292625	Green Accepted			2022-12-28	WOS:000329718600037
J	Abril, G; Martinez, JM; Artigas, LF; Moreira-Turcq, P; Benedetti, MF; Vidal, L; Meziane, T; Kim, JH; Bernardes, MC; Savoye, N; Deborde, J; Souza, EL; Alberic, P; de Souza, MFL; Roland, F				Abril, Gwenael; Martinez, Jean-Michel; Artigas, L. Felipe; Moreira-Turcq, Patricia; Benedetti, Marc F.; Vidal, Luciana; Meziane, Tarik; Kim, Jung-Hyun; Bernardes, Marcelo C.; Savoye, Nicolas; Deborde, Jonathan; Souza, Edivaldo Lima; Alberic, Patrick; Landim de Souza, Marcelo F.; Roland, Fabio			Amazon River carbon dioxide outgassing fuelled by wetlands	NATURE			English	Article							NET PRIMARY PRODUCTIVITY; FRESH-WATER WETLANDS; FLOODPLAIN LAKE; GAS-EXCHANGE; TROPICAL RESERVOIR; LAGO GRANDE; CO2; VEGETATION; RESPIRATION; INUNDATION	River systems connect the terrestrial biosphere, the atmosphere and the ocean in the global carbon cycle(1). A recent estimate suggests that up to 3 petagrams of carbon per year could be emitted as carbon dioxide (CO2) from global inland waters, offsetting the carbon uptake by terrestrial ecosystems(2). It is generally assumed that inland waters emit carbon that has been previously fixed upstream by land plant photosynthesis, then transferred to soils, and subsequently transported downstream in run-off. But at the scale of entire drainage basins, the lateral carbon fluxes carried by small rivers upstream do not account for all of the CO2 emitted from inundated areas downstream(3,4). Three-quarters of the world's flooded land consists of temporary wetlands(5), but the contribution of these productive ecosystems(6) to the inland water carbon budget has been largely overlooked. Here we show that wetlands pump large amounts of atmospheric CO2 into river waters in the floodplains of the central Amazon. Flooded forests and floating vegetation export large amounts of carbon to river waters and the dissolved CO2 can be transported dozens to hundreds of kilometres downstream before being emitted. We estimate that Amazonian wetlands export half of their gross primary production to river waters as dissolved CO2 and organic carbon, compared with only a few per cent of gross primary production exported in upland (not flooded) ecosystems(1,7). Moreover, we suggest that wetland carbon export is potentially large enough to account for at least the 0.21 petagrams of carbon emitted per year as CO2 from the central Amazon River and its floodplains(8). Global carbon budgets should explicitly address temporary or vegetated flooded areas, because these ecosystems combine high aerial primary production with large, fast carbon export, potentially supporting a substantial fraction of CO2 evasion from inland waters.	[Abril, Gwenael; Savoye, Nicolas; Deborde, Jonathan] Univ Bordeaux 1, CNRS, Lab Environm & Paleoenvironm Ocean & Continentaux, F-33405 Talence, France; [Abril, Gwenael; Martinez, Jean-Michel; Moreira-Turcq, Patricia] Univ Toulouse 3, Inst Rech Dev, Lab Geosci & Environm Toulouse, F-31400 Toulouse, France; [Artigas, L. Felipe] Univ Littoral Cote dOpale, CNRS, Lab Oceanol & Geosci, F-62930 Wimereux, France; [Benedetti, Marc F.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Equipe Geochim Eaux, F-75205 Paris 13, France; [Vidal, Luciana; Roland, Fabio] Univ Fed Juiz de Fora, Dept Biol, Aquat Ecol Lab, BR-36036900 Juiz De Fora, MG, Brazil; [Meziane, Tarik] UPMC, Museum Natl Hist Nat, Lab Biol Organismes & Ecosyst Aquat BOREA, CNRS,IRD, F-75005 Paris, France; [Kim, Jung-Hyun] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Bernardes, Marcelo C.] Univ Fed Fluminense, Programa Geoquim, BR-24020015 Niteroi, RJ, Brazil; [Souza, Edivaldo Lima] Univ Brasilia, Inst Geociencias, BR-70910900 Brasilia, DF, Brazil; [Alberic, Patrick] Inst Sci Terre Orleans, F-45071 Orleans 2, France; [Landim de Souza, Marcelo F.] Univ Estadual Santa Cruz, Lab Oceanog Quim, BR-45662900 Ilheus, BA, Brazil	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite du Littoral-Cote-d'Opale; UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Juiz de Fora; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidade Federal Fluminense; Universidade de Brasilia; Universidade Estadual de Santa Cruz	Abril, G (corresponding author), Univ Bordeaux 1, CNRS, Lab Environm & Paleoenvironm Ocean & Continentaux, Ave Fac, F-33405 Talence, France.	g.abril@epoc.u-bordeaux1.fr	Meziane, Tarik/A-5465-2009; Benedetti, Marc F./S-3675-2019; Roland, Fabio/C-7918-2013; Vidal, Luciana O/D-5957-2013; Meziane, Tarik/AAF-7906-2020; Martinez, Jean-Michel Albert/AAK-4410-2020; Benedetti, Marc F./A-5463-2011; Artigas, Luis Felipe/L-1264-2016; Bernardes, Marcelo C/H-7869-2012; Vidal, Luciana O/V-4819-2019; Souza, Marcelo F.L./H-8743-2013; Abril, Gwenaël/C-7835-2011	Meziane, Tarik/0000-0003-2142-6441; Meziane, Tarik/0000-0003-2142-6441; Martinez, Jean-Michel Albert/0000-0003-3281-8512; Benedetti, Marc F./0000-0003-1075-8205; Bernardes, Marcelo C/0000-0002-4338-4353; Abril, Gwenaël/0000-0002-4914-086X; Deborde, Jonathan/0000-0002-4045-5953; Vidal, Luciana/0000-0001-5065-0835; Artigas, Luis Felipe/0000-0003-0512-5315	French National Agency for Research [08-BLAN-0221]; French INSU national programme EC2CO; National Council of Research and Development (CNPq), Brazil [477655/2010-6]; Environmental Research Observatory Hydrology and Geochemistry of the Amazon Basin (HYBAM); INSU; IRD (Institute for Research and Development, France); CNPq; Brazilian 'Excellent Researcher' fellowship	French National Agency for Research(French National Research Agency (ANR)); French INSU national programme EC2CO; National Council of Research and Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Environmental Research Observatory Hydrology and Geochemistry of the Amazon Basin (HYBAM); INSU(Centre National de la Recherche Scientifique (CNRS)); IRD (Institute for Research and Development, France); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian 'Excellent Researcher' fellowship	This research is a contribution to the CARBAMA project, funded by the French National Agency for Research (grant number 08-BLAN-0221), the French INSU national programme EC2CO, and the National Council of Research and Development (CNPq), Brazil (Universal Program number 477655/2010-6). It was conducted under the auspices of the Environmental Research Observatory Hydrology and Geochemistry of the Amazon Basin (HYBAM), supported by the INSU and the IRD (Institute for Research and Development, France). F.R. was supported by CNPq and a Brazilian 'Excellent Researcher' fellowship. We thank all the participants of the CARBAMA cruises.	Abril G, 2006, SCI TOTAL ENVIRON, V354, P246, DOI 10.1016/j.scitotenv.2004.12.051; Abril G, 2009, ESTUAR COAST SHELF S, V83, P342, DOI 10.1016/j.ecss.2009.03.006; Alin SR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001398; Alsdorf D, 2010, REMOTE SENS ENVIRON, V114, P2448, DOI 10.1016/j.rse.2010.05.020; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Bonnet MP, 2008, J HYDROL, V349, P18, DOI 10.1016/j.jhydrol.2007.10.055; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Costa M, 2005, INT J REMOTE SENS, V26, P4527, DOI 10.1080/01431160500213433; Davidson EA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI [10.1029/20091G001202, 10.1029/2009JG001202]; DEVOL AH, 1987, LIMNOL OCEANOGR, V32, P235, DOI 10.4319/lo.1987.32.1.0235; DEVOL AH, 1995, GLOBAL BIOGEOCHEM CY, V9, P307, DOI 10.1029/95GB01145; Downing JA, 2009, INT VER THEOR ANGEW, V30, P1149; Duarte CM, 2005, ECOSYSTEMS, V8, P862, DOI 10.1007/s10021-005-0177-4; Ellis EE, 2012, LIMNOL OCEANOGR, V57, P527, DOI 10.4319/lo.2012.57.2.0527; Engle DL, 2008, GLOBAL CHANGE BIOL, V14, P369, DOI 10.1111/j.1365-2486.2007.01481.x; Ferreira CS., 2010, CENTRAL AMAZONIAN FL, P127, DOI [10.1007/978-90-481-8725-6_6, DOI 10.1007/978-90-481-8725-6_6]; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; Guerin F, 2007, J MARINE SYST, V66, P161, DOI 10.1016/j.jmarsys.2006.03.019; HAMILTON SK, 1995, BIOGEOCHEMISTRY, V30, P115; Hess LL, 2003, REMOTE SENS ENVIRON, V87, P404, DOI 10.1016/j.rse.2003.04.001; Horna V., 2010, AMAZONIAN FLOODPLAIN, P223; JAHNE B, 1987, J GEOPHYS RES-OCEANS, V92, P1937, DOI 10.1029/JC092iC02p01937; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W.J., 2010, AMAZONIAN FLOODPLAIN, V210, P511, DOI [10.1007/978-90-481-8725-6_24, DOI 10.1007/978-90-481-8725-6_24]; JUNK WJ, 1993, HYDROBIOLOGIA, V263, P155, DOI 10.1007/BF00006266; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; LEE JS, 1983, IEEE T SYST MAN CYB, V13, P85, DOI 10.1109/TSMC.1983.6313036; Lloyd J, 2007, BIOGEOSCIENCES, V4, P759, DOI 10.5194/bg-4-759-2007; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; MacIntyre HL, 2010, DEVEL APPL PHYCOL, V4, P129, DOI 10.1007/978-90-481-9268-7_7; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Martinez JM, 2007, REMOTE SENS ENVIRON, V108, P209, DOI 10.1016/j.rse.2006.11.012; Maurice Bourgoin L, 2007, J HYDROL, V335, P140, DOI 10.1016/j.jhydrol.2006.11.023; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; Melack JM, 2009, GEOPHYS MONOGR SER, V186, P525, DOI 10.1029/2008GM000721; Mertes LAK, 1996, GEOL SOC AM BULL, V108, P1089, DOI 10.1130/0016-7606(1996)108<1089:CFGATS>2.3.CO;2; Meyer U., 2010, AMAZONIAN FLOODPLAIN, P163; Moreira-Turcq P, 2004, PALAEOGEOGR PALAEOCL, V214, P27, DOI 10.1016/j.palaeo.2004.06.013; Moreira-Turcq P, 2013, GLOBAL BIOGEOCHEM CY, V27, P119, DOI 10.1002/gbc.20022; Morison JIL, 2000, OECOLOGIA, V125, P400, DOI 10.1007/s004420000464; Mortillaro JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046141; Parolin P, 2004, BOT REV, V70, P357, DOI 10.1663/0006-8101(2004)070[0357:CAFFTA]2.0.CO;2; Parolin P., 2010, AMAZONIAN FLOODPLAIN, P105; Polsenaere P, 2013, GEOPHYS RES LETT, V40, P1734, DOI 10.1002/grl.50291; QUAY PD, 1992, LIMNOL OCEANOGR, V37, P857, DOI 10.4319/lo.1992.37.4.0857; Quegan S, 2000, IEEE T GEOSCI REMOTE, V38, P741, DOI 10.1109/36.842003; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Richey JE, 2009, GEOPHYS MONOGR SER, V186, P489, DOI 10.1029/2008GM000734; Rosenqvist A, 2002, INT J REMOTE SENS, V23, P1303, DOI 10.1080/01431160110092911; Rudorff CM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001699; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Salter ME, 2011, J GEOPHYS RES-OCEANS, V116, DOI [10.1029/2011J0007023, 10.1029/2011JC007023]; Santos IR, 2012, ENVIRON SCI TECHNOL, V46, P7685, DOI 10.1021/es301961b; Schongart J., 2010, AMAZONIAN FLOODPLAIN, P347; Schulze ED, 2010, GLOBAL CHANGE BIOL, V16, P1451, DOI 10.1111/j.1365-2486.2010.02215.x; Sioli H, 1968, AMAZONIANA, V1, P267; Trigg MA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011888; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Ward ND, 2013, NAT GEOSCI, V6, P530, DOI [10.1038/NGEO1817, 10.1038/ngeo1817]; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Whittaker RH, 1975, PRIMARY PRODUCTIVITY, P305, DOI DOI 10.1007/978-3-642-80913-2_15; Worbes M., 1997, CENTRAL AMAZON FLOOD, VVol. 126, P223, DOI [DOI 10.1007/978-3-662-03416-3_11, 10.1007/978-3-662-03416-3_11]; Zappa CJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028790	69	228	242	29	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					395	+		10.1038/nature12797	http://dx.doi.org/10.1038/nature12797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24336199				2022-12-28	WOS:000329621800041
J	Spence, D				Spence, Des			Bad medicine: restless legs syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROPINIROLE; DIAGNOSIS											Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Garcia-Borreguero D, SUMMARY RECOMMENDATI; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; ICMJE ICoMJE-, ICMJE FORM DISCL POT; International Restless Legs Syndrome Study Group, 2001, INT RESTL LEGS SYNDR; National Institute of Neurological Disorders and Stroke, 2013, NIH PUBL; Quilici S, 2008, SLEEP MED, V9, P715, DOI 10.1016/j.sleep.2007.11.020; Scholz H, 2011, COCHRANE DB SYST REV, V3; Trenkwalder C, 2004, J NEUROL NEUROSUR PS, V75, P92	11	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7615	10.1136/bmj.f7615	http://dx.doi.org/10.1136/bmj.f7615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355578				2022-12-28	WOS:000328824300012
J	Watts, G				Watts, Geoff			Deenan Pillay: virologist in HIV's heartlands	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1975	1975		10.1016/S0140-6736(13)62647-1	http://dx.doi.org/10.1016/S0140-6736(13)62647-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24332071	Bronze			2022-12-28	WOS:000328223700015
J	Hsieh-Wilson, LC; Griffin, ME				Hsieh-Wilson, Linda C.; Griffin, Matthew E.			Improving Biologic Drugs via Total Chemical Synthesis	SCIENCE			English	Editorial Material							ERYTHROPOIETIN; GLYCOPOLYPEPTIDES; DESULFURIZATION; LIGATION; CYSTEINE; PROTEINS; ADVANCE		[Hsieh-Wilson, Linda C.; Griffin, Matthew E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Griffin, Matthew E.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Hsieh-Wilson, LC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lhw@caltech.edu		Griffin, Matthew/0000-0001-9549-4418	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; Huggett B, 2013, NAT BIOTECHNOL, V31, P697, DOI 10.1038/nbt.2653; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Mattio M, 2011, BIOTECHNOL PROGR, V27, P1018, DOI 10.1002/btpr.633; NARHI LO, 1991, J BIOL CHEM, V266, P23022; Sytkowski A. J., 2004, ERYTHROPOIETIN BLOOD; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Wang P, 2012, ANGEW CHEM INT EDIT, V51, P11571, DOI 10.1002/anie.201205038; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m	12	8	8	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1332	1333		10.1126/science.1247615	http://dx.doi.org/10.1126/science.1247615			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337286				2022-12-28	WOS:000328196000037
J	Rosenfeldt, MT; O'Prey, J; Morton, JP; Nixon, C; MacKay, G; Mrowinska, A; Au, A; Rai, TS; Zheng, L; Ridgway, R; Adams, PD; Anderson, KI; Gottlieb, E; Sansom, OJ; Ryan, KM				Rosenfeldt, Mathias T.; O'Prey, Jim; Morton, Jennifer P.; Nixon, Colin; MacKay, Gillian; Mrowinska, Agata; Au, Amy; Rai, Taranjit Singh; Zheng, Liang; Ridgway, Rachel; Adams, Peter D.; Anderson, Kurt I.; Gottlieb, Eyal; Sansom, Owen J.; Ryan, Kevin M.			p53 status determines the role of autophagy in pancreatic tumour development	NATURE			English	Article							CELL; SUPPRESSION; PROGRESSION; PRINCIPLES; DISEASE; GROWTH; CANCER; DAMAGE	Macroautophagy (hereafter referred to as autophagy) is a process in which organelles termed autophagosomes deliver cytoplasmic constituents to lysosomes for degradation(1). Autophagy has a major role in cellular homeostasis and has been implicated in various forms of human disease(2-4). The role of autophagy in cancer seems to be complex, with reports indicating both pro-tumorigenic and tumour-suppressive roles(3,5-12). Here we show, in a humanized genetically-modified mouse model of pancreatic ductal adenocarcinoma(PDAC), that autophagy's role in tumour development is intrinsically connected to the status of the tumour suppressor p53. Mice with pancreases containing an activated oncogenic allele of Kras (also called Ki-Ras)-the most common mutational event in PDAC(13)-develop a small number of pre-cancerous lesions that stochastically develop into PDAC over time. However, mice also lacking the essential autophagy genes Atg5 or Atg7 accumulate low-grade, pre-malignant pancreatic intraepithelial neoplasia lesions, but progression to high-grade pancreatic intraepithelial neoplasias and PDAC is blocked. In marked contrast, in mice containing oncogenic Kras and lacking p53, loss of autophagy no longer blocks tumour progression, but actually accelerates tumour onset, with metabolic analysis revealing enhanced glucose uptake and enrichment of anabolic pathways, which can fuel tumour growth. These findings provide considerable insight into the role of autophagy in cancer and have important implications for autophagy inhibition in cancer therapy. In this regard, we also show that treatment of mice with the autophagy inhibitor hydroxychloroquine, which is currently being used in several clinical trials(14), significantly accelerates tumour formation in mice containing oncogenic Kras but lacking p53.	[Rosenfeldt, Mathias T.; O'Prey, Jim; Morton, Jennifer P.; Nixon, Colin; MacKay, Gillian; Mrowinska, Agata; Au, Amy; Zheng, Liang; Ridgway, Rachel; Anderson, Kurt I.; Gottlieb, Eyal; Sansom, Owen J.; Ryan, Kevin M.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rai, Taranjit Singh; Adams, Peter D.] Univ Glasgow, Inst Canc Studies, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; University of Glasgow	Ryan, KM (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Morton, Jennifer P/E-1633-2011; Rosenfeldt, Mathias/ABE-4736-2022; Rai, Taranjit Singh/A-3659-2012; Morton, Jennifer/AAJ-5113-2021; Gottlieb, Eyal/G-6450-2010; Singh, Taranjit/ABE-8233-2020	Morton, Jennifer P/0000-0001-5766-9141; Rosenfeldt, Mathias/0000-0001-7650-8458; Rai, Taranjit Singh/0000-0002-7276-7492; Morton, Jennifer/0000-0001-5766-9141; Gottlieb, Eyal/0000-0002-9770-0956; Singh, Taranjit/0000-0002-7276-7492; Zheng, Liang/0000-0002-5346-4111; Anderson, Kurt/0000-0002-9324-9598; Adams, Peter/0000-0002-0684-1770; Sansom, Owen J./0000-0001-9540-3010; Ryan, Kevin M./0000-0002-1059-9681	Cancer Research UK; Pancreatic Cancer Research Fund; Cancer Research UK [11650, 15565, 15816, 12481, 16566] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Pancreatic Cancer Research Fund; Cancer Research UK(Cancer Research UK)	We are grateful to M. Komatsu for providing the Atg7 floxed mice that were used in this study, and we thank M. O'Prey for help with fluorescent microscopy; G. Gillen for help with PET; T. McBryan for help with statistics; C. Frezza for help with metabolic studies; and A. Rosenwald for help and advice on pathology. This work was supported by Cancer Research UK and the Pancreatic Cancer Research Fund.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Caldwell ME, 2012, ONCOGENE, V31, P1599, DOI 10.1038/onc.2011.350; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Rosenfeldt MT, 2012, AUTOPHAGY, V8, P963, DOI 10.4161/auto.20186; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	33	510	527	8	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					296	+		10.1038/nature12865	http://dx.doi.org/10.1038/nature12865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305049				2022-12-28	WOS:000328121500040
J	Wylam, ME; Kennedy, CC; Hernandez, NM; Peters, SG; Maleszewski, JJ; Cassivi, SD; Scott, JP				Wylam, Mark E.; Kennedy, Cassie C.; Hernandez, Nina M.; Peters, Steve G.; Maleszewski, Joseph J.; Cassivi, Stephen D.; Scott, John P.			Fatal hyperammonaemia caused by Mycoplasma hominis	LANCET			English	Editorial Material							PLEUROPNEUMONIA-LIKE ORGANISMS; ARGININE		[Wylam, Mark E.; Kennedy, Cassie C.; Peters, Steve G.; Scott, John P.] Mayo Clin, Coll Med, Div Pulm & Crit Care Internal Med, Rochester, MN 55905 USA; [Maleszewski, Joseph J.] Mayo Clin, Coll Med, Dept Anat Pathol, Rochester, MN 55905 USA; [Cassivi, Stephen D.] Mayo Clin, Coll Med, Div Thorac Surg, Rochester, MN 55905 USA; [Hernandez, Nina M.] Purdue Univ, Lafayette, IN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Purdue University System; Purdue University	Wylam, ME (corresponding author), Mayo Clin, Coll Med, Div Pulm & Crit Care Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	wylam.mark@mayo.edu						Lichtenstein GR, 1997, GASTROENTEROLOGY, V112, P236, DOI 10.1016/S0016-5085(97)70240-3; ROUSE HC, 1963, VIROLOGY, V20, P357, DOI 10.1016/0042-6822(63)90125-9; SCHIMKE RT, 1963, J BACTERIOL, V86, P195, DOI 10.1128/JB.86.2.195-206.1963; Waites KB, 2001, J CLIN MICROBIOL, V39, P4328, DOI 10.1128/JCM.39.12.4328-4331.2001; WATSON AJ, 1985, LANCET, V2, P1271	5	38	39	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1956	1956		10.1016/S0140-6736(13)62115-7	http://dx.doi.org/10.1016/S0140-6736(13)62115-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24315178				2022-12-28	WOS:000328222400034
J	Arora, VK; Schenkein, E; Murali, R; Subudhi, SK; Wongvipat, J; Balbas, MD; Shah, N; Cai, L; Efstathiou, E; Logothetis, C; Zheng, DY; Sawyers, CL				Arora, Vivek K.; Schenkein, Emily; Murali, Rajmohan; Subudhi, Sumit K.; Wongvipat, John; Balbas, Minna D.; Shah, Neel; Cai, Ling; Efstathiou, Eleni; Logothetis, Chris; Zheng, Deyou; Sawyers, Charles L.			Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade	CELL			English	Article							PROSTATE-CANCER; INCREASED SURVIVAL; LUNG-CANCER; ABIRATERONE; ENZALUTAMIDE; INHIBITION; GEFITINIB; MUTATION; GROWTH	The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Here, we identify induction of glucocorticoid receptor (GR) expression as a common feature of drug-resistant tumors in a credentialed preclinical model, a finding also confirmed in patient samples. GR substituted for the androgen receptor (AR) to activate a similar but distinguishable set of target genes and was necessary for maintenance of the resistant phenotype. The GR agonist dexamethasone was sufficient to confer enzalutamide resistance, whereas a GR antagonist restored sensitivity. Acute AR inhibition resulted in GR upregulation in a subset of prostate cancer cells due to relief of AR-mediated feedback repression of GR expression. These findings establish a mechanism of escape from AR blockade through expansion of cells primed to drive AR target genes via an alternative nuclear receptor upon drug exposure.	[Arora, Vivek K.; Schenkein, Emily; Murali, Rajmohan; Wongvipat, John; Balbas, Minna D.; Shah, Neel; Cai, Ling; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Arora, Vivek K.; Subudhi, Sumit K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Balbas, Minna D.; Shah, Neel] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Efstathiou, Eleni; Logothetis, Chris] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016; Murali, Rajmohan/A-7960-2008	Subudhi, Sumit/0000-0001-5208-7732; Zheng, Deyou/0000-0003-4354-5337; Murali, Rajmohan/0000-0001-6988-4295	CDMRP Physician Research Training Award [PC102106]; NIH [R01CA155169, P50CA09262, U01 CA141502]; Howard Hughes Medical Institute; Medivation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA155169, P50CA092629, U01CA141502] Funding Source: NIH RePORTER	CDMRP Physician Research Training Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medivation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Phil Iaquinta, Brett Carver, Yu Chen, Phil Watson, Haley Hieronymus, Bea Darimont, and Howard Scher for helpful discussions. We thank Tom Scanlan (Portland, Oregon) for generously providing compound 15, Yu Chen for generously providing the pMItDT-EGFP vector, Agnes Viales and Liping Sun of the MSKCC Genomics Core Facility for ChIP-seq library prep and sequencing, Jeffrey Zhao for assistance with microarray data analysis, Ouathek Ouerfelli of the MSKCC organic synthesis core for synthesizing ORG34517, HuiYong Zhao and Philicia Moonsamy for technical assistance with xenograft experiments, Marina Asher of the MSKCC Pathology Core Facility for assistance with IHC, and Anuradha Gopalan for providing the tissue microarray of primary untreated prostate cancer. The work is funded by CDMRP Physician Research Training Award PC102106, NIH R01CA155169, NIH P50CA09262, U01 CA141502, and the Howard Hughes Medical Institute. The human tissue acquisition study at MDACC was given financial support from Medivation. V.K.A. is funded by a Young Investigator Award from the Prostate Cancer Foundation. C.L.S. and J.W. are coinventors of enzalutamide and ARN-509 and may be entitled to royalties.	Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; DAVIES P, 1990, J MOL ENDOCRINOL, V5, P117, DOI 10.1677/jme.0.0050117; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; TANNOCK I, 1989, J CLIN ONCOL, V7, P590, DOI 10.1200/JCO.1989.7.5.590; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	29	623	657	4	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1309	1322		10.1016/j.cell.2013.11.012	http://dx.doi.org/10.1016/j.cell.2013.11.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315100	Green Accepted, Bronze			2022-12-28	WOS:000328271100015
J	Bhutta, ZA; Black, RE				Bhutta, Zulfiqar A.; Black, Robert E.			Global Maternal, Newborn, and Child Health - So Near and Yet So Far	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; PUBLIC-HEALTH; LOW-INCOME; INTERVENTIONS; MORTALITY; COVERAGE; TOOL; NUTRITION; OUTCOMES		[Bhutta, Zulfiqar A.] Hosp Sick Children SickKids, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bhutta, ZA (corresponding author), Hosp Sick Children SickKids, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada.	zulfiqar.bhut-ta@sickkids.ca						Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Awasthi Shally, 2003, Indian Pediatr, V40, P1145; Bassani DG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S30; BHUTTA ZA, 2010, GLOBAL EXPERIENCE; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2009, GLOB SOC POLICY, V9, P119, DOI 10.1177/1468018109106888; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bocquier P, 2011, J URBAN HEALTH, V88, P266, DOI 10.1007/s11524-010-9497-6; Chulov Martin, 2013, GUARDIAN; *COMM SOCIAL DETER, 2008, CLOSING GAP GENERAT; COUSENS S, 2011, NATL REGIONAL WORLD, V377, P1319; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Dean SV, 2013, NESTLE NUTR WORKS SE, V74, P63, DOI 10.1159/000348402; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; *FOOD AGR ORG UN, 2013, WORLD FOOD SITUATION; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Hicks MHR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000415; Hicks MHR, 2008, PLOS MED, V5, P1658, DOI 10.1371/journal.pmed.0050243; *IND EXPERT REV GR, EVERY WOMAN EVERY; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lassi ZS, 2010, COCHRANE DATABASE SY, V11; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LEWIN S, 2013, COCHRANE DATABASE SY, V3; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Marmot Michael, 2009, Glob Health Promot, VSuppl 1, P23, DOI 10.1177/1757975909103742; Matthews Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000327; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Requejo JH, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-42; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; Southall D, 2011, EARLY HUM DEV, V87, P735, DOI 10.1016/j.earlhumdev.2011.08.020; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; *UN COMM LIFE SAV, 2012, COMMISSIONERS REP; *UN INTER AGENCY, 2013, MORTSLITY ESTIMAT; *UN POPUL FUND, 2009, FINANCING ICPD PROG; *UNICEF, 2012, COMMITTING CHILD; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; *WHO, 2013, COUNTDOWN 2015 MATER; *WHO, 2012, TRENDS MORTAL 1990	45	207	211	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2226	2235		10.1056/NEJMra1111853	http://dx.doi.org/10.1056/NEJMra1111853			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304052				2022-12-28	WOS:000327801100009
J	Boissiere, L; Obeid, I				Boissiere, Louis; Obeid, Ibrahim			Spinal Fracture and a Widened Interspinous Gap	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 14-year-old girl presented to the emergency department after a car accident; she had been wearing a lap-shoulder seat belt. She had severe back pain but had normal strength and sensation of touch in her legs. A 14-year-old girl presented to the emergency department after a car accident; she had been wearing a lap-shoulder seat belt. She had severe back pain but had normal strength and sensation of touch in her legs; she reported no paresthesias. Palpation of the lumbar spine revealed prominence of the spinous process of the first lumbar vertebra (Panel A, arrow) and an increased gap between the first and second lumbar spinous processes, findings that aroused suspicion of a flexion-distraction injury. Computed tomography revealed disruption of the ligaments in the posterior column (Panel B, arrowhead) and the middle column, as well as ...	[Boissiere, Louis; Obeid, Ibrahim] Bordeaux Univ Hosp, Bordeaux, France	CHU Bordeaux	Boissiere, L (corresponding author), Bordeaux Univ Hosp, Bordeaux, France.	boissierelouis@yahoo.fr							0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					E31	E31		10.1056/NEJMicm1305681	http://dx.doi.org/10.1056/NEJMicm1305681			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304064				2022-12-28	WOS:000327801100001
J	Burzyn, D; Kuswanto, W; Kolodin, D; Shadrach, JL; Cerletti, M; Jang, Y; Sefik, E; Tan, TG; Wagers, AJ; Benoist, C; Mathis, D				Burzyn, Dalia; Kuswanto, Wilson; Kolodin, Dmitriy; Shadrach, Jennifer L.; Cerletti, Massimiliano; Jang, Young; Sefik, Esen; Tan, Tze Guan; Wagers, Amy J.; Benoist, Christophe; Mathis, Diane			A Special Population of Regulatory T Cells Potentiates Muscle Repair	CELL			English	Article							GROWTH-FACTOR; UNIQUE POPULATION; SYSTEM; DIFFERENTIATION; AMPHIREGULIN; REGENERATION; CYTOKINE; SURVIVAL; SUBSETS; MICE	Long recognized to be potent suppressors of immune responses, Foxp3(+)CD4(+) regulatory T (Treg) cells are being rediscovered as regulators of nonimmunological processes. We describe a phenotypically and functionally distinct population of Treg cells that rapidly accumulated in the acutely injured skeletal muscle of mice, just as invading myeloid-lineage cells switched from a proinflammatory to a proregenerative state. A Treg population of similar phenotype accumulated in muscles of genetically dystrophic mice. Punctual depletion of Treg cells during the repair process prolonged the proinflammatory infiltrate and impaired muscle repair, while treatments that increased or decreased Treg activities diminished or enhanced (respectively) muscle damage in a dystrophy model. Muscle Treg cells expressed the growth factor Amphiregulin, which acted directly on muscle satellite cells in vitro and improved muscle repair in vivo. Thus, Treg cells and their products may provide new therapeutic opportunities for wound repair and muscular dystrophies.	[Burzyn, Dalia; Kuswanto, Wilson; Kolodin, Dmitriy; Sefik, Esen; Tan, Tze Guan; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shadrach, Jennifer L.; Cerletti, Massimiliano; Jang, Young; Wagers, Amy J.] Harvard Univ, Cambridge, MA 02138 USA; [Shadrach, Jennifer L.; Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Mathis, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cbdm@hms.harvard.edu		Sefik, Esen/0000-0002-6807-3498	NIH [R37AI051530, RO1DK092541, R01AG033053, UO1HL100402]; Kaneb Fellowship; NSF fellowship; Boehringer Ingelheim Fonds Fellowship; A*STAR Graduate Scholarship (Singapore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK092541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033053] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaneb Fellowship; NSF fellowship(National Science Foundation (NSF)); Boehringer Ingelheim Fonds Fellowship(Boehringer Ingelheim); A*STAR Graduate Scholarship (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Florence, K. Rothamel, N. Asinovski, A. Ortiz-Lopez, D. Jepson, K. Hattori, J. Ericson, S. Davis, H. Paik, R. Cruse, J. LaVecchio, and G. Buruzula for experimental support. Cell sorting was performed at the HSCI/DRC Flow Core (NIH P30DK036836). This work benefited from public data generated by the Immunological Genome Project (http://www.immgen.org) and was funded by NIH grants R37AI051530 and RO1DK092541 (to C.B. and D.M.) and R01AG033053 and UO1HL100402 (to A.J.W.). A.J.W. is an Early Career Scientist at the Howard Hughes Institute. D.B. was supported by a Kaneb Fellowship, D.K. by an NSF fellowship, E.S. by a Boehringer Ingelheim Fonds Fellowship, and T.G.T. by an A*STAR Graduate Scholarship (Singapore).	Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cipolletta D, 2011, SEMIN IMMUNOL, V23, P431, DOI 10.1016/j.smim.2011.06.002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Horikawa M, 1999, FEBS LETT, V459, P100, DOI 10.1016/S0014-5793(99)01213-2; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	30	702	716	4	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1282	1295		10.1016/j.cell.2013.10.054	http://dx.doi.org/10.1016/j.cell.2013.10.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315098	Bronze, Green Accepted			2022-12-28	WOS:000328271100013
J	Golub, RM				Golub, Robert M.			Containing Multitudes Medical Education 2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									JAMA, Chicago, IL 60611 USA		Golub, RM (corresponding author), JAMA, 330 N Wabash, Chicago, IL 60611 USA.	robert.golub@jamanetwork.org						Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Chi J, 2013, JAMA-J AM MED ASSOC, V310, P2257, DOI 10.1001/jama.2013.281828; Cohen JJ, 2013, JAMA-J AM MED ASSOC, V310, P2253, DOI 10.1001/jama.2013.283389; Curtis JR, 2013, JAMA-J AM MED ASSOC, V310, P2271, DOI 10.1001/jama.2013.282081; Deane RP, 2013, JAMA-J AM MED ASSOC, V310, P2282, DOI 10.1001/jama.2013.282228; Dhaliwal G, 2013, JAMA-J AM MED ASSOC, V310, P2247, DOI 10.1001/jama.2013.282322; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Grumbach K, 2006, JAMA-J AM MED ASSOC, V296, P1079, DOI 10.1001/jama.296.9.1079; Guevara JP, 2013, JAMA-J AM MED ASSOC, V310, P2297, DOI 10.1001/jama.2013.282116; Haist SA, 2013, JAMA-J AM MED ASSOC, V310, P2245, DOI 10.1001/jama.2013.282328; Horwitz LI, 2013, JAMA-J AM MED ASSOC, V310, P2255, DOI 10.1001/jama.2013.281827; Kirch DG, 2013, JAMA-J AM MED ASSOC, V310, P2243, DOI 10.1001/jama.2013.282093; Pageler NM, 2013, JAMA-J AM MED ASSOC, V310, P2249, DOI 10.1001/jama.2013.282326; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; Saha S, 2008, JAMA-J AM MED ASSOC, V300, P1135, DOI 10.1001/jama.300.10.1135; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Teherani A, 2013, JAMA-J AM MED ASSOC, V310, P2309, DOI 10.1001/jama.2013.283198; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Walsh CM, 2013, JAMA-J AM MED ASSOC, V310, P2307, DOI 10.1001/jama.2013.281671; Warner DO, 2013, JAMA-J AM MED ASSOC, V310, P2289, DOI 10.1001/jama.2013.281954	22	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2259	2261		10.1001/jama.2013.283429	http://dx.doi.org/10.1001/jama.2013.283429			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302088				2022-12-28	WOS:000327746300010
J	Hales, CM; Harpaz, R; Joesoef, MR; Bialek, SR				Hales, Craig M.; Harpaz, Rafael; Joesoef, M. Riduan; Bialek, Stephanie R.			Examination of Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; RISK-FACTORS; COMPLICATION RATES; VIRUS-INFECTIONS; OLDER-ADULTS; EPIDEMIOLOGY; EXPOSURE; SHINGLES; REACTIVATION; CONTACTS	Background: Introduction of a universal varicella vaccine program for U.S. children in 1996 sparked concern that less-frequent exposure to varicella would decrease external boosting of immunity to varicella zoster virus and thereby increase incidence of herpes zoster (HZ). Objective: To determine whether the varicella vaccination program has influenced trends in HZ incidence in the U.S. population older than 65 years. Design: Retrospective study of Medicare claims. Setting: Medicare, 1992 through 2010. Participants: 2 848 765 beneficiaries older than 65 years. Measurements: Annual HZ incidence from 1992 through 2010; rate ratios (RRs) for HZ incidence by age, sex, and race or ethnicity; and state-level varicella vaccination coverage. Results: 281 317 incident cases of HZ occurred. Age- and sex-standardized HZ incidence increased 39% from 10.0 per 1000 person-years in 1992 to 13.9 per 1000 person-years in 2010 with no evidence of a statistically significant change in the rate of in-crease after introduction of the varicella vaccination program. Before introduction of this program, HZ incidence was higher in women (RR, 1.21 [95% CI, 1.19 to 1.24]) than men and was lower in black persons (RR, 0.51 [CI, 0.48 to 0.53]) and Hispanic persons (RR, 0.76 [CI, 0.72 to 0.81]) than white persons. In a model adjusted for sex, age, and calendar year from 1997 to 2010, HZ incidence did not vary by state varicella vaccination coverage (RR, 0.9998 [CI, 0.9993 to 1.0003]). Limitation: Uncertain level and consistency of health-seeking behavior and access and uncertain accuracy of disease coding. Conclusion: Age- specific HZ incidence increased in the U.S. population older than 65 years even before implementation of the childhood varicella vaccination program. Introduction and widespread use of the vaccine did not seem to affect this increase. This information is reassuring for countries considering universal varicella vaccination.	[Hales, Craig M.; Harpaz, Rafael; Joesoef, M. Riduan; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Hales, CM (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mail Stop A-34, Atlanta, GA 30333 USA.	chales@cdc.gov		Hales, Craig/0000-0002-2355-1177	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Agency for Healthcare Research and Quality, 2008, CREAT VAL IND SOC ST; [Anonymous], 1996, US BUREAU CENSUS CUR; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Centers for Disease Control and Prevention, 2013, US VACC COV REP VIA; Centers for Medicare & Medicaid Services (CMS), 2001, FED REGISTER, V66, P55245; Chao DY, 2012, EPIDEMIOL INFECT, V140, P1131, DOI 10.1017/S0950268811001786; Chaves SS, 2007, PUBLIC HEALTH REP, V122, P155, DOI 10.1177/003335490712200204; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Fleming DM, 2004, EUR J EPIDEMIOL, V19, P1113, DOI 10.1007/s10654-004-2219-1; Fleming DM, 2004, EPIDEMIOL INFECT, V132, P1, DOI 10.1017/S0950268803001523; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Gershon AA, 1996, J INFECT DIS, V173, P450, DOI 10.1093/infdis/173.2.450; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Jumaan AO, 2003, 41 ANN M INF DIS SOC, P899; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Kleinbaum D. G., 1998, APPL REGRESSION ANAL; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; LJUNGMAN P, 1986, J INFECT DIS, V153, P840, DOI 10.1093/infdis/153.5.840; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; LUBY JP, 1977, J INFECT DIS, V135, P659, DOI 10.1093/infdis/135.4.659; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Opstelten W, 2006, ANN EPIDEMIOL, V16, P692, DOI 10.1016/j.annepidem.2005.12.002; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Russell ML, 2007, EPIDEMIOL INFECT, V135, P908, DOI 10.1017/S0950268807007893; Sadzot-Delvaux C, 2008, J INFECT DIS, V197, pS185, DOI 10.1086/522163; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Wolfe S., 2012, EPIDEMIOLOGY PREVENT, V12; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2011, AM J EPIDEMIOL, V174, P1054, DOI 10.1093/aje/kwr206	49	92	95	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					739	+		10.7326/0003-4819-159-11-201312030-00006	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297190	Green Accepted			2022-12-28	WOS:000328731000003
J	Sharon, I; Banfield, JF				Sharon, Itai; Banfield, Jillian F.			Genomes from Metagenomics	SCIENCE			English	Editorial Material							METABOLISM; BACTERIA		[Sharon, Itai; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sharon, I (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Sharon, Itai/M-4472-2019	Sharon, Itai/0000-0003-0705-2316; Banfield, Jill/0000-0001-8203-8771				Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	15	98	105	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1057	1058		10.1126/science.1247023	http://dx.doi.org/10.1126/science.1247023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288324				2022-12-28	WOS:000327518600046
J	Hawton, K; Linsell, L; Adeniji, T; Sariaslan, A; Fazel, S				Hawton, Keith; Linsell, Louise; Adeniji, Tunde; Sariaslan, Amir; Fazel, Seena			Self-harm in prisons in England and Wales: an epidemiological study of prevalence, risk factors, clustering, and subsequent suicide	LANCET			English	Article							PSYCHIATRIC-DISORDERS; FEMALE PRISONERS; IDEATION; BEHAVIOR; CUSTODY	Background Self-harm and suicide are common in prisoners, yet robust information on the full extent and characteristics of people at risk of self-harm is scant. Furthermore, understanding how frequently self-harm is followed by suicide, and in which prisoners this progression is most likely to happen, is important. We did a case-control study of all prisoners in England and Wales to ascertain the prevalence of self-harm in this population, associated risk factors, clustering effects, and risk of subsequent suicide after self-harm. Methods Records of self-harm incidents in all prisons in England and Wales were gathered routinely between January, 2004, and December, 2009. We did a case-control comparison of prisoners who self-harmed and those who did not between January, 2006, and December, 2009. We also used a Bayesian approach to look at clustering of people who self-harmed. Prisoners who self-harmed and subsequently died by suicide in prison were compared with other inmates who self-harmed. Findings 139 195 self-harm incidents were recorded in 26 510 individual prisoners between 2004 and 2009; 5-6% of male prisoners and 20-24% of female inmates self-harmed every year. Self-harm rates were more than ten times higher in female prisoners than in male inmates. Repetition of self-harm was common, particularly in women and teenage girls, in whom a subgroup of 102 prisoners accounted for 17 307 episodes. In both sexes, self-harm was associated with younger age, white ethnic origin, prison type, and a life sentence or being unsentenced; in female inmates, committing a violent offence against an individual was also a factor. Substantial evidence was noted of clustering in time and location of prisoners who self-harmed (adjusted intra-class correlation 0.15, 95% CI 0.11-0.18). 109 subsequent suicides in prison were reported in individuals who self-harmed; the risk was higher in those who self-harmed than in the general prison population, and more than half the deaths occurred within a month of self-harm. Risk factors for suicide after self-harm in male prisoners were older age and a previous self-harm incident of high or moderate lethality; in female inmates, a history of more than five self-harm incidents within a year was associated with subsequent suicide. Interpretation The burden of self-harm in prisoners is substantial, particularly in women. Self-harm in prison is associated with subsequent suicide in this setting. Prevention and treatment of self-harm in prisoners is an essential component of suicide prevention in prisons.	[Hawton, Keith] Univ Oxford, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England; [Linsell, Louise] Univ Oxford, Clin Trials Unit, Natl Perinatal Epidemiol Unit, Oxford OX3 7JX, England; [Adeniji, Tunde] Minist Justice, Equal Rights & Decency Grp, Natl Offender Management Serv, London, England; [Sariaslan, Amir] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford; University of Oxford; Karolinska Institutet; University of Oxford	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008; Lorente, Rosa/AAL-5850-2021	Fazel, Seena/0000-0002-5383-5365; Sariaslan, Amir/0000-0002-6151-3278	Wellcome Trust; National Institute for Health Research; Department of Health; National Offender Management Service; National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health; National Offender Management Service; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding Wellcome Trust, National Institute for Health Research, National Offender Management Service, and Department of Health.	Bebbington PE, 2010, EUR PSYCHIAT, V25, P427, DOI 10.1016/j.eurpsy.2009.12.004; Brooker C, 2008, SHORT CHANGED SPENDI; Charles DR, 2003, J CONTEMP CRIM JUST, V19, P65, DOI [10.1177/1043986202239742, DOI 10.1177/1043986202239742]; Corston J, 2007, CORSTON REPORT REV W; Department of Health, 2012, PREV SUIC ENGL CROSS; Dixon-Gordon K, 2012, INT J FORENSIC MENT, V11, P33, DOI 10.1080/14999013.2012.667513; Duncan GJ, 1999, EDUC PSYCHOL-US, V34, P29, DOI 10.1207/s15326985ep3401_3; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Fazel S, 2011, SOC PSYCH PSYCH EPID, V46, P191, DOI 10.1007/s00127-010-0184-4; Fazel S, 2009, BRIT J PSYCHIAT, V194, P183, DOI 10.1192/bjp.bp.107.046490; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Haw C, 2013, SUICIDE LIFE-THREAT, V43, P97, DOI 10.1111/j.1943-278X.2012.00130.x; Humber N, 2013, SOC PSYCH PSYCH EPID, V48, P1177, DOI 10.1007/s00127-012-0632-4; Humber N, 2011, J FORENSIC PSYCHI PS, V22, P22, DOI 10.1080/14789949.2010.518245; Jenkins R, 2005, PSYCHOL MED, V35, P257, DOI 10.1017/S0033291704002958; Kapur N, 2013, PSYCHOL MED, V43, P61, DOI 10.1017/S0033291712000864; Larney S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-14; Lohner J, 2007, INT J PRISON HEALTH, V3, P135, DOI 10.1080/17449200701321654; Lohner J, 2006, INT J LAW PSYCHIAT, V29, P370, DOI 10.1016/j.ijlp.2006.03.004; Magaletta P. R., 2008, PSYCHOL SERV, V5, P351, DOI [DOI 10.1037/1541-1559.5.4.351, 10.1037/1541-1559.5.4.351]; Marzano L, 2011, SOC SCI MED, V72, P874, DOI 10.1016/j.socscimed.2010.12.028; Marzano L, 2010, BRIT J PSYCHIAT, V197, P219, DOI 10.1192/bjp.bp.109.075424; McKenzie N, 2007, SUICIDE LIFE-THREAT, V37, P538, DOI 10.1521/suli.2007.37.5.538; Ministry of Justice, 2012, GUID SAF CUST STAT; National Institute for Health and Clinical Excellence, 2011, SELF HARM LONG TERM; Opitz-Welke A, 2013, INT J LAW PSYCHIAT, V36, P386, DOI 10.1016/j.ijlp.2013.06.018; Rabe K, 2012, INT J LAW PSYCHIAT, V35, P222, DOI 10.1016/j.ijlp.2012.02.012; Rivlin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068944; Rivlin A, 2010, BRIT J PSYCHIAT, V197, P313, DOI 10.1192/bjp.bp.110.077883; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Saunders KEA, 2012, J AFFECT DISORDERS, V139, P205, DOI 10.1016/j.jad.2011.08.024; Stockford SM, 2011, METAANALYSIS INTRACL; Towl G., 1998, CRIM BEHAV MENT HEAL, V8, P184, DOI DOI 10.1002/CBM.245; US Department of Health and Human Services (HHS) Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012, NAT STRAT SUIC PREV; Vollm BA, 2009, J FORENSIC PSYCHI PS, V20, P741, DOI 10.1080/14789940903174030; Zhang J, 2010, INT J OFFENDER THER, V54, P959, DOI 10.1177/0306624X09348200; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	39	165	166	3	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1147	1154		10.1016/S0140-6736(13)62118-2	http://dx.doi.org/10.1016/S0140-6736(13)62118-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24351319	Green Published, hybrid			2022-12-28	WOS:000333956000034
J	Doitsh, G; Galloway, NLK; Geng, X; Yang, ZY; Monroe, KM; Zepeda, O; Hunt, PW; Hatano, H; Sowinski, S; Munoz-Arias, I; Greene, WC				Doitsh, Gilad; Galloway, Nicole L. K.; Geng, Xin; Yang, Zhiyuan; Monroe, Kathryn M.; Zepeda, Orlando; Hunt, Peter W.; Hatano, Hiroyu; Sowinski, Stefanie; Munoz-Arias, Isa; Greene, Warner C.			Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EX-VIVO; DENDRITIC CELLS; LYMPHOID-TISSUE; APOPTOSIS; ACTIVATION; INHIBITORS; MATURATION; IL-1-BETA; MONOCYTES	The pathway causing CD4 T-cell death in HIV-infected hosts remains poorly understood although apoptosis has been proposed as a key mechanism. We now show that caspase-3-mediated apoptosis accounts for the death of only a small fraction of CD4 T cells corresponding to those that are both activated and productively infected. The remaining over 95% of quiescent lymphoid CD4 T cells die by caspase-1-mediated pyroptosis triggered by abortive viral infection. Pyroptosis corresponds to an intensely inflammatory form of programmed cell death in which cytoplasmic contents and pro-inflammatory cytokines, including IL-1 beta, are released. This death pathway thus links the two signature events in HIV infection-CD4 T-cell depletion and chronic inflammation-and creates a pathogenic vicious cycle in which dying CD4 T cells release inflammatory signals that attract more cells to die. This cycle can be broken by caspase 1 inhibitors shown to be safe in humans, raising the possibility of a new class of 'anti-AIDS' therapeutics targeting the host rather than the virus.	[Doitsh, Gilad; Galloway, Nicole L. K.; Geng, Xin; Yang, Zhiyuan; Monroe, Kathryn M.; Zepeda, Orlando; Sowinski, Stefanie; Munoz-Arias, Isa; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Hunt, Peter W.; Hatano, Hiroyu; Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870	NIH/NIAID [R21AI102782, 1DP1036502, U19 AI0961133]; UCSF/Robert John Sabo Trust Award; A. P. Giannini Foundation Postdoctoral Research Fellowship; NIH [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, T32AI060537, P30AI027763, R21AI102782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036502] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF/Robert John Sabo Trust Award; A. P. Giannini Foundation Postdoctoral Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. N. Levy for the NLENG1 plasmid; L. A. J. O'Neill for CRID3 and parthenolide; R. Collman for the HIV-1 89.6 clone; and Vertex Pharmaceuticals for the VX-765 and VRT-043198 compounds. HIV-infected lymph node tissue was obtained from the SCOPE cohort at HIV/AIDS clinic of the San Francisco General Hospital (SFGH) Positive Health Program, with the help of R. Hoh, and M. Kerbelski. We thank W. Schecter for surgical removal of the lymph nodes from HIV-infected subjects. We thank L. Napolitano and Y. Lie from Monogram Biosciences for performing Trofile assays to determine HIV co-receptor tropism in samples of HIV-infected volunteers. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: AMD3100, efavirenz and raltegravir. Wethank C. Miller, director of the Gladstone HistologyCore for performing the immunostaining assays and M. Cavrois, M. Gesner, and J. Tawney for assistance with flow cytometry. We also thank G. Howard and A. L. Lucido for editorial assistance; J. C. W. Carroll, G. Maki, and T. Roberts for graphics arts; and R. Givens and S. Cammack for administrative assistance. Special thanks to N. Roan for comments on the manuscript and to J. Neidleman for stimulating discussions and technical advice. We thank the NIH/NIAID for funding (R21AI102782, 1DP1036502, U19 AI0961133). Funding was also provided by the UCSF/Robert John Sabo Trust Award (G. D.) and A. P. Giannini Foundation Postdoctoral Research Fellowship(K. M. M.). We also acknowledge support from NIH P30 AI027763 (UCSF-GIVI Center for AIDS Research) for support to S. S. and Z. Y., and for Immunology Core services.	Agosto LM, 2009, J VIROL, V83, P8153, DOI 10.1128/JVI.00220-09; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bedner E, 2000, EXP CELL RES, V259, P308, DOI 10.1006/excr.2000.4955; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Boxer M.B., 2010, PROBE REPORTS NIH MO; Boxer MB, 2010, CHEMMEDCHEM, V5, P730, DOI 10.1002/cmdc.200900531; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Gondois-Rey F, 2002, AIDS, V16, P1245, DOI 10.1097/00002030-200206140-00006; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Grivel JC, 2000, J VIROL, V74, P8077, DOI 10.1128/JVI.74.17.8077-8084.2000; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Huang M.B., 2008, ETHNIC DIS, V18; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; MACKAY CR, 1993, ADV IMMUNOL, V53, P217, DOI 10.1016/S0065-2776(08)60501-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Monroe, 2013, SCIENCE         1219; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Penn ML, 1999, P NATL ACAD SCI USA, V96, P663, DOI 10.1073/pnas.96.2.663; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Pitha PM, 2011, VIRUSES-BASEL, V3, P1179, DOI 10.3390/v3071179; Randle JCR, 2001, EXPERT OPIN INV DRUG, V10, P1207, DOI 10.1517/13543784.10.7.1207; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Rosok BI, 1998, AIDS RES HUM RETROV, V14, P1635, DOI 10.1089/aid.1998.14.1635; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zhou Y, 2008, J VIROL, V82, P9154, DOI 10.1128/JVI.00773-08	69	709	757	14	281	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					509	+		10.1038/nature12940	http://dx.doi.org/10.1038/nature12940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24356306	Green Accepted			2022-12-28	WOS:000329995000031
J	Sun, L; Young, LN; Zhang, XZ; Boudko, SP; Fokine, A; Zbornik, E; Roznowski, AP; Molineux, IJ; Rossmann, MG; Fane, BA				Sun, Lei; Young, Lindsey N.; Zhang, Xinzheng; Boudko, Sergei P.; Fokine, Andrei; Zbornik, Erica; Roznowski, Aaron P.; Molineux, Ian J.; Rossmann, Michael G.; Fane, Bentley A.			Icosahedral bacteriophage Phi X174 forms a tail for DNA transport during infection	NATURE			English	Article							EXTERNAL SCAFFOLDING PROTEIN; SINGLE-STRANDED-DNA; H SPIKE PROTEIN; ESCHERICHIA-COLI; 2ND-SITE SUPPRESSORS; ADSORPTION; PREDICTION; MECHANISM; MODEL; HOST	Prokaryotic viruses have evolved various mechanisms to transport their genomes across bacterial cell walls(1). Many bacteriophages use a tail to perform this function, whereas tail-less phages rely on host organelles(2-4). However, the tail-less, icosahedral, single-stranded DNA Phi X174-like coliphages do not fall into these well-defined infection processes. For these phages, DNA delivery requires a DNA pilot protein(5). Here we show that the Phi X174 pilot protein H oligomerizes to forma tube whose function is most probably to deliver the DNA genome across the host's periplasmic space to the cytoplasm. The 2.4 angstrom resolution crystal structure of the in vitro assembled H protein's central domain consists of a 170 angstrom-long alpha-helical barrel. The tube is constructed of ten alpha-helices with their amino termini arrayed in a right-handed super-helical coiled-coil and their carboxy termini arrayed in a left-handed super-helical coiled-coil. Genetic and biochemical studies demonstrate that the tube is essential for infectivity but does not affect in vivo virus assembly. Cryo-electron tomograms show that tubes span the periplasmic space and are present while the genome is being delivered into the host cell's cytoplasm. Both ends of the H protein contain transmembrane domains, which anchor the assembled tubes into the inner and outer cell membranes. The central channel of the H-protein tube is lined with amide and guanidinium side chains. This may be a general property of viral DNA conduits and is likely to be critical for efficient genome translocation into the host.	[Sun, Lei; Zhang, Xinzheng; Boudko, Sergei P.; Fokine, Andrei; Zbornik, Erica; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Young, Lindsey N.; Roznowski, Aaron P.; Fane, Bentley A.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Young, Lindsey N.; Roznowski, Aaron P.; Fane, Bentley A.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Molineux, Ian J.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Arizona; University of Arizona; University of Texas System; University of Texas Austin	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mr@purdue.edu; bfane@email.arizona.edu	Fokine, Andrei/A-1330-2013; Zhang, Xinzheng/E-6339-2013; zhang, xinzheng/L-6254-2019; Sun, Lei/F-5167-2012	Boudko, Sergei/0000-0003-3856-4859	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DEAC02-06CH11357]; National Science Foundation [MCB-0948399, MCB-0443899]; US Department of Agriculture; Div Of Molecular and Cellular Bioscience [1014547] Funding Source: National Science Foundation	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. Kelly for help in preparing the manuscript. Use of the Advanced Photon Source (Sector 23) was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DEAC02-06CH11357. This research was supported by National Science Foundation grants MCB-0948399 (to B.A.F.) and MCB-0443899 (to M.G.R.) and US Department of Agriculture Hatch funds to the University of Arizona (to B.A.F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOYAMA A, 1983, P NATL ACAD SCI-BIOL, V80, P4195, DOI 10.1073/pnas.80.14.4195; BAYER ME, 1972, VIROLOGY, V49, P236, DOI 10.1016/S0042-6822(72)80026-6; BENEVIDES JM, 1991, BIOCHEMISTRY-US, V30, P4855, DOI 10.1021/bi00234a004; BOWES JM, 1974, J VIROL, V13, P53, DOI 10.1128/JVI.13.1.53-61.1974; BURGESS AB, 1969, P NATL ACAD SCI USA, V64, P613, DOI 10.1073/pnas.64.2.613; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Cherwa JE, 2011, J MOL BIOL, V412, P387, DOI 10.1016/j.jmb.2011.07.070; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANE BA, 1991, GENETICS, V128, P663; FANE BA, 1993, GENETICS, V134, P1003; Gordon EB, 2012, J VIROL, V86, P9911, DOI 10.1128/JVI.01120-12; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; INCARDONA NL, 1973, J VIROL, V11, P775, DOI 10.1128/JVI.11.5.775-782.1973; JAZWINSKI SM, 1975, VIROLOGY, V66, P283, DOI 10.1016/0042-6822(75)90198-1; JAZWINSKI SM, 1975, VIROLOGY, V66, P294, DOI 10.1016/0042-6822(75)90199-3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Perez GL, 2009, J BACTERIOL, V191, P135, DOI 10.1128/JB.00778-08; ROOF WD, 1994, J BIOL CHEM, V269, P2902; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUSSEL M, 2006, BACTERIOPHAGES, P146; Shepard W, 1998, STRUCT FOLD DES, V6, P849, DOI 10.1016/S0969-2126(98)00087-2; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SINSHEIMER R. L., 1959, BROOKHAVEN SYMPOSIA IN BIOL, V12, P27; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uchiyama A, 2005, J VIROL, V79, P6751, DOI 10.1128/JVI.79.11.6751-6756.2005; Wang YA, 2006, J MOL BIOL, V361, P209, DOI 10.1016/j.jmb.2006.06.027; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002	45	73	77	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					432	+		10.1038/nature12816	http://dx.doi.org/10.1038/nature12816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24336205				2022-12-28	WOS:000329621800049
J	Turner-Moss, E				Turner-Moss, Eleanor			Child labour must be on the post-2015 agenda	LANCET			English	Editorial Material							HEALTH; EXPOSURE; WORKERS; LEAD		[Turner-Moss, Eleanor] Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Turner-Moss, E (corresponding author), Barts & London Queen Marys Sch Med & Dent, Garrod Bldg,Turner St, London E1 2AD, England.	e.turnermoss@gmail.com						Ambadekar NN, 1999, PUBLIC HEALTH, V113, P303, DOI 10.1016/S0033-3506(99)00185-7; Awan S, 2010, INT J OCCUP ENV HEAL, V16, P115; Banza CLN, 2009, ENVIRON RES, V109, P745, DOI 10.1016/j.envres.2009.04.012; Bose-O'Reilly S, 2008, ENVIRON RES, V107, P89, DOI 10.1016/j.envres.2008.01.009; Brown G., 2012, CHILD LABOUR ED DISA; de Vasconcelos RBA, 2010, CHILD CARE HLTH DEV, V36, P369, DOI 10.1111/j.1365-2214.2010.01078.x; Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P409, DOI 10.1289/ehp.99107s3409; Feinstein L., 2006, P COP S OECD PAR; HARARI R, 1995, ARCH ENVIRON HEALTH, V50, P393; Harper C, 2003, WORLD DEV, V31, P535, DOI 10.1016/S0305-750X(03)00010-X; Ide LSR, 2005, PUBLIC HEALTH REP, V120, P607, DOI 10.1177/003335490512000608; International Labour Organisation, 2013, ILO CONV REC CHILD L; International Labour Organisation, 2010, ACC ACT CHILD LAB; ISLAM MA, 1994, EUR J CLIN NUTR, V48, P416; MITRA S, 1993, BRIT J IND MED, V50, P938; Myers WE, 2001, ANN AM ACAD POLIT SS, V575, P38, DOI 10.1177/0002716201575001003; Noweir M B, 1993, J Egypt Public Health Assoc, V68, P443; RAJU T N K, 1989, Indian Journal of Pediatrics, V56, P193, DOI 10.1007/BF02726606; Saddik B, 2003, NEUROTOXICOLOGY, V24, P733, DOI 10.1016/S0161-813X(03)00053-6; Saif I., 2006, RAPID ASSESSMENT WOR; Tsai SY, 1997, ENVIRON RES, V73, P146, DOI 10.1006/enrs.1997.3704; UNICEF, 2012, CONV RIGHTS CHILD; United Nations, 2013, MILL DEV GOALS GOAL; Whetten R, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-1	24	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					E52	E53		10.1016/S0140-6736(13)61975-3	http://dx.doi.org/10.1016/S0140-6736(13)61975-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24315618				2022-12-28	WOS:000328687800004
J	Roberts, D				Roberts, Dorothy			Adrienne Asch (1946-2013) OBITUARY	NATURE			English	Biographical-Item									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Roberts, D (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	dorothyroberts@law.upenn.edu						ASCH A, PUBLICATION LIST	1	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					377	377		10.1038/504377a	http://dx.doi.org/10.1038/504377a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24352283	Bronze			2022-12-28	WOS:000328575300037
J	Thorne, RM; Li, W; Ni, B; Ma, Q; Bortnik, J; Chen, L; Baker, DN; Spence, HE; Reeves, GD; Henderson, MG; Kletzing, CA; Kurth, WS; Hospodarsky, GB; Blake, JB; Fennell, JF; Claudepierre, SG; Kanekal, SG				Thorne, R. M.; Li, W.; Ni, B.; Ma, Q.; Bortnik, J.; Chen, L.; Baker, D. N.; Spence, H. E.; Reeves, G. D.; Henderson, M. G.; Kletzing, C. A.; Kurth, W. S.; Hospodarsky, G. B.; Blake, J. B.; Fennell, J. F.; Claudepierre, S. G.; Kanekal, S. G.			Rapid local acceleration of relativistic radiation-belt electrons by magnetospheric chorus	NATURE			English	Article							WHISTLER-MODE CHORUS; WAVES; ENERGIZATION; SCATTERING; DIFFUSION	Recent analysis of satellite data obtained during the 9 October 2012 geomagnetic storm identified the development of peaks in electron phase space density(1), which are compelling evidence for local electron acceleration in the heart of the outer radiation belt(2,3), but are inconsistent with acceleration by inward radial diffusive transport(4,5). However, the precise physical mechanism responsible for the acceleration on 9 October was not identified. Previous modelling has indicated that a magnetospheric electromagnetic emission known as chorus could be a potential candidate for local electron acceleration(6-10), but a definitive resolution of the importance of chorus for radiation-belt acceleration was not possible because of limitations in the energy range and resolution of previous electron observations and the lack of a dynamic global wave model. Here we report high-resolution electron observations(11) obtained during the 9 October storm and demonstrate, using a two-dimensional simulation performed with a recently developed time-varying data-driven model(12), that chorus scattering explains the temporal evolution of both the energy and angular distribution of the observed relativistic electron flux increase. Our detailed modelling demonstrates the remarkable efficiency of wave acceleration in the Earth's outer radiation belt, and the results presented have potential application to Jupiter, Saturn and other magnetized astrophysical objects.	[Thorne, R. M.; Li, W.; Ni, B.; Ma, Q.; Bortnik, J.; Chen, L.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Baker, D. N.] Univ Colorado, Lab Atmospher & Space Res, Boulder, CO 80303 USA; [Spence, H. E.] Univ New Hampshire, Each Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Reeves, G. D.; Henderson, M. G.] Los Alamos Natl Lab, Space Sci & Applicat Grp, Los Alamos, NM 87544 USA; [Kletzing, C. A.; Kurth, W. S.; Hospodarsky, G. B.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Blake, J. B.; Fennell, J. F.; Claudepierre, S. G.] Aerosp Corp, Los Angeles, CA 90245 USA; [Kanekal, S. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University System Of New Hampshire; University of New Hampshire; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Iowa; Aerospace Corporation - USA; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Thorne, RM (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	rmt@atmos.ucla.edu	Claudepierre, Seth G/A-6109-2012; Spence, Harlan E/A-1942-2011; Kurth, William/AAA-7334-2019; Henderson, Michael G/A-3948-2011; Hospodarsky, George B/A-7996-2015; Li, Wen/F-3722-2011; Chen, Lunjin/L-1250-2013; Reeves, Geoffrey D/E-8101-2011	Claudepierre, Seth G/0000-0001-5513-5947; Spence, Harlan E/0000-0002-2526-2205; Kurth, William/0000-0002-5471-6202; Henderson, Michael G/0000-0003-4975-9029; Hospodarsky, George B/0000-0001-9200-9878; Chen, Lunjin/0000-0003-2489-3571; Reeves, Geoffrey D/0000-0002-7985-8098; Kletzing, Craig/0000-0002-4136-3348	JHU/APL under NASA [967399, 921647, NAS5-01072]; EMFISIS [1001057397:01]; ECT [13-041]	JHU/APL under NASA; EMFISIS; ECT	This work was supported by JHU/APL contracts 967399 and 921647 under NASA's prime contract NAS5-01072. The analysis at UCLA was supported by the EMFISIS sub-award 1001057397:01 and by the ECT sub-award 13-041. We thank OMNIweb for providing geomagnetic indices and solar wind parameters used in this study and the NOAA POES team for providing POES electron data.	Baker DN, 2013, SPACE SCI REV, V179, P337, DOI 10.1007/s11214-012-9950-9; Baker DN, 1998, J GEOPHYS RES-SPACE, V103, P17279, DOI 10.1029/97JA03329; Blake JB, 2013, SPACE SCI REV, V179, P383, DOI 10.1007/s11214-013-9991-8; Chen Y, 2007, NAT PHYS, V3, P614, DOI 10.1038/nphys655; Green JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010153; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; Horne RB, 2005, NATURE, V437, P227, DOI 10.1038/nature03939; Horne RB, 1998, GEOPHYS RES LETT, V25, P3011, DOI 10.1029/98GL01002; Horne RB, 2008, NAT PHYS, V4, P301, DOI 10.1038/nphys897; Kataoka R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031842; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; Kletzing CA, 2013, SPACE SCI REV, V179, P127, DOI 10.1007/s11214-013-9993-6; Li W, 2013, GEOPHYS RES LETT, V40, P4526, DOI 10.1002/grl.50920; Li W, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA017035; Li W, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014845; Li W, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037595; MCPHERRON RL, 1993, J ATMOS TERR PHYS, V55, P1091, DOI 10.1016/0021-9169(93)90040-6; Meredith NP, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017978; Ni B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034032; Nishimura Y, 2010, SCIENCE, V330, P81, DOI 10.1126/science.1193186; Perry KL, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010760; Reeves GD, 2013, SCIENCE, V341, P991, DOI 10.1126/science.1237743; Sheeley BW, 2001, J GEOPHYS RES-SPACE, V106, P25631, DOI 10.1029/2000JA000286; Shue JH, 1998, J GEOPHYS RES-SPACE, V103, P17691, DOI 10.1029/98JA01103; Summers D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016039; Summers D, 1998, J GEOPHYS RES-SPACE, V103, P20487, DOI 10.1029/98JA01740; Thorne RM, 2010, NATURE, V467, P943, DOI 10.1038/nature09467; Thorne RM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044990; Turner DL, 2012, NAT PHYS, V8, P208, DOI [10.1038/nphys2185, 10.1038/NPHYS2185]; Ukhorskiy AY, 2009, ANN GEOPHYS-GERMANY, V27, P2173, DOI 10.5194/angeo-27-2173-2009	30	519	522	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					411	+		10.1038/nature12889	http://dx.doi.org/10.1038/nature12889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24352287				2022-12-28	WOS:000328575300046
J	Luce, CH; Abatzoglou, JT; Holden, ZA				Luce, C. H.; Abatzoglou, J. T.; Holden, Z. A.			The Missing Mountain Water: Slower Westerlies Decrease Orographic Enhancement in the Pacific Northwest USA	SCIENCE			English	Article							CLIMATE-CHANGE; PRECIPITATION; VARIABILITY; STREAMFLOW; SNOWPACK; FLOW; SENSITIVITY; PATTERNS; SHIFTS; TRENDS	Trends in streamflow timing and volume in the Pacific Northwest United States have been attributed to increased temperatures, because trends in precipitation at lower-elevation stations were negligible. We demonstrate that observed streamflow declines are probably associated with declines in mountain precipitation, revealing previously unexplored differential trends. Lower-troposphere winter (November to March) westerlies are strongly correlated with high-elevation precipitation but weakly correlated with low-elevation precipitation. Decreases in lower-tropospheric winter westerlies across the region from 1950 to 2012 are hypothesized to have reduced orographic precipitation enhancement, yielding differential trends in precipitation across elevations and contributing to the decline in annual streamflow. Climate projections show weakened lower-troposphere zonal flow across the region under enhanced greenhouse forcing, highlighting an additional stressor that is relevant for climate change impacts on hydrology.	[Luce, C. H.] US Forest Serv Res & Dev, Boise, ID 83702 USA; [Abatzoglou, J. T.] Univ Idaho, Dept Geog, Moscow, ID 83844 USA; [Holden, Z. A.] US Forest Serv Reg 1, Missoula, MT 59807 USA	United States Department of Agriculture (USDA); United States Forest Service; Idaho; University of Idaho	Luce, CH (corresponding author), US Forest Serv Res & Dev, 322 East Front St, Boise, ID 83702 USA.	cluce@fs.fed.us	Abatzoglou, John T/C-7635-2012; Luce, Charles/A-9267-2008; Abatzoglou, John T/ABE-6134-2020	Abatzoglou, John T/0000-0001-7599-9750; Luce, Charles/0000-0002-6938-9662; Abatzoglou, John T/0000-0001-7599-9750	NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) [EPS-0814387]; NASA [NNH11ZDA001N-FIRES]	NSF's Experimental Program to Stimulate Competitive Research (EPSCoR); NASA(National Aeronautics & Space Administration (NASA))	We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in table S1 of this paper) for producing and making available their model output. The U. S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support for CMIP and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We thank the reviewers for their comments and insights, which substantially improved the paper. J.T.A. was supported by NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) (EPS-0814387). This work was partially supported by NASA through NNH11ZDA001N-FIRES.	Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Braganza K, 2004, CLIM DYNAM, V22, P823, DOI 10.1007/s00382-004-0413-1; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Burt TP, 2013, WATER RESOUR RES, V49, P3504, DOI 10.1002/wrcr.20297; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Clark GM, 2010, J AM WATER RESOUR AS, V46, P486, DOI 10.1111/j.1752-1688.2009.00416.x; Colle BA, 2004, J ATMOS SCI, V61, P588, DOI 10.1175/1520-0469(2004)061<0588:SOOPTC>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dettinger M, 2004, J HYDROMETEOROL, V5, P1102, DOI 10.1175/JHM-390.1; Fu GB, 2010, HYDROL PROCESS, V24, P866, DOI 10.1002/hyp.7527; Gedalof Z, 2004, J AM WATER RESOUR AS, V40, P1579, DOI 10.1111/j.1752-1688.2004.tb01607.x; Holden ZA, 2012, ECOHYDROLOGY, V5, P677, DOI 10.1002/eco.257; Houze RA, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000365; Hughes M, 2009, J ATMOS SCI, V66, P508, DOI 10.1175/2008JAS2689.1; Jiang Y, 2010, THEOR APPL CLIMATOL, V99, P421, DOI 10.1007/s00704-009-0152-7; Luce CH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039407; Lutz ER, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010687; McVicar TR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042255; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Minder JR, 2010, J CLIMATE, V23, P2634, DOI 10.1175/2009JCLI3263.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Gorman PA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025207; Panziera L, 2010, Q J ROY METEOR SOC, V136, P222, DOI 10.1002/qj.544; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Ralph FM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026689; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; Salathe EP, 2010, CLIMATIC CHANGE, V102, P51, DOI 10.1007/s10584-010-9849-y; Service RF, 2004, SCIENCE, V303, P1124, DOI 10.1126/science.303.5661.1124; Siler N, 2013, J HYDROMETEOROL, V14, P122, DOI 10.1175/JHM-D-12-045.1; Smith R. B., 1979, ADV GEOPHYS, V21, P87, DOI 10.1016/S0065-2687(08)60262-9; Smith RB, 2004, J ATMOS SCI, V61, P1377, DOI 10.1175/1520-0469(2004)061<1377:ALTOOP>2.0.CO;2; Solomon S., 2007, PHYS SCI BASIS WORKI; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Yuter SE, 2011, J HYDROMETEOROL, V12, P329, DOI 10.1175/2010JHM1239.1	37	123	137	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1360	1364		10.1126/science.1242335	http://dx.doi.org/10.1126/science.1242335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24292627				2022-12-28	WOS:000328196000048
J	Schuchmann, K; Muller, V				Schuchmann, K.; Mueller, V.			Direct and Reversible Hydrogenation of CO2 to Formate by a Bacterial Carbon Dioxide Reductase	SCIENCE			English	Article							FORMIC-ACID; INTERCONVERSION; DEHYDROGENASE; CATALYST	Storage and transportation of hydrogen is a major obstacle for its use as a fuel. An increasingly considered alternative for the direct handling of hydrogen is to use carbon dioxide (CO2) as an intermediate storage material. However, CO2 is thermodynamically stable, and developed chemical catalysts often require high temperatures, pressures, and/or additives for high catalytic rates. Here, we present the discovery of a bacterial hydrogen-dependent carbon dioxide reductase from Acetobacterium woodii directly catalyzing the hydrogenation of CO2. We also demonstrate a whole-cell system able to produce formate as the sole end product from dihydrogen (H-2) and CO2 as well as syngas. This discovery opens biotechnological alternatives for efficient CO2 hydrogenation either by using the isolated enzyme or by employing whole-cell catalysis.	[Schuchmann, K.; Mueller, V.] Johann Wolfgang Goethe Univ Frankfurt Main, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Johann Wolfgang Goethe Univ Frankfurt Main, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Academic Foundation	We are grateful to M. Herzberg and D. Nies for the ICP-MS measurements and to J. Langer for protein identification via peptide mass fingerprinting. This work was supported by grants from the Deutsche Forschungsgemeinschaft and the German National Academic Foundation. Part of this work is filed as a patent (EP-No. 13172411.4). The data reported in this paper are tabulated in the supplementary materials.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Aslam NM, 2012, APCBEE PROC, V3, P33, DOI 10.1016/j.apcbee.2012.06.042; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Crable Bryan R, 2011, Enzyme Res, V2011, P532536, DOI 10.4061/2011/532536; da Silva SM, 2013, MICROBIOL-SGM, V159, P1760, DOI 10.1099/mic.0.067868-0; Drake S. L. D. H. L., 1994, ACETOGENESIS, P3; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Fujita E, 2013, BBA-BIOENERGETICS, V1827, P1031, DOI 10.1016/j.bbabio.2012.11.004; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Jeletic MS, 2013, J AM CHEM SOC, V135, P11533, DOI 10.1021/ja406601v; KLIBANOV AM, 1982, BIOTECHNOL BIOENG, V24, P25, DOI 10.1002/bit.260240104; Matson EG, 2010, ENVIRON MICROBIOL, V12, P2245, DOI 10.1111/j.1462-2920.2010.02188.x; Muller N, 2010, ENV MICROBIOL REP, V2, P489, DOI 10.1111/j.1758-2229.2010.00147.x; Muller V, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P251; Munasinghe PC, 2010, BIORESOURCE TECHNOL, V101, P5013, DOI 10.1016/j.biortech.2009.12.098; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Reda T, 2008, P NATL ACAD SCI USA, V105, P10654, DOI 10.1073/pnas.0801290105; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; WU WM, 1993, ARCH MICROBIOL, V159, P57, DOI 10.1007/BF00244265	22	237	244	15	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1382	1385		10.1126/science.1244758	http://dx.doi.org/10.1126/science.1244758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337298				2022-12-28	WOS:000328196000054
J	Thompson, M; Vodicka, TA; Blair, PS; Buckley, DI; Heneghan, C; Hay, AD				Thompson, Matthew; Vodicka, Talley A.; Blair, Peter S.; Buckley, David I.; Heneghan, Carl; Hay, Alastair D.		TARGET Programme Team	Duration of symptoms of respiratory tract infections in children: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE OTITIS-MEDIA; PLACEBO-CONTROLLED TRIAL; ACUTE SORE THROAT; DOUBLE-BLIND; ORAL DEXAMETHASONE; PRESCHOOL-CHILDREN; ACUTE COUGH; CLINICAL-COURSE; YOUNG-CHILDREN; PRIMARY-CARE	Objective To determine the expected duration of symptoms of common respiratory tract infections in children in primary and emergency care. Design Systematic review of existing literature to determine durations of symptoms of earache, sore throat, cough (including acute cough, bronchiolitis, and croup), and common cold in children. Data sources PubMed, DARE, and CINAHL (all to July 2012). Eligibility criteria for selecting studies Randomised controlled trials or observational studies of children with acute respiratory tract infections in primary care or emergency settings in high income countries who received either a control treatment or a placebo or over-the-counter treatment. Study quality was assessed with the Cochrane risk of bias framework for randomised controlled trials, and the critical appraisal skills programme framework for observational studies. Main outcome measures Individual study data and, when possible, pooled daily mean proportions and 95% confidence intervals for symptom duration. Symptom duration (in days) at which each symptom had resolved in 50% and 90% of children. Results Of 22 182 identified references, 23 trials and 25 observational studies met inclusion criteria. Study populations varied in age and duration of symptoms before study onset. In 90% of children, earache was resolved by seven to eight days, sore throat between two and seven days, croup by two days, bronchiolitis by 21 days, acute cough by 25 days, common cold by 15 days, and non-specific respiratory tract infections symptoms by 16 days. Conclusions The durations of earache and common colds are considerably longer than current guidance given to parents in the United Kingdom and the United States; for other symptoms such as sore throat, acute cough, bronchiolitis, and croup the current guidance is consistent with our findings. Updating current guidelines with new evidence will help support parents and clinicians in evidence based decision making for children with respiratory tract infections.	[Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Vodicka, Talley A.; Buckley, David I.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Blair, Peter S.] Univ Bristol, St Michaels Hosp, Sch Social & Community Med, Bristol, Avon, England; [Heneghan, Carl] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Heneghan, Carl] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Heneghan, Carl] Oregon Hlth & Sci Univ, Dept Publ Hlth, Portland, OR 97201 USA; [Heneghan, Carl] Oregon Hlth & Sci Univ, Dept Prevent Med, Portland, OR 97201 USA; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England	University of Washington; University of Washington Seattle; University of Oxford; University of Bristol; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Bristol	Thompson, M (corresponding author), Univ Washington, Dept Family Med, Box 354696, Seattle, WA 98195 USA.	mjt@uw.edu	Blair, Peter S/C-1213-2009; Hay, Alastair/L-1818-2019	Blair, Peter/0000-0002-7832-8087; Hay, Alastair/0000-0003-3012-375X	National Institute for Health Research (NIHR) [RP-PG-0608-10018]; National Institute for Health Research	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) under its programme grants for applied research funding scheme (RP-PG-0608-10018) and from a career development fellowship (for MT) supported by the National Institute for Health Research. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funding agency had no involvement in the study design, data collection, analysis, writing of the manuscript, or decision to submit it for publication.	Bernard DW, 1999, ACTA PAEDIATR, V88, P465, DOI 10.1080/08035259950169891; Bjornson CL, 2004, NEW ENGL J MED, V351, P1306, DOI 10.1056/NEJMoa033534; Bulloch B, 2003, ANN EMERG MED, V41, P601, DOI 10.1067/mem.2003.136; BURKE P, 1991, BRIT MED J, V303, P558, DOI 10.1136/bmj.303.6802.558; Butler CC, 2005, FAM PRACT, V22, P92, DOI 10.1093/fampra/cmh713; Butler CC, 2004, BRIT J GEN PRACT, V54, P536; Butler CC, 2003, BRIT MED J, V327, P1088, DOI 10.1136/bmj.327.7423.1088; Carabin H, 2000, CHILD CARE HLTH DEV, V26, P471, DOI 10.1046/j.1365-2214.2000.00168.x; Centers for Disease Control and Prevention (CDC), GET SMART RESP ILLN; CHAPPLE PAL, 1956, BMJ-BRIT MED J, V1, P705, DOI 10.1136/bmj.1.4969.705; Cobb JMT, 1998, J PSYCHOSOM RES, V45, P319, DOI 10.1016/S0022-3999(97)00311-5; CRUZ MN, 1995, PEDIATRICS, V96, P220; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Geelhoed GC, 1996, BRIT MED J, V313, P140, DOI 10.1136/bmj.313.7050.140; Greenberg D, 2003, EUR J PEDIATR, V162, P576, DOI 10.1007/s00431-003-1260-5; Gruber C, 2008, PEDIAT ALLERG IMM-UK, V19, P505, DOI 10.1111/j.1399-3038.2007.00688.x; Hay AD, 2005, FAM PRACT, V22, P367, DOI 10.1093/fampra/cmi035; Hay AD, 2003, FAM PRACT, V20, P696, DOI 10.1093/fampra/cmg613; Hay AD, 2007, BRIT J GEN PRACT, V57, P530; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; HUTTON N, 1991, J PEDIATR-US, V118, P125, DOI 10.1016/S0022-3476(05)81865-7; Jacobs B, 2000, J CLIN EPIDEMIOL, V53, P793, DOI 10.1016/S0895-4356(99)00238-3; Jedrychowski W, 2005, EUR J EPIDEMIOL, V20, P775, DOI 10.1007/s10654-005-1048-1; Kristo A, 2006, PEDIATR INFECT DIS J, V25, P108, DOI 10.1097/01.inf.0000201048.65828.b5; Kristo A, 2005, ACTA PAEDIATR, V94, P1208, DOI [10.1080/08035250510028236, 10.1111/j.1651-2227.2005.tb02076.x]; Kusel MM, 2007, J PAEDIATR CHILD H, V43, P139, DOI 10.1111/j.1440-1754.2007.01033.x; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Le Saux N, 2005, CAN MED ASSOC J, V172, P335, DOI 10.1503/cmaj.1040771; Macknin ML, 1998, JAMA-J AM MED ASSOC, V279, P1962, DOI 10.1001/jama.279.24.1962; Mitra Andrew, 2011, Prim Health Care Res Dev, V12, P329, DOI 10.1017/S1463423611000193; MYGIND N, 1981, CLIN OTOLARYNGOL, V6, P5, DOI 10.1111/j.1365-2273.1981.tb01781.x; National Bank of Georgia, 2011, TSLIUR ANG; NELSON JD, 1984, PEDIATR INFECT DIS J, V3, P10, DOI 10.1097/00006454-198401000-00004; Neumark T, 2007, SCAND J PRIM HEALTH, V25, P166, DOI 10.1080/02813430701267405; NICE Short Clinical Guidelines Technical Team, 2008, RESP TRACT INF ANT P; Olympia RP, 2005, ARCH PEDIAT ADOL MED, V159, P278, DOI 10.1001/archpedi.159.3.278; Pappas DE, 2008, PEDIATR INFECT DIS J, V27, P8, DOI 10.1097/INF.0b013e31814847d9; Patel H, 2003, J PEDIATR-US, V142, P509, DOI 10.1067/mpd.2003.196; Petruzella FD, 2010, PEDIATRICS, V126, pE285, DOI 10.1542/peds.2009-2189; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS32, DOI 10.1016/j.otohns.2007.06.724; Ruperto N, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-48; SAMET JM, 1993, AM REV RESPIR DIS, V148, P441, DOI 10.1164/ajrccm/148.2.441; Smith L, 2010, BRIT J GEN PRACT, V60, P101, DOI 10.3399/bjgp10X483148; STEINWEG KK, 1983, J FAM PRACTICE, V17, P61; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Taylor JA, 2003, JAMA-J AM MED ASSOC, V290, P2824, DOI 10.1001/jama.290.21.2824; Taylor JA, 2010, PEDIATR RES, V68, P252, DOI 10.1203/00006450-201011001-00493; von Linstow ML, 2008, PEDIATR PULM, V43, P584, DOI 10.1002/ppul.20828; WALD ER, 1991, PEDIATRICS, V87, P129; Zwart S, 2003, BRIT MED J, V327, P1324, DOI 10.1136/bmj.327.7427.1324	54	88	96	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f7027	10.1136/bmj.f7027	http://dx.doi.org/10.1136/bmj.f7027			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335668	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000328575000002
J	Pal, K; Melcher, K; Xu, HE				Pal, Kuntal; Melcher, Karsten; Xu, H. Eric			Structure Modeling Using Genetically Engineered Crosslinking	CELL			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; RECOGNITION		[Pal, Kuntal; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Struct & Funct Drug Targets, VARI SIMM Ctr,Key Lab Receptor Res, Shanghai 201203, Peoples R China	Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org; eric.xu@vai.org	sarkar, sabyasachi/A-9896-2010; Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020; Pal, Kuntal/W-6348-2019	sarkar, sabyasachi/0000-0002-8954-4375; Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; PAL, KUNTAL/0000-0001-7094-2456				Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859	9	1	1	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1207	1208		10.1016/j.cell.2013.11.018	http://dx.doi.org/10.1016/j.cell.2013.11.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315089	Bronze			2022-12-28	WOS:000328271100003
J	Starmer, AJ; Sectish, TC; Simon, DW; Keohane, C; McSweeney, ME; Chung, EY; Yoon, CS; Lipsitz, SR; Wassner, AJ; Harper, MB; Landrigan, CP				Starmer, Amy J.; Sectish, Theodore C.; Simon, Dennis W.; Keohane, Carol; McSweeney, Maireade E.; Chung, Erica Y.; Yoon, Catherine S.; Lipsitz, Stuart R.; Wassner, Ari J.; Harper, Marvin B.; Landrigan, Christopher P.			Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG EVENTS; SIGN-OUT; PATIENT-CARE; HOUSE STAFF; HEALTH-CARE; CONTINUITY; SAFETY; INTERVENTION; EDUCATION; IMPACT	IMPORTANCE Handoff miscommunications are a leading cause of medical errors. Studies comprehensively assessing handoff improvement programs are lacking. OBJECTIVE To determine whether introduction of a multifaceted handoff program was associated with reduced rates of medical errors and preventable adverse events, fewer omissions of key data in written handoffs, improved verbal handoffs, and changes in resident-physician workflow. DESIGN, SETTING, AND PARTICIPANTS Prospective intervention study of 1255 patient admissions (642 before and 613 after the intervention) involving 84 resident physicians (42 before and 42 after the intervention) from July-September 2009 and November 2009-January 2010 on 2 inpatient units at Boston Children's Hospital. INTERVENTIONS Resident handoff bundle, consisting of standardized communication and handoff training, a verbal mnemonic, and a new team handoff structure. On one unit, a computerized handoff tool linked to the electronic medical record was introduced. MAIN OUTCOMES AND MEASURES The primary outcomes were the rates of medical errors and preventable adverse events measured by daily systematic surveillance. The secondary outcomes were omissions in the printed handoff document and resident time-motion activity. RESULTS Medical errors decreased from 33.8 per 100 admissions (95% CI, 27.3-40.3) to 18.3 per 100 admissions (95% CI, 14.7-21.9; P < .001), and preventable adverse events decreased from 3.3 per 100 admissions (95% CI, 1.7-4.8) to 1.5 (95% CI, 0.51-2.4) per 100 admissions (P = .04) following the intervention. There were fewer omissions of key handoff elements on printed handoff documents, especially on the unit that received the computerized handoff tool (significant reductions of omissions in 11 of 14 categories with computerized tool; significant reductions in 2 of 14 categories without computerized tool). Physicians spent a greater percentage of time in a 24-hour period at the patient bedside after the intervention (8.3%; 95% CI 7.1%-9.8%) vs 10.6%(95% CI, 9.2%-12.2%; P = .03). The average duration of verbal handoffs per patient did not change. Verbal handoffs were more likely to occur in a quiet location (33.3%; 95% CI, 14.5%-52.2% vs 67.9%; 95% CI, 50.6%-85.2%; P = .03) and private location (50.0%; 95% CI, 30%-70% vs 85.7%; 95% CI, 72.8%-98.7%; P = .007) after the intervention. CONCLUSIONS AND RELEVANCE Implementation of a handoff bundle was associated with a significant reduction in medical errors and preventable adverse events among hospitalized children. Improvements in verbal and written handoff processes occurred, and resident workflow did not change adversely.	[Starmer, Amy J.; Sectish, Theodore C.; Simon, Dennis W.; McSweeney, Maireade E.; Chung, Erica Y.; Wassner, Ari J.; Harper, Marvin B.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat,Dept Med, Boston, MA 02115 USA; [Starmer, Amy J.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA; [Simon, Dennis W.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Keohane, Carol; Yoon, Catherine S.; Lipsitz, Stuart R.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Keohane, Carol; Yoon, Catherine S.; Lipsitz, Stuart R.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Chung, Erica Y.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02903 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Starmer, AJ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat,Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	amy.starmer@childrens.harvard.edu	Harper, Marvin B/O-9780-2017; Ramotar, Matt W/K-2193-2019	Harper, Marvin B/0000-0003-1385-0218; Landrigan, Christopher/0000-0001-8386-4100; Wassner, Ari/0000-0003-0894-9301	Controlled Risk Insurance Company Risk Management Foundation Grant Program; Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program; Agency for Healthcare Research and Quality [T32 HP10018, 1K12HS019456-01]; Child Health Corporation of America; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) [UL1TR000128]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019456] Funding Source: NIH RePORTER	Controlled Risk Insurance Company Risk Management Foundation Grant Program; Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Child Health Corporation of America; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by the Controlled Risk Insurance Company Risk Management Foundation Grant Program as well as a grant from the Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program. Dr Starmer was supported by grants T32 HP10018, a National Research Service Award in Pediatrics and 1K12HS019456-01 from the Oregon Comparative Effectiveness Research K12 Program through the Agency for Healthcare Research and Quality. Dr Landrigan is partially supported by the Child Health Corporation of America for his work as a member of the PRIS Network Executive Council. Some support for statistical analyses provided in part by the Oregon Clinical and Translational Research Institute (OCTRI) and grant UL1TR000128 from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).	Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Arora V, 2006, JT COMM J QUAL PATIE, V32, P646, DOI 10.1016/S1553-7250(06)32084-3; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Cohen MD, 2010, QUAL SAF HEALTH CARE, V19, P493, DOI 10.1136/qshc.2009.033480; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Gordon M, 2011, MED EDUC, V45, P1081, DOI 10.1111/j.1365-2923.2011.04049.x; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horwitz LI, 2007, J GEN INTERN MED, V22, P1470, DOI 10.1007/s11606-007-0331-0; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Horwitz LI, 2009, ANN EMERG MED, V53, P701, DOI 10.1016/j.annemergmed.2008.05.007; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kitch BT, 2008, JT COMM J QUAL PATIE, V34, P563, DOI 10.1016/S1553-7250(08)34071-9; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Li P, 2013, J HOSP MED, V8, P456, DOI 10.1002/jhm.1988; Lipsitz SR, 2000, BIOMETRICS, V56, P528, DOI 10.1111/j.0006-341X.2000.00528.x; McDonald KM, 2007, CLOSING THE QUALITY, V7; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pizziferri L, 2005, J BIOMED INFORM, V38, P176, DOI 10.1016/j.jbi.2004.11.009; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Riesenberg LA, 2009, AM J MED QUAL, V24, P196, DOI 10.1177/1062860609332512; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; The Joint Commission, SENTINEL EVENT STATI; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; Wohlauer MV, 2012, ACAD MED, V87, P411, DOI 10.1097/ACM.0b013e318248e766; Young JQ, 2011, ANN INTERN MED, V155, P309, DOI 10.7326/0003-4819-155-5-201109060-00354; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	185	186	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2262	2270		10.1001/jama.2013.281961	http://dx.doi.org/10.1001/jama.2013.281961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302089				2022-12-28	WOS:000327746300011
J	Field, N; Mercer, CH; Sonnenberg, P; Tanton, C; Clifton, S; Mitchell, KR; Erens, B; Macdowall, W; Wu, F; Datta, J; Jones, KG; Stevens, A; Prah, P; Copas, AJ; Phelps, A; Wellings, K; Johnson, AM				Field, Nigel; Mercer, Catherine H.; Sonnenberg, Pam; Tanton, Clare; Clifton, Soazig; Mitchell, Kirstin R.; Erens, Bob; Macdowall, Wendy; Wu, Frederick; Datta, Jessica; Jones, Kyle G.; Stevens, Amy; Prah, Philip; Copas, Andrew J.; Phelps, Andrew; Wellings, Kaye; Johnson, Anne M.			Associations between health and sexual lifestyles in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	LANCET			English	Article							UNITED-STATES; OLDER-ADULTS; PRIMARY-CARE; MYOCARDIAL-INFARCTION; MEN; MIDDLE; WOMEN; BEHAVIOR; AGE; DEPRESSION	Background Physical and mental health could greatly affect sexual activity and fulfilment, but the nature of associations at a population level is poorly understood. We used data from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) to explore associations between health and sexual lifestyles in Britain (England, Scotland, and Wales). Methods Men and women aged 16-74 years who were resident in households in Britain were interviewed between Sept 6, 2010, and Aug 31, 2012. Participants completed the survey in their own homes through computer-assisted face-to-face interviews and self-interview. We analysed data for self-reported health status, chronic conditions, and sexual lifestyles, weighted to account for unequal selection probabilities and non-response to correct for differences in sex, age group, and region according to 2011 Census figures. Findings Interviews were done with 15 162 participants (6293 men, 8869 women). The proportion reporting recent sexual activity (one or more occasion of vaginal, oral, or anal sex with a partner of the opposite sex, or oral or anal sex or genital contact with a partner of the same sex in the past 4 weeks) decreased with age after the age of 45 years in men and after the age of 35 years in women, while the proportion in poorer health categories increased with age. Recent sexual activity was less common in participants reporting bad or very bad health than in those reporting very good health (men: 35.7% [95% CI 28.6-43.5] vs 74.8% [72.7-76.7]; women: 34.0% [28.6-39.9] vs 67.4% [65.4-69.3]), and this association remained after adjusting for age and relationship status (men: adjusted odds ratio [AOR] 0.29 [95% CI 0.19-0.44]; women: 0.43 [0.31-0.61]). Sexual satisfaction generally decreased with age, and was significantly lower in those reporting bad or very bad health than in those reporting very good health (men: 45.4% [38.4-52.7] vs 69.5% [67.3-71.6], AOR 0.51 [0.36-0.72]; women: 48.6% [42.9-54.3] vs 65.6% [63.6-67.4], AOR 0.69 [0.53-0.91]). In both sexes, reduced sexual activity and reduced satisfaction were associated with limiting disability and depressive symptoms, and reduced sexual activity was associated with chronic airways disease and difficulty walking up the stairs because of a health problem. 16.6% (95% CI 15.4-17.7) of men and 17.2% (16.3-18.2) of women reported that their health had affected their sex life in the past year, increasing to about 60% in those reporting bad or very bad health. 23.5% (20.3-26.9) of men and 18.4% (16.0-20.9) of women who reported that their health affected their sex life reported that they had sought clinical help (>80% from general practitioners; <10% from specialist services). Interpretation Poor health is independently associated with decreased sexual activity and satisfaction at all ages in Britain. Many people in poor health report an effect on their sex life, but few seek clinical help. Sexual lifestyle advice should be a component of holistic health care for patients with chronic ill health.	[Field, Nigel; Mercer, Catherine H.; Sonnenberg, Pam; Tanton, Clare; Clifton, Soazig; Erens, Bob; Jones, Kyle G.; Stevens, Amy; Prah, Philip; Copas, Andrew J.; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England; [Mitchell, Kirstin R.; Macdowall, Wendy; Datta, Jessica; Wellings, Kaye] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Erens, Bob] London Sch Hyg & Trop Med, London WC1, England; [Wu, Frederick] Univ Manchester, Inst Human Dev, Ctr Endocrinol & Diabet, Manchester, Lancs, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Manchester	Field, N (corresponding author), UCL, Mortimer Market Ctr, Res Dept Infect & Populat Hlth, London WC1E 6JB, England.	nigel.field@ucl.ac.uk	Weatherburn, Peter/AAC-2701-2019; Field, Nigel/ABG-3948-2020	Jones, Kyle/0000-0002-7127-1612; Mercer, Catherine/0000-0002-4220-5034; Sonnenberg, Pam/0000-0002-1067-1583; Tanton, Clare/0000-0002-4612-1858; Clifton, Soazig/0000-0002-4171-0805; Field, Nigel/0000-0002-2825-6652; Johnson, Anne/0000-0003-1330-7100; Copas, Andrew/0000-0001-8968-5963; Erens, Bob/0000-0002-4430-954X; Prah, Philip/0000-0002-4742-9686; Erens, Robert/0000-0002-3054-504X; Mitchell, Kirstin/0000-0002-4409-6601; Macdowall, Wendy/0000-0001-5868-8336	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [CL-2010-18-010, NF-SI-0508-10244, MET-11-19-101] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and Department of Health.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Davison SL, 2009, J SEX MED, V6, P2690, DOI 10.1111/j.1743-6109.2009.01406.x; DeLamater J, 2007, J AGING HEALTH, V19, P921, DOI 10.1177/0898264307308342; DeLamater J, 2012, J SEX RES, V49, P125, DOI 10.1080/00224499.2011.603168; Erens B, 3 NATL SURVEY SEXUAL; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Goodson P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c850; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, FAM PRACT, V20, P690, DOI 10.1093/fampra/cmg612; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Gray M., 2009, NATL SURVEY SEXUAL A; Haapanen N, 1997, AM J EPIDEMIOL, V145, P762, DOI 10.1093/aje/145.8.762; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2011; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Hill EK, 2011, CANCER-AM CANCER SOC, V117, P2643, DOI 10.1002/cncr.25832; Hinchliff S, 2011, J SEX RES, V48, P106, DOI 10.1080/00224499.2010.548610; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 1994, SEXUAL ATTITUDES LIF; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Karraker A, 2011, J GERONTOL B-PSYCHOL, V66, P502, DOI 10.1093/geronb/gbr058; Kontula O, 2009, J SEX RES, V46, P46, DOI 10.1080/00224490802624414; Laumann EO, 2006, ARCH SEX BEHAV, V35, P145, DOI 10.1007/s10508-005-9005-3; Lindau S.T., 2010, BMJ-BRIT MED J, V340, P810, DOI DOI 10.1136/BMJ.C810; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2012, AM J CARDIOL, V109, P1439, DOI 10.1016/j.amjcard.2012.01.355; Lindau ST, 2010, DIABETES CARE, V33, P2202, DOI 10.2337/dc10-0524; Lusti-Narasimhan M, 2013, B WORLD HEALTH ORGAN, V91, P707, DOI 10.2471/BLT.13.119230; Mercer CH, 2013, LANCET; Mitchell KR, 2013, LANCET; Nusbaum MRH, 2002, AM FAM PHYSICIAN, V66, P1705; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Palacios-Cena D, 2012, J SEX MED, V9, P121, DOI 10.1111/j.1743-6109.2011.02511.x; Prah P, 2014, SEX TRANSM INFECT, V90, P90, DOI 10.1136/sextrans-2013-051360; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P164, DOI 10.1111/j.1467-842X.2003.tb00804.x; Spatz ES, 2013, J HYPERTENS, V31, P1096, DOI 10.1097/HJH.0b013e32835fdefa; Stead ML, 2001, BRIT MED J, V323, P836, DOI 10.1136/bmj.323.7317.836; Tan HM, 2012, J SEX MED, V9, P663, DOI 10.1111/j.1743-6109.2011.02582.x; Taylor A, 2011, AGE AGEING, V40, P538, DOI 10.1093/ageing/afr049; UK Department of Health, 2013, FRAM SEX HLTH IMPR E; UK Department of Health, 2008, RAIS PROF LONG TERM; World Health Organization, 2006, DEF SEX HLTH REP TEC; Young Y, 2010, J AM MED DIR ASSOC, V11, P645, DOI 10.1016/j.jamda.2009.12.084	51	111	112	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1830	1844		10.1016/S0140-6736(13)62222-9	http://dx.doi.org/10.1016/S0140-6736(13)62222-9			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286788	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000327540700027
J	Jagadeesh, RV; Surkus, AE; Junge, H; Pohl, MM; Radnik, J; Rabeah, J; Huan, HM; Schunemann, V; Bruckner, A; Beller, M				Jagadeesh, Rajenahally V.; Surkus, Annette-Enrica; Junge, Henrik; Pohl, Marga-Martina; Radnik, Joerg; Rabeah, Jabor; Huan, Heming; Schuenemann, Volker; Brueckner, Angelika; Beller, Matthias			Nanoscale Fe2O3-Based Catalysts for Selective Hydrogenation of Nitroarenes to Anilines	SCIENCE			English	Article							CHEMOSELECTIVE HYDROGENATION; IRON CATALYSTS; REDUCTION; NANOPARTICLES; EFFICIENT; PLATINUM; WATER; COORDINATION; GENERATION	Production of anilines-key intermediates for the fine chemical, agrochemical, and pharmaceutical industries-relies on precious metal catalysts that selectively hydrogenate aryl nitro groups in the presence of other easily reducible functionalities. Herein, we report convenient and stable iron oxide (Fe2O3)-based catalysts as a more earth-abundant alternative for this transformation. Pyrolysis of iron-phenanthroline complexes on carbon furnishes a unique structure in which the active Fe2O3 particles are surrounded by a nitrogen-doped carbon layer. Highly selective hydrogenation of numerous structurally diverse nitroarenes (more than 80 examples) proceeded in good to excellent yield under industrially viable conditions.	[Jagadeesh, Rajenahally V.; Surkus, Annette-Enrica; Junge, Henrik; Pohl, Marga-Martina; Radnik, Joerg; Rabeah, Jabor; Brueckner, Angelika; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, D-18059 Rostock, Germany; [Huan, Heming; Schuenemann, Volker] Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany	Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT); University of Rostock; University of Kaiserslautern	Beller, M (corresponding author), Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29A, D-18059 Rostock, Germany.	matthias.beller@catalysis.de	Rabeah, Jabor/GZM-0264-2022; Rajenahally Venkataswamygowda, Jagadeesh/A-5368-2016; Schünemann, Volker/C-6603-2016; Radnik, Joerg/D-1396-2018; Junge, Henrik/C-4652-2016	Rabeah, Jabor/0000-0003-2162-0981; Rajenahally Venkataswamygowda, Jagadeesh/0000-0001-6079-0962; Radnik, Joerg/0000-0003-0302-6815; Junge, Henrik/0000-0002-7603-1984; Surkus, Annette-Enrica/0000-0003-1161-9848; Bruckner, Angelika/0000-0003-4647-1273	Federal Ministry of Education and Research (BMBF); State of Mecklenburg-Vorpommern	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern	We gratefully acknowledge the support from the Federal Ministry of Education and Research (BMBF) and the State of Mecklenburg-Vorpommern. We thank the analytical department of the Leibniz-Institute for Catalysis, Rostock for the nuclear magnetic resonance measurements. The Leibniz Institute for Catalysis has filed a patent on the catalysts reported herein. Author contributions: M.B. and R.V.J. planned the project; R.V.J. developed and prepared the catalysts; R.V.J designed and performed all catalytic hydrogenation experiments; R.V.J., M.B., and A.B. wrote the paper; A.-E.S., H.J., and M.B were involved in the development of this class of catalysts; M.-M.P. performed TEM measurements and analysis; J. Radnik did the XPS measurements; J. Rabeah and A.B. conducted EPR measurements; and H.H. and V.S. performed Mossbauer measurements.	[Anonymous], PLATINUM TODAY; Blaser H.-U., 2001, FINE CHEM HETEROGENE; Blaser HU, 2009, CHEMCATCHEM, V1, P210, DOI 10.1002/cctc.200900129; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h; Bolm C, 2009, NAT CHEM, V1, P420, DOI 10.1038/nchem.315; Buchner F, 2008, J PHYS CHEM C, V112, P15458, DOI 10.1021/jp8052955; Cabrero-Antonino JR, 2013, CHEM-EUR J, V19, P8627, DOI 10.1002/chem.201300386; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Cornils B., 2002, APPL HOMOGENEOUS CAT; Driller KM, 2011, ANGEW CHEM INT EDIT, V50, P537, DOI 10.1002/anie.201005823; Enthaler S, 2008, ANGEW CHEM INT EDIT, V47, P3317, DOI 10.1002/anie.200800012; Fillol JL, 2011, NAT CHEM, V3, P807, DOI [10.1038/nchem.1140, 10.1038/NCHEM.1140]; Gartner F, 2011, CHEM-EUR J, V17, P6425, DOI 10.1002/chem.201003564; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Gopalaiah K, 2013, CHEM REV, V113, P3248, DOI 10.1021/cr300236r; Hennessy ET, 2013, SCIENCE, V340, P591, DOI 10.1126/science.1233701; Hitomi Y, 2012, ANGEW CHEM INT EDIT, V51, P3448, DOI 10.1002/anie.201108933; Jagadeesh RV, 2011, CHEM COMMUN, V47, P10972, DOI 10.1039/c1cc13728j; Jaouen F, 2009, ACS APPL MATER INTER, V1, P1623, DOI 10.1021/am900219g; Koeken ACJ, 2012, ANGEW CHEM INT EDIT, V51, P7190, DOI 10.1002/anie.201200280; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Li J, 2011, ACS CATAL, V1, P657, DOI 10.1021/cs200105u; Li WM, 2010, J AM CHEM SOC, V132, P17056, DOI 10.1021/ja106217u; Morandi B, 2012, SCIENCE, V335, P1471, DOI 10.1126/science.1218781; Motoyama Y, 2011, CHEMCATCHEM, V3, P1578, DOI 10.1002/cctc.201100135; Ono N., 2001, NITRO GROUP ORGANIC; Pandarus V, 2011, ADV SYNTH CATAL, V353, P1306, DOI 10.1002/adsc.201000945; Plietker B., 2008, IRON CATALYSIS ORGAN; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Sun CL, 2011, CHEM REV, V111, P1293, DOI 10.1021/cr100198w; Takasaki M, 2008, ORG LETT, V10, P1601, DOI 10.1021/ol800277a; Tondreau AM, 2012, SCIENCE, V335, P567, DOI 10.1126/science.1214451; Westerhaus FA, 2013, NAT CHEM, V5, P537, DOI [10.1038/NCHEM.1645, 10.1038/nchem.1645]; Yang ZQ, 2011, ENERG ENVIRON SCI, V4, P4500, DOI 10.1039/c1ee01428e; Ziebart C, 2012, J AM CHEM SOC, V134, P20701, DOI 10.1021/ja307924a	36	732	743	41	1065	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1073	1076		10.1126/science.1242005	http://dx.doi.org/10.1126/science.1242005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288327				2022-12-28	WOS:000327518600051
J	Lyons, RA; Ford, DV; Moore, L; Rodgers, SE				Lyons, Ronan A.; Ford, David V.; Moore, Laurence; Rodgers, Sarah E.			Use of data linkage to measure the population health effect of non-health-care interventions	LANCET			English	Editorial Material							ENVIRONMENT; BENEFITS		[Lyons, Ronan A.; Ford, David V.; Rodgers, Sarah E.] Swansea Univ, Ctr Improvement Populat Hlth Records Res E, Swansea SA2 8PP, W Glam, Wales; [Moore, Laurence] Cardiff Univ, DECIPHer Ctr Publ Hlth Res, Cardiff CF10 3AX, S Glam, Wales	Swansea University; Cardiff University	Lyons, RA (corresponding author), Swansea Univ, Coll Med, ILS2 Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	r.a.lyons@swansea.ac.uk		Lyons, Ronan/0000-0001-5225-000X; Rodgers, Sarah/0000-0002-4483-0845; Ford, David/0000-0001-6551-721X; Moore, Laurence/0000-0003-2182-823X	ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MC_UU_12017/4, MR/K023233/1, MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K023233/1, MC_UU_12017/4] Funding Source: researchfish; National Institute for Health Research [09/3006/02] Funding Source: researchfish; Chief Scientist Office [SPHSU1] Funding Source: researchfish; Arthritis Research UK Funding Source: Medline; British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [MR/K006525/1] Funding Source: Medline; Wellcome Trust [MR/K006525/1, WT087640MA] Funding Source: Medline; Chief Scientist Office Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Campbell R, 2008, LANCET, V371, P1595, DOI 10.1016/S0140-6736(08)60692-3; Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268; Committee on Public Health Strategies to Improve Health; Institute of Medicine, 2012, PUBL HLTH INV HLTH F; Cooksey D., 2006, REV UK HLTH RES FUND; Fone D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-428; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Gatrell AC, 2005, SOC SCI MED, V60, P2661, DOI 10.1016/j.socscimed.2004.11.002; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hutchings HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070601; Lyons RA, 2006, AM J PREV MED, V30, P513, DOI 10.1016/j.amepre.2006.02.007; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Marmot Review Team, 2011, HLTH IMPACTS COLD HO; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; *MED RES COUNC, 2011, US NAT EXP EV POP HL; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Rodgers SE, 2014, INT J EPIDEMIOL, V43, P52, DOI 10.1093/ije/dys200; Rodgers SE, 2012, HEALTH PLACE, V18, P209, DOI 10.1016/j.healthplace.2011.09.006; Rodgers SE, 2009, J PUBLIC HEALTH-UK, V31, P582, DOI 10.1093/pubmed/fdp041; Snooks H, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-2; The UK Administrative Data Research Network, 2012, IMPR ACC RES POL REP; THOMAS R, 2008, DATA SHARING REV REP; UCL Institute of Health Equity, 2010, FAIR SOC HLTH LIV ST; University of Warwick London School of Hygiene & Tropical Medicine Office of the Deputy Prime Minister, 2003, STAT EV SUPP HOUS HL	25	26	27	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1517	1519		10.1016/S0140-6736(13)61750-X	http://dx.doi.org/10.1016/S0140-6736(13)61750-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24290768				2022-12-28	WOS:000335325800032
J	Ashby, RL; Gabe, R; Ali, S; Adderley, U; Bland, JM; Cullum, NA; Dumville, JC; Iglesias, CP; Kang'ombe, AR; Soares, MO; Stubbs, NC; Torgerson, DJ				Ashby, Rebecca L.; Gabe, Rhian; Ali, Shehzad; Adderley, Una; Bland, J. Martin; Cullum, Nicky A.; Dumville, Jo C.; Iglesias, Cynthia P.; Kang'ombe, Arthur R.; Soares, Marta O.; Stubbs, Nikki C.; Torgerson, David J.			Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial	LANCET			English	Article							MANAGEMENT; STOCKINGS; EFFICACY; THERAPY	Background Drawbacks exist with the standard treatment (four-layer compression bandages) for venous leg ulcers. We have therefore compared the clinical effectiveness and cost-effectiveness of two-layer compression hosiery with the four-layer bandage for the treatment of such ulcers. Methods We undertook this pragmatic, open, randomised controlled trial with two parallel groups in 34 centres in England and Northern Ireland. The centres were community nurse teams or services, family doctor practices, leg ulcer clinics, tissue viability clinics or services, and wound clinics. Participants were aged 18 years or older with a venous leg ulcer and an ankle brachial pressure index of at least 0.8, and were tolerant of high compression. We randomly allocated participants (1: 1) to receive two-layer compression hosiery or a four-layer bandage, using a remote randomisation service and prevalidated computer randomisation program. Participants were stratified by ulcer duration and ulcer area with permuted blocks (block sizes four and six). The primary endpoint was time to ulcer healing, with a maximum follow-up of 12 months. Although participants and health-care providers were not masked to treatment allocation, the primary endpoint was measured by masked assessment of photographs. Primary analysis was intention to treat with Cox regression, with adjustment for ulcer area, ulcer duration, physical mobility, and centre. This trial is registered with the ISRCTN register, number ISRCTN49373072. Findings We randomly allocated 457 participants to the two treatment groups: 230 to two-layer hosiery and 227 to the four-layer bandage, of whom 453 (230 hosiery and 223 bandage) contributed data for analysis. Median time to ulcer healing was 99 days (95% CI 84-126) in the hosiery group and 98 days (85-112) in the bandage group, and the proportion of ulcers healing was much the same in the two groups (70.9% hosiery and 70.4% bandage). More hosiery participants changed their allocated treatment (38.3% hosiery vs 27.0% bandage; p=0.02). 300 participants had 895 adverse events, of which 85 (9.5%) were classed as serious but unrelated to trial treatment. Interpretation Two-layer compression hosiery is a viable alternative to the four-layer bandage-it is equally as effective at healing venous leg ulcers. However, a higher rate of treatment changes in participants in the hosiery group than in the bandage group suggests that hosiery might not be suitable for all patients.	[Ashby, Rebecca L.; Gabe, Rhian; Ali, Shehzad; Bland, J. Martin; Iglesias, Cynthia P.; Torgerson, David J.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Soares, Marta O.] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Adderley, Una] Univ Leeds, Sch Healthcare, Leeds, W Yorkshire, England; [Cullum, Nicky A.; Dumville, Jo C.] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Kang'ombe, Arthur R.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Stubbs, Nikki C.] Leeds Community Healthcare Trust, Leeds, W Yorkshire, England	University of York - UK; University of York - UK; University of Leeds; University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool	Dumville, JC (corresponding author), Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England.	jo.dumville@manchester.ac.uk	Cullum, Nicky/AAT-5888-2020; Cullum, Nicky A/F-2438-2011; Torgerson, David/L-4566-2019; Dumville, Jo C/O-7867-2014	Cullum, Nicky/0000-0003-2631-123X; Cullum, Nicky A/0000-0003-2631-123X; Torgerson, David/0000-0002-1667-4275; Dumville, Jo C/0000-0002-6546-3685; Soares, Marta Ferreira Oliveira/0000-0003-1579-8513; Adderley, Una/0000-0003-1894-3755; Gabe, Rhian/0000-0002-0273-3094	NIHR Health Technology Assessment programme [07/60/26]; MRC [G0501892] Funding Source: UKRI; Medical Research Council [G0501892] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10028, 07/60/26] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NIHR Health Technology Assessment programme (07/60/26).	Abbade LPF, 2005, INT J DERMATOL, V44, P449, DOI 10.1111/j.1365-4632.2004.02456.x; Adderley U, 2007, J Wound Care, V16, P217; Balding DJ, 2004, APPL LONGITUDINAL AN; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Brazier J, 2016, MEASURING VALUING HL; Collett, 2003, MODELLING SURVIVAL D; Cox D. R., 1984, ANAL SURVIVAL DATA; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Finlayson KJ, 2014, INT WOUND J, V11, P21, DOI 10.1111/j.1742-481X.2012.01033.x; Glick H, EC EVALUATION CLIN T; Hickie S, 1998, J CLIN NURS, V7, P45, DOI 10.1046/j.1365-2702.1998.00124.x; Iglesias C, 2004, HEALTH TECHNOL ASSES, V8, P1; Jull A B, 2004, J Wound Care, V13, P90; Junger M, 2004, CURR MED RES OPIN, V20, P1613, DOI 10.1185/030079904X4086; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kind P, 1996, QUALITY LIFE PHARMAC; LAING W, 1992, CHRONIC VENOUS DIS L; Maggisano R, 2004, VENOUS SYSTEM; Margolis DJ, 1999, ARCH DERMATOL, V135, P920, DOI 10.1001/archderm.135.8.920; Mariani F, 2008, PHLEBOLOGIE, V37, P191; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Meyer FJ, 2003, BRIT J SURG, V90, P934, DOI 10.1002/bjs.4173; National Institute for Clinical Excellence, GUID METH TECHN APPR; Nelson EA, 2012, COCHRANE DB SYST REV, V8; O'Meara S, 2012, COCHRANE DB SYST REV, V1; O'Meara S, 2007, 17 ANN M EUR TISS RE; Polignano R, 2004, J Wound Care, V13, P387; Raju S, 2007, ANN VASC SURG, V21, P790, DOI 10.1016/j.avsg.2007.07.014; Royal College of Nursing, 2006, NURS MAN VEN LEG ULC; Saris-Baglama R., 2007, QUALITYMETRIC HLTH O; Schoenfeld D., 1982, BIOMETRIKA, V69, P51; Scottish Intercollegiate Guidelines Network, 1998, CAR PAT CHRONIC LEG; Scottish Intercollegiate Guidelines Network, 2010, MAN CHRON VEN LEG UL; Taradaj J, 2009, PHLEBOLOGIE, V38, P157; Taylor R J, 1997, J Wound Care, V6, P123; Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.111633; Verbeke G, 2000, LINEAR MIXED MODELS; WHO, 2012, BMI CLASS	39	97	102	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					871	879		10.1016/S0140-6736(13)62368-5	http://dx.doi.org/10.1016/S0140-6736(13)62368-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3FC	24315520				2022-12-28	WOS:000332399500027
J	Neto, EHD; Aynajian, P; Frano, A; Comin, R; Schierle, E; Weschke, E; Gyenis, A; Wen, JS; Schneeloch, J; Xu, ZJ; Ono, S; Gu, GD; Le Tacon, M; Yazdani, A				da Silva Neto, Eduardo H.; Aynajian, Pegor; Frano, Alex; Comin, Riccardo; Schierle, Enrico; Weschke, Eugen; Gyenis, Andras; Wen, Jinsheng; Schneeloch, John; Xu, Zhijun; Ono, Shimpei; Gu, Genda; Le Tacon, Mathieu; Yazdani, Ali			Ubiquitous Interplay Between Charge Ordering and High-Temperature Superconductivity in Cuprates	SCIENCE			English	Article							QUASI-PARTICLE INTERFERENCE; FLUCTUATING STRIPES; COOPER PAIRS; BI2SR2CACU2O8+DELTA; PSEUDOGAP; ONSET; STATE; GAP	Besides superconductivity, copper-oxide high-temperature superconductors are susceptible to other types of ordering. We used scanning tunneling microscopy and resonant elastic x-ray scattering measurements to establish the formation of charge ordering in the high-temperature superconductor Bi2Sr2CaCu2O8+x. Depending on the hole concentration, the charge ordering in this system occurs with the same period as those found in Y-based or La-based cuprates and displays the analogous competition with superconductivity. These results indicate the similarity of charge organization competing with superconductivity across different families of cuprates. We observed this charge ordering to leave a distinct electron-hole asymmetric signature (and a broad resonance centered at +20 milli-electron volts) in spectroscopic measurements, indicating that it is likely related to the organization of holes in a doped Mott insulator.	[da Silva Neto, Eduardo H.; Aynajian, Pegor; Gyenis, Andras; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [da Silva Neto, Eduardo H.; Aynajian, Pegor; Gyenis, Andras; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Frano, Alex; Le Tacon, Mathieu] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Frano, Alex; Schierle, Enrico; Weschke, Eugen] Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany; [Comin, Riccardo] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Wen, Jinsheng; Schneeloch, John; Xu, Zhijun; Gu, Genda] BNL, Upton, NY 11973 USA; [Schneeloch, John] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Ono, Shimpei] Cent Res Inst Elect Power Ind, Komae, Tokyo 2018511, Japan	Princeton University; Princeton University; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of British Columbia; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Central Research Institute of Electric Power Industry - Japan	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	, Le Tacon Matthieu/D-8023-2011; xu, zhijun/A-3264-2013; Wen, Jinsheng/F-4209-2010; Comin, Riccardo/H-7731-2016; Ono, Shimpei/D-2918-2017; Weschke, Eugen/J-4404-2013; Schierle, Enrico/J-4356-2013	, Le Tacon Matthieu/0000-0002-5838-3724; xu, zhijun/0000-0001-7486-2015; Wen, Jinsheng/0000-0001-5864-1466; Comin, Riccardo/0000-0002-1069-9973; XU, ZHIJUN/0000-0002-4960-3801; Schneeloch, John/0000-0002-3577-9574; Weschke, Eugen/0000-0002-2141-0944; Schierle, Enrico/0000-0002-6981-2301; Ono, Shimpei/0000-0003-1514-8879; Yazdani, Ali/0000-0003-4996-8904; Aynajian, Pegor/0000-0002-0123-527X	U.S. Department of Energy (DOE) Basic Energy Sciences; NSF-Materials Research and Engineering Center program through Princeton Center for Complex Materials [DMR-0819860]; Eric & Wendy Schmidt Transformative Fund; W. M. Keck Foundation; DOE [DE-AC02-98CH10886]; Max Planck-UBC Centre for Quantum Materials; Canadian Insititute for Advanced Research Quantum Materials; NSF [PHYS-1066293]; Center for Emergent Superconductivity, an Energy Frontier Research Center;  [NSF-DMR1104612]; Grants-in-Aid for Scientific Research [23684031] Funding Source: KAKEN; Division Of Materials Research [1104612] Funding Source: National Science Foundation	U.S. Department of Energy (DOE) Basic Energy Sciences(United States Department of Energy (DOE)); NSF-Materials Research and Engineering Center program through Princeton Center for Complex Materials(National Science Foundation (NSF)); Eric & Wendy Schmidt Transformative Fund; W. M. Keck Foundation(W.M. Keck Foundation); DOE(United States Department of Energy (DOE)); Max Planck-UBC Centre for Quantum Materials; Canadian Insititute for Advanced Research Quantum Materials; NSF(National Science Foundation (NSF)); Center for Emergent Superconductivity, an Energy Frontier Research Center; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work at Princeton was primarily supported by a grant from the U.S. Department of Energy (DOE) Basic Energy Sciences. The instrumentation and infrastructure at the Princeton Nanoscale Microscopy Laboratory used for this work were also supported by grants from NSF-DMR1104612, the NSF-Materials Research and Engineering Center program through Princeton Center for Complex Materials (DMR-0819860), the Eric & Wendy Schmidt Transformative Fund, and the W. M. Keck Foundation. Work at BNL was supported by DOE under contract DE-AC02-98CH10886. The Max Planck-UBC Centre for Quantum Materials and Canadian Insititute for Advanced Research Quantum Materials also supported this work. We thank P. W. Anderson, E. Abrahams, S. Kivelson, S. Misra, and N. P. Ong for fruitful discussions. We also acknowledge A. Damascelli and B. Keimer for discussions and for sharing the results of their x-ray studies on Bi-2201 before publication. A.Y. acknowledges the hospitality of the Aspen Center for Physics, supported under NSF grant PHYS-1066293. The synthesis of the oxygen-doped Bi2212 samples was supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Anderson PW, 2006, J PHYS CHEM SOLIDS, V67, P1, DOI 10.1016/j.jpcs.2005.10.132; BUCHNER B, 1994, PHYS REV LETT, V73, P1841, DOI 10.1103/PhysRevLett.73.1841; CAVA RJ, 1987, PHYS REV B, V35, P6716, DOI 10.1103/PhysRevB.35.6716; Chatterjee U, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107006; Comin R., 2013, SCIENCE, V343; Neto EHD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.104521; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Ding H, 1997, PHYS REV LETT, V78, P2628, DOI 10.1103/PhysRevLett.78.2628; Fradkin E, 2012, NAT PHYS, V8, P864, DOI 10.1038/nphys2498; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; Mans A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107007; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Randeria M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137001; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Vishik IM, 2009, NAT PHYS, V5, P718, DOI 10.1038/NPHYS1375; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Yang HB, 2008, NATURE, V456, P77, DOI 10.1038/nature07400	28	434	435	12	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169					393	396		10.1126/science.1243479	http://dx.doi.org/10.1126/science.1243479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24356110	Green Submitted			2022-12-28	WOS:000330039300041
J	David, LA; Maurice, CF; Carmody, RN; Gootenberg, DB; Button, JE; Wolfe, BE; Ling, AV; Devlin, AS; Varma, Y; Fischbach, MA; Biddinger, SB; Dutton, RJ; Turnbaugh, PJ				David, Lawrence A.; Maurice, Corinne F.; Carmody, Rachel N.; Gootenberg, David B.; Button, Julie E.; Wolfe, Benjamin E.; Ling, Alisha V.; Devlin, A. Sloan; Varma, Yug; Fischbach, Michael A.; Biddinger, Sudha B.; Dutton, Rachel J.; Turnbaugh, Peter J.			Diet rapidly and reproducibly alters the human gut microbiome	NATURE			English	Article							SULFATE-REDUCING BACTERIA; BILE-ACIDS; PATTERNS; ENUMERATION; DIVERSITY; DISCOVERY; COMMUNITY; DATABASE; GENOMES; MARKER	Long-term dietary intake influences the structure and activity of the trillions of microorganisms residing in the human gut(1-5), but it remains unclear how rapidly and reproducibly the human gut microbiome responds to short-term macronutrient change. Here we show that the short-term consumption of diets composed entirely of animal or plant products alters microbial community structure and overwhelms inter-individual differences in microbial gene expression. The animal-based diet increased the abundance of bile-tolerant microorganisms (Alistipes, Bilophila and Bacteroides) and decreased the levels of Firmicutes that metabolize dietary plant polysaccharides (Roseburia, Eubacterium rectale and Ruminococcus bromii). Microbial activity mirrored differences between herbivorous and carnivorous mammals(2), reflecting trade-offs between carbohydrate and protein fermentation. Foodborne microbes from both diets transiently colonized the gut, including bacteria, fungi and even viruses. Finally, increases in the abundance and activity of Bilophila wadsworthia on the animal-based diet support a link between dietary fat, bile acids and the outgrowth of microorganisms capable of triggering inflammatory bowel disease(6). In concert, these results demonstrate that the gut microbiome can rapidly respond to altered diet, potentially facilitating the diversity of human dietary lifestyles.	[David, Lawrence A.; Maurice, Corinne F.; Carmody, Rachel N.; Gootenberg, David B.; Button, Julie E.; Wolfe, Benjamin E.; Dutton, Rachel J.; Turnbaugh, Peter J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [David, Lawrence A.] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Ling, Alisha V.; Biddinger, Sudha B.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Endocrinol, Boston, MA 02115 USA; [Devlin, A. Sloan; Varma, Yug; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Devlin, A. Sloan; Varma, Yug; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Turnbaugh, PJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	David, Lawrence Anthony/HCJ-0062-2022	David, Lawrence Anthony/0000-0002-3570-4767; Fischbach, Michael/0000-0003-3079-8247; Turnbaugh, Peter/0000-0002-0888-2875; Gootenberg, David/0000-0001-5416-106X; Maurice, Corinne/0000-0001-7187-3472	National Institutes of Health [P50 GM068763]; Boston Nutrition Obesity Research Center [DK0046200]; General Mills Bell Institute of Health and Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094162, P30DK034854, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Nutrition Obesity Research Center; General Mills Bell Institute of Health and Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Murray, G. Guidotti, E. O'Shea, J. Moffitt and B. Stern for insightful comments; M. Delaney for biochemical analyses; C. Daly, M. Clamp and C. Reardon for sequencing support; N. Fierer for providing ITS primers; A. Luong and K. Bauer for technical assistance; J. Brulc and R. Menon for nutritional guidelines; A. Rahman for menu suggestions; A. Must and J. Queenan for nutritional analysis; and our diet study volunteers for their participation. This work was supported by the National Institutes of Health (P50 GM068763), the Boston Nutrition Obesity Research Center (DK0046200), and the General Mills Bell Institute of Health and Nutrition.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; [Anonymous], 2010, DIET HIST QUEST VERS; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bourdichon F., 2012, B INT DAIRY FEDERATI, V455, P1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; HAWKES K, 1991, PHILOS T R SOC B, V334, P243, DOI 10.1098/rstb.1991.0113; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jones E., 2001, SCIPY OPEN SOURCE SC; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McGavin WJ, 2009, VIRUS RES, V139, P10, DOI 10.1016/j.virusres.2008.09.004; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; NYCHAS GJE, 1990, J APPL BACTERIOL, V69, pS167, DOI 10.1111/j.1365-2672.1990.tb01806.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; PITTARD J, 1966, J BACTERIOL, V91, P1494, DOI 10.1128/JB.91.4.1494-1508.1966; Porter JL, 2003, J LAB CLIN MED, V141, P411, DOI 10.1016/S0022-2143(03)00040-4; REDDY BS, 1981, CANCER RES, V41, P3766; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SINHA R, 1995, CANCER RES, V55, P4516; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Smith EA, 1998, FEMS MICROBIOL ECOL, V25, P355, DOI 10.1016/S0168-6496(98)00004-X; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Walker H. K., 1990, KETONURIA; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	56	5215	5442	146	2637	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					559	+		10.1038/nature12820	http://dx.doi.org/10.1038/nature12820			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24336217	Green Submitted, Green Accepted			2022-12-28	WOS:000329995000042
J	Shalem, O; Sanjana, NE; Hartenian, E; Shi, X; Scott, DA; Mikkelsen, TS; Heckl, D; Ebert, BL; Root, DE; Doench, JG; Zhang, F				Shalem, Ophir; Sanjana, Neville E.; Hartenian, Ella; Shi, Xi; Scott, David A.; Mikkelsen, Tarjei S.; Heckl, Dirk; Ebert, Benjamin L.; Root, David E.; Doench, John G.; Zhang, Feng			Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells	SCIENCE			English	Article							RNA; TRANSCRIPTION; GENE; CAS9; SPECIFICITY; SEQUENCE; BRAF	The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables both negative and positive selection screening in human cells. First, we used the GeCKO library to identify genes essential for cell viability in cancer and pluripotent stem cells. Next, in a melanoma model, we screened for genes whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the same gene and a high rate of hit confirmation, demonstrating the promise of genome-scale screening with Cas9.	[Shalem, Ophir; Sanjana, Neville E.; Hartenian, Ella; Shi, Xi; Scott, David A.; Mikkelsen, Tarjei S.; Root, David E.; Doench, John G.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Shalem, Ophir; Sanjana, Neville E.; Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Shi, Xi] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Heckl, Dirk; Ebert, Benjamin L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Heckl, Dirk/GMW-5407-2022; Doench, John G/HCI-9570-2022; Mikkelsen, Tarjei S/A-1306-2007; Doench, John/ABE-6251-2020; Macrae, Rhiannon/AAX-1536-2020	Doench, John G/0000-0002-3707-9889; Mikkelsen, Tarjei S/0000-0002-8133-3135; Doench, John/0000-0002-3707-9889; Shalem, Ophir/0000-0002-2267-0801	German Cancer Foundation; NIH [1DP1-MH100706]; NIH Transformative R01 grant [1R01-DK097768]; Keck Foundation; McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	German Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Transformative R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Cowley, W. Harrington, J. Wright, E. Hodis, S. Whittaker, J. Merkin, C. Burge, D. Peters, C. Cowan, L. P. Club, and the entire Zhang laboratory for technical support and critical discussions. O.S. is a Klarman Family Foundation Fellow, N.S. is a Simons Center for the Social Brain Postdoctoral Fellow, D. A. S. is an NSF Fellow, and J. D. is a Merkin Institute Fellow. D. H. was funded by the German Cancer Foundation. F.Z. is supported by an NIH Director's Pioneer Award (1DP1-MH100706); a NIH Transformative R01 grant (1R01-DK097768); the Keck, McKnight, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations; and Bob Metcalfe and Jane Pauley. The authors have no conflicting financial interests. A patent application has been filed relating to this work, and the authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools at the Zhang laboratory Web site (www.genome-engineering.org).	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blanchard AP, 1996, NAT BIOTECHNOL, V14, P1649, DOI 10.1038/nbt1296-1649; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lin AL, 2013, NAT REV CLIN ONCOL, V10, P616, DOI 10.1038/nrclinonc.2013.144; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470	26	2972	3269	76	1682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					84	87		10.1126/science.1247005	http://dx.doi.org/10.1126/science.1247005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24336571	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000329162000053
J	Vaishnava, P; Eagle, K				Vaishnava, Prashant; Eagle, Kim			Review: In noncardiac surgery, beta-blockers started before surgery increase 30-day mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSOCIATION; BLOCKADE		[Vaishnava, Prashant; Eagle, Kim] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Vaishnava, P (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.							Chopra V, 2012, AM J MED, V125, P953, DOI 10.1016/j.amjmed.2012.03.014; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC2	10.7326/0003-4819-159-12-201312170-02002	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343407				2022-12-28	WOS:000329735300001
J	Kass, MD; Rosenthal, MC; Pottackal, J; McGann, JP				Kass, Marley D.; Rosenthal, Michelle C.; Pottackal, Joseph; McGann, John P.			Fear Learning Enhances Neural Responses to Threat-Predictive Sensory Stimuli	SCIENCE			English	Article							OLFACTORY MARKER PROTEIN; ODOR; NEURONS; CORTEX; MOUSE; PLASTICITY; SYSTEM; BRAIN; RATS	The central nervous system rapidly learns that particular stimuli predict imminent danger. This learning is thought to involve associations between neutral and harmful stimuli in cortical and limbic brain regions, though associative neuroplasticity in sensory structures is increasingly appreciated. We observed the synaptic output of olfactory sensory neurons (OSNs) in individual mice before and after they learned that a particular odor indicated an impending foot shock. OSNs are the first cells in the olfactory system, physically contacting the odor molecules in the nose and projecting their axons to the brain's olfactory bulb. OSN output evoked by the shock-predictive odor was selectively facilitated after fear conditioning. These results indicate that affective information about a stimulus can be encoded in its very earliest representation in the nervous system.	[Kass, Marley D.; Rosenthal, Michelle C.; Pottackal, Joseph; McGann, John P.] Rutgers State Univ, Dept Psychol, Behav & Syst Neurosci Sect, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	McGann, JP (corresponding author), Rutgers State Univ, Dept Psychol, Behav & Syst Neurosci Sect, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	jmcgann@rci.rutgers.edu		Rosenthal, Michelle/0000-0002-6963-0049; Pottackal, Joseph/0000-0002-8307-0631; Kass, Marley/0000-0003-2460-9366	NIH [DC009442, MH101293, DC013090]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009442, R00DC009442, R01DC013090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants DC009442, MH101293, and DC013090 to J.P.M. M. D. K., M. C. R., and J.P.M. conceived and designed the experiments. M. C. R., M. D. K., and J.P.M. collected and analyzed the behavioral and imaging data. J.P. and J.P. M. collected and analyzed the respiration data. J.P. M., M. D. K., M. C. R., and J.P. prepared the manuscript. All data are reported in the main article and in the supplementary materials. We thank T. Otto, L. Matzel, and L. Czarnecki for helpful comments.	Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CARR VM, 1993, EXP NEUROL, V124, P308, DOI 10.1006/exnr.1993.1201; Chen CFF, 2011, J NEUROPHYSIOL, V106, P3136, DOI 10.1152/jn.00721.2011; Czarnecki LA, 2012, TOXICOL SCI, V126, P534, DOI 10.1093/toxsci/kfs030; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; EDELINE JM, 1991, BEHAV NEUROSCI, V105, P618, DOI 10.1037/0735-7044.105.5.618; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fletcher ML, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00016; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Headley DB, 2013, J NEUROSCI, V33, P5705, DOI 10.1523/JNEUROSCI.4915-12.2013; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kass MD, 2013, J NEUROSCI, V33, P6594, DOI 10.1523/JNEUROSCI.1442-12.2013; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Krusemark EA, 2013, J NEUROSCI, V33, P587, DOI [10.1523/JNEUROSCI.1379-12.2013, 10.1523/JNEUROSCI.1835-13.2013]; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McGann JP, 2013, CHEM SENSES, V38, P459, DOI 10.1093/chemse/bjt018; MIRAGALL F, 1982, BRAIN RES, V239, P245, DOI 10.1016/0006-8993(82)90846-0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337	24	115	115	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1389	1392		10.1126/science.1244916	http://dx.doi.org/10.1126/science.1244916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337299	Green Accepted			2022-12-28	WOS:000328196000056
J	Sale, JE; Patel, KJ; Batista, FD				Sale, Julian E.; Patel, Ketan J.; Batista, Facundo D.			Michael Neuberger (1953-2013)	SCIENCE			English	Biographical-Item									[Sale, Julian E.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge, England; [Batista, Facundo D.] Canc Res UK, London Res Inst, London, England	MRC Laboratory Molecular Biology; Cancer Research UK	Sale, JE (corresponding author), MRC Lab Mol Biol, Cambridge, England.	jes@mrc-lmb.cam.ac.uk; kjp@mrc-lmb.cam.ac.uk; facundo.batista@cancer.org.uk		Sale, Julian/0000-0002-5031-3780	MRC [MC_U105178808, MC_U105178811] Funding Source: UKRI; Cancer Research UK [15691] Funding Source: researchfish; Medical Research Council [MC_U105178811, MC_U105178808] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		NEUBERGER MS, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1335	1335		10.1126/science.1248808	http://dx.doi.org/10.1126/science.1248808			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337288				2022-12-28	WOS:000328196000039
J	Parikh, RB; Kirch, RA; Smith, TJ; Temel, JS				Parikh, Ravi B.; Kirch, Rebecca A.; Smith, Thomas J.; Temel, Jennifer S.			Early Specialty Palliative Care-Translating Data in Oncology into Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL LUNG-CANCER; RANDOMIZED CONTROLLED-TRIAL; IMPROVE; OPPORTUNITIES; CHEMOTHERAPY; PERCEPTIONS; ACCESS; IMPACT; MODEL; LIFE		[Parikh, Ravi B.] Harvard Univ, Sch Med, Boston, MA USA; [Temel, Jennifer S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kirch, Rebecca A.] Amer Canc Soc, Washington, DC USA; [Smith, Thomas J.] Johns Hopkins Univ, Baltimore, MD USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; American Cancer Society; Johns Hopkins University	Temel, JS (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, 55 Fruit St,Yawkey 7B, Boston, MA 02114 USA.	jtemel@partners.org		Smith, Thomas/0000-0003-3040-6434	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2013, OV APPR; [Anonymous], 2012, PALL CAR SERV SOL BE; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Center to Advance Palliative Care, 2011, 2011 PUBL OP RES PAL; Center to Advance Palliative Care, 2011, STAT BY STAT REP CAR; Centers for Medicare and Medicaid Services, 2013, MED HOSP BEN; Chen AB, 2013, J CLIN ONCOL, V31, P2730, DOI 10.1200/JCO.2012.48.5748; Ciemins EL, 2007, J PALLIAT MED, V10, P1347, DOI 10.1089/jpm.2007.0065; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Goldsmith B, 2008, J PALLIAT MED, V11, P1094, DOI 10.1089/jpm.2008.0053; Greer JA, 2013, CA CANC J CLIN; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Hauptman PJ, 2005, ARCH INTERN MED, V165, P374, DOI 10.1001/archinte.165.4.374; Higginson IJ, 2011, POSTGRAD MED J, V87, P769, DOI 10.1136/postgradmedj-2011-130290; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; *I MED, 2003, IMPR PALL CAR CANC S; Institute for Healthcare Improvement, 2013, IHI TRIPL AIM IN; Kaiser Family Foundation, 2012, MED SPEND FIN FACT S; Krakauer R, 2009, HEALTH AFFAIR, V28, P1357, DOI 10.1377/hlthaff.28.5.1357; Meier~ DE, 2010, PALLIATIVE CARE TRAN, V1st; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Morrison LJ, 2012, J PALLIAT MED, V15, P784, DOI 10.1089/jpm.2011.0482; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Pirl WF, 2012, J CLIN ONCOL, V30, P1310, DOI 10.1200/JCO.2011.38.3166; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Sulmasy DP, 2008, J PALLIAT MED, V11, P707, DOI 10.1089/jpm.2007.0210; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Zimmermann C, 2012, 2012 AM SOC CLIN ONC	33	177	182	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2347	2351		10.1056/NEJMsb1305469	http://dx.doi.org/10.1056/NEJMsb1305469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268FV	24328469	Green Accepted, Bronze			2022-12-28	WOS:000328156300014
J	Kim, JY				Kim, Jim Yong			Time for even greater ambition in global health	LANCET			English	Editorial Material									World Bank Grp, Washington, DC 20433 USA	The World Bank	Kim, JY (corresponding author), World Bank Grp, Washington, DC 20433 USA.	president@worldbank.org						Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Jamison DT, 2013, LANCET; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, 2011, GROW DANG NONC DIS A	5	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					E33	E34		10.1016/S0140-6736(13)62374-0	http://dx.doi.org/10.1016/S0140-6736(13)62374-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309476				2022-12-28	WOS:000328222400001
J	Xu, R; de Vries, RP; Zhu, XY; Nycholat, CM; McBride, R; Yu, WL; Paulson, JC; Wilson, IA				Xu, Rui; de Vries, Robert P.; Zhu, Xueyong; Nycholat, Corwin M.; McBride, Ryan; Yu, Wenli; Paulson, James C.; Wilson, Ian A.			Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses	SCIENCE			English	Article							HUMAN INFECTION; BINDING; TRANSMISSION; SPECIFICITY; HEMAGGLUTININS; FERRETS; DETERMINANT; COMPLEXES; ORIGIN; ACID	The 2013 outbreak of avian-origin H7N9 influenza in eastern China has raised concerns about its ability to transmit in the human population. The hemagglutinin glycoprotein of most human H7N9 viruses carries Leu(226), a residue linked to adaptation of H2N2 and H3N2 pandemic viruses to human receptors. However, glycan array analysis of the H7 hemagglutinin reveals negligible binding to humanlike alpha 2-6-linked receptors and strong preference for a subset of avian-like alpha 2-3-linked glycans recognized by all avian H7 viruses. Crystal structures of H7N9 hemagglutinin and six hemagglutinin-glycan complexes have elucidated the structural basis for preferential recognition of avian-like receptors. These findings suggest that the current human H7N9 viruses are poorly adapted for efficient human-to-human transmission.	[Xu, Rui; Zhu, Xueyong; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [de Vries, Robert P.; Nycholat, Corwin M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [de Vries, Robert P.; Nycholat, Corwin M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jpaulson@scripps.edu; wilson@scripps.edu	de Vries, Robert/K-7212-2013; McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Zhu, Xueyong/ABE-3068-2021	de Vries, Robert/0000-0002-1586-4464	NIH [R56 AI099275]; Skaggs Institute for Chemical Biology; Centers for Disease Control; Netherlands Organization for Scientific Research (NWO); National Institute of General Medical Sciences (NIGMS) [GM62116]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; DOE Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; National Center for Research Resources (NCRR) [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM062116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH R56 AI099275 (I. A. W.) and the Skaggs Institute for Chemical Biology, the Scripps Microarray Core Facility, and a contract from the Centers for Disease Control (J.C.P.). R.P.d.V. is a recipient of a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). Several glycans used for HA binding assays were provided by the Consortium for Functional Glycomics (www.functionalglycomics.org/) funded by National Institute of General Medical Sciences (NIGMS) grant GM62116 (J.C.P.). X-ray diffraction data were collected at the Advanced Photon Source beamline 23ID-B (GM/CA CAT) and the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 12-2. GM/CA CAT is funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. DOE Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, NIGMS (including P41GM103393) and the National Center for Research Resources (NCRR, P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR, or NIH. This is publication 24079 from the Scripps Research Institute. Coordinates and structure factors are deposited in the PDB (4N5J, 4N5K, 4N60, 4N61, 4N62, 4N63, and 4N64).	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-85; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kahn RE, 2013, VECTOR-BORNE ZOONOT, V13, P347, DOI 10.1089/vbz.2013.999.ceezad; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Morens DM, 2013, NEW ENGL J MED, V368, P2345, DOI 10.1056/NEJMp1307009; Paulson JC, 2013, VIRUS RES, V178, P99, DOI 10.1016/j.virusres.2013.02.015; Ramos I, 2013, J GEN VIROL, V94, P2417, DOI 10.1099/vir.0.056184-0; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Steinhauer DA, 2013, NATURE, V499, P412, DOI 10.1038/nature12455; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; World Health Organization, 2013, OV EM CHAR AV INFL A; Xiong X, 2013, VIRUS RES, V178, P12, DOI 10.1016/j.virusres.2013.08.007; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu R., 2012, STRUCTURAL GLYCOMICS, P235; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	35	120	127	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1230	1235		10.1126/science.1243761	http://dx.doi.org/10.1126/science.1243761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311689	Green Accepted			2022-12-28	WOS:000327857900047
J	Marks, M; Murch, NR; Beckles, MA; Drebes, AB; Beynon, HL				Marks, Michael; Murch, Nick R.; Beckles, Michael A.; Drebes, Anja B.; Beynon, Huw L.			Pleuritic chest pain	LANCET			English	Editorial Material									[Marks, Michael; Murch, Nick R.; Beckles, Michael A.; Beynon, Huw L.] Royal Free London NHS Fdn Trust, Dept Acute Med, London NW3 2QG, England; [Drebes, Anja B.] Royal Free London NHS Fdn Trust, Haemophilia Ctr, London NW3 2QG, England; [Drebes, Anja B.] Royal Free London NHS Fdn Trust, Thrombisis Unit, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust	Marks, M (corresponding author), Royal Free London NHS Fdn Trust, Dept Acute Med, Pond St, London NW3 2QG, England.			Marks, Michael/0000-0002-7585-4743	National Institute for Health Research [ACF-2012-20-001] Funding Source: researchfish; Wellcome Trust [100714] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					E32	E32		10.1016/S0140-6736(13)62547-7	http://dx.doi.org/10.1016/S0140-6736(13)62547-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24290590				2022-12-28	WOS:000327540700004
J	Tuomi, T; Santoro, N; Caprio, S; Cai, MY; Weng, JP; Groop, L				Tuomi, Tiinamaija; Santoro, Nicola; Caprio, Sonia; Cai, Mengyin; Weng, Jianping; Groop, Leif			The many faces of diabetes: a disease with increasing heterogeneity	LANCET			English	Review							GLUTAMIC-ACID DECARBOXYLASE; IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; GLOBAL PREVALENCE; HEPATIC STEATOSIS; NATURAL-HISTORY; RISK-FACTORS; ADULTS LADA; LATENT	Diabetes is a much more heterogeneous disease than the present subdivision into types 1 and 2 assumes; type 1 and type 2 diabetes probably represent extremes on a range of diabetic disorders. Both type 1 and type 2 diabetes seem to result from a collision between genes and environment. Although genetic predisposition establishes susceptibility, rapid changes in the environment (ie, lifestyle factors) are the most probable explanation for the increase in incidence of both forms of diabetes. Many patients have genetic predispositions to both forms of diabetes, resulting in hybrid forms of diabetes (eg, latent autoimmune diabetes in adults). Obesity is a strong modifi er of diabetes risk, and can account for not only a large proportion of the epidemic of type 2 diabetes in Asia but also the ever-increasing number of adolescents with type 2 diabetes. With improved characterisation of patients with diabetes, the range of diabetic subgroups will become even more diverse in the future.	[Tuomi, Tiinamaija] Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Santoro, Nicola; Caprio, Sonia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Cai, Mengyin; Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Groop, Leif] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Groop, Leif] Univ Helsinki, FIMM, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; Yale University; Sun Yat Sen University; Lund University; University of Helsinki	Groop, L (corresponding author), Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden.	leif.groop@med.lu.se	Santoro, Nicola/A-4897-2014	Santoro, Nicola/0000-0001-6437-4173; Tuomi, Tiinamaija/0000-0002-8306-6202; Weng, Jianping/0000-0002-7889-1697	European Research Council; Swedish Research Council; Academy of Finland; National Science Fund for Distinguished Young Scholars [81025005]	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Academy of Finland(Academy of Finland); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	LG is funded by the European Research Council, the Swedish Research Council, and the Academy of Finland. JW is funded by the National Science Fund for Distinguished Young Scholars 81025005.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alderete TL, 2013, J CLIN ENDOCR METAB, V98, P3748, DOI 10.1210/jc.2013-1138; AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Andersen M., 2012, THESIS U HELSINKI; Andersen MK, 2013, AUTOIMMUNITY, V46, P251, DOI 10.3109/08916934.2012.741155; Andersen MK, 2012, EUR J ENDOCRINOL, V167, P27, DOI 10.1530/EJE-12-0023; Andersen MK, 2010, DIABETES CARE, V33, P2062, DOI 10.2337/dc09-2188; Arslanian SA, 2002, DIABETES, V51, P3014, DOI 10.2337/diabetes.51.10.3014; Balasubramanyam A, 2006, DIABETES CARE, V29, P2575, DOI 10.2337/dc06-0749; BANERJI MA, 1994, DIABETES, V43, P741, DOI 10.2337/diabetes.43.6.741; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Bennett B, 2012, OBESITY, V20, P371, DOI 10.1038/oby.2011.264; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Buzzetti R, 2007, DIABETES CARE, V30, P932, DOI 10.2337/dc06-1696; Cali AMG, 2009, HEPATOLOGY, V49, P1896, DOI 10.1002/hep.22858; Castleden HAJ, 2006, DIABETIC MED, V23, P834, DOI 10.1111/j.1464-5491.2006.01915.x; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Chines PS, 2013, DIABETES, V61, P1974; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; Dabelea D, 2011, DIABETOLOGIA, V54, P535, DOI 10.1007/s00125-010-1982-7; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Desai M, 2006, DIABETES, V55, P1890, DOI 10.2337/db06-0089; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fourlanos S, 2006, DIABETES CARE, V29, P970, DOI 10.2337/dc05-2101; Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7; Gale EAM, 2005, DIABETOLOGIA, V48, P2195, DOI 10.1007/s00125-005-1954-5; Giannini C, 2014, DIABETES CARE, V37, P475, DOI 10.2337/dc13-1458; Giannini C, 2012, DIABETES, V61, P606, DOI 10.2337/db11-1111; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 2006, DIABETOLOGIA, V49, P1996, DOI 10.1007/s00125-006-0345-x; GROOP LC, 1986, DIABETES, V35, P237, DOI 10.2337/diabetes.35.2.237; GROOP LC, 1991, DIABETOLOGIA, V34, P46, DOI 10.1007/BF00404024; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gungor N, 2004, J PEDIATR-US, V144, P656, DOI 10.1016/j.jpeds.2003.12.045; Hannon TS, 2008, DIABETES CARE, V31, P1445, DOI 10.2337/dc08-0116; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; Hattersley A, 2006, PEDIATR DIABETES, V7, P352, DOI 10.1111/j.1399-5448.2006.00217.x; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; International Diabetes Federation, IDF DIAB ATL; International Diabetes Federation, IDF CONS WORLDW DEF; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jeffery AN, 2012, DIABETES CARE, V35, P536, DOI 10.2337/dc11-1281; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kim G, 2013, DIABETES CARE, V36, P130, DOI 10.2337/dc12-0277; Klingensmith GJ, 2010, DIABETES CARE, V33, P1970, DOI 10.2337/dc10-0373; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Leslie RDG, 2008, DIABETES-METAB RES, V24, P511, DOI 10.1002/dmrr.877; Leslie RDG, 2006, J CLIN ENDOCR METAB, V91, P1654, DOI 10.1210/jc.2005-1623; Lesser IA, 2012, J OBES, V2012, DOI 10.1155/2012/703941; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Liska D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000569; Lukacs K, 2012, DIABETOLOGIA, V55, P689, DOI 10.1007/s00125-011-2378-z; Lundgren VM, 2013, DIABETIC MED, V30, pE163, DOI 10.1111/dme.12069; Lundgren VM, 2010, DIABETES, V59, P416, DOI 10.2337/db09-0747; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Maioli M, 2010, EUR J ENDOCRINOL, V163, P541, DOI 10.1530/EJE-10-0427; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; NISKANEN LK, 1995, DIABETES CARE, V18, P1557, DOI 10.2337/diacare.18.12.1557; Oilinki T, 2012, PEDIATR DIABETES, V13, P176, DOI 10.1111/j.1399-5448.2011.00783.x; Palmer JP, 2005, DIABETES, V54, pS62, DOI 10.2337/diabetes.54.suppl_2.S62; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petrone A, 2008, DIABETES CARE, V31, P534, DOI 10.2337/dc07-1457; Pettersen E, 2010, DIABETES, V59, P302, DOI 10.2337/db09-0923; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pleis John R, 2009, Vital Health Stat 10, P1; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Porter JR, 2006, DIABETIC MED, V23, P1257, DOI 10.1111/j.1464-5491.2006.01958.x; Radtke MA, 2009, DIABETES CARE, V32, P245, DOI 10.2337/dc08-1468; Reinehr T, 2006, ARCH DIS CHILD, V91, P473, DOI 10.1136/adc.2005.088229; Rewers A, 2008, PEDIATRICS, V121, pE1258, DOI 10.1542/peds.2007-1105; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sorgjerd EP, 2012, DIABETOLOGIA, V55, P1310, DOI 10.1007/s00125-012-2463-y; T1D base, HUM TYP 1 DIAB SUSC; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Tripathy D, 2000, DIABETOLOGIA, V43, P1476, DOI 10.1007/s001250051558; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Umpierrez GE, 2006, DIABETES CARE, V29, P2755, DOI 10.2337/dc06-1870; US National Institute of Diabetes and Digestive and Kidney Diseases, 2011, NAT DIAB STAT; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; WINTER WE, 1987, NEW ENGL J MED, V316, P285, DOI 10.1056/NEJM198702053160601; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zalloua P, 2008, HUM MOL GENET, V17, P4012, DOI 10.1093/hmg/ddn304; Zampetti S, 2012, J CLIN ENDOCR METAB, V97, P3759, DOI 10.1210/jc.2012-2037; Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207; Zinman B, 2004, DIABETES, V53, P3193, DOI 10.2337/diabetes.53.12.3193	110	363	377	55	286	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1084	1094		10.1016/S0140-6736(13)62219-9	http://dx.doi.org/10.1016/S0140-6736(13)62219-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24315621				2022-12-28	WOS:000333521200034
J	Burgio, KL				Burgio, Kathryn L.			Pelvic floor muscle training for pelvic organ prolapse	LANCET			English	Editorial Material							OVERACTIVE BLADDER		[Burgio, Kathryn L.] Univ Alabama Birmingham, Birmingham, AL 35244 USA; [Burgio, Kathryn L.] Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Birmingham, AL 35244 USA	University of Alabama System; University of Alabama Birmingham; Geriatric Research Education & Clinical Center	Burgio, KL (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35244 USA.	kburgio@uabmc.edu						Bo K, 2004, INT UROGYNECOL J, V15, P76, DOI 10.1007/s00192-004-1125-0; Braekken IH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.037; Burgio KL, 2011, J AM GERIATR SOC, V59, P2209, DOI 10.1111/j.1532-5415.2011.03724.x; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Hagen S, 2010, NEUROUROL URODYNAM, V29, P1055; Hagen S, 2014, LANCET, V383, P796, DOI 10.1016/S0140-6736(13)61977-7; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Johnson TM, 2013, BR J UROL INT, V110, P100; Kashyap R, 2013, INT J GYNECOL OBSTET, V121, P69, DOI 10.1016/j.ijgo.2012.11.012; Moore K., 2013, INCONTINENCE, P1101, DOI DOI 10.1183/13993003.00541-2019; Mouritsen L, 2003, INT UROGYNECOL J PEL, V14, P122, DOI 10.1007/s00192-002-1024-1; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6	13	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					760	762		10.1016/S0140-6736(13)62372-7	http://dx.doi.org/10.1016/S0140-6736(13)62372-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24290405				2022-12-28	WOS:000332398700006
J	Bateman, DN; Dear, JW; Thanacoody, HKR; Thomas, SHL; Eddleston, M; Sandilands, EA; Coyle, J; Cooper, JG; Rodriguez, A; Butcher, I; Lewis, SC; Vliegenthart, ADB; Veiraiah, A; Webb, DJ; Gray, A				Bateman, D. Nicholas; Dear, James W.; Thanacoody, H. K. Ruben; Thomas, Simon H. L.; Eddleston, Michael; Sandilands, Euan A.; Coyle, Judy; Cooper, Jamie G.; Rodriguez, Aryelly; Butcher, Isabella; Lewis, Steff C.; Vliegenthart, A. D. Bastiaan; Veiraiah, Aravindan; Webb, David J.; Gray, Alasdair			Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial	LANCET			English	Article							N-ACETYLCYSTEINE; ANAPHYLACTOID REACTIONS; MEDICATION ERRORS; INFUSION RATES; ACETAMINOPHEN; MULTICENTER; RISK	Background Paracetamol poisoning is common worldwide. It is treated with intravenous acetylcysteine, but the standard regimen is complex and associated with frequent adverse effects related to concentration, which can cause treatment interruption. We aimed to ascertain whether adverse effects could be reduced with either a shorter modified acetylcysteine schedule, antiemetic pretreatment, or both. Methods We undertook a double-blind, randomised factorial study at three UK hospitals, between Sept 6, 2010, and Dec 31, 2012. We randomly allocated patients with acute paracetamol overdose to either the standard intravenous acetylcysteine regimen (duration 20.25 h) or a shorter (12 h) modified protocol, with or without intravenous ondansetron pretreatment (4 mg). Masking was achieved by infusion of 5% dextrose (during acetylcysteine delivery) or saline (for antiemetic pretreatment). Randomisation was done via the internet and included a minimisation procedure by prognostic factors. The primary outcome was absence of vomiting, retching, or need for rescue antiemetic treatment at 2 h. Prespecified secondary outcomes included a greater than 50% increase in alanine aminotransferase activity over the admission value. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov (identifier NCT01050270). Findings Of 222 patients who underwent randomisation, 217 were assessable 2 h after the start of acetylcysteine treatment. Vomiting, retching, or need for rescue antiemetic treatment at 2 h was reported in 39 of 108 patients assigned to the shorter modified protocol compared with 71 of 109 allocated to the standard acetylcysteine regimen (adjusted odds ratio 0.26, 97.5% CI 0.13- 0.52; p<0.0001), and in 45 of 109 patients who received ondansetron compared with 65 of 108 allocated placebo (0.41, 0.20-0.80; p=0.003). Severe anaphylactoid reactions were recorded in five patients assigned to the shorter modified acetylcysteine regimen versus 31 who were allocated to the standard protocol (adjusted common odds ratio 0.23, 97.5% CI 0.12-0.43; p<0.0001). The proportion of patients with a 50% increase in alanine aminotransferase activity did not differ between the standard (9/110) and shorter modified (13/112) regimens (adjusted odds ratio 0.60, 97.5% CI 0.20-1.83); however, the proportion was higher with ondansetron (16/111) than with placebo (6/111; 3.30, 1.01-10.72; p=0.024). Interpretation In patients with paracetamol poisoning, a 12 h modified acetylcysteine regimen resulted in less vomiting, fewer anaphylactoid reactions, and reduced need for treatment interruption. This study was not powered to detect non-inferiority of the shorter protocol versus the standard approach; therefore, further research is needed to confirm the efficacy of the 12 h modified acetylcysteine regimen.	[Bateman, D. Nicholas; Dear, James W.; Eddleston, Michael; Sandilands, Euan A.; Veiraiah, Aravindan] Royal Infirm Edinburgh NHS Trust, Natl Poisons Informat Serv, Edinburgh EH16 4SA, Midlothian, Scotland; [Dear, James W.; Eddleston, Michael; Vliegenthart, A. D. Bastiaan; Webb, David J.] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Thanacoody, H. K. Ruben; Thomas, Simon H. L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thanacoody, H. K. Ruben; Thomas, Simon H. L.] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Coyle, Judy; Gray, Alasdair] Royal Infirm Edinburgh NHS Trust, Emergency Med Res Grp, Dept Emergency Med, Edinburgh EH16 4SA, Midlothian, Scotland; [Cooper, Jamie G.] Aberdeen Royal Infirm, Emergency Dept, Aberdeen, Scotland; [Rodriguez, Aryelly] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Butcher, Isabella; Lewis, Steff C.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh; University of Edinburgh	Bateman, DN (corresponding author), Royal Infirm Edinburgh NHS Trust, Natl Poisons Informat Serv, Edinburgh EH16 4SA, Midlothian, Scotland.	spib@luht.scot.nhs.uk	Thanacoody, Harry Krishna Ruben/AFU-0492-2022; Thomas, Simon/AAK-9674-2021	Thanacoody, Harry Krishna Ruben/0000-0001-7543-6026; Cooper, Jamie/0000-0003-3812-7026; Bateman, David Nicholas/0000-0002-8971-862X; Lewis, Steff/0000-0003-1210-2314	Chief Scientist Office of the Scottish Government; Chief Scientist Office, Scotland [CZB/4/722]; Chief Scientist Office [CZB/4/722, SCD/05] Funding Source: researchfish	Chief Scientist Office of the Scottish Government; Chief Scientist Office, Scotland; Chief Scientist Office	Chief Scientist Office of the Scottish Government.; We thank our colleagues in the treating hospitals who assisted with recruitment and patients' management, the Data Monitoring Committee (R E Ferner, J E Gray, and K Simpson), and the programmers in the Edinburgh Clinical Trials Unit. The trial was funded by Chief Scientist Office, Scotland (award CZB/4/722).	Al-Hourani K, 2013, QJM-INT J MED, V106, P541, DOI 10.1093/qjmed/hct062; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; British Medical Association Royal Pharmaceutical Society of Great Britain, 2009, BRIT NATL FORMULARY; Brok J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003328.pub2; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; Commission on Human Medicines Paracetamol Expert Group, 2013, BEN RISK PROF AC MAN; Fathalla S, 2008, CLIN TOXICOL, V46, P401; Ferner RE, 2001, BRIT J CLIN PHARMACO, V52, P573, DOI 10.1046/j.0306-5251.2001.01490.x; Ferner Robin E, 2011, BMJ, V342, pd2218, DOI 10.1136/bmj.d2218; Hayes BD, 2008, ANN PHARMACOTHER, V42, P766, DOI 10.1345/aph.1K685; Health and Social Care Information Centre, 2012, HOSP EP STAT ADM PAT; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Kerr F, 2005, ANN EMERG MED, V45, P402, DOI 10.1016/j.annemergmed.2004.08.040; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lynch Richard M, 2004, Accid Emerg Nurs, V12, P10, DOI 10.1016/j.aaen.2003.07.001; Pakravan N, 2008, CLIN TOXICOL, V46, P697, DOI 10.1080/15563650802245497; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; PRESCOTT LF, 1977, LANCET, V2, P432; PRESCOTT LF, 1989, EUR J CLIN PHARMACOL, V37, P501, DOI 10.1007/BF00558131; Rumack BH, 2012, CLIN TOXICOL, V50, P91, DOI 10.3109/15563650.2012.659252; Sandilands EA, 2009, CLIN TOXICOL, V47, P81, DOI 10.1080/15563650802665587; Schmidt LE, 2013, CLIN TOXICOL, V51, P467, DOI 10.3109/15563650.2013.799677; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Thanacoody HKR, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-20; Waring WS, 2006, CLIN TOXICOL, V44, P441; Whyte IM, 2000, THER DRUG MONIT, V22, P742, DOI 10.1097/00007691-200012000-00015; Wright RO, 1999, J TOXICOL-CLIN TOXIC, V37, P35, DOI 10.1081/CLT-100102406	30	138	148	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					697	704		10.1016/S0140-6736(13)62062-0	http://dx.doi.org/10.1016/S0140-6736(13)62062-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24290406	Green Published, hybrid			2022-12-28	WOS:000331653300030
J	Dohm, JC; Minoche, AE; Holtgrawe, D; Capella-Gutierrez, S; Zakrzewski, F; Tafer, H; Rupp, O; Sorensen, T; Stracke, R; Reinhardt, R; Goesmann, A; Kraft, T; Schulz, B; Stadler, PF; Schmidt, T; Gabaldon, T; Lehrach, H; Weisshaar, B; Himmelbauer, H				Dohm, Juliane C.; Minoche, Andre E.; Holtgraewe, Daniela; Capella-Gutierrez, Salvador; Zakrzewski, Falk; Tafer, Hakim; Rupp, Oliver; Soerensen, ThomasRosleff; Stracke, Ralf; Reinhardt, Richard; Goesmann, Alexander; Kraft, Thomas; Schulz, Britta; Stadler, Peter F.; Schmidt, Thomas; Gabaldon, Toni; Lehrach, Hans; Weisshaar, Bernd; Himmelbauer, Heinz			The genome of the recently domesticated crop plant sugar beet (Beta vulgaris)	NATURE			English	Article							RESISTANCE GENE ANALOGS; DE-NOVO IDENTIFICATION; INTEGRATION; PROGRAM; L.; CHROMOSOME; ALIGNMENT; FAMILIES; DATABASE; MAP	Sugar beet (Beta vulgaris ssp. vulgaris) is an important crop of temperate climates which provides nearly 30% of the world's annual sugar production and is a source for bioethanol and animal feed. The species belongs to the order of Caryophylalles, is diploid with 2n=18 chromosomes, has an estimated genome size of 714-758 megabases(1) and shares an ancient genome triplication with other eudicot plants(2). Leafy beets have been cultivated since Roman times, but sugar beet is one of the most recently domesticated crops. It arose in the late eighteenth century when lines accumulating sugar in the storage root were selected from crosses made with chard and fodder beet(3). Here we present a reference genome sequence for sugar beet as the first non-rosid, non-asterid eudicot genome, advancing comparative genomics and phylogenetic reconstructions. The genome sequence comprises 567 megabases, of which 85% could be assigned to chromosomes. The assembly covers a large proportion of the repetitive sequence content that was estimated(4) to be 63%. We predicted 27,421 protein-coding genes supported by transcript data and annotated them on the basis of sequence homology. Phylogenetic analyses provided evidence for the separation of Caryophyllales before the split of asterids and rosids, and revealed lineage-specific gene family expansions and losses. We sequenced spinach (Spinacia oleracea), another Caryophyllales species, and validated features that separate this clade from rosids and asterids. Intraspecific genomic variation was analysed based on the genome sequences of sea beet (Beta vulgaris ssp. maritima; progenitor of all beet crops) and four additional sugar beet accessions. We identified seven million variant positions in the reference genome, and also large regions of low variability, indicating artificial selection. The sugar beet genome sequence enables the identification of genes affecting agronomically relevant traits, supports molecular breeding and maximizes the plant's potential in energy biotechnology.	[Dohm, Juliane C.; Minoche, Andre E.; Lehrach, Hans; Himmelbauer, Heinz] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Dohm, Juliane C.; Minoche, Andre E.; Capella-Gutierrez, Salvador; Gabaldon, Toni; Himmelbauer, Heinz] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Dohm, Juliane C.; Minoche, Andre E.; Capella-Gutierrez, Salvador; Gabaldon, Toni; Himmelbauer, Heinz] UPF, Barcelona 08003, Spain; [Holtgraewe, Daniela; Rupp, Oliver; Soerensen, ThomasRosleff; Stracke, Ralf; Goesmann, Alexander; Weisshaar, Bernd] Univ Bielefeld, CeBiTec, D-33615 Bielefeld, Germany; [Holtgraewe, Daniela; Rupp, Oliver; Soerensen, ThomasRosleff; Stracke, Ralf; Goesmann, Alexander; Weisshaar, Bernd] Univ Bielefeld, Dept Biol, D-33615 Bielefeld, Germany; [Zakrzewski, Falk; Schmidt, Thomas] Tech Univ Dresden, Dept Biol, D-01217 Dresden, Germany; [Tafer, Hakim; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; [Reinhardt, Richard] Max Planck Genome Ctr Cologne, D-50829 Cologne, Germany; [Kraft, Thomas] Syngenta, S-26123 Landskrona, Sweden; [Schulz, Britta] KWS SAAT AG, D-37574 Einbeck, Germany; [Gabaldon, Toni] ICREA, Barcelona 08010, Spain	Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Bielefeld; University of Bielefeld; Technische Universitat Dresden; Leipzig University; Max Planck Society; Syngenta; KWS Saat AG; ICREA	Himmelbauer, H (corresponding author), Max Planck Inst Mol Genet, Ihnestr 63-73, D-14195 Berlin, Germany.	bernd.weisshaar@uni-bielefeld.de; Heinz.himmelbauer@crg.es	Weisshaar, Bernd/B-3859-2014; Gabaldón, Toni/A-7336-2008; Stadler, Peter F. F/L-7857-2015; Capella-Gutierrez, Salvador/H-5053-2015	Weisshaar, Bernd/0000-0002-7635-3473; Gabaldón, Toni/0000-0003-0019-1735; Stadler, Peter F. F/0000-0002-5016-5191; Capella-Gutierrez, Salvador/0000-0002-0309-604X; Holtgrawe, Daniela/0000-0002-1062-4576; Reinhardt, Richard/0000-0001-9376-2132; Himmelbauer, Heinz/0000-0001-8897-2928; Bryan, Laura/0000-0003-2009-799X; Stracke, Ralf/0000-0002-9261-2279; Rupp, Oliver/0000-0003-2755-6458; Goesmann, Alexander/0000-0002-7086-2568; Tafer, Hakim/0000-0002-6252-9802	BMBF [FKZ 0315069A, 0315069B, FKZ 0315962 A, 0315962 B, 0315962 C]; ICREA Funding Source: Custom	BMBF(Federal Ministry of Education & Research (BMBF)); ICREA(ICREA)	This work was supported by the BMBF grant "Verbundprojekt GABI BeetSeq: Erstellung einer Referenzsequenz fur das Genomder Zuckerrube (Beta vulgaris)", FKZ 0315069A and 0315069B (to H.H. and B.W.) and by the BMBF grant "AnnoBeet: Annotation des Genoms der Zuckerrube unter Berucksichtigung von Genfunktionen und struktureller Variabilitat fur Nutzung von Genomdaten in der Pflanzenbiotechnologie.", FKZ 0315962 A, 0315962 B and 0315962 C (to B.W., H.H., and T.S.). We are grateful to M. Zehnsdorf, H. Kang, P. Viehoever, E. Castillo, A. Menoyo and C. Lange for library preparation and sequencing; to D. Datta for sequencing data base calling; to D. Kedra for discussions; and to D. Boyd and M. Isalan for language editing. We thank P. Pin, B. Briggs, and Strube Research for providing plant material and for discussions. We thank Roche for data generation on the 454 sequencing platform (cDNA and genomic 20 kb mate-pairs) and for early access to the Newbler genome assembly software.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angiosperm Phylogeny Group, 2003, BOT J LINN SOC, V141, P399, DOI [10.1046/j.1095-8339.2003.t01-1-00158.x, DOI 10.1046/J.1095-8339.2003.T01-1-00158.X]; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biancardi E, 2012, BETA MARITMA: THE ORIGIN OF BEETS, P1, DOI 10.1007/978-1-4614-0842-0; Biancardi E, 2010, HANDB PLANT BREED, V7, P173, DOI 10.1007/978-0-387-92765-7_6; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brown JWS, 2003, NUCLEIC ACIDS RES, V31, P432, DOI 10.1093/nar/gkg009; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Dohm JC, 2012, PLANT J, V70, P528, DOI 10.1111/j.1365-313X.2011.04898.x; Dohm JC, 2009, PLANT J, V57, P14, DOI 10.1111/j.1365-313X.2008.03665.x; FISCHER HE, 1989, EUPHYTICA, V41, P75, DOI 10.1007/BF00022414; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hohmann U, 2003, MOL GENET GENOMICS, V269, P126, DOI 10.1007/s00438-003-0821-7; Huerta-Cepas J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r109; Hunger S, 2003, GENOME, V46, P70, DOI 10.1139/G02-106; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim J, 2012, MOL CELLS, V33, P385, DOI 10.1007/s10059-012-0003-8; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lange C, 2008, GENOME, V51, P948, DOI 10.1139/G08-071; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; NEI M, 1986, MOL BIOL EVOL, V3, P418; Paesold S, 2012, PLANT J, V72, P600, DOI 10.1111/j.1365-313X.2012.05102.x; Pin PA, 2012, CURR BIOL, V22, P1095, DOI 10.1016/j.cub.2012.04.007; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tian Y, 2004, J MOL EVOL, V58, P40, DOI 10.1007/s00239-003-2524-4; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	45	331	383	6	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					546	+		10.1038/nature12817	http://dx.doi.org/10.1038/nature12817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24352233	Green Published, hybrid			2022-12-28	WOS:000329995000039
J	Monteferrario, D; Bolar, NA; Marneth, AE; Hebeda, KM; Bergevoet, SM; Veenstra, H; Laros-van Gorkom, BAP; MacKenzie, MA; Khandanpour, C; Botezatu, L; Fransen, E; Van Camp, G; Duijnhouwer, AL; Salemink, S; Willemsen, B; Huls, G; Preijers, F; Van Heerde, W; Jansen, JH; Kempers, MJE; Loeys, BL; Van Laer, L; Van der Reijden, BA				Monteferrario, Davide; Bolar, Nikhita A.; Marneth, Anna E.; Hebeda, Konnie M.; Bergevoet, Saskia M.; Veenstra, Hans; Laros-van Gorkom, Britta A. P.; MacKenzie, Marius A.; Khandanpour, Cyrus; Botezatu, Lacramiora; Fransen, Erik; Van Camp, Guy; Duijnhouwer, Anthonie L.; Salemink, Simone; Willemsen, Brigith; Huls, Gerwin; Preijers, Frank; Van Heerde, Waander; Jansen, Joop H.; Kempers, Marlies J. E.; Loeys, Bart L.; Van Laer, Lut; Van der Reijden, Bert A.			A Dominant-Negative GFI1B Mutation in the Gray Platelet Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-GRANULES; GROWTH-FACTOR; BONE-MARROW; NBEAL2; GFI-1B; DIFFERENTIATION; THROMBOPOIESIS; PROTEIN; CELLS; GENE	The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding disorder caused by a deficiency of alpha granules in platelets. We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome. Both gray platelets and megakaryocytes had abnormal marker expression. In addition, the megakaryocytes had dysplastic features, and they were abnormally distributed in the bone marrow. The GFI1B mutant protein inhibited nonmutant GFI1B transcriptional activity in a dominant-negative manner. Our studies show that GFI1B, in addition to being causally related to the gray platelet syndrome, is key to megakaryocyte and platelet development. A large family is described with gray platelet syndrome due to an autosomal dominant inheritance pattern related to a dominant-negative mutation in GFI1B. The mutation leads to a loss in gene repression during megakaryocyte development. Platelets are formed through fragmentation of megakaryocytes that reside in the bone marrow.(1),(2) Platelet alpha granules, which are by far the most abundant platelet organelles, store proteins that stimulate platelet adhesiveness, hemostasis, and wound healing.(3),(4) The gray platelet syndrome is an inherited bleeding disorder characterized by defective production of alpha granules.(5),(6) Patients with this syndrome have reduced numbers of larger-than-normal platelets, and on light microscopy these platelets have a typical gray appearance caused by the lack of alpha granules. For a final diagnosis, the lack of alpha granules must be confirmed by means of electron microscopy.(7) Clinically, ...	[Monteferrario, Davide; Marneth, Anna E.; Bergevoet, Saskia M.; Veenstra, Hans; Huls, Gerwin; Preijers, Frank; Van Heerde, Waander; Jansen, Joop H.; Van der Reijden, Bert A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Lab Hematol, NL-6525 GA Nijmegen, Netherlands; [Hebeda, Konnie M.; Willemsen, Brigith] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands; [Laros-van Gorkom, Britta A. P.; MacKenzie, Marius A.; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 GA Nijmegen, Netherlands; [Duijnhouwer, Anthonie L.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 GA Nijmegen, Netherlands; [Salemink, Simone; Kempers, Marlies J. E.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Bolar, Nikhita A.; Fransen, Erik; Van Camp, Guy; Loeys, Bart L.; Van Laer, Lut] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, Statua Ctr Stat, B-2020 Antwerp, Belgium; [Khandanpour, Cyrus; Botezatu, Lacramiora] Univ Hosp, Dept Hematol, Essen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Antwerp; University of Antwerp; University of Duisburg Essen	Van der Reijden, BA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Huispost 475,Geert Grootepl Zuid 8, NL-6525 GA Nijmegen, Netherlands.	lut.vanlaer@uantwerp.be; bert.vanderreijden@radboudumc.nl	Marneth, Anna/G-6236-2016; MacKenzie, M.A./L-4499-2015; Loeys, Bart/B-3236-2017; van der Reijden, Bert A/A-3543-2014; Bergevoet, Saskia M/F-4926-2016; van Heerde, Waander/L-4357-2015; Jansen, J.H./H-8054-2014; Duijnhouwer, Anthonie/AAV-1578-2020; Fransen, Erik/C-4102-2015; Van Camp, Guy/F-3386-2013; Willemsen, Brigith K.T./F-3706-2016; Loeys, B.L./L-4493-2015; Duijnhouwer, Anthonie/P-6287-2015; Gorkom, B.A.P. Laros-van/L-4475-2015; Hebeda, K./L-4354-2015; Huls, G.A./L-4398-2015; Preijers, Frank/L-4586-2015; Marneth, Anna/AAX-7358-2021	Marneth, Anna/0000-0001-9065-0581; Loeys, Bart/0000-0003-3703-9518; van Heerde, Waander/0000-0001-7101-8775; Jansen, J.H./0000-0001-9459-568X; Duijnhouwer, Anthonie/0000-0001-5064-0143; Fransen, Erik/0000-0001-7785-4790; Van Camp, Guy/0000-0001-5105-9000; Duijnhouwer, Anthonie/0000-0001-5064-0143; Hebeda, K./0000-0002-4181-3302; Khandanpour, Cyrus/0000-0003-4655-6269				Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; BRETONGORIUS J, 1981, AM J PATHOL, V102, P10; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Gunay-Aygun M, 2010, BLOOD, V116, P4990, DOI 10.1182/blood-2010-05-286534; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; KURSTJENS R, 1968, BRIT J HAEMATOL, V15, P305, DOI 10.1111/j.1365-2141.1968.tb01541.x; Lee S, 2010, J MOL BIOL, V397, P1055, DOI 10.1016/j.jmb.2010.02.006; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; MORI K, 1984, TOHOKU J EXP MED, V143, P261, DOI 10.1620/tjem.143.261; Nurden AT, 2007, BLOOD REV, V21, P21, DOI 10.1016/j.blre.2005.12.003; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; RACCUGLIA G, 1971, AM J MED, V51, P818, DOI 10.1016/0002-9343(71)90311-1; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; WEISS HJ, 1979, BLOOD, V54, P1296; WHITE JG, 1979, AM J PATHOL, V95, P445; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	25	106	107	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					245	253		10.1056/NEJMoa1308130	http://dx.doi.org/10.1056/NEJMoa1308130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24325358	Green Published			2022-12-28	WOS:000330035600010
J	Jones, OR; Scheuerlein, A; Salguero-Gomez, R; Camarda, CG; Schaible, R; Casper, BB; Dahlgren, JP; Ehrlen, J; Garcia, MB; Menges, ES; Quintana-Ascencio, PF; Caswell, H; Baudisch, A; Vaupel, JW				Jones, Owen R.; Scheuerlein, Alexander; Salguero-Gomez, Roberto; Camarda, Carlo Giovanni; Schaible, Ralf; Casper, Brenda B.; Dahlgren, Johan P.; Ehrlen, Johan; Garcia, Maria B.; Menges, Eric S.; Quintana-Ascencio, Pedro F.; Caswell, Hal; Baudisch, Annette; Vaupel, James W.			Diversity of ageing across the tree of life	NATURE			English	Article							HISTORY VARIATION; SENESCENCE; MORTALITY; AGE; REPRODUCTION; LONGEVITY; SELECTION; EVOLUTION; MODELS; PLANTS	Evolution drives, and is driven by, demography. A genotype moulds its phenotype's age patterns of mortality and fertility in an environment; these two patterns in turn determine the genotype's fitness in that environment. Hence, to understand the evolution of ageing, age patterns of mortality and reproduction need to be compared for species across the tree of life. However, few studies have done so and only for a limited range of taxa. Here we contrast standardized patterns over age for 11 mammals, 12 other vertebrates, 10 invertebrates, 12 vascular plants and a green alga. Although it has been predicted that evolution should inevitably lead to increasing mortality and declining fertility with age after maturity, there is great variation among these species, including increasing, constant, decreasing, humped and bowed trajectories for both long-and short-lived species. This diversity challenges theoreticians to develop broader perspectives on the evolution of ageing and empiricists to study the demography of more species.	[Jones, Owen R.; Dahlgren, Johan P.; Vaupel, James W.] Max Planck Odense Ctr Biodemog Aging, DK-5230 Odense M, Denmark; [Jones, Owen R.; Dahlgren, Johan P.; Caswell, Hal] Univ Southern Denmark, Dept Biol, DK-5230 Odense M, Denmark; [Scheuerlein, Alexander; Salguero-Gomez, Roberto; Schaible, Ralf; Caswell, Hal; Baudisch, Annette; Vaupel, James W.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Salguero-Gomez, Roberto] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Camarda, Carlo Giovanni] Inst Natl Etud Demog, F-75980 Paris 20, France; [Casper, Brenda B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ehrlen, Johan] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Garcia, Maria B.] CSIC, Pyrenean Inst Ecol, Zaragoza 50059, Spain; [Menges, Eric S.] Archbold Biol Stn, Venus, FL 33960 USA; [Quintana-Ascencio, Pedro F.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Caswell, Hal] Woods Hole Oceanog Inst, Biol Dept MS 34, Woods Hole, MA 02543 USA; [Caswell, Hal] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Vaupel, James W.] Duke Univ, Duke Populat Res Inst, Durham, NC 27705 USA	University of Southern Denmark; Max Planck Society; University of Queensland; University of Pennsylvania; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); State University System of Florida; University of Central Florida; Woods Hole Oceanographic Institution; University of Amsterdam; Duke University	Jones, OR (corresponding author), Max Planck Odense Ctr Biodemog Aging, Campusvej 55, DK-5230 Odense M, Denmark.	jones@biology.sdu.dk	Andersen, Mette Adalheidur/D-5608-2017; Jones, Owen/B-8439-2008; Garcia, Maria Begoña/B-6630-2015; Baudisch, Annette/ABA-2290-2020; Salguero-Gómez, Rob/N-6016-2016; Scheuerlein, Alexander/AAK-1111-2021; Quintana-Ascencio, Pedro F/F-7263-2013; Salguero-Gomez, Rob/AAB-8488-2022	Jones, Owen/0000-0001-5720-4686; Garcia, Maria Begoña/0000-0003-4231-6006; Salguero-Gómez, Rob/0000-0002-6085-4433; Dahlgren, Johan/0000-0002-1125-9769; Vaupel, James/0000-0003-0783-3905; Caswell, Hal/0000-0003-4394-6894; Ehrlen, Johan/0000-0001-8539-8967; Baudisch, Annette/0000-0002-4202-089X	NIH [PO1 AG-031719]; Alexander von Humboldt Foundation; European Research Council [322989]; ARC [DP110100727]; Max Planck Society; NERC [NE/G004854/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P01AG031719] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/G004854/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); ARC(Australian Research Council); Max Planck Society(Max Planck SocietyFoundation CELLEX); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Alberts for data on baboon demography, J. Curtsinger for data on Drosophila demography and O. Burger, D. Levitis, B. Pietrzak, F. Quade, F. Ringelhan and L. Vinicius for contributing published data about various species. J. W. V. and A. S. acknowledge support from NIH grant PO1 AG-031719. H. C. acknowledges a Research Award from the Alexander von Humboldt Foundation and Advanced Grant 322989 from the European Research Council. R.S.-G. acknowledges support from ARC DP110100727. A. B. acknowledges funding from the Max Planck Society to establish the Max Planck Research Group 'Modeling the Evolution of Aging'.	Baudisch A, 2008, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-76656-8; Baudisch A, 2013, J ECOL, V101, P596, DOI 10.1111/1365-2745.12084; Baudisch A, 2012, SCIENCE, V338, P618, DOI 10.1126/science.1226467; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Baudisch A, 2010, DEMOGR RES, V23, P655, DOI 10.4054/DemRes.2010.23.23; BELL G, 1984, EVOLUTION, V38, P300, DOI 10.1111/j.1558-5646.1984.tb00289.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; BUSS LW, 1988, PALEOBIOLOGY, V14, P313, DOI 10.1017/S0094837300012069; Caswell, 2000, MATRIX POPULATION MO; Caswell H., 1985, P187; Caswell H, 2013, J ECOL, V101, P585, DOI 10.1111/1365-2745.12088; Caswell H, 2012, THEOR ECOL-NETH, V5, P403, DOI 10.1007/s12080-011-0132-2; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Chiang CL, 1984, LIFE TABLE ITS APPL; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Finch C.E., 1994, LONGEVITY SENESCENCE; Finch CE, 2009, GERONTOLOGY, V55, P307, DOI 10.1159/000215589; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Horvitz CC, 2008, AM NAT, V172, P203, DOI 10.1086/589453; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; MARTINEZ DE, 1992, P NATL ACAD SCI USA, V89, P9920, DOI 10.1073/pnas.89.20.9920; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medawar P., 1952, UNSOLVED PROBLEM BIO; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; ORIVE ME, 1995, AM NAT, V145, P90, DOI 10.1086/285729; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; PEDERSEN B, 1995, THEOR POPUL BIOL, V47, P292, DOI 10.1006/tpbi.1995.1013; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Salguero-Gomez R, 2013, J ECOL, V101, P545, DOI 10.1111/1365-2745.12089; SCHAFFER WM, 1974, ECOLOGY, V55, P291, DOI 10.2307/1935217; Shefferson RP, 2013, J ECOL, V101, P577, DOI 10.1111/1365-2745.12079; Stearns S.C., 1992, pi; Tuomi J, 2013, J ECOL, V101, P566, DOI 10.1111/1365-2745.12086; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	49	527	545	11	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					169	+		10.1038/nature12789	http://dx.doi.org/10.1038/nature12789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317695	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000329441500029
J	Wilensky, GR				Wilensky, Gail R.			Improving Value in Medicare with an SGR Fix	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Congressional attention is being directed toward developing an alternative Medicare reimbursement system that rewards physicians who improve the quality and efficiency of care, rather than trying to fix the sustainable growth rate formula. With the end of another year approaching and a scheduled reduction of 24.4% in physician fees, physicians and policymakers are once again concerned about what the sustainable growth rate formula (SGR) that is used to calculate Medicare's physician fees could mean for physician payment.(1) This year, however, is different from most years, when attention has generally been limited to finding ways to postpone the scheduled payment reductions (which have actually been enacted only once). This year, for the first time, bipartisan, bicameral attention is being directed toward developing an alternative reimbursement system that rewards physicians who improve the quality and ...	Project HOPE, Bethesda, MD USA		Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD USA.							Centers for Medicare & Medicaid Services, EST GROWTH RAT CONV	1	9	9	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2014	370	1					1	+		10.1056/NEJMp1313927	http://dx.doi.org/10.1056/NEJMp1313927			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284XA	24328440				2022-12-28	WOS:000329354100001
J	Arthur, C				Arthur, Charles			Academics should not remain silent on hacking	NATURE			English	Editorial Material												charles.arthur@gmail.com							0	1	1	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					333	333		10.1038/504333a	http://dx.doi.org/10.1038/504333a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273ZR	24352258	Bronze			2022-12-28	WOS:000328575300012
J	Rokas, A				Rokas, Antonis			My Oldest Sister Is a Sea Walnut?	SCIENCE			English	Editorial Material							ANIMAL EVOLUTION		Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Dawkins R., 2004, THE ANCESTORS TALE A; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Pang Kevin, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.emo106; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130	10	7	7	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1327	1329		10.1126/science.1248424	http://dx.doi.org/10.1126/science.1248424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337283				2022-12-28	WOS:000328196000034
J	Manolaridis, I; Kulkarni, K; Dodd, RB; Ogasawara, S; Zhang, ZG; Bineva, G; O'Reilly, N; Hanrahan, SJ; Thompson, AJ; Cronin, N; Iwata, S; Barford, D				Manolaridis, Ioannis; Kulkarni, Kiran; Dodd, Roger B.; Ogasawara, Satoshi; Zhang, Ziguo; Bineva, Ganka; O'Reilly, Nicola; Hanrahan, Sarah J.; Thompson, Andrew J.; Cronin, Nora; Iwata, So; Barford, David			Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1	NATURE			English	Article							SECONDARY STRUCTURE; STRUCTURAL BASIS; A-FACTOR; CRYSTAL-STRUCTURE; RAS; ENDOPROTEOLYSIS; LOCALIZATION; TRAFFICKING; SPECIFICITY; REVEALS	CAAX proteins have essential roles in multiple signalling pathways, controlling processes such as proliferation, differentiation and carcinogenesis(1). The similar to 120 mammalian CAAX proteins function at cellular membranes and include the Ras superfamily of small GTPases, nuclear lamins, the gamma-subunit of heterotrimeric GTPases, and several protein kinases and phosphatases(2). The proper localization of CAAX proteins to cell membranes is orchestrated by a series of post-translational modifications of the carboxy-terminal CAAX motifs(3) (where C is cysteine, A is an aliphatic amino acid and X is any amino acid). These reactions involve prenylation of the cysteine residue, cleavage at the AAX tripeptide and methylation of the carboxyl-prenylated cysteine residue. The major CAAX protease activity is mediated by Rce1 (Ras and a-factor converting enzyme 1), an intramembrane protease (IMP) of the endoplasmic reticulum(4,5). Information on the architecture and proteolytic mechanism of Rce1 has been lacking. Here we report the crystal structure of a Methano-coccus maripaludis homologue of Rce1, whose endopeptidase specificity for farnesylated peptides mimics that of eukaryotic Rce1. Its structure, comprising eight transmembrane alpha-helices, and catalytic site are distinct from those of other IMPs. The catalytic residues are located similar to 10 angstrom into the membrane and are exposed to the cytoplasm and membrane through a conical cavity that accommodates the prenylated CAAX substrate. We propose that the farnesyl lipid binds to a site at the opening of two transmembrane alpha-helices, which results in the scissile bond being positioned adjacent to a glutamate-activated nucleophilic water molecule. This study suggests that Rce1 is the founding member of a novel IMP family, the glutamate IMPs.	[Manolaridis, Ioannis; Kulkarni, Kiran; Dodd, Roger B.; Zhang, Ziguo; Hanrahan, Sarah J.; Thompson, Andrew J.; Cronin, Nora; Barford, David] Inst Canc Res, London SW3 6JB, England; [Ogasawara, Satoshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Ogasawara, Satoshi; Iwata, So] JST, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Bineva, Ganka; O'Reilly, Nicola] Canc Res UK London Res Inst, London WC2A 3LY, England; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Kyoto University; Japan Science & Technology Agency (JST); Cancer Research UK; Imperial College London	Barford, D (corresponding author), Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	dbarford@mrc-lmb.cam.ac.uk	Thompson, Andrew/B-1463-2014	Thompson, Andrew/0000-0003-2413-3281; Barford, David/0000-0001-8810-950X; Zhang, Ziguo/0000-0002-7268-9631; Dodd, Roger/0000-0003-4268-1863; Bineva-Todd, Ganka/0000-0001-8926-9417; O'Reilly, Nicola/0000-0002-4204-6491	Cancer Research UK; Japan Science and Technology agency; BBSRC [BB/G023425/1]; MRC [MC_UP_1201/6] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Japan Science and Technology agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Cancer Research UK grant to D. B. Part of this work was supported by the research acceleration program of the Japan Science and Technology agency and by BBSRC BB/G023425/1 (S. I.). We thank staff at the I04-1 Diamond Light Source for help with data collection, J. Yang for advice and discussions, I. De Moraes for support and T. Daviter for help with the circular dichroism experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Christiansen JR, 2011, P NATL ACAD SCI USA, V108, P8862, DOI 10.1073/pnas.1103627108; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hollander I, 2000, ANAL BIOCHEM, V286, P129, DOI 10.1006/abio.2000.4795; Hollander IJ, 2003, BBA-PROTEINS PROTEOM, V1649, P24, DOI 10.1016/S1570-9639(03)00150-X; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wahlstrom AM, 2007, BLOOD, V109, P763, DOI 10.1182/blood-2006-05-024752; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	51	116	123	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					301	+		10.1038/nature12754	http://dx.doi.org/10.1038/nature12754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24291792	Green Accepted			2022-12-28	WOS:000328121500041
J	Chang, D				Chang, Diane			Scut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Montefiore Med Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Chang, D (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	diachang@gmail.com						[Anonymous], 2013 US POV GUID; Benson B, 2013, CRAINS NEW YORK 0331; Bilton N, 2013, NY TIMES; College of Engineering at Georgia Tech, ROB COD LEARNS BATH; Hagman A, BESTIC EATING ASS DE; United States Department of Labor, 2014, OCC EMPL STAT OCC EM	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2399	2400		10.1001/jama.2013.282710	http://dx.doi.org/10.1001/jama.2013.282710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327036				2022-12-28	WOS:000328030900017
J	Lam, JR; Schneider, JL; Zhao, W; Corley, DA				Lam, Jameson R.; Schneider, Jennifer L.; Zhao, Wei; Corley, Douglas A.			Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B-12 Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COBALAMIN DEFICIENCY; TERM; OMEPRAZOLE; PREVALENCE; RISK; VALIDATION; CHILDREN; THERAPY; ABSENCE; DISEASE	IMPORTANCE Proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) suppress the production of gastric acid and thus may lead to malabsorption of vitamin B-12. However, few data exist regarding the associations between long-term exposure to these medications and vitamin B-12 deficiency in large population-based studies. OBJECTIVE To study the association between use of PPIs and H2RAs and vitamin B-12 deficiency in a community-based setting in the United States. DESIGN, SETTING, AND PATIENTS We evaluated the association between vitamin B-12 deficiency and prior use of acid-suppressing medication using a case-control study within the Kaiser Permanente Northern California population. We compared 25 956 patients having incident diagnoses of vitamin B-12 deficiency between January 1997 and June 2011 with 184 199 patients without B-12 deficiency. Exposures and outcomes were ascertained via electronic pharmacy, laboratory, and diagnostic databases. MAIN OUTCOMES AND MEASURES Risk of vitamin B-12 deficiency was estimated using odds ratios (ORs) from conditional logistic regression. RESULTS Among patients with incident diagnoses of vitamin B-12 deficiency, 3120 (12.0%) were dispensed a 2 or more years' supply of PPIs, 1087 (4.2%) were dispensed a 2 or more years' supply of H2RAs (without any PPI use), and 21 749 (83.8%) had not received prescriptions for either PPIs or H2RAs. Among patients without vitamin B-12 deficiency, 13 210 (7.2%) were dispensed a 2 or more years' supply of PPIs, 5897 (3.2%) were dispensed a 2 or more years' supply of H2RAs (without any PPI use), and 165 092 (89.6%) had not received prescriptions for either PPIs or H2RAs. Both a 2 or more years' supply of PPIs (OR, 1.65 [95% CI, 1.58-1.73]) and a 2 or more years' supply of H2RAs (OR, 1.25 [95% CI, 1.17-1.34]) were associated with an increased risk for vitamin B-12 deficiency. Doses more than 1.5 PPI pills/d were more strongly associated with vitamin B-12 deficiency (OR, 1.95 [95% CI, 1.77-2.15]) than were doses less than 0.75 pills/d (OR, 1.63 [95% CI, 1.48-1.78]; P = .007 for interaction). CONCLUSIONS AND RELEVANCE Previous and current gastric acid inhibitor use was significantly associated with the presence of vitamin B-12 deficiency. These findings should be considered when balancing the risks and benefits of using these medications.	[Lam, Jameson R.; Schneider, Jennifer L.; Zhao, Wei; Corley, Douglas A.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA	Kaiser Permanente	Corley, DA (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	douglas.corley@kp.org			Kaiser Permanente Community Benefit grant	Kaiser Permanente Community Benefit grant	This project was supported by a Kaiser Permanente Community Benefit grant.	[Anonymous], 2013, DECL MED US COSTS BE; Breslow NE, 1980, IARC SCI PUBL, P5; DASTUR DK, 1972, BMJ-BRIT MED J, V3, P260, DOI 10.1136/bmj.3.5821.260; Den Elzen WPJ, 2008, ALIMENT PHARM THER, V27, P491, DOI 10.1111/j.1365-2036.2008.03601.x; Dhamiarajan TS, 2008, J AM MED DIR ASSOC, V9, P162, DOI 10.1016/j.jamda.2007.10.004; Evatt ML, WHY VITAMIN B12 DEFI; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hirschowitz BI, 2008, ALIMENT PHARM THER, V27, P1110, DOI 10.1111/j.1365-2036.2008.03658.x; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jabbar Abdul, 2008, J Pak Med Assoc, V58, P258; Kaptan K, 2000, ARCH INTERN MED, V160, P1349, DOI 10.1001/archinte.160.9.1349; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; KOOP H, 1992, J CLIN GASTROENTEROL, V14, P288, DOI 10.1097/00004836-199206000-00005; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Laufer EM, 2004, EUR J CLIN NUTR, V58, P1518, DOI 10.1038/sj.ejcn.1602002; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; MARCUARD SP, 1994, ANN INTERN MED, V120, P211, DOI 10.7326/0003-4819-120-3-199402010-00006; Ness-Abramof R, 2006, AM J MED SCI, V332, P119, DOI 10.1097/00000441-200609000-00004; PENNYPACKER LC, 1992, J AM GERIATR SOC, V40, P1197, DOI 10.1111/j.1532-5415.1992.tb03641.x; Pflipsen MC, 2010, J AM BOARD FAM MED, V23, P695, DOI 10.3122/jabfm.2010.05.100185; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SALTZMAN JR, 1994, J AM COLL NUTR, V13, P584; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; Schenk BE, 1996, ALIMENT PHARM THERAP, V10, P541, DOI 10.1046/j.1365-2036.1996.27169000.x; Stabler SP, 1997, AM J CLIN NUTR, V66, P741, DOI 10.1093/ajcn/66.4.741; ter Heide H, 2001, J PEDIATR GASTR NUTR, V33, P342, DOI 10.1097/00005176-200109000-00023; Termanini B, 1998, AM J MED, V104, P422, DOI 10.1016/S0002-9343(98)00087-4; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Tolia V, 2008, DIGEST DIS SCI, V53, P385, DOI 10.1007/s10620-007-9880-7; Valuck RJ, 2004, J CLIN EPIDEMIOL, V57, P422, DOI 10.1016/j.jclinepi.2003.08.015; Wasay Mohammad, 2009, J Pak Med Assoc, V59, P196	35	284	299	3	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2435	2442		10.1001/jama.2013.280490	http://dx.doi.org/10.1001/jama.2013.280490			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327038	Bronze			2022-12-28	WOS:000328030900024
J	Nissen, SE				Nissen, Steven E.			Rosiglitazone: a case of regulatory hubris	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.	nissens@ccf.org						Food and Drug Administration, 2010, FDA BRIEF DOC ADV CO; Food and Drug Administration, 2001, DRUG APPR PACK AV RO; Food and Drug Administration, 2013, FDA BRIEF DOC READJ; Harris Gardiner, 2010, NY TIMES; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7144; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; US Senate Committee on Finance, 2010, STAFF REP GLAXOSMITH	7	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f7428	10.1136/bmj.f7428	http://dx.doi.org/10.1136/bmj.f7428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335808				2022-12-28	WOS:000328575000007
J	Chan, M				Chan, Margaret			Investing in health: progress but hard choices remain	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	porria@who.int						Jamison DT, 2013, LANCET; Task Team for the Global Thematic Consultation on Health, 2013, HLTH POST 2015 AG RE; WHO, 2013, 12 GEN PROGR WORK 20; WHO, 2013, WHOS ROL GLOB HLTH G; *WORLD BANK, 1993, WORLD DEV REP 1993 I	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					E34	E35		10.1016/S0140-6736(13)62336-3	http://dx.doi.org/10.1016/S0140-6736(13)62336-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309477				2022-12-28	WOS:000328222400002
J	Dybul, M				Dybul, Mark			A grand convergence and a historic opportunity	LANCET			English	Editorial Material									Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier Geneva, Switzerland		Dybul, M (corresponding author), Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier Geneva, Switzerland.	Denise.McElhinney@theglobalfund.org						Jamison DT, 2013, LANCET; *WORLD BANK, 1993, WORLD DEV REP 1993 I	2	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					E38	E39		10.1016/S0140-6736(13)62344-2	http://dx.doi.org/10.1016/S0140-6736(13)62344-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269DX	24309479				2022-12-28	WOS:000328222400004
J	Frede, J; Jones, PH				Frede, Julia; Jones, Philip H.			Permission to Proliferate	SCIENCE			English	Editorial Material							PROGENITOR CELLS; STEM; MAINTAIN		[Frede, Julia; Jones, Philip H.] Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Cambridge CB2 0XZ, England	University of Cambridge	Frede, J (corresponding author), Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England.	phj20@mrc-cu.cam.ac.uk	Jones, Philip/D-2464-2009	Jones, Philip/0000-0002-5904-795X; Frede, Julia/0000-0002-4380-9673	MRC [MC_UU_12022/3, MC_U105370181] Funding Source: UKRI; Medical Research Council [MC_U105370181, MC_UU_12022/3] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcolea MP, 2013, NAT REV CANCER, V13, P161, DOI 10.1038/nrc3460; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doupe DP, 2013, BIOESSAYS, V35, P443, DOI 10.1002/bies.201200166; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Solanas G, 2013, NAT REV MOL CELL BIO, V14, P737, DOI 10.1038/nrm3675; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777	14	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1183	1184		10.1126/science.1248274	http://dx.doi.org/10.1126/science.1248274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311674				2022-12-28	WOS:000327857900029
J	Loh, H; Cossel, KC; Grau, MC; Ni, KK; Meyer, ER; Bohn, JL; Ye, J; Cornell, EA				Loh, H.; Cossel, K. C.; Grau, M. C.; Ni, K. -K.; Meyer, E. R.; Bohn, J. L.; Ye, J.; Cornell, E. A.			Precision Spectroscopy of Polarized Molecules in an Ion Trap	SCIENCE			English	Article							LASER	Polar molecules are desirable systems for quantum simulations and cold chemistry. Molecular ions are easily trapped, but a bias electric field applied to polarize them tends to accelerate them out of the trap. We present a general solution to this issue by rotating the bias field slowly enough for the molecular polarization axis to follow but rapidly enough for the ions to stay trapped. We demonstrate Ramsey spectroscopy between Stark-Zeeman sublevels in (HfF+)-Hf-180-F-19 with a coherence time of 100 milliseconds. Frequency shifts arising from well-controlled topological (Berry) phases are used to determine magnetic g factors. The rotating-bias-field technique may enable using trapped polar molecules for precision measurement and quantum information science, including the search for an electron electric dipole moment.	[Loh, H.; Cossel, K. C.; Grau, M. C.; Ni, K. -K.; Bohn, J. L.; Ye, J.; Cornell, E. A.] NIST, JILA, Boulder, CO 80309 USA; [Loh, H.; Cossel, K. C.; Grau, M. C.; Ni, K. -K.; Bohn, J. L.; Ye, J.; Cornell, E. A.] Univ Colorado, Boulder, CO 80309 USA; [Loh, H.; Cossel, K. C.; Grau, M. C.; Ni, K. -K.; Bohn, J. L.; Ye, J.; Cornell, E. A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Meyer, E. R.] Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Kansas State University	Loh, H (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	loh@jilau1.colorado.edu; ye@jila.colorado.edu; cornell@jila.colorado.edu	Meyer, Edmund/HDO-7188-2022; Ye, Jun/C-3312-2011; Loh, Huanqian/K-6811-2015	Ye, Jun/0000-0003-0076-2112; Loh, Huanqian/0000-0002-7325-0815; Cossel, Kevin/0000-0001-5416-2310; GRAU, MATTHEW/0000-0002-2684-6923; Meyer, Edmund/0000-0002-8025-3002	NIST; Marsico Foundation; NSF [1125844]; Agency for Science, Technology and Research (Singapore); NIST/NRC	NIST(National Institute of Standards & Technology (NIST) - USA); Marsico Foundation; NSF(National Science Foundation (NSF)); Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); NIST/NRC(National Institute of Standards & Technology (NIST) - USA)	This work is supported by NIST, the Marsico Foundation, and NSF grant number 1125844. H. L. is partly funded by the Agency for Science, Technology and Research (Singapore). K.-K. N. acknowledges a NIST/NRC Postdoctoral Fellowship. We thank T. Fridey for his contributions and D. Gresh for discussions.	Baron J., 2013, ARXIV13107534; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bressel U, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.183003; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Commins E. D., 1999, ADV ATOM MOL OPT PHY, V40, P1; DeMille D, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.052507; Ding S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023028; Eckel S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052130; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Goeders JE, 2013, J PHYS CHEM A, V117, P9725, DOI 10.1021/jp312368a; Khriplovich I. B., 1997, CP VIOLATION STRANGE; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Leanhardt AE, 2011, J MOL SPECTROSC, V270, P1, DOI 10.1016/j.jms.2011.06.007; Meyer ER, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.062110; Meyer ER, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010502; Meyer ER, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062108; Muller H, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.076004; Nguyen JHV, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063023; Pendlebury JM, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.032102; Petrov AN, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.030501; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Rellergert WG, 2013, NATURE, V495, P490, DOI 10.1038/nature11937; Rupasinghe M, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033427; Schuster DI, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012311; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; Vutha AC, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/7/074007; Willitsch S, 2008, PHYS CHEM CHEM PHYS, V10, P7200, DOI 10.1039/b813408c	30	84	85	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1220	1222		10.1126/science.1243683	http://dx.doi.org/10.1126/science.1243683			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311686	Green Submitted			2022-12-28	WOS:000327857900044
J	Tobalem, M; Uckay, I				Tobalem, Mickael; Uckay, Ilker			Evolution of a Diabetic Foot Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An obese 50-year-old man with no known medical history presented with a necrotizing infection of his right foot that had begun 10 days previously with lesions that he attributed to wearing new shoes. He was found to have diabetes with peripheral neuropathy. An obese 50-year-old man with no known medical history presented with a necrotizing infection of his right foot that had begun 10 days previously with lesions that he attributed to wearing new shoes. He was found to have diabetes (glycated hemoglobin level, 10.5%) with peripheral neuropathy; he was afebrile, without leukocytosis or radiographic evidence of bone involvement in his right foot. The patient had photographed the lesion twice daily, thinking it would heal spontaneously (Panel A). The preoperative photographs show erythema (day 1), blisters (day 3), a necrotizing abscess (day 6), and wound infection requiring surgery (day 10). The patient ...	[Tobalem, Mickael; Uckay, Ilker] Univ Hosp Geneva, Geneva, Switzerland	University of Geneva	Tobalem, M (corresponding author), Univ Hosp Geneva, Geneva, Switzerland.	mickaeltobalem@gmail.com							0	18	18	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2252	2252		10.1056/NEJMicm1211053	http://dx.doi.org/10.1056/NEJMicm1211053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304054				2022-12-28	WOS:000327801100011
J	Gilani, A				Gilani, Artaza			Unintended Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UCL, London, England	University of London; University College London	Gilani, A (corresponding author), UCL, London, England.	artaza.gilani@ucl.ac.uk		Gilani, Artaza/0000-0002-5385-8524					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2251	2252		10.1001/jama.2013.282107	http://dx.doi.org/10.1001/jama.2013.282107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302084				2022-12-28	WOS:000327746300006
J	Kramer, CK; Zinman, B; Retnakaran, R				Kramer, Caroline K.; Zinman, Bernard; Retnakaran, Ravi			Are Metabolically Healthy Overweight and Obesity Benign Conditions? A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							BODY-MASS INDEX; NORMAL-WEIGHT; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PUBLICATION BIAS; RISK-FACTOR; ALL-CAUSE; MORTALITY; PHENOTYPES; INFLAMMATION	Background: Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI). Purpose: To determine the effect of metabolic status on all-cause mortality and cardiovascular events in normal-weight, overweight, and obese persons. Data Sources: Studies were identified from electronic databases. Study Selection: Included studies evaluated all-cause mortality or cardiovascular events (or both) and clinical characteristics of 6 patient groups defined by BMI category (normal weight/overweight/obesity) and metabolic status (healthy/unhealthy), as defined by the presence or absence of components of the metabolic syndrome by Adult Treatment Panel III or International Diabetes Federation criteria. Data Extraction: Two independent reviewers extracted the data. Metabolically healthy people of normal weight made up the reference group. Data Synthesis: Eight studies (n = 61 386; 3988 events) evaluated participants for all-cause mortality and/or cardiovascular events. Metabolically healthy obese individuals (relative risk [RR], 1.24; 95% CI, 1.02 to 1.55) had increased risk for events compared with metabolically healthy normal-weight individuals when only studies with 10 or more years of follow-up were considered. All metabolically unhealthy groups had a similarly elevated risk: normal weight (RR, 3.14; CI, 2.36 to 3.93), overweight (RR, 2.70; CI, 2.08 to 3.30), and obese (RR, 2.65; CI, 2.18 to 3.12). Limitation: Duration of exposure to the metabolic-BMI phenotypes was not described in the studies and could partially affect the estimates. Conclusion: Compared with metabolically healthy normal-weight individuals, obese persons are at increased risk for adverse long-term outcomes even in the absence of metabolic abnormalities, suggesting that there is no healthy pattern of increased weight.	[Retnakaran, Ravi] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON M5T 3L9, Canada; Univ Toronto, Toronto, ON, Canada; Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3L9, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Retnakaran, R (corresponding author), Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St,Suite L5-025,Mailbox 21, Toronto, ON M5T 3L9, Canada.	rretnakaran@mtsinai.on.ca	Kramer, Caroline K/L-9093-2018; Retnakaran, Ravi/P-2002-2015; Zinman, Bernard/E-7266-2013	Retnakaran, Ravi/0000-0003-1989-027X; 	Leadership Sinai Centre for Diabetes	Leadership Sinai Centre for Diabetes	Intramural funds from the Leadership Sinai Centre for Diabetes.	Abhyankar S, 2012, CRIT CARE, V16, DOI 10.1186/cc11903; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gilbert J, 2004, DIABETES CARE, V27, P990, DOI 10.2337/diacare.27.4.990; Gross JL, 2011, ANN INTERN MED, V154, P672, DOI 10.7326/0003-4819-154-10-201105170-00007; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hosseinpanah F, 2011, AM J CARDIOL, V107, P412, DOI 10.1016/j.amjcard.2010.09.034; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Khan UI, 2011, ATHEROSCLEROSIS, V217, P179, DOI 10.1016/j.atherosclerosis.2011.01.007; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Kramer CK, 2011, OBES REV, V12, pe338, DOI 10.1111/j.1467-789X.2010.00846.x; Kramer CK, 2013, LANCET DIABETES ENDO, V1, P28, DOI 10.1016/S2213-8587(13)70006-8; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Kvamme JM, 2012, J EPIDEMIOL COMMUN H, V66, P611, DOI 10.1136/jech.2010.123232; Lee SK, 2013, J HYPERTENS, V31, P145, DOI 10.1097/HJH.0b013e32835a3637; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Lind L, 2011, ARTERIOSCL THROM VAS, V31, pE27, DOI 10.1161/ATVBAHA.110.221572; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Park J, 2011, J HYPERTENS, V29, P1765, DOI 10.1097/HJH.0b013e32834a50f3; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Song YQ, 2007, AM J CARDIOL, V100, P1654, DOI 10.1016/j.amjcard.2007.06.073; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Tarantino G, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-6; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2011, OBESITY, V19, P1482, DOI 10.1038/oby.2010.332; World Health Organization, 2013, OB OV FACT SHEET; YOUNG TK, 1995, JAMA-J AM MED ASSOC, V274, P1939, DOI 10.1001/jama.274.24.1939	58	633	662	5	94	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					758	+		10.7326/0003-4819-159-11-201312030-00008	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00008			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297192				2022-12-28	WOS:000328731000005
J	Ruff, CT; Giugliano, RP; Braunwald, E; Hoffman, EB; Deenadayalu, N; Ezekowitz, MD; Camm, AJ; Weitz, JI; Lewis, BS; Parkhomenko, A; Yamashita, T; Antman, EM				Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Hoffman, Elaine B.; Deenadayalu, Naveen; Ezekowitz, Michael D.; Camm, A. John; Weitz, Jeffrey I.; Lewis, Basil S.; Parkhomenko, Alexander; Yamashita, Takeshi; Antman, Elliott M.			Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials	LANCET			English	Article							NORMALIZED RATIO CONTROL; STROKE PREVENTION; RISK-FACTORS; SUBGROUP ANALYSIS; DABIGATRAN; THERAPY; APIXABAN; RIVAROXABAN; THROMBOEMBOLISM; VALIDATION	Background Four new oral anticoagulants compare favourably with warfarin for stroke prevention in patients with atrial fibrillation; however, the balance between efficacy and safety in subgroups needs better definition. We aimed to assess the relative benefit of new oral anticoagulants in key subgroups, and the effects on important secondary outcomes. Methods We searched Medline from Jan 1, 2009, to Nov 19, 2013, limiting searches to phase 3, randomised trials of patients with atrial fibrillation who were randomised to receive new oral anticoagulants or warfarin, and trials in which both efficacy and safety outcomes were reported. We did a prespecified meta-analysis of all 71 683 participants included in the RE-LY, ROCKET AF, ARISTOTLE, and ENGAGE AF-TIMI 48 trials. The main outcomes were stroke and systemic embolic events, ischaemic stroke, haemorrhagic stroke, all-cause mortality, myocardial infarction, major bleeding, intracranial haemorrhage, and gastrointestinal bleeding. We calculated relative risks (RRs) and 95% CIs for each outcome. We did subgroup analyses to assess whether differences in patient and trial characteristics affected outcomes. We used a random-effects model to compare pooled outcomes and tested for heterogeneity. Findings 42 411 participants received a new oral anticoagulant and 29 272 participants received warfarin. New oral anticoagulants significantly reduced stroke or systemic embolic events by 19% compared with warfarin (RR 0.81, 95% CI 0.73-0.91; p<0.0001), mainly driven by a reduction in haemorrhagic stroke (0.49, 0.38-0.64; p<0.0001). New oral anticoagulants also significantly reduced all-cause mortality (0.90, 0.85-0.95; p=0.0003) and intracranial haemorrhage (0.48, 0.39-0.59; p<0.0001), but increased gastrointestinal bleeding (1.25, 1.01-1.55; p= 0.04). We noted no heterogeneity for stroke or systemic embolic events in important subgroups, but there was a greater relative reduction in major bleeding with new oral anticoagulants when the centre-based time in therapeutic range was less than 66% than when it was 66% or more (0.69, 0.59-0.81 vs 0.93, 0.76-1.13; p for interaction 0.022). Low-dose new oral anticoagulant regimens showed similar overall reductions in stroke or systemic embolic events to warfarin (1.03, 0.84-1.27; p= 0.74), and a more favourable bleeding profile (0.65, 0.43-1.00; p= 0.05), but significantly more ischaemic strokes (1.28, 1.02-1.60; p= 0.045). Interpretation This meta-analysis is the first to include data for all four new oral anticoagulants studied in the pivotal phase 3 clinical trials for stroke prevention or systemic embolic events in patients with atrial fibrillation. New oral anticoagulants had a favourable risk-benefit profile, with significant reductions in stroke, intracranial haemorrhage, and mortality, and with similar major bleeding as for warfarin, but increased gastrointestinal bleeding. The relative efficacy and safety of new oral anticoagulants was consistent across a wide range of patients. Our findings off er clinicians a more comprehensive picture of the new oral anticoagulants as a therapeutic option to reduce the risk of stroke in this patient population.	[Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Hoffman, Elaine B.; Deenadayalu, Naveen; Antman, Elliott M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene; Hoffman, Elaine B.; Deenadayalu, Naveen; Antman, Elliott M.] Harvard Univ, Sch Med, Boston, MA USA; [Ezekowitz, Michael D.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Ezekowitz, Michael D.] Cardiovasc Res Fdn, New York, NY USA; [Camm, A. John] St Georges Univ, London, England; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Parkhomenko, Alexander] ND Strazhesko Cardiol Res Inst, Kiev, Ukraine; [Yamashita, Takeshi] Cardiovasc Inst, Tokyo, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jefferson University; Cardiovascular Research Foundation (CRF); St Georges University London; McMaster University; McMaster University; Clalit Health Services; Carmel Medical Center; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine	Ruff, CT (corresponding author), Thrombolysis Myocardial Infarct TIMI Study Grp, 350 Longwood Ave,1st Floor Off, Boston, MA 02115 USA.	cruff@partners.org	Ezekowitz, Michael/AAJ-2543-2021; Lavu, Madhav/A-9409-2013; Weitz, Jeffrey/AAD-1929-2019; Giugliano, Robert/N-7233-2017	Weitz, Jeffrey/0000-0002-1092-7550; Giugliano, Robert/0000-0003-4110-7675	Daiichi Sankyo; Johnson Johnson; Merck; Duke University; AstraZeneca; Merck Co; Sanofi - Aventis; GlaxoSmith Kline; Bristol-Myers Squibb; Beckman Coulter; Roche Diagnostics; Pfizer; Genyzme; Amorcyte; Medicines Co; CardioRentis; CVRx; Eli Lilly; Menarini International; Medscape; Bayer; Boehringer Ingelheim	Daiichi Sankyo(Daiichi Sankyo Company Limited); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck(Merck & Company); Duke University; AstraZeneca(AstraZeneca); Merck Co(Merck & Company); Sanofi - Aventis(Sanofi-Aventis); GlaxoSmith Kline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Beckman Coulter; Roche Diagnostics; Pfizer(Pfizer); Genyzme; Amorcyte; Medicines Co; CardioRentis; CVRx; Eli Lilly(Eli Lilly); Menarini International(Menarini Group); Medscape; Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim)	CTR has served as a consultant and has received honoraria from Daiichi Sankyo, Boehringer Ingelheim, and Bristol-Myers Squibb. RPG has served as a consultant and has received honoraria from Bristol-Myers Squibb, Janssen, Daiichi Sankyo, Merck, Sanofi, and is a member of the TIMI Study Group, which has received research grant support from Daiichi Sankyo, Johnson & Johnson, and Merck. EB has recieved grants and personal fees for lectures from Daiichi Sankyo; grants from Duke University, AstraZeneca, Johnson & Johnson, Merck & Co, Sanofi - Aventis, GlaxoSmith Kline, Bristol-Myers Squibb, Beckman Coulter, Roche Diagnostics, and Pfizer; uncompensated personal fees for consultancy from Merck & Co; personal fees for consultancies from Genyzme, Amorcyte, Medicines Co, CardioRentis, and Sanofi - Aventis; uncompensated personal fees for lectures from Merck and CVRx; and personal fees for lectures from Eli Lilly, Menarini International, Medscape, and Bayer outside the submitted work. MDE has served as a consultant and has received honoraria from Boehringer Ingelheim, Bayer, Johnson & Johnson, Janssen, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Sanofi, Portola, Medtronics, Aegerion, Merck, Gilead, and Pozen. AJC has served as a consultant and has received honoraria from Boehringer Ingelheim, Bayer, Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo. JIW has served as a consultant and has received honoraria from Boehringer Ingelheim, Bayer, Janssen, Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo. BSL has served as a consultant to Bayer, Bristol-Myers Squibb, and Pfizer and received research grants in these trials from Boehringer Ingelheim, Bayer, Bristol-Myers Squibb, Pfizer, and Daiichi Sankyo. AP has received a research grant from Daiichi Sankyo, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb. TY has received honoraria from Boehringer Ingelheim, Bayer, Bristol-Myers Squibb, Pfi zer, and Daiichi Sankyo. EMA has received a research grant from Daiichi Sankyo. All other authors declare that they have no conflicts of interest.	Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Cabral KP, 2011, J THROMB HAEMOST, V9, P441, DOI 10.1111/j.1538-7836.2010.04179.x; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cleophas TJ, 2007, CIRCULATION, V115, P2870, DOI 10.1161/CIRCULATIONAHA.105.594960; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Ezekowitz MD, 2010, CIRCULATION, V122, P2246, DOI 10.1161/CIRCULATIONAHA.110.973735; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Garcia DA, 2010, THROMB HAEMOSTASIS, V104, P1099, DOI 10.1160/TH10-07-0491; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Mahaffey KW, 2013, ANN INTERN MED, V158, P861, DOI 10.7326/0003-4819-158-12-201306180-00003; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4	40	2992	3104	9	298	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					955	962		10.1016/S0140-6736(13)62343-0	http://dx.doi.org/10.1016/S0140-6736(13)62343-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24315724				2022-12-28	WOS:000333520700026
J	Shi, C; Murphy, CT				Shi, Cheng; Murphy, Coleen T.			Mating Induces Shrinking and Death in Caenorhabditis Mothers	SCIENCE			English	Article							ELEGANS LIFE-SPAN; C-ELEGANS; SPERM; DAF-16; GENES; FERTILIZATION; METABOLISM; GENETICS; SIGNALS; LONG	Interactions between the germ line and the soma help optimize reproductive success. We discovered a phenomenon linking reproductive status to longevity: In both hermaphroditic and gonochoristic Caenorhabditis, mating leads to female shrinking and death, compressing postreproductive life span. Male sperm induces germline- and DAF-9/DAF-12-dependent shrinking, osmotic stress susceptibility, and subsequent life-span decrease, whereas seminal fluid induces DAF-16-dependent life-span decrease and fat loss. Our study provides insight into the communication between males and the female germ line and soma to regulate reproduction and longevity, revealing a high-reproduction, low-life-span state induced by mating. Postmating somatic collapse may be an example of the sexually antagonistic influence that males in many species exert on female behavior to maximize their own reproductive success.	[Murphy, Coleen T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu	Shi, Cheng/M-4951-2015	Shi, Cheng/0000-0003-0365-8273	NIH [DP2OD004402]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Caenorhabditis Genetics Center for strains, J. Ashraf for assistance, M. Barr for useful discussion, and Z. Gitai and members of the Murphy laboratory for critically reading the manuscript. This work was supported by an NIH Innovator award (DP2OD004402) to C.T.M.	ARGON Y, 1980, GENETICS, V96, P413; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Fisher AL, 2006, AGING CELL, V5, P127, DOI 10.1111/j.1474-9726.2006.00203.x; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimble Judith, 2005, WormBook, P1; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Luo SJ, 2011, GENESIS, V49, P53, DOI 10.1002/dvg.20694; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Morsci NS, 2011, GENETICS, V189, P1341, DOI 10.1534/genetics.111.133603; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Sun AY, 1997, GENETICS, V147, P1077; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wolfner M.F., 2007, P183; Wu DQ, 2012, EXP GERONTOL, V47, P759, DOI 10.1016/j.exger.2012.06.010; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810	29	81	84	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					536	540		10.1126/science.1242958	http://dx.doi.org/10.1126/science.1242958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24356112	Green Accepted			2022-12-28	WOS:000330343700046
J	Zhou, XM; Levin, EJ; Pan, YP; McCoy, JG; Sharma, R; Kloss, B; Bruni, R; Quick, M; Zhou, M				Zhou, Xiaoming; Levin, Elena J.; Pan, Yaping; McCoy, Jason G.; Sharma, Ruchika; Kloss, Brian; Bruni, Renato; Quick, Matthias; Zhou, Ming			Structural basis of the alternating-access mechanism in a bile acid transporter	NATURE			English	Article							CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; STRUCTURE REFINEMENT; EXPRESSION CLONING; SODIUM SYMPORTER; OUTWARD-OPEN; SUBSTRATE; PROTEINS; FAMILY; CHOLESTEROL	Bile acids are synthesized from cholesterol in hepatocytes and secreted through the biliary tract into the small intestine, where they aid in absorption of lipids and fat-soluble vitamins. Through a process known as enterohepatic recirculation, more than 90% of secreted bile acids are then retrieved from the intestine and returned to the liver for resecretion(1). In humans, there are two Na+-dependent bile acid transporters involved in enterohepatic recirculation, the Na+-taurocholate co-transporting polypeptide (NTCP; also known as SLC10A1) expressed in hepatocytes, and the apical sodium-dependent bile acid transporter (ASBT; also known as SLC10A2) expressed on enterocytes in the terminal ileum(2). In recent years, ASBT has attracted much interest as a potential drug target for treatment of hypercholesterolaemia, because inhibition of ASBT reduces reabsorption of bile acids, thus increasing bile acid synthesis and consequently cholesterol consumption(3,4). However, a lack of three-dimensional structures of bile acid transporters hampers our ability to understand the molecular mechanisms of substrate selectivity and transport, and to interpret the wealth of existing functional data(2,5-8). The crystal structure of an ASBT homologue from Neisseria meningitidis (ASBT(NM)) in detergent was reported recently(9), showing the protein in an inward-open conformation bound to two Na+ and a taurocholic acid. However, the structural changes that bring bile acid and Na+ across the membrane are difficult to infer from a single structure. To understand the structural changes associated with the coupled transport of Na+ and bile acids, here we solved two structures of an ASBT homologue from Yersinia frederiksenii (ASBT(Yf)) in a lipid environment, which reveal that a large rigid-body rotation of a substrate-binding domain gives the conserved 'crossover' region, where two discontinuous helices cross each other, alternating accessibility from either side of the cell membrane. This result has implications for the location and orientation of the bile acid during transport, as well as for the translocation pathway for Na+.	[Zhou, Xiaoming; Levin, Elena J.; Pan, Yaping; McCoy, Jason G.; Zhou, Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhou, Xiaoming; Sharma, Ruchika; Zhou, Ming] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kloss, Brian; Bruni, Renato] New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Quick, Matthias] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Zhou, Ming] Chinese Acad Sci, Kunming Inst Zool, Ion Channel Res & Drug Dev Ctr, Kunming 650223, Peoples R China	Baylor College of Medicine; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhou, M (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mq2102@columbia.edu; mzhou@bcm.edu		Bruni, Renato/0000-0002-2312-0254; Zhou, Xiaoming/0000-0001-8866-7245; Kloss, Brian/0000-0003-0130-8739	US National Institutes of Health [R01DK088057, R01GM098878, U54GM095315, U54GM087519]; American Heart Association [12EIA8850017]; Cancer Prevention and Research Institute of Texas [R12MZ]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, U54GM075026, U54GM095315, R01GM098878] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were collected at beamlines 8.2.2 at the Advanced Light Source, X-29 at the National Synchrotron Light Source, and 24ID-E and 17ID-B at the Advanced Photon Source. This work was supported by the US National Institutes of Health (R01DK088057, R01GM098878, U54GM095315 and U54GM087519), the American Heart Association (12EIA8850017), and the Cancer Prevention and Research Institute of Texas (R12MZ). M.Z. thanks R. MacKinnon for advice and guidance on scientific directions.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Braun A, 2008, ATHEROSCLEROSIS, V198, P77, DOI 10.1016/j.atherosclerosis.2007.10.012; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Kalayil S, 2013, P NATL ACAD SCI USA, V110, P17296, DOI 10.1073/pnas.1309071110; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kramer W, 2006, CURR MED CHEM, V13, P997, DOI 10.2174/092986706776361003; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tolle-Sander S, 2004, MOL PHARMACEUT, V1, P40, DOI 10.1021/mp034010t; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; West KL, 2002, J PHARMACOL EXP THER, V303, P293, DOI 10.1124/jpet.102.038711; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	40	101	105	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					569	573		10.1038/nature12811	http://dx.doi.org/10.1038/nature12811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24317697	Green Accepted			2022-12-28	WOS:000329995000044
J	Sarela, AI				Sarela, Abeezar I.			Stop sitting on the fence: recommendations are essential to informed decision making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Sarela, AI (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.							Beauchamp T, 2013, PRINCIPLES BIOMEDICA; General Medical Council, CONS GUID DOCT PAT M; Manson NC, 2007, RETHINKING INFORMED CONSENT IN BIOETHICS, P1; Shaw D, 2013, JAMA-J AM MED ASSOC, V309, P1689, DOI 10.1001/jama.2013.2179	4	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2013	347								f7600	10.1136/bmj.f7600	http://dx.doi.org/10.1136/bmj.f7600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277MS	24355389				2022-12-28	WOS:000328824300011
J	Brownlee, WJ; Playle, VM; Gaskin, JCF; Anderson, NE				Brownlee, Wallace J.; Playle, Veronica M.; Gaskin, Jennifer C. Fan; Anderson, Neil E.			Bilateral visual loss in a patient with endocarditis	LANCET			English	Editorial Material									[Brownlee, Wallace J.; Anderson, Neil E.] Auckland Dist Hlth Board, Dept Neurol, Auckland 1142, New Zealand; [Playle, Veronica M.] Auckland Dist Hlth Board, Dept Gen Med, Auckland 1142, New Zealand; [Gaskin, Jennifer C. Fan] Auckland Dist Hlth Board, Dept Ophthalmol, Auckland 1142, New Zealand	Auckland District Health Board; Auckland District Health Board; Auckland District Health Board	Brownlee, WJ (corresponding author), Auckland Dist Hlth Board, Dept Neurol, Private Bag 92024, Auckland 1142, New Zealand.	wj.brownlee@gmail.com						Chee SP, 2001, CURR OPIN OPHTHALMOL, V12, P464, DOI 10.1097/00055735-200112000-00012; Jackson TL, 2003, SURV OPHTHALMOL, V48, P403, DOI 10.1016/S0039-6257(03)00054-7	2	0	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					2038	2038		10.1016/S0140-6736(13)62156-X	http://dx.doi.org/10.1016/S0140-6736(13)62156-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24332079				2022-12-28	WOS:000328223700030
J	Gajendragadkar, PR; Moualed, DJ; Nicolson, PLR; Adjei, FD; Cakebread, HE; Duehmke, RM; Martin, CA				Gajendragadkar, Parag R.; Moualed, Daniel J.; Nicolson, Phillip L. R.; Adjei, Felicia D.; Cakebread, Holly E.; Duehmke, Rudolf M.; Martin, Claire A.			CHRISTMAS 2013: RESEARCH The survival time of chocolates on hospital wards: covert observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To quantify the consumption of chocolates in a hospital ward environment. Design Multicentre, prospective, covert observational study. Setting Four wards at three hospitals (where the authors worked) within the United Kingdom. Participants Boxes of Quality Street (Nestle) and Roses (Cadbury) on the ward and anyone eating these chocolates. Intervention Observers covertly placed two 350 g boxes of Quality Street and Roses chocolates on each ward (eight boxes were used in the study containing a total of 258 individual chocolates). These boxes were kept under continuous covert surveillance, with the time recorded when each chocolate was eaten. Main outcome measure Median survival time of a chocolate. Results 191 out of 258 (74%) chocolates were observed being eaten. The mean total observation period was 254 minutes (95% confidence interval 179 to 329). The median survival time of a chocolate was 51 minutes (39 to 63). The model of chocolate consumption was non-linear, with an initial rapid rate of consumption that slowed with time. An exponential decay model best fitted these findings (model R-2=0.844, P<0.001), with a survival half life (time taken for 50% of the chocolates to be eaten) of 99 minutes. The mean time taken to open a box of chocolates from first appearance on the ward was 12 minutes (95% confidence interval 0 to 24). Quality Street chocolates survived longer than Roses chocolates (hazard ratio for survival of Roses v Quality Street 0.70, 95% confidence interval 0.53 to 0.93, P=0.014). The highest percentages of chocolates were consumed by healthcare assistants (28%) and nurses (28%), followed by doctors (15%). Conclusions From our observational study, chocolate survival in a hospital ward was relatively short, and was modelled well by an exponential decay model. Roses chocolates were preferentially consumed to Quality Street chocolates in a ward setting. Chocolates were consumed primarily by healthcare assistants and nurses, followed by doctors. Further practical studies are needed.	[Gajendragadkar, Parag R.; Adjei, Felicia D.; Cakebread, Holly E.; Duehmke, Rudolf M.; Martin, Claire A.] Bedford Hosp, Dept Cardiol, Bedford MK42 9DJ, England; [Moualed, Daniel J.] Great Western Hosp, Dept Ear Nose & Throat Surg, Swindon, Wilts, England; [Nicolson, Phillip L. R.] Univ Hosp North Staffordshire, Dept Haematol, Stoke On Trent, Staffs, England		Gajendragadkar, PR (corresponding author), Bedford Hosp, Dept Cardiol, Bedford MK42 9DJ, England.	gajendragadkar@gmail.com	Gajendragadkar, Parag/AAM-2281-2021	Gajendragadkar, Parag/0000-0003-3312-0183; NIcolson, Phillip/0000-0002-4843-2975; Duehmke, Rudolf/0000-0003-2341-5578				Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299	3	14	14	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2013	347								f7198	10.1136/bmj.f7198	http://dx.doi.org/10.1136/bmj.f7198			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZX	24333986	Green Published, hybrid			2022-12-28	WOS:000328575900001
J	Cole, TB				Cole, Thomas B.			From an Upstairs Window, Winter L. L. FitzGerald	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2370	2371		10.1001/jama.2013.5457	http://dx.doi.org/10.1001/jama.2013.5457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327021				2022-12-28	WOS:000328030900001
J	Azad, MB; Coneys, JG; Kozyrskyj, AL; Field, CJ; Ramsey, CD; Becker, AB; Friesen, C; Abou-Setta, AM; Zarychanski, R				Azad, Meghan B.; Coneys, J. Gerard; Kozyrskyj, Anita L.; Field, Catherine J.; Ramsey, Clare D.; Becker, Allan B.; Friesen, Carol; Abou-Setta, Ahmed M.; Zarychanski, Ryan			Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LACTOBACILLUS-RHAMNOSUS HN001; PLACEBO-CONTROLLED TRIAL; CESAREAN-DELIVERED CHILDREN; RANDOMIZED CONTROLLED-TRIAL; UNTIL AGE 5; DOUBLE-BLIND; ATOPIC-DERMATITIS; ALLERGIC DISEASE; FOLLOW-UP; AIRWAY INFLAMMATION	Objective To evaluate the association of probiotic supplementation during pregnancy or infancy with childhood asthma and wheeze. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Medline, Embase, and Central (Cochrane Library) databases from inception to August 2013, plus the World Health Organization's international clinical trials registry platform and relevant conference proceedings for the preceding five years. Included trials and relevant reviews were forward searched in Web of Science. Review methods Two reviewers independently identified randomised controlled trials evaluating probiotics administered to mothers during pregnancy or to infants during the first year of life. The primary outcome was doctor diagnosed asthma; secondary outcomes included wheeze and lower respiratory tract infection. Results We identified 20 eligible trials including 4866 children. Trials were heterogeneous in the type and duration of probiotic supplementation, and duration of follow-up. Only five trials conducted follow-up beyond participants' age of 6 years (median 24 months), and none were powered to detect asthma as the primary outcome. The overall rate of doctor diagnosed asthma was 10.7%; overall rates of incident wheeze and lower respiratory tract infection were 33.3% and 13.9%, respectively. Among 3257 infants enrolled in nine trials contributing asthma data, the risk ratio of doctor diagnosed asthma in participants randomised to receive probiotics was 0.99 (95% confidence interval 0.81 to 1.21, I-2=0%). The risk ratio of incident wheeze was 0.97 (0.87 to 1.09, I-2=0%, 9 trials, 1949 infants). Among 1364 infants enrolled in six trials, the risk ratio of lower respiratory tract infection after probiotic supplementation was 1.26 (0.99 to 1.61, I-2=0%). We adjudicated most trials to be of high (ten trials) or unclear (nine trials) risk of bias, mainly due to attrition. Conclusions We found no evidence to support a protective association between perinatal use of probiotics and doctor diagnosed asthma or childhood wheeze. Randomised controlled trials to date have not yielded sufficient evidence to recommend probiotics for the primary prevention of these disorders. Extended follow-up of existing trials, along with further clinical and basic research, are needed to accurately define the role of probiotics in the prevention of childhood asthma.	[Azad, Meghan B.; Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 1C9, Canada; [Coneys, J. Gerard; Ramsey, Clare D.; Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Ramsey, Clare D.; Zarychanski, Ryan] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Field, Catherine J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Becker, Allan B.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [Becker, Allan B.] Univ Manitoba, Winnipeg, MB, Canada; [Friesen, Carol; Abou-Setta, Ahmed M.; Zarychanski, Ryan] Univ Manitoba, George & Fay Yee Ctr Healthcare Innovat, Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Friesen, Carol] Univ Manitoba Libraries, Neil John Maclean Hlth Sci Lib, Winnipeg, MB, Canada	University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Manitoba; University of Manitoba	Azad, MB (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB T6G 1C9, Canada.	meghan.azad@ualberta.ca	Zarychanski, Ryan/AAB-6369-2022; Azad, Meghan/H-7226-2019	Azad, Meghan/0000-0002-5942-4444; Field, Catherine/0000-0001-7285-4767; Friesen, Carol/0000-0001-6437-9126; Zarychanski, Ryan/0000-0001-9455-6138	Parker B Francis research opportunity award; Alberta Innovates Health Solutions incentive award; Canadian Institute of Health Research	Parker B Francis research opportunity award; Alberta Innovates Health Solutions incentive award; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	No specific funding was obtained for this study. MBA is a Canadian Institutes of Health Research Banting postdoctoral fellow, and recipient of a Parker B Francis research opportunity award and Alberta Innovates Health Solutions incentive award. RZ is a recipient of a randomised controlled trial mentorship award from the Canadian Institute of Health Research. ALK is the research chair in maternal-child health and the environment at the Women and Children's Health Research Institute. None of the funders influenced the conduct of this research.	Abrahamsson TR, 2011, CLIN EXP ALLERGY, V41, P1729, DOI 10.1111/j.1365-2222.2011.03827.x; Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Abrahamsson TR, 2013, PEDIAT ALLERG IMM-UK, V24, P556, DOI 10.1111/pai.12104; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Accordini S, 2013, INT ARCH ALLERGY IMM, V160, P93, DOI 10.1159/000338998; Allen SJ, 2010, J NUTR, V140, P483, DOI 10.3945/jn.109.117093; [Anonymous], 2012, REV MAN REVMAN VERS; Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Azad MB, 2013, PROSPERO INT PROSPEC; Azad MB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/932072; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Becker A, 2005, CAN MED ASSOC J, V173, pS3; *BIOST, 2005, COMPR MET VERS 2; Blumer N, 2007, CLIN EXP ALLERGY, V37, P348, DOI 10.1111/j.1365-2222.2007.02671.x; Boyle RJ, 2011, ALLERGY, V66, P509, DOI 10.1111/j.1398-9995.2010.02507.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Cabana MD, 2007, PAEDIATR PERINAT EP, V21, P23, DOI 10.1111/j.1365-3016.2007.00881.x; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Chouraqui JP, 2008, AM J CLIN NUTR, V87, P1365, DOI 10.1093/ajcn/87.5.1365; Dekker JW, 2009, INT DAIRY J, V19, P149, DOI 10.1016/j.idairyj.2008.10.004; Dotterud C, 2009, ALLERGY, V64, P64; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; Durackova Z., 2010, ISRCTN28722693; Fiocchi A, 2012, WORLD ALLERGY ORGAN, V5, P148, DOI 10.1097/WOX.0b013e3182784ee0; Garner Rochelle, 2008, Health Rep, V19, P45; Gore C, 2012, CLIN EXP ALLERGY, V42, P112, DOI 10.1111/j.1365-2222.2011.03885.x; Gruber C, 2007, ALLERGY, V62, P1270, DOI 10.1111/j.1398-9995.2007.01543.x; HARRISON BDW, 1993, J ROY COLL PHYS LOND, V27, P387; Hascoet JM, 2011, J PEDIATR GASTR NUTR, V52, P756, DOI 10.1097/MPG.0b013e3182105850; Hascoet JM, 2007, PEDIAT ACAD SOC; Herzog R, 2011, MT SINAI J MED, V78, P645, DOI 10.1002/msj.20285; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hol J, 2008, J ALLERGY CLIN IMMUN, V121, P1448, DOI 10.1016/j.jaci.2008.03.018; Ismail IH, 2013, J PAEDIATR CHILD H, V49, P709, DOI 10.1111/jpc.12175; Jensen MP, 2012, J ALLERGY CLIN IMMUN, V130, P1209, DOI 10.1016/j.jaci.2012.07.018; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Kopp MV, 2008, PEDIATRICS, V121, pE850, DOI 10.1542/peds.2007-1492; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Kuitunen M, 2009, ALLERGY, V64, P64; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Kukkonen AK, 2011, PEDIAT ALLERG IMM-UK, V22, P249, DOI 10.1111/j.1399-3038.2010.01079.x; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Kull I, 2010, J ALLERGY CLIN IMMUN, V125, P1013, DOI 10.1016/j.jaci.2010.01.051; Lee J, 2013, J MICROBIOL BIOTECHN, V23, P724, DOI 10.4014/jmb.1211.11079; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ly NP, 2006, PEDIATRICS, V117, pE1132, DOI 10.1542/peds.2005-2271; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maldonado J, 2012, J PEDIATR GASTR NUTR, V54, P55, DOI 10.1097/MPG.0b013e3182333f18; Mallol J, 2010, THORAX, V65, P1004, DOI 10.1136/thx.2009.115188; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Niers L, 2009, ALLERGY, V64, P1349, DOI 10.1111/j.1398-9995.2009.02021.x; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Ou CY, 2012, CLIN EXP ALLERGY, V42, P1386, DOI 10.1111/j.1365-2222.2012.04037.x; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Puccio G, 2006, EUR J PEDIATR S1, V165, P115; Puccio G, 2007, NUTRITION, V23, P1, DOI 10.1016/j.nut.2006.09.007; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Shreiner A, 2008, ADV EXP MED BIOL, V635, P113, DOI 10.1007/978-0-387-09550-9_10; Stein Renato T, 2009, Paediatr Respir Rev, V10 Suppl 1, P29, DOI 10.1016/S1526-0542(09)70013-2; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; van der Aa L, 2010, ALLERGY, V65, P313; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; van der Aa LB, 2010, CLIN EXP ALLERGY, V40, P795, DOI 10.1111/j.1365-2222.2010.03465.x; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; West CE, 2013, ALLERGY, V68, P1015, DOI 10.1111/all.12191; West CE, 2008, PEDIAT ALLERG IMM-UK, V19, P53, DOI 10.1111/j.1399-3038.2007.00583.x; West CE, 2009, PEDIATR ALLERGY IMMU, V20, P430, DOI 10.1111/j.1399-3038.2009.00745.x; Wickens K, 2010, ALLERGY, V65, P751; Wickens K, 2013, CLIN EXP ALLERGY, V43, P1048, DOI 10.1111/cea.12154; Wickens K, 2012, CLIN EXP ALLERGY, V42, P1071, DOI 10.1111/j.1365-2222.2012.03975.x; Wickens K, 2011, J ALLERGY CLIN IMMUN, V127, pAB38, DOI 10.1016/j.jaci.2010.12.160; Wickens K, 2010, INTERN MED J S4, V40, P19; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011; Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	85	144	199	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2013	347								f6471	10.1136/bmj.f6471	http://dx.doi.org/10.1136/bmj.f6471			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DN	24304677	Green Published, hybrid			2022-12-28	WOS:000328148900001
J	Kirch, DG; Mitchell, K; Ast, C				Kirch, Darrell G.; Mitchell, Karen; Ast, Cori			The New 2015 MCAT Testing Competencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kirch, Darrell G.; Mitchell, Karen; Ast, Cori] Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Ast, C (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	cast@aamc.org						AAMC-HHMI Committee, 2009, SCIENTIFIC FOUNDATIO; Association of American Medical Colleges, 2011, BEHAVIORAL AND SOCIA; Association of American Medical Colleges, PREVIEW GUIDE FOR TH; Kaplan RM, 2012, NEW ENGL J MED, V366, P1265, DOI 10.1056/NEJMp1113274; McGaghie WC, 2002, JAMA-J AM MED ASSOC, V288, P1085, DOI 10.1001/jama.288.9.1085; Schwartzstein RM, 2013, ACAD MED, V88, P560, DOI 10.1097/ACM.0b013e31828c4ae0	6	19	19	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2243	2244		10.1001/jama.2013.282093	http://dx.doi.org/10.1001/jama.2013.282093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302080				2022-12-28	WOS:000327746300002
J	Patel, G; Fancher, TL				Patel, Gayatri; Fancher, Tonya L.			Generalized Anxiety Disorder	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DOUBLE-BLIND; PRIMARY-CARE; EARLY INTERVENTION; UNITED-STATES; PLACEBO; COMORBIDITY; DULOXETINE; METAANALYSIS; PREVENTION; ESCITALOPRAM											American Psychiatric Association, SEV MEAS GEN ANX DIS; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ayers CR, 2007, PSYCHOL AGING, V22, P8, DOI 10.1037/0882-7974.22.1.8; Baldwin DS, 2006, BRIT J PSYCHIAT, V189, P264, DOI 10.1192/bjp.bp.105.012799; Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Ball SG, 2005, J CLIN PSYCHIAT, V66, P94, DOI 10.4088/JCP.v66n0113; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53; Bartley CA, 2013, PROG NEURO-PSYCHOPH, V45, P34, DOI 10.1016/j.pnpbp.2013.04.016; Bose A, 2008, DEPRESS ANXIETY, V25, P854, DOI 10.1002/da.20355; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; Brawman-Mintzer O, 2006, J CLIN PSYCHIAT, V67, P874, DOI 10.4088/JCP.v67n0603; BRAWMANMINTZER O, 1993, AM J PSYCHIAT, V150, P1216; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Canadian Psychiatric Association, 2006, CAN J PSYCHIAT, V51, p9S; Chessick CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006115; Dadds MR, 1999, J CONSULT CLIN PSYCH, V67, P145, DOI 10.1037/0022-006X.67.1.145; Davidson JRT, 2008, EUR NEUROPSYCHOPHARM, V18, P673, DOI 10.1016/j.euroneuro.2008.05.002; Deacon BJ, 2004, J CLIN PSYCHOL, V60, P429, DOI 10.1002/jclp.10255; Freedman R, 2006, AM J PSYCHIAT, V163, P3; Fricchione G, 2004, NEW ENGL J MED, V351, P675, DOI 10.1056/NEJMcp022342; Gale C, 2007, BMJ-BRIT MED J, V334, P579, DOI 10.1136/bmj.39133.559282.BE; Hartford J, 2007, INT CLIN PSYCHOPHARM, V22, P167, DOI 10.1097/YIC.0b013e32807fb1b2; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Ipser JC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005473.pub2; Kasen S, 2008, INT J OBESITY, V32, P558, DOI 10.1038/sj.ijo.0803736; Katon W, 2007, ANN INTERN MED, V146, P390, DOI 10.7326/0003-4819-146-5-200703060-00011; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khan A, 2002, J AFFECT DISORDERS, V68, P183, DOI 10.1016/S0165-0327(01)00354-8; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P811; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Leichsenring F, 2009, AM J PSYCHIAT, V166, P875, DOI 10.1176/appi.ajp.2009.09030441; Lenze EJ, 2009, JAMA-J AM MED ASSOC, V301, P295, DOI 10.1001/jama.2008.977; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Marciniak MD, 2005, DEPRESS ANXIETY, V21, P178, DOI 10.1002/da.20074; Means-Christensen AJ, 2006, GEN HOSP PSYCHIAT, V28, P108, DOI 10.1016/j.genhosppsych.2005.08.010; Montgomery S, 2008, BRIT J PSYCHIAT, V193, P389, DOI 10.1192/bjp.bp.107.037788; National Collaborating Centre for Mental Health, 2011, NICE CLIN GUID 113 G; Nicolini H, 2009, PSYCHOL MED, V39, P267, DOI 10.1017/S0033291708003401; Norton PJ, 2007, J NERV MENT DIS, V195, P521, DOI 10.1097/01.nmd.0000253843.70149.9a; Pfizer, PAT HLTH QUEST SCREE; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Rapee RM, 2005, J CONSULT CLIN PSYCH, V73, P488, DOI 10.1037/0022-006X.73.3.488; Revicki DA, 2012, J AFFECT DISORDERS, V140, P103, DOI 10.1016/j.jad.2011.11.014; Rollman BL, 2005, J GEN INTERN MED, V20, P623, DOI 10.1007/s11606-005-0108-2; Rynn M, 2008, DEPRESS ANXIETY, V25, P182, DOI 10.1002/da.20271; Schuurmans J, 2006, AM J GERIAT PSYCHIAT, V14, P255, DOI 10.1097/01.JGP.0000196629.19634.00; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stanley MA, 2009, JAMA-J AM MED ASSOC, V301, P1460, DOI 10.1001/jama.2009.458; Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.01.013; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355	54	4	4	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					ITC1	ITC612		10.7326/0003-4819-159-11-201312030-01006	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-01006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NU	24297210				2022-12-28	WOS:000209756500001
J	Schachner, ER; Cieri, RL; Butler, JP; Farmer, CG				Schachner, Emma R.; Cieri, Robert L.; Butler, James P.; Farmer, C. G.			Unidirectional pulmonary airflow patterns in the savannah monitor lizard	NATURE			English	Article							BODY-SIZE; LUNG; EVOLUTION; VENTILATION; MECHANICS; ANATOMY; ORIGIN	The unidirectional airflow patterns in the lungs of birds have long been considered a unique and specialized trait associated with the oxygen demands of flying, their endothermic metabolism(1) and unusual pulmonary architecture(2,3). However, the discovery of similar flow patterns in the lungs of crocodilians indicates that this character is probably ancestral for all archosaurs-the group that includes extant birds and crocodilians as well as their extinct relatives, such as pterosaurs and dinosaurs(4-6). Unidirectional flow in birds results from aerodynamic valves, rather than from sphincters or other physical mechanisms(7,8), and similar aerodynamic valves seem to be present in crocodilians(4-6). The anatomical and developmental similarities in the primary and secondary bronchi of birds and crocodilians suggest that these structures and airflow patterns may be homologous(4-6,9). The origin of this pattern is at least as old as the split between crocodilians and birds, which occurred in the Triassic period(10). Alternatively, this pattern of flow may be even older; this hypothesis can be tested by investigating patterns of airflow in members of the outgroup to birds and crocodilians, the Lepidosauromorpha (tuatara, lizards and snakes). Here we demonstrate region-specific unidirectional airflow in the lungs of the savannah monitor lizard (Varanus exanthematicus). The presence of unidirectional flow in the lungs of V. exanthematicus thus gives rise to two possible evolutionary scenarios: either unidirectional airflow evolved independently in archosaurs and monitor lizards, or these flow patterns are homologous in archosaurs and V. exanthematicus, having evolved only once in ancestral diapsids (the clade encompassing snakes, lizards, crocodilians and birds). If unidirectional airflow is plesiomorphic for Diapsida, this respiratory character can be reconstructed for extinct diapsids, and evolved in a small ectothermic tetrapod during the Palaeozoic era at least a hundred million years before the origin of birds.	[Schachner, Emma R.; Cieri, Robert L.; Farmer, C. G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Butler, James P.] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA 02215 USA; [Butler, James P.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Schachner, ER (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	eschachner@gmail.com; cg.frmr@gmail.com	Cieri, Robert L/O-4645-2018	Cieri, Robert L/0000-0001-6905-9148; Schachner, Emma/0000-0002-8636-925X	American Association of Anatomists Postdoctoral Fellowship; American Philosophical Society Franklin Research Grant; National Science Foundation [IOS-1055080, IOS-0818973]; Division Of Integrative Organismal Systems [0818973, 1055080] Funding Source: National Science Foundation	American Association of Anatomists Postdoctoral Fellowship; American Philosophical Society Franklin Research Grant; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Dix (Reptile Rescue Service) for the donation of deceased varanid specimens, J. Bourke for assistance with Avizo, and D. Shafer for German translations. This work was supported by an American Association of Anatomists Postdoctoral Fellowship and an American Philosophical Society Franklin Research Grant to E. R. S., National Science Foundation grants to C. G. F. (IOS-1055080 and IOS-0818973) and a generous donation to the Farmer laboratory by S. Meyer.	BECKER H-O, 1989, Bonner Zoologische Beitraege, V40, P27; BRACKENBURY JH, 1972, J EXP BIOL, V57, P543; Burnell A, 2012, B SOC GEOL FR, V183, P159, DOI 10.2113/gssgfbull.183.2.159; BUTLER JP, 1988, RESP PHYSIOL, V72, P241, DOI 10.1016/0034-5687(88)90010-2; Collar DC, 2011, EVOLUTION, V65, P2664, DOI 10.1111/j.1558-5646.2011.01335.x; Conrad JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041767; Farmer CG, 2010, PHYSIOL BIOCHEM ZOOL, V83, P561, DOI 10.1086/605335; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; HAZELHOFF EH, 1951, POULTRY SCI, V30, P3, DOI 10.3382/ps.0300003; Holmes RB, 2010, PALAEONTOLOGY, V53, P1099, DOI 10.1111/j.1475-4983.2010.00994.x; Maina JN, 2007, RESP PHYSIOL NEUROBI, V155, P1, DOI 10.1016/j.resp.2006.05.005; MAINA JN, 1989, ANAT RECORD, V224, P514, DOI 10.1002/ar.1092240409; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Milani A., 1897, ZOOL JB ABT ANAT ONT, V10, P93; MILSOM WK, 1984, J EXP BIOL, V113, P187; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Owerkowicz T, 1999, SCIENCE, V284, P1661, DOI 10.1126/science.284.5420.1661; PERRY SF, 1978, RESP PHYSIOL, V34, P61, DOI 10.1016/0034-5687(78)90049-X; Perry Steven F., 1998, V19, P1; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Sanders RK, 2012, ANAT REC, V295, P699, DOI 10.1002/ar.22427; Schachner ER, 2013, PEERJ, V1, DOI 10.7717/peerj.60; Thompson GG, 1997, PHYSIOL ZOOL, V70, P307, DOI 10.1086/639605; WALLACH V, 1998, BIOL REPTILIA, V19, P93; [No title captured]; [No title captured]	26	52	54	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					367	+		10.1038/nature12871	http://dx.doi.org/10.1038/nature12871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24336209	Green Submitted			2022-12-28	WOS:000331477800041
J	Di Stefano, B; Sardina, JL; van Oevelen, C; Collombet, S; Kallin, EM; Vicent, GP; Lu, J; Thieffry, D; Beato, M; Graf, T				Di Stefano, Bruno; Sardina, Jose Luis; van Oevelen, Chris; Collombet, Samuel; Kallin, Eric M.; Vicent, Guillermo P.; Lu, Jun; Thieffry, Denis; Beato, Miguel; Graf, Thomas			C/EBP alpha poises B cells for rapid reprogramming into induced pluripotent stem cells	NATURE			English	Article							NETWORK; TRANSDIFFERENTIATION; MACROPHAGES; TET2; REQUIREMENT; REVEALS	CCAAT/enhancer binding protein-alpha (C/EBP alpha) induces transdifferentiation of B cells into macrophages at high efficiencies and enhances reprogramming into induced pluripotent stem (iPS) cells when co-expressed with the transcription factors Oct4 (Pou5f1), Sox2, Klf4 and Myc (hereafter called OSKM)(1,2). However, how C/EBP alpha accomplishes these effects is unclear. Here we find that in mouse primary B cells transient C/EBP alpha expression followed by OSKM activation induces a 100-fold increase in iPS cell reprogramming efficiency, involving 95% of the population. During this conversion, pluripotency and epithelial-mesenchymal transition genes become markedly upregulated, and 60% of the cells express Oct4 within 2 days. C/EBP alpha acts as a 'path-breaker' as it transiently makes the chromatin of pluripotency genes more accessible to DNase I. C/EBP alpha also induces the expression of the dioxygenase Tet2 and promotes its translocation to the nucleus where it binds to regulatory regions of pluripotency genes that become demethylated after OSKM induction. In line with these findings, overexpression of Tet2 enhances OSKM-induced B-cell reprogramming. Because the enzyme is also required for efficient C/EBP alpha-induced immune cell conversion(3), our data indicate that Tet2 provides a mechanistic link between iPS cell reprogramming and B-cell transdifferentiation. The rapid iPS reprogramming approach described here should help to fully elucidate the process and has potential clinical applications.	[Di Stefano, Bruno; Sardina, Jose Luis; van Oevelen, Chris; Kallin, Eric M.; Vicent, Guillermo P.; Beato, Miguel; Graf, Thomas] CRG, Gene Regulat Stem Cells & Canc Programme, Barcelona 08003, Spain; [Di Stefano, Bruno; Sardina, Jose Luis; van Oevelen, Chris; Kallin, Eric M.; Vicent, Guillermo P.; Beato, Miguel; Graf, Thomas] UPF, Barcelona 08003, Spain; [Collombet, Samuel; Thieffry, Denis] ENS, Inst Biol, F-75005 Paris, France; [Collombet, Samuel; Thieffry, Denis] INSERM, U1024, F-75005 Paris, France; [Collombet, Samuel; Thieffry, Denis] CNRS, UMR 8197, F-75005 Paris, France; [Lu, Jun] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Graf, Thomas] Pg Lluis Co 23, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Yale University; ICREA	Graf, T (corresponding author), UPF, Dr Aiguader 88, Barcelona 08003, Spain.	Thomas.Graf@crg.eu	Di Stefano, Bruno/H-7232-2015; Beato, Miguel/B-5564-2015; Graf, Thomas/B-4252-2015; Sardina, José Luis/H-7047-2015; Thieffry, Denis/Y-3930-2019; collombet, Samuel/AAS-8227-2021; Vicent, Guillermo P./K-5432-2015; Di Stefano, Bruno/K-5020-2017	Di Stefano, Bruno/0000-0003-2532-3087; Beato, Miguel/0000-0002-2878-2222; Graf, Thomas/0000-0003-2774-4117; Sardina, José Luis/0000-0002-8493-3937; Vicent, Guillermo P./0000-0002-0554-2226; Di Stefano, Bruno/0000-0003-2532-3087; Thieffry, Denis/0000-0003-0271-1757	Ministerio de Educacion y Ciencia [SAF.2007-63058, AGAUR 2009 SGR768]; La Caixa International PhD Fellowship; ICREA Funding Source: Custom	Ministerio de Educacion y Ciencia(Spanish Government); La Caixa International PhD Fellowship(La Caixa Foundation); ICREA(ICREA)	We thank L. Batlle for generating the chimaeric mice, M. Stadtfeld, D. Egli, P. Cosma, G. Filion, B. Lehner and J. Valcarcel for critical reading of the manuscript, V. Broccoli, P. Munoz and S. Aznar Benitah for constructs and antibodies and H. Schoeler for the Oct4 reporter mice. This work was supported by the Ministerio de Educacion y Ciencia, SAF.2007-63058 and AGAUR 2009 SGR768. B. D. S. holds a La Caixa International PhD Fellowship.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Cheng JJ, 2013, CELL REP, V5, P471, DOI 10.1016/j.celrep.2013.08.050; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Di Stefano B, 2011, STEM CELLS, V29, P1684, DOI 10.1002/stem.726; Di Tullio A, 2012, CELL CYCLE, V11, P2739, DOI 10.4161/cc.21119; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	30	138	144	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2014	506	7487					235	+		10.1038/nature12885	http://dx.doi.org/10.1038/nature12885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA5AK	24336202	Green Published			2022-12-28	WOS:000331107700041
J	Dafny, L				Dafny, Leemore			Hospital Industry Consolidation - Still More to Come?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The Affordable Care Act has unleashed a hospital-merger frenzy that could lead to substantial health care price increases with little or no countervailing benefit. Unless new initiatives are developed to discourage consolidation, most mergers will proceed unchallenged. The Affordable Care Act (ACA) has unleashed a merger frenzy, with hospitals scrambling to shore up their market positions, improve operational efficiency, and create organizations capable of managing population health. The figures are impressive: 105 deals were reported in 2012 alone, up from 50 to 60 annually in the pre-ACA, pre-recession years of 2005-2007.(1) This activity could have lasting repercussions for consumers; the last hospital-merger wave (in the 1990s) led to substantial price increases with little or no countervailing benefit.(2) Since the primary driver of growth in private spending in recent years has been price increases for health care services, ...	Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA	Northwestern University	Dafny, L (corresponding author), Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA.							[Anonymous], 2013, NY TIMES; Berenson RA, 2012, HEALTH AFFAIR, V31, P973, DOI 10.1377/hlthaff.2011.0920; Gaynor M., 2012, IMPACT HOSP CONSOLID; Health Care Cost Institute, HLTH CAR COST UT REP; Lewis M, 2013, HOSP SYSTEMS BARGAIN	5	81	82	3	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					198	199		10.1056/NEJMp1313948	http://dx.doi.org/10.1056/NEJMp1313948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HK	24328443				2022-12-28	WOS:000330035600005
J	Roth, TL; Nayak, D; Atanasijevic, T; Koretsky, AP; Latour, LL; McGavern, DB				Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.			Transcranial amelioration of inflammation and cell death after brain injury	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; STERILE INFLAMMATION; HEAD-INJURY; MICE; BIOMARKERS; INSERTION; RELEASE; CORTEX; FLUID	Traumatic brain injury (TBI) is increasingly appreciated to be highly prevalent and deleterious to neurological function(1,2). At present, no effective treatment options are available, and little is known about the complex cellular response to TBI during its acute phase. To gain insights into TBI pathogenesis, we developed a novel murine closed-skull brain injury model that mirrors some pathological features associated with mild TBI in humans and used long-term intravital microscopy to study the dynamics of the injury response from its inception. Here we demonstrate that acute brain injury induces vascular damage, meningeal cell death, and the generation of reactive oxygen species (ROS) that ultimately breach the glial limitans and promote spread of the injury into the parenchyma. In response, the brain elicits a neuroprotective, purinergic-receptor-dependent inflammatory response characterized by meningeal neutrophil swarming and microglial reconstitution of the damaged glial limitans. We also show that the skull bone is permeable to small-molecular-weight compounds, and use this delivery route to modulate inflammation and therapeutically ameliorate brain injury through transcranial administration of the ROS scavenger, glutathione. Our results shed light on the acute cellular response to TBI and provide a means to locally deliver therapeutic compounds to the site of injury.	[Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	McGavern, Dorian/HCH-3601-2022; Latour, Larry/AAH-5663-2021; Koretsky, Alan P/C-7940-2015	McGavern, Dorian/0000-0001-9568-545X; Latour, Larry/0000-0001-6160-5263; Koretsky, Alan P/0000-0002-8085-4756; Nayak, Debasis/0000-0002-4762-4553; Roth, Theodore/0000-0002-3970-9573	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NIH; Department of Defense; Walter Reed National Military Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002989, ZIANS003120] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Walter Reed National Military Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS), and the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences-a collaborative effort between the NIH, the Department of Defense and the Walter Reed National Military Medical Center to develop innovative approaches for brain injury diagnosis and recovery.	Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Faust N, 2000, BLOOD, V96, P719; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	26	356	369	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					223	+		10.1038/nature12808	http://dx.doi.org/10.1038/nature12808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317693	Green Accepted			2022-12-28	WOS:000329441500040
J	Engebretson, SP; Hyman, LG; Michalowicz, BS; Schoenfeld, ER; Gelato, MC; Hou, W; Seaquist, ER; Reddy, MS; Lewis, CE; Oates, TW; Tripathy, D; Katancik, JA; Orlander, PR; Paquette, DW; Hanson, NQ; Tsai, MY				Engebretson, Steven P.; Hyman, Leslie G.; Michalowicz, Bryan S.; Schoenfeld, Elinor R.; Gelato, Marie C.; Hou, Wei; Seaquist, Elizabeth R.; Reddy, Michael S.; Lewis, Cora E.; Oates, Thomas W.; Tripathy, Devjit; Katancik, James A.; Orlander, Philip R.; Paquette, David W.; Hanson, Naomi Q.; Tsai, Michael Y.			The Effect of Nonsurgical Periodontal Therapy on Hemoglobin A(1c) Levels in Persons With Type 2 Diabetes and Chronic Periodontitis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVE GLYCEMIC CONTROL; TOOTH LOSS; MELLITUS; INFLAMMATION; DOXYCYCLINE; GINGIVAL; DISEASE	IMPORTANCE Chronic periodontitis, a destructive inflammatory disorder of the supporting structures of the teeth, is prevalent in patients with diabetes. Limited evidence suggests that periodontal therapy may improve glycemic control. OBJECTIVE To determine if nonsurgical periodontal treatment reduces levels of glycated hemoglobin (HbA(1c)) in persons with type 2 diabetes and moderate to advanced chronic periodontitis. DESIGN, SETTING, AND PARTICIPANTS The Diabetes and Periodontal Therapy Trial (DPTT), a 6-month, single-masked, multicenter, randomized clinical trial. Participants had type 2 diabetes, were taking stable doses of medications, had HbA(1c) levels between 7% and less than 9%, and untreated chronic periodontitis. Five hundred fourteen participants were enrolled between November 2009 and March 2012 from diabetes and dental clinics and communities affiliated with 5 academic medical centers. INTERVENTIONS The treatment group (n = 257) received scaling and root planing plus chlorhexidine oral rinse at baseline and supportive periodontal therapy at 3 and 6 months. The control group (n = 257) received no treatment for 6 months. MAIN OUTCOMES AND MEASURES Difference in change in HbA(1c) level from baseline between groups at 6 months. Secondary outcomes included changes in probing pocket depths, clinical attachment loss, bleeding on probing, gingival index, fasting glucose level, and Homeostasis Model Assessment (HOMA2) score. RESULTS Enrollment was stopped early because of futility. At 6 months, mean HbA(1c) levels in the periodontal therapy group increased 0.17% (SD, 1.0), compared with 0.11% (SD, 1.0) in the control group, with no significant difference between groups based on a linear regression model adjusting for clinical site (mean difference, -0.05%[95% CI, -0.23% to 0.12%]; P = .55). Periodontal measures improved in the treatment group compared with the control group at 6 months, with adjusted between-group differences of 0.28 mm (95% CI, 0.18 to 0.37) for probing depth, 0.25 mm (95% CI, 0.14 to 0.36) for clinical attachment loss, 13.1% (95% CI, 8.1% to 18.1%) for bleeding on probing, and 0.27 (95% CI, 0.17 to 0.37) for gingival index (P < .001 for all). CONCLUSIONS AND RELEVANCE Nonsurgical periodontal therapy did not improve glycemic control in patients with type 2 diabetes and moderate to advanced chronic periodontitis. These findings do not support the use of nonsurgical periodontal treatment in patients with diabetes for the purpose of lowering levels of HbA(1c).	[Engebretson, Steven P.] NYU, Dept Periodontol & Implant Dent, New York, NY USA; [Michalowicz, Bryan S.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN USA; [Seaquist, Elizabeth R.] Univ Minnesota, Dept Med, Minneapolis, MN USA; [Reddy, Michael S.] Univ Alabama Birmingham, Dept Periodontol, Birmingham, AL USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Oates, Thomas W.] Univ Texas San Antonio, Sch Dent, San Antonio, TX USA; [Tripathy, Devjit] Univ Texas San Antonio, Dept Med, Hlth Sci Ctr, San Antonio, TX USA; [Katancik, James A.] Univ Texas Houston, Dept Periodont, Houston, TX USA; [Orlander, Philip R.] Univ Texas Houston, Dept Internal Med, Hlth Sci Ctr, Houston, TX USA; [Orlander, Philip R.] Univ Texas Houston, Dept Endocrinol, Hlth Sci Ctr, Houston, TX USA; [Hyman, Leslie G.; Schoenfeld, Elinor R.; Gelato, Marie C.; Hou, Wei] SUNY Stony Brook, Sch Med, Dept Prevent Med, Stony Brook, NY USA; [Paquette, David W.] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY USA; [Hanson, Naomi Q.; Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA	New York University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Minnesota System; University of Minnesota Twin Cities	Engebretson, SP (corresponding author), NYU, Coll Dent, Dept Periodontol & Implant Dent, 345 E 24th St 3W, New York, NY 10010 USA.	spe2002@nyu.edu	hou, wei/GWM-4800-2022	Tsai, Michael/0000-0001-7553-3408; Paquette, David/0000-0002-5555-1390	National Institute of Dental and Craniofacial Research, National Institutes of Health [UO1 DE018902, U01 DE018886]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE018886, U01DE018902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The DPTT study was funded through cooperative agreements grants UO1 DE018902 (Dr Engebretson) and U01 DE018886 (Dr Hyman) from the National Institute of Dental and Craniofacial Research, National Institutes of Health.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Armitage GC, 2003, J PERIODONTOL, V74, P1237, DOI 10.1902/jop.2003.74.8.1237; Caton JG, 2000, J PERIODONTOL, V71, P521, DOI 10.1902/jop.2000.71.4.521; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Engebretson S, 2013, CONTEMP CLIN TRIALS, V36, P515, DOI 10.1016/j.cct.2013.09.010; Engebretson S, 2013, J CLIN PERIODONTOL, V40, pS153, DOI [10.1111/jcpe.12084, 10.1902/jop.2013.1340017]; Engebretson SP, 2011, PHARMACOL RES, V64, P624, DOI 10.1016/j.phrs.2011.06.024; Goldfine AB, 2011, CLIN CHEM, V57, P162, DOI 10.1373/clinchem.2010.148833; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; HIRSCHFELD L, 1978, J PERIODONTOL, V49, P225, DOI 10.1902/jop.1978.49.5.225; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Janket SJ, 2005, J DENT RES, V84, P1154, DOI 10.1177/154405910508401212; Jones JA, 2007, J CLIN PERIODONTOL, V34, P46, DOI 10.1111/j.1600-051X.2006.01002.x; LAN KKG, 1988, BIOMETRICS, V44, P579, DOI 10.2307/2531870; Lenton PA, 1998, EXAMINER GUIDE MEASU, V1; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Loe H, 1967, J Periodontol, V38; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Lopez NJ, 2012, J PERIODONTOL, V83, P267, DOI 10.1902/jop.2011.110227; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; OLIVER RC, 1993, J AM DENT ASSOC, V124, P71, DOI 10.14219/jada.archive.1993.0247; PAGE RC, 1978, JAMA-J AM MED ASSOC, V240, P545, DOI 10.1001/jama.240.6.545; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Taylor GW, 2000, J PUBLIC HEALTH DENT, V60, P313, DOI 10.1111/j.1752-7325.2000.tb03341.x; TERVONEN T, 1993, J CLIN PERIODONTOL, V20, P431, DOI 10.1111/j.1600-051X.1993.tb00384.x; TERVONEN T, 1986, ORAL SURG ORAL MED O, V61, P346, DOI 10.1016/0030-4220(86)90417-2; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Williams RC, 2001, J PERIODONTOL, V72, P1535, DOI 10.1902/jop.2001.72.11.1535	31	156	160	2	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2523	2532		10.1001/jama.2013.282431	http://dx.doi.org/10.1001/jama.2013.282431			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24346989	Green Accepted, Bronze			2022-12-28	WOS:000328503600022
J	DeLoughery, T				DeLoughery, Thomas			Review: Contemporary oral contraceptives are associated with venous thromboembolism and stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK; THROMBOSIS		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x; Vlieg AVH, 2010, ARTERIOSCL THROM VAS, V30, P2297, DOI 10.1161/ATVBAHA.110.211482	4	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC11	10.7326/0003-4819-159-12-201312170-02011	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343404				2022-12-28	WOS:000329735300010
J	Stergachis, AB; Haugen, E; Shafer, A; Fu, WQ; Vernot, B; Reynolds, A; Raubitschek, A; Ziegler, S; LeProust, EM; Akey, JM; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Haugen, Eric; Shafer, Anthony; Fu, Wenqing; Vernot, Benjamin; Reynolds, Alex; Raubitschek, Anthony; Ziegler, Steven; LeProust, Emily M.; Akey, Joshua M.; Stamatoyannopoulos, John A.			Exonic Transcription Factor Binding Directs Codon Choice and Affects Protein Evolution	SCIENCE			English	Article							CODING SEQUENCE; SYNONYMOUS MUTATIONS; GENE EXPRESSIVITY; ESCHERICHIA-COLI; CATALOG USAGE; SELECTION; GENOME; SUBSTITUTION; METHYLATION; ENHANCERS	Genomes contain both a genetic code specifying amino acids and a regulatory code specifying transcription factor (TF) recognition sequences. We used genomic deoxyribonuclease I footprinting to map nucleotide resolution TF occupancy across the human exome in 81 diverse cell types. We found that similar to 15% of human codons are dual-use codons ("duons") that simultaneously specify both amino acids and TF recognition sites. Duons are highly conserved and have shaped protein evolution, and TF-imposed constraint appears to be a major driver of codon usage bias. Conversely, the regulatory code has been selectively depleted of TFs that recognize stop codons. More than 17% of single-nucleotide variants within duons directly alter TF binding. Pervasive dual encoding of amino acid and regulatory information appears to be a fundamental feature of genome evolution.	[Stergachis, Andrew B.; Haugen, Eric; Shafer, Anthony; Fu, Wenqing; Vernot, Benjamin; Reynolds, Alex; Akey, Joshua M.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Raubitschek, Anthony] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Raubitschek, Anthony; Ziegler, Steven] Benaroya Res Inst, Seattle, WA 98101 USA; [LeProust, Emily M.] Agilent Technol, Santa Clara, CA 95051 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute; Agilent Technologies; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Haugen, Eric/0000-0001-7444-8981; Akey, Joshua/0000-0002-4411-1330	NIH [U54HG004592, U54HG007010, U01ES01156]; National Institute of Diabetes and Digestive and Kidney Diseases [FDK095678A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank many colleagues for their insightful comments and critical readings of the manuscript. We also thank many colleagues who provided individual cell samples for DNaseI analysis. We also thank E. Rynes for his technical assistance. This work was supported by NIH grants U54HG004592, U54HG007010, and U01ES01156 to J.A.S. A. B. S. was supported by grant FDK095678A from the National Institute of Diabetes and Digestive and Kidney Diseases. J.M.A. is a paid consultant for Glenview Capital. All data from this study are available through the ENCODE data repository at UCSC (www.encodeproject.org) and the Roadmap Epigenomics data repository at NCBI (www.ncbi.nlm.nih.gov/epigenomics).	Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; Carlini DB, 2003, GENETICS, V163, P239; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HYDER SM, 1995, J BIOL CHEM, V270, P8506, DOI 10.1074/jbc.270.15.8506; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Khan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046098; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Li W. H, 1997, MOL EVOLUTION; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Ritter DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035202; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Warnecke T, 2009, BIOCHEM SOC T, V37, P756, DOI 10.1042/BST0370756; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; zur Megede J, 2000, J VIROL, V74, P2628, DOI 10.1128/JVI.74.6.2628-2635.2000	35	190	200	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1367	1372		10.1126/science.1243490	http://dx.doi.org/10.1126/science.1243490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337295	Green Accepted			2022-12-28	WOS:000328196000050
J	Williams, TA; Foster, PG; Cox, CJ; Embley, TM				Williams, Tom A.; Foster, Peter G.; Cox, Cymon J.; Embley, T. Martin			An archaeal origin of eukaryotes supports only two primary domains of life	NATURE			English	Review							ARCHAEBACTERIAL ORIGIN; EVOLUTIONARY TREES; EUBACTERIAL GENES; RNA-POLYMERASES; CELL-DIVISION; RIBOSOMAL-RNA; GENOME; SEQUENCE; PHYLOGENY; CRENARCHAEOTA	The discovery of the Archaea and the proposal of the three-domains 'universal' tree, based on ribosomal RNA and core genes mainly involved in protein translation, catalysed new ideas for cellular evolution and eukaryotic origins. However, accumulating evidence suggests that the three-domains tree may be incorrect: evolutionary trees made using newer methods place eukaryotic core genes within the Archaea, supporting hypotheses in which an archaeon participated in eukaryotic origins by founding the host lineage for the mitochondrial endosymbiont. These results provide support for only two primary domains of life-Archaea and Bacteria-because eukaryotes arose through partnership between them.	[Williams, Tom A.; Embley, T. Martin] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Foster, Peter G.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Cox, Cymon J.] Univ Algarve, Ctr Ciencias Mar, P-8005139 Faro, Portugal	Newcastle University - UK; Natural History Museum London; Universidade do Algarve	Embley, TM (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Martin.Embley@ncl.ac.uk	Cox, Cymon/D-1303-2012	Cox, Cymon/0000-0002-4927-979X; Williams, Tom/0000-0003-1072-0223; Foster, Peter/0000-0003-0194-9237; Embley, Thomas Martin/0000-0002-1484-340X	Marie Curie postdoctoral fellowship; European Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/C006143/1, BB/C508777/1] Funding Source: researchfish	Marie Curie postdoctoral fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Marie Curie postdoctoral fellowship to T. A. W. T. M. E. acknowledges support from the European Research Council Advanced Investigator Programme and the Wellcome Trust. We thank J. Archibald for comments on the manuscript.	Allwood AC, 2009, P NATL ACAD SCI USA, V106, P9548, DOI 10.1073/pnas.0903323106; Alsmark C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r19; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Blombach F, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-39; Boucher Y, 2004, MOL MICROBIOL, V52, P515, DOI 10.1111/j.1365-2958.2004.03992.x; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Cavalier-Smith T, 1983, ENDOCYTOBIOLOGY, pl027; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Cotton JA, 2010, P NATL ACAD SCI USA, V107, P17252, DOI 10.1073/pnas.1000265107; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Creevey CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022099; Csuros M, 2009, MOL BIOL EVOL, V26, P2087, DOI 10.1093/molbev/msp123; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dagan T, 2010, GENOME BIOL EVOL, V2, P379, DOI 10.1093/gbe/evq025; Daniels JP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-24; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; DOOLITTLE WF, 1994, P NATL ACAD SCI USA, V91, P6721, DOI 10.1073/pnas.91.15.6721; Doolittle WF, 2013, PROKARYOTES PROKARYO; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Ettema TJG, 2011, MOL MICROBIOL, V80, P1052, DOI 10.1111/j.1365-2958.2011.07635.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Fischer WW, 2008, NATURE, V455, P1051, DOI 10.1038/4551051a; Foster PG, 2009, PHILOS T R SOC B, V364, P2197, DOI 10.1098/rstb.2009.0034; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; GOUY M, 1989, NATURE, V339, P145, DOI 10.1038/339145a0; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Guldan H, 2011, ANGEW CHEM INT EDIT, V50, P8188, DOI 10.1002/anie.201101832; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Horner DS, 1996, P ROY SOC B-BIOL SCI, V263, P1053, DOI 10.1098/rspb.1996.0155; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katoh K, 2001, J MOL EVOL, V53, P477, DOI 10.1007/s002390010238; Kelly S, 2011, P ROY SOC B-BIOL SCI, V278, P1009, DOI 10.1098/rspb.2010.1427; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-38; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; LAKE JA, 1991, MOL BIOL EVOL, V8, P378; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lake JA, 2009, PHILOS T R SOC B, V364, P2177, DOI 10.1098/rstb.2009.0035; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lasek-Nesselquist E, 2013, MOL PHYLOGENET EVOL, V69, P17, DOI 10.1016/j.ympev.2013.05.006; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lombard J, 2012, MOL BIOL EVOL, V29, P3261, DOI 10.1093/molbev/mss160; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Madigan M. T., 2010, BROCK BIOLOGY OF MIC; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; OLSEN GJ, 1987, COLD SPRING HARB SYM, V52, P825, DOI 10.1101/SQB.1987.052.01.090; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pace NR, 2006, NATURE, V441, P289, DOI 10.1038/441289a; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pitcher A, 2011, APPL ENVIRON MICROB, V77, P3468, DOI 10.1128/AEM.02758-10; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Ribeiro S, 1998, MOL BIOL EVOL, V15, P779, DOI 10.1093/oxfordjournals.molbev.a025983; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Shimada H, 2011, BIOCHEMISTRY-US, V50, P4114, DOI 10.1021/bi200172d; SIDOW A, 1990, J MOL EVOL, V31, P51, DOI 10.1007/BF02101792; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Tan HH, 2012, ANGEW CHEM INT EDIT, V51, P533, DOI 10.1002/anie.201106470; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Tourasse NJ, 1999, MOL PHYLOGENET EVOL, V13, P159, DOI 10.1006/mpev.1999.0675; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; van der Giezen M, 2005, INT REV CYTOL, V244, P175, DOI 10.1016/S0074-7696(05)44005-X; Williams D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-45; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, J MOL EVOL, V10, P1, DOI 10.1007/BF01796132; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; YANG ZH, 1995, MOL BIOL EVOL, V12, P451; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-10	108	316	327	8	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					231	236		10.1038/nature12779	http://dx.doi.org/10.1038/nature12779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24336283	Green Submitted			2022-12-28	WOS:000328121500027
J	Ikeda, Y; Kumagai, H; Skach, A; Sato, M; Yanagisawa, M				Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi			Modulation of Circadian Glucocorticoid Oscillation via Adrenal Opioid-CXCR7 Signaling Alters Emotional Behavior	CELL			English	Article							SUBCAPSULAR CELL HYPERPLASIA; MAJOR DEPRESSION; MICE DEFICIENT; ANIMAL-MODEL; STRESS; CLOCK; MOUSE; RHYTHM; PROENKEPHALIN; RECEPTOR	Circulating glucocorticoid levels oscillate with a robust circadian rhythm, yet the physiological relevance of this rhythmicity remains unclear. Here, we show that modulation of circadian glucocorticoid oscillation by enhancing its amplitude leads to anxiolytic-like behavior. We observed that mice with adrenal subcapsular cell hyperplasia (SCH), a common histological change in the adrenals, are less anxious than mice without SCH. This behavioral change was found to be dependent on the higher amplitude of glucocorticoid oscillation, although the total glucocorticoid secretion is not increased in these mice. Genetic and pharmacologic experiments demonstrated that intermediate opioid peptides secreted from SCH activate CXCR7, a beta-arrestin-biased G-protein-coupled receptor (GPCR), to augment circadian oscillation of glucocorticoid levels in a paracrine manner. Furthermore, recapitulating this paracrine axis by subcutaneous administration of a synthetic CXCR7 ligand is sufficient to induce anxiolytic-like behavior. Adrenocortical beta-arrestin-biased GPCR signaling is a potential target for modulating circadian glucocorticoid oscillation and emotional behavior.	[Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kumagai, Hidetoshi; Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba	Yanagisawa, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	masashi.yanagisawa@utsouthwestern.edu			Perot Family Foundation; Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)	Perot Family Foundation; Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)	We thank members of the M.Y. laboratory, Dr. Christopher Sinton, and Dr. James Richardson for technical assistance and scientific discussion. We also thank Tairo Ogura and Tubasa Ibushi (Shimadzu Corporation) for mass spectrometry analyses of adrenal peptides. This research was supported in part by the Perot Family Foundation, the Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO), and the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST). M.Y. is an Investigator of the Howard Hughes Medical Institute.	Aiba M, 2011, J HISTOCHEM CYTOCHEM, V59, P557, DOI 10.1369/0022155411404071; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bastida CM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1010, DOI 10.1152/ajpendo.00316.2006; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Bland ML, 2003, ANN NY ACAD SCI, V995, P59, DOI 10.1111/j.1749-6632.2003.tb03210.x; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; DILLEN L, 1993, NEUROCHEM INT, V22, P315, DOI 10.1016/0197-0186(93)90016-X; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Gallo-Payet N, 2003, MICROSC RES TECHNIQ, V61, P275, DOI 10.1002/jemt.10337; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jahn H, 2004, ARCH GEN PSYCHIAT, V61, P1235, DOI 10.1001/archpsyc.61.12.1235; Janes ME, 2008, ENDOCRINOLOGY, V149, P1898, DOI 10.1210/en.2007-0949; JINGAMI H, 1984, EUR J BIOCHEM, V142, P441, DOI 10.1111/j.1432-1033.1984.tb08306.x; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Keers R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038263; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kim JS, 2005, EXP ANIM TOKYO, V54, P107, DOI 10.1538/expanim.54.107; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; KOVATCH RM, 1986, ENVIRON HEALTH PERSP, V68, P105, DOI 10.2307/3430254; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; STARKMAN MN, 1981, PSYCHOSOM MED, V43, P3, DOI 10.1097/00006842-198102000-00002; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YOSHIDA A, 1986, JPN J VET SCI, V48, P719; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	56	66	70	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1323	1336		10.1016/j.cell.2013.10.052	http://dx.doi.org/10.1016/j.cell.2013.10.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315101	Bronze, Green Accepted			2022-12-28	WOS:000328271100016
J	Jagoutz, O; Behn, MD				Jagoutz, Oliver; Behn, Mark D.			Foundering of lower island-arc crust as an explanation for the origin of the continental Moho	NATURE			English	Article							SEISMIC VELOCITY STRUCTURE; NORTHERN HONSHU; JAPAN; MANTLE; WAVE; CRYSTALLIZATION; CONSTRAINTS; EVOLUTION; PRESSURE; TERRANE	A long-standing theory for the genesis of continental crust is that it is formed in subduction zones(1). However, the observed seismic properties of lower crust and upper mantle in oceanic island arcs(2,3) differ significantly from those in the continental crust(4). Accordingly, significant modifications of lower arc crust must occur, if continental crust is indeed formed from island arcs. Here we investigate how the seismic characteristics of arc crust are transformed into those of the continental crust by calculating the density and seismic structure of two exposed sections of island arc (Kohistan and Talkeetna). The Kohistan crustal section is negatively buoyant with respect to the underlying depleted upper mantle at depths exceeding 40 kilometres and is characterized by a steady increase in seismic velocity similar to that observed in active arcs. In contrast, the lower Talkeetna crust is density sorted, preserving only relicts (about ten to a hundred metres thick) of rock with density exceeding that of the underlying mantle. Specifically, the foundering of the lower Talkeetna crust resulted in the replacement of dense mafic and ultramafic cumulates by residual upper mantle, producing a sharp seismic discontinuity at depths of around 38 to 42 kilometres, characteristic of the continental Mohorovicic discontinuity (the Moho). Dynamic calculations indicate that foundering is an episodic process that occurs in most arcs with a periodicity of half a million to five million years. Moreover, because foundering will continue after arc magmatism ceases, this process ultimately results in the formation of the continental Moho.	[Jagoutz, Oliver] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Behn, Mark D.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Jagoutz, O (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jagoutz@mit.edu	Behn, Mark D/F-5813-2012	Behn, Mark D/0000-0002-2001-1335	NSF [EAR 0910644, EAR 1316333]	NSF(National Science Foundation (NSF))	The work was supported by NSF grant numbers EAR 0910644 (to O.J.) and EAR 1316333 (to M. D. B.). We thank N. Arndt for comments that helped to improve the manuscript. J. Connolly's help in recalibrating the elastic property calculation of Perple_X is appreciated, as are discussions with P. Kelemen and B. Hacker.	ARNDT NT, 1989, TECTONOPHYSICS, V161, P201, DOI 10.1016/0040-1951(89)90154-6; Behn MD, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004327; Behn MD, 2007, SCIENCE, V317, P108, DOI 10.1126/science.1141269; Calvert AJ, 2011, FRONT EARTH SCI SER, P87, DOI 10.1007/978-3-540-88558-0_4; Calvert AJ, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004939; CHRISTENSEN NI, 1995, J GEOPHYS RES-SOL EA, V100, P9761, DOI 10.1029/95JB00259; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Conrad CP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004608; Conrad CP, 1997, GEOPHYS J INT, V129, P95, DOI 10.1111/j.1365-246X.1997.tb00939.x; Cottrell E, 2011, EARTH PLANET SC LETT, V305, P270, DOI 10.1016/j.epsl.2011.03.014; Eberhart-Philips D, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004240; Greene AR, 2006, J PETROL, V47, P1051, DOI 10.1093/petrology/egl002; GUGGISBERG B, 1991, TECTONOPHYSICS, V195, P105, DOI 10.1016/0040-1951(91)90208-A; Hacker BR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000614; Hacker BR, 2011, EARTH PLANET SC LETT, V307, P501, DOI 10.1016/j.epsl.2011.05.024; Hacker BR, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005208; Holbrook WS, 1999, GEOLOGY, V27, P31; IWASAKI T, 1990, GEOPHYS J INT, V102, P631, DOI 10.1111/j.1365-246X.1990.tb04587.x; IWASAKI T, 1994, J GEOPHYS RES-SOL EA, V99, P22187, DOI 10.1029/94JB00732; Jagoutz O, 2013, EARTH PLANET SC LETT, V371, P177, DOI 10.1016/j.epsl.2013.03.051; Jagoutz O, 2012, CHEM GEOL, V298, P79, DOI 10.1016/j.chemgeo.2011.10.022; Jagoutz O., 2011, AGU FALL M, P2628; Jagoutz O, 2013, CONTRIB MINERAL PETR, V166, P1099, DOI 10.1007/s00410-013-0911-4; Jagoutz O, 2011, EARTH PLANET SC LETT, V303, P25, DOI 10.1016/j.epsl.2010.12.017; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Kelemen P.B., 2007, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03035-8, DOI 10.1016/B0-08-043751-6/03035-8]; Kelemen P.B., 2003, AM GEOPHYS UNION GEO, V138, P293, DOI DOI 10.1029/138GM13; Kodaira S, 2007, GEOLOGY, V35, P1031, DOI 10.1130/G23901A.1; Kodaira S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004593; Kono Y, 2009, TECTONOPHYSICS, V467, P44, DOI 10.1016/j.tecto.2008.12.010; Kopp H, 2011, EARTH PLANET SC LETT, V304, P121, DOI 10.1016/j.epsl.2011.01.024; KUSHIRO I, 1966, J PETROL, V7, P337, DOI 10.1093/petrology/7.3.337; MILLER DJ, 1994, J GEOPHYS RES-SOL EA, V99, P11623, DOI 10.1029/94JB00059; Muntener O, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027629; Muntener O, 2001, CONTRIB MINERAL PETR, V141, P643; Nakanishi A, 2009, TECTONOPHYSICS, V472, P105, DOI 10.1016/j.tecto.2008.03.003; Ringuette L, 1999, GEOLOGY, V27, P139, DOI 10.1130/0091-7613(1999)027<0139:MCICAD>2.3.CO;2; Shillington DJ, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000715; Shillington DJ, 2013, GEOPHYS RES LETT, V40, P2579, DOI 10.1002/grl.50375; Sobolev S.V., 1989, GEOPHYS MONOGR SER, V51, P311, DOI [10.1029/gm051p0311, DOI 10.1029/GM051P0311]; Syracuse EM, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001963; Takahashi N, 2007, GEOLOGY, V35, P203, DOI 10.1130/G23212A.1; Takahashi N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005120; Tatsumi Y, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005121; Taylor S.R., 1985, CONTINENTAL CRUST IT; Wang Z, 2006, PHYS EARTH PLANET IN, V157, P269, DOI 10.1016/j.pepi.2006.04.008; Zhang HJ, 2004, GEOLOGY, V32, P361, DOI 10.1130/G20261.2	48	94	96	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					131	+		10.1038/nature12758	http://dx.doi.org/10.1038/nature12758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305163				2022-12-28	WOS:000327851700045
J	Rando, G; Schibler, U				Rando, Gianpaolo; Schibler, Ueli			Glucocorticoid Rhythm Renders Female Mice More Daring	CELL			English	Editorial Material									[Rando, Gianpaolo; Schibler, Ueli] Univ Geneva, Dept Mol Biol Sci 3, CH-1211 Geneva, Switzerland	University of Geneva	Rando, G (corresponding author), Univ Geneva, Dept Mol Biol Sci 3, CH-1211 Geneva, Switzerland.	gianpaolo.rando@unige.ch; ueli.schibler@unige.ch						Aiba M, 2011, J HISTOCHEM CYTOCHEM, V59, P557, DOI 10.1369/0022155411404071; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kino T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003333; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Rando G, 2011, BBA-MOL BASIS DIS, V1812, P964, DOI 10.1016/j.bbadis.2010.12.023; VRANG N, 1995, BRAIN RES, V684, P61, DOI 10.1016/0006-8993(95)00425-P	9	2	2	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1211	1212		10.1016/j.cell.2013.11.017	http://dx.doi.org/10.1016/j.cell.2013.11.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315091	Bronze			2022-12-28	WOS:000328271100005
J	Murayama, Y; Uhlmann, F				Murayama, Yasuto; Uhlmann, Frank			Biochemical reconstitution of topological DNA binding by the cohesin ring	NATURE			English	Article							SISTER-CHROMATID COHESION; STRAND-BREAK REPAIR; FISSION YEAST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; S-PHASE; COMPLEX; CONDENSIN; PROTEIN	Cohesion between sister chromatids, mediated by the chromosomal cohesin complex, is a prerequisite for faithful chromosome segregation in mitosis. Cohesin also has vital roles in DNA repair and transcriptional regulation. The ring-shaped cohesin complex is thought to encircle sister DNA strands, but its molecular mechanism of action is poorly understood and the biochemical reconstitution of cohesin activity in vitro has remained an unattained goal. Here we reconstitute cohesin loading onto DNA using purified fission yeast cohesin and its loader complex, Mis4(Scc2)-Ssl3(Scc4) (Schizosaccharomyces pombe gene names appear throughout with their more commonly known Saccharomyces cerevisiae counterparts added in superscript). Incubation of cohesin with DNA leads to spontaneous topological loading, but this remains inefficient. The loader contacts cohesin at multiple sites around the ring circumference, including the hitherto enigmatic Psc3(Scc3) subunit, and stimulates cohesin's ATPase, resulting in efficient topological loading. The in vitro reconstitution of cohesin loading onto DNA provides mechanistic insight into the initial steps of the establishment of sister chromatid cohesion and other chromosomal processes mediated by cohesin.	[Murayama, Yasuto; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3LY, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619	European Research Council; Japanese Society for the Promotion of Science (JSPS); Cancer Research UK [15671] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research UK(Cancer Research UK)	We are grateful to N. O'Reilly for peptide synthesis, A. Alidoust and N. Patel for fermentation and J. Hurwitz, T. Toda and members of the Chromosome Segregation Laboratory for discussion and comments on the manuscript. This work was supported by the European Research Council. Y.M. was supported by the Japanese Society for the Promotion of Science (JSPS).	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bermudez VP, 2012, P NATL ACAD SCI USA, V109, P9366, DOI 10.1073/pnas.1206840109; Bernard P, 2006, CURR BIOL, V16, P875, DOI 10.1016/j.cub.2006.03.037; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Matsuyama A, 2008, BIOCHEM BIOPH RES CO, V374, P315, DOI 10.1016/j.bbrc.2008.07.015; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Onn I, 2011, P NATL ACAD SCI USA, V108, P12198, DOI 10.1073/pnas.1107504108; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222	45	183	184	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					367	+		10.1038/nature12867	http://dx.doi.org/10.1038/nature12867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24291789	Green Accepted			2022-12-28	WOS:000329621800035
J	Sato, H; Kosaka, W; Matsuda, R; Hori, A; Hijikata, Y; Belosludov, RV; Sakaki, S; Takata, M; Kitagawa, S				Sato, Hiroshi; Kosaka, Wataru; Matsuda, Ryotaro; Hori, Akihiro; Hijikata, Yuh; Belosludov, Rodion V.; Sakaki, Shigeyoshi; Takata, Masaki; Kitagawa, Susumu			Self-Accelerating CO Sorption in a Soft Nanoporous Crystal	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORKS; ADSORPTION PROPERTIES; COORDINATION-POLYMER; CAPTURE; GASES	Carbon monoxide (CO) produced in many large-scale industrial oxidation processes is difficult to separate from nitrogen (N-2), and afterward, CO is further oxidized to carbon dioxide. Here, we report a soft nanoporous crystalline material that selectively adsorbs CO with adaptable pores, and we present crystallographic evidence that CO molecules can coordinate with copper(II) ions. The unprecedented high selectivity was achieved by the synergetic effect of the local interaction between CO and accessible metal sites and a global transformation of the framework. This transformable crystalline material realized the separation of CO from mixtures with N-2, a gas that is the most competitive to CO. The dynamic and efficient molecular trapping and releasing system is reminiscent of sophisticated biological systems such as heme proteins.	[Sato, Hiroshi; Kosaka, Wataru; Matsuda, Ryotaro; Kitagawa, Susumu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, Kyoto 6158510, Japan; [Sato, Hiroshi; Kosaka, Wataru; Matsuda, Ryotaro; Hori, Akihiro; Takata, Masaki; Kitagawa, Susumu] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Hijikata, Yuh; Sakaki, Shigeyoshi] Kyoto Univ, Fukui Inst Fundamental Chem, Kyoto 6068103, Japan; [Belosludov, Rodion V.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takata, Masaki] Japan Synchrotron Radiat Res Inst SPring 8, Sayo, Hyogo 6795198, Japan; [Kitagawa, Susumu] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	Kyoto University; RIKEN; Kyoto University; Tohoku University; Japan Synchrotron Radiation Research Institute; Kyoto University	Matsuda, R (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, Kyoto 6158510, Japan.	rmatsuda@icems.kyoto-u.ac.jp; kitagawa@icems.kyoto-u.ac.jp	Kosaka, Wataru/P-6119-2014; Matsuda, Ryotaro/AGA-6072-2022; Kitagawa, Susumu/AAB-1753-2019; Hijikata, Yuh/E-5399-2011; Belosludov, Rodion/A-1748-2013; Sato, Hiroshi/AAD-2455-2022; Takata, Masaki/M-1525-2014	Kosaka, Wataru/0000-0002-2445-5099; Matsuda, Ryotaro/0000-0002-7665-6212; Kitagawa, Susumu/0000-0001-6956-9543; Hijikata, Yuh/0000-0003-4883-5085; Sato, Hiroshi/0000-0002-5899-1340; Belosludov, Rodion/0000-0003-4661-9194	Exploratory Research for Advanced Technology, Japan Science and Technology Agency; KAKENHI by the Japan Society of the Promotion of Science [25000007]; Integrated Materials Research Center for a Low-Carbon Society; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23241027];  [22000009]	Exploratory Research for Advanced Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); KAKENHI by the Japan Society of the Promotion of Science; Integrated Materials Research Center for a Low-Carbon Society; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Exploratory Research for Advanced Technology, Japan Science and Technology Agency. H. S. and S. K. acknowledge the financial support of KAKENHI, a Grant-in-Aid for Specially Promoted Research (grant no. 25000007) by the Japan Society of the Promotion of Science. S. S. and Y.H. are thankful for a Grant-in-Aid for Specially Promoted Research (grant no. 22000009). R. V. B. would like to express sincere thanks to the staff of the Center for Computational Materials Science of the Institute for Materials Research, Tohoku University, for their continuous support of the SR16000-M1 supercomputing facilities and also to the Integrated Materials Research Center for a Low-Carbon Society and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant no. 23241027) for financial support. The x-ray crystallographic coordinates for structures reported in this paper have been deposited at the Cambridge Crystallographic Data Centre under deposition numbers CCDC 973391, 973449, and 973450. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre (www.ccdc.cam.ac.uk/Community/Requestastructure/Pages/DataRequest.aspx).	Bordiga S, 2007, PHYS CHEM CHEM PHYS, V9, P2676, DOI 10.1039/b703643d; Bradshaw D, 2007, SCIENCE, V315, P977, DOI 10.1126/science1135445; Bureekaew S, 2010, ANGEW CHEM INT EDIT, V49, P7660, DOI 10.1002/anie.201002259; Chandler BD, 2008, NAT MATER, V7, P229, DOI 10.1038/nmat2101; Chui SSY, 1999, SCIENCE, V283, P1148, DOI 10.1126/science.283.5405.1148; Garrone E, 2005, CHEM SOC REV, V34, P846, DOI 10.1039/b407049f; Halder GJ, 2002, SCIENCE, V298, P1762, DOI 10.1126/science.1075948; Haynes A, 2010, ADV CATAL, V53, P1, DOI 10.1016/S0360-0564(10)53001-3; Hill A. V., 1910, PROC PHYS SOC, V40, P4; HOGENDOORN JA, 1995, CHEM ENG J BIOCH ENG, V59, P243, DOI 10.1016/0923-0467(94)02959-8; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Mohideen MIH, 2011, NAT CHEM, V3, P304, DOI 10.1038/NCHEM.1003; Moulton B, 2002, ANGEW CHEM INT EDIT, V41, P2821, DOI 10.1002/1521-3773(20020802)41:15<2821::AID-ANIE2821>3.0.CO;2-Y; Paulik F. E., 1968, CHEM COMMUN, V1968, p1578a; Petsko G. A., 2003, PROTEIN STRUCTURE AN; Rabone J, 2010, SCIENCE, V329, P1053, DOI 10.1126/science.1190672; ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739; Sato H, 2010, NAT MATER, V9, P661, DOI [10.1038/NMAT2808, 10.1038/nmat2808]; Serre C, 2007, SCIENCE, V315, P1828, DOI 10.1126/science.1137975; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Tabares LC, 2001, J AM CHEM SOC, V123, P383, DOI 10.1021/ja002624a; WAUGH KC, 1992, CATAL TODAY, V15, P51, DOI 10.1016/0920-5861(92)80122-4; Weissermel K., 2008, INDUSTRIAL ORGANIC C; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	26	355	359	21	517	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					167	170		10.1126/science.1246423	http://dx.doi.org/10.1126/science.1246423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24336572				2022-12-28	WOS:000329440800038
J	Masarwa, A; Didier, D; Zabrodski, T; Schinkel, M; Ackermann, L; Marek, I				Masarwa, Ahmad; Didier, Dorian; Zabrodski, Tamar; Schinkel, Marvin; Ackermann, Lutz; Marek, Ilan			Merging allylic carbon-hydrogen and selective carbon-carbon bond activation	NATURE			English	Article							QUATERNARY STEREOGENIC CENTERS; HECK ARYLATIONS; BUILDING-BLOCKS; METAL; DERIVATIVES; PRODUCTS	Since the nineteenth century, many synthetic organic chemists have focused on developing new strategies to regio-, diastereo- and enantioselectively build carbon-carbon and carbon-heteroatom bonds in a predictable and efficient manner(1-3). Ideal syntheses should use the least number of synthetic steps, with few or no functional group transformations and by-products, and maximum atom efficiency. One potentially attractive method for the synthesis of molecular skeletons that are difficult to prepare would be through the selective activation of C-H and C-C bonds(4-8), instead of the conventional construction of new C-C bonds. Here we present an approach that exploits the multifold reactivity of easily accessible substrates(9) with a single organometallic species to furnish complex molecular scaffolds through the merging of otherwise difficult transformations: allylic C-H and selective C-C bond activations(10-12). The resulting bifunctional nucleophilic species, all of which have an all-carbon quaternary stereogenic centre, can then be selectively derivatized by the addition of two different electrophiles to obtain more complex molecular architecture from these easily available starting materials.	[Masarwa, Ahmad; Didier, Dorian; Zabrodski, Tamar; Marek, Ilan] Technion Israel Inst Technol, Schulich Fac Chem, Mallat Family Lab Organ Chem, IL-32000 Haifa, Israel; [Masarwa, Ahmad; Didier, Dorian; Zabrodski, Tamar; Marek, Ilan] Technion Israel Inst Technol, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-32000 Haifa, Israel; [Schinkel, Marvin; Ackermann, Lutz] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Gottingen	Marek, I (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, Mallat Family Lab Organ Chem, IL-32000 Haifa, Israel.	chilanm@tx.technion.ac.il	Ackermann, Lutz/C-8117-2014; Ackermann, Lutz/AAX-7733-2021	Ackermann, Lutz/0000-0001-7034-8772; didier, dorian/0000-0002-6358-1485	Niedersachsen-Technion Research Cooperation Program; Israel Science Foundation [140/12]; European Research Council under the European Community [338912]	Niedersachsen-Technion Research Cooperation Program; Israel Science Foundation(Israel Science Foundation); European Research Council under the European Community(European Research Council (ERC))	This research was supported by the Niedersachsen-Technion Research Cooperation Program, by the Israel Science Foundation administrated by the Israel Academy of Sciences and Humanities (140/12) and by the European Research Council under the European Community's Seventh Framework Programme (ERC grant agreement no. 338912). I. M. is holder of the Sir Michael and Lady Sobell Academic Chair.	Ackermann L., 2013, ACC CHEM RES; Aissa C, 2007, J AM CHEM SOC, V129, P14836, DOI 10.1021/ja0746316; Aloise AD, 2000, J AM CHEM SOC, V122, P12610, DOI 10.1021/ja0055920; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; BERGMAN RG, 1984, SCIENCE, V223, P902, DOI 10.1126/science.223.4639.902; Chinkov N, 2006, ANGEW CHEM INT EDIT, V45, P465, DOI 10.1002/anie.200501946; Chinkov N, 2003, J AM CHEM SOC, V125, P13258, DOI 10.1021/ja036751t; Chinkov N, 2002, J AM CHEM SOC, V124, P10282, DOI 10.1021/ja027027y; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; Das JP, 2009, NAT CHEM, V1, P128, DOI [10.1038/NCHEM.131, 10.1038/nchem.131]; Delaye PO, 2013, ANGEW CHEM INT EDIT, V52, P5333, DOI 10.1002/anie.201300664; DIMMOCK PW, 1994, J CHEM SOC CHEM COMM, P2323, DOI 10.1039/c39940002323; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; GOZIN M, 1993, NATURE, V364, P699, DOI 10.1038/364699a0; Harada S, 1997, J ORG CHEM, V62, P3994, DOI 10.1021/jo962064r; Kliman LT, 2012, ANGEW CHEM INT EDIT, V51, P521, DOI 10.1002/anie.201105716; Marek I, 2006, SYNLETT, P501, DOI 10.1055/s-2006-932483; Marek I, 2007, ANGEW CHEM INT EDIT, V46, P7364, DOI 10.1002/anie.200604774; Masarwa A, 2010, CHEM-EUR J, V16, P9712, DOI 10.1002/chem.201001246; Mei TS, 2013, J AM CHEM SOC, V135, P6830, DOI 10.1021/ja402916z; Minko Y, 2012, NATURE, V490, P522, DOI 10.1038/nature11569; Nakamura I, 2002, ADV SYNTH CATAL, V344, P111, DOI 10.1002/1615-4169(200202)344:2<111::AID-ADSC111>3.0.CO;2-0; NEGISHI E, 1988, SYNTHESIS-STUTTGART, P1; Rybtchinski B, 1999, ANGEW CHEM INT EDIT, V38, P870, DOI 10.1002/(SICI)1521-3773(19990401)38:7<870::AID-ANIE870>3.0.CO;2-3; Seiser T, 2009, ANGEW CHEM INT EDIT, V48, P6320, DOI 10.1002/anie.200903189; Simaan S, 2006, ANGEW CHEM INT EDIT, V45, P3963, DOI 10.1002/anie.200600556; Simaan S, 2010, CHEM-EUR J, V16, P774, DOI 10.1002/chem.200902656; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Wender PA, 2009, NATURE, V460, P197, DOI 10.1038/460197a; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208	30	160	160	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					199	203		10.1038/nature12761	http://dx.doi.org/10.1038/nature12761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317692				2022-12-28	WOS:000329441500035
J	Meara, JG; Hagander, L; Leather, AJM				Meara, John G.; Hagander, Lars; Leather, Andrew J. M.			Surgery and global health: a Lancet Commission	LANCET			English	Editorial Material									[Meara, John G.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Meara, John G.] Boston Childrens Hosp, Boston, MA USA; [Hagander, Lars] Lund Univ, Fac Med, Childrens Hosp, Dept Clin Sci Lund, Lund, Sweden; [Leather, Andrew J. M.] Kings Coll London, Kings Ctr Global Hlth, London WC2R 2LS, England; [Leather, Andrew J. M.] Kings Hlth Partners, Weston Educ Ctr, London, England	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Lund University; University of London; King's College London; University of London; King's College London	Meara, JG (corresponding author), Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu		Meara, John G./0000-0003-4369-3209; Roy, Nobhojit/0000-0003-2022-7416; Leather, Andy/0000-0003-0500-5962				Farmer P, 2013, CALIF SER PUB ANTHR, V26, P1; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163	4	144	147	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					12	13		10.1016/S0140-6736(13)62345-4	http://dx.doi.org/10.1016/S0140-6736(13)62345-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284SP	24332309				2022-12-28	WOS:000329341200011
J	Herman, F; Seward, D; Valla, PG; Carter, A; Kohn, B; Willett, SD; Ehlers, TA				Herman, Frederic; Seward, Diane; Valla, Pierre G.; Carter, Andrew; Kohn, Barry; Willett, Sean D.; Ehlers, Todd A.			Worldwide acceleration of mountain erosion under a cooling climate	NATURE			English	Article							GLACIAL EROSION; NEIGHBORHOOD ALGORITHM; GEOPHYSICAL INVERSION; CLOSURE TEMPERATURE; TEMPORAL VARIATIONS; APATITE; RATES; THERMOCHRONOLOGY; SEDIMENT; ALPS	Climate influences the erosion processes acting at the Earth's surface. However, the effect of cooling during the Late Cenozoic era, including the onset of Pliocene-Pleistocene Northern Hemisphere glaciation (about two to three million years ago), on global erosion rates remains unclear(1-4). The uncertainty arises mainly from a lack of consensus on the use of the sedimentary record as a proxy for erosion(3,4) and the difficulty of isolating the respective contributions of tectonics and climate to erosion(5-7). Here we compile 18,000 bedrock thermochronometric ages from around the world and use a formal inversion procedure(8) to estimate temporal and spatial variations in erosion rates. This allows for the quantification of erosion for the source areas that ultimately produce the sediment record on a timescale of millions of years. We find that mountain erosion rates have increased since about six million years ago and most rapidly since two million years ago. The increase of erosion rates is observed at all latitudes, but is most pronounced in glaciated mountain ranges, indicating that glacial processes played an important part. Because mountains represent a considerable fraction of the global production of sediments(9), our results imply an increase in sediment flux at a global scale that coincides closely with enhanced cooling during the Pliocene and Pleistocene epochs(10,11).	[Herman, Frederic; Valla, Pierre G.] Univ Lausanne, Inst Earth Sci, CH-1015 Lausanne, Switzerland; [Herman, Frederic; Valla, Pierre G.; Willett, Sean D.] Swiss Fed Inst Technol, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Seward, Diane] Victoria Univ, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Carter, Andrew] Birkbeck Univ London, Dept Earth & Planetary Sci, London WC1E 7HX, England; [Kohn, Barry] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Ehlers, Todd A.] Univ Tubingen, Dept Geosci, D-72074 Tubingen, Germany	University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Victoria University Wellington; University of London; Birkbeck University London; University of Melbourne; Eberhard Karls University of Tubingen	Herman, F (corresponding author), Univ Lausanne, Inst Earth Sci, CH-1015 Lausanne, Switzerland.	frederic.herman@unil.ch	Valla, Pierre/I-8525-2012; Willett, Sean D/B-1716-2008; Ehlers, Todd A/A-9582-2012; Carter, Andrew/C-1371-2008	Ehlers, Todd A/0000-0001-9436-0303; Carter, Andrew/0000-0002-0090-5868; Kohn, Barry/0000-0001-5064-5454; Herman, Frederic/0000-0002-7237-4656	SNF [PP00P2_138956]	SNF	We thank J.-D. Champagnac and M. Brandon for discussions throughout the study. We also thank S. Jaccard and P. Molnar for their feedback on the manuscript and K. Huntington for her constructive review. The computations presented here were performed on the Brutus facility at ETH Zurich, Switzerland. F. H. was funded by SNF grant PP00P2_138956.	Aster RC, 2019, PARAMETER ESTIMATION AND INVERSE PROBLEMS, 3RD EDITION; Bartoli G, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002055; Berger AL, 2008, NAT GEOSCI, V1, P793, DOI 10.1038/ngeo334; Braun J., 2006, QUANTITATIVE THERMOC; Braun J, 2012, TECTONOPHYSICS, V524, P1, DOI 10.1016/j.tecto.2011.12.035; Champagnac JD, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008348; DiBiase RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002095; DODSON MH, 1973, CONTRIB MINERAL PETR, V40, P259, DOI 10.1007/BF00373790; Ehlers TA, 2005, REV MINERAL GEOCHEM, V58, P315, DOI 10.2138/rmg.2005.58.12; Ehlers TA, 2003, EARTH PLANET SC LETT, V206, P1, DOI 10.1016/S0012-821X(02)01069-5; Farley KA, 1996, GEOCHIM COSMOCHIM AC, V60, P4223, DOI 10.1016/S0016-7037(96)00193-7; Farley KA, 2000, J GEOPHYS RES-SOL EA, V105, P2903, DOI 10.1029/1999JB900348; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fox M., 2013, EARTH SURF DYNAM DIS, V1, P207; Gallagher K, 2005, EARTH PLANET SC LETT, V237, P193, DOI 10.1016/j.epsl.2005.06.025; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; GLEADOW AJW, 1981, NUCL TRACKS RAD MEAS, V5, P169, DOI 10.1016/0191-278X(81)90039-1; GREEN PF, 1989, CHEM GEOL, V79, P155, DOI 10.1016/0168-9622(89)90018-3; Guralnik B, 2013, EARTH PLANET SC LETT, V384, P209, DOI 10.1016/j.epsl.2013.10.003; Herman F, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006126; HURFORD AJ, 1982, EARTH PLANET SC LETT, V59, P343, DOI 10.1016/0012-821X(82)90136-4; HURFORD AJ, 1991, GEOL RUNDSCH, V80, P349, DOI 10.1007/BF01829371; Lague D, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000259; Li B, 2012, TECTONOPHYSICS, V580, P242, DOI 10.1016/j.tecto.2012.09.023; Mancktelow NS, 1997, TECTONOPHYSICS, V270, P167, DOI 10.1016/S0040-1951(96)00279-X; Menke W, 2012, GEOPHYSICAL DATA ANALYSIS: DISCRETE INVERSE THEORY, 3RD EDITION, P1; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Moore J, 2013, CHEM GEOL, V341, P110, DOI 10.1016/j.chemgeo.2013.01.005; Pedersen VK, 2013, NATURE, V493, P206, DOI 10.1038/nature11786; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Reiners PW, 2006, ANNU REV EARTH PL SC, V34, P419, DOI 10.1146/annurev.earth.34.031405.125202; Sambridge M, 1999, GEOPHYS J INT, V138, P727, DOI 10.1046/j.1365-246x.1999.00900.x; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; Schumer R, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2009JF001266; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; SHACKLETON NJ, 1977, NATURE, V270, P216, DOI 10.1038/270216a0; Shuster DL, 2011, SCIENCE, V332, P84, DOI 10.1126/science.1198401; Shuster DL, 2005, SCIENCE, V310, P1668, DOI 10.1126/science.1118519; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P19, DOI 10.1016/S0012-821X(03)00594-6; Steer P, 2012, NAT GEOSCI, V5, P635, DOI [10.1038/NGEO1549, 10.1038/ngeo1549]; Sternai P, 2013, EARTH PLANET SC LETT, V368, P119, DOI 10.1016/j.epsl.2013.02.039; SUPPE J, 1983, AM J SCI, V283, P684, DOI 10.2475/ajs.283.7.684; Tarantola A, 2005, INVERSE PROBLEM THEO; Thiede RC, 2013, EARTH PLANET SC LETT, V371, P278, DOI 10.1016/j.epsl.2013.03.004; Thomson SN, 2010, NATURE, V467, P313, DOI 10.1038/nature09365; Valla PG, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002043; Vernon AJ, 2008, EARTH PLANET SC LETT, V270, P316, DOI 10.1016/j.epsl.2008.03.053; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; WAGNER GA, 1972, EARTH PLANET SC LETT, V14, P263, DOI 10.1016/0012-821X(72)90018-0; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Willenbring JK, 2013, GEOLOGY, V41, P343, DOI 10.1130/G33918.1; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	57	308	320	19	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					423	+		10.1038/nature12877	http://dx.doi.org/10.1038/nature12877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24352288				2022-12-28	WOS:000328575300049
J	Ferner, RE; Aronson, JK				Ferner, R. E.; Aronson, J. K.			CHRISTMAS 2013: FOOD FOR THOUGHT Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-FEATURES; LAUGHING HEADACHE; HUMOR; CATAPLEXY; SYNCOPE; QUESTIONNAIRE; CHILDREN; STRESS; CURE	Objective To review the beneficial and harmful effects of laughter. Design Narrative synthesis. Data sources and review methods We searched Medline (1946 to June 2013) and Embase (1974 to June 2013) for reports of benefits or harms from laughter in humans, and counted the number of papers in each category. Results Benefits of laughter include reduced anger, anxiety, depression, and stress; reduced tension (psychological and cardiovascular); increased pain threshold; reduced risk of myocardial infarction (presumably requiring hearty laughter); improved lung function; increased energy expenditure; and reduced blood glucose concentration. However, laughter is no joke-dangers include syncope, cardiac and oesophageal rupture, and protrusion of abdominal hernias (from side splitting laughter or laughing fit to burst), asthma attacks, interlobular emphysema, cataplexy, headaches, jaw dislocation, and stress incontinence (from laughing like a drain). Infectious laughter can disseminate real infection, which is potentially preventable by laughing up your sleeve. As a side effect of our search for side effects, we also list pathological causes of laughter, among them epilepsy (gelastic seizures), cerebral tumours, Angelman's syndrome, strokes, multiple sclerosis, and amyotrophic lateral sclerosis or motor neuron disease. Conclusions Laughter is not purely beneficial. The harms it can cause are immediate and dose related, the risks being highest for Homeric (uncontrollable) laughter. The benefit-harm balance is probably favourable. It remains to be seen whether sick jokes make you ill or jokes in bad taste cause dysgeusia, and whether our views on comedians stand up to further scrutiny.	[Ferner, R. E.] City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Ferner, R. E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Aronson, J. K.] Green Templeton Coll, Oxford, England	University of Birmingham; University of Birmingham; University of Oxford	Ferner, RE (corresponding author), City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Adams P, 2002, POSTGRAD MED J, V78, P447, DOI 10.1136/pmj.78.922.447; Amaki M, 2007, INT HEART J, V48, P123, DOI 10.1536/ihj.48.123; Andreasen Dorthe Bach, 2010, Ugeskr Laeger, V172, P3496; Anic-Labat S, 1999, SLEEP, V22, P77; [Anonymous], 1982, LANCET, V1, P1000; [Anonymous], 1898, BMJ-BRIT MED J, V2, P829; [Anonymous], 1899, BMJ-BRIT MED J, V1, P989; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Bennett MP, 2009, EVID-BASED COMPL ALT, V6, P159, DOI 10.1093/ecam/nem149; Bergmann MS, 1999, HUMOR PSYCHE PSYCHOA; Bloomfield D, 2005, JAMA-J AM MED ASSOC, V293, P2863, DOI 10.1001/jama.293.23.2863-b; Braga SS, 2005, LANCET, V366, P426, DOI 10.1016/S0140-6736(05)67027-4; Bragg Matthew J, 2006, Emerg Med Australas, V18, P518, DOI 10.1111/j.1742-6723.2006.00877.x; BROCKLEBANK JT, 1981, ARCH DIS CHILD, V56, P232, DOI 10.1136/adc.56.3.232; Brutsche Martin H, 2008, Int J Chron Obstruct Pulmon Dis, V3, P185; Buchowski MS, 2007, INT J OBESITY, V31, P131, DOI 10.1038/sj.ijo.0803353; Cabot RC, 1928, NEW ENGL J MED, V198, P585; Chan TC, 2008, J EMERG MED, V34, P435, DOI 10.1016/j.jemermed.2007.06.037; Chen GH, 2012, PSYCHOL REP, V110, P25, DOI 10.2466/04.09.20.PR0.110.1.25-34; Chow GV, 2012, J CARDIOVASC ELECTR, V23, P1136, DOI 10.1111/j.1540-8167.2012.02296.x; Clark A, 2001, INT J CARDIOL, V80, P87, DOI 10.1016/S0167-5273(01)00470-3; Duchenne de Boulogne Guillaume-Benjamin, 1862, MECANISME PHYSIONOMI; Dunbar RIM, 2012, P ROY SOC B-BIOL SCI, V279, P1161, DOI 10.1098/rspb.2011.1373; El Otmani H, 2012, REV MED INTERNE, V33, P522, DOI 10.1016/j.revmed.2012.06.004; Empkie T M, 1987, Fam Med, V19, P430; Fletcher GW, 1921, CAN MED ASSOC J, V11, P332; Friedler S, 2011, FERTIL STERIL, V95, P2127, DOI 10.1016/j.fertnstert.2010.12.016; GAYRARD P, 1978, LANCET, V2, P1105; Gelkopf M., 2011, EVID-BASED COMPL ALT, V2011; Gelkopf M, 2006, J NERV MENT DIS, V194, P880, DOI 10.1097/01.nmd.0000243811.29997.f7; Gillespie RD, 1936, BRIT MED J, V1936, P1285, DOI 10.1136/bmj.1.3938.1285; Glies BG, 2007, SOC SCI MED, V64, P562, DOI 10.1016/j.socscimed.2006.09.007; Hall FDH, 1913, BRIT MED J, V1913, P967; Hasan H, 2009, INT J MED SCI, V6, P200; Hayashi K, 2003, DIABETES CARE, V26, P1651, DOI 10.2337/diacare.26.5.1651; Hayashi T, 2009, LIFE SCI, V85, P185, DOI 10.1016/j.lfs.2009.05.002; Herms AMRD, 2006, NEUROIMAGE, V29, P267, DOI 10.1016/j.neuroimage.2005.07.018; Janjua KJ, 1997, POSTGRAD MED J, V73, P265, DOI 10.1136/pgmj.73.859.265; Kadari R, 2012, ANN INTERN MED, V157, P756, DOI 10.7326/0003-4819-157-10-201211200-00022; Kimata H, 2009, J PSYCHOSOM RES, V66, P173, DOI 10.1016/j.jpsychores.2008.06.006; Krahn LE, 2005, J NEUROPSYCH CLIN N, V17, P45, DOI 10.1176/appi.neuropsych.17.1.45; Kratochvil S, 1993, Cesk Psychiatr, V89, P296; Lammers GJ, 2000, CLIN NEUROPHYSIOL, V111, P1276, DOI 10.1016/S1388-2457(00)00306-0; LASCELLES RG, 1976, J NEUROL NEUROSUR PS, V39, P1023, DOI 10.1136/jnnp.39.10.1023; Levin M, 2003, HEADACHE, V43, P801, DOI 10.1046/j.1526-4610.2003.03141.x; Liangas G, 2003, PEDIATR PULM, V36, P107, DOI 10.1002/ppul.10313; Lo R, 2007, AM J MED, V120, pE5, DOI 10.1016/j.amjmed.2006.07.019; Locke E A, 1927, Trans Am Climatol Clin Assoc, V43, P30; McGarvey L, 2009, PULM PHARMACOL THER, V22, P59, DOI 10.1016/j.pupt.2008.11.003; Meisel V, 2009, PSICOTHEMA, V21, P604; Morales-Asin F, 1998, HEADACHE, V38, P552, DOI 10.1046/j.1526-4610.1998.3807552.x; Muller GP, 1933, ANN SURG, V98, P1018, DOI 10.1097/00000658-193312000-00004; Nishimoto K, 2008, J ADV MECH DES SYST, V2, P197, DOI [10.1299/jamdsm.2.197, 10.1186/1752-1947-2-197]; Nissan E, 2012, ISR J HUMOR RES, V1, P1; Overeem S, 2011, SLEEP MED, V12, P12, DOI 10.1016/j.sleep.2010.05.010; Pandian JD, 2007, J CLIN NEUROSCI, V14, P786, DOI 10.1016/j.jocn.2006.05.012; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; Robbiolo L, 2005, INTERNISTA, V13, P52; ROURKE JTB, 1988, CAN MED ASSOC J, V138, P721; Schultz WW, 1999, BRIT MED J, V319, P1596, DOI 10.1136/bmj.319.7225.1596; SCHWARTZ A, 1968, SCIENCE, V160, P323, DOI 10.1126/science.160.3825.323; Shah AA, 2010, AM J MED, V123, P609, DOI 10.1016/j.amjmed.2010.02.009; Sharma H, 2007, BRIT J SPORT MED, V41, P688, DOI 10.1136/bjsm.2007.036087; SHER PK, 1994, PEDIATR NEUROL, V10, P81, DOI 10.1016/0887-8994(94)90076-0; Skerritt E M, 1892, Br Med J, V1, P1010; Strick M, 2012, J EXP PSYCHOL-APPL, V18, P213, DOI 10.1037/a0028534; Sugawara J, 2010, AM J CARDIOL, V106, P856, DOI 10.1016/j.amjcard.2010.05.011; Tan Stanley A, 2007, Adv Mind Body Med, V22, P8; Tang JLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021392; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Vanagt WY, 2005, PEDIATR CARDIOL, V26, P866, DOI 10.1007/s00246-005-0985-5; Vlachopoulos C, 2009, PSYCHOSOM MED, V71, P446, DOI 10.1097/PSY.0b013e318198dcd4; Vrooman CH, 1934, CAN MED ASSOC J, V30, P265; Walter M, 2007, INT J GERIATR PSYCH, V22, P77, DOI 10.1002/gps.1658; Williams C T, 1874, Br Med J, V1, P769; YouTube, 2010, GODN FARV LISB DAH U	76	10	10	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f7274	10.1136/bmj.f7274	http://dx.doi.org/10.1136/bmj.f7274			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZQ	24336308	hybrid, Green Published			2022-12-28	WOS:000328575200008
J	Geng, Y; Bush, M; Mosyak, L; Wang, F; Fan, QR				Geng, Yong; Bush, Martin; Mosyak, Lidia; Wang, Feng; Fan, Qing R.			Structural mechanism of ligand activation in human GABA(B) receptor	NATURE			English	Article							AMINOBUTYRIC ACID(B) RECEPTORS; PROTEIN-COUPLED RECEPTOR; N-TERMINAL DOMAIN; EXTRACELLULAR DOMAIN; GB2 SUBUNITS; GLUTAMATE; BINDING; PHARMACOLOGY; ANTAGONIST; EXPRESSION	Human GABA(B) (gamma-aminobutyric acid class B) receptor is a G-protein-coupled receptor central to inhibitory neurotransmission in the brain. It functions as an obligatory heterodimer of the subunits GBR1 and GBR2. Here we present the crystal structures of a heterodimeric complex between the extracellular domains of GBR1 and GBR2 in the apo, agonist-bound and antagonist-bound forms. The apo and antagonist-bound structures represent the resting state of the receptor; the agonist-bound complex corresponds to the active state. Both subunits adopt an open conformation at rest, and only GBR1 closes on agonist-induced receptor activation. The agonists and antagonists are anchored in the interdomain crevice of GBR1 by an overlapping set of residues. An antagonist confines GBR1 to the open conformation of the inactive state, whereas an agonist induces its domain closure for activation. Our data reveal a unique activation mechanism for GABA(B) receptor that involves the formation of a novel heterodimer interface between subunits.	[Geng, Yong; Bush, Martin; Mosyak, Lidia; Wang, Feng; Fan, Qing R.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Fan, Qing R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Fan, QR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	qf13@columbia.edu			American Heart Association [SDG0835183N]; National Institute of Health [R01GM088454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088454] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. A. Hendrickson and R. Kass for advice and support; I. Berger for the gift of pFBDM vector; K. Rajashankar, K. Perry, S. Banerjee, F. Murphy, I. Kourinov and D. Neau for help with data collection; Y. Chen for technical assistance; and M. Evelyn for reading the manuscript. This work was supported by the American Heart Association grant SDG0835183N and the National Institute of Health grant R01GM088454 (both to Q. R. F.). Q. R. F. is an Irma Hirschl Career Scientist, Pew Scholar, McKnight Scholar and Schaefer Scholar.	Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Froestl W, 2010, ADV PHARMACOL, V58, P19, DOI 10.1016/S1054-3589(10)58002-5; FRYDENVANG K, 1994, CHIRALITY, V6, P583, DOI 10.1002/chir.530060712; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kerr DIB, 1995, EUR J PHARMACOL, V287, P185, DOI 10.1016/0014-2999(95)00641-9; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ng GYK, 1999, J BIOL CHEM, V274, P7607, DOI 10.1074/jbc.274.12.7607; Nomura R, 2008, J BIOL CHEM, V283, P4665, DOI 10.1074/jbc.M705202200; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagano A, 2001, J NEUROSCI, V21, P1189; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	62	131	139	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					254	+		10.1038/nature12725	http://dx.doi.org/10.1038/nature12725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305054	Green Accepted			2022-12-28	WOS:000328121500031
J	Stone-Brown, K				Stone-Brown, Keir			Syria: a healthcare system on the brink of collapse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stone-Brown, Keir] Univ Manchester, Manchester M13 9PL, Lancs, England; [Stone-Brown, Keir] City Univ London, London EC1V 0HB, England	University of Manchester; City University London	Stone-Brown, K (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	Keir.Stone-Brown.1@city.ac.uk						[Anonymous], 2012, IRIN            1211; [Anonymous], 2012, BBC NEWS; Doucet L., 2013, BBC NEWS; Eichner M, 2013, LANCET, V382, P1777, DOI 10.1016/S0140-6736(13)62220-5; Sen K, 2013, J PUBLIC HEALTH-UK, V35, P195, DOI 10.1093/pubmed/fds090	5	13	13	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7375	10.1136/bmj.f7375	http://dx.doi.org/10.1136/bmj.f7375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24327182				2022-12-28	WOS:000328574700008
J	Boets, B; Op de Beeck, HP; Vandermosten, M; Scott, SK; Gillebert, CR; Mantini, D; Bulthe, J; Sunaert, S; Wouters, J; Ghesquiere, P				Boets, Bart; Op de Beeck, Hans P.; Vandermosten, Maaike; Scott, Sophie K.; Gillebert, Celine R.; Mantini, Dante; Bulthe, Jessica; Sunaert, Stefan; Wouters, Jan; Ghesquiere, Pol			Intact But Less Accessible Phonetic Representations in Adults with Dyslexia	SCIENCE			English	Article							SPEECH; ORGANIZATION; CONNECTIVITY; LANGUAGE; CHILDREN	Dyslexia is a severe and persistent reading and spelling disorder caused by impairment in the ability to manipulate speech sounds. We combined functional magnetic resonance brain imaging with multivoxel pattern analysis and functional and structural connectivity analysis in an effort to disentangle whether dyslexics' phonological deficits are caused by poor quality of the phonetic representations or by difficulties in accessing intact phonetic representations. We found that phonetic representations are hosted bilaterally in primary and secondary auditory cortices and that their neural quality (in terms of robustness and distinctness) is intact in adults with dyslexia. However, the functional and structural connectivity between the bilateral auditory cortices and the left inferior frontal gyrus (a region involved in higher-level phonological processing) is significantly hampered in dyslexics, suggesting deficient access to otherwise intact phonetic representations.	[Boets, Bart] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Boets, Bart; Vandermosten, Maaike; Ghesquiere, Pol] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, B-3000 Louvain, Belgium; [Op de Beeck, Hans P.; Bulthe, Jessica] Katholieke Univ Leuven, Lab Biol Psychol, B-3000 Louvain, Belgium; [Scott, Sophie K.] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Gillebert, Celine R.; Mantini, Dante] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Mantini, Dante] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland; [Sunaert, Stefan] Katholieke Univ Leuven, Dept Radiol, B-3000 Louvain, Belgium; [Wouters, Jan] Katholieke Univ Leuven, Dept Neurosci, ExpORL, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; University of London; University College London; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; KU Leuven; KU Leuven	Boets, B (corresponding author), Katholieke Univ Leuven, B-3000 Louvain, Belgium.	bart.boets@ppw.kuleuven.be	Wouters, Jan/D-1800-2015; Mantini, Dante/D-6989-2014; Ghesquière, Pol/B-9226-2009; Boets, Bart/AAB-1646-2020; Scott, Sophie K/A-1843-2010; Vandermosten, Maaike/AAC-2979-2021; Sunaert, Stefan/E-8031-2011	Wouters, Jan/0000-0002-0093-698X; Mantini, Dante/0000-0001-6485-5559; Ghesquière, Pol/0000-0001-9056-7550; Boets, Bart/0000-0002-4718-667X; Scott, Sophie K/0000-0001-7510-6297; Vandermosten, Maaike/0000-0002-9928-1580; Sunaert, Stefan/0000-0002-1177-4680; Op de Beeck, Hans/0000-0002-2250-212X; Gillebert, Celine/0000-0001-6686-7262	KU Leuven [OT/07/034, IDO/10/003]; Research Foundation Flanders [G0331.08]; European Research Council [ERC-2011-Stg-284101]; Federal Research Action [IUAP/PAI P7/11]; Queen Fabiola Foundation; Wellcome Trust [098771/Z/12/Z, 101253/Z/13/Z, WT090961MA]; Royal Society [101253/Z/13/Z]	KU Leuven(KU Leuven); Research Foundation Flanders(FWO); European Research Council(European Research Council (ERC)European Commission); Federal Research Action; Queen Fabiola Foundation; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	Supported by KU Leuven (OT/07/034, IDO/10/003), Research Foundation Flanders (G0331.08, postdoctoral fellowship of B. B. and M. V.), European Research Council (grant ERC-2011-Stg-284101), Federal Research Action (IUAP/PAI P7/11), Queen Fabiola Foundation, Wellcome Trust [Sir Henry Wellcome fellowship of C. R. G. (098771/Z/12/Z), Sir Henry Dale fellowship of D. M. (101253/Z/13/Z), and grant WT090961MA of S. K. S.], and the Royal Society (D. M.: 101253/Z/13/Z). Matlab scripts are available in the supplementary materials. We thank R. Peeters and H. Poelmans for assistance. B. B., H.P.O.d.B., M. V., S. K. S., S. S., J.W., and P. G. designed the study; B. B. and M. V. collected the data; B. B. analyzed the data and wrote the manuscript; H.P.O.d.B. and J.B. contributed to MVPA analyses; M. V. and S. S. contributed to DTI analyses; C. R. G. and D. M. contributed to functional connectivity analyses; and all authors discussed the results and commented on the manuscript.	Boets B, 2010, BRIT J DEV PSYCHOL, V28, P5, DOI 10.1348/026151010X485223; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Goswami U, 2000, Dyslexia, V6, P133, DOI 10.1002/(SICI)1099-0909(200004/06)6:2<133::AID-DYS160>3.0.CO;2-A; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Obleser J, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00232; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	25	233	236	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1251	1254		10.1126/science.1244333	http://dx.doi.org/10.1126/science.1244333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311693	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000327857900052
J	Dickey, SW; Baker, RP; Cho, S; Urban, S				Dickey, Seth W.; Baker, Rosanna P.; Cho, Sangwoo; Urban, Sinisa			Proteolysis inside the Membrane Is a Rate-Governed Reaction Not Driven by Substrate Affinity	CELL			English	Article							RHOMBOID PROTEASE; INTRAMEMBRANE PROTEOLYSIS; ESCHERICHIA-COLI; GAMMA-SECRETASE; PROVIDENCIA-STUARTII; MECHANISM; SPECIFICITY; CATALYSIS; IDENTIFICATION; GLYCOSYLASE	Enzymatic cleavage of transmembrane anchors to release proteins from the membrane controls diverse signaling pathways and is implicated in more than a dozen diseases. How catalysis works within the viscous, water-excluding, two-dimensional membrane is unknown. We developed an inducible reconstitution system to interrogate rhomboid proteolysis quantitatively within the membrane in real time. Remarkably, rhomboid proteases displayed no physiological affinity for substrates (K-d similar to 190 mu M/0.1 mol%). Instead, similar to 10,000-fold differences in proteolytic efficiency with substrate mutants and diverse rhomboid proteases were reflected in k(cat) values alone. Analysis of gate-open mutant and solvent isotope effects revealed that substrate gating, not hydrolysis, is rate limiting. Ultimately, a single proteolytic event within the membrane normally takes minutes. Rhomboid intramembrane proteolysis is thus a slow, kinetically controlled reaction not driven by transmembrane protein-protein affinity. These properties are unlike those of other studied proteases or membrane proteins but are strikingly reminiscent of one subset of DNA-repair enzymes, raising important mechanistic and drug-design implications.	[Dickey, Seth W.; Baker, Rosanna P.; Cho, Sangwoo; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Urban, S (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Room 507 PCTB,725 North Wolfe St, Baltimore, MD 21205 USA.	surban@jhmi.edu	Dickey, Seth/AIC-7671-2022	Baker, Rosanna/0000-0002-9970-6278	NIH [2R01AI066025, GM-103485]; Howard Hughes Medical Institute; David and Lucile Packard Foundation; NSF [DMR-0936384]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, P41GM103485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant 2R01AI066025, the Howard Hughes Medical Institute, and the David and Lucile Packard Foundation. Part of this research was conducted using instruments at the Malaria Research Institute Biophysics Core (CD spectrometer), and CHESS (beamline supported by NSF grant DMR-0936384 and NIH grant GM-103485).	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; ELROD JP, 1980, J AM CHEM SOC, V102, P3917, DOI 10.1021/ja00531a039; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; Huntington JA, 2012, BBA-PROTEINS PROTEOM, V1824, P246, DOI 10.1016/j.bbapap.2011.07.005; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Lazareno-Saez C, 2013, J MOL BIOL, V425, P1127, DOI 10.1016/j.jmb.2013.01.019; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; SCHNAITM.CA, 1970, J BACTERIOL, V104, P890, DOI 10.1128/JB.104.2.890-901.1970; SCHNAITM.CA, 1970, J BACTERIOL, V104, P882, DOI 10.1128/JB.104.2.882-889.1970; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zhang DN, 2006, BIOCHEMISTRY-US, V45, P14175, DOI 10.1021/bi061218m; Zhou YZ, 2012, STRUCTURE, V20, P1255, DOI 10.1016/j.str.2012.04.022	47	98	99	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1270	1281		10.1016/j.cell.2013.10.053	http://dx.doi.org/10.1016/j.cell.2013.10.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315097	Green Accepted, Bronze			2022-12-28	WOS:000328271100012
J	Ryan, SD; Dolatabadi, N; Chan, SF; Zhang, XF; Akhtar, MW; Parker, J; Soldner, F; Sunico, CR; Nagar, S; Talantova, M; Lee, B; Lopez, K; Nutter, A; Shan, B; Molokanova, E; Zhang, YY; Han, XM; Nakamura, T; Masliah, E; Yates, JR; Nakanishi, N; Andreyev, AY; Okamoto, S; Jaenisch, R; Ambasudhan, R; Lipton, SA				Ryan, Scott D.; Dolatabadi, Nima; Chan, Shing Fai; Zhang, Xiaofei; Akhtar, Mohd Waseem; Parker, James; Soldner, Frank; Sunico, Carmen R.; Nagar, Saumya; Talantova, Maria; Lee, Brian; Lopez, Kevin; Nutter, Anthony; Shan, Bing; Molokanova, Elena; Zhang, Yaoyang; Han, Xuemei; Nakamura, Tomohiro; Masliah, Eliezer; Yates, John R., III; Nakanishi, Nobuki; Andreyev, Aleksander Y.; Okamoto, Shu-ichi; Jaenisch, Rudolf; Ambasudhan, Rajesh; Lipton, Stuart A.			Isogenic Human iPSC Parkinson's Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1 alpha Transcription	CELL			English	Article							PROTEIN S-NITROSYLATION; PLURIPOTENT STEM-CELLS; ALPHA-SYNUCLEIN; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL-FUNCTION; MEF2; PARAQUAT; NEURONS; DIFFERENTIATION	Parkinson's disease (PD) is characterized by loss of A9 dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). An association has been reported between PD and exposure to mitochondrial toxins, including environmental pesticides paraquat, maneb, and rotenone. Here, using a robust, patient-derived stem cell model of PD allowing comparison of A53T alpha-synuclein (alpha-syn) mutant cells and isogenic mutation-corrected controls, we identify mitochondrial toxin-induced perturbations in A53T alpha-syn A9 DA neurons (hNs). We report a pathway whereby basal and toxin-induced nitrosative/oxidative stress results in S-nitrosylation of transcription factor MEF2C in A53T hNs compared to corrected controls. This redox reaction inhibits the MEF2-CPGC1 alpha transcriptional network, contributing to mitochondrial dysfunction and apoptotic cell death. Our data provide mechanistic insight into gene-environmental interaction (GxE) in the pathogenesis of PD. Furthermore, using small-molecule high-throughput screening, we identify the MEF2C-PGC1 alpha pathway as a therapeutic target to combat PD.	[Ryan, Scott D.; Dolatabadi, Nima; Chan, Shing Fai; Zhang, Xiaofei; Akhtar, Mohd Waseem; Parker, James; Sunico, Carmen R.; Nagar, Saumya; Talantova, Maria; Lee, Brian; Lopez, Kevin; Nutter, Anthony; Molokanova, Elena; Nakamura, Tomohiro; Nakanishi, Nobuki; Okamoto, Shu-ichi; Ambasudhan, Rajesh; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Web Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shan, Bing; Zhang, Yaoyang; Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Andreyev, Aleksander Y.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92039 USA; [Masliah, Eliezer; Lipton, Stuart A.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92039 USA	Sanford Burnham Prebys Medical Discovery Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; rajesh@sbmri.org; slipton@sbmri.org		Andreyev, Alexander Y./0000-0002-9246-9943; Zhang, Yaoyang/0000-0001-5363-9834; Nagar, Saumya/0000-0002-9111-477X; Lipton, Stuart/0000-0002-3490-1259; Ryan, Scott/0000-0001-9829-4649	NIH [P01 HD29587, P01 ES016738, P30 NS076411]; United Mitochondrial Disease Foundation; Parkinson Society of Canada Fellowship;  [R37 CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, R01NS086890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Parkinson Society of Canada Fellowship; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants P01 HD29587, P01 ES016738, and P30 NS076411 (to S.A.L.); R37 CA084198 (to R.J.); United Mitochondrial Disease Foundation grant (to R.A.); and a Parkinson Society of Canada Fellowship (to S.D.R.).	Bonneh-Barkay D, 2005, ANTIOXID REDOX SIGN, V7, P649, DOI 10.1089/ars.2005.7.649; Chavarria C, 2013, ARCH BIOCHEM BIOPHYS, V533, P25, DOI 10.1016/j.abb.2013.02.009; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Cooper O., 2012, SCI TRANSL MED, V4; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	52	303	307	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1351	1364		10.1016/j.cell.2013.11.009	http://dx.doi.org/10.1016/j.cell.2013.11.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24290359	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000328271100018
J	Smetacek, V; Zingone, A				Smetacek, Victor; Zingone, Adriana			Green and golden seaweed tides on the rise	NATURE			English	Article							LARGEST MACROALGAL BLOOM; HARMFUL ALGAL BLOOMS; YELLOW SEA; ULVA-PROLIFERA; WATERS; ENTEROMORPHA; SARGASSUM; RESPONSES; GROWTH; REGION	Sudden beaching of huge seaweed masses smother the coastline and form rotting piles on the shore. The number of reports of these events in previously unaffected areas has increased worldwide in recent years. These 'seaweed tides' can harm tourism-based economies, smother aquaculture operations or disrupt traditional artisanal fisheries. Coastal eutrophication is the obvious, ultimate explanation for the increase in seaweed biomass, but the proximate processes that are responsible for individual beaching events are complex and require dedicated study to develop effective mitigation strategies. Harvesting the macroalgae, a valuable raw material, before they beach could well be developed into an effective solution.	[Smetacek, Victor] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Zingone, Adriana] Ecol & Evolut Plankton, Stn Zool Anton Dohrn, I-80121 Naples, Italy	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Stazione Zoologica Anton Dohrn di Napoli	Smetacek, V (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany.	victor.smetacek@awi.de; zingone@szn.it	Zingone, Adriana/E-4518-2010	Zingone, Adriana/0000-0001-5946-6532				Ackah-Baidoo A, 2013, COMMUNITY DEV J, V48, P406, DOI 10.1093/cdj/bst022; Algae Industry Magazine, 2013, OLM OP ALG BIOR BRIT; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; [Anonymous], 2011, OPEN OCEAN J, DOI [10.2174/1874252101105010001, DOI 10.2174/1874252101105010001]; Back S, 2000, ANN BOT FENN, V37, P155; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Charlier Roger H., 2008, International Journal of Environmental Studies, V65, P197, DOI 10.1080/00207230701791448; deVlas J., 2009, WADDEN SEA ECOSYSTEM, P1; Diaz M, 2013, ENVIRON INNOV SOC TR, V8, P62, DOI 10.1016/j.eist.2013.04.002; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; GEERTZHANSEN O, 1993, AQUAT BOT, V46, P101, DOI 10.1016/0304-3770(93)90039-Y; GEOHAB, 2001, GLOB EC OC HARMF ALG; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Gower J, 2013, REMOTE SENS LETT, V4, P764, DOI 10.1080/2150704X.2013.796433; Harder T, 2004, MAR ECOL PROG SER, V274, P133, DOI 10.3354/meps274133; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hemphill A., 2013, CHANGE IS AIR SEAWEE; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; Jacobs A., 2013, NY TIMES; Jing L., 2013, S CHINA MORNING POST; JOHNSON DL, 1977, J EXP MAR BIOL ECOL, V28, P255, DOI 10.1016/0022-0981(77)90095-8; Kamermans Pauline, 2002, Aquatic Ecology, V36, P425, DOI 10.1023/A:1016551911754; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Laffoley D., 2011, PROTECTION MANAGEMEN, P1; LAPOINTE BE, 1995, LIMNOL OCEANOGR, V40, P625, DOI 10.4319/lo.1995.40.3.0625; Arroyo NL, 2012, J EXP MAR BIOL ECOL, V420, P77, DOI 10.1016/j.jembe.2012.03.020; Lin HZ, 2011, ENVIRON SCI TECHNOL, V45, P5996, DOI 10.1021/es200579q; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; McDiarmid J., 2011, W GHANAS FISHERFOLK; Nelson TA, 2003, J PHYCOL, V39, P874, DOI 10.1046/j.1529-8817.2003.02157.x; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norkko A, 1996, MAR ECOL PROG SER, V140, P141, DOI 10.3354/meps140141; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; *S ATL FISH MAN CO, 2002, FISH MAN PLAN PEL SA; Saltmarsh M, 2010, NY TIMES; Samuel Henry, 2013, TELEGRAPH; Sfriso A, 1996, BIORESOURCE TECHNOL, V58, P299, DOI 10.1016/S0960-8524(96)00120-4; Sun S., 2008, NATURE PRECEDINGS, DOI 10101/npre.2008.2266.1; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Viscusi G., 2011, BOSTON GLOBE; Williams A, 2010, ENVIRON MANAGE, V46, P738, DOI 10.1007/s00267-010-9558-3; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang JH, 2013, J APPL PHYCOL, V25, P795, DOI 10.1007/s10811-012-9972-4; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	48	459	496	36	366	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					84	88		10.1038/nature12860	http://dx.doi.org/10.1038/nature12860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305152	Green Published			2022-12-28	WOS:000327851700029
J	Zhang, YJJ; Reddy, MC; Ioerger, TR; Rothchild, AC; Dartois, V; Schuster, BM; Trauner, A; Wallis, D; Galaviz, S; Huttenhower, C; Sacchettini, JC; Behar, SM; Rubin, EJ				Zhang, Yanjia J.; Reddy, Manchi C.; Ioerger, Thomas R.; Rothchild, Alissa C.; Dartois, Veronique; Schuster, Brian M.; Trauner, Andrej; Wallis, Deeann; Galaviz, Stacy; Huttenhower, Curtis; Sacchettini, James C.; Behar, Samuel M.; Rubin, Eric J.			Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing	CELL			English	Article							INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE-RESPONSE; NITRIC-OXIDE; TUBERCULOSIS; PERSISTENCE; EXPRESSION; INFECTION; SURVIVAL; MACROPHAGES	Bacteria that cause disease rely on their ability to counteract and overcome host defenses. Here, we present a genome-scale study of Mycobacterium tuberculosis (Mtb) that uncovers the bacterial determinants of surviving host immunity, sets of genes we term "counteractomes." Through this analysis, we found that CD4 T cells attempt to contain Mtb growth by starving it of tryptophan-a mechanism that successfully limits infections by Chlamydia and Leishmania, natural tryptophan auxotrophs. Mtb, however, can synthesize tryptophan under stress conditions, and thus, starvation fails as an Mtb-killing mechanism. We then identify a small-molecule inhibitor of Mtb tryptophan synthesis, which converts Mtb into a tryptophan auxotroph and restores the efficacy of a failed host defense. Together, our findings demonstrate that the Mtb immune counteractomes serve as probes of host immunity, uncovering immune-mediated stresses that can be leveraged for therapeutic discovery.	[Zhang, Yanjia J.; Schuster, Brian M.; Trauner, Andrej; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Reddy, Manchi C.; Wallis, Deeann; Galaviz, Stacy; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77842 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77842 USA; [Rothchild, Alissa C.; Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Dartois, Veronique] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	erubin@hsph.harvard.edu	Rothchild, Alissa/AAM-2635-2020	Rothchild, Alissa/0000-0001-7484-1193; Rubin, Eric/0000-0001-5120-962X; Behar, Samuel/0000-0002-3374-6699; Trauner, Andrej/0000-0002-6260-9829	National Institutes of Health [T32 GM007753, R01 AI 098637, P01 AI095208]; Herchel Smith Graduate Fellowship of Harvard; Wolfe-Welch Chair; Cambridge University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208, R01AI106725, R01AI098637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herchel Smith Graduate Fellowship of Harvard; Wolfe-Welch Chair; Cambridge University(University of Cambridge); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael DeJesus, Chris Sassetti, and Justin Pritchard for their ongoing collaboration and thoughtful conversations about genomic profiling in Mtb. We thank Xiaohua Li and Spandana Valluru for technical support. Noman Sidddiqi and Larry Pipkin manage and run our BL3 facility; we thank them for their support. We thank our tremendous scientific community, including Marcia Goldberg, Laurence Rahme, Sarah Fortune, and Barry Bloom, for its constant support and feedback. The project described was supported by the National Institutes of Health (T32 GM007753 to Y.J.Z., R01 AI 098637 to S.M.B., and P01 AI095208 to J.C.S. and E.J.R.), the Herchel Smith Graduate Fellowship of Harvard and Cambridge University (to Y.J.Z.), and the Wolfe-Welch Chair (to J.C.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlberatiGiani D, 1997, J IMMUNOL, V159, P419; [Anonymous], 2011, GLOB TUB CONTR 2011; BAKER TI, 1966, J BIOL CHEM, V241, P5577; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Coggins JR, 2003, BIOCHEM SOC T, V31, P548, DOI 10.1042/BST0310548; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ibana JA, 2011, INFECT IMMUN, V79, P4425, DOI 10.1128/IAI.05659-11; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lesic B, 2007, PLOS PATHOG, V3, P1229, DOI 10.1371/journal.ppat.0030126; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TARSHIS MS, 1953, AM REV TUBERC PULM, V67, P391; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; WHO, 2007, WHO TECH REP SER, V935, P1; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	46	216	221	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1296	1308		10.1016/j.cell.2013.10.045	http://dx.doi.org/10.1016/j.cell.2013.10.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315099	Green Accepted, Bronze			2022-12-28	WOS:000328271100014
J	Warner, DO; Berge, K; Sun, HP; Harman, A; Hanson, A; Schroeder, DR				Warner, David O.; Berge, Keith; Sun, Huaping; Harman, Ann; Hanson, Andrew; Schroeder, Darrell R.			Substance Use Disorder Among Anesthesiology Residents, 1975-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEMICAL DEPENDENCY; ABUSE; PHYSICIANS; AUSTRALIA; PROGRAMS; HISTORY	IMPORTANCE Substance use disorder (SUD) among anesthesiologists and other physicians poses serious risks to both physicians and patients. Formulation of policy and individual treatment plans is hampered by lack of data regarding the epidemiology and outcomes of physician SUD. OBJECTIVE To describe the incidence and outcomes of SUD among anesthesiology residents. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of physicians who began training in United States anesthesiology residency programs from July 1, 1975, to July 1, 2009, including 44 612 residents contributing 177 848 resident-years to analysis. Follow-up for incidence and relapse was to the end of training and December 31, 2010, respectively. MAIN OUTCOMES AND MEASURES Cases of SUD (including initial SUD episode and any relapse, vital status and cause of death, and professional consequences of SUD) ascertained through training records of the American Board of Anesthesiology, including information from the Disciplinary Action Notification Service of the Federation of State Medical Boards and cause of death information from the National Death Index. RESULTS Of the residents, 384 had evidence of SUD during training, with an overall incidence of 2.16 (95% CI, 1.95-2.39) per 1000 resident-years (2.68 [95% CI, 2.41-2.98] men and 0.65 [95% CI, 0.44-0.93] women per 1000 resident-years). During the study period, an initial rate increase was followed by a period of lower rates in 1996-2002, but the highest incidence has occurred since 2003 (2.87 [95% CI, 2.42-3.39] per 1000 resident-years). The most common substance category was intravenous opioids, followed by alcohol, marijuana or cocaine, anesthetics/hypnotics, and oral opioids. Twenty-eight individuals (7.3%; 95% CI, 4.9%-10.4%) died during the training period; all deaths were related to SUD. The Kaplan-Meier estimate of the cumulative proportion of survivors experiencing at least 1 relapse by 30 years after the initial episode (based on a median follow-up of 8.9 years [interquartile range, 5.0-18.8 years]) was 43%(95% CI, 34%-51%). Rates of relapse and death did not depend on the category of substance used. Relapse rates did not change over the study period. CONCLUSIONS AND RELEVANCE Among anesthesiology residents entering primary training from 1975 to 2009, 0.86% had evidence of SUD during training. Risk of relapse over the follow-up period was high, indicating persistence of risk after training.	[Warner, David O.; Berge, Keith] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Hanson, Andrew; Schroeder, Darrell R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Warner, David O.; Sun, Huaping; Harman, Ann] Amer Board Anesthesiol, Raleigh, NC USA	Mayo Clinic; Mayo Clinic	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55905 USA.	warner.david@mayo.edu			Mayo Foundation; National Institutes of Health Clinical and Translational Science Award at Mayo Clinic [UL1TR000135]	Mayo Foundation; National Institutes of Health Clinical and Translational Science Award at Mayo Clinic	The American Board of Anesthesiology provided support for the collection and management of the data by allowing staff time to be used for this purpose. Funds from Mayo Foundation supported the analysis of the deidentified data. The REDCap system used to abstract the data is supported by the National Institutes of Health Clinical and Translational Science Award at Mayo Clinic (grant UL1TR000135).	Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008; Berge KH, 2008, ANESTHESIOLOGY, V109, P762, DOI 10.1097/ALN.0b013e31818a3814; Berge KH, 2009, MAYO CLIN PROC, V84, P625, DOI 10.1016/S0025-6196(11)60751-9; Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB; Bryson EO, 2009, J CLIN ANESTH, V21, P508, DOI 10.1016/j.jclinane.2008.12.026; Carinci AJ, 2009, PAIN PHYSICIAN, V12, P487; Collins GB, 2005, ANESTH ANALG, V101, P1457, DOI 10.1213/01.ANE.0000180837.78169.04; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; DuPont RL, 2009, J SUBST ABUSE TREAT, V37, P1, DOI 10.1016/j.jsat.2009.03.010; Fry RA, 2005, ANAESTH INTENS CARE, V33, P248, DOI 10.1177/0310057X0503300216; GRAVENSTEIN JS, 1983, ANESTH ANALG, V62, P467; HUGHES PH, 1992, AM J PSYCHIAT, V149, P1348; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; KLEIN RL, 1992, ANESTHESIOLOGY, V77, P806, DOI 10.1097/00000542-199210000-00026; LUTSKY I, 1993, CAN J ANAESTH, V40, P915, DOI 10.1007/BF03010092; McLellan AT, 2008, BMJ-BRIT MED J, V4, P337; MENK EJ, 1990, JAMA-J AM MED ASSOC, V263, P3060, DOI 10.1001/jama.263.22.3060; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; National Center on Addiction and Substance Abuse (CASA) at Columbia University, 2012, ADD MED CLOS GAP SCI; Oreskovich MR, 2009, MAYO CLIN PROC, V84, P576, DOI 10.1016/S0025-6196(11)60745-3; PELTON C, 1991, J PSYCHOACTIVE DRUGS, V23, P427, DOI 10.1080/02791072.1991.10471613; Skipper GE, 2009, ANESTH ANALG, V109, P891, DOI 10.1213/ane.0b013e3181adc39d; TALBOTT GD, 1987, JAMA-J AM MED ASSOC, V257, P2927, DOI 10.1001/jama.257.21.2927; WEEKS AM, 1993, ANAESTH INTENS CARE, V21, P151, DOI 10.1177/0310057X9302100203; Wilson JE, 2008, ANAESTHESIA, V63, P616, DOI 10.1111/j.1365-2044.2008.05444.x; Wischmeyer PE, 2007, ANESTH ANALG, V105, P1066, DOI 10.1213/01.ane.0000270215.86253.30	26	63	64	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2289	2296		10.1001/jama.2013.281954	http://dx.doi.org/10.1001/jama.2013.281954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302092	Green Accepted, Bronze			2022-12-28	WOS:000327746300014
J	Dewland, TA; Vittinghoff, E; Mandyam, MC; Heckbert, SR; Siscovick, DS; Stein, PK; Psaty, BM; Sotoodehnia, N; Gottdiener, JS; Marcus, GM				Dewland, Thomas A.; Vittinghoff, Eric; Mandyam, Mala C.; Heckbert, Susan R.; Siscovick, David S.; Stein, Phyllis K.; Psaty, Bruce M.; Sotoodehnia, Nona; Gottdiener, John S.; Marcus, Gregory M.			Atrial Ectopy as a Predictor of Incident Atrial Fibrillation A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RISK; RECLASSIFICATION; INITIATION; ABLATION; CATHETER; TRIAL	Background: Atrial fibrillation (AF) prediction models have unclear clinical utility given the absence of AF prevention therapies and the immutability of many risk factors. Premature atrial contractions (PACs) play a critical role in AF pathogenesis and may be modifiable. Objective: To investigate whether PAC count improves model performance for AF risk. Design: Prospective cohort study. Setting: 4 U.S. communities. Patients: A random subset of 1260 adults without prevalent AF enrolled in the Cardiovascular Health Study between 1989 and 1990. Measurements: The PAC count was quantified by 24-hour electrocardiography. Participants were followed for the diagnosis of incident AF or death. The Framingham AF risk algorithm was used as the comparator prediction model. Results: In adjusted analyses, doubling the hourly PAC count was associated with a significant increase in AF risk (hazard ratio, 1.17 [95% CI, 1.13 to 1.22]; P < 0.001) and overall mortality (hazard ratio, 1.06 [CI, 1.03 to 1.09]; P < 0.001). Compared with the Framingham model, PAC count alone resulted in similar AF risk discrimination at 5 and 10 years of follow-up and superior risk discrimination at 15 years. The addition of PAC count to the Framingham model resulted in significant 10-year AF risk discrimination improvement (c-statistic, 0.65 vs. 0.72; P < 0.001), net reclassification improvement (23.2% [CI, 12.8% to 33.6%]; P < 0.001), and integrated discrimination improvement (5.6% [CI, 4.2% to 7.0%]; P < 0.001). The specificity for predicting AF at 15 years exceeded 90% for PAC counts more than 32 beats/h. Limitation: This study does not establish a causal link between PACs and AF. Conclusion: The addition of PAC count to a validated AF risk algorithm provides superior AF risk discrimination and significantly improves risk reclassification. Further study is needed to determine whether PAC modification can prospectively reduce AF risk.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Seattle, WA 98195 USA; Grp Hlth Res Inst, Seattle, WA USA; Washington Univ, Sch Med, St Louis, MO USA; Univ Maryland, Med Ctr, Baltimore, MD 21201 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore	Marcus, GM (corresponding author), 505 Parnassus Ave,M-1180B, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021; Stein, Phyllis/ABG-6179-2021	Marcus, Gregory/0000-0001-5197-7696; Stein, Phyllis/0000-0002-2263-3330	American Heart Association; Joseph Drown Foundation; National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC085081, N01HC085086, N01HC055222, N01HC085082, N01HC085083, N01HC085080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083, R01HL116747, R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, R56AG023629] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Joseph Drown Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	American Heart Association, Joseph Drown Foundation, and National Institutes of Health.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Binici Z, 2010, CIRCULATION, V121, P1904, DOI 10.1161/CIRCULATIONAHA.109.874982; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chong BH, 2012, EUROPACE, V14, P942, DOI 10.1093/europace/eur389; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kolb C, 2001, AM J CARDIOL, V88, P853, DOI 10.1016/S0002-9149(01)01891-4; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Marcus GM, 2010, ARCH INTERN MED, V170, P1874, DOI 10.1001/archinternmed.2010.426; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Schnabel RB, 2010, ARCH INTERN MED, V170, P1909, DOI 10.1001/archinternmed.2010.434; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Wallmann D, 2007, STROKE, V38, P2292, DOI 10.1161/STROKEAHA.107.485110; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wolowacz SE, 2011, EUROPACE, V13, P1375, DOI 10.1093/europace/eur194	23	108	111	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					721	+		10.7326/0003-4819-159-11-201312030-00004	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297188	Green Accepted			2022-12-28	WOS:000328731000001
J	Gibilisco, P; Vogel, AP				Gibilisco, Peter; Vogel, Adam P.			A PATIENT'S JOURNEY Friedreich ataxia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gibilisco, Peter] Univ Melbourne, Melbourne, Vic 3010, Australia; [Vogel, Adam P.] Monash Med Ctr, Friedreich Ataxia Clin, Melbourne, Vic, Australia; [Vogel, Adam P.] Univ Melbourne, Speech Neurosci Unit, Melbourne, Vic 3010, Australia	University of Melbourne; Monash University; University of Melbourne	Vogel, AP (corresponding author), Monash Med Ctr, Friedreich Ataxia Clin, Melbourne, Vic, Australia.	vogela@unimelb.edu.au	Vogel, Adam/ABD-7685-2020	Vogel, Adam/0000-0002-3505-2631					0	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2013	347								f7062	10.1136/bmj.f7062	http://dx.doi.org/10.1136/bmj.f7062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DF	24301267	Green Published, Bronze			2022-12-28	WOS:000328147900003
J	McCallion, P; McCarron, M				McCallion, Philip; McCarron, Mary			Deaths of people with intellectual disabilities in the UK	LANCET			English	Editorial Material							MORTALITY		[McCallion, Philip] SUNY Albany, Ctr Excellence Aging & Community Wellness, Albany, NY 12222 USA; [McCarron, Mary] Univ Dublin Trinity Coll, Fac Hlth Sci, Dublin 2, Ireland	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Trinity College Dublin	McCallion, P (corresponding author), SUNY Albany, Ctr Excellence Aging & Community Wellness, Albany, NY 12222 USA.	pmccallion@albany.edu	MCCALLION, PHILIP/Q-6672-2019	McCarron, Mary/0000-0002-2531-0422; McCallion, Philip/0000-0001-5129-6399				CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conroy JW, 1998, MENT RETARD, V36, P380, DOI 10.1352/0047-6765(1998)036<0380:MAPCMT>2.0.CO;2; Haveman M, 2010, J POLICY PRACT INTEL, V7, P59, DOI 10.1111/j.1741-1130.2010.00248.x; Heslop P, 2014, LANCET, V383, P889, DOI 10.1016/S0140-6736(13)62026-7; McCallion P, 2013, INT REV RES DEV DISA, V45, P225, DOI 10.1016/B978-0-12-407760-7.00006-2; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; O'Brien K, 1988, MENT RETARD, V36, P372; Shavelle R., 2005, J DATA SCI, V3, P371; Strauss D, 1996, AM J MENT RETARD, V101, P26; Strauss D, 1998, MENT RETARD, V36, P406, DOI 10.1352/0047-6765(1998)036<0406:WCWLFT>2.0.CO;2; Tyrer F, 2009, J INTELL DISABIL RES, V53, P898, DOI 10.1111/j.1365-2788.2009.01201.x; Walsh KK, 2006, MENT RETARD, V44, P353, DOI 10.1352/0047-6765(2006)44[353:THCIOE]2.0.CO;2	12	8	8	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					853	855		10.1016/S0140-6736(13)62190-X	http://dx.doi.org/10.1016/S0140-6736(13)62190-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	24332308	hybrid			2022-12-28	WOS:000332399500008
J	ten Cate-Hoek, AJ				ten Cate-Hoek, Arina J.			Elastic compression stockings-is there any benefit?	LANCET			English	Editorial Material							VEIN-THROMBOSIS; THERAPY; PREVENT		Maastricht Univ, Med Ctr, Inst Maastricht, Dept Internal Med & Cardiovasc Res, NL-6202 AZ Maastricht, Netherlands	Maastricht University	ten Cate-Hoek, AJ (corresponding author), Maastricht Univ, Med Ctr, Inst Maastricht, Dept Internal Med & Cardiovasc Res, NL-6202 AZ Maastricht, Netherlands.	arina.tencate@maastrichtuniversity.nl						Aschwanden M, 2008, J VASC SURG, V47, P1015, DOI 10.1016/j.jvs.2008.01.008; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Cooley BC, 2013, THROMB RES, V131, P55, DOI 10.1016/j.thromres.2012.01.004; Ginsberg JS, 2001, ARCH INTERN MED, V161, P2105, DOI 10.1001/archinte.161.17.2105; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Mosti G, 2012, J VASC SURG, V55, P122, DOI 10.1016/j.jvs.2011.07.071; Motykie GD, 1999, DERMATOL SURG, V25, P116, DOI 10.1046/j.1524-4725.1999.08095.x; Partsch H, 2008, INT ANGIOL, V27, P193; Partsch H, 2004, INT ANGIOL, V23, P206; Partsch H, 2000, J VASC SURG, V32, P861, DOI 10.1067/mva.2000.110352; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; ten Cate-Hoek AJ, 2010, J VASC SURG, V52, P132, DOI 10.1016/j.jvs.2010.01.089	13	14	14	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					851	853		10.1016/S0140-6736(13)62347-8	http://dx.doi.org/10.1016/S0140-6736(13)62347-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3FC	24315518				2022-12-28	WOS:000332399500007
J	Coleman, MP				Coleman, Michel P.			Cancer survival: global surveillance will stimulate health policy and improve equity	LANCET			English	Article							BREAST-CANCER; SOCIOECONOMIC INEQUALITIES; BENCHMARKING PARTNERSHIP; MEDICAL INSURANCE; CHILDHOOD-CANCER; AVOIDABLE DEATHS; POPULATION; EUROPE; COUNTRIES; CARE	Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.	London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, Keppel St, London WC1E 7HT, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine	Coleman, MP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, Keppel St, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807	Cancer Research UK [16148, 11700] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Aareleid T, 2002, INT J CANCER, V102, P45, DOI 10.1002/ijc.10663; Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Allemani C, 2013, INT J CANCER, V132, P1170, DOI 10.1002/ijc.27725; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; [Anonymous], 2012, LANCET ONCOL, V13, P1171, DOI 10.1016/S1470-2045(12)70526-0; Autier P, 2007, LANCET ONCOL, V8, P1050, DOI 10.1016/S1470-2045(07)70354-6; Baili P, 2008, TUMORI J, V94, P658; Beniaiche K., 2012, WATAN ALGERIA   1130; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 1999, IARC SCI PUBLICATION, V151; Berrino F, 2008, RESPONDING CHALLENGE, P151; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Brawley OW, 1999, J NATL CANCER I, V91, P1908, DOI 10.1093/jnci/91.22.1908; Brawley OW, 2002, JNCI-J NATL CANCER I, V94, P471; Brawley OW., 2012, WE DO HARM DOCTOR BR; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Chan M, COMMUNICATION; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2008, RESPONDING CHALLENGE; Commission of the European Communities, COMM COMM EUR PARL C; Cookson JB, 2000, LANCET, V356, P1611, DOI 10.1016/S0140-6736(05)74461-5; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Department of Health, 2012, IMPR OUTC STRAT CANC; Department of Health, 2011, IMPR OUTC STRAT CANC; Department of Health, 2000, NHS CANC PLAN PLAN I; Department of Health, 2011, NHS OUTC FRAM 2012 1; Dickman PW, 1997, J EPIDEMIOL COMMUN H, V51, P289, DOI 10.1136/jech.51.3.289; Eckhouse S, 2006, PLOS MED, V3, P994, DOI 10.1371/journal.pmed.0030267; Ellis L, 2012, EUR J CANCER, V48, P270, DOI 10.1016/j.ejca.2011.10.008; Eloranta S, 2013, CANCER CAUSE CONTROL, V24, P505, DOI 10.1007/s10552-012-0141-5; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Ferlay J, CANC INCIDENCE 5 CON, VI; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Francisci S, 2009, EUR J CANCER, V45, P1067, DOI 10.1016/j.ejca.2008.11.034; Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9; International Atomic Energy Agency, 2011, IAEA HUM HLTH REP; Jansen L, 2012, EUR J EPIDEMIOL, V27, P689, DOI 10.1007/s10654-012-9723-5; Jeffreys M, 2005, AM J PUBLIC HEALTH, V95, P834, DOI 10.2105/AJPH.2004.053678; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karanikolos Marina, 2013, Journal of the National Cancer Institute Monographs, P7, DOI 10.1093/jncimonographs/lgt003; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Keating N, 2011, CLOSING CANC DIVIDE, P289; Kelly R, 2002, CANC DEATHS COMMONS; Knaul FM, 2011, CLOSING CANC DIVIDE, P71; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Perez-Saldivar ML, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-355; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Micheli A, 2003, ANN ONCOL, V14, pV41, DOI 10.1093/annonc/mdg753; Ministry of Health, 2001, PIAN SAN NAZ 2001 20; Morrell S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-168; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Munoz Hernandez O, 2011, INFORM FINAL ANALISI; O'Callaghan T, 2011, NATURE, V471, pS2, DOI 10.1038/471S2a; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Perez-Cuevas R, 2013, PEDIATR BLOOD CANCER, V60, P196, DOI 10.1002/pbc.24265; Philipson T, 2012, HEALTH AFFAIR, V31, P667, DOI 10.1377/hlthaff.2011.1298; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Quaresma M, 2013, STAT MED, DOI [10.1002/sim.5953, DOI 10.1002/SIM.5953.[]; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; Roetzheim RG, 2000, AM J PUBLIC HEALTH, V90, P1746, DOI 10.2105/AJPH.90.11.1746; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Seppa K, 2012, BRIT J CANCER, V106, P1846, DOI 10.1038/bjc.2012.169; Shah A, 2008, BRIT J CANCER, V99, P219, DOI 10.1038/sj.bjc.6604466; Sikora K, 1999, ANN ONCOL, V10, P385, DOI 10.1023/A:1008367822016; SONDIK EJ, 1990, J NATL CANCER I, V82, P825; Storm Hans Henrik, 2008, Ugeskr Laeger, V170, P3065; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Union for International Cancer Control, 2010, WORLD CANC DECL UICC; United Nations, HIGH LEV M GEN ASS P; Vedsted P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588484; Verdecchia A, 1998, INT J CANCER, V77, P322, DOI 10.1002/(SICI)1097-0215(19980729)77:3<322::AID-IJC2>3.0.CO;2-Q; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walters S, 2013, INT J CANCER, V132, P676, DOI 10.1002/ijc.27651; Woods LM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3399; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Bank, 2011, LIST EC; World Health Organization, 2013, ASS NAT CAP PREV CON; World Health Organization, 2012, M DEV GLOB CONS PREC	90	100	108	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					564	573		10.1016/S0140-6736(13)62225-4	http://dx.doi.org/10.1016/S0140-6736(13)62225-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KH	24351320				2022-12-28	WOS:000331136400033
J	Butz, B; Dolle, C; Niekiel, F; Weber, K; Waldmann, D; Weber, HB; Meyer, B; Spiecker, E				Butz, Benjamin; Dolle, Christian; Niekiel, Florian; Weber, Konstantin; Waldmann, Daniel; Weber, Heiko B.; Meyer, Bernd; Spiecker, Erdmann			Dislocations in bilayer graphene	NATURE			English	Article							BAND-GAP; LAYER	Dislocations represent one of the most fascinating and fundamental concepts in materials science(1-3). Most importantly, dislocations are the main carriers of plastic deformation in crystalline materials(4-6). Furthermore, they can strongly affect the local electronic and optical properties of semiconductors and ionic crystals(7,8). In materials with small dimensions, they experience extensive image forces, which attract them to the surface to release strain energy(9). However, in layered crystals such as graphite, dislocation movement is mainly restricted to the basal plane. Thus, the dislocations cannot escape, enabling their confinement in crystals as thin as only two monolayers. To explore the nature of dislocations under such extreme boundary conditions, the material of choice is bilayer graphene, the thinnest possible quasi-two-dimensional crystal in which such linear defects can be confined. Homogeneous and robust graphene membranes derived from high-quality epitaxial graphene on silicon carbide(10) provide an ideal platform for their investigation. Here we report the direct observation of basal-plane dislocations in freestanding bilayer graphene using transmission electron microscopy and their detailed investigation by diffraction contrast analysis and atomistic simulations. Our investigation reveals two striking size effects. First, the absence of stacking-fault energy, a unique property of bilayer graphene, leads to a characteristic dislocation pattern that corresponds to an alternating AB <-> AC change of the stacking order. Second, our experiments in combination with atomistic simulations reveal a pronounced buckling of the bilayer graphene membrane that results directly from accommodation of strain. In fact, the buckling changes the strain state of the bilayer graphene and is of key importance for its electronic properties(11-14). Our findings will contribute to the understanding of dislocations and of their role in the structural, mechanical and electronic properties of bilayer and few-layer graphene.	[Butz, Benjamin; Dolle, Christian; Niekiel, Florian; Spiecker, Erdmann] Univ Erlangen Nurnberg, Ctr Nanoanal & Electron Microscopy, D-91058 Erlangen, Germany; [Weber, Konstantin; Meyer, Bernd] Univ Erlangen Nurnberg, Interdisziplinares Zentrum Mol Mat, D-91052 Erlangen, Germany; [Weber, Konstantin; Meyer, Bernd] Univ Erlangen Nurnberg, Comp Chem Ctr, D-91052 Erlangen, Germany; [Waldmann, Daniel; Weber, Heiko B.] Univ Erlangen Nurnberg, Lehrstuhl Angew Phys, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Butz, B (corresponding author), Univ Erlangen Nurnberg, Ctr Nanoanal & Electron Microscopy, Cauerstr 6, D-91058 Erlangen, Germany.	benjamin.butz@ww.uni-erlangen.de; erdmann.spiecker@ww.uni-erlangen.de	Butz, Benjamin/A-3937-2013; Dolle, Christian/AAG-4893-2019; Spiecker, Erdmann/B-3902-2017; Niekiel, Florian/AAB-8437-2019; Weber, Heiko B/D-2654-2012	Butz, Benjamin/0000-0002-9744-3419; Dolle, Christian/0000-0003-1503-9744; Weber, Heiko B/0000-0002-6403-9022	Deutsche Forschungsgemeinschaft [SFB 953]; Cluster of Excellence EXC 315 'Engineering of Advanced Materials' at the Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence EXC 315 'Engineering of Advanced Materials' at the Friedrich-Alexander-Universitat Erlangen-Nurnberg	We acknowledge use of experimental equipment of P. Schmuki. Furthermore, we thank J. Muller, E. Bitzek and A. Kohlmeyer for discussions. This research was supported by the Deutsche Forschungsgemeinschaft within the frameworks of the SFB 953 'Synthetic Carbon Allotropes' and the Cluster of Excellence EXC 315 'Engineering of Advanced Materials' at the Friedrich-Alexander-Universitat Erlangen-Nurnberg.	Alden JS, 2013, P NATL ACAD SCI USA, V110, P11256, DOI 10.1073/pnas.1309394110; AMELINCKX S, 1960, NATURE, V185, P603, DOI 10.1038/185603a0; Bao W, 2011, NAT PHYS, V7, P948, DOI [10.1038/NPHYS2103, 10.1038/nphys2103]; Brenner DW, 2002, J PHYS-CONDENS MAT, V14, P783, DOI 10.1088/0953-8984/14/4/312; Brown L, 2012, NANO LETT, V12, P1609, DOI 10.1021/nl204547v; Chen S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214103; COTTRELL AH, 1949, P PHYS SOC LOND A, V62, P49, DOI 10.1088/0370-1298/62/1/308; DELAVIGNETTE P, 1962, J NUCL MATER, V5, P17, DOI 10.1016/0022-3115(62)90038-7; ESHELBY JD, 1951, PHILOS MAG, V42, P1401; FRANK FC, 1950, PHYS REV, V79, P722, DOI 10.1103/PhysRev.79.722; Hattendorf S, 2013, SURF SCI, V610, P53, DOI 10.1016/j.susc.2013.01.005; Hull D., 2001, INTRO DISLOCATIONS; Kirkland E.J., 2010, ADV COMPUTING ELECT, V2nd; Kolmogorov AN, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235415; Lehtinen O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3098; Lin JH, 2013, NANO LETT, V13, P3262, DOI 10.1021/nl4013979; Lui CH, 2011, NAT PHYS, V7, P944, DOI [10.1038/nphys2102, 10.1038/NPHYS2102]; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Meyer JC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196102; MOTT NF, 1953, NATURE, V171, P234, DOI 10.1038/171234a0; NABARRO FRN, 1952, ADV PHYS, V1, P269, DOI 10.1080/00018735200101211; Orowan E, 1934, Z PHYS, V89, P634, DOI 10.1007/BF01341480; Ping JL, 2012, NANO LETT, V12, P4635, DOI 10.1021/nl301932v; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Shevitski B, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045417; Shimizu F, 2007, MATER TRANS, V48, P2923, DOI 10.2320/matertrans.MJ200769; SHOCKLEY W, 1953, PHYS REV, V91, P228; SIEMS R, 1962, PHYS STATUS SOLIDI, V2, P421, DOI 10.1002/pssb.19620020407; Smoluchowski R., 1966, J PHYS, V27, pC3; Taylor G.I., 1934, P ROY SOC LOND A MAT, P388, DOI DOI 10.1098/RSPA.1934.0107; Tewary VK, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125416; Vaezi A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021018; Waldmann D, 2013, ACS NANO, V7, P4441, DOI 10.1021/nn401037c; Warner JH, 2012, SCIENCE, V337, P209, DOI 10.1126/science.1217529; Wong JH, 2012, J PHYS CHEM C, V116, P8271, DOI 10.1021/jp300840k; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420	36	142	143	17	449	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					533	+		10.1038/nature12780	http://dx.doi.org/10.1038/nature12780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24352231				2022-12-28	WOS:000329995000036
J	Whiteus, C; Freitas, C; Grutzendler, J				Whiteus, Christina; Freitas, Catarina; Grutzendler, Jaime			Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; BARREL CORTEX; MECHANISM; ISCHEMIA; SEIZURES; SYSTEM	During the neonatal period, activity-dependent neural-circuit remodelling coincides with growth and refinement of the cerebral microvasculature(1,2). Whether neural activity also influences the patterning of the vascular bed is not known. Here we show in neonatal mice, that neither reduction of sensory input through whisker trimming nor moderately increased activity by environmental enrichment affects cortical microvascular development. Unexpectedly, chronic stimulation by repetitive sounds, whisker deflection or motor activity led to a near arrest of angiogenesis in barrel, auditory and motor cortices, respectively. Chemically induced seizures also caused robust reductions in microvascular density. However, altering neural activity in adult mice did not affect the vasculature. Histological analysis and time-lapse in vivo two-photon microscopy revealed that hyperactivity did not lead to cell death or pruning of existing vessels but rather to reduced endothelial proliferation and vessel sprouting. This anti-angiogenic effect was prevented by administration of the nitric oxide synthase (NOS) inhibitor L-NAME and in mice with neuronal and inducible NOS deficiency, suggesting that excessive nitric oxide released from hyperactive interneurons and glia inhibited vessel growth. Vascular deficits persisted long after cessation of hyperstimulation, providing evidence for a critical period after which proper microvascular patterning cannot be re-established. Reduced microvascular density diminished the ability of the brain to compensate for hypoxic challenges, leading to dendritic spine loss in regions distant from capillaries. Therefore, excessive sensorimotor stimulation and repetitive neural activation during early childhood may cause lifelong deficits in microvascular reserve, which could have important consequences for brain development, function and pathology.	[Whiteus, Christina; Freitas, Catarina; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Whiteus, Christina; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Grutzendler, J (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06511 USA.	jaime.grutzendler@yale.edu	Freitas, Catarina M/A-2555-2017	Freitas, Catarina M/0000-0002-3393-5326	AHA [10POST2570007];  [R01AG027855];  [R01HL106815];  [F31NS068041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS068041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	AHA(American Heart Association); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors appreciate the expert advice of W. Sessa, M. Simons and F. Moraes. A. Schain helped with design of ImageJ macros and G. P. Flowers critically read the manuscript. This study was supported by the following Grants: R01AG027855 and R01HL106815 (J.G.); F31NS068041 (C.W.) and AHA# 10POST2570007 (C.F.).	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Buskila Y, 2010, J NEUROPHYSIOL, V103, P1322, DOI 10.1152/jn.00676.2009; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Devor A, 2011, J NEUROSCI, V31, P13676, DOI 10.1523/JNEUROSCI.1968-11.2011; Dunning HS, 1937, J COMP NEUROL, V67, P433, DOI 10.1002/cne.900670305; Etzel RA, 1997, PEDIATRICS, V100, P724; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Heller R, 1999, ATHEROSCLEROSIS, V144, P49, DOI 10.1016/S0021-9150(99)00041-6; Jones MK, 2004, BIOCHEM BIOPH RES CO, V318, P520, DOI 10.1016/j.bbrc.2004.04.055; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Keilhoff G, 1996, NEUROSCIENCE, V75, P1193, DOI 10.1016/0306-4522(96)00330-2; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Perrenoud Q, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00036; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Strata F, 2005, P NATL ACAD SCI USA, V102, P19156, DOI 10.1073/pnas.0509520102; van den Tweel ERW, 2005, J NEUROIMMUNOL, V167, P64, DOI 10.1016/j.jneuroim.2005.06.031; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	36	81	84	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					407	+		10.1038/nature12821	http://dx.doi.org/10.1038/nature12821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24305053	Green Accepted			2022-12-28	WOS:000329621800044
J	Doran, KM; Misa, EJ; Shah, NR				Doran, Kelly M.; Misa, Elizabeth J.; Shah, Nirav R.			Housing as Health Care - New York's Boundary-Crossing Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The role of social determinants of health, and the business case for addressing them, is clear when it comes to homelessness and housing. New York State is undertaking an experiment that uses Medicaid funds for supportive housing for high-risk, homeless Medicaid recipients. Among the countries in the Organization for Economic Cooperation and Development (OECD), the United States ranks first in health care spending but 25th in spending on social services.(1) These are not two unrelated statistics: high spending on the former may result from low spending on the latter. Studies have shown the powerful effects that social determinants such as safe housing, healthful food, and opportunities for education and employment have on health. In fact, experts estimate that medical care accounts for only 10% of overall health, with social, environmental, and behavioral factors accounting for the rest.(2) Lack of upstream investment in ...	[Doran, Kelly M.] New York Univ Sch Med, Dept Emergency Med, New York, NY 10012 USA; [Doran, Kelly M.] New York Univ Sch Med, Dept Populat Hlth, New York, NY USA; [Doran, Kelly M.] Bellevue Hosp Ctr, New York, NY 10016 USA; [Misa, Elizabeth J.] New York State Dept Hlth, Off Hlth Insurance Programs, New York, NY USA; [Shah, Nirav R.] New York State Dept Hlth, Off Commissioner, New York, NY USA	New York University; New York University; Bellevue Hospital Center	Doran, KM (corresponding author), New York Univ Sch Med, Dept Emergency Med, New York, NY 10012 USA.		Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865; Doran, Kelly/0000-0001-8961-3724				Asch DA, 2012, NEW ENGL J MED, V367, P888, DOI 10.1056/NEJMp1206862; Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; Burt MR, 2011, MEDICAID PERMANENT S; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Raven MC, 2009, J URBAN HEALTH, V86, P230, DOI 10.1007/s11524-008-9336-1	5	64	64	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2374	2377		10.1056/NEJMp1310121	http://dx.doi.org/10.1056/NEJMp1310121			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274DQ	24350949				2022-12-28	WOS:000328586000005
J	Weinstein, DF; Arora, V; Drolet, B; Reynolds, EE				Weinstein, Debra F.; Arora, Vineet; Drolet, Brian; Reynolds, Eileen E.			Perspective Roundtable: Residency Training - A Decade of Duty-Hours Regulations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Arora, Vineet/0000-0002-4745-7599					0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					E32	E32		10.1056/NEJMp1313677	http://dx.doi.org/10.1056/NEJMp1313677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328487				2022-12-28	WOS:000328156300036
J	Hawkes, N				Hawkes, Nigel			Welcome to the most exclusive club in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], 2011, FINANCIAL TIMES; Department of Health, MIDST NHS FDN TRUST; Wittenberg D, 2013, TIMES	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2013	347								f7318	10.1136/bmj.f7318	http://dx.doi.org/10.1136/bmj.f7318			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZO	24335671				2022-12-28	WOS:000328575000005
J	Korn, D; Carlat, D				Korn, David; Carlat, Daniel			Conflicts of Interest in Medical Education Recommendations From the Pew Task Force on Medical Conflicts of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INDUSTRY		[Korn, David] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Carlat, Daniel] Pew Charitable Trusts, Washington, DC 20004 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Carlat, D (corresponding author), Pew Charitable Trusts, 901 E St NW, Washington, DC 20004 USA.	dcarlat@pewtrusts.org						AAMC, 2008, IND FUND MED ED; American Medical Student Association (AMSA), 2013, AMSA PHARMFR SCOR; Austad KE, 2013, J GEN INTERN MED, V28, P1064, DOI 10.1007/s11606-013-2361-0; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Chimonas S, 2013, ACAD MED, V88, P1464, DOI 10.1097/ACM.0b013e3182a2e204; Institute of Medicine, 2009, CONFLICT INTEREST ME; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Pew Charitable Trusts, 2013, CONFL OF INT POL AC; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	10	19	19	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2397	2398		10.1001/jama.2013.280889	http://dx.doi.org/10.1001/jama.2013.280889			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327035				2022-12-28	WOS:000328030900016
J	Bauer, JE; Cai, WJ; Raymond, PA; Bianchi, TS; Hopkinson, CS; Regnier, PAG				Bauer, James E.; Cai, Wei-Jun; Raymond, Peter A.; Bianchi, Thomas S.; Hopkinson, Charles S.; Regnier, Pierre A. G.			The changing carbon cycle of the coastal ocean	NATURE			English	Review							DISSOLVED ORGANIC-CARBON; INORGANIC CARBON; BIOGEOCHEMICAL CYCLES; CONTINENTAL MARGINS; RIVER PLUME; CO2 UPTAKE; MATTER; FLUXES; ESTUARINE; DIOXIDE	The carbon cycle of the coastal ocean is a dynamic component of the global carbon budget. But the diverse sources and sinks of carbon and their complex interactions in these waters remain poorly understood. Here we discuss the sources, exchanges and fates of carbon in the coastal ocean and how anthropogenic activities have altered the carbon cycle. Recent evidence suggests that the coastal ocean may have become a net sink for atmospheric carbon dioxide during post-industrial times. Continued human pressures in coastal zones will probably have an important impact on the future evolution of the coastal ocean's carbon budget.	[Bauer, James E.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Biogeochem Lab, Columbus, OH 43210 USA; [Cai, Wei-Jun] Univ Delaware, Sch Marine Sci & Policy, Newark, DE 19716 USA; [Raymond, Peter A.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Bianchi, Thomas S.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Hopkinson, Charles S.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Regnier, Pierre A. G.] Univ Libre Bruxelles, Dept Earth & Environm Sci, B-1050 Brussels, Belgium	University System of Ohio; Ohio State University; University of Delaware; Yale University; State University System of Florida; University of Florida; University System of Georgia; University of Georgia; Universite Libre de Bruxelles	Bauer, JE (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Biogeochem Lab, Columbus, OH 43210 USA.	bauer.362@osu.edu	Bianchi, Thomas S/L-4060-2014; Raymond, Peter A/C-4087-2009; Cai, Wei-Jun/C-1361-2013	Bianchi, Thomas S/0000-0002-3068-2933; Raymond, Peter A/0000-0002-8564-7860; Cai, Wei-Jun/0000-0003-3606-8325; hopkinson, charles/0000-0002-7331-8322	National Science Foundation; NASA Interdisciplinary Research in Earth Science program NOAA; Georgia Sea Grant; European Union; government of the Brussels-Capital Region; Directorate For Geosciences [1237140, 1238212] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Interdisciplinary Research in Earth Science program NOAA; Georgia Sea Grant; European Union(European Commission); government of the Brussels-Capital Region; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by the National Science Foundation's Chemical and Biological Oceanography, Integrated Carbon Cycle Research, Arctic Natural Sciences, Long-Term Ecological Research, and Ecosystem Ecology programs; NASA Interdisciplinary Research in Earth Science program NOAA; Georgia Sea Grant; the European Union's Seventh Framework Program project GEOCARBON; and the government of the Brussels-Capital Region. We acknowledge our late friend and colleague Y. Wang, whose contributions to coastal carbon cycle research and CO<INF>2</INF> measurement technology have significantly advanced the field. We also thank A. Grottoli for comments and discussion on an earlier version of this manuscript.	Andersson AJ, 2005, AM J SCI, V305, P875, DOI 10.2475/ajs.305.9.875; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Azetsu-Scott K, 2004, LIMNOL OCEANOGR, V49, P741, DOI 10.4319/lo.2004.49.3.0741; Bates NR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027028; Bauer JE, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P7; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Beaulieu E, 2012, NAT CLIM CHANGE, V2, P346, DOI [10.1038/NCLIMATE1419, 10.1038/nclimate1419]; Bernard CY, 2011, BIOGEOSCIENCES, V8, P551, DOI 10.5194/bg-8-551-2011; Bianchi TS, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P69; Bianchi T.S., 2011, CHEM BIOMARKERS AQUA; Bianchi TS, 2013, GEOPHYS RES LETT, V40, P116, DOI 10.1029/2012GL054145; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023053; Cai WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026219; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/NGEO1297, 10.1038/ngeo1297]; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cai WJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016312; Cai WJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017633; Cai WJ, 2003, GEOCHIM COSMOCHIM AC, V67, P631, DOI 10.1016/S0016-7037(02)01167-5; Calmels D, 2007, GEOLOGY, V35, P1003, DOI 10.1130/G24132A.1; Chen CTA, 2013, BIOGEOSCIENCES, V10, P6509, DOI 10.5194/bg-10-6509-2013; Chen RF, 1996, CONT SHELF RES, V16, P409, DOI 10.1016/0278-4343(95)00026-7; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; da Cunha LC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002718; Dai MH, 2006, MAR CHEM, V102, P159, DOI 10.1016/j.marchem.2005.09.020; Dai MH, 2012, CURR OPIN ENV SUST, V4, P170, DOI 10.1016/j.cosust.2012.03.003; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dittmar T, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002570; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Godsey SE, 2009, HYDROL PROCESS, V23, P1844, DOI 10.1002/hyp.7315; Gruber N., 2011, BIOGEOCHEMICAL DISCU, V8, P5617, DOI DOI 10.5194/BGD-8-5617-2011; Hales B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002295; Hartmann J, 2009, GLOBAL PLANET CHANGE, V69, P185, DOI 10.1016/j.gloplacha.2009.07.007; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hertkorn N, 2006, GEOCHIM COSMOCHIM AC, V70, P2990, DOI 10.1016/j.gca.2006.03.021; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Hofmann AF, 2008, BIOGEOSCIENCES, V5, P981, DOI 10.5194/bg-5-981-2008; Hofmann EE, 2011, ANNU REV MAR SCI, V3, P93, DOI 10.1146/annurev-marine-120709-142740; Hopkinson CS, 2012, CURR OPIN ENV SUST, V4, P186, DOI 10.1016/j.cosust.2012.03.005; Hopkinson CS, 2005, NATURE, V433, P142, DOI 10.1038/nature03191; HOPKINSON CS, 1995, ESTUARIES, V18, P598, DOI 10.2307/1352380; Hopkinson CS, 1998, BIOGEOCHEMISTRY, V43, P211, DOI 10.1023/A:1006016030299; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Huang WJ, 2013, LIMNOL OCEANOGR, V58, P1727, DOI 10.4319/lo.2013.58.5.1727; Ingalls A.E., 2005, OCEANOGRAPHY, V18, P18, DOI DOI 10.5670/0CEAN0G.2005.22; IPCC, 2013, CLIMATE CHANGE 2022; Jahnke RA, 2010, GLOB CHANGE IGBP SER, P597, DOI 10.1007/978-3-540-92735-8_16; Jiang LQ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004366; Keil RG, 1997, GEOCHIM COSMOCHIM AC, V61, P1507, DOI 10.1016/S0016-7037(97)00044-6; Krumins V, 2013, BIOGEOSCIENCES, V10, P371, DOI 10.5194/bg-10-371-2013; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Laruelle GG, 2013, HYDROL EARTH SYST SC, V17, P2029, DOI 10.5194/hess-17-2029-2013; Laruelle GG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043691; Laudon H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053033; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Liu K.K., 2010, CARBON NUTR FLUXES C; Mackenzie F.T., 2005, SEA, V13, P193; Mackenzie FT, 2004, BIOGEOSCIENCES, V1, P11, DOI 10.5194/bg-1-11-2004; MANTOURA RFC, 1983, GEOCHIM COSMOCHIM AC, V47, P1293, DOI 10.1016/0016-7037(83)90069-8; Mayer LM, 2006, LIMNOL OCEANOGR, V51, P1064, DOI 10.4319/lo.2006.51.2.1064; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Moore S, 2013, NATURE, V493, P660, DOI 10.1038/nature11818; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Moran MA, 2000, LIMNOL OCEANOGR, V45, P1254, DOI 10.4319/lo.2000.45.6.1254; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Raymond PA, 2004, MAR CHEM, V92, P353, DOI 10.1016/j.marchem.2004.06.036; Raymond PA, 2001, ORG GEOCHEM, V32, P469, DOI 10.1016/S0146-6380(00)00190-X; Raymond PA, 2003, ECOSYSTEMS, V6, P694, DOI 10.1007/s10021-002-0213-6; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002783; Raymond PA, 2008, NATURE, V451, P449, DOI 10.1038/nature06505; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schlesinger W. H., 1997, Biogeochemistry: an analysis of global change.; Seitzinger SP, 1996, BIOGEOCHEMISTRY, V35, P235, DOI 10.1007/BF02179829; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; Smith EM, 2005, AQUAT MICROB ECOL, V40, P37, DOI 10.3354/ame040037; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Stedmon CA, 2011, MAR CHEM, V124, P108, DOI 10.1016/j.marchem.2010.12.007; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Testa J. M., 2013, ESTUARINE ECOLOGY, P381; Tsunogai S, 1999, TELLUS B, V51, P701, DOI 10.1034/j.1600-0889.1999.t01-2-00010.x; Vanderborght JP, 2002, BIOGEOCHEMISTRY, V59, P207, DOI 10.1023/A:1015573131561; WALSH JJ, 1991, NATURE, V350, P53, DOI 10.1038/350053a0; Williams Peter J. le B., 2005, P1, DOI 10.1093/acprof:oso/9780198527084.003.0001; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Yoon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052785; Zhai WD, 2007, MAR CHEM, V107, P342, DOI 10.1016/j.marchem.2007.02.011	100	845	894	179	1180	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					61	70		10.1038/nature12857	http://dx.doi.org/10.1038/nature12857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305149	Green Published			2022-12-28	WOS:000327851700026
J	Madhani, HD				Madhani, Hiten D.			snRNA Catalysts in the Spliceosome's Ancient Core	CELL			English	Editorial Material							RNA; MECHANISM; REVEALS		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01 GM071801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Butcher SE, 2011, METAL IONS LIFE SCI, V9, P235, DOI 10.1039/978184973251200235; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; MADHANI HD, 1994, ANNU REV GENET, V28, P1; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; YU YT, 1995, RNA, V1, P46	11	3	4	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1213	1215		10.1016/j.cell.2013.11.022	http://dx.doi.org/10.1016/j.cell.2013.11.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315092	Green Accepted, Bronze			2022-12-28	WOS:000328271100006
J	Liebman, SW; Haber, JE				Liebman, Susan W.; Haber, James E.			Fred Sherman (1932-2013) RETROSPECTIVE	SCIENCE			English	Biographical-Item									[Liebman, Susan W.] Univ Illinois, Chicago, IL 60607 USA; [Liebman, Susan W.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Nevada System of Higher Education (NSHE); University of Nevada Reno; Brandeis University; Brandeis University	Liebman, SW (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	sliebman@unr.edu; haber@brandeis.edu							0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1059	1059		10.1126/science.1248055	http://dx.doi.org/10.1126/science.1248055			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288325	Green Submitted			2022-12-28	WOS:000327518600047
J	Beelen, R; Raaschou-Nielsen, O; Stafoggia, M; Andersen, ZJ; Weinmayr, G; Hoffmann, B; Wolf, K; Samoli, E; Fischer, P; Nieuwenhuijsen, M; Vineis, P; Xun, WW; Katsouyanni, K; Dimakopoulou, K; Oudin, A; Forsberg, B; Modig, L; Havulinna, AS; Lanki, T; Turunen, A; Oftedal, B; Nystad, W; Nafstad, P; De Faire, U; Pedersen, NL; Ostenson, CG; Fratiglioni, L; Penell, J; Korek, M; Pershagen, G; Eriksen, KT; Overvad, K; Ellermann, T; Eeftens, M; Peeters, PH; Meliefste, K; Wang, M; Bueno-de-Mesquita, B; Sugiri, D; Kramer, U; Heinrich, J; de Hoogh, K; Key, T; Peters, A; Hampel, R; Concin, H; Nagel, G; Ineichen, A; Schaffner, E; Probst-Hensch, N; Kunzli, N; Schindler, C; Schikowski, T; Adam, M; Phuleria, H; Vilier, A; Clavel-Chapelon, F; Declercq, C; Grioni, S; Krogh, V; Tsai, MY; Ricceri, F; Sacerdote, C; Galassi, C; Migliore, E; Ranzi, A; Cesaroni, G; Badaloni, C; Forastiere, F; Tamayo, I; Amiano, P; Dorronsoro, M; Katsoulis, M; Trichopoulou, A; Brunekreef, B; Hoek, G				Beelen, Rob; Raaschou-Nielsen, Ole; Stafoggia, Massimo; Andersen, Zorana Jovanovic; Weinmayr, Gudrun; Hoffmann, Barbara; Wolf, Kathrin; Samoli, Evangelia; Fischer, Paul; Nieuwenhuijsen, Mark; Vineis, Paolo; Xun, Wei W.; Katsouyanni, Klea; Dimakopoulou, Konstantina; Oudin, Anna; Forsberg, Bertil; Modig, Lars; Havulinna, Aki S.; Lanki, Timo; Turunen, Anu; Oftedal, Bente; Nystad, Wenche; Nafstad, Per; De Faire, Ulf; Pedersen, Nancy L.; Ostenson, Claes-Goeran; Fratiglioni, Laura; Penell, Johanna; Korek, Michal; Pershagen, Goeran; Eriksen, Kirsten Thorup; Overvad, Kim; Ellermann, Thomas; Eeftens, Marloes; Peeters, Petra H.; Meliefste, Kees; Wang, Meng; Bueno-de-Mesquita, Bas; Sugiri, Dorothea; Kraemer, Ursula; Heinrich, Joachim; de Hoogh, Kees; Key, Timothy; Peters, Annette; Hampel, Regina; Concin, Hans; Nagel, Gabriele; Ineichen, Alex; Schaffner, Emmanuel; Probst-Hensch, Nicole; Kuenzli, Nino; Schindler, Christian; Schikowski, Tamara; Adam, Martin; Phuleria, Harish; Vilier, Alice; Clavel-Chapelon, Francoise; Declercq, Christophe; Grioni, Sara; Krogh, Vittorio; Tsai, Ming-Yi; Ricceri, Fulvio; Sacerdote, Carlotta; Galassi, Claudia; Migliore, Enrica; Ranzi, Andrea; Cesaroni, Giulia; Badaloni, Chiara; Forastiere, Francesco; Tamayo, Ibon; Amiano, Pilar; Dorronsoro, Miren; Katsoulis, Michail; Trichopoulou, Antonia; Brunekreef, Bert; Hoek, Gerard			Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE project	LANCET			English	Article							USE REGRESSION-MODELS; CARDIOVASCULAR-DISEASE; AIRBORNE PARTICLES; PM2.5 ABSORBENCY; BLACK CARBON; LUNG-CANCER; NO2; AREAS; PM10; STABILITY	Background Few studies on long-term exposure to air pollution and mortality have been reported from Europe. Within the multicentre European Study of Cohorts for Air Pollution Effects (ESCAPE), we aimed to investigate the association between natural-cause mortality and long-term exposure to several air pollutants. Methods We used data from 22 European cohort studies, which created a total study population of 367 251 participants. All cohorts were general population samples, although some were restricted to one sex only. With a strictly standardised protocol, we assessed residential exposure to air pollutants as annual average concentrations of particulate matter (PM) with diameters of less than 2.5 mu m (PM2.5), less than 10 mu m (PM10), and between 10 mu m and 2.5 mu m (PMcoarse), PM2.5 absorbance, and annual average concentrations of nitrogen oxides (NO2 and NOx), with land use regression models. We also investigated two traffic intensity variables-traffic intensity on the nearest road (vehicles per day) and total traffic load on all major roads within a 100 m buff er. We did cohort-specific statistical analyses using confounder models with increasing adjustment for confounder variables, and Cox proportional hazards models with a common protocol. We obtained pooled effect estimates through a random-effects meta-analysis. Findings The total study population consisted of 367 251 participants who contributed 5 118 039 person-years at risk (average follow-up 13.9 years), of whom 29 076 died from a natural cause during follow-up. A significantly increased hazard ratio (HR) for PM2.5 of 1.07 (95% CI 1.02-1.13) per 5 mu g/m(3) was recorded. No heterogeneity was noted between individual cohort effect estimates (I-2 p value=0.95). HRs for PM2.5 remained significantly raised even when we included only participants exposed to pollutant concentrations lower than the European annual mean limit value of 25 mu g/m(3) (HR 1.06, 95% CI 1.00-1.12) or below 20 mu g/m(3) (1.07, 1.01-1.13). Interpretation Long-term exposure to fine particulate air pollution was associated with natural-cause mortality, even within concentration ranges well below the present European annual mean limit value.	[Beelen, Rob; Eeftens, Marloes; Meliefste, Kees; Wang, Meng; Brunekreef, Bert; Hoek, Gerard] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Raaschou-Nielsen, Ole; Andersen, Zorana Jovanovic; Eriksen, Kirsten Thorup] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Stafoggia, Massimo; Cesaroni, Giulia; Badaloni, Chiara; Forastiere, Francesco] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Andersen, Zorana Jovanovic] Univ Copenhagen, Ctr Epidemiol & Screening, Dept Publ Hlth, Copenhagen, Denmark; [Weinmayr, Gudrun; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Weinmayr, Gudrun; Hoffmann, Barbara; Sugiri, Dorothea; Kraemer, Ursula] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Wolf, Kathrin; Peters, Annette; Hampel, Regina] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Samoli, Evangelia; Katsouyanni, Klea; Dimakopoulou, Konstantina] Univ Athens, Dept Hyg Epidemiol & Med Stat, Sch Med, Athens, Greece; [Fischer, Paul; Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Nieuwenhuijsen, Mark] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Nieuwenhuijsen, Mark; Tamayo, Ibon; Amiano, Pilar; Dorronsoro, Miren] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Vineis, Paolo; Xun, Wei W.; de Hoogh, Kees] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Xun, Wei W.] UCL, CeLSIUS, London, England; [Oudin, Anna; Forsberg, Bertil; Modig, Lars] Umea Univ, Div Occupat & Environm Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Havulinna, Aki S.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Lanki, Timo; Turunen, Anu] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Oftedal, Bente; Nystad, Wenche; Nafstad, Per] Norwegian Inst Publ Hlth, Div Environm Med, Oslo, Norway; [Nafstad, Per] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [De Faire, Ulf; Penell, Johanna; Korek, Michal; Pershagen, Goeran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostenson, Claes-Goeran] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Fratiglioni, Laura] Karolinska Inst, Ageing Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Ellermann, Thomas] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Peeters, Petra H.; Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra H.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, Fac Med, London, England; [Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Key, Timothy] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria; [Ineichen, Alex; Schaffner, Emmanuel; Probst-Hensch, Nicole; Kuenzli, Nino; Schindler, Christian; Schikowski, Tamara; Adam, Martin; Phuleria, Harish; Tsai, Ming-Yi] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ineichen, Alex; Schaffner, Emmanuel; Probst-Hensch, Nicole; Kuenzli, Nino; Schindler, Christian; Schikowski, Tamara; Adam, Martin; Phuleria, Harish; Tsai, Ming-Yi] Univ Basel, Basel, Switzerland; [Vilier, Alice; Clavel-Chapelon, Francoise] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Nutr Hormones & Womens Hlth Team, Villejuif, France; [Vilier, Alice; Clavel-Chapelon, Francoise] Univ Paris Sud, UMRS, F-94805 Villejuif, France; [Vilier, Alice; Clavel-Chapelon, Francoise] Inst Gustave Roussy, F-94805 Villejuif, France; [Declercq, Christophe] French Inst Publ Hlth Surveillance InVS, St Maurice, France; [Grioni, Sara; Krogh, Vittorio] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Tsai, Ming-Yi] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Ricceri, Fulvio] HuGeF, Turin, Italy; [Sacerdote, Carlotta; Galassi, Claudia; Migliore, Enrica] Univ Turin, AO Citta Salute & Sci, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta; Galassi, Claudia; Migliore, Enrica] Ctr Canc Prevent, Turin, Italy; [Ranzi, Andrea] Reg Agcy Environm Prevent Emilia Romagna, Environm Hlth Reference Ctr, Modena, Italy; [Tamayo, Ibon; Amiano, Pilar; Dorronsoro, Miren] Basque Govt, Publ Hlth Div Gipuzkoa, Gipuzkoa, Spain; [Katsoulis, Michail; Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece	Utrecht University; Danish Cancer Society; University of Copenhagen; Ulm University; Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Athens Medical School; National & Kapodistrian University of Athens; Netherlands National Institute for Public Health & the Environment; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of London; University College London; Umea University; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Aarhus University; Aarhus University; Utrecht University; Utrecht University Medical Center; Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institute of Public Health Surveillance; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Washington; University of Washington Seattle; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Basque Government	Beelen, R (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, POB 80178, NL-3508 TD Utrecht, Netherlands.	r.m.j.beelen@uu.nl	Heinrich, Joachim/N-1720-2013; Kuenzli, Nino/F-7195-2014; Andersen, Zorana Jovanovic/P-4983-2014; Havulinna, Aki/AAM-4769-2021; Cesaroni, Giulia/K-1500-2016; vhmpp, aks/F-9756-2012; Grioni, Sara/K-5320-2016; Wolf, Kathrin/I-4461-2017; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Krogh, Vittorio/AAA-9171-2019; Krogh, Vittorio/K-2628-2016; de Hoogh, Kees/ABE-1274-2021; Ricceri, Fulvio/I-9910-2018; Tamayo-Uria, Ibon/H-5283-2019; Forastiere, Francesco/J-9067-2016; Nagel, Gabriele/C-3635-2012; Clavel-Chapelon, Francoise/G-6733-2014; Nieuwenhuijsen, Mark J/C-3914-2017; Eeftens, Marloes/T-3073-2017; Peters, Annette/A-6117-2011; Galassi, Claudia/K-3041-2016; Raaschou-Nielsen, Ole/GOK-0338-2022; Penell, Johanna/HGE-9306-2022; Badaloni, Chiara/AAM-7821-2020; Badaloni, Chiara/O-9750-2015; Schindler, Christian/D-3472-2015; Katsouyanni, Klea/D-4856-2014; Stafoggia, Massimo/K-2261-2016; Oudin, Anna/A-5446-2013	Heinrich, Joachim/0000-0002-9620-1629; Kuenzli, Nino/0000-0001-8360-080X; Andersen, Zorana Jovanovic/0000-0003-4138-9828; Cesaroni, Giulia/0000-0001-7361-9072; Grioni, Sara/0000-0002-5891-8426; Wolf, Kathrin/0000-0002-4343-201X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Ricceri, Fulvio/0000-0001-8749-9737; Tamayo-Uria, Ibon/0000-0002-8183-7106; Forastiere, Francesco/0000-0002-9162-5684; Nagel, Gabriele/0000-0001-6185-8535; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Eeftens, Marloes/0000-0002-1002-3412; Peters, Annette/0000-0001-6645-0985; Galassi, Claudia/0000-0003-1502-4390; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Penell, Johanna/0000-0003-2083-4048; Badaloni, Chiara/0000-0003-3768-8841; Badaloni, Chiara/0000-0003-3768-8841; Katsouyanni, Klea/0000-0002-0132-9575; , Evangelia/0000-0002-9266-9929; Stafoggia, Massimo/0000-0003-2843-2908; Ranzi, Andrea/0000-0002-0037-9167; brunekreef, bert/0000-0001-9908-0060; Korek, Michal/0000-0001-9326-3675; Pershagen, Goran/0000-0002-9701-1130; Katsoulis, Michail/0000-0002-1756-9530; Overvad, Kim/0000-0001-6429-7921; Oudin, Anna/0000-0002-9876-0627; Sacerdote, Carlotta/0000-0002-8008-5096	European Community; NATIONAL INSTITUTE ON AGING [R01AG008724] Funding Source: NIH RePORTER	European Community(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	European Community's Seventh Framework Program (FP7/2007-2011).	Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Beelen R, 2007, ATMOS ENVIRON, V41, P1343, DOI 10.1016/j.atmosenv.2006.10.020; Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cesaroni G, 2013, ENVIRON HEALTH PERSP, V121, P324, DOI 10.1289/ehp.1205862; Cesaroni G, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-48; Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Eeftens M, 2011, OCCUP ENVIRON MED, V68, P765, DOI 10.1136/oem.2010.061135; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Gulliver J, 2013, ENVIRON SCI TECHNOL, V47, P7804, DOI 10.1021/es4008849; Heinrich J, 2013, OCCUP ENVIRON MED, V70, P179, DOI 10.1136/oemed-2012-100876; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388; McCracken J, 2010, ENVIRON HEALTH PERSP, V118, P1564, DOI 10.1289/ehp.0901831; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; Pascal M, 2013, SCI TOTAL ENVIRON, V449, P390, DOI 10.1016/j.scitotenv.2013.01.077; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Wang RR, 2013, ATMOS ENVIRON, V64, P312, DOI 10.1016/j.atmosenv.2012.09.056	30	856	885	16	412	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					785	795		10.1016/S0140-6736(13)62158-3	http://dx.doi.org/10.1016/S0140-6736(13)62158-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24332274				2022-12-28	WOS:000332398700025
J	Vineis, P; Wild, CP				Vineis, Paolo; Wild, Christopher P.			Global cancer patterns: causes and prevention	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; HEPATOCELLULAR-CARCINOMA; HUMAN-PAPILLOMAVIRUS; LIFE-STYLE; RISK; MORTALITY; HEALTH; CARCINOGENICITY; OVERDIAGNOSIS; MESOTHELIOMA	Cancer is a global and growing, but not uniform, problem. An increasing proportion of the burden is falling on low-income and middle-income countries because of not only demographic change but also a transition in risk factors, whereby the consequences of the globalisation of economies and behaviours are adding to an existing burden of cancers of infectious origin. We argue that primary prevention is a particularly effective way to fight cancer, with between a third and a half of cancers being preventable on the basis of present knowledge of risk factors. Primary prevention has several advantages: the effectiveness could have benefits for people other than those directly targeted, avoidance of exposure to carcinogenic agents is likely to prevent other non-communicable diseases, and the cause could be removed or reduced in the long term-eg, through regulatory measures against occupational or environmental exposures (ie, the preventive effort does not need to be renewed with every generation, which is especially important when resources are in short supply). Primary prevention must therefore be prioritised as an integral part of global cancer control.	[Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Vineis, Paolo] HuGeF Fdn, Turin, Italy; [Wild, Christopher P.] Int Agcy Res Canc, F-69372 Lyon, France	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC)	Vineis, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Norfolk Pl, London W2 1PG, England.	p.vineis@imperial.ac.uk	Wild, Christopher/ABC-6260-2020	Wild, Christopher/0000-0003-0249-8669	Compagnia di San Paolo (HuGeF grant); ECNIS2 [266198]	Compagnia di San Paolo (HuGeF grant)(Compagnia di San Paolo); ECNIS2	PV has received financial supported from Compagnia di San Paolo (HuGeF grant), and PV and CPW have received financial support from ECNIS2 (an FP7 Coordination and Support Action project, Grant Agreement 266198). We thank Max Parkin, Mike Joffe, Valentina Gallo, Marc Chadeau-Hyam, Dario Mirabelli, Silvia Franceschi, David Forman, Freddie Bray, and Wei Xun for their thoughtful comments; and Helga Elvira Laszlo for valuable technical assistance.	Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Ahn Jiyoung, 2011, IARC Sci Publ, P189; Alavanja MCR, 2012, J TOXICOL ENV HEAL B, V15, P238, DOI 10.1080/10937404.2012.632358; American Cancer Society, 2011, COL CANC FACTS FIG 2; [Anonymous], 2010, MARMOT REV; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Benbrahim-Tallaa L, 2012, LANCET ONCOL, V13, P663, DOI 10.1016/S1470-2045(12)70280-2; Beral V, 2011, J MED SCREEN, V18, P210, DOI 10.1258/jms.2011.011134; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Burdorf A, 2005, INT J CANCER, V113, P298, DOI 10.1002/ijc.20552; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Clague J, 2012, CURR ONCOL REP, V14, P550, DOI 10.1007/s11912-012-0265-5; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Cokkinides V, CA CANC J CLIN, V59, P352; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Curado MP., 2007, CANC INCIDENCE 5 CON, VIX, P1; Darby S, 2001, ANN ONCOL, V12, P1341, DOI 10.1023/A:1012518223463; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Denny L, 2012, DISCOV MED, V14, P125; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dowell D, 2012, LANCET, V380, P1787, DOI 10.1016/S0140-6736(12)60733-8; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Fineberg HV, 2013, JAMA-J AM MED ASSOC, V310, P85, DOI 10.1001/jama.2013.7518; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hagger-Johnson G, 2013, PREV MED, V56, P304, DOI 10.1016/j.ypmed.2013.02.004; Harford JB, 2011, LANCET ONCOL, V12, P306, DOI 10.1016/S1470-2045(10)70273-4; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Herrero R, 2011, CANCER DISCOV, V1, P408, DOI 10.1158/2159-8290.CD-11-0131; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; International Agency for Research on Cancer, 1987, OV EV CARC UPD IARC, P1; International Agency for Research on Cancer, IARC HDB CANC PREV; Joshi R, 2012, J AM COLL CARDIOL, V59, P1188, DOI 10.1016/j.jacc.2011.10.901; Knaul FM, 2012, CLOSING CANC DIVIDE, P1; Kondilis E, 2013, AM J PUBLIC HEALTH, V103, P973, DOI 10.2105/AJPH.2012.301126; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Magnani C, 2008, OCCUP ENVIRON MED, V65, P164, DOI 10.1136/oem.2007.032847; Makin JK, 2013, BRIT J DERMATOL, V168, P154, DOI 10.1111/bjd.12082; McCormack VA, 2012, CANCER EPIDEMIOL, V36, P1, DOI 10.1016/j.canep.2011.09.005; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; MEIGS JW, 1986, J NATL CANCER I, V76, P1; Menvielle G, 2009, JNCI-J NATL CANCER I, V101, P321, DOI 10.1093/jnci/djn513; Miller AB, 2013, INT J CANCER, V133, P2511, DOI 10.1002/ijc.28258; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Nagel G, 2007, INT J EPIDEMIOL, V36, P66, DOI 10.1093/ije/dyl275; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nweke OC, 2009, ENVIRON HEALTH PERSP, V117, P863, DOI 10.1289/ehp.0800126; Oreskes N., 2010, MERCHANTS DOUBT; Ormiston-Smith N, 2013, BRIT J CANCER, V108, P2413, DOI 10.1038/bjc.2013.260; Park J, 2009, AM J IND MED, V52, P625, DOI 10.1002/ajim.20723; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; Patel D, 2012, ASIAN PAC J CANCER P, V13, P4173, DOI 10.7314/APJCP.2012.13.8.4173; Peer N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19216; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Richardson DB, 2008, ENVIRON HEALTH PERSP, V116, P370, DOI 10.1289/ehp.10841; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Rohrmann S, 2012, EUR J CLIN NUTR, V66, P957, DOI 10.1038/ejcn.2012.55; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Sampath P, 2012, GLOB J HLTH SCI, V4, P118; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sullivan R, 2012, EUR J CANCER, V48, P2043, DOI 10.1016/j.ejca.2012.01.019; Sylla BS, 2012, INT J CANCER, V130, P245, DOI 10.1002/ijc.26333; Tanumihardjo SA, 2007, J AM DIET ASSOC, V107, P1966, DOI 10.1016/j.jada.2007.08.007; The Independent UK Panel on Breast Cancer Screening, 2012, BEN HARMS BREAST CAN, P1; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; UN Environment Programme, 2012, GLOB CHEM OUTL SOUND, P1; Vineis P, 2009, ANN ONCOL, V20, P205, DOI 10.1093/annonc/mdn596; Wagner KH, 2012, PREV MED, V54, pS38, DOI 10.1016/j.ypmed.2011.11.012; Wand H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-159; Ward EM, 2010, ENVIRON HEALTH PERSP, V118, P1355, DOI 10.1289/ehp.0901828; Weill H, 2004, OCCUP ENVIRON MED, V61, P438, DOI 10.1136/oem.2003.010165; WHO, GLOB STAT REP NONC D, P1; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Wild CP, 2012, J NATL CANCER I, V104, P1051, DOI 10.1093/jnci/djs262; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; World Cancer Research Fund and the American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P1; Zablocki RW, 2013, PREV MED, DOI S0091-7435(13)00452-0	92	374	391	11	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					549	557		10.1016/S0140-6736(13)62224-2	http://dx.doi.org/10.1016/S0140-6736(13)62224-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24351322				2022-12-28	WOS:000331136400031
J	Gelinas, S; Rao, A; Kumar, A; Smith, SL; Chin, AW; Clark, J; van der Poll, TS; Bazan, GC; Friend, RH				Gelinas, Simon; Rao, Akshay; Kumar, Abhishek; Smith, Samuel L.; Chin, Alex W.; Clark, Jenny; van der Poll, Tom S.; Bazan, Guillermo C.; Friend, Richard H.			Ultrafast Long-Range Charge Separation in Organic Semiconductor Photovoltaic Diodes	SCIENCE			English	Article							EXCITON DISSOCIATION; SOLAR-CELLS; PERFORMANCE; ENERGY	Understanding the charge-separation mechanism in organic photovoltaic cells (OPVs) could facilitate optimization of their overall efficiency. Here we report the time dependence of the separation of photogenerated electron hole pairs across the donor-acceptor heterojunction in OPV model systems. By tracking the modulation of the optical absorption due to the electric field generated between the charges, we measure similar to 200 millielectron volts of electrostatic energy arising from electron-hole separation within 40 femtoseconds of excitation, corresponding to a charge separation distance of at least 4 nanometers. At this separation, the residual Coulomb attraction between charges is at or below thermal energies, so that electron and hole separate freely. This early time behavior is consistent with charge separation through access to delocalized pi-electron states in ordered regions of the fullerene acceptor material.	[Gelinas, Simon; Rao, Akshay; Kumar, Abhishek; Smith, Samuel L.; Chin, Alex W.; Clark, Jenny; Friend, Richard H.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [van der Poll, Tom S.; Bazan, Guillermo C.] Univ Calif Santa Barbara, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA	University of Cambridge; University of California System; University of California Santa Barbara	Friend, RH (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	rhf10@cam.ac.uk	Bazan, Guillermo C/B-7625-2014; Bazan, Guillermo/AAJ-5313-2020; Clark, Jenny/R-1064-2017	Clark, Jenny/0000-0001-9664-967X; Friend, Richard Henry/0000-0001-6565-6308; Rao, Akshay/0000-0003-0320-2962; Rao, Akshay/0000-0003-4261-0766	Engineering and Physical Sciences Research Council; Winton Programme (Cambridge) for the Physics of Sustainability; Fonds quebecois de recherche sur la nature et les technologies; Corpus Christi College; National Research Foundation Singapore; Royal Society; Center for Energy Efficient Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DC0001009]; EPSRC [EP/G060738/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060738/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Winton Programme (Cambridge) for the Physics of Sustainability; Fonds quebecois de recherche sur la nature et les technologies(FQRNT); Corpus Christi College; National Research Foundation Singapore(National Research Foundation, Singapore); Royal Society(Royal Society of London); Center for Energy Efficient Materials, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Engineering and Physical Sciences Research Council, and the Winton Programme (Cambridge) for the Physics of Sustainability for funding. S.G. acknowledges funding from the Fonds quebecois de recherche sur la nature et les technologies; A. R. thanks Corpus Christi College for a Research Fellowship; A. K. thanks National Research Foundation Singapore for a scholarship; J.C. thanks the Royal Society for a Dorothy Hodgkin Fellowship; and T.S.v.d.P. acknowledges funding from the Center for Energy Efficient Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under Award DC0001009.	Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Bakulin AA, 2010, ADV FUNCT MATER, V20, P1653, DOI 10.1002/adfm.200902099; Blom PWM, 2007, ADV MATER, V19, P1551, DOI 10.1002/adma.200601093; Blouin N, 2007, ADV MATER, V19, P2295, DOI 10.1002/adma.200602496; Bredas JL, 2009, ACCOUNTS CHEM RES, V42, P1691, DOI 10.1021/ar900099h; Cabanillas-Gonzalez J, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045207; Cabanillas-Gonzalez J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106601; Campbell IH, 1996, PHYS REV LETT, V76, P1900, DOI 10.1103/PhysRevLett.76.1900; Caruso D, 2012, P NATL ACAD SCI USA, V109, P13498, DOI 10.1073/pnas.1206172109; Clarke TM, 2010, CHEM REV, V110, P6736, DOI 10.1021/cr900271s; Collins BA, 2013, ADV ENERGY MATER, V3, P65, DOI 10.1002/aenm.201200377; Devizis A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.027404; Gelinas S, 2011, J PHYS CHEM C, V115, P7114, DOI 10.1021/jp200466y; Grancini G, 2013, NAT MATER, V12, P29, DOI [10.1038/NMAT3502, 10.1038/nmat3502]; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; He ZC, 2011, ADV MATER, V23, P4636, DOI 10.1002/adma.201103006; Jailaubekov AE, 2013, NAT MATER, V12, P66, DOI [10.1038/NMAT3500, 10.1038/nmat3500]; Kaake LG, 2013, J PHYS CHEM LETT, V4, P2264, DOI 10.1021/jz4010569; Kaake LG, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799348; Liu F, 2012, J POLYM SCI POL PHYS, V50, P1018, DOI 10.1002/polb.23063; Love JA, 2013, ADV FUNCT MATER, V23, P5019, DOI 10.1002/adfm.201300099; MacKenzie RCI, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3315872; Mayer AC, 2009, ADV FUNCT MATER, V19, P1173, DOI 10.1002/adfm.200801684; Miller NC, 2012, NANO LETT, V12, P1566, DOI 10.1021/nl204421p; Morteani AC, 2003, ADV MATER, V15, P1708, DOI 10.1002/adma.200305618; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Pensack RD, 2010, J PHYS CHEM LETT, V1, P2255, DOI 10.1021/jz1005225; SEBASTIAN L, 1981, CHEM PHYS, V61, P125, DOI 10.1016/0301-0104(81)85055-0; Sun YM, 2012, NAT MATER, V11, P44, DOI [10.1038/nmat3160, 10.1038/NMAT3160]; Tamura H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054301; van der Poll TS, 2012, ADV MATER, V24, P3646, DOI 10.1002/adma.201201127; Vithanage DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3334; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhu XY, 2009, ACCOUNTS CHEM RES, V42, P1779, DOI 10.1021/ar800269u	34	724	728	18	667	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					512	516		10.1126/science.1246249	http://dx.doi.org/10.1126/science.1246249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24336568	Green Submitted			2022-12-28	WOS:000330343700039
J	Besnard, F; Refahi, Y; Morin, V; Marteaux, B; Brunoud, G; Chambrier, P; Rozier, F; Mirabet, V; Legrand, J; Laine, S; Thevenon, E; Farcot, E; Cellier, C; Das, P; Bishopp, A; Dumas, R; Parcy, F; Helariutta, Y; Boudaoud, A; Godin, C; Traas, J; Guedon, Y; Vernoux, T				Besnard, Fabrice; Refahi, Yassin; Morin, Valerie; Marteaux, Benjamin; Brunoud, Geraldine; Chambrier, Pierre; Rozier, Frederique; Mirabet, Vincent; Legrand, Jonathan; Laine, Stephanie; Thevenon, Emmanuel; Farcot, Etienne; Cellier, Coralie; Das, Pradeep; Bishopp, Anthony; Dumas, Renaud; Parcy, Francois; Helariutta, Yka; Boudaoud, Arezki; Godin, Christophe; Traas, Jan; Guedon, Yann; Vernoux, Teva			Cytokinin signalling inhibitory fields provide robustness to phyllotaxis	NATURE			English	Article							SHOOT APICAL MERISTEM; GENE-EXPRESSION; CELL-DIVISION; AUXIN; MODEL; GROWTH; DIFFERENTIATION; INITIATION; TRANSPORT; PATTERNS	How biological systems generate reproducible patterns with high precision is a central question in science(1). The shoot apical meristem (SAM), a specialized tissue producing plant aerial organs, is a developmental system of choice to address this question. Organs are periodically initiated at the SAM at specific spatial positions and this spatiotemporal pattern defines phyllotaxis. Accumulation of the plant hormone auxin triggers organ initiation(2-5), whereas auxin depletion around organs generates inhibitory fields that are thought to be sufficient to maintain these patterns and their dynamics(4,6-13). Here we show that another type of hormone-based inhibitory fields, generated directly downstream of auxin by intercellular movement of the cytokinin signalling inhibitor ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 6 (AHP6)(14), is involved in regulating phyllotactic patterns. We demonstrate that AHP6-based fields establish patterns of cytokinin signalling in the meristem that contribute to the robustness of phyllotaxis by imposing a temporal sequence on organ initiation. Our findings indicate that not one but two distinct hormone-based fields may be required for achieving temporal precision during formation of reiterative structures at the SAM, thus indicating an original mechanism for providing robustness to a dynamic developmental system.	[Besnard, Fabrice; Morin, Valerie; Marteaux, Benjamin; Brunoud, Geraldine; Chambrier, Pierre; Rozier, Frederique; Mirabet, Vincent; Legrand, Jonathan; Laine, Stephanie; Cellier, Coralie; Das, Pradeep; Boudaoud, Arezki; Traas, Jan; Vernoux, Teva] Univ Lyon, Lab Reprod & Dev Plantes, CNRS, INRA,ENS Lyon,UCBL, F-69364 Lyon, France; [Refahi, Yassin; Legrand, Jonathan; Farcot, Etienne; Godin, Christophe; Guedon, Yann] Inst Biol Computat, Virtual Plants INRIA, INRA Project Team, CIRAD,UMRAGAP, F-34095 Montpellier, France; [Mirabet, Vincent; Legrand, Jonathan; Das, Pradeep; Boudaoud, Arezki] Univ Lyon, Lab Joliot Curie, CNRS, ENS Lyon, F-69364 Lyon, France; [Thevenon, Emmanuel; Dumas, Renaud; Parcy, Francois] UJF, Lab Physiol Cellulaire & Vegetale, CEA, CNRS,INRA, F-38041 Grenoble, France; [Bishopp, Anthony; Helariutta, Yka] Univ Helsinki, Dept Biosci, Inst Biotechnol, FIN-00014 Helsinki, Finland	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); CIRAD; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Helsinki	Vernoux, T (corresponding author), Univ Lyon, Lab Reprod & Dev Plantes, CNRS, INRA,ENS Lyon,UCBL, F-69364 Lyon, France.	teva.vernoux@ens-lyon.fr	Boudaoud, Arezki/Q-7436-2016; Parcy, François/G-9177-2011; Helariutta, Yrjo/AAE-8149-2020; Traas, Jan/AAZ-7004-2020; Dumas, Renaud/E-1835-2011; BESNARD, Fabrice/AAW-9722-2021; Vernoux, Teva/J-1695-2019; Godin, Christophe/C-1218-2008	Boudaoud, Arezki/0000-0002-2780-4717; Parcy, François/0000-0003-2191-500X; Helariutta, Yrjo/0000-0002-7287-8459; Traas, Jan/0000-0001-5107-1472; BESNARD, Fabrice/0000-0003-4619-5547; Vernoux, Teva/0000-0002-8257-4088; Godin, Christophe/0000-0002-1202-8460; dumas, renaud/0000-0003-1404-3274; Bishopp, Anthony/0000-0003-2962-9542; Refahi, Yassin/0000-0001-6136-608X	Human Frontier Science Program Organization [HFSPO CDA 0047/2007]; Agence National de la Recherche [ANR-07-JCJC-0115]; AuxiFlo [ANR-12-BSV6-0005]; transnational EraSysBio Grant (iSAM); French Ministry of Research; CJS grant from INRA	Human Frontier Science Program Organization(Human Frontier Science Program); Agence National de la Recherche(French National Research Agency (ANR)); AuxiFlo; transnational EraSysBio Grant (iSAM); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CJS grant from INRA	We thank M. Heisler, B. Muller and D. Weijers for sharing materials; A. Miyawaki for VENUS; D. Mast for help with plant analysis; C. Chamot and C. Lionnet (PLATIM) for help with confocal microscopy and ImageJ (C. Chamot); S. Chamot for help with live imaging; C. Gauthier and A. Laugraud (PRABI, Universite Lyon I) for help with statistical analyses; Xavier Jaurand (Pi2) for help with the SEM; Y. Couder, S. Douady, M. Bennett and M.-A. Felix for their insights and support; Y. Jaillais, O. Hamant and C. Scutt for comments on the manuscript. T.V. was supported by HFSPO CDA 0047/2007 (Human Frontier Science Program Organization) and ANR-07-JCJC-0115 (Agence National de la Recherche) grants; R.D., F.P. and T.V. by the ANR-12-BSV6-0005 grant (AuxiFlo); J.L., J.T., C.G., Y.H. and T.V. by a transnational EraSysBio Grant (iSAM); F.B. by a predoctoral grant of the French Ministry of Research; and Y.R. by a CJS grant from INRA.	Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couder Y, 1998, ACTA SOC BOT POL, V67, P129, DOI 10.5586/asbp.1998.016; Csiszar I, 2006, IEEE T INFORM THEORY, V52, P1007, DOI 10.1109/TIT.2005.864431; de Reuille PB, 2005, PLANT J, V44, P1045, DOI 10.1111/j.1365-313X.2005.02576.x; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Deveaux Y, 2003, PLANT J, V36, P918, DOI 10.1046/j.1365-313X.2003.01922.x; Douady S, 1996, J THEOR BIOL, V178, P275, DOI 10.1006/jtbi.1996.0025; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Guedon Y., 2013, J THEOR BIOL; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hotton S, 2003, J THEOR BIOL, V225, P15, DOI 10.1016/S0022-5193(03)00217-0; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mardia KV, 2000, DIRECTIONAL STAT; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Mirabet V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002389; MITCHISON GJ, 1977, SCIENCE, V196, P270, DOI 10.1126/science.196.4287.270; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Peaucelle A, 2007, DEVELOPMENT, V134, P1045, DOI 10.1242/dev.02774; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradal C, 2009, GRAPH MODELS, V71, P1, DOI 10.1016/j.gmod.2008.10.001; Refahi Y, 2011, LECT NOTES COMPUT SC, V6661, P323; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stoma S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-126; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; VEEN AH, 1977, PLANT PHYSIOL, V60, P127, DOI 10.1104/pp.60.1.127; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	55	176	178	3	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					417	+		10.1038/nature12791	http://dx.doi.org/10.1038/nature12791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24336201				2022-12-28	WOS:000329621800046
J	Johnson, BE; Mazor, T; Hong, CB; Barnes, M; Aihara, K; McLean, CY; Fouse, SD; Yamamoto, S; Ueda, H; Tatsuno, K; Asthana, S; Jalbert, LE; Nelson, SJ; Bollen, AW; Gustafson, WC; Charron, E; Weiss, WA; Smirnov, IV; Song, JS; Olshen, AB; Cha, S; Zhao, YJ; Moore, RA; Mungall, AJ; Jones, SJM; Hirst, M; Marra, MA; Saito, N; Aburatani, H; Mukasa, A; Berger, MS; Chang, SM; Taylor, BS; Costello, JF				Johnson, Brett E.; Mazor, Tali; Hong, Chibo; Barnes, Michael; Aihara, Koki; McLean, Cory Y.; Fouse, Shaun D.; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji; Asthana, Saurabh; Jalbert, Llewellyn E.; Nelson, Sarah J.; Bollen, Andrew W.; Gustafson, W. Clay; Charron, Elise; Weiss, William A.; Smirnov, Ivan V.; Song, Jun S.; Olshen, Adam B.; Cha, Soonmee; Zhao, Yongjun; Moore, Richard A.; Mungall, Andrew J.; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.; Saito, Nobuhito; Aburatani, Hiroyuki; Mukasa, Akitake; Berger, Mitchel S.; Chang, Susan M.; Taylor, Barry S.; Costello, Joseph F.			Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma	SCIENCE			English	Article							HUMAN-MALIGNANT GLIOMAS; HUMAN CANCER; INTRATUMOR HETEROGENEITY; CLONAL EVOLUTION; MSH6 MUTATIONS; IDH1 MUTATIONS; TEMOZOLOMIDE; GROWTH; RETINOBLASTOMA; IDENTIFICATION	Tumor recurrence is a leading cause of cancer mortality. Therapies for recurrent disease may fail, at least in part, because the genomic alterations driving the growth of recurrences are distinct from those in the initial tumor. To explore this hypothesis, we sequenced the exomes of 23 initial low-grade gliomas and recurrent tumors resected from the same patients. In 43% of cases, at least half of the mutations in the initial tumor were undetected at recurrence, including driver mutations in TP53, ATRX, SMARCA4, and BRAF; this suggests that recurrent tumors are often seeded by cells derived from the initial tumor at a very early stage of their evolution. Notably, tumors from 6 of 10 patients treated with the chemotherapeutic drug temozolomide (TMZ) followed an alternative evolutionary path to high-grade glioma. At recurrence, these tumors were hypermutated and harbored driver mutations in the RB (retinoblastoma) and Akt-mTOR (mammalian target of rapamycin) pathways that bore the signature of TMZ-induced mutagenesis.	[Johnson, Brett E.; Mazor, Tali; Hong, Chibo; McLean, Cory Y.; Fouse, Shaun D.; Weiss, William A.; Smirnov, Ivan V.; Cha, Soonmee; Berger, Mitchel S.; Chang, Susan M.; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA; [Barnes, Michael; Bollen, Andrew W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Aihara, Koki; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Lab, Meguro Ku, Tokyo 1538904, Japan; [Aihara, Koki; Saito, Nobuhito; Mukasa, Akitake] Univ Tokyo, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; [Asthana, Saurabh; Taylor, Barry S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Asthana, Saurabh; Olshen, Adam B.; Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Jalbert, Llewellyn E.; Nelson, Sarah J.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Nelson, Sarah J.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Gustafson, W. Clay; Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Song, Jun S.; Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Zhao, Yongjun; Moore, Richard A.; Mungall, Andrew J.; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tokyo; University of Tokyo; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; British Columbia Cancer Agency	Taylor, BS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA.	barry.taylor@ucsf.edu; jcostello@cc.ucsf.edu	Jones, Steven J/C-3621-2009; Song, Jun S/E-2526-2016; Hirst, Martin/B-7684-2016; Kuo, John S/D-3561-2013; Mukasa, Akitake/H-7615-2019; Marra, Marco A/B-5987-2008; Mungall, Andrew J./U-7067-2018; Tatsuno, Kenji/B-1765-2008	Jones, Steven J/0000-0003-3394-2208; Song, Jun S/0000-0002-0422-2175; Kuo, John S/0000-0001-6809-4806; Mukasa, Akitake/0000-0001-7776-9086; Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Weiss, William/0000-0003-2230-9132	Accelerate Brain Cancer Cure; Grove Foundation; TDC Foundation; Anne and Jason Farber Foundation; Samuel Waxman Cancer Research Foundation; Alex Lemonade Stand Foundation; Entertainment Industry Foundation; Anne Feeley; National Institute of General Medical Sciences [T32GM008568]; NIH [1T32CA15102201, R25NS070680, P50CA097257]; National Cancer Institute [R01CA169316-01, P01CA81403, P30CA82103, R01CA163336]; National Institute of Neurological Disorders and Stroke [K08NS079485]; UCSF Academic Senate; Sontag Foundation; BC Cancer Foundation; Genome BC; Genome Canada; Goldhirsh Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23134501, 24221011]; NATIONAL CANCER INSTITUTE [P30CA082103, P01CA081403, R01CA163336, R01CA169316, T32CA128583, P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS070680, K08NS079485] Funding Source: NIH RePORTER	Accelerate Brain Cancer Cure; Grove Foundation; TDC Foundation; Anne and Jason Farber Foundation; Samuel Waxman Cancer Research Foundation; Alex Lemonade Stand Foundation; Entertainment Industry Foundation; Anne Feeley; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSF Academic Senate; Sontag Foundation; BC Cancer Foundation; Genome BC; Genome Canada(Genome Canada); Goldhirsh Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Gonzalez for assistance with the collection of clinical information; R. Kang for assistance with mutation validation; H. van Thuijl for assistance with MGMT methylation; and J. Wiencke and G. Hsuang for assistance with droplet digital PCR. Supported by Accelerate Brain Cancer Cure (J. F. C.), the Grove Foundation, the TDC Foundation, the Anne and Jason Farber Foundation, the Samuel Waxman Cancer Research Foundation, the Alex Lemonade Stand Foundation, the Entertainment Industry Foundation and Anne Feeley, and a generous gift from the Dabbiere family. Also supported by National Institute of General Medical Sciences grant T32GM008568 (T. M.); NIH grants 1T32CA15102201 and R25NS070680 (M. B.); NIH grant P50CA097257 (L. E. J., S. J. N., M. S. B., S. M. C., J. F. C., and B. S. T.); National Cancer Institute grants R01CA169316-01 (J. F. C.), P01CA81403 (W. C. G., E. C., and W. A. W.), P30CA82103 (A. B. O.), and R01CA163336 (J. S. S.); National Institute of Neurological Disorders and Stroke grant K08NS079485 (W. C. G., E. C., and W. A. W.); the UCSF Academic Senate and the Sontag Foundation (J. S. S., J. F. C., and B. S. T.); the BC Cancer Foundation, Genome BC, and Genome Canada (M. A. M.); the Goldhirsh Foundation (J. F. C.); and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) (A. M., N. S., and H. A.), Grant-in-Aid for Scientific Research on Innovative Areas (no. 23134501) (A. M.), and Grant-in-Aid for Scientific Research (S) (no. 24221011) (H. A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. C. Y. M. was a Damon Runyon Cancer Research Postdoctoral Fellow. M. A. M. is a Canada Research Chair in Genome Science. All exome and transcriptome sequencing data have been deposited in the European Genome-phenome Archive under accession number EGAS00001000579, and data from patients 24 to 29 have also been deposited to the Japanese Genotype-phenotype Archive under accession number JGAS00000000004.	Bodell WJ, 2003, CANCER EPIDEM BIOMAR, V12, P545; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fargnoli MC, 1998, J INVEST DERMATOL, V111, P1202, DOI 10.1046/j.1523-1747.1998.00412.x; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han SY, 2000, CANCER RES, V60, P3147; Houdayer C, 2004, HUM MUTAT, V23, P193, DOI 10.1002/humu.10303; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tsai T, 2004, ARCH OPHTHALMOL-CHIC, V122, P239, DOI 10.1001/archopht.122.2.239; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Watanabe K, 1997, CLIN CANCER RES, V3, P523; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	36	874	895	0	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					189	193		10.1126/science.1239947	http://dx.doi.org/10.1126/science.1239947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24336570	Green Accepted			2022-12-28	WOS:000329440800044
J	Ariey, F; Witkowski, B; Amaratunga, C; Beghain, J; Langlois, AC; Khim, N; Kim, S; Duru, V; Bouchier, C; Ma, L; Lim, P; Leang, R; Duong, S; Sreng, S; Suon, S; Chuor, CM; Bout, DM; Menard, S; Rogers, WO; Genton, B; Fandeur, T; Miotto, O; Ringwald, P; Le Bras, J; Berry, A; Barale, JC; Fairhurst, RM; Benoit-Vical, F; Mercereau-Puijalon, O; Menard, D				Ariey, Frederic; Witkowski, Benoit; Amaratunga, Chanaki; Beghain, Johann; Langlois, Anne-Claire; Khim, Nimol; Kim, Saorin; Duru, Valentine; Bouchier, Christiane; Ma, Laurence; Lim, Pharath; Leang, Rithea; Duong, Socheat; Sreng, Sokunthea; Suon, Seila; Chuor, Char Meng; Bout, Denis Mey; Menard, Sandie; Rogers, William O.; Genton, Blaise; Fandeur, Thierry; Miotto, Olivo; Ringwald, Pascal; Le Bras, Jacques; Berry, Antoine; Barale, Jean-Christophe; Fairhurst, Rick M.; Benoit-Vical, Franoise; Mercereau-Puijalon, Odile; Menard, Didier			A molecular marker of artemisinin-resistant Plasmodium falciparum malaria	NATURE			English	Article							KELCH-REPEAT SUPERFAMILY; IN-VITRO; PARASITE CLEARANCE; CHLOROQUINE RESISTANCE; ANTIMALARIAL-DRUGS; POINT MUTATIONS; SUSCEPTIBILITY; DISRUPTION; MEFLOQUINE; ARTESUNATE	Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.	[Ariey, Frederic; Beghain, Johann; Langlois, Anne-Claire; Fandeur, Thierry; Barale, Jean-Christophe; Mercereau-Puijalon, Odile] Inst Pasteur, Parasite Mol Immunol Unit, F-75724 Paris 15, France; [Ariey, Frederic; Beghain, Johann; Langlois, Anne-Claire; Barale, Jean-Christophe; Mercereau-Puijalon, Odile] CNRS, URA 2581, F-75724 Paris 15, France; [Witkowski, Benoit; Khim, Nimol; Kim, Saorin; Duru, Valentine; Lim, Pharath; Fandeur, Thierry; Menard, Didier] Inst Pasteur Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Amaratunga, Chanaki; Lim, Pharath; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Bouchier, Christiane; Ma, Laurence] Inst Pasteur, Dept Genomes & Genet, F-75724 Paris 15, France; [Lim, Pharath; Leang, Rithea; Duong, Socheat; Sreng, Sokunthea; Suon, Seila; Chuor, Char Meng] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Bout, Denis Mey] Natl Ctr Parasitol Entomol & Malaria Control, SSA WHO, Phnom Penh, Cambodia; [Menard, Sandie; Berry, Antoine] Ctr Hosp Univ Toulouse, Serv Parasitol & Mycol, F-31059 Toulouse 9, France; [Rogers, William O.] Naval Med Res Unit 2 Detachment, Phnom Penh, Cambodia; [Genton, Blaise] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland; [Miotto, Olivo] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford OX3 7BN, England; [Miotto, Olivo] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Miotto, Olivo] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ringwald, Pascal] WHO, Global Malaria Program, CH-1211 Geneva, Switzerland; [Le Bras, Jacques] CHU Bichat Claude Bernard, APHP, PRES Sorbonne Paris Cite, Ctr Natl Reference Paludisme, F-75018 Paris, France; [Benoit-Vical, Franoise] CNRS, Lab Chim Coordinat, UPR8241, F-31077 Toulouse 4, France; [Benoit-Vical, Franoise] Univ Toulouse, UPS, Inst Natl Polytech Toulouse, F-31077 Toulouse 4, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Center Parasitology, Entomology & Malaria Control; National Center Parasitology, Entomology & Malaria Control; CHU de Toulouse; University of Basel; Swiss Tropical & Public Health Institute; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Wellcome Trust Sanger Institute; World Health Organization; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Ariey, F (corresponding author), Inst Pasteur, Genet & Genom Insect Vectors Unit, F-75724 Paris 15, France.	frederic.ariey@pasteur.fr; rfairhurst@niaid.nih.gov; Francoise.Vical@inserm.fr; odile.puijalon@pasteur.fr; dmenard@pasteur-kh.org	Langlois, Anne-Claire/GZX-5048-2022; Benoit-Vical, Francoise/E-3938-2016; Lim, Pharath/AAF-6699-2020; Mercereau-Puijalon, Odile/AAA-2242-2020; ariey, frederic/P-1185-2017; Miotto, Olivo/AAE-7124-2019; Witkowski, Benoit/T-1118-2019; Menard, Didier/O-3294-2013; Berry, Antoine/J-9352-2014	Benoit-Vical, Francoise/0000-0002-9468-4823; ariey, frederic/0000-0002-0680-1090; Miotto, Olivo/0000-0001-8060-6771; Menard, Didier/0000-0003-1357-4495; Lim, Pharath/0000-0002-1012-2461; Berry, Antoine/0000-0002-6626-7766; Menard, sandie/0000-0001-6972-3598; Langlois, Anne-Claire/0000-0002-9001-2667	Global Fund Grant Malaria Program [CAM-607-G10M-CNM3, CAM-S10-G14-M]; Bill and Melinda Gates Foundation; USAID (through the World Health Organization); US DOD Global Epidemic Information System; Intramural Research Program, NIAID, NIH; Banque Natixis; Laboratoire d'Excellence IBEID (Agence Nationale de la Recherche, France); Institut Pasteur, Division International [ACIP A-10-2010]; Institut Pasteur, Division International; French Ministry of Foreign Affairs; Wellcome Trust [098051, 090770/Z/09/Z]; MRC [G0600718]; Rotary Club-Versailles; Medical Research Council [G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI001000] Funding Source: NIH RePORTER	Global Fund Grant Malaria Program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USAID (through the World Health Organization)(United States Agency for International Development (USAID)); US DOD Global Epidemic Information System; Intramural Research Program, NIAID, NIH; Banque Natixis; Laboratoire d'Excellence IBEID (Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); Institut Pasteur, Division International; Institut Pasteur, Division International; French Ministry of Foreign Affairs; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rotary Club-Versailles; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patients and field staff involved in clinical trials and sample collections. We are grateful to the provincial health department directors and other staff of the Cambodian Ministry of Health. Clinical trials and sample collections were supported in part by the Global Fund Grant Malaria Program Rounds 6 (CAM-607-G10M-CNM3) and 9 (CAM-S10-G14-M), the Bill and Melinda Gates Foundation and USAID (through the World Health Organization), the US DOD Global Epidemic Information System, and the Intramural Research Program, NIAID, NIH. Laboratory work was supported by grants from Banque Natixis (to O.M.-P. and D. M.) and Laboratoire d'Excellence IBEID (Agence Nationale de la Recherche, France) and Institut Pasteur, Division International (ACIP A-10-2010). B. W. was supported by a postdoctoral fellowship from Institut Pasteur, Division International; J.B. by an Institut Pasteur Paris Master-Pro fellowship; and D. M. by the French Ministry of Foreign Affairs. We are grateful to the Wellcome Trust Sanger Institute and the MalariaGEN resource centre for sequencing, genotyping and population structure analysis of some Cambodian clinical samples, funded by the Wellcome Trust (098051; 090770/Z/09/Z) and the MRC (G0600718). We thank the Rotary Club-Versailles for funding computer equipment. P. R., D. M. B. and W.O.R. are staff members of the World Health Organization and the US Navy, respectively. They alone are responsible for the views expressed in this publication, and they do not necessarily represent the decisions, policy or views of the World Health Organization or the US Navy.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Borges S, 2011, ANTIMICROB AGENTS CH, V55, P4858, DOI 10.1128/AAC.01748-10; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chen NH, 2010, ANTIMICROB AGENTS CH, V54, P3395, DOI 10.1128/AAC.01421-09; Cui L, 2012, MOL MICROBIOL, V86, P111, DOI 10.1111/j.1365-2958.2012.08180.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorin-Semblat D, 2008, EUKARYOT CELL, V7, P279, DOI 10.1128/EC.00245-07; Eichhorn T, 2013, BIOCHEM PHARMACOL, V85, P38, DOI 10.1016/j.bcp.2012.10.006; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Hunt P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-499; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Krishna S, 2010, TRENDS PARASITOL, V26, P517, DOI 10.1016/j.pt.2010.06.014; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lobo CA, 1999, MOL CELL, V3, P793, DOI 10.1016/S1097-2765(01)80011-3; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Olivieri A, 2009, MOL MICROBIOL, V73, P180, DOI 10.1111/j.1365-2958.2009.06762.x; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Sharma A, 2003, NAT STRUCT BIOL, V10, P197, DOI 10.1038/nsb899; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2020, GLOB REP ANT DRUG EF; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	62	1235	1284	6	576	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					50	+		10.1038/nature12876	http://dx.doi.org/10.1038/nature12876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24352242	Green Published, Green Accepted			2022-12-28	WOS:000329163300021
J	Sherwood, OA; Guilderson, TP; Batista, FC; Schiff, JT; McCarthy, MD				Sherwood, Owen A.; Guilderson, Thomas P.; Batista, Fabian C.; Schiff, John T.; McCarthy, Matthew D.			Increasing subtropical North Pacific Ocean nitrogen fixation since the Little Ice Age	NATURE			English	Article							ISOTOPIC COMPOSITION; STATION ALOHA; AMINO-ACIDS; VARIABILITY; SEA; RADIOCARBON; CIRCULATION; PATTERNS; BIOGEOCHEMISTRY; DENITRIFICATION	The North Pacific subtropical gyre (NPSG) plays a major part in the export of carbon and other nutrients to the deep ocean(1). Primary production in the NPSG has increased in recent decades despite a reduction in nutrient supply to surface waters(2,3). It is thought that this apparent paradox can be explained by a shift in plankton community structure from mostly eukaryotes to mostly nitrogen-fixing prokaryotes(2-4). It remains uncertain, however, whether the plankton community domain shift can be linked to cyclical climate variability or a long-term global warming trend(5). Here we analyse records of bulk and amino-acid-specific N-15/N-14 isotopic ratios (delta N-15) preserved in the skeletons of long-lived deep-sea proteinaceous corals collected from the Hawaiian archipelago; these isotopic records serve as a proxy for the source of nitrogen-supported export production through time. We find that the recent increase in nitrogen fixation is the continuation of a much larger, centennial-scale trend. After a millennium of relatively minor fluctuation, delta N-15 decreases between 1850 and the present. The total shift in delta N-15 of -2 per mil over this period is comparable to the total change in global mean sedimentary delta N-15 across the Pleistocene-Holocene transition, but it is happening an order of magnitude faster(6). We use a steady-state model and find that the isotopic mass balance between nitrate and nitrogen fixation implies a 17 to 27 per cent increase in nitrogen fixation over this time period. A comparison with independent records(7,8) suggests that the increase in nitrogen fixation might be linked to Northern Hemisphere climate change since the end of the Little Ice Age.	[Sherwood, Owen A.; Guilderson, Thomas P.; Batista, Fabian C.; Schiff, John T.; McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Guilderson, Thomas P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Guilderson, Thomas P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz	Sherwood, OA (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	owen.sherwood@colorado.edu		SHERWOOD, OWEN/0000-0003-1055-3162	NOAA/NURP; National Geographic Society [7717-04]; US Department of Energy [DE-AC52-07NA27344]; NSF [OCE 1061689]; Directorate For Geosciences [1061689] Funding Source: National Science Foundation; Division Of Ocean Sciences [1260164] Funding Source: National Science Foundation	NOAA/NURP(National Oceanic Atmospheric Admin (NOAA) - USA); National Geographic Society(National Geographic Society); US Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain and crew of the RV Ka'imikai-o-Kanaloa and the pilots and engineers of the Hawaiian Undersea Research Laboratory's Pisces V submersible for their assistance in collecting the specimens presented here. Funding for sample collection was from NOAA/NURP and the National Geographic Society (grant number 7717-04). Radiocarbon analyses were performed under the auspices of the US Department of Energy (grant number DE-AC52-07NA27344). The bulk of the work presented here was funded by the NSF (grant number OCE 1061689).	Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Boyle EA, 2005, GEOCHIM COSMOCHIM AC, V69, P933, DOI 10.1016/j.gca.2004.07.034; Broek TAB, 2013, RAPID COMMUN MASS SP, V27, P2327, DOI 10.1002/rcm.6695; Casciotti KL, 2008, DEEP-SEA RES PT II, V55, P1661, DOI 10.1016/j.dsr2.2008.04.017; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Corno G, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003730; Dave AC, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006507; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Diaz HF, 2012, GLOBAL PLANET CHANGE, V98-99, P97, DOI 10.1016/j.gloplacha.2012.08.011; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Druffel ERM, 2001, RADIOCARBON, V43, P15; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Galbraith ED, 2013, NAT GEOSCI, V6, P579, DOI [10.1038/NGEO1832, 10.1038/ngeo1832]; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; GRIFFIN S, 1989, RADIOCARBON, V31, P533; Gruber N., 2004, OCEAN CARBON CYCLE C, P97, DOI DOI 10.1007/978-1-4020-2087-2_4; Guilderson TP, 2013, BIOGEOSCIENCES, V10, P6019, DOI 10.5194/bg-10-6019-2013; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Popp BN, 2007, TERR ECOL SER, V1, P173; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Sherwood OA, 2011, P NATL ACAD SCI USA, V108, P1011, DOI 10.1073/pnas.1004904108; Sigman DM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035784; Sinniger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052607; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Styring AK, 2010, GEOCHIM COSMOCHIM AC, V74, P241, DOI 10.1016/j.gca.2009.09.022; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916; Wiley AE, 2013, P NATL ACAD SCI USA, V110, P8972, DOI 10.1073/pnas.1300213110; Wilson R, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003188	47	66	69	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					78	+		10.1038/nature12784	http://dx.doi.org/10.1038/nature12784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24336216				2022-12-28	WOS:000329163300027
J	Jain, VK; Rivera, L; Zaman, K; Espos, RA; Sirivichayakul, C; Quiambao, BP; Rivera-Medina, DM; Kerdpanich, P; Ceyhan, M; Dinleyici, EC; Cravioto, A; Yunus, M; Chanthavanich, P; Limkittikul, K; Kurugol, Z; Alhan, E; Caplanusi, A; Durviaux, S; Boutet, P; Ofori-Anyinam, O; Chandrasekaran, V; Dbaibo, G; Innis, BL				Jain, Varsha K.; Rivera, Luis; Zaman, Khalequ; Espos, Roberto A., Jr.; Sirivichayakul, Chukiat; Quiambao, Beatriz P.; Rivera-Medina, Doris M.; Kerdpanich, Pirunghul; Ceyhan, Mehmet; Dinleyici, Ener C.; Cravioto, Alejandro; Yunus, Mohammed; Chanthavanich, Pornthep; Limkittikul, Kriengsak; Kurugol, Zafer; Alhan, Emre; Caplanusi, Adrian; Durviaux, Serge; Boutet, Philippe; Ofori-Anyinam, Opokua; Chandrasekaran, Vijayalakshmi; Dbaibo, Ghassan; Innis, Bruce L.			Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEASONAL INFLUENZA; B VIRUSES; EFFICACY; INFECTION; RESPONSES; INFANTS; NETWORK; DISEASE; VISITS; BURDEN	Background Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffective against viruses of the other B lineage. We evaluated the efficacy of a candidate inactivated quadrivalent influenza vaccine (QIV) containing both B lineages. Methods In this multinational, phase 3, observer-blinded study, we randomly assigned children 3 to 8 years of age, in a 1:1 ratio, to receive the QIV or a hepatitis A vaccine (control). The primary end point was influenza A or B confirmed by real-time polymerase chain reaction (rt-PCR). Secondary end points were rt-PCR-confirmed, moderate-to-severe influenza and rt-PCR-positive, culture-confirmed influenza. The vaccine efficacy and the effect of vaccination on daily activities and utilization of health care resources were assessed in the total vaccinated cohort (2584 children in each group) and the per-protocol cohort (2379 children in the QIV group and 2398 in the control group). Results In the total vaccinated cohort, 62 children in the QIV group (2.40%) and 148 in the control group (5.73%) had rt-PCR-confirmed influenza, representing a QIV efficacy of 59.3% (95% confidence interval [CI], 45.2 to 69.7), with efficacy against culture-confirmed influenza of 59.1% (97.5% CI, 41.2 to 71.5). For moderate-to-severe rt-PCR-confirmed influenza, the attack rate was 0.62% (16 cases) in the QIV group and 2.36% (61 cases) in the control group, representing a QIV efficacy of 74.2% (97.5% CI, 51.5 to 86.2). In the per-protocol cohort, the QIV efficacy was 55.4% (95% CI, 39.1 to 67.3), and the efficacy against culture-confirmed influenza 55.9% (97.5% CI, 35.4 to 69.9); the efficacy among children with moderate-to-severe influenza was 73.1% (97.5% CI, 47.1 to 86.3). The QIV was associated with reduced risks of a body temperature above 39 degrees C and lower respiratory tract illness, as compared with the control vaccine, in the per-protocol cohort (relative risk, 0.29 [95% CI, 0.16 to 0.56] and 0.20 [95% CI, 0.04 to 0.92], respectively). The QIV was immunogenic against all four strains. Serious adverse events occurred in 36 children in the QIV group (1.4%) and in 24 children in the control group (0.9%). Conclusions The QIV was efficacious in preventing influenza in children. (Funded by GlaxoSmithKline Biologicals; ClinicalTrials.gov number, NCT01218308.)	[Jain, Varsha K.; Chandrasekaran, Vijayalakshmi; Innis, Bruce L.] GlaxoSmithKline Vaccines, King Of Prussia, PA USA; [Rivera, Luis] Hosp Maternidad Nuestra Senora Altagracia, Dept Neonatal Perinatal Med, Santo Domingo, Dominican Rep; [Zaman, Khalequ] ICDDR, Ctr Child & Adolescent Hlth, Dhaka, Bangladesh; [Cravioto, Alejandro] ICDDR, Execut Directors Off, Dhaka, Bangladesh; [Yunus, Mohammed] ICDDR, Ctr Child & Adolescent Hlth, Dhaka, Bangladesh; [Espos, Roberto A., Jr.] De La Salle Hlth Sci Inst, Dept Pediat, Dasmarinas City, Philippines; [Espos, Roberto A., Jr.] De La Salle Coll Med, Dasmarinas City, Philippines; [Quiambao, Beatriz P.] Res Inst Trop Med, Div Clin Res, Muntinlupa, Philippines; [Sirivichayakul, Chukiat; Chanthavanich, Pornthep; Limkittikul, Kriengsak] Mahidol Univ, Dept Trop Pediat, Bangkok 10700, Thailand; [Kerdpanich, Pirunghul] Royal Thai Army, Dept Infect Pediat, Phramongkutklao Hosp, Bangkok, Thailand; [Rivera-Medina, Doris M.] ODISH, Dept Clin Res, Tegucigalpa, Honduras; [Ceyhan, Mehmet] Hacettepe Univ, Dept Pediat & Infect Dis, Ankara, Turkey; [Dinleyici, Ener C.] Eskisehir Osmangazi Univ, Dept Pediat Intens Care, Fac Med, Eskisehir, Turkey; [Dinleyici, Ener C.] Eskisehir Osmangazi Univ, Infect Dis Unit, Fac Med, Eskisehir, Turkey; [Kurugol, Zafer] Ege Univ, Fac Med, Dept Pediat, Izmir, Turkey; [Alhan, Emre] Cukurova Univ, Dept Pediat, Div Pediat Infect Dis, Adana, Turkey; [Caplanusi, Adrian; Durviaux, Serge; Boutet, Philippe; Ofori-Anyinam, Opokua] GlaxoSmithKline Vaccines, Wavre, Belgium; [Dbaibo, Ghassan] Amer Univ Beirut, Dept Pediat & Adolescent Med, Med Ctr, Beirut 110236, Lebanon	GlaxoSmithKline; International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); De La Salle University; De La Salle University Dasmarinas; De La Salle University Dasmarinas; Research Institute for Tropical Medicine - Philippines; Mahidol University; Phramongkutklao Hospital; Hacettepe University; Eskisehir Osmangazi University; Eskisehir Osmangazi University; Ege University; Cukurova University; GlaxoSmithKline; American University of Beirut	Dbaibo, G (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Med Ctr, Rm C-649,Cairo St, Beirut 110236, Lebanon.	gdbaibo@aub.edu.lb	Dbaibo, Ghassan S./X-2978-2019; Dinleyici, Ener Cagri/AAF-8688-2019	Dinleyici, Ener Cagri/0000-0002-0339-0134; Innis, Bruce/0000-0002-1753-7248; Yunus, Mohammed/0000-0003-1116-4978	GlaxoSmithKline Biologicals	GlaxoSmithKline Biologicals(GlaxoSmithKline)	Funded by GlaxoSmithKline Biologicals	Armstrong PK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000016; Baxter R, 2010, PEDIATR INFECT DIS J, V29, P924, DOI 10.1097/INF.0b013e3181e075be; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Beran J, 2009, J INFECT DIS, V200, P1861, DOI 10.1086/648406; Bourgeois FT, 2006, PEDIATRICS, V118, pE1, DOI 10.1542/peds.2005-2248; CLOVER RD, 1991, J INFECT DIS, V163, P300, DOI 10.1093/infdis/163.2.300; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Domachowske JB, 2013, J INFECT DIS, V207, P1878, DOI 10.1093/infdis/jit091; Englund JA, 2006, PEDIATRICS, V118, pE579, DOI 10.1542/peds.2006-0201; Gooskens J, 2008, J CLIN VIROL, V41, P7, DOI 10.1016/j.jcv.2007.10.023; Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128; Hehme NW, 2002, CLIN DRUG INVEST, V22, P751, DOI 10.2165/00044011-200222110-00004; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jansen AGSC, 2008, J PEDIATR-US, V153, P764, DOI 10.1016/j.jpeds.2008.05.060; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Kieninger D, 2012, INFL VACC WORLD IVW; Langley JM, 2012, IDWEEK SAN DIEG CA O; LEVANDOWSKI RA, 1991, PEDIATRICS, V88, P1031; Liao RS, 2009, J CLIN MICROBIOL, V47, P527, DOI 10.1128/JCM.01213-08; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Saunders NR, 2003, CAN MED ASSOC J, V168, P25; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Tinoco JC, 2012, IDWEEK SAN DIEG CA O; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Vesikari T, 2012, J CLIN VIROL, V53, P22, DOI 10.1016/j.jcv.2011.10.013; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7	33	99	100	3	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2013	369	26					2481	2491		10.1056/NEJMoa1215817	http://dx.doi.org/10.1056/NEJMoa1215817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BT	24328444				2022-12-28	WOS:000328863700006
J	Lee, SJ; Leipzig, RM; Walter, LC				Lee, Sei J.; Leipzig, Rosanne M.; Walter, Louise C.			Incorporating Lag Time to Benefit Into Prevention Decisions for Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lee, Sei J.; Walter, Louise C.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94121 USA; [Leipzig, Rosanne M.] Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, New York, NY USA	University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai	Lee, SJ (corresponding author), Univ Calif San Francisco, Div Geriatr, 4150 Clement St,Bldg 1,Room 220F, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA134425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG041180, P30AG044281, K23AG040779] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA134425, R01 CA134425] Funding Source: Medline; NIA NIH HHS [P30 AG044281, L30 AG030755, K24AG041180, K23 AG040779, K23AG040779, K24 AG041180] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Wei Rong, 2008, Natl Vital Stat Rep, V57, P1; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	8	117	119	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2013	310	24					2609	2610		10.1001/jama.2013.282612	http://dx.doi.org/10.1001/jama.2013.282612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277KN	24322396	Green Accepted			2022-12-28	WOS:000328818000007
J	Holland, WL; Scherer, PE				Holland, William L.; Scherer, Philipp E.			Ronning After the Adiponectin Receptors	SCIENCE			English	Editorial Material							INSULIN ACTION; OBESITY; MICE		[Holland, William L.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Holland, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	NIDDK NIH HHS [R01 DK055758, R01 DK099110, P01 DK088761] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099110, P01DK088761, R01DK055758] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Mancia F, 2004, STRUCTURE, V12, P1355, DOI 10.1016/j.str.2004.06.012; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001	15	57	58	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1460	1461		10.1126/science.1249077	http://dx.doi.org/10.1126/science.1249077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357309	Green Accepted			2022-12-28	WOS:000328644300042
J	Weintraub, K				Weintraub, Karen			DRUG DEVELOPMENT Releasing the brakes	NATURE			English	Editorial Material							ANTI-PD-1; SAFETY											Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Schadendorf D., 2013, EUR CANC C 2013, VLBA24; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	4	16	17	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					S6	S8		10.1038/504S6a	http://dx.doi.org/10.1038/504S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24352363	Bronze			2022-12-28	WOS:000328575300004
J	Yamaguchi, S; Shen, L; Liu, YT; Sendler, D; Zhang, Y				Yamaguchi, Shinpei; Shen, Li; Liu, Yuting; Sendler, Damian; Zhang, Yi			Role of Tet1 in erasure of genomic imprinting	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; POSTNATAL-DEVELOPMENT; GENE; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; DYNAMICS; 5-METHYLCYTOSINE; DEFICIENCY; EXPRESSION	Genomic imprinting is an allele-specific gene expression system that is important for mammalian development and function(1). The molecular basis of genomic imprinting is allele-specific DNA methylation(1,2). Although it is well known that the de novo DNA methyltransferases Dnmt3a and Dnmt3b are responsible for the establishment of genomic imprinting(3), how the methylation mark is erased during primordial germ cell (PGC) reprogramming remains unclear. Tet1 is one of the ten-eleven translocation family proteins, which have the capacity to oxidize 5-methylcytosine (5mC)(4-6), specifically expressed in reprogramming PGCs(7). Here we report that Tet1 has a critical role in the erasure of genomic imprinting. We show that despite their identical genotype, progenies derived from mating between Tet1 knockout males and wild-type females exhibit a number of variable phenotypes including placental, fetal and postnatal growth defects, and early embryonic lethality. These defects are, at least in part, caused by the dysregulation of imprinted genes, such as Peg10 and Peg3, which exhibit aberrant hypermethylation in the paternal allele of differential methylated regions (DMRs). RNA-seq reveals extensive dysregulation of imprinted genes in the next generation due to paternal loss of Tet1 function. Genome-wide DNA methylation analysis of embryonic day 13.5 PGCs and sperm of Tet1 knockout mice revealed hypermethylation of DMRs of imprinted genes in sperm, which can be traced back to PGCs. Analysis of the DNA methylation dynamics in reprogramming PGCs indicates that Tet1 functions to wipe out remaining methylation, including imprinted genes, at the late reprogramming stage. Furthermore, we provide evidence supporting the role of Tet1 in the erasure of paternal imprints in the female germ line. Thus, our study establishes a critical function of Tet1 in the erasure of genomic imprinting.	[Yamaguchi, Shinpei; Shen, Li; Liu, Yuting; Sendler, Damian; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Liu, Yuting; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Liu, Yuting; Zhang, Yi] Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu		Zhang, Yi/0000-0002-2789-0811; Yamaguchi, Shinpei/0000-0002-9377-4835	NIH [U01DK089565]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Jiang for help with FACS sorting of PGCs; A. Inoue, S. Matoba and D. Cai for critical reading of the manuscript. This project is supported by NIH U01DK089565 (to Y.Z.). S.Y. is supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science (JSPS). Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kobayashi H, 2006, CYTOGENET GENOME RES, V113, P130, DOI 10.1159/000090824; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709	30	153	164	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					460	+		10.1038/nature12805	http://dx.doi.org/10.1038/nature12805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24291790	Green Accepted, Green Submitted			2022-12-28	WOS:000328575300057
J	Pronovost, PJ				Pronovost, Peter J.			Enhancing Physicians' Use of Clinical Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Pronovost, Peter J.] Johns Hopkins Univ, Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA.	ppronovo@jhmi.edu						Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Institute of Medicine, 2012, BEST CAR LOW COST PA; Needham DM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2124; Pronovost PJ, 2012, JAMA-J AM MED ASSOC, V308, P769, DOI 10.1001/jama.2012.9537; Wachter RM, 2013, ANN INTERN MED, V158, P350, DOI 10.7326/0003-4819-158-5-201303050-00010; Wise ME, 2013, INFECT CONT HOSP EP, V34, P547, DOI 10.1086/670629	6	153	158	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2013	310	23					2501	2502		10.1001/jama.2013.281334	http://dx.doi.org/10.1001/jama.2013.281334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272ZZ	24310916				2022-12-28	WOS:000328503600016
J	Aung, K				Aung, KoKo			A 13-item score predicted survival to discharge with good neurologic status after CPR for in-hospital cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Aung, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Nassar AP, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.016	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC13	10.7326/0003-4819-159-12-201312170-02013	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343406				2022-12-28	WOS:000329735300011
J	Barlow, MJ; Swinyard, BM; Owen, PJ; Cernicharo, J; Gomez, HL; Ivison, RJ; Krause, O; Lim, TL; Matsuura, M; Miller, S; Olofsson, G; Polehampton, ET				Barlow, M. J.; Swinyard, B. M.; Owen, P. J.; Cernicharo, J.; Gomez, H. L.; Ivison, R. J.; Krause, O.; Lim, T. L.; Matsuura, M.; Miller, S.; Olofsson, G.; Polehampton, E. T.			Detection of a Noble Gas Molecular Ion, (ArH+)-Ar-36, in the Crab Nebula	SCIENCE			English	Article							ROTATIONAL-EXCITATION; HERSCHEL; SPECTROSCOPY; KNOTS; HEH+	Noble gas molecules have not hitherto been detected in space. From spectra obtained with the Herschel Space Observatory, we report the detection of emission in the 617.5- and 1234.6-gigahertz J = 1-0 and 2-1 rotational lines of (ArH+)-Ar-36 at several positions in the Crab Nebula, a supernova remnant known to contain both molecular hydrogen and regions of enhanced ionized argon emission. Argon-36 is believed to have originated from explosive nucleosynthesis in massive stars during core-collapse supernova events. Its detection in the Crab Nebula, the product of such a supernova event, confirms this expectation. The likely excitation mechanism for the observed (ArH+)-Ar-36 emission lines is electron collisions in partially ionized regions with electron densities of a few hundred per centimeter cubed.	[Barlow, M. J.; Swinyard, B. M.; Owen, P. J.; Matsuura, M.; Miller, S.] Univ London Univ Coll, Dept Phys & Astron, London WC1E 6BT, England; [Swinyard, B. M.; Lim, T. L.; Polehampton, E. T.] Rutherford Appleton Lab, Space Sci & Technol Dept, Didcot OX11 0QX, Oxon, England; [Cernicharo, J.] CSIC, Inst Nacl Tecn Aeroesp, Lab Mol Astrophys, Dept Astrophys,Ctr Astrobiol, Madrid 28850, Spain; [Gomez, H. L.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales; [Ivison, R. J.] Royal Observ Edinburgh, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Krause, O.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Olofsson, G.] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, S-10691 Stockholm, Sweden; [Polehampton, E. T.] Univ Lethbridge, Dept Phys & Astron, Inst Space Imaging Sci, Lethbridge, AB T1K 3M4, Canada	University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Cardiff University; University of Edinburgh; Max Planck Society; Stockholm University; University of Lethbridge	Barlow, MJ (corresponding author), Univ London Univ Coll, Dept Phys & Astron, Gower St, London WC1E 6BT, England.	mjb@star.ucl.ac.uk	Ivison, R. J./G-4450-2011; Cernicharo, Jose/G-3059-2015; Barlow, Michael J/A-5638-2009	Ivison, R. J./0000-0001-5118-1313; Cernicharo, Jose/0000-0002-3518-2524; Barlow, Michael J/0000-0002-3875-1171; Polehampton, Edward/0000-0003-3153-813X; Matsuura, Mikako/0000-0002-5529-5593; Miller, Steven/0000-0002-7159-6871; Gomez, Haley/0000-0003-3398-0052	MINECO [AYA2009-07304, AYA2012-32032]; Consolider program ASTROMOL [CSD2009-00038]; STFC [ST/J001511/1, ST/G002827/1, ST/K000926/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000926/1, ST/G002827/1, 1090801, ST/J001511/1] Funding Source: researchfish	MINECO(Spanish Government); Consolider program ASTROMOL; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the anonymous referees for their constructive reports. We thank E. Bergin for drawing our attention to the 2010 HEXOS Herschel HIFI spectrum of SgR B2 (M) that shows an unidentified broad absorption feature below 618 GHz. Herschel is a European Space Agency (ESA) space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and including University of Lethbridge (Canada); National Astronomical Observatories, Chinese Academy of Sciences Commissariat a l'energie atomique et aux energies alternatives Laboratoire d'Astrophysique de Marseille (France); Istituto di fisica dello Spazio Interplanetario University of Padua (Italy); Instituto de Astrofisica de Canarias (Spain); Stockholm Observatory (Sweden); Imperial College London, Rutherford Appleton Laboratory, University College London-Mullard Space Science Laboratory, United Kingdom Astronomy Technology Centre, University of Sussex (UK); and California Institute of Technology, Jet Propulson Laboratory, NASA Herschel Science Center, University of Colorado (USA). This development has been supported by national funding agencies: Canadian Space Agency (Canada); NAOC (China); CEA, Centre national d'etudes spatiales, Centre national de la recherche scientifique (France); Agenzia Spaziale Italiana (Italy); Ministerio de Economia (Spain); Swedish National Space Board (Sweden); Science Technology and Facilities Council and United Kingdom Space Agency (UK); and NASA (USA). J.C. thanks MINECO for financial support under projects AYA2009-07304, AYA2012-32032, and Consolider program ASTROMOL CSD2009-00038.	Anicich V. G., 2003, NASA JPL PUBL, P03; Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Cernicharo J, 2013, EAS PUBLICATIONS, V58, P251, DOI 10.1051/eas/1258040; DAVIDSON K, 1985, ANNU REV ASTRON ASTR, V23, P119; Gomez HL, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/96; GRAHAM JR, 1990, ASTROPHYS J, V352, P172, DOI 10.1086/168525; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Groenewegen MAT, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015829; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; LIAS SG, 1984, J PHYS CHEM REF DATA, V13, P695, DOI 10.1063/1.555719; Lim AJ, 1999, MON NOT R ASTRON SOC, V306, P473, DOI 10.1046/j.1365-8711.1999.02533.x; Liu XW, 1997, MON NOT R ASTRON SOC, V290, pL71, DOI 10.1093/mnras/290.4.L71; Loh ED, 2012, MON NOT R ASTRON SOC, V421, P789, DOI 10.1111/j.1365-2966.2011.20353.x; Loh ED, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/30; MACALPINE GM, 1994, ASTROPHYS J, V432, pL131, DOI 10.1086/187529; Meshik A, 2007, SCIENCE, V318, P433, DOI 10.1126/science.1145528; Mitchell JBA, 2005, J PHYS B-AT MOL OPT, V38, pL175, DOI 10.1088/0953-4075/38/10/L07; MOORHEAD JM, 1988, ASTROPHYS J, V326, P899, DOI 10.1086/166147; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Neufeld DA, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015077; Nkem C, 2009, J MOL STRUC-THEOCHEM, V901, P220, DOI 10.1016/j.theochem.2009.01.037; Ott S, 2010, ASTR SOC P, V434, P139; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Roach A. C., 1970, CHEM COMMUN, P1336; Schaller EL, 2002, ASTRON J, V123, P941, DOI 10.1086/338310; Schilke P., 2010, P HERSCH 1 RES S; Spinoglio L, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/108; Swinyard BM, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014605; Temim T, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/72; van der Werf PP, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014682; WYATT JR, 1975, J CHEM PHYS, V62, P2555, DOI 10.1063/1.430836	32	121	121	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1343	1345		10.1126/science.1243582	http://dx.doi.org/10.1126/science.1243582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24337290	Green Submitted, Green Accepted			2022-12-28	WOS:000328196000042
J	Ray, A; Muse, VV; Boyer, DF				Ray, Alaka; Muse, Victorine V.; Boyer, Daniel F.			Case 38-2013: A 30-Year-Old Man with Fever and Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KIKUCHI-FUJIMOTO-DISEASE; HISTIOCYTIC NECROTIZING LYMPHADENITIS; FAMILY-PRACTICE; DIAGNOSIS; BIOPSY; MANAGEMENT; CELLS		[Ray, Alaka] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Boyer, Daniel F.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ray, Alaka] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Boyer, Daniel F.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ray, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.							ALLHISER JN, 1981, J FAM PRACTICE, V12, P27; Chau I, 2003, BRIT J CANCER, V88, P354, DOI 10.1038/sj.bjc.6600738; Chen H, 2004, AM J SURG PATHOL, V28, P505, DOI 10.1097/00000478-200404000-00010; DORFMAN RF, 1988, SEMIN DIAGN PATHOL, V5, P329; FIJTEN GH, 1988, J FAM PRACTICE, V27, P373; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Hu S, 2003, PATHOL INT, V53, P221, DOI 10.1046/j.1320-5463.2003.01458.x; Hutchinson CB, 2010, ARCH PATHOL LAB MED, V134, P289, DOI 10.1043/1543-2165-134.2.289; Jang YJ, 2000, J LARYNGOL OTOL, V114, P709; Jha BC, 2001, POSTGRAD MED J, V77, P185, DOI 10.1136/pmj.77.905.185; Kim BM, 2007, J ULTRAS MED, V26, P585, DOI 10.7863/jum.2007.26.5.585; Kishimoto K, 2010, DIAGN CYTOPATHOL, V38, P521, DOI 10.1002/dc.21265; Kucukardali Y, 2007, CLIN RHEUMATOL, V26, P50, DOI 10.1007/s10067-006-0230-5; KUO TT, 1995, AM J SURG PATHOL, V19, P798, DOI 10.1097/00000478-199507000-00008; LEE YTN, 1980, J SURG ONCOL, V14, P53, DOI 10.1002/jso.2930140108; Mahajan VK, 2004, INT J DERMATOL, V43, P370, DOI 10.1111/j.1365-4632.2004.01906.x; Menasce LP, 1998, HISTOPATHOLOGY, V33, P248, DOI 10.1046/j.1365-2559.1998.00469.x; Mohan A, 2007, NATL MED J INDIA, V20, P78; Motyckova G, 2012, HEMATOL ONCOL CLIN N, V26, P395, DOI 10.1016/j.hoc.2012.02.005; PANGALIS GA, 1993, SEMIN ONCOL, V20, P570; Pilichowska ME, 2009, AM J CLIN PATHOL, V131, P174, DOI 10.1309/AJCP7V1QHJLOTKKJ; Prignano F, 2012, INT J DERMATOL, V51, P564, DOI 10.1111/j.1365-4632.2011.05052.x; Ramkumar A, 2011, INDIAN J OTOLARYNGOL, V63, pS110, DOI 10.1007/s12070-011-0218-6; TB India, 2009, TB IND 2009 REV NAT; Tong TRSW, 2001, ACTA CYTOL, V45, P953; TSANG WYW, 1994, AM J CLIN PATHOL, V102, P454, DOI 10.1093/ajcp/102.4.454; Yasukawa K, 2001, BRIT J DERMATOL, V144, P885, DOI 10.1046/j.1365-2133.2001.04151.x	27	2	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2333	2343		10.1056/NEJMcpc1310002	http://dx.doi.org/10.1056/NEJMcpc1310002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328468				2022-12-28	WOS:000328156300012
J	Schiffman, M; Solomon, D				Schiffman, Mark; Solomon, Diane			Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIQUID-BASED CYTOLOGY; AMERICAN SOCIETY; 5-YEAR RISKS; GRADE 3; HPV; WOMEN; NEOPLASIA; TESTS; DNA; INFECTION		[Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Solomon, Diane] NCI, Canc Prevent Div, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schiffman, M (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Rockville, MD 20850 USA.	schiffmm@exchange.nih.gov	Schiffman, Mark/B-9766-2015					Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Rodriguez AC, 2012, INT J CANCER, V131, P1874, DOI 10.1002/ijc.27418; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chen HC, 2011, JNCI-J NATL CANCER I, V103, P1387, DOI 10.1093/jnci/djr283; Committee on Practice Bulletins-Gynecology, 2012, OBSTET GYNECOL, V120, P1222, DOI [DOI 10.1097/AOG.0B013E318277C92A, 10.1097/ AOG.0b013e318277c92a]; Darragh T, 2013, J LOW GENIT TRACT DI, V17, P368; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Einstein MH, 2010, GYNECOL ONCOL, V118, P116, DOI 10.1016/j.ygyno.2010.04.013; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2011, CANCER DISCOV, V1, P408, DOI 10.1158/2159-8290.CD-11-0131; International Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Int J Cancer, V118, P1481, DOI 10.1002/ijc.21493; Katki HA, 2011, LANCET ONCOL, V12, P722; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS50, DOI 10.1097/LGT.0b013e3182854282; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS28, DOI 10.1097/LGT.0b013e318285423c; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS36, DOI 10.1097/LGT.0b013e3182854253; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kulasingam SL, 2013, J LOW GENIT TRACT DI, V17, P193, DOI 10.1097/LGT.0b013e3182616241; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Massad SL, 2013, J LOW GENIT TRACT DI, V17, P367; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Monsonego J, 2011, INT J CANCER, V129, P691, DOI 10.1002/ijc.25726; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, BRIT J CANCER, V106, P975, DOI 10.1038/bjc.2011.581; Ronco G, 2013, LANCET; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Shiffman M, 2008, LANCET ONCOL, V9, P404, DOI 10.1016/S1470-2045(08)70110-4; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P2322; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solomon D, 2007, CA-CANCER J CLIN, V57, P105, DOI 10.3322/canjclin.57.2.105; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	53	72	81	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2324	2331		10.1056/NEJMcp1210379	http://dx.doi.org/10.1056/NEJMcp1210379			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24328466				2022-12-28	WOS:000328156300010
J	Nakahara, S; Tomio, J; Takahashi, H; Ichikawa, M; Nishida, M; Morimura, N; Sakamoto, T				Nakahara, Shinji; Tomio, Jun; Takahashi, Hideto; Ichikawa, Masao; Nishida, Masamichi; Morimura, Naoto; Sakamoto, Tetsuya			Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical services for patients with out of hospital cardiac arrest in Japan: controlled propensity matched retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; CARDIOVASCULAR CARE; VENTRICULAR-FIBRILLATION; SURVIVAL; TRIAL; DEFIBRILLATION; HYPOTHERMIA; GUIDELINES	Objectives To evaluate the effectiveness of pre-hospital adrenaline (epinephrine) administered by emergency medical services to patients with out of hospital cardiac arrest. Design Controlled propensity matched retrospective cohort study, in which pairs of patients with or without (control) adrenaline were created with a sequential risk set matching based on time dependent propensity score. Setting Japan's nationwide registry database of patients with out of hospital cardiac arrest registered between January 2007 and December 2010. Participants Among patients aged 15-94 with out of hospital cardiac arrest witnessed by a bystander, we created 1990 pairs of patients with and without adrenaline with an initial rhythm of ventricular fibrillation or pulseless ventricular tachycardia (VF/VT) and 9058 pairs among those with non-VF/VT. Main outcome measures Overall and neurologically intact survival at one month or at discharge, whichever was earlier. Results After propensity matching, pre-hospital administration of adrenaline by emergency medical services was associated with a higher proportion of overall survival (17.0% v 13.4%; unadjusted odds ratio 1.34, 95% confidence interval 1.12 to 1.60) but not with neurologically intact survival (6.6% v 6.6%; 1.01, 0.78 to 1.30) among those with VF/VT; and higher proportions of overall survival (4.0% v 2.4%; odds ratio 1.72, 1.45 to 2.04) and neurologically intact survival (0.7% v 0.4%; 1.57, 1.04 to 2.37) among those with non-VF/VT. Conclusions Pre-hospital administration of adrenaline by emergency medical services improves the long term outcome in patients with out of hospital cardiac arrest, although the absolute increase of neurologically intact survival was minimal.	[Nakahara, Shinji] St Marianna Univ, Sch Med, Dept Epidemiol & Hlth Promot, Kawasaki, Kanagawa, Japan; [Tomio, Jun] Univ Tokyo, Dept Publ Hlth, Grad Sch Med, Tokyo, Japan; [Tomio, Jun] Tokyo Univ Hosp, Dept Disaster Med Management, Tokyo 113, Japan; [Takahashi, Hideto; Ichikawa, Masao] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Nishida, Masamichi] Toranomon Gen Hosp, Dept Emergency Med, Tokyo, Japan; [Morimura, Naoto] Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Yokohama, Kanagawa 232, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo 173, Japan	Saint Marianna University; University of Tokyo; University of Tokyo; University of Tsukuba; Toranomon Hospital; Yokohama City University; Teikyo University	Nakahara, S (corresponding author), Kanagawa Univ Human Serv, 1-10-1 Heiseicho, Yokosuka, Kanagawa 2388522, Japan.	snakahara-tky@umin.net		Nakahara, Shinji/0000-0001-7243-4797				Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bur A, 2001, INTENS CARE MED, V27, P1474, DOI 10.1007/s001340101045; Guo S, 2010, PROPENSITY SCORE ANA, P127; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Hayashi Y, 2012, CIRC J, V76, P1639, DOI 10.1253/circj.CJ-11-1433; HERLITZ J, 1995, RESUSCITATION, V29, P195, DOI 10.1016/0300-9572(94)00851-6; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd, P339; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Leuven E, PSMATCH2 STATA MODUL; Li YFP, 2001, J AM STAT ASSOC, V96, P870, DOI 10.1198/016214501753208573; Lu B, 2005, BIOMETRICS, V61, P721, DOI 10.1111/j.1541-0420.2005.00356.x; McQueen C, 2012, RESUSCITATION, V83, P921, DOI 10.1016/j.resuscitation.2012.06.001; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Nagao K, 2007, LANCET, V369, P920; Nakahara S, 2012, ACAD EMERG MED, V19, P782, DOI 10.1111/j.1553-2712.2012.01387.x; Olasveengen TM, 2012, RESUSCITATION, V83, P327, DOI 10.1016/j.resuscitation.2011.11.011; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Shirako T, 2010, J JPN SOC EMERG MED, V13, P341; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X	29	85	88	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f6829	10.1136/bmj.f6829	http://dx.doi.org/10.1136/bmj.f6829			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24326886	Green Published, hybrid			2022-12-28	WOS:000328574700001
J	Le Borgne, M; Shaw, AS				Le Borgne, Marie; Shaw, Andrey S.			Do T Cells Have a Cilium?	SCIENCE			English	Editorial Material									[Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Le Borgne, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid, St Louis, MO 63110 USA.	ashaw@wustl.edu	Le Borgne, Marie/P-2313-2015	Le Borgne, Marie/0000-0002-3439-4867	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; de la Roche M, 2013, SCIENCE, V342, P1247, DOI 10.1126/science.1244689; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021	8	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1177	1178		10.1126/science.1248078	http://dx.doi.org/10.1126/science.1248078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311670				2022-12-28	WOS:000327857900025
J	Tauxe, GM; MacWilliam, D; Boyle, SM; Guda, T; Ray, A				Tauxe, Genevieve M.; MacWilliam, Dyan; Boyle, Sean Michael; Guda, Tom; Ray, Anandasankar			Targeting a Dual Detector of Skin and CO2 to Modify Mosquito Host Seeking	CELL			English	Article							VECTOR ANOPHELES-GAMBIAE; MM-X TRAPS; CARBON-DIOXIDE; MALARIA MOSQUITO; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; AVOIDANCE-BEHAVIOR; FLIGHT MANEUVERS; RECEPTOR NEURONS; MAXILLARY PALP	Female mosquitoes that transmit deadly diseases locate human hosts by detecting exhaled CO2 and skin odor. The identities of olfactory neurons and receptors required for attraction to skin odor remain a mystery. Here, we show that the CO2-sensitive olfactory neuron is also a sensitive detector of human skin odorants in both Aedes aegypti and Anopheles gambiae. We demonstrate that activity of this neuron is important for attraction to skin odor, establishing it as a key target for intervention. We screen similar to 0.5 million compounds in silico and identify several CO2 receptor ligands, including an antagonist that reduces attraction to skin and an agonist that lures mosquitoes to traps as effectively as CO2. Analysis of the CO2 receptor ligand space provides a foundation for understanding mosquito host-seeking behavior and identifies odors that are potentially safe, pleasant, and affordable for use in a new generation of mosquito control strategies worldwide.	[Tauxe, Genevieve M.; MacWilliam, Dyan; Boyle, Sean Michael; Guda, Tom; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ray, Anandasankar] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	NSF IGERT fellowship; University of California Global Health Institute; Bill and Melinda Gates Foundation; NIH (NIAID) [RO1AI087785, R56AI099778]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099778, R01AI087785] Funding Source: NIH RePORTER	NSF IGERT fellowship(National Science Foundation (NSF)); University of California Global Health Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.S. Perecko for building behavior equipment; L.B. Vosshall for kindly providing orco mutants; S.T. Chen for preliminary studies; J.S. McElfresh and W. van der Goes van Naters for assistance with EAG; K.A. Klinger, E.S. Lacey, M.C. Wirth, W.E. Walton, and B.J. White for providing mosquitoes; R.T. Carde and members of the Ray lab for useful discussions. S.M.B. was partly supported by an NSF IGERT fellowship. G.M.T. was partly supported by a summer research fellowship from the University of California Global Health Institute and the Bill and Melinda Gates Foundation. This work was supported by grants to A.R. from the NIH (NIAID), award numbers RO1AI087785 and R56AI099778. A.R., S.M.B., and D.M. are listed as inventors on pending patent applications filed by the University of California, Riverside. A.R. is a founding member of Olfactor Labs Inc., that has licensed pending patents from the University.	Belsito D, 2012, FOOD CHEM TOXICOL, V50, pS517, DOI 10.1016/j.fct.2012.04.019; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bjostad L., 1998, METHODS CHEM ECOLOGY, V1, P339; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Geier M, 1999, J EXP BIOL, V202, P1639; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Grant AJ, 1996, CIBA F SYMP, V200, P233; HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Karatzoglou A, 2006, J STAT SOFTW, V15; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Mboera LEG, 2000, B ENTOMOL RES, V90, P155, DOI 10.1017/S0007485300000262; Munch D, 2013, CHEM SENSES, V38, P293, DOI 10.1093/chemse/bjs138; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; SCHRECK CE, 1982, J CHEM ECOL, V8, P429, DOI 10.1007/BF00987791; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Xue RD, 2008, J AM MOSQUITO CONTR, V24, P249, DOI 10.2987/5701.1	48	98	106	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1365	1379		10.1016/j.cell.2013.11.013	http://dx.doi.org/10.1016/j.cell.2013.11.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315103	Bronze, Green Accepted			2022-12-28	WOS:000328271100019
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP Dethroning the king of condiments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; DIETARY-SODIUM; SALT; METAANALYSIS; HYPERTENSION; SCIENCE; TRIALS; HEALTH					kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; ELLIOTT P, 1988, BRIT MED J, V297, P319; Graudal N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2741; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Hamlyn JM, 2013, CURR OPIN NEPHROL HY, V22, P51, DOI 10.1097/MNH.0b013e32835b36ec; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Moss Michael, 2010, NY TIMES; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; SWALES JD, 1988, BRIT MED J, V297, P307, DOI 10.1136/bmj.297.6644.307; Taubes C, 1998, SCIENCE, V281, P898, DOI 10.1126/science.281.5379.898; TAUBES G, 1998, SCIENCE, V281, P903; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115	15	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2013	347								f7192	10.1136/bmj.f7192	http://dx.doi.org/10.1136/bmj.f7192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DN	24307726				2022-12-28	WOS:000328148900015
J	Pageler, NM; Friedman, CP; Longhurst, CA				Pageler, Natalie M.; Friedman, Charles P.; Longhurst, Christopher A.			Refocusing Medical Education in the EMR Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pageler, Natalie M.] Stanford Univ, Sch Med, Div Crit Care Med, Stanford, CA 94304 USA; [Pageler, Natalie M.; Longhurst, Christopher A.] Stanford Univ, Sch Med, Div Syst Med, Stanford, CA 94304 USA; [Pageler, Natalie M.; Longhurst, Christopher A.] Lucile Packard Childrens Hosp Stanford, Dept Clin Informat, Stanford, CA USA; [Friedman, Charles P.] Univ Michigan, Sch Informat, Hlth Informat Program, Ann Arbor, MI 48109 USA; [Friedman, Charles P.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pageler, NM (corresponding author), Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, Div Pediat Crit Care Med, 770 Welch Rd,Ste 350, Stanford, CA 94304 USA.	npageler@stanford.edu		Longhurst, Christopher/0000-0003-4908-6856				Accreditation Council for Graduate Medical Education (ACGME), 2013, ACGME COMM PROGR REQ, P1; Adams ES, 2011, PEDIATRICS, V127, pE1112, DOI 10.1542/peds.2010-3252; Goddard K, 2012, J AM MED INFORM ASSN, V19, P121, DOI 10.1136/amiajnl-2011-000089; Hammoud MM, 2012, TEACH LEARN MED, V24, P257, DOI 10.1080/10401334.2012.692284; Hirschtick RE, 2006, JAMA-J AM MED ASSOC, V295, P2335, DOI 10.1001/jama.295.20.2335; Tierney MJ, 2013, ACAD MED, V88, P753, DOI 10.1097/ACM.0b013e3182905ceb; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	8	32	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2249	2250		10.1001/jama.2013.282326	http://dx.doi.org/10.1001/jama.2013.282326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302083				2022-12-28	WOS:000327746300005
J	Qaseem, A; Humphrey, LL; Fitterman, N; Starkey, M; Shekelle, P				Qaseem, Amir; Humphrey, Linda L.; Fitterman, Nick; Starkey, Melissa; Shekelle, Paul		Amer Coll Phys	Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; BLOOD-CELL TRANSFUSIONS; DARBEPOETIN-ALPHA; INTRAVENOUS IRON; DOUBLE-BLIND; SUBCUTANEOUS ERYTHROPOIETIN; RESTRICTIVE TRANSFUSION; EXERCISE TOLERANCE; ACCESS SITE	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease. Methods: This guideline is based on published literature in the English language on anemia and iron deficiency from 1947 to July 2012 that was identified using MEDLINE and the Cochrane Library. Literature was reassessed in April 2013, and additional studies were included. Outcomes evaluated for this guideline included mortality; hospitalization; exercise tolerance; quality of life; and cardiovascular events (defined as myocardial infarction, congestive heart failure exacerbation, arrhythmia, or cardiac death) and harms, including hypertension, venous thromboembolic events, and ischemic cerebrovascular events. The target audience for this guideline includes all clinicians, and the target patient population is anemic or iron-deficient adult patients with heart disease. This guideline grades the evidence and recommendations using the ACP's clinical practice guidelines grading system. Recommendation 1: ACP recommends using a restrictive red blood cell transfusion strategy (trigger hemoglobin threshold of 7 to 8 g/dL compared with higher hemoglobin levels) in hospitalized patients with coronary heart disease. (Grade: weak recommendation; low-quality evidence) Recommendation 2: ACP recommends against the use of erythropoiesis-stimulating agents in patients with mild to moderate anemia and congestive heart failure or coronary heart disease. (Grade: strong recommendation; moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Huntington Hosp, Pasadena, CA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; Oregon Health & Science University; University of Southern California; Huntington Memorial Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Aggarwal C, 2011, CORONARY ARTERY DIS, V22, P194, DOI 10.1097/MCA.0b013e328342cd81; Alexander KP, 2008, AM HEART J, V155, P1047, DOI 10.1016/j.ahj.2008.01.009; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Aronson D, 2008, AM J CARDIOL, V102, P115, DOI 10.1016/j.amjcard.2008.03.027; Athar MK, 2011, J CRIT CARE, V26, P335, DOI 10.1016/j.jcrc.2010.08.008; BELLINGHIERI G, 1994, CONTRIB NEPHROL, V106, P135; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2008, NEW ENGL J MED, V358, P433, DOI 10.1056/NEJMc076523; Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x; Bursi F, 2009, EUR J VASC ENDOVASC, V37, P311, DOI 10.1016/j.ejvs.2008.12.002; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson J, 2009, BLOOD, V114; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Comin-Colet J, 2009, J CARD FAIL, V15, P727, DOI 10.1016/j.cardfail.2009.05.010; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Doyle BJ, 2008, JACC-CARDIOVASC INTE, V1, P202, DOI 10.1016/j.jcin.2007.12.006; Felker GM, 2004, J AM COLL CARDIOL, V44, P959, DOI 10.1016/j.jacc.2004.05.070; Garty M, 2009, AM HEART J, V158, P653, DOI 10.1016/j.ahj.2009.08.001; Ghali JK, 2008, CIRCULATION, V117, P526, DOI 10.1161/CIRCULATIONAHA.107.698514; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jani SM, 2007, CLIN CARDIOL, V30, P49, DOI 10.1002/clc.20236; Jolicoeur EM, 2009, EUR HEART J, V30, P2575, DOI 10.1093/eurheartj/ehp279; Kansagara D, 2011, TREATMENT ANEMIA PAT; Kansagara D, 2013, ANN INTERN MED, V159, P746, DOI 10.7326/0003-4819-159-11-201312030-00007; Kao DP, 2011, AM J CARDIOL, V107, P69, DOI 10.1016/j.amjcard.2010.08.046; Kim P, 2007, CLIN CARDIOL, V30, P35, DOI 10.1002/clc.20231; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Komajda M, 2006, EUR HEART J, V27, P1440, DOI 10.1093/eurheartj/ehl012; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Kourea K, 2008, EUR J CARDIOV PREV R, V15, P365, DOI 10.1097/HJR.0b013e3282f849d0; Maluenda G, 2009, AM J CARDIOL, V104, P1069, DOI 10.1016/j.amjcard.2009.06.006; Maluenda G, 2009, J AM COLL CARDIOL, V53, pA84; Maluenda G, 2009, J AM COLL CARDIOL, V53, pA72; Malyszko J, 2010, ISR MED ASSOC J, V12, P489; Mancini DM, 2003, KIDNEY INT, V64, pS48, DOI 10.1046/j.1523-1755.64.s87.8.x; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Nikolsky E, 2009, JACC-CARDIOVASC INTE, V2, P624, DOI 10.1016/j.jcin.2009.05.004; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Palazzuoli A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.005; Palazzuoli A, 2009, J CARDIOVASC PHARM, V53, P462, DOI 10.1097/FJC.0b013e3181a6ac38; Palazzuoli A, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.022; Parissis JT, 2009, AM J CARDIOL, V103, P1134, DOI 10.1016/j.amjcard.2008.12.041; Parissis JT, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2008.01.016; Pfeffer MA, 2009, AM J KIDNEY DIS, V54, P59, DOI 10.1053/j.ajkd.2009.04.008; Ponikowski P, 2007, J AM COLL CARDIOL, V49, P753, DOI 10.1016/j.jacc.2006.11.024; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6; Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7; Singla I, 2007, AM J CARDIOL, V99, P1119, DOI 10.1016/j.amjcard.2006.11.056; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Szczech LA, 2010, KIDNEY INT, V77, P239, DOI 10.1038/ki.2009.415; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; van Veldhuisen DJ, 2007, EUR HEART J, V28, P2208, DOI 10.1093/eurheartj/ehm328; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yang G, 2005, J AM COLL CARDIOL, V46, P1490, DOI 10.1016/j.jacc.2005.06.072; Yatskar L, 2007, CATHETER CARDIO INTE, V69, P961, DOI 10.1002/ccd.21087	66	91	96	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					770	+		10.7326/0003-4819-159-11-201312030-00009	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297193				2022-12-28	WOS:000328731000006
J	Bullock, RM				Bullock, R. Morris			Abundant Metals Give Precious Hydrogenation Performance	SCIENCE			English	Editorial Material							ASYMMETRIC TRANSFER HYDROGENATION; IRON; CATALYSIS; MECHANISM		Pacific NW Natl Lab, Ctr Mol Electrocatalysis, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Bullock, RM (corresponding author), Pacific NW Natl Lab, Ctr Mol Electrocatalysis, POB 999,K2-57, Richland, WA 99352 USA.	morris.bullock@pnnl.gov	Bullock, R. Morris/L-6802-2016	Bullock, R. Morris/0000-0001-6306-4851				Bell S, 2006, SCIENCE, V311, P642, DOI 10.1126/science.1121977; Bolm C, 2009, NAT CHEM, V1, P420, DOI 10.1038/nchem.315; Bullock R. M., 2010, CATALYSIS PRECIOUS M; Enthaler S, 2008, ANGEW CHEM INT EDIT, V47, P3317, DOI 10.1002/anie.200800012; Friedfeld MR, 2013, SCIENCE, V342, P1076, DOI 10.1126/science.1243550; Jagadeesh RV, 2013, SCIENCE, V342, P1073, DOI 10.1126/science.1242005; LANDIS CR, 1987, J AM CHEM SOC, V109, P1746, DOI 10.1021/ja00240a025; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Mikhailine AA, 2012, J AM CHEM SOC, V134, P12266, DOI 10.1021/ja304814s; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Noyori R, 2001, J ORG CHEM, V66, P7931, DOI 10.1021/jo010721w; Perry MC, 2003, J AM CHEM SOC, V125, P113, DOI 10.1021/ja028142b; Simmons TR, 2013, ANGEW CHEM INT EDIT, V52, P6143, DOI 10.1002/anie.201302908; Zuo WW, 2013, SCIENCE, V342, P1080, DOI 10.1126/science.1244466	14	213	214	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1054	1055		10.1126/science.1247240	http://dx.doi.org/10.1126/science.1247240			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288322				2022-12-28	WOS:000327518600044
J	McNulty, JK; Olson, MA; Meltzer, AL; Shaffer, MJ				McNulty, James K.; Olson, Michael A.; Meltzer, Andrea L.; Shaffer, Matthew J.			Though They May Be Unaware, Newlyweds Implicitly Know Whether Their Marriage Will Be Satisfying	SCIENCE			English	Article							RACIAL-ATTITUDES	For decades, social psychological theories have posited that the automatic processes captured by implicit measures have implications for social outcomes. Yet few studies have demonstrated any long-term implications of automatic processes, and some scholars have begun to question the relevance and even the validity of these theories. At baseline of our longitudinal study, 135 newlywed couples (270 individuals) completed an explicit measure of their conscious attitudes toward their relationship and an implicit measure of their automatic attitudes toward their partner. They then reported their marital satisfaction every 6 months for the next 4 years. We found no correlation between spouses' automatic and conscious attitudes, which suggests that spouses were unaware of their automatic attitudes. Further, spouses' automatic attitudes, not their conscious ones, predicted changes in their marital satisfaction, such that spouses with more positive automatic attitudes were less likely to experience declines in marital satisfaction over time.	[McNulty, James K.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Olson, Michael A.; Shaffer, Matthew J.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Meltzer, Andrea L.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA	State University System of Florida; Florida State University; University of Tennessee System; University of Tennessee Knoxville; Southern Methodist University	McNulty, JK (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	mcnulty@psy.fsu.edu		Shaffer, Matthew/0000-0001-6254-0924	National Institute of Child Health and Human Development [RHD058314A]; NSF [BCS-1251520]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF))	Supported by National Institute of Child Health and Human Development grant RHD058314A and NSF grant BCS-1251520 (J.K.M.). We thank D. Atkins, R. Baumeister, and J. Maner for their helpful comments regarding this research. Data are available from the first author upon request.	Arkes HR, 2004, PSYCHOL INQ, V15, P257, DOI 10.1207/s15327965pli1504_01; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dijksterhuis A, 2009, ATTITUDES INSIGHTS N, P229; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Fazio RH, 2000, J PERS SOC PSYCHOL, V78, P197, DOI 10.1037/0022-3514.78.2.197; Lavner JA, 2013, J FAM PSYCHOL, V27, P531, DOI 10.1037/a0033423; LeBel EP, 2013, SOC PSYCHOL PERS SCI, V4, P167, DOI 10.1177/1948550612448196; Lebel EP, 2009, J EXP SOC PSYCHOL, V45, P1291, DOI 10.1016/j.jesp.2009.07.003; Lee S, 2010, PSYCHOL SCI, V21, P857, DOI 10.1177/0956797610371342; McNulty JK, 2008, J PERS SOC PSYCHOL, V94, P631, DOI 10.1037/0022-3514.94.4.631; Murray SL, 2013, J PERS SOC PSYCHOL, V104, P305, DOI 10.1037/a0030513; Murray SL, 2011, PSYCHOL SCI, V22, P619, DOI 10.1177/0956797611403155; Olson M.A., 2009, ATTITUDES INSIGHTS N, P19, DOI DOI 10.1080/02699931.2010.544160; Osgood C.E., 1957, MEASUREMENT MEANING; Pashler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042510; Scinta A, 2007, PERS SOC PSYCHOL B, V33, P1008, DOI 10.1177/0146167207301013; Tofighi D, 2011, BEHAV RES METHODS, V43, P692, DOI 10.3758/s13428-011-0076-x; Towles-Schwen T, 2006, J EXP SOC PSYCHOL, V42, P698, DOI 10.1016/j.jesp.2005.11.003	21	66	66	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1119	1120		10.1126/science.1243140	http://dx.doi.org/10.1126/science.1243140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259HS	24288337				2022-12-28	WOS:000327518600064
J	Vogel, C				Vogel, Christine			Protein Expression Under Pressure	SCIENCE			English	Editorial Material							INSIGHTS		NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Vogel, C (corresponding author), NYU, Ctr Genom & Syst Biol, 550 1St Ave, New York, NY 10003 USA.	cvogel@nyu.edu						Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Dahan O, 2011, TRENDS GENET, V27, P316, DOI 10.1016/j.tig.2011.05.008; Howden AJM, 2013, NAT METHODS, V10, P343, DOI [10.1038/NMETH.2401, 10.1038/nmeth.2401]; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185	15	13	13	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1052	1053		10.1126/science.1247833	http://dx.doi.org/10.1126/science.1247833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288321				2022-12-28	WOS:000327518600043
J	Farley, KA; Malespin, C; Mahaffy, P; Grotzinger, JP; Vasconcelos, PM; Milliken, RE; Malin, M; Edgett, KS; Pavlov, AA; Hurowitz, JA; Grant, JA; Miller, HB; Arvidson, R; Beegle, L; Calef, F; Conrad, PG; Dietrich, WE; Eigenbrode, J; Gellert, R; Gupta, S; Hamilton, V; Hassler, DM; Lewis, KW; McLennan, SM; Ming, D; Navarro-Gonzalez, R; Schwenzer, SP; Steele, A; Stolper, EM; Sumner, DY; Vaniman, D; Vasavada, A; Williford, K; Wimmer-Schweingruber, RF				Farley, K. A.; Malespin, C.; Mahaffy, P.; Grotzinger, J. P.; Vasconcelos, P. M.; Milliken, R. E.; Malin, M.; Edgett, K. S.; Pavlov, A. A.; Hurowitz, J. A.; Grant, J. A.; Miller, H. B.; Arvidson, R.; Beegle, L.; Calef, F.; Conrad, P. G.; Dietrich, W. E.; Eigenbrode, J.; Gellert, R.; Gupta, S.; Hamilton, V.; Hassler, D. M.; Lewis, K. W.; McLennan, S. M.; Ming, D.; Navarro-Gonzalez, R.; Schwenzer, S. P.; Steele, A.; Stolper, E. M.; Sumner, D. Y.; Vaniman, D.; Vasavada, A.; Williford, K.; Wimmer-Schweingruber, R. F.		MSL Sci Team	In Situ Radiometric and Exposure Age Dating of the Martian Surface	SCIENCE			English	Article							GALE CRATER; MARS; EVOLUTION; HISTORY; ORIGIN; CHRONOLOGY; ISOTOPES; FIELD	We determined radiogenic and cosmogenic noble gases in a mudstone on the floor of Gale Crater. A K-Ar age of 4.21 +/- 0.35 billion years represents a mixture of detrital and authigenic components and confirms the expected antiquity of rocks comprising the crater rim. Cosmic-ray-produced He-3, Ne-21, and Ar-36 yield concordant surface exposure ages of 78 +/- 30 million years. Surface exposure occurred mainly in the present geomorphic setting rather than during primary erosion and transport. Our observations are consistent with mudstone deposition shortly after the Gale impact or possibly in a later event of rapid erosion and deposition. The mudstone remained buried until recent exposure by wind-driven scarp retreat. Sedimentary rocks exposed by this mechanism may thus offer the best potential for organic biomarker preservation against destruction by cosmic radiation.	[Farley, K. A.; Grotzinger, J. P.; Miller, H. B.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Malespin, C.; Mahaffy, P.; Pavlov, A. A.; Conrad, P. G.; Eigenbrode, J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Vasconcelos, P. M.] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Milliken, R. E.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Malin, M.; Edgett, K. S.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Hurowitz, J. A.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Arvidson, R.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Beegle, L.; Calef, F.; Vasavada, A.; Williford, K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Dietrich, W. E.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Hamilton, V.; Hassler, D. M.] SW Res Inst, Boulder, CO 80302 USA; [Lewis, K. W.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ming, D.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Schwenzer, S. P.] CEPSAR, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Vaniman, D.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wimmer-Schweingruber, R. F.] Univ Kiel, D-24098 Kiel, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Queensland; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Berkeley; University of Guelph; Imperial College London; Princeton University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Universidad Nacional Autonoma de Mexico; Carnegie Institution for Science; University of California System; University of California Davis; University of Kiel	Farley, KA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	farley@gps.caltech.edu	Beegle, Luther/AAU-5538-2021; Williford, Kenneth/L-4436-2017; Martin-Torres, Javier/G-6329-2015; Gómez, Felipe/L-7315-2014; Steele, Andrew/A-3573-2013; szopa, cyril/C-6865-2015; Balic-Zunic, Tonci/A-6362-2013; Zorzano, María-Paz/F-2184-2015; Schwenzer, Susanne P/H-6992-2019; Farley, Kenneth/AAE-7735-2020; Blanco, Juan Jose/E-3627-2014; Muller, Jan-Peter/Q-8886-2019; Hayes, Alexander G/P-2024-2014; Franz, Heather B/F-3508-2012; Rodriguez-Manfredi, Jose/L-8001-2014; Ramos, Miguel/K-2230-2014; De Pablo, Miguel Ángel/J-6442-2014; Rodriguez-Manfredi, Jose/AAG-9826-2021; FABRE, Cécile/B-5827-2012; Avalos, Juan Jose Blanco/AAB-9447-2021; Dworkin, Jason P./C-9417-2012; Sumner, Dawn Y/E-8744-2011; Wimmer-Schweingruber, Robert/AAQ-5794-2021; Stipp, Susan L.S./B-8494-2019; Gomez-Elvira, Javier/K-5829-2014; Lemmon, Mark T/E-9983-2010; Harri, Ari-Matti/C-7142-2012; Glavin, Daniel P/D-6194-2012; Pavlov, Alexander A./F-3779-2012; Eigenbrode, Jennifer L/D-4651-2012; Benna, Mehdi/F-3489-2012; Prats, Benito/F-9467-2019; Navarro-González, Rafael/D-1748-2009; Vicenzi, Edward/T-9430-2017; Malakhov, Alexey/F-7953-2017	Williford, Kenneth/0000-0003-0633-408X; Martin-Torres, Javier/0000-0001-6479-2236; Gómez, Felipe/0000-0001-9977-7060; Steele, Andrew/0000-0001-9643-2841; szopa, cyril/0000-0002-0090-4056; Balic-Zunic, Tonci/0000-0003-1687-1233; Zorzano, María-Paz/0000-0002-4492-9650; Schwenzer, Susanne P/0000-0002-9608-0759; Blanco, Juan Jose/0000-0002-8666-0696; Muller, Jan-Peter/0000-0002-5077-3736; Hayes, Alexander G/0000-0001-6397-2630; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Ramos, Miguel/0000-0003-3648-6818; De Pablo, Miguel Ángel/0000-0002-4496-2741; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; FABRE, Cécile/0000-0001-8627-4050; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Dworkin, Jason P./0000-0002-3961-8997; Sumner, Dawn Y/0000-0002-7343-2061; Wimmer-Schweingruber, Robert/0000-0002-7388-173X; Stipp, Susan L.S./0000-0001-7009-643X; Gomez-Elvira, Javier/0000-0002-9068-9846; Lemmon, Mark T/0000-0002-4504-5136; Harri, Ari-Matti/0000-0001-8541-2802; Glavin, Daniel P/0000-0001-7779-7765; Pavlov, Alexander A./0000-0001-8771-1646; Eigenbrode, Jennifer L/0000-0003-3089-1986; Prats, Benito/0000-0003-3869-3351; Navarro-González, Rafael/0000-0002-6078-7621; Edgett, Kenneth/0000-0001-7197-5751; Vicenzi, Edward/0000-0003-2085-6546; Wilson, Sharon/0000-0001-8872-8546; Malakhov, Alexey/0000-0003-4292-7077; Farley, Kenneth/0000-0002-7846-7546; Gupta, Sanjeev/0000-0001-6415-1332; Grant, John/0000-0001-8276-1281; McLennan, Scott/0000-0003-4259-7178; Beegle, Luther/0000-0002-4944-4353	National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005169/1, ST/I003118/1, ST/J005339/1] Funding Source: researchfish	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	The authors are indebted to the Mars Science Laboratory (MSL) Project engineering and management teams for their exceptionally skilled and diligent efforts in making the mission as effective as possible and enhancing science operations. We are also grateful to all those MSL team members who participated in tactical and strategic operations. Without the support of both the engineering and science teams, the data presented here could not have been collected. Three anonymous reviewers provided many helpful suggestions. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. Data presented in this paper are archived in the Planetary Data System (pds.nasa.gov).	Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; Bachmann O, 2002, J PETROL, V43, P1469, DOI 10.1093/petrology/43.8.1469; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bogard D, 2009, METEORIT PLANET SCI, V44, P905, DOI 10.1111/j.1945-5100.2009.tb00777.x; Bridges JC, 2012, EARTH PLANET SC LETT, V359, P117, DOI 10.1016/j.epsl.2012.09.044; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; CERLING TE, 1994, ANNU REV EARTH PL SC, V22, P273, DOI 10.1146/annurev.ea.22.050194.001421; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Deer W.A., 2001, ROCK FORMING MINERAL, V4; Eggleton R.E., 1962, ADV ASTRONAUT SCI, V8, P70; Eugster O, 2003, CHEM ERDE-GEOCHEM, V63, P3, DOI 10.1078/0009-2819-00021; Grant JA, 2012, PLANET SPACE SCI, V72, P44, DOI 10.1016/j.pss.2012.05.020; Grant JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046844; Greeley R., 1987, GEOLOGIC MAP E EQUAT, V1-~802-B; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; KELLER LP, 1994, GEOCHIM COSMOCHIM AC, V58, P5589, DOI 10.1016/0016-7037(94)90252-6; LAL D, 1993, GEOCHIM COSMOCHIM AC, V57, P4627, DOI 10.1016/0016-7037(93)90188-3; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Le Deit L, 2013, J GEOPHYS RES-PLANET, V118, P2439, DOI 10.1002/2012JE004322; Mangold N, 2012, ICARUS, V220, P530, DOI 10.1016/j.icarus.2012.05.026; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221, DOI 10.1146/annurev.ea.20.050192.001253; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Pavlov AA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052166; Rao MN, 2002, ICARUS, V156, P352, DOI 10.1006/icar.2001.6809; Scott D. H., 1995, GEOLOGIC TOPOGRAPHIC; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; WARD WR, 1973, SCIENCE, V181, P260, DOI 10.1126/science.181.4096.260; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Wray JJ, 2013, INT J ASTROBIOL, V12, P25, DOI 10.1017/S1473550412000328	35	174	175	0	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1247166	10.1126/science.1247166	http://dx.doi.org/10.1126/science.1247166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324273				2022-12-28	WOS:000330039300007
J	Rose, S; Prevoteau, A; Elziere, P; Hourdet, D; Marcellan, A; Leibler, L				Rose, Severine; Prevoteau, Alexandre; Elziere, Paul; Hourdet, Dominique; Marcellan, Alba; Leibler, Ludwik			Nanoparticle solutions as adhesives for gels and biological tissues	NATURE			English	Article							POLY(ETHYLENE GLYCOL); HYDROGELS; ADSORPTION; COMPLEXITY; CHEMISTRY; POLYMERS; LAYERS	Adhesives are made of polymers(1) because, unlike other materials, polymers ensure good contact between surfaces by covering asperities, and retard the fracture of adhesive joints by dissipating energy under stress(2,3). But using polymers to 'glue' together polymer gels is difficult, requiring chemical reactions, heating, pH changes, ultraviolet irradiation or an electric field(4-7). Here we show that strong, rapid adhesion between two hydrogels can be achieved at room temperature by spreading a droplet of a nanoparticle solution on one gel's surface and then bringing the other gel into contact with it. The method relies on the nanoparticles' ability to adsorb onto polymer gels and to act as connectors between polymer chains, and on the ability of polymer chains to reorganize and dissipate energy under stress when adsorbed onto nanoparticles. We demonstrate this approach by pressing together pieces of hydrogels, for approximately 30 seconds, that have the same or different chemical properties or rigidities, using various solutions of silica nanoparticles, to achieve a strong bond. Furthermore, we show that carbon nanotubes and cellulose nanocrystals that do not bond hydrogels together become adhesive when their surface chemistry is modified. To illustrate the promise of the method for biological tissues, we also glued together two cut pieces of calf's liver using a solution of silica nanoparticles. As a rapid, simple and efficient way to assemble gels or tissues, this method is desirable for many emerging technological and medical applications such as microfluidics, actuation, tissue engineering and surgery.	[Rose, Severine; Elziere, Paul; Hourdet, Dominique; Marcellan, Alba] Univ Paris 06, Ecole Super Phys & Chim Ind, CNRS, Physicochim Polymeres & Milieux Disperses UMR7615, F-75005 Paris, France; [Prevoteau, Alexandre; Marcellan, Alba; Leibler, Ludwik] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Matiere Molle & Chim UMR 7167, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Leibler, L (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, Matiere Molle & Chim UMR 7167, 10 Rue Vauquelin, F-75005 Paris, France.	alba.marcellan@espci.fr; ludwik.leibler@espci.fr			ED397, UPMC, Paris France; CNRS; ESPCI; UPMC	ED397, UPMC, Paris France; CNRS(Centre National de la Recherche Scientifique (CNRS)); ESPCI; UPMC	We thank D. Montero and L. Olanier for technical assistance with electron microscopy and tensile test equipment, respectively. We also thank L. Alison and L. Negre for help with experiments and A. Legrand for synthesis of silica AL-30 particles. We thank A. Johner for discussions on adsorption and M. Cloitre, J. Lewiner, A. Maggs, R. Nicolay and F. Tournilhac for encouragements and discussions. S.R. and A.P. acknowledge PhD fellowship funding from ED397, UPMC, Paris France. The financial support of the CNRS, the ESPCI and the UPMC is acknowledged.	Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4; Carlsson L, 2010, SOFT MATTER, V6, P3619, DOI 10.1039/c0sm00009d; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; deGennes PG, 1996, LANGMUIR, V12, P4497, DOI 10.1021/la950886y; Duarte AP, 2012, PROG POLYM SCI, V37, P1031, DOI 10.1016/j.progpolymsci.2011.12.003; Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023; Gent AN, 2003, J ADHESION, V79, P905, DOI 10.1080/714906144; Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p; Greensmith H.W., 1963, J APPL POLYM SCI, V7, P993, DOI [10.1002/app.1963.070070316, DOI 10.1002/APP.1963.070070316]; GRIOT O, 1965, T FARADAY SOC, V61, P1026, DOI 10.1039/tf9656101026; Harada A, 2011, NAT CHEM, V3, P34, DOI [10.1038/nchem.893, 10.1038/NCHEM.893]; Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248; Hourdet D, 2010, MACROMOL SYMP, V291-292, P144, DOI 10.1002/masy.201050518; JOHNER A, 1992, J CHEM PHYS, V96, P6257, DOI 10.1063/1.462617; KENDALL K, 1975, J ADHESION, V7, P137, DOI 10.1080/00218467508075045; Kendall K., 2001, MOLECULAR ADHESION A; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; Montarnal D, 2011, SCIENCE, V334, P965, DOI 10.1126/science.1212648; Nah C, 2012, POLYM TEST, V31, P248, DOI 10.1016/j.polymertesting.2011.11.007; Netz RR, 2003, PHYS REP, V380, P1, DOI 10.1016/S0370-1573(03)00118-2; Nicolay R, 2010, MACROMOLECULES, V43, P4355, DOI 10.1021/ma100378r; Prevoteau A, 2012, J AM CHEM SOC, V134, P19961, DOI 10.1021/ja309029n; Reutenauer P, 2009, CHEM-EUR J, V15, P1893, DOI 10.1002/chem.200802145; Sahlin JJ, 1997, J BIOMAT SCI-POLYM E, V8, P421, DOI 10.1163/156856297X00362; Saito J, 2011, POLYM CHEM-UK, V2, P575, DOI 10.1039/c0py00272k; Santore MM, 2005, CURR OPIN COLLOID IN, V10, P176, DOI 10.1016/j.cocis.2005.05.005; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Tamagawa H, 2008, MATER CHEM PHYS, V107, P164, DOI 10.1016/j.matchemphys.2007.06.063; Techawanitchai P, 2012, SOFT MATTER, V8, P2844, DOI 10.1039/c2sm07277g; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693	30	532	550	72	1534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					382	+		10.1038/nature12806	http://dx.doi.org/10.1038/nature12806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24336207				2022-12-28	WOS:000329621800038
J	Schattner, A				Schattner, Ami			Review: Strength training, with or without flexibility and aerobic training, reduces pain in lower limb osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre	Schattner, A (corresponding author), Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Baker KR, 2001, J RHEUMATOL, V28, P1655; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159	2	3	3	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2013	159	12							JC7	10.7326/0003-4819-159-12-201312170-02007	http://dx.doi.org/10.7326/0003-4819-159-12-201312170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ED	24343412				2022-12-28	WOS:000329735300006
J	Johnson, V				Johnson, Victoria			A Resitern's Reflections on Duty-Hours Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Johnson, V (corresponding author), Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA.		Johnson, Victoria/GVU-7127-2022					Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Higginson JD, 2009, ACAD MED, V84, P310, DOI 10.1097/ACM.0b013e3181971bf2; Rosenbaum L., 2013, NEW YORKER; Shem Samuel, 1978, HOUSE GOD; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2278	2279		10.1056/NEJMp1307514	http://dx.doi.org/10.1056/NEJMp1307514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268FV	24328464				2022-12-28	WOS:000328156300004
J	Zenobi, R				Zenobi, R.			Single-Cell Metabolomics: Analytical and Biological Perspectives	SCIENCE			English	Review							MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; FLUORESCENCE DETECTION; MOLECULAR ANALYSIS; CHEMICAL-ANALYSIS; YEAST-CELLS; IN-VITRO; IONIZATION; ARRAY; CYTOMETRY	There is currently much interest in broad molecular profiling of single cells; a cell's metabolome-its full complement of small-molecule metabolites-is a direct indicator of phenotypic diversity of single cells and a nearly immediate readout of how cells react to environmental influences. However, the metabolome is very difficult to measure at the single-cell level because of rapid metabolic dynamics, the structural diversity of the molecules, and the inability to amplify or tag small-molecule metabolites. Measurement techniques including mass spectrometry, capillary electrophoresis, and, to a lesser extent, optical spectroscopy and fluorescence detection have led to impressive advances in single-cell metabolomics. Even though none of these methodologies can currently measure the metabolome of a single cell completely, rapidly, and nondestructively, progress has been sufficient such that the field is witnessing a shift from feasibility studies to investigations that yield new biological insight. Particularly interesting fields of application are cancer biology, stem cell research, and monitoring of xenobiotics and drugs in tissue sections at the single-cell level.	ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Zenobi, R (corresponding author), ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.	zenobi@org.chem.ethz.ch			Swiss National Science Foundation; ETH Zurich; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); European Union(European Commission)	I thank A. Ibanez and M. Zenobi-Wong for critical reading of this manuscript and for helpful suggestions, and J. Krismer and J. Sobek for making data available for Fig. 2. I am also indebted to a number of talented individuals: A. Amantonico, S. Fagerer, M. Heinemann, A. Ibanez, J. Krismer, M. Pabst, R. Steinhoff, and P. L. Urban have all contributed substantially to the success of the single-cell metabolomics project in the author's laboratory over the past few years. Supported by the Swiss National Science Foundation, ETH Zurich, and the European Union.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Amantonico A., 2008, ANGEW CHEM, V120, P5462, DOI DOI 10.1002/ANGE.200705923; Amantonico A, 2010, ANAL BIOANAL CHEM, V398, P2493, DOI 10.1007/s00216-010-3850-1; An GH, 2000, BIOTECHNOL LETT, V22, P1031, DOI 10.1023/A:1005614010003; Barros LF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00027; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Borland LM, 2008, ANNU REV ANAL CHEM, V1, P191, DOI 10.1146/annurev.anchem.1.031207.113100; Boukany PE, 2011, NAT NANOTECHNOL, V6, P747, DOI [10.1038/nnano.2011.164, 10.1038/NNANO.2011.164]; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Castaing R., 1962, J MICROSC PARIS, V1, P395; Chandra S, 2010, METHODS MOL BIOL, V656, P113, DOI 10.1007/978-1-60761-746-4_6; Cohen D, 2008, ANNU REV ANAL CHEM, V1, P165, DOI 10.1146/annurev.anchem.1.031207.113104; Dedecker P, 2013, J AM CHEM SOC, V135, P2387, DOI 10.1021/ja309768d; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Dimov IK, 2011, LAB CHIP, V11, P2701, DOI 10.1039/c1lc20105k; Edwards JL, 2005, ANAL CHEM, V77, P2201, DOI 10.1021/ac048323r; Ellis SR, 2012, ANAL CHEM, V84, P9679, DOI 10.1021/ac302634u; Essaka DC, 2012, NEUROCHEM RES, V37, P1308, DOI 10.1007/s11064-012-0733-1; Essaka DC, 2012, ANAL CHEM, V84, P2799, DOI 10.1021/ac2031892; Eyer K, 2013, ANAL CHEM, V85, P3280, DOI 10.1021/ac303628j; Eyer K, 2012, LAB CHIP, V12, P765, DOI 10.1039/c2lc20876h; Fagerer SR, 2013, ANALYST, V138, P6732, DOI 10.1039/c3an01135f; Fogarty SW, 2013, ANALYST, V138, P240, DOI 10.1039/c2an36197c; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fritzsch FSO, 2012, ANNU REV CHEM BIOMOL, V3, P129, DOI 10.1146/annurev-chembioeng-062011-081056; Fung EN, 1998, ANAL CHEM, V70, P3206, DOI 10.1021/ac980290q; Gao D, 2012, TRAC-TREND ANAL CHEM, V35, P150, DOI 10.1016/j.trac.2012.02.008; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Heien ML, 2010, METHODS MOL BIOL, V656, P85, DOI 10.1007/978-1-60761-746-4_4; Heinemann M, 2011, CURR OPIN BIOTECH, V22, P26, DOI 10.1016/j.copbio.2010.09.008; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hu S, 2004, ANAL CHEM, V76, P4044, DOI 10.1021/ac0498314; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; Huang WE, 2010, ADV APPL MICROBIOL, V70, P153, DOI 10.1016/S0065-2164(10)70005-8; Ibanez AJ, 2013, P NATL ACAD SCI USA, V110, P8790, DOI 10.1073/pnas.1209302110; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Keithley RB, 2013, ANALYST, V138, P164, DOI 10.1039/c2an36286d; KENNEDY RT, 1989, SCIENCE, V246, P57, DOI 10.1126/science.2675314; Kleparnik K, 2013, ELECTROPHORESIS, V34, P70, DOI 10.1002/elps.201200488; Koestler M, 2008, RAPID COMMUN MASS SP, V22, P3275, DOI 10.1002/rcm.3733; Krylov SN, 2000, ANAL BIOCHEM, V283, P133, DOI 10.1006/abio.2000.4648; Krylov SN, 1999, CYTOMETRY, V37, P14, DOI 10.1002/(SICI)1097-0320(19990901)37:1<14::AID-CYTO2>3.0.CO;2-J; Kurishita Y, 2010, J AM CHEM SOC, V132, P13290, DOI 10.1021/ja103615z; Lau AY, 2006, LAB CHIP, V6, P1510, DOI 10.1039/b608439g; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; Mizuno H, 2008, J MASS SPECTROM, V43, P1692, DOI 10.1002/jms.1460; Moro AJ, 2010, CHEM COMMUN, V46, P1085, DOI 10.1039/b919661g; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Nemes P, 2013, NAT PROTOC, V8, P783, DOI 10.1038/nprot.2013.035; Nemes P, 2012, ACS CHEM NEUROSCI, V3, P782, DOI 10.1021/cn300100u; Nemes P, 2011, ANAL CHEM, V83, P6810, DOI 10.1021/ac2015855; O'Brien PJ, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-4; Oikawa A, 2012, PLANT J, V70, P30, DOI 10.1111/j.1365-313X.2012.04967.x; Prideaux B, 2012, J PROTEOMICS, V75, P4999, DOI 10.1016/j.jprot.2012.07.028; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Salieb-Beugelaar GB, 2010, ANAL CHEM, V82, P4848, DOI 10.1021/ac1009707; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Schmid A, 2010, CURR OPIN BIOTECH, V21, P12, DOI 10.1016/j.copbio.2010.01.007; Schmitz CHJ, 2009, LAB CHIP, V9, P44, DOI 10.1039/b809670h; Sellick CA, 2011, NAT PROTOC, V6, P1241, DOI 10.1038/nprot.2011.366; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Svatos A, 2011, ANAL CHEM, V83, P5037, DOI 10.1021/ac2003592; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104; Tejedor ML, 2012, ANAL CHEM, V84, P5221, DOI 10.1021/ac202447t; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Trouillon R, 2013, ANAL CHEM, V85, P522, DOI 10.1021/ac303290s; Tsuyama N, 2008, ANAL SCI, V24, P559, DOI 10.2116/analsci.24.559; Urban PL, 2011, MOL BIOSYST, V7, P2837, DOI 10.1039/c1mb05248a; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Urban PL, 2010, LAB CHIP, V10, P3206, DOI 10.1039/c0lc00211a; Vertes, 2013, ANGEW CHEM, V125, P3738, DOI DOI 10.1002/ANGE.201207348; Walker BN, 2012, ANAL CHEM, V84, P7756, DOI 10.1021/ac301238k; WALLINGFORD RA, 1989, ANAL CHEM, V61, P98, DOI 10.1021/ac00177a004; Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110; Weber P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101508; Wei J, 1999, NATURE, V399, P243, DOI 10.1038/20400; WEIBEL KE, 1974, ANAL BIOCHEM, V58, P208, DOI 10.1016/0003-2697(74)90459-X; Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632; Yan RX, 2012, NAT NANOTECHNOL, V7, P191, DOI [10.1038/nnano.2011.226, 10.1038/NNANO.2011.226]; Zavalin A, 2012, J MASS SPECTROM, V47, P1473, DOI 10.1002/jms.3108; Zhang X, 2012, CHEMPHYSCHEM, V13, P1054, DOI 10.1002/cphc.201100890; Zheng XT, 2012, CHEM SOC REV, V41, P2061, DOI 10.1039/c1cs15265c; Zhu Z, 2012, LAB CHIP, V12, P906, DOI 10.1039/c2lc20911j; Zimmerman TA, 2011, J AM SOC MASS SPECTR, V22, P828, DOI 10.1007/s13361-011-0111-2	91	404	419	67	1001	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1201	+	1243259	10.1126/science.1243259	http://dx.doi.org/10.1126/science.1243259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311695				2022-12-28	WOS:000327857900037
J	Woodruff, JD; Irish, JL; Camargo, SJ				Woodruff, Jonathan D.; Irish, Jennifer L.; Camargo, Suzana J.			Coastal flooding by tropical cyclones and sea-level rise	NATURE			English	Review							LAST GLACIAL MAXIMUM; GULF-OF-MEXICO; CLIMATE-CHANGE; STORM-SURGE; BEACH RECOVERY; TIDAL FLATS; IMPACTS; INTENSITY; HISTORY; VARIABILITY	The future impacts of climate change on landfalling tropical cyclones are unclear. Regardless of this uncertainty, flooding by tropical cyclones will increase as a result of accelerated sea-level rise. Under similar rates of rapid sea-level rise during the early Holocene epoch most low-lying sedimentary coastlines were generally much less resilient to storm impacts. Society must learn to live with a rapidly evolving shoreline that is increasingly prone to flooding from tropical cyclones. These impacts can be mitigated partly with adaptive strategies, which include careful stewardship of sediments and reductions in human-induced land subsidence.	[Woodruff, Jonathan D.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Irish, Jennifer L.] Virginia Tech, Blacksburg, VA 24061 USA; [Camargo, Suzana J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Massachusetts System; University of Massachusetts Amherst; Virginia Polytechnic Institute & State University; Columbia University	Woodruff, JD (corresponding author), Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA.	woodruff@geo.umass.edu	Camargo, Suzana J./C-6106-2009	Camargo, Suzana J./0000-0002-0802-5160; Irish, Jennifer/0000-0002-2429-5953	US National Science Foundation (NSF) [EAR-1158780, EAR-1148244]; Risk Prediction Initiative at the Bermuda Institute of Ocean Sciences [RPI11-1-001/11-5110]; Hudson River Foundation; National Oceanic and Atmospheric Administration (NOAA) [NA110AR4310093, NA100AR4310124]; NSF [AGS-1143959, AGS-1064081]; NOAA's National Sea Grant College Program [24036078]; South Atlantic Landscape Conservation Cooperative [24036078]; Div Atmospheric & Geospace Sciences [1064081, 1143959] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); Risk Prediction Initiative at the Bermuda Institute of Ocean Sciences; Hudson River Foundation; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); NOAA's National Sea Grant College Program; South Atlantic Landscape Conservation Cooperative; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We wish to thank our colleagues for the many comments and suggestions that improved this manuscript, as well as thoughtful discussions at the 2013 Joint AGU/GSA Conference on 'Coastal Processes and Environments Under Sea-Level Rise and Changing Climate: Science to Inform Management'. J.D.W. is funded through the US National Science Foundation (NSF, grant number EAR-1158780 and EAR-1148244), the Risk Prediction Initiative at the Bermuda Institute of Ocean Sciences (grant number RPI11-1-001/11-5110), and the Hudson River Foundation. S.J.C. acknowledges funding from the National Oceanic and Atmospheric Administration (NOAA, grant number NA110AR4310093 and NA100AR4310124) and NSF (grant number AGS-1143959 and AGS-1064081). J.L.I. received funding for this work through NOAA's National Sea Grant College Program (grant number 24036078) and the South Atlantic Landscape Conservation Cooperative (grant number 24036078). The views expressed herein do not necessarily reflect the views of any of these organizations.	Ali A, 1999, CLIMATE RES, V12, P109, DOI 10.3354/cr012109; Amante C., 2008, ETOPO1 1 ARC MINUTE; Anderson J., 2010, EOS T AM GEOPHYS UN, V91, P205, DOI [DOI 10.1029/2010EO230001, 10.1029/2010EO230001]; [Anonymous], CPO1 NOAA OAR; Barrett BS, 2009, MON WEATHER REV, V137, P727, DOI 10.1175/2008MWR2602.1; Brecht H, 2012, J ENVIRON DEV, V21, P120, DOI 10.1177/1070496511433601; Camargo S. J., 2010, GLOBAL PERSPECTIVES, V4; Camargo SJ, 2007, J CLIMATE, V20, P4819, DOI 10.1175/JCLI4282.1; Chu J.H., 2002, NRLMR7540 0216; Church JA, 2006, AUST METEOROL MAG, V55, P253; Cooper JAG, 2004, GLOBAL PLANET CHANGE, V43, P157, DOI 10.1016/j.gloplacha.2004.07.001; Cooper MJP, 2008, CLIMATIC CHANGE, V90, P475, DOI 10.1007/s10584-008-9422-0; Dasgupta S, 2011, CLIMATIC CHANGE, V106, P567, DOI 10.1007/s10584-010-9959-6; Davis M., 1988, NHC22 NOAA NWS; Done TJ, 1999, AM ZOOL, V39, P66; Donoghue JF, 2011, CLIMATIC CHANGE, V107, P17, DOI 10.1007/s10584-011-0077-x; ELLISON JC, 1991, J COASTAL RES, V7, P151; EM-DAT, 2013, OFDA DRED INT DIS DA; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMERY K. O., 1965, LIMNOL OCEANOGR, V10, pR97; Fagherazzi S, 2006, P NATL ACAD SCI USA, V103, P8337, DOI 10.1073/pnas.0508379103; FIELD ME, 1979, GEOL SOC AM BULL, V90, P618, DOI 10.1130/0016-7606(1979)90<618:UQPDOT>2.0.CO;2; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Frank WM, 2007, MON WEATHER REV, V135, P3587, DOI 10.1175/MWR3435.1; Frank WM, 2001, MON WEATHER REV, V129, P2249, DOI 10.1175/1520-0493(2001)129<2249:EOVWSO>2.0.CO;2; Friedrichs C., 2001, J COASTAL RES, P7; Goodbred SL, 1998, J SEDIMENT RES, V68, P240, DOI 10.2110/jsr.68.240; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Gray WM., 1979, METEOROLOGY TROPICAL, P155, DOI DOI 10.1175/1520-0450; Han M., 1995, J COASTAL RES, V14, P79; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffman RN, 2010, WEATHER CLIM SOC, V2, P271, DOI 10.1175/2010WCAS1050.1; Huang ZG, 2004, NAT HAZARDS, V33, P247, DOI 10.1023/B:NHAZ.0000037038.18814.b0; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Irish JL, 2013, J WATERW PORT COAST, V139, P126, DOI 10.1061/(ASCE)WW.1943-5460.0000157; Irish JL, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006626; Jones SC, 2003, WEATHER FORECAST, V18, P1052, DOI 10.1175/1520-0434(2003)018<1052:TETOTC>2.0.CO;2; Karim MF, 2008, GLOBAL ENVIRON CHANG, V18, P490, DOI 10.1016/j.gloenvcha.2008.05.002; Kim JH, 2008, J CLIMATE, V21, P1171, DOI 10.1175/2007JCLI1493.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Knutson TR, 2008, CLIMATE EXTREMES AND SOCIETY, P120, DOI 10.1017/CBO9780511535840.010; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Kossin JP, 2009, CLIMATIC CHANGE, V97, P329, DOI 10.1007/s10584-009-9748-2; KRAFT JC, 1971, GEOL SOC AM BULL, V82, P2131, DOI 10.1130/0016-7606(1971)82[2131:SFPAGH]2.0.CO;2; Larcombe P, 2004, QUATERNARY SCI REV, V23, P107, DOI 10.1016/j.quascirev.2003.10.003; Lewis SE, 2013, QUATERNARY SCI REV, V74, P115, DOI 10.1016/j.quascirev.2012.09.006; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Mann ME, 2009, NATURE, V460, P880, DOI 10.1038/nature08219; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; McTaggart-Cowan R, 2006, MON WEATHER REV, V134, P3029, DOI 10.1175/MWR3330.1; Mendelsohn R, 2012, NAT CLIM CHANGE, V2, P205, DOI 10.1038/NCLIMATE1357; Menendez M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005997; Milne GA, 2005, QUATERNARY SCI REV, V24, P1183, DOI 10.1016/j.quascirev.2004.10.005; Morton RA, 2003, J COASTAL RES, V19, P560; MORTON RA, 1994, J COASTAL RES, V10, P884; Neumann J. E., 2012, 201281 WP UNU WIDER; NEWMAN WS, 1965, SCIENCE, V148, P1464, DOI 10.1126/science.148.3676.1464; Nicholls R.J., 1995, GEOJOURNAL, V37, P369, DOI [10.1007/BF00814018, DOI 10.1007/BF00814018]; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; NOAA (National Oceanic and Atmospheric Administration) Ocean Service CO-OPS, 2013, SEA LEV TRENDS; Nott J, 2006, J COASTAL RES, V22, P49, DOI 10.2112/05A-0005.1; Nott J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052236; Otvos EG, 2005, J COASTAL RES, P141; PARKINSON RW, 1994, J COASTAL RES, V10, P1077; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Peltier WR, 2002, QUATERNARY SCI REV, V21, P377, DOI 10.1016/S0277-3791(01)00084-1; Permanent Service for Mean Sea Level, 2013, OBT TID GAUG DAT; Pluet J., 1991, WORLD ATLAS HOLOCENE, V58; Pugh D. T., 2004, CHANGING SEA LEVELS; Ranasinghe R, 2013, NAT CLIM CHANGE, V3, P83, DOI [10.1038/NCLIMATE1664, 10.1038/nclimate1664]; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; RHODES EG, 1982, SEDIMENTOLOGY, V29, P201, DOI 10.1111/j.1365-3091.1982.tb01719.x; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Scileppi E, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001463; Smith JM, 2010, OCEAN ENG, V37, P37, DOI 10.1016/j.oceaneng.2009.07.008; STANLEY DJ, 1994, SCIENCE, V265, P228, DOI 10.1126/science.265.5169.228; Stevenson SL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052759; STUMPF RP, 1983, ESTUAR COAST SHELF S, V17, P495, DOI 10.1016/0272-7714(83)90002-1; Takahashi C, 2011, SOLA, V7, P201, DOI 10.2151/sola.2011-051; Tippett MK, 2011, J CLIMATE, V24, P2335, DOI 10.1175/2010JCLI3811.1; Uehara K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003531; United Nations, 2012, WORLD URB PROSP 2011; Villarini G, 2013, J CLIMATE, V26, P3231, DOI 10.1175/JCLI-D-12-00441.1; Villarini G, 2012, NAT CLIM CHANGE, V2, P604, DOI 10.1038/NCLIMATE1530; Wamsley TV, 2009, NAT HAZARDS, V51, P207, DOI 10.1007/s11069-009-9378-z; Wang J, 2012, CLIMATIC CHANGE, V115, P537, DOI 10.1007/s10584-012-0468-7; Wang P, 2006, J COASTAL RES, V22, P1382, DOI 10.2112/05-0440.1; Webster PJ, 2013, NATURE, V493, P17, DOI 10.1038/493017a; Weinkle J, 2012, J CLIMATE, V25, P4729, DOI 10.1175/JCLI-D-11-00719.1; Woodruff JD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002043; Woodworth PL, 2003, J COASTAL RES, V19, P287; Zhang KQ, 2002, J GEOL, V110, P493, DOI 10.1086/340633; Zhang KQ, 2000, J CLIMATE, V13, P1748, DOI 10.1175/1520-0442(2000)013<1748:TCSAAT>2.0.CO;2	100	385	403	39	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					44	52		10.1038/nature12855	http://dx.doi.org/10.1038/nature12855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305147	Green Published			2022-12-28	WOS:000327851700024
J	Feinmann, J				Feinmann, Jane			BMJ CHRISTMAS APPEAL 2013 After the typhoon: how volunteer doctors are bringing medical care to those most in need	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f7193	10.1136/bmj.f7193	http://dx.doi.org/10.1136/bmj.f7193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297998	Bronze, Green Published			2022-12-28	WOS:000328146700011
J	Sonnenberg, P; Clifton, S; Beddows, S; Field, N; Soldan, K; Tanton, C; Mercer, CH; da Silva, FC; Alexander, S; Copas, AJ; Phelps, A; Erens, B; Prah, P; Macdowall, W; Wellings, K; Ison, CA; Johnson, AM				Sonnenberg, Pam; Clifton, Soazig; Beddows, Simon; Field, Nigel; Soldan, Kate; Tanton, Clare; Mercer, Catherine H.; da Silva, Filomeno Coelho; Alexander, Sarah; Copas, Andrew J.; Phelps, Andrew; Erens, Bob; Prah, Philip; Macdowall, Wendy; Wellings, Kaye; Ison, Catherine A.; Johnson, Anne M.			Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)	LANCET			English	Article							ANTI-HIV; HEALTH; URINE; MEN; PARTNERSHIPS; BEHAVIOR; WOMEN	Background Population-based estimates of prevalence, risk distribution, and intervention uptake inform delivery of control programmes for sexually transmitted infections (STIs). We undertook the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) after implementation of national sexual health strategies, and describe the epidemiology of four STIs in Britain (England, Scotland, and Wales) and the uptake of interventions. Methods Between Sept 6, 2010 and Aug 31, 2012, we did a probability sample survey of 15 162 women and men aged 16-74 years in Britain. Participants were interviewed with computer-assisted face-to-face and self-completion questionnaires. Urine from a sample of participants aged 16-44 years who reported at least one sexual partner over the lifetime was tested for the presence of Chlamydia trachomatis, type-specific human papillomavirus (HPV), Neisseria gonorrhoeae, and HIV antibody. We describe age-specific and sex-specific prevalences of infection and intervention uptake, in relation to demographic and behavioural factors, and explore changes since Natsal-1 (1990-91) and Natsal-2 (1999-2001). Findings Of 8047 eligible participants invited to provide a urine sample, 4828 (60%) agreed. We excluded 278 samples, leaving 4550 (94%) participants with STI test results. Chlamydia prevalence was 1.5% (95% CI 1.1-2.0) in women and 1.1% (0.7-1.6) in men. Prevalences in individuals aged 16-24 years were 3.1% (2.2-4.3) in women and 2.3% (1.5-3.4) in men. Area-level deprivation and higher numbers of partners, especially without use of condoms, were risk factors. However, 60.4% (45.5-73.7) of chlamydia in women and 43.3% (25.9-62.5) in men was in individuals who had had one partner in the past year. Among sexually active 16-24-year-olds, 54.2% (51.4-56.9) of women and 34.6% (31.8-37.4) of men reported testing for chlamydia in the past year, with testing higher in those with more partners. High-risk HPV was detected in 15.9% (14.4-17.5) of women, similar to in Natsal-2. Coverage of HPV catch-up vaccination was 61.5% (58.2-64.7). Prevalence of HPV types 16 and 18 in women aged 18-20 years was lower in Natsal-3 than Natsal-2 (5.8% [3.9-8.6] vs 11.3% [6.8-18.2]; age-adjusted odds ratio 0.44 [0.21-0.94]). Gonorrhoea (<0.1% prevalence in women and men) and HIV (0.1% prevalence in women and 0.2% in men) were uncommon and restricted to participants with recognised high-risk factors. Since Natsal-2, substantial increases were noted in attendance at sexual health clinics (from 6.7% to 21.4% in women and from 7.7% to 19.6% in men) and HIV testing (from 8.7% to 27.6% in women and from 9.2% to 16.9% in men) in the past 5 years. Interpretation STIs were distributed heterogeneously, requiring general and infection-specific interventions. Increases in testing and attendance at sexual health clinics, especially in people at highest risk, are encouraging. However, STIs persist both in individuals accessing and those not accessing services. Our findings provide empirical evidence to inform future sexual health interventions and services.	[Sonnenberg, Pam; Clifton, Soazig; Field, Nigel; Tanton, Clare; Mercer, Catherine H.; Copas, Andrew J.; Erens, Bob; Prah, Philip; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, Mortimer Market Ctr, London WC1E 6JB, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England; [Beddows, Simon; da Silva, Filomeno Coelho] Publ Hlth England, Virus Reference Dept, London, England; [Soldan, Kate] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England; [Alexander, Sarah; Ison, Catherine A.] Publ Hlth England, Sexually Transmitted Bacteria Reference Unit, London, England; [Erens, Bob] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England; [Macdowall, Wendy; Wellings, Kaye] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Res, London WC1E 7HT, England	University of London; University College London; Public Health England; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Sonnenberg, P (corresponding author), UCL, Res Dept Infect & Populat Hlth, Mortimer Market Ctr, London WC1E 6JB, England.	p.sonnenberg@ucl.ac.uk	Field, Nigel/ABG-3948-2020; King, Carina/C-8883-2016	Mercer, Catherine/0000-0002-4220-5034; Johnson, Anne/0000-0003-1330-7100; Sonnenberg, Pam/0000-0002-1067-1583; Field, Nigel/0000-0002-2825-6652; Macdowall, Wendy/0000-0001-5868-8336; Beddows, Simon/0000-0002-6879-6215; Erens, Robert/0000-0002-3054-504X; Prah, Philip/0000-0002-4742-9686; Clifton, Soazig/0000-0002-4171-0805; Copas, Andrew/0000-0001-8968-5963; Erens, Bob/0000-0002-4430-954X; Tanton, Clare/0000-0002-4612-1858; Soldan, Kate/0000-0002-0361-3174	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [CL-2010-18-010, NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; [Anonymous], 2005, RESP RESP STRAT ACT; [Anonymous], 2010, SEX HLTH WELLB ACT P; [Anonymous], 2001, STRAT FRAM PROM SEX; Australian Department of Health and Ageing, 2010, 2 NAT SEX TRANSM INF; Bissett SL, 2011, J MED VIROL, V83, P1744, DOI 10.1002/jmv.22167; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; British HIV Association British Association of Sexual Health and HIV British Infection Society, 2008, UK NAT GUID HIV TEST; Centers for Disease Control and Prevention, NAT HLTH NUTR EXAM S; CONNELL JA, 1990, LANCET, V335, P1366, DOI 10.1016/0140-6736(90)91245-6; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department of Health, 2008, SEX HLTH PROM STRAT; Department of Health, 2001, NAT STRAT SEX HLTH H; Department of Health, 2013, FRAM SEX HLTH IMPR E; Department of Health, 2012, PUBL HLTH OUTC FRAM; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Erens B., 2013, 3 NATL SURVEY SEXUAL; Erens B, 2013, SEX TRANSM INFECT; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Field N, 2012, J MED ETHICS, V38, P380, DOI 10.1136/medethics-2011-100068; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Gray M., 2009, NATL SURVEY SEXUAL A; Health Protection Agency, 2012, HIV UK 2012 REP; Howell-Jones R, 2012, 28 INT PAP C SAN JUA, pE07; Hughes A, EUROSURVEIL IN PRESS; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 1994, NATL SURVEY SEXUAL A; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Laboratory Centre for Disease Control (Canada), 1997, P NAT STD CONS M NAT; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Lowndes CM, 2004, SEX TRANSM INFECT, V80, P264, DOI 10.1136/sti.2004.010389; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mercer CH, 2009, INT J EPIDEMIOL, V38, P206, DOI 10.1093/ije/dyn216; Mercer CH, 2013, LANCET; Ministry of Health, 2001, SEX REPR HLTH STRAT; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; PARRY JV, 1995, J MED VIROL, V45, P10, DOI 10.1002/jmv.1890450103; Payne R. A., 2012, Health Statistics Quarterly, P22; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Public Health England, GEN MED CLIN ACT DAT; Public Health England, 2013, HLTH PROTECTION REPO; Sheringham J, 2013, SEX TRANSM INFECT, V89, P175, DOI 10.1136/sextrans-2011-050223; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; University of North Carolina Carolina Population Center, ADD HLTH; Wisniewski CA, 2008, J CLIN MICROBIOL, V46, P1466, DOI 10.1128/JCM.02241-07; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2001, WHO REG STRAT SEX RE	50	243	249	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1795	1806		10.1016/S0140-6736(13)61947-9	http://dx.doi.org/10.1016/S0140-6736(13)61947-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24286785	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000327540700024
J	Foster, V				Foster, Valerie			Exploring the Evolution of Human Mate Preference	SCIENCE			English	Editorial Material									Pasadena City Coll, Nat Sci Div, Pasadena, CA 91106 USA		Foster, V (corresponding author), Pasadena City Coll, Nat Sci Div, 1570 East Colorado Blvd, Pasadena, CA 91106 USA.	vsfoster@pasadena.edu						BOSTON C, 2002, PRACT ASSESS RES EVA, V8; Brown R. T., 1990, STUDYING PSYCHOL MAN; Hmelo-Silver CE, 2004, EDUC PSYCHOL REV, V16, P235, DOI 10.1023/B:EDPR.0000034022.16470.f3; Hmelo-Silver CE, 2007, EDUC PSYCHOL-US, V42, P99, DOI 10.1080/00461520701263368; Miller G. F., 1998, HDB EVOLUTIONARY PSY; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087	6	0	0	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1060	1061		10.1126/science.1230005	http://dx.doi.org/10.1126/science.1230005			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259HS	24288326				2022-12-28	WOS:000327518600048
J	Kong, L; Giang, E; Nieusma, T; Kadam, RU; Cogburn, KE; Hua, YZ; Dai, XP; Stanfield, RL; Burton, DR; Ward, AB; Wilson, IA; Law, M				Kong, Leopold; Giang, Erick; Nieusma, Travis; Kadam, Rameshwar U.; Cogburn, Kristin E.; Hua, Yuanzi; Dai, Xiaoping; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.; Law, Mansun			Hepatitis C Virus E2 Envelope Glycoprotein Core Structure	SCIENCE			English	Article							CRYSTAL-STRUCTURE; VIRAL-HEPATITIS; 3D STRUCTURE; ANTIBODY; NEUTRALIZATION; IDENTIFICATION; INSIGHT; SITE	Hepatitis C virus (HCV), a Hepacivirus, is a major cause of viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV envelope glycoproteins E1 and E2 mediate fusion and entry into host cells and are the primary targets of the humoral immune response. The crystal structure of the E2 core bound to broadly neutralizing antibody AR3C at 2.65 angstroms reveals a compact architecture composed of a central immunoglobulin-fold beta sandwich flanked by two additional protein layers. The CD81 receptor binding site was identified by electron microscopy and site-directed mutagenesis and overlaps with the AR3C epitope. The x-ray and electron microscopy E2 structures differ markedly from predictions of an extended, three-domain, class II fusion protein fold and therefore provide valuable information for HCV drug and vaccine design.	[Kong, Leopold; Nieusma, Travis; Kadam, Rameshwar U.; Cogburn, Kristin E.; Hua, Yuanzi; Dai, Xiaoping; Stanfield, Robyn L.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Giang, Erick; Cogburn, Kristin E.; Burton, Dennis R.; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	abward@scripps.edu; wilson@scripps.edu; mlaw@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Ward, Andrew/ABD-7728-2021; Cheng, Yushao/E-6256-2011; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Law, Mansun/0000-0002-8934-9756; Kong, Leopold/0000-0001-7456-1773	NIH [AI079031, AI080916, AI071084, AI084817, U54 GM094586]; Skaggs Institute; American Foundation for AIDS Research; Swiss National Science Foundation; NIH through the National Center for Research Resources' P41 program at the National Center for Research Resources [RR017573]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences (NIGMS); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071084, R21AI080916, R01AI084817, R01AI079031, R56AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U54GM094586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; American Foundation for AIDS Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH through the National Center for Research Resources' P41 program at the National Center for Research Resources; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien, T. Clayton, and M. C. Deller for help in setting up crystallization screens using the CrystalMation and Douglas robots; J. Robbins for help with protein purification; N. Laursen for useful discussions on refinement; L. Jaroszewski for help in analyzing the HCV E2c protein fold; P. Verdino for discussion of Ig folds; and J. P. Verenini for help in manuscript formatting. This work is supported by NIH grants AI079031 and AI080916 (to M.L.), AI071084 (to D.R.B.), and AI084817 and U54 GM094586 (to I.A.W.) and the Skaggs Institute (I.A.W.). L.K. is grateful to the American Foundation for AIDS Research for a Mathilde Krim Fellowship in Basic Biomedical Research, and R.U.K., to the Swiss National Science Foundation for a postdoctoral fellowship. The EM data were collected at the U.S. National Resource for Automated Molecular Microscopy (NRAMM) at the Scripps Research Institute, which is supported by the NIH through the National Center for Research Resources' P41 program (RR017573) at the National Center for Research Resources. X-ray data sets were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 12-2, a Directorate of the Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Coordinates and structure factors for the E2c complex with Fab AR3C have been deposited with the Protein Data Bank under accession code 4MWF. The EM reconstruction densities for the E2 Delta TM-Fab AR3C, E2 Delta TM-Fab AR3C-Fab AR2A, and E2 Delta TM-FabAR2A-CD81 LEL complexes have been deposited with the Electron Microscopy Data Bank under accession codes EMD-5759, EMD-5760, and EMD-5761, respectively. Antibodies and expression vectors used in this work are available from the authors (contact M.L.) under a materials transfer agreement with the Scripps Research Institute. The content is the responsibility of the authors and does not necessarily reflect the official views of the NIGMS, National Cancer Institute, or NIH. This is manuscript 24038 from the Scripps Research Institute. The authors declare no competing financial interests.	Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Whidby J, 2009, J VIROL, V83, P11078, DOI 10.1128/JVI.00800-09; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	35	296	301	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1090	1094		10.1126/science.1243876	http://dx.doi.org/10.1126/science.1243876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288331	Green Accepted			2022-12-28	WOS:000327518600056
J	Liechti, GW; Kuru, E; Hall, E; Kalinda, A; Brun, YV; VanNieuwenhze, M; Maurelli, AT				Liechti, G. W.; Kuru, E.; Hall, E.; Kalinda, A.; Brun, Y. V.; VanNieuwenhze, M.; Maurelli, A. T.			A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis	NATURE			English	Article							D-CYCLOSERINE; PENICILLIN; ACID; INHIBITION; PROTEINS; BACTERIA; HUMANS; MURC	Peptidoglycan (PG), an essential structure in the cell walls of the vast majority of bacteria, is critical for division and maintaining cell shape and hydrostatic pressure(1). Bacteria comprising the Chlamydiales were thought to be one of the few exceptions. Chlamydia harbour genes for PG biosynthesis(2-7) and exhibit susceptibility to 'anti-PG' antibiotics(8,9), yet attempts to detect PG in any chlamydial species have proven unsuccessful (the 'chlamydial anomaly'(10)). We used a novel approach to metabolically label chlamydial PG using D-amino acid dipeptide probes and click chemistry. Replicating Chlamydia trachomatis were labelled with these probes throughout their biphasic developmental life cycle, and the results of differential probe incorporation experiments conducted in the presence of ampicillin are consistent with the presence of chlamydial PG-modifying enzymes. These findings culminate 50 years of speculation and debate concerning the chlamydial anomaly and are the strongest evidence so far that chlamydial species possess functional PG.	[Liechti, G. W.; Maurelli, A. T.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Kuru, E.] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; [Hall, E.; Kalinda, A.; VanNieuwenhze, M.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Brun, Y. V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Uniformed Services University of the Health Sciences - USA; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Maurelli, AT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mvannieu@indiana.edu; anthony.maurelli@usuhs.edu	Liechti, George/C-3129-2015; VanNieuwenhze, Michael/B-5120-2018	Liechti, George/0000-0003-3028-8474; VanNieuwenhze, Michael/0000-0001-6093-5949; Maurelli, Anthony/0000-0002-4788-6166; Brun, Yves/0000-0002-9289-1909	NIH [AI044033, GM51986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044033, R56AI044033, R01AI044033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants to A. T. M. (AI044033) and Y.V.B. (GM51986). We would like to thank D. McDaniel and M. Murgai for their help with image acquisition and presentation, P. Foster and D. Kearns for help in early stages of the project, R. Calvo for help with strain construction, and M. Winkler for providing strains and advice.	Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P2865, DOI 10.1128/AAC.49.7.2865-2873.2005; Breinbauer R, 2003, CHEMBIOCHEM, V4, P1147, DOI 10.1002/cbic.200300705; Brown WJ, 2000, INFECT IMMUN, V68, P708, DOI 10.1128/IAI.68.2.708-715.2000; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; FOX A, 1990, INFECT IMMUN, V58, P835, DOI 10.1128/IAI.58.3.835-837.1990; GORDON FB, 1972, ANTIMICROB AGENTS CH, V2, P242, DOI 10.1128/AAC.2.3.242; Hatch TP, 1996, J BACTERIOL, V178, P1; Hesse L, 2003, J BACTERIOL, V185, P6507, DOI 10.1128/JB.185.22.6507-6512.2003; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McCoy AJ, 2003, J BACTERIOL, V185, P1218, DOI 10.1128/JB.185.4.1218-1228.2003; McCoy AJ, 2005, MOL MICROBIOL, V57, P41, DOI 10.1111/j.1365-2958.2005.04661.x; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; MOULDER JW, 1993, INFECT AGENT DIS, V2, P87; MOULDER JW, 1963, J BACTERIOL, V85, P707, DOI 10.1128/JB.85.3.707-711.1963; NEUHAUS FC, 1981, PHARMACOL THERAPEUT, V14, P265, DOI 10.1016/0163-7258(81)90030-9; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Patin D, 2012, ARCH MICROBIOL, V194, P505, DOI 10.1007/s00203-011-0784-8; Patin D, 2009, J BACTERIOL, V191, P7430, DOI 10.1128/JB.01029-09; Sambrook J., 2001, MOL CLONING LAB MANU; Sham LT, 2011, P NATL ACAD SCI USA, V108, pE1061, DOI 10.1073/pnas.1108323108; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; TAMURA A, 1968, J BACTERIOL, V96, P875, DOI 10.1128/JB.96.4.875-880.1968; Turner RD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2503; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377	38	218	227	2	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					507	+		10.1038/nature12892	http://dx.doi.org/10.1038/nature12892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24336210	Green Accepted			2022-12-28	WOS:000332165100042
J	Coleman, EA				Coleman, Eric A.			Extending Simulation Learning Experiences to Patients With Chronic Health Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Coleman, Eric A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Coleman, EA (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus,13199 E Montview Blvd,Ste 400, Aurora, CO 80045 USA.	eric.coleman@ucdenver.edu						Bennett Heather D, 2010, Fam Pract Manag, V17, P24; Centers for Medicare & Medicaid Services (CMS), TRANS CAR MAN SERV; Coleman EA, 2013, AM J MED QUAL, V28, P383, DOI 10.1177/1062860612472931; Coleman EA, 2013, POPUL HEALTH MANAG, V16, P227, DOI 10.1089/pop.2012.0069; Morris MG., 2011, NE MISSISSIPPI  1021; NCQA, NCQA PCMH 2011 STAND; Passiment M, MED SIMULATION MED E; Reinhard S.C., HOME ALONE FAMILY CA	8	18	20	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					243	244		10.1001/jama.2013.283057	http://dx.doi.org/10.1001/jama.2013.283057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24343769	Green Published			2022-12-28	WOS:000329566400013
J	Baron, RJ; Davis, K				Baron, Richard J.; Davis, Karen			Accelerating the Adoption of High-Value Primary Care - A New Provider Type under Medicare?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baron, Richard J.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Davis, Karen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Roger C Lipitz Ctr Integrated Hlth Care, Baltimore, MD USA	American Board of Internal Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baron, RJ (corresponding author), Amer Board Internal Med, Philadelphia, PA 19106 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Davis K, 2013, HEALTH AFFAIR, V32, P900, DOI 10.1377/hlthaff.2012.1203; Doherty RB, 2013, ANN INTERN MED, V159, P620, DOI 10.7326/0003-4819-159-9-201311050-00710; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579	3	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2014	370	2					99	101		10.1056/NEJMp1314933	http://dx.doi.org/10.1056/NEJMp1314933			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TA	24350900	Bronze			2022-12-28	WOS:000336119800003
J	Gillis, KM; Snow, JE; Klaus, A; Abe, N; Adriao, AB; Akizawa, N; Ceuleneer, G; Cheadle, MJ; Faak, K; Falloon, TJ; Friedman, SA; Godard, M; Guerin, G; Harigane, Y; Horst, AJ; Hoshide, T; Ildefonse, B; Jean, MM; John, BE; Koepke, J; Machi, S; Maeda, J; Marks, NE; McCaig, AM; Meyer, R; Morris, A; Nozaka, T; Python, M; Saha, A; Wintsch, RP				Gillis, Kathryn M.; Snow, Jonathan E.; Klaus, Adam; Abe, Natsue; Adriao, Alden B.; Akizawa, Norikatsu; Ceuleneer, Georges; Cheadle, Michael J.; Faak, Kathrin; Falloon, Trevor J.; Friedman, Sarah A.; Godard, Marguerite; Guerin, Gilles; Harigane, Yumiko; Horst, Andrew J.; Hoshide, Takashi; Ildefonse, Benoit; Jean, Marlon M.; John, Barbara E.; Koepke, Juergen; Machi, Sumiaki; Maeda, Jinichiro; Marks, Naomi E.; McCaig, Andrew M.; Meyer, Romain; Morris, Antony; Nozaka, Toshio; Python, Marie; Saha, Abhishek; Wintsch, Robert P.			Primitive layered gabbros from fast-spreading lower oceanic crust	NATURE			English	Article							EAST PACIFIC RISE; MIDOCEAN RIDGE BASALTS; HESS DEEP RIFT; LIQUID EQUILIBRIA; MAGMA CHAMBERS; UPPER-MANTLE; MELT; MODEL; FLOW; DIFFERENTIATION	Three-quarters of the oceanic crust formed at fast-spreading ridges is composed of plutonic rocks whose mineral assemblages, textures and compositions record the history of melt transport and crystallization between the mantle and the sea floor. Despite the importance of these rocks, sampling them in situ is extremely challenging owing to the overlying dykes and lavas. This means that models for understanding the formation of the lower crust are based largely on geophysical studies(1) and ancient analogues (ophiolites)(2-5) that did not form at typical mid-ocean ridges. Here we describe cored intervals of primitive, modally layered gabbroic rocks from the lower plutonic crust formed at a fast-spreading ridge, sampled by the Integrated Ocean Drilling Program at the Hess Deep rift. Centimetre-scale, modally layered rocks, some of which have a strong layering-parallel foliation, confirm a long-held belief that such rocks are a key constituent of the lower oceanic crust formed at fast-spreading ridges(3,6). Geochemical analysis of these primitive lower plutonic rocks-in combination with previous geochemical data for shallow-level plutonic rocks, sheeted dykes and lavas-provides the most completely constrained estimate of the bulk composition of fast-spreading oceanic crust so far. Simple crystallization models using this bulk crustal composition as the parental melt accurately predict the bulk composition of both the lavas and the plutonic rocks. However, the recovered plutonic rocks show early crystallization of orthopyroxene, which is not predicted by current models of melt extraction from the mantle(7) and mid-ocean-ridge basalt differentiation(8,9). The simplest explanation of this observation is that compositionally diverse melts are extracted from the mantle and partly crystallize before mixing to produce the more homogeneous magmas that erupt.	[Gillis, Kathryn M.; Faak, Kathrin] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 2Y2, Canada; [Snow, Jonathan E.] Univ Houston, Houston, TX 77204 USA; [Klaus, Adam] Texas A&M Univ, Integrated Ocean Drilling Program, US Implementing Org, College Stn, TX 77845 USA; [Abe, Natsue] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Adriao, Alden B.] Univ Fed Rio Grande do Sul, Inst Geosci, BR-91501970 Porto Alegre, RS, Brazil; [Akizawa, Norikatsu; Machi, Sumiaki] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Ceuleneer, Georges] Univ Toulouse 3, CNRS, UMS 831, Observ Midipyrenees, F-31400 Toulouse, France; [Cheadle, Michael J.; John, Barbara E.] Univ Wyoming, Dept 3006, Dept Geol & Geophys, Laramie, WY 82071 USA; [Faak, Kathrin] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44780 Bochum, Germany; [Falloon, Trevor J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Falloon, Trevor J.] Univ Tasmania, Sch Earth Sci, Hobart, Tas, Australia; [Friedman, Sarah A.] So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA; [Godard, Marguerite; Ildefonse, Benoit] Univ Montpellier 2, CNRS UMR5243, Geosci Montpellier, CC 60, F-34095 Montpellier 5, France; [Guerin, Gilles] Columbia Univ, Lamont Doherty Earth Observ, Borehole Res Grp, Palisades, NY USA; [Harigane, Yumiko] Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Inst Geol & Geoinformat, Tsukuba, Ibaraki 3058567, Japan; [Horst, Andrew J.] Oberlin Coll, Dept Geol, Oberlin, OH 44074 USA; [Hoshide, Takashi] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Jean, Marlon M.] No Illinois Univ, Dept Geol & Environm, De Kalb, IL 60115 USA; [Koepke, Juergen] Leibniz Univ Hannover, Inst Mineral, D-30167 Hannover, Germany; [Maeda, Jinichiro; Python, Marie] Hokkaido Univ, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Marks, Naomi E.] Lawrence Livermore Natl Lab, Chem & Mat Sci Dept, Livermore, CA 94551 USA; [McCaig, Andrew M.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Meyer, Romain] Univ Bergen, Ctr Geobiol, N-5007 Bergen, Norway; [Meyer, Romain] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Morris, Antony] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth PL4 8AA, Devon, England; [Nozaka, Toshio] Okayama Univ, Dept Earth Sci, Okayama 7008530, Japan; [Saha, Abhishek] Univ Calcutta, Dept Geol, Kolkata 700019, India; [Wintsch, Robert P.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of Victoria; University of Houston System; University of Houston; Texas A&M University System; Texas A&M University College Station; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Universidade Federal do Rio Grande do Sul; Kanazawa University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wyoming; Ruhr University Bochum; University of Tasmania; University of Tasmania; Southern Illinois University System; Southern Illinois University; Universite de Montpellier; Columbia University; National Institute of Advanced Industrial Science & Technology (AIST); Oberlin College; Tohoku University; Northern Illinois University; Leibniz University Hannover; Hokkaido University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Leeds; University of Bergen; University of Bergen; University of Plymouth; Okayama University; University of Calcutta; Indiana University System; Indiana University Bloomington	Gillis, KM (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 1700 Stn CSC, Victoria, BC V8W 2Y2, Canada.	kgillis@uvic.ca	Falloon, Trevor John/J-2381-2019; Jean, Marlon/HGV-1474-2022; Snow, Jonathan/E-5591-2011; Guérin, Gilles/AAK-7882-2021; Godard, Marguerite/A-7127-2008; Abe, Natsue/AAP-7388-2021; NOZAKA, Toshio/B-2096-2011; ildefonse, benoit/A-6205-2009; Harigane, Yumiko/L-4382-2018; McCaig, Andrew/C-1066-2014	Godard, Marguerite/0000-0003-3097-5135; Abe, Natsue/0000-0002-2734-0035; ildefonse, benoit/0000-0001-7635-9288; Harigane, Yumiko/0000-0002-8133-0700; Morris, Antony/0000-0003-2862-7377; HOSHIDE, TAKASHI/0000-0002-2474-6718; McCaig, Andrew/0000-0001-7416-4911; Falloon, Trevor/0000-0001-6528-9739	NERC [NE/K011030/1, NE/K011057/1, NE/C509023/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [11J04217, 25400515] Funding Source: KAKEN; Natural Environment Research Council [NE/C509023/1, NE/K011030/1, NE/K011057/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arai S., 1996, P ODP SCI RES, V147, P135, DOI DOI 10.2973/ODP.PROC.SR.147.008.1996; ARISKIN AA, 1993, COMPUT GEOSCI, V19, P1155, DOI 10.1016/0098-3004(93)90020-6; BEATTIE P, 1993, CONTRIB MINERAL PETR, V115, P103, DOI 10.1007/BF00712982; Berndt J, 2005, J PETROL, V46, P135, DOI 10.1093/petrology/egh066; Blackman DK, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007931; BLUM N, 1991, THESIS U KARLSRUHE, P232; Boudier F, 1996, EARTH PLANET SC LETT, V144, P239, DOI 10.1016/0012-821X(96)00167-7; Boudreau AE, 1997, J PETROL, V38, P1003, DOI 10.1093/petrology/38.8.1003; CANN JR, 1974, GEOPHYS J ROY ASTR S, V39, P169, DOI 10.1111/j.1365-246X.1974.tb05446.x; Coogan LA, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000230; Danyushevsky LV, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003516; Danyushevsky LV, 2001, J VOLCANOL GEOTH RES, V110, P265, DOI 10.1016/S0377-0273(01)00213-X; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Ferrini VL, 2013, MAR GEOL, V339, P13, DOI 10.1016/j.margeo.2013.03.006; FORD CE, 1983, J PETROL, V24, P256, DOI 10.1093/petrology/24.3.256; FRANCHETEAU J, 1990, EARTH PLANET SC LETT, V101, P281, DOI 10.1016/0012-821X(90)90160-Y; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; GILLIS KM, 1993, P OCEAN DRILL PROGRA, V147, P45; GROVE TL, 1992, GEOPH MONOG SERIES, V71, P281; GROVE TL, 1989, CONTRIB MINERAL PETR, V103, P287, DOI 10.1007/BF00402916; HANNA HD, 2004, THESIS DUKE U; HEKINIAN R, 1993, J GEOPHYS RES-SOL EA, V98, P8069, DOI 10.1029/92JB02072; HENSTOCK TJ, 1993, J GEOPHYS RES-SOL EA, V98, P4143, DOI 10.1029/92JB02661; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; Karson JA, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000155; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Kelemen PB, 1998, GEOPH MONOG SERIES, V106, P267; KINZLER RJ, 1992, J GEOPHYS RES-SOL EA, V97, P6907, DOI 10.1029/91JB02841; KRESS VC, 1988, AM MINERAL, V73, P1267; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Lissenberg CJ, 2013, EARTH PLANET SC LETT, V361, P436, DOI 10.1016/j.epsl.2012.11.012; McBirney AR, 1997, J PETROL, V38, P569, DOI 10.1093/petrology/38.5.569; NASLUND HR, 1996, DEV PETROLO, V15, P1; Natland J.H, 1996, P OCEAN DRILL PROGRA, V147, P103, DOI DOI 10.2973/ODP.PROC.SR.147.007.1996; Natland JH, 2009, LITHOS, V112, P73, DOI 10.1016/j.lithos.2009.06.017; NICOLAS A, 1988, MAR GEOPHYS RES, V9, P293, DOI 10.1007/BF00315002; Nicolas A, 1996, J GEOPHYS RES-SOL EA, V101, P17941, DOI 10.1029/96JB00195; Nilsson K., 1993, THESIS U CALIFORNIA; O'Neill HS, 2012, NATURE, V491, P698, DOI 10.1038/nature11678; OHARA MJ, 1968, NATURE, V220, P683, DOI 10.1038/220683a0; PALLISTER JS, 1981, J GEOPHYS RES, V86, P2593, DOI 10.1029/JB086iB04p02593; Pedersen R. B., 1996, P ODP SCI RESULTS CO, V147, P3, DOI [10.2973/odp.proc.sr.147.001, DOI 10.2973/ODP.PROC.SR.147.001]; QUICK JE, 1993, J GEOPHYS RES-SOL EA, V98, P14015, DOI 10.1029/93JB00698; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Stewart MA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000545	45	85	88	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					204	+		10.1038/nature12778	http://dx.doi.org/10.1038/nature12778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24291793	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000329441500036
J	Nathanson, DA; Gini, B; Mottahedeh, J; Visnyei, K; Koga, T; Gomez, G; Eskin, A; Hwang, K; Wang, J; Masui, K; Paucar, A; Yang, HJ; Ohashi, M; Zhu, SJ; Wykosky, J; Reed, R; Nelson, SF; Cloughesy, TF; James, CD; Rao, PN; Kornblum, HI; Heath, JR; Cavenee, WK; Furnari, FB; Mischel, PS				Nathanson, David A.; Gini, Beatrice; Mottahedeh, Jack; Visnyei, Koppany; Koga, Tomoyuki; Gomez, German; Eskin, Ascia; Hwang, Kiwook; Wang, Jun; Masui, Kenta; Paucar, Andres; Yang, Huijun; Ohashi, Minori; Zhu, Shaojun; Wykosky, Jill; Reed, Rachel; Nelson, Stanley F.; Cloughesy, Timothy F.; James, C. David; Rao, P. Nagesh; Kornblum, Harley I.; Heath, James R.; Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.			Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA	SCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; DOUBLE-MINUTE CHROMOSOMES; HOMOGENEOUSLY STAINING REGIONS; DRUG-RESISTANCE; CELL-LINES; GLIOBLASTOMA-MULTIFORME; KINASE INHIBITORS; GENE; AMPLIFICATION; TUMORIGENICITY	Intratumoral heterogeneity contributes to cancer drug resistance, but the underlying mechanisms are not understood. Single-cell analyses of patient-derived models and clinical samples from glioblastoma patients treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) demonstrate that tumor cells reversibly up-regulate or suppress mutant EGFR expression, conferring distinct cellular phenotypes to reach an optimal equilibrium for growth. Resistance to EGFR TKIs is shown to occur by elimination of mutant EGFR from extrachromosomal DNA. After drug withdrawal, reemergence of clonal EGFR mutations on extrachromosomal DNA follows. These results indicate a highly specific, dynamic, and adaptive route by which cancers can evade therapies that target oncogenes maintained on extrachromosomal DNA.	[Gini, Beatrice; Koga, Tomoyuki; Gomez, German; Masui, Kenta; Yang, Huijun; Zhu, Shaojun; Wykosky, Jill; Reed, Rachel; Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Nathanson, David A.; Paucar, Andres; Ohashi, Minori; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Hwang, Kiwook; Wang, Jun; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91030 USA; [Hwang, Kiwook; Wang, Jun; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91030 USA; [Mottahedeh, Jack; Visnyei, Koppany; Paucar, Andres; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Neuropsychiat Inst, Los Angeles, CA 90095 USA; [James, C. David] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cloughesy, Timothy F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Henry Singleton Brain Tumor Program, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Rao, P. Nagesh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Eskin, Ascia; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego	Mischel, PS (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	pmischel@ucsd.edu	Cloughesy, Timothy Francis/AGV-1013-2022; Wang, Jun/A-8216-2015; Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Furnari, Frank/0000-0003-1909-4361; Koga, Tomoyuki/0000-0002-8330-117X; Mischel, Paul/0000-0002-4560-2211	Ben and Catherine Ivy Foundation; National Institutes of Health (NIH) [NS73831, U54 CA151819, P01-CA95616, R01-NS080939, NINDS R01 NS052563]; Ziering Family Foundation; Art of the Brain Fund; James S. McDonnell Foundation; European Commission [PIOF-GA-2010-271819]; Ruth L. Kirschstein Institutional National Research Service Award [T32 CA009056]; UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program; NATIONAL CANCER INSTITUTE [P01CA095616, P30CA023100, T32CA009056, U54CA151819, U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939, R01NS073831, R01NS052563] Funding Source: NIH RePORTER	Ben and Catherine Ivy Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ziering Family Foundation; Art of the Brain Fund; James S. McDonnell Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Ruth L. Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Ben and Catherine Ivy Foundation Fund (P. S. M., J.R.H., and T. F. C.); by National Institutes of Health (NIH) grants NS73831 (P. S. M.), U54 CA151819 (P. S. M. and J.R.H., principal investigator), P01-CA95616 (W. K. C. and F. B. F.), R01-NS080939 (F. B. F.), and NINDS R01 NS052563 (H. I. K.); and by the Ziering Family Foundation in memory of Sigi Ziering (T. F. C. and P. S. M.), the Art of the Brain Fund (T. F. C.), the James S. McDonnell Foundation (to F. B. F.), the European Commission PIOF-GA-2010-271819 (B. G.), Ruth L. Kirschstein Institutional National Research Service Award T32 CA009056 (D.A.N.), and the UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program (D.A.N.). W. K. C. is a Fellow of the National Foundation for Cancer Research. We thank R. Kolodner for careful reading of the manuscript and helpful suggestions. We also thank W. Yong and the UCLA Brain Tumor Translational Resource.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; BIGNER SH, 1990, CANCER RES, V50, P8017; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Frederick L, 2000, CANCER RES, V60, P1383; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; HABER DA, 1981, CELL, V26, P355, DOI 10.1016/0092-8674(81)90204-X; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1084, DOI 10.1128/MCB.1.12.1084; KURPAD SN, 1995, GLIA, V15, P244, DOI 10.1002/glia.440150306; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Sun J, 2010, CANCER RES, V70, P6128, DOI 10.1158/0008-5472.CAN-10-0076; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165	34	328	351	7	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					72	76		10.1126/science.1241328	http://dx.doi.org/10.1126/science.1241328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24310612	Green Accepted			2022-12-28	WOS:000329162000050
J	Berlin, A				Berlin, Alex			No Barriers to Cellulose Breakdown	SCIENCE			English	Editorial Material							GLYCOSIDE HYDROLASE FAMILY; LIGNIN; HYDROLYSIS		Novozymes, Davis, CA 95618 USA	Novozymes	Berlin, A (corresponding author), Novozymes, Davis, CA 95618 USA.	axbl@novozymes.com						Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; dos Santos WD, 2011, ROUTES TO CELLULOSIC ETHANOL, P15, DOI 10.1007/978-0-387-92740-4_2; Ekwe E, 2013, IND BIOTECHNOL, V9, P123, DOI DOI 10.1089/IND.2013.0010; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Moilanen U, 2011, ENZYME MICROB TECH, V49, P492, DOI 10.1016/j.enzmictec.2011.09.012; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750	12	19	22	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1454	1456		10.1126/science.1247697	http://dx.doi.org/10.1126/science.1247697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24357305				2022-12-28	WOS:000328644300038
J	Nangalia, J; Massie, CE; Baxter, EJ; Nice, FL; Gundem, G; Wedge, DC; Avezov, E; Li, J; Kollmann, K; Kent, DG; Aziz, A; Godfrey, AL; Hinton, J; Martincorena, I; Van Loo, P; Jones, AV; Guglielmelli, P; Tarpey, P; Harding, HP; Fitzpatrick, JD; Goudie, CT; Ortmann, CA; Loughran, SJ; Raine, K; Jones, DR; Butler, AP; Teague, JW; O'Meara, S; McLaren, S; Bianchi, M; Silber, Y; Dimitropoulou, D; Bloxham, D; Mudie, L; Maddison, M; Robinson, B; Keohane, C; Maclean, C; Hill, K; Orchard, K; Tauro, S; Du, MQ; Greaves, M; Bowen, D; Huntly, BJP; Harrison, CN; Cross, NCP; Ron, D; Vannucchi, AM; Papaemmanuil, E; Campbell, PJ; Green, AR				Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Gundem, G.; Wedge, D. C.; Avezov, E.; Li, J.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Hinton, J.; Martincorena, I.; Van Loo, P.; Jones, A. V.; Guglielmelli, P.; Tarpey, P.; Harding, H. P.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Raine, K.; Jones, D. R.; Butler, A. P.; Teague, J. W.; O'Meara, S.; McLaren, S.; Bianchi, M.; Silber, Y.; Dimitropoulou, D.; Bloxham, D.; Mudie, L.; Maddison, M.; Robinson, B.; Keohane, C.; Maclean, C.; Hill, K.; Orchard, K.; Tauro, S.; Du, M-Q; Greaves, M.; Bowen, D.; Huntly, B. J. P.; Harrison, C. N.; Cross, N. C. P.; Ron, D.; Vannucchi, A. M.; Papaemmanuil, E.; Campbell, P. J.; Green, A. R.			Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; ACTIVATING MUTATION; EXON-12 MUTATIONS; V617F MUTATION; CALRETICULIN; MECHANISMS; MYELOFIBROSIS; GUIDELINE	BackgroundSomatic mutations in the Janus kinase 2 gene (JAK2) occur in many myeloproliferative neoplasms, but the molecular pathogenesis of myeloproliferative neoplasms with nonmutated JAK2 is obscure, and the diagnosis of these neoplasms remains a challenge. MethodsWe performed exome sequencing of samples obtained from 151 patients with myeloproliferative neoplasms. The mutation status of the gene encoding calreticulin (CALR) was assessed in an additional 1345 hematologic cancers, 1517 other cancers, and 550 controls. We established phylogenetic trees using hematopoietic colonies. We assessed calreticulin subcellular localization using immunofluorescence and flow cytometry. ResultsExome sequencing identified 1498 mutations in 151 patients, with medians of 6.5, 6.5, and 13.0 mutations per patient in samples of polycythemia vera, essential thrombocythemia, and myelofibrosis, respectively. Somatic CALR mutations were found in 70 to 84% of samples of myeloproliferative neoplasms with nonmutated JAK2, in 8% of myelodysplasia samples, in occasional samples of other myeloid cancers, and in none of the other cancers. A total of 148 CALR mutations were identified with 19 distinct variants. Mutations were located in exon 9 and generated a +1 base-pair frameshift, which would result in a mutant protein with a novel C-terminal. Mutant calreticulin was observed in the endoplasmic reticulum without increased cell-surface or Golgi accumulation. Patients with myeloproliferative neoplasms carrying CALR mutations presented with higher platelet counts and lower hemoglobin levels than patients with mutated JAK2. Mutation of CALR was detected in hematopoietic stem and progenitor cells. Clonal analyses showed CALR mutations in the earliest phylogenetic node, a finding consistent with its role as an initiating mutation in some patients. ConclusionsSomatic mutations in the endoplasmic reticulum chaperone CALR were found in a majority of patients with myeloproliferative neoplasms with nonmutated JAK2. (Funded by the Kay Kendall Leukaemia Fund and others.) The authors show that the diverse mutations in CALR that occur in nonmutated JAK2 myeloproliferative diseases all introduce frameshift mutations that alter the C-terminal part of the protein and affect its distribution within cells. The myeloproliferative neoplasms are chronic myeloid cancers that are characterized by the overproduction of mature blood cells, and that may evolve into acute myeloid leukemia.(1),(2) In addition to chronic myeloid leukemia with the BCR-ABL fusion gene, the three most common myeloproliferative neoplasms are essential thrombocythemia, polycythemia vera, and myelofibrosis. Many patients with a BCR-ABL-negative myeloproliferative neoplasm carry a Janus kinase 2 (JAK2) V617F mutation.(3)-(6) The JAK2 V617F mutation or JAK2 exon 12 mutations are found in most patients with polycythemia vera,(7),(8) whereas the JAK2 V617F mutation is found in only 50 to 60% of ...	[Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Green, A. R.] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Li, J.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Green, A. R.] Wellcome Trust MRC Stem Cell Inst, Cambridge, England; [Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Li, J.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Campbell, P. J.; Green, A. R.] Univ Cambridge, Dept Haematol, Cambridge CB2 1TN, England; [Du, M-Q] Univ Cambridge, Div Mol Histopathol, Dept Pathol, Cambridge CB2 1TN, England; [Nangalia, J.; Massie, C. E.; Gundem, G.; Wedge, D. C.; Hinton, J.; Martincorena, I.; Van Loo, P.; Tarpey, P.; Raine, K.; Jones, D. R.; Butler, A. P.; Teague, J. W.; O'Meara, S.; McLaren, S.; Mudie, L.; Maddison, M.; Robinson, B.; Papaemmanuil, E.; Campbell, P. J.] Wellcome Trust Sanger Inst, Cambridge, England; [Nangalia, J.; Godfrey, A. L.; Bianchi, M.; Bloxham, D.; Maclean, C.; Huntly, B. J. P.; Campbell, P. J.; Green, A. R.] Addenbrookes Hosp, Dept Haematol, Cambridge, England; [Avezov, E.; Harding, H. P.; Ron, D.] Univ Cambridge, Metab Res Labs, Cambridge, England; [Avezov, E.; Harding, H. P.; Ron, D.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Jones, A. V.; Cross, N. C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Hill, K.; Orchard, K.] Southampton Univ Hosp, Dept Haematol, Southampton, Hants, England; [Keohane, C.; Harrison, C. N.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Guys Hosp, London, England; [Greaves, M.] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England; [Tauro, S.] Ninewells Hosp, Dept Hematol, Dundee DD1 9SY, Scotland; [Bloxham, D.] St James Hosp, St James Inst Oncol, Leeds LS9 7TF, W Yorkshire, England; [Van Loo, P.] VIB, Dept Human Genet, Louvain, Belgium; [Van Loo, P.] Katholieke Univ Leuven, Louvain, Belgium; [Guglielmelli, P.; Vannucchi, A. M.] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Southampton; University of Southampton; Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Dundee; Saint James's University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Florence	Green, AR (corresponding author), Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	arg1000@cam.ac.uk	Orchard, Kim H/A-3073-2016; Cross, Nicholas/B-4817-2009; Guglielmelli, Paola/K-7509-2016; Wedge, David/AAC-4977-2021; Vannucchi, Alessandro M./K-7499-2016; Kent, David/AAZ-4916-2021; huntly, brian JP/E-6725-2014	Orchard, Kim H/0000-0003-2276-3925; Cross, Nicholas/0000-0001-5481-2555; Guglielmelli, Paola/0000-0003-1809-284X; Vannucchi, Alessandro M./0000-0001-5755-0730; Kent, David/0000-0001-7871-8811; huntly, brian JP/0000-0003-0312-161X; Fitzpatrick, John D./0000-0003-0342-1364; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Martincorena, Inigo/0000-0003-1122-4416; Kollmann, Karoline/0000-0002-7937-4245; Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974; Jones, Amy Victoria/0000-0003-3467-6765; Avezov, Edward/0000-0002-2894-0585; Raine, Keiran/0000-0002-5634-1539; Massie, Charlie/0000-0003-2314-4843; Van Loo, Peter/0000-0003-0292-1949; Green, Anthony/0000-0002-9795-0218; Wedge, David/0000-0002-7572-3196; Du, Ming-Qing/0000-0002-1017-5045	Kay Kendall Leukaemia Fund; Wellcome Trust; Leukemia and Lymphoma Research; Cancer Research UK; National Institute for Health Research Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America; Research Foundation-Flanders; Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative; Canadian Institutes of Health Research; Lady Tata Memorial Trust; Cancer Research UK [15488, 12526, 12765, 8961] Funding Source: researchfish; Medical Research Council [G0300497, 1479733] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10079] Funding Source: researchfish; MRC [G0300497] Funding Source: UKRI	Kay Kendall Leukaemia Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Leukemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Research Foundation-Flanders(FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lady Tata Memorial Trust; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the Kay Kendall Leukaemia Fund (including a clinical research fellowship to Drs. Nangalia and Godfrey), the Wellcome Trust (including fellowships to Drs. Campbell and Ron), Leukemia and Lymphoma Research, Cancer Research UK, the National Institute for Health Research Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia and Lymphoma Society of America; a postdoctoral research grant from the Research Foundation-Flanders (to Dr. Van Loo); a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative (to Drs. Vannucchi and Guglielmelli); and a Canadian Institutes of Health Research Fellowship and the Lady Tata Memorial Trust grant (to Dr. Kent).	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; Ambaglio I, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2755.2755; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Butcher CM, 2008, LEUKEMIA, V22, P870, DOI 10.1038/sj.leu.2404971; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Carbuccia N, 2009, LEUKEMIA, V23, P2183, DOI 10.1038/leu.2009.141; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Godfrey AL, 2012, BLOOD, V120, P2704, DOI 10.1182/blood-2012-05-431791; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lasho TL, 2010, NEW ENGL J MED, V363, P1189, DOI 10.1056/NEJMc1006966; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; McMullin MF, 2007, BRIT J HAEMATOL, V138, P821, DOI 10.1111/j.1365-2141.2007.06741.x; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pardanani A, 2010, LEUKEMIA, V24, P1146, DOI 10.1038/leu.2010.77; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009	41	1213	1285	6	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2391	2405		10.1056/NEJMoa1312542	http://dx.doi.org/10.1056/NEJMoa1312542			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24325359	Green Accepted			2022-12-28	WOS:000328586000007
J	Donze, J; Lipsitz, S; Bates, DW; Schnipper, JL				Donze, Jacques; Lipsitz, Stuart; Bates, David W.; Schnipper, Jeffrey L.			Causes and patterns of readmissions in patients with common comorbidities: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; PHARMACIST INTERVENTION; HOSPITAL READMISSIONS; EXACERBATIONS; VALIDATION; DISCHARGE; DISEASE	Objective To evaluate the primary diagnoses and patterns of 30 day readmissions and potentially avoidable readmissions in medical patients with each of the most common comorbidities. Design Retrospective cohort study. Setting Academic tertiary medical centre in Boston, 2009-10. Participants 10 731 consecutive adult discharges from a medical department. Main outcome measures Primary readmission diagnoses of readmissions within 30 days of discharge and potentially avoidable 30 day readmissions to the index hospital or two other hospitals in its network. Results Among 10 731 discharges, 2398 (22.3%) were followed by a 30 day readmission, of which 858 (8.0%) were identified as potentially avoidable. Overall, infection, neoplasm, heart failure, gastrointestinal disorder, and liver disorder were the most frequent primary diagnoses of potentially avoidable readmissions. Almost all of the top five diagnoses of potentially avoidable readmissions for each comorbidity were possible direct or indirect complications of that comorbidity. In patients with a comorbidity of heart failure, diabetes, ischemic heart disease, atrial fibrillation, or chronic kidney disease, the most common diagnosis of potentially avoidable readmission was acute heart failure. Patients with neoplasm, heart failure, and chronic kidney disease had a higher risk of potentially avoidable readmissions than did those without those comorbidities. Conclusions The five most common primary diagnoses of potentially avoidable readmissions were usually possible complications of an underlying comorbidity. Post-discharge care should focus attention not just on the primary index admission diagnosis but also on the comorbidities patients have.	[Donze, Jacques; Lipsitz, Stuart; Bates, David W.; Schnipper, Jeffrey L.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02120 USA; [Donze, Jacques; Lipsitz, Stuart; Bates, David W.; Schnipper, Jeffrey L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Donze, Jacques] Univ Hosp Bern, Div Gen Internal Med, CH-3010 Bern, Switzerland; [Bates, David W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Schnipper, Jeffrey L.] Brigham & Womens Hosp, BWH Hospitalist Serv, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Bern; University Hospital of Bern; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Donze, J (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Boston, MA 02120 USA.	donze.author@gmail.com	Bates, David/AAE-7283-2019		Swiss National Science Foundation; Swiss Foundation for Medical-Biological Scholarships	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Medical-Biological Scholarships	JD was supported by the Swiss National Science Foundation and the Swiss Foundation for Medical-Biological Scholarships. The Swiss Science National Foundation and the Swiss Foundation for Medical-Biological Scholarships had no role in the design and conduct of this study, the analysis or interpretation of the data, or the preparation of this manuscript.	[Anonymous], 2013, POT AV READM; Chu LW, 1999, GERONTOLOGY, V45, P220, DOI 10.1159/000022091; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gunen H, 2010, EUR RESPIR J, V35, P1243, DOI 10.1183/09031936.00120909; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Maldonado F, 2010, CHEST, V138, P1295, DOI 10.1378/chest.09-2567; Naeije Robert, 2005, Proc Am Thorac Soc, V2, P20, DOI 10.1513/pats.200407-037MS; Schnipper JL, 2010, CIRC-CARDIOVASC QUAL, V3, P212, DOI 10.1161/CIRCOUTCOMES.109.921833; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shetty R, 2008, J THROMB THROMBOLYS, V26, P35, DOI 10.1007/s11239-007-0157-y; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Williams M, ACAD MED IN PRESS; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zekry D, 2012, J AM MED DIR ASSOC, V13, P272, DOI 10.1016/j.jamda.2010.11.011; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	25	132	133	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2013	347								f7171	10.1136/bmj.f7171	http://dx.doi.org/10.1136/bmj.f7171			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277LV	24342737	hybrid, Green Published			2022-12-28	WOS:000328821800002
J	Iddon, J; Dixon, JM				Iddon, Julie; Dixon, J. Michael			Mastalgia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREMENSTRUAL MASTALGIA								Breast Cancer Now [EDN-DIXON] Funding Source: researchfish	Breast Cancer Now		Barros Alfredo Carlos S. D., 1999, Breast J, V5, P162, DOI 10.1046/j.1524-4741.1999.98089.x; BOYD NF, 1988, LANCET, V2, P128, DOI 10.1016/S0140-6736(88)90684-8; Department of Health, 2002, EPINET MESSAGE; GATELEY CA, 1992, BRIT J SURG, V79, P407, DOI 10.1002/bjs.1800790511; GEMB Group Argentine, 1997, BREAST, V5, P212; Halaska M., 1998, CESKA GYNECOLOGIE, V63, P388; Kaleli S, 2001, FERTIL STERIL, V75, P718, DOI 10.1016/S0015-0282(01)01668-5; Kontostolis E, 1997, GYNECOL ENDOCRINOL, V11, P393, DOI 10.3109/09513599709152566; MADDOX PR, 1990, ANN ROY COLL SURG, V72, P71; MANSEL RE, 1982, LANCET, V1, P928; McFayden I.J., 2009, BREAST, V9, P271; Mishra S. K., 1994, National Medical Journal of India, V7, P60; O'Brien PMS, 1999, AM J OBSTET GYNECOL, V180, P18, DOI 10.1016/S0002-9378(99)70142-0; PASHBY NL, 1981, BRIT J SURG, V68, P801; PETERS F, 1981, KLIN WOCHENSCHR, V59, P403, DOI 10.1007/BF01698519; PETERS F, 1992, LANCET, V339, P205, DOI 10.1016/0140-6736(92)90005-N; Schellenberg R, 2001, BRIT MED J, V322, P134, DOI 10.1136/bmj.322.7279.134; Srivastava A, 2007, BREAST, V16, P503, DOI 10.1016/j.breast.2007.03.003	18	19	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2013	347									10.1136/bmj.f3288	http://dx.doi.org/10.1136/bmj.f3288			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZU	24336097				2022-12-28	WOS:000328575600001
J	Johnson, G; Guha, IN; Davies, P				Johnson, Graham; Guha, Indra Neil; Davies, Patrick			CHRISTMAS 2013: RESEARCH Were James Bond's drinks shaken because of alcohol induced tremor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; RISK; DYSFUNCTION	Objective To quantify James Bond's consumption of alcohol as detailed in the series of novels by Ian Fleming. Design Retrospective literature review. Setting The study authors' homes, in a comfy chair. Participants Commander James Bond, 007; Mr Ian Lancaster Fleming. Main outcome measures Weekly alcohol consumption by Commander Bond. Methods All 14 James Bond books were read by two of the authors. Contemporaneous notes were taken detailing every alcoholic drink taken. Predefined alcohol unit levels were used to calculate consumption. Days when Bond was unable to consume alcohol (such as through incarceration) were noted. Results After exclusion of days when Bond was unable to drink, his weekly alcohol consumption was 92 units a week, over four times the recommended amount. His maximum daily consumption was 49.8 units. He had only 12.5 alcohol free days out of 87.5 days on which he was able to drink. Conclusions James Bond's level of alcohol intake puts him at high risk of multiple alcohol related diseases and an early death. The level of functioning as displayed in the books is inconsistent with the physical, mental, and indeed sexual functioning expected from someone drinking this much alcohol. We advise an immediate referral for further assessment and treatment, a reduction in alcohol consumption to safe levels, and suspect that the famous catchphrase "shaken, not stirred" could be because of alcohol induced tremor affecting his hands.	[Johnson, Graham] Royal Derby Hosp, Emergency Dept, Derby, England; [Guha, Indra Neil] Univ Nottingham, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2RD, England; [Davies, Patrick] Nottingham Univ Hosp NHS Trust, Paediat Intens Care Dept, Nottingham, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust	Davies, P (corresponding author), Nottingham Univ Hosp NHS Trust, Paediat Intens Care Dept, Nottingham, England.	patrick.davies@nuh.nhs.uk	Davies, P/L-7923-2019; Guha, Indra Neil/AAR-6347-2020	Guha, Indra Neil/0000-0002-6940-5861; Johnson, Graham/0000-0001-6004-6244				[Anonymous], TREM FACT SHEET; Arackal Bijil Simon, 2007, Indian J Psychiatry, V49, P109, DOI 10.4103/0019-5545.33257; Azagba S, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-15; Bares Martin, 2012, Tremor Other Hyperkinet Mov (N Y), V2; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; Boniface S, 2013, ALCOHOL CLIN EXP RES, V37, P978, DOI 10.1111/acer.12046; Eigenbrodt ML, 2001, AM J EPIDEMIOL, V153, P1102, DOI 10.1093/aje/153.11.1102; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FAHRNER EM, 1987, ARCH SEX BEHAV, V16, P247, DOI 10.1007/BF01541612; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x; Louis ED, 2009, J NEUROL NEUROSUR PS, V80, P494, DOI 10.1136/jnnp.2008.162701; Memes James Bond, DRINKING ENGLAND ANA; OFarrell TJ, 1997, J STUD ALCOHOL, V58, P91, DOI 10.15288/jsa.1997.58.91; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; World Health Organization, 2011, GLOB STAT REP ALC HL	17	14	14	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2013	347								f7255	10.1136/bmj.f7255	http://dx.doi.org/10.1136/bmj.f7255			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273ZQ	24336307	Green Published, hybrid			2022-12-28	WOS:000328575200007
J	Powell, JS; Pasi, KJ; Ragni, MV; Ozelo, MC; Valentino, LA; Mahlangu, JN; Josephson, NC; Perry, D; Manco-Johnson, MJ; Apte, S; Baker, RI; Chan, GC; Novitzky, N; Wong, RS; Krassova, S; Allen, G; Jiang, HY; Innes, A; Li, SL; Cristiano, LM; Goyal, J; Sommer, JM; Dumont, JA; Nugent, K; Vigliani, G; Brennan, A; Luk, A; Pierce, GF				Powell, Jerry S.; Pasi, K. John; Ragni, Margaret V.; Ozelo, Margareth C.; Valentino, Leonard A.; Mahlangu, Johnny N.; Josephson, Neil C.; Perry, David; Manco-Johnson, Marilyn J.; Apte, Shashikant; Baker, Ross I.; Chan, Godfrey C.; Novitzky, Nicolas; Wong, Raymond S.; Krassova, Snejana; Allen, Geoffrey; Jiang, Haiyan; Innes, Alison; Li, Shuanglian; Cristiano, Lynda M.; Goyal, Jaya; Sommer, Jurg M.; Dumont, Jennifer A.; Nugent, Karen; Vigliani, Gloria; Brennan, Aoife; Luk, Alvin; Pierce, Glenn F.		B-LONG Investigators	Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVIOUSLY TREATED PATIENTS; PHARMACOKINETIC PROPERTIES; PROLONGED ACTIVITY; FACTOR-VIII; PROPHYLAXIS; SAFETY; DEFICIENCY; INHIBITORS; MODERATE; DISEASE	BackgroundProphylactic factor replacement in patients with hemophilia B improves outcomes but requires frequent injections. A recombinant factor IX Fc fusion protein (rFIXFc) with a prolonged half-life was developed to reduce the frequency of injections required. MethodsWe conducted a phase 3, nonrandomized, open-label study of the safety, efficacy, and pharmacokinetics of rFIXFc for prophylaxis, treatment of bleeding, and perioperative hemostasis in 123 previously treated male patients. All participants were 12 years of age or older and had severe hemophilia B (endogenous factor IX level of 2 IU per deciliter, or 2% of normal levels). The study included four treatment groups: group 1 received weekly dose-adjusted prophylaxis (50 IU of rFIXFc per kilogram of body weight to start), group 2 received interval-adjusted prophylaxis (100 IU per kilogram every 10 days to start), group 3 received treatment as needed for bleeding episodes (20 to 100 IU per kilogram), and group 4 received treatment in the perioperative period. A subgroup of group 1 underwent comparative sequential pharmacokinetic assessments of recombinant factor IX and rFIXFc. The primary efficacy end point was the annualized bleeding rate, and safety end points included the development of inhibitors and adverse events. ResultsAs compared with recombinant factor IX, rFIXFc exhibited a prolonged terminal half-life (82.1 hours) (P<0.001). The median annualized bleeding rates in groups 1, 2, and 3 were 3.0, 1.4, and 17.7, respectively. In group 2, 53.8% of participants had dosing intervals of 14 days or more during the last 3 months of the study. In groups 1, 2 and 3, 90.4% of bleeding episodes resolved after one injection. Hemostasis was rated as excellent or good during all major surgeries. No inhibitors were detected in any participants receiving rFIXFc; in groups 1, 2, and 3, 73.9% of participants had at least one adverse event, and serious adverse events occurred in 10.9% of participants. These events were mostly consistent with those expected in the general population of patients with hemophilia. ConclusionsProphylactic rFIXFc, administered every 1 to 2 weeks, resulted in low annualized bleeding rates in patients with hemophilia B. (Funded by Biogen Idec; ClinicalTrials.gov number, NCT01027364.)	[Powell, Jerry S.] Univ Calif Davis, Davis, CA 95616 USA; [Pasi, K. John] Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England; [Ragni, Margaret V.] Univ Pittsburgh, Pittsburgh, PA USA; [Ragni, Margaret V.] Hemophilia Ctr Western Penn, Pittsburgh, PA USA; [Ozelo, Margareth C.] Univ Estadual Campinas, INCT Sangue Hemoctr UNICAMP, Campinas, SP, Brazil; [Valentino, Leonard A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Mahlangu, Johnny N.] Univ Witwatersrand, Haemophilia Comprehens Care Ctr, Natl Hlth Lab Serv, Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa; [Novitzky, Nicolas] Univ Cape Town, Sch Med, Comprehens Haemophilia Ctr, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Josephson, Neil C.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Perry, David] Addenbrookes Hosp, Cambridge, England; [Manco-Johnson, Marilyn J.] Univ Colorado, Sch Med, Childrens Hosp, Aurora, CO USA; [Manco-Johnson, Marilyn J.] Univ Colorado, Sch Med, Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO USA; [Apte, Shashikant] Sahyadri Hosp, Dept Hematol, Mahara, India; [Baker, Ross I.] Murdoch Univ, Royal Perth Hosp, Ctr Thrombosis & Haemophilia, Perth, WA, Australia; [Chan, Godfrey C.] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Raymond S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Krassova, Snejana; Allen, Geoffrey; Jiang, Haiyan; Innes, Alison; Li, Shuanglian; Cristiano, Lynda M.; Goyal, Jaya; Sommer, Jurg M.; Dumont, Jennifer A.; Nugent, Karen; Brennan, Aoife; Luk, Alvin; Pierce, Glenn F.] Biogen Idec Hemophilia, Cambridge, MA USA	University of California System; University of California Davis; University of London; Queen Mary University London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Estadual de Campinas; Rush University; National Health Laboratory Service; University of Witwatersrand; University of Cape Town; Puget Sound Blood Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Pierce, GF (corresponding author), Biogen Idec Inc, 225 Binney St, Cambridge, MA 02142 USA.	glenn.pierce@biogenidec.com	Wong, Raymond S. M./H-9644-2016; Mahlangu, Johnny Ndoni/H-7558-2019; Baker, Ross/AAG-5798-2021; VALENTINO, LEONARD A/W-7818-2019; Ozelo, Margareth C/K-5819-2012	Wong, Raymond S. M./0000-0002-9011-4268; Mahlangu, Johnny Ndoni/0000-0001-5781-7669; Baker, Ross/0000-0002-2728-6788; Ozelo, Margareth C/0000-0001-5938-0675; Allen, Geoffrey/0000-0003-4351-1014	Biogen Idec	Biogen Idec(Biogen)	Supported by Biogen Idec.	ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; [Anonymous], 2011, BENEFIX COAG FACT 9; [Anonymous], 2012, GUID CLIN INV REC HU; Chang HH, 2007, J FORMOS MED ASSOC, V106, P281, DOI 10.1016/S0929-6646(09)60253-9; Chitlur M, 2009, HAEMOPHILIA, V15, P1027, DOI 10.1111/j.1365-2516.2009.02039.x; CHMP, 2007, GUID IMM ASS BIOT DE; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dimichele D, 2002, HAEMOPHILIA, V8, P280, DOI 10.1046/j.1365-2516.2002.00626.x; Dimichele DM, 2012, HAEMOPHILIA, V18, P18, DOI 10.1111/j.1365-2516.2012.02824.x; DiMichele D, 2007, BRIT J HAEMATOL, V138, P305, DOI 10.1111/j.1365-2141.2007.06657.x; Ewenstein BM, 2002, TRANSFUSION, V42, P190, DOI 10.1046/j.1537-2995.2002.00039.x; FDA Food and Drug Administration, 2009, GUID IND GU IN PRESS; Giangrande P, 2005, EXPERT OPIN PHARMACO, V6, P1517, DOI 10.1517/14656566.6.9.1517; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Kisker CT, 2003, HAEMOPHILIA, V9, P279, DOI 10.1046/j.1365-2516.2003.00751.x; Klintman J, 2013, HAEMOPHILIA, V19, P106, DOI 10.1111/j.1365-2516.2012.02903.x; Lambert T, 2007, HAEMOPHILIA, V13, P450, DOI 10.1111/j.1365-2516.2007.01513.x; Lambert T, 2007, HAEMOPHILIA, V13, P233, DOI 10.1111/j.1365-2516.2007.01458.x; Lissitchkov T, 2013, HAEMOPHILIA, V19, P674, DOI 10.1111/hae.12148; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mannucci P., 2001, NEW ENGL J MED, V345, P384; Mannucci PM, 2013, EXPERT OPIN INV DRUG, V22, P945, DOI 10.1517/13543784.2013.798302; Martinowitz U, 2012, HAEMOPHILIA, V18, P881, DOI 10.1111/j.1365-2516.2012.02897.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; National Hemophilia Foundation, 179 MED SCI ADV COUN; Negrier C, 2011, BLOOD, V118, P2695, DOI 10.1182/blood-2011-02-335596; NILSSON IM, 1976, ACTA PAEDIATR SCAND, V65, P129, DOI 10.1111/j.1651-2227.1976.tb16525.x; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Panicker J, 2003, HAEMOPHILIA, V9, P272, DOI 10.1046/j.1365-2516.2003.00757.x; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; Pipe SW, 2010, HEMATOL-AM SOC HEMAT, P203, DOI 10.1182/asheducation-2010.1.203; Ragni MV, 2002, HAEMOPHILIA, V8, P91, DOI 10.1046/j.1365-2516.2002.00587.x; Rath T, CRIT REV BIOTECHNOL; Recht M, 2011, HAEMOPHILIA, V17, P494, DOI 10.1111/j.1365-2516.2011.02436.x; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Shapiro AD, 2012, BLOOD, V119, P666, DOI 10.1182/blood-2011-07-367003; Tandra A, 2010, TXB HEMOPHILI, P97; Whelan SFJ, 2013, BLOOD, V121, P1039, DOI 10.1182/blood-2012-07-444877; White GC, 1997, THROMB HAEMOSTASIS, V78, P261	41	251	260	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2313	2323		10.1056/NEJMoa1305074	http://dx.doi.org/10.1056/NEJMoa1305074			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268FV	24304002	Green Published			2022-12-28	WOS:000328156300009
J	Hong, WZ				Hong, Weizhe			Assembly of a Neural Circuit	SCIENCE			English	Editorial Material							CHEMOAFFINITY		CALTECH, Div Biol & Biol Engn, Pasadena, CA 91106 USA	California Institute of Technology	Hong, WZ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91106 USA.	whong@caltech.edu	Hong, Weizhe/AAD-7172-2020; Hong, Weizhe/E-3164-2010	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575				Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Hong WZ, 2014, GENETICS, V196, P17, DOI 10.1534/genetics.113.154336; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	10	0	0	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163								10.1126/science.1247568	http://dx.doi.org/10.1126/science.1247568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311677				2022-12-28	WOS:000327857900032
J	Campbell, J; Colvin, LA				Campbell, James; Colvin, Lesley A.			ABC of Pain Management of Low Back Pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Campbell, James] Royal Infirm Edinburgh NHS Trust, Dept Orthopaed, Edinburgh, Midlothian, Scotland; [Colvin, Lesley A.] Univ Edinburgh, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Campbell, J (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Orthopaed, Edinburgh, Midlothian, Scotland.			Colvin, Lesley/0000-0002-1563-8600				[Anonymous], 2009, ABS SPINAL DISORDERS; Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Cochrane Back Review Group, FREQ UPD REV EV BACK; Eubanks JD, 2007, SPINE, V32, P2058, DOI 10.1097/BRS.0b013e318145a3a9; Gibson JNA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001350.pub4; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Staal JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001824.pub3; [No title captured]	8	2	2	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2013	347								f3148	10.1136/bmj.f3148	http://dx.doi.org/10.1136/bmj.f3148			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DX	24308922				2022-12-28	WOS:000328150000001
J	Deith, J				Deith, Jane			COMMISSIONING A healthy market? Lack of transparency raises doubts about NHS commissioning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												janedeith@yahoo.co.uk							0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2013	347								f7115	10.1136/bmj.f7115	http://dx.doi.org/10.1136/bmj.f7115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DN	24307724				2022-12-28	WOS:000328148900003
